text,title,id,project_number,terms,administration,organization,mechanism,year,funding,score
"FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY During late fetal development, the lung must prepare for the transition to air breathing.  Maintaining alveolar stability becomes vital for survival. Therapy with glucocorticoids to enhance lung maturity may have immediate and long term consequences for lung structure and function.  This series of investigations is directed toward furthering our basic knowledge of lung secretory cell development.  We will use structural and biochemical methods to test hypotheses of secretory cell function and to test the probabilities that glucocorticoids damage fetal and newborn lung structure.  We intend to study biochemical and 3-dimensional morphologic changes during epithelial cell maturation in the last days of fetal development.  We will test hypotheses of the assembly of lamellar bodies and assess the changes in type II cell maturation induced by glucocorticoids.  This drug induced accelerated maturation is a relevant clinical concern as the effects are widespread within the lung and have not been shown to be entirely reversible during postnatal growth.  A detailed 3-dimensional morphologic study of groups of alveolar septa and of terminal bronchiolar structure will be conducted at allow magnification level that will test the microanatomic basis for theories of cell-cell interactions.  ",FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY,3343489,R01HL032188,"['stainings ', ' pulmonary surfactants ', ' lung alveolus ', ' lung ', ' bronchus ', ' respiratory function ', ' embryo /fetus drug adverse effect ', ' gestational age ', ' embryo /fetus ', ' longitudinal animal study ', ' density gradient ultracentrifugation ', ' thin layer chromatography ', ' phospholipids ', ' photography ', ' electron microscopy ', ' morphology ', ' postnatal growth disorder ', ' computer graphics /printing ', ' artificial intelligence ', ' cell morphology ', ' cell differentiation ', ' Golgi apparatus ', ' cell cell interaction ', ' secretion ', ' biochemistry ', ' glucocorticoids ', ' ']",NHLBI,DUKE UNIVERSITY,R01,1985,148451,0.2304313376393357
"A COMPLETE SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP DA This project will develop a computer system for the automated analysis of sleep data which includes the capability for detecting the waveforms normally occurring in the sleep EEG (macroanalysis), and for making a detailed analysis of the waves in these waveforms (microanalysis).  The system will include a data base management system for maintaining a library of processed records from which one can select records sorted for a particular parameter or parameters such are age.  The work will incorporate recent advances in Artificial Intelligence on the design of Expert Systems.  The system will include software which allows the user to communicate with the computer in human language form.  Much of the knowledge and expertise required for the operation of automated sleep analysis systems will be programmed into the computer.  The proposed system will allow all sleep investigators to easily use such a computer.  The Expert System will also serve as a repository for knowledge accumulated by many sleep specialists.  The computer will enable one to obtain a more detailed description of the sleep process than is currently obtained using visual scoring, and it will provide objective data which can be shared by all laboratories.  In addition, the system will provide an economical method for providing sleep analysis to a large subject population.  The Association of Sleep Disorder Centers will supply data and evaluate results of the automated analysis.  The study will assist the establishment of objective criteria for the diagnosis and treatment of sleep disorders.  The resulting system can provide a method for making sleep studies easily and economically available to a broad subject population.  ",A COMPLETE SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP DA,3400143,R01NS019996,"['sleep ', ' sleep disorders ', ' information systems ', ' computer graphics /printing ', ' computer data analysis ', ' online computer ', ' computer system design /evaluation ', ' artificial intelligence ', ' computers ', ' electroencephalography ', ' computer assisted medical decision making ', ' computer assisted diagnosis ', ' ']",NINDS,UNIVERSITY OF FLORIDA,R01,1985,92380,0.12882126692996337
"A COMPLETE SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP DA This project will develop a computer system for the automated analysis of sleep data which includes the capability for detecting the waveforms normally occurring in the sleep EEG (macroanalysis), and for making a detailed analysis of the waves in these waveforms (microanalysis).  The system will include a data base management system for maintaining a library of processed records from which one can select records sorted for a particular parameter or parameters such are age.  The work will incorporate recent advances in Artificial Intelligence on the design of Expert Systems.  The system will include software which allows the user to communicate with the computer in human language form.  Much of the knowledge and expertise required for the operation of automated sleep analysis systems will be programmed into the computer.  The proposed system will allow all sleep investigators to easily use such a computer.  The Expert System will also serve as a repository for knowledge accumulated by many sleep specialists.  The computer will enable one to obtain a more detailed description of the sleep process than is currently obtained using visual scoring, and it will provide objective data which can be shared by all laboratories.  In addition, the system will provide an economical method for providing sleep analysis to a large subject population.  The Association of Sleep Disorder Centers will supply data and evaluate results of the automated analysis.  The study will assist the establishment of objective criteria for the diagnosis and treatment of sleep disorders.  The resulting system can provide a method for making sleep studies easily and economically available to a broad subject population.  ",A COMPLETE SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP DA,3400146,R01NS019996,"['sleep ', ' sleep disorders ', ' information systems ', ' computer graphics /printing ', ' computer data analysis ', ' online computer ', ' computer system design /evaluation ', ' artificial intelligence ', ' computers ', ' electroencephalography ', ' computer assisted medical decision making ', ' computer assisted diagnosis ', ' ']",NINDS,UNIVERSITY OF FLORIDA,R01,1986,93559,0.12882126692996337
"FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY During late fetal development, the lung must prepare for the transition to air breathing.  Maintaining alveolar stability becomes vital for survival. Therapy with glucocorticoids to enhance lung maturity may have immediate and long term consequences for lung structure and function.  This series of investigations is directed toward furthering our basic knowledge of lung secretory cell development.  We will use structural and biochemical methods to test hypotheses of secretory cell function and to test the probabilities that glucocorticoids damage fetal and newborn lung structure.  We intend to study biochemical and 3-dimensional morphologic changes during epithelial cell maturation in the last days of fetal development.  We will test hypotheses of the assembly of lamellar bodies and assess the changes in type II cell maturation induced by glucocorticoids.  This drug induced accelerated maturation is a relevant clinical concern as the effects are widespread within the lung and have not been shown to be entirely reversible during postnatal growth.  A detailed 3-dimensional morphologic study of groups of alveolar septa and of terminal bronchiolar structure will be conducted at allow magnification level that will test the microanatomic basis for theories of cell-cell interactions.  ",FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY,3343490,R01HL032188,"['stainings ', ' pulmonary surfactants ', ' lung alveolus ', ' lung ', ' bronchus ', ' respiratory function ', ' embryo /fetus drug adverse effect ', ' gestational age ', ' embryo /fetus ', ' longitudinal animal study ', ' density gradient ultracentrifugation ', ' thin layer chromatography ', ' phospholipids ', ' photography ', ' electron microscopy ', ' morphology ', ' postnatal growth disorder ', ' computer graphics /printing ', ' artificial intelligence ', ' cell morphology ', ' cell differentiation ', ' Golgi apparatus ', ' cell cell interaction ', ' secretion ', ' biochemistry ', ' glucocorticoids ', ' ']",NHLBI,DUKE UNIVERSITY,R01,1986,145910,0.2304313376393357
"FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY During late fetal development, the lung must prepare for the transition to air breathing.  Maintaining alveolar stability becomes vital for survival. Therapy with glucocorticoids to enhance lung maturity may have immediate and long term consequences for lung structure and function.  This series of investigations is directed toward furthering our basic knowledge of lung secretory cell development.  We will use structural and biochemical methods to test hypotheses of secretory cell function and to test the probabilities that glucocorticoids damage fetal and newborn lung structure.  We intend to study biochemical and 3-dimensional morphologic changes during epithelial cell maturation in the last days of fetal development.  We will test hypotheses of the assembly of lamellar bodies and assess the changes in type II cell maturation induced by glucocorticoids.  This drug induced accelerated maturation is a relevant clinical concern as the effects are widespread within the lung and have not been shown to be entirely reversible during postnatal growth.  A detailed 3-dimensional morphologic study of groups of alveolar septa and of terminal bronchiolar structure will be conducted at allow magnification level that will test the microanatomic basis for theories of cell-cell interactions.  ",FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY,3343486,R01HL032188,"['stainings ', ' pulmonary surfactants ', ' lung alveolus ', ' lung ', ' bronchus ', ' respiratory function ', ' embryo /fetus drug adverse effect ', ' gestational age ', ' embryo /fetus ', ' longitudinal animal study ', ' density gradient ultracentrifugation ', ' thin layer chromatography ', ' phospholipids ', ' photography ', ' electron microscopy ', ' morphology ', ' postnatal growth disorder ', ' computer graphics /printing ', ' artificial intelligence ', ' cell morphology ', ' cell differentiation ', ' Golgi apparatus ', ' cell cell interaction ', ' secretion ', ' biochemistry ', ' glucocorticoids ', ' ']",NHLBI,DUKE UNIVERSITY,R01,1987,160617,0.2304313376393357
"A COMPLETE SYSTEM FOR AUTOMATED ANALYSIS OF SLEEP DATA This project will develop a computer system for the automated analysis of sleep data including EEG, EOG, EMG, and respiration signals.  The system will include a data base management system for maintaining a library of processed records from which one can select records sorted for a particular parameter or parameters such as age.  The work will incorporate recent advances in Artificial Intelligence on the design of Expert Systems.  The system will include software which allows the user to communicate with the computer in human language form.  Much of the knowledge and expertise required for the operation of automated sleep analysis systems will be programmed into the computer.  The system will also serve as a repository for knowledge accumulated by many sleep specialists.  The computer will enable one to obtain a more detailed description of the sleep process than is currently obtained using visual scoring, and it will provide objective data which can be shared by all laboratories.  In addition, the system will provide objective data which can be shared by all laboratories.  In addition, the system will provide an economical method for providing sleep analysis to a large subject population.  The system is to be evaluated with sleep records, a magnetic tape, which has been hand scored by three independent laboratories.  In addition to EEG/EOG/EMG data the system will analyze respiration patterns, oxygen saturation levels, heart rate and leg myoclonus.  The study will assist the establishment of objective criteria for the diagnosis and treatment of sleep disorders.  The resulting system can provide a method for making sleep studies easily and economically available to a broad subject population.  ",A COMPLETE SYSTEM FOR AUTOMATED ANALYSIS OF SLEEP DATA,3400145,R01NS019996,"['respiratory gas level ', ' pulmonary respiration ', ' respiratory center dysfunction ', ' REM sleep ', ' sleep ', ' myoclonus ', ' sleep disorders ', ' electromyography ', ' heart rate ', ' electrooculography ', ' computer simulation ', ' computer graphics /printing ', ' online computer ', ' computer human interaction ', ' computer system design /evaluation ', ' artificial intelligence ', ' electroencephalography ', ' computer assisted diagnosis ', ' biomedical automation ', ' biomedical registry /referral center ', ' ']",NINDS,UNIVERSITY OF FLORIDA,R01,1987,82523,0.11984777288217045
"ASSAY OF NUCLEOSIDES IN SMALL CELL CARCINOMA OF THE LUNG Several investigators have implicated modified ribonucleosides presumably modification products from transfer ribonucleic acids (tRNA's) as potential biological markers for cancer.  Elevated levels of these molecules have been quantitated in the serum or urine of cancer patients by HPLCUV or immunoassay.  In this proposal we will demonstrate the feasability of preparation of antibodies to two common modified nucleosides and the development of an immunoassay for their easy quantitation. Additionally, the levels of 30 modified nucleosides will be determined in the serum from lung cancer patients and normal controls.  These data will be subjected to pattern recognition analysis to develop a profile of selected serum modified nucleoside concentrations which can define a biological marker(s) for lung cancer.  An immunoassay diagnostic kit will be developed for detection of these biomarkers with attributes of high sensitivity and specificity.  ",ASSAY OF NUCLEOSIDES IN SMALL CELL CARCINOMA OF THE LUNG,3491790,R43CA045844,"['high performance liquid chromatography ', ' nucleosides ', ' transfer RNA ', ' small cell lung cancer ', ' neoplasm /cancer immunodiagnosis ', ' human tissue ', ' artificial intelligence ', ' ']",NCI,"IMBIC, INC.",R43,1987,50000,0.13857871697224142
"A COMPLETE SYSTEM FOR AUTOMATED ANALYSIS OF SLEEP DATA This project will develop a computer system for the automated analysis of sleep data including EEG, EOG, EMG, and respiration signals.  The system will include a data base management system for maintaining a library of processed records from which one can select records sorted for a particular parameter or parameters such as age.  The work will incorporate recent advances in Artificial Intelligence on the design of Expert Systems.  The system will include software which allows the user to communicate with the computer in human language form.  Much of the knowledge and expertise required for the operation of automated sleep analysis systems will be programmed into the computer.  The system will also serve as a repository for knowledge accumulated by many sleep specialists.  The computer will enable one to obtain a more detailed description of the sleep process than is currently obtained using visual scoring, and it will provide objective data which can be shared by all laboratories.  In addition, the system will provide objective data which can be shared by all laboratories.  In addition, the system will provide an economical method for providing sleep analysis to a large subject population.  The system is to be evaluated with sleep records, a magnetic tape, which has been hand scored by three independent laboratories.  In addition to EEG/EOG/EMG data the system will analyze respiration patterns, oxygen saturation levels, heart rate and leg myoclonus.  The study will assist the establishment of objective criteria for the diagnosis and treatment of sleep disorders.  The resulting system can provide a method for making sleep studies easily and economically available to a broad subject population.  ",A COMPLETE SYSTEM FOR AUTOMATED ANALYSIS OF SLEEP DATA,3400147,R01NS019996,"['respiratory gas level ', ' pulmonary respiration ', ' respiratory center dysfunction ', ' REM sleep ', ' sleep ', ' myoclonus ', ' sleep disorders ', ' electromyography ', ' heart rate ', ' electrooculography ', ' computer simulation ', ' computer graphics /printing ', ' online computer ', ' computer human interaction ', ' computer system design /evaluation ', ' artificial intelligence ', ' electroencephalography ', ' computer assisted diagnosis ', ' biomedical automation ', ' biomedical registry /referral center ', ' ']",NINDS,UNIVERSITY OF FLORIDA,R01,1988,76930,0.11984777288217045
"COMPUTER SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP A system for the objective analysis of physiological data (EEG, EMG, EOG, NPT, periodic leg movements, respiration, oxygen saturation level, and body temperature) occurring during sleep, is to be designed and evaluated.  The system will include a token generator (signal processor) interfaced to a host computer.  The token generator will detect and quantify the waveforms of interest and transmit the information to the host computer.  The host (a personal computer based system) will be designed using an expert system design shell and will include a knowledge base, knowledge base editor, user interface, interactive graphics and a data base management system.  The result will be a system easy to use by operators not familiar with computers or signal processing and one which can readily be expanded as more knowledge about the system and sleep analysis are acquired.  The research will include systematic studies, by two independent sleep laboratories, to demonstrate the utility and validity of the information obtained from automated analysis.  These studies will also provide information which will be used to further improve the system design.  The resulting system will provide a much more detailed description of the sleep process than is now possible, increase standardization of sleep studies, and provide a means for bringing sleep studies to a larger patient population.  ",COMPUTER SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP,3508966,R44MH041679,"['sleep ', ' electromyography ', ' electrooculography ', ' computer graphics /printing ', ' computer system design /evaluation ', ' artificial intelligence ', ' electroencephalography ', ' patient monitoring device ', ' clinical biomedical equipment ', ' ']",NIMH,MICROTRONICS,R44,1988,206001,0.10675689138111545
"FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY During late fetal development, the lung must prepare for the transition to air breathing.  Maintaining alveolar stability becomes vital for survival. Therapy with glucocorticoids to enhance lung maturity may have immediate and long term consequences for lung structure and function.  This series of investigations is directed toward furthering our basic knowledge of lung secretory cell development.  We will use structural and biochemical methods to test hypotheses of secretory cell function and to test the probabilities that glucocorticoids damage fetal and newborn lung structure.  We intend to study biochemical and 3-dimensional morphologic changes during epithelial cell maturation in the last days of fetal development.  We will test hypotheses of the assembly of lamellar bodies and assess the changes in type II cell maturation induced by glucocorticoids.  This drug induced accelerated maturation is a relevant clinical concern as the effects are widespread within the lung and have not been shown to be entirely reversible during postnatal growth.  A detailed 3-dimensional morphologic study of groups of alveolar septa and of terminal bronchiolar structure will be conducted at allow magnification level that will test the microanatomic basis for theories of cell-cell interactions.  ",FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY,3343491,R01HL032188,"['stainings ', ' pulmonary surfactants ', ' lung alveolus ', ' lung ', ' bronchus ', ' respiratory function ', ' elastin ', ' collagen ', ' embryo /fetus drug adverse effect ', ' gestational age ', ' embryo /fetus ', ' longitudinal animal study ', ' density gradient ultracentrifugation ', ' thin layer chromatography ', ' phospholipids ', ' photography ', ' electron microscopy ', ' morphology ', ' postnatal growth disorder ', ' computer graphics /printing ', ' artificial intelligence ', ' cell morphology ', ' cell differentiation ', ' Golgi apparatus ', ' cell cell interaction ', ' secretion ', ' biochemistry ', ' laboratory rat ', ' glucocorticoids ', ' ']",NHLBI,DUKE UNIVERSITY,R01,1988,163405,0.2304313376393357
"FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY During late fetal development, the lung must prepare for the transition to air breathing.  Maintaining alveolar stability becomes vital for survival. Therapy with glucocorticoids to enhance lung maturity may have immediate and long term consequences for lung structure and function.  This series of investigations is directed toward furthering our basic knowledge of lung secretory cell development.  We will use structural and biochemical methods to test hypotheses of secretory cell function and to test the probabilities that glucocorticoids damage fetal and newborn lung structure.  We intend to study biochemical and 3-dimensional morphologic changes during epithelial cell maturation in the last days of fetal development.  We will test hypotheses of the assembly of lamellar bodies and assess the changes in type II cell maturation induced by glucocorticoids.  This drug induced accelerated maturation is a relevant clinical concern as the effects are widespread within the lung and have not been shown to be entirely reversible during postnatal growth.  A detailed 3-dimensional morphologic study of groups of alveolar septa and of terminal bronchiolar structure will be conducted at allow magnification level that will test the microanatomic basis for theories of cell-cell interactions.  ",FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY,3343492,R01HL032188,"['stainings ', ' pulmonary surfactants ', ' lung alveolus ', ' lung ', ' bronchus ', ' respiratory function ', ' elastin ', ' collagen ', ' embryo /fetus drug adverse effect ', ' gestational age ', ' embryo /fetus ', ' longitudinal animal study ', ' density gradient ultracentrifugation ', ' thin layer chromatography ', ' phospholipids ', ' photography ', ' electron microscopy ', ' morphology ', ' postnatal growth disorder ', ' computer graphics /printing ', ' artificial intelligence ', ' cell morphology ', ' cell differentiation ', ' Golgi apparatus ', ' cell cell interaction ', ' secretion ', ' biochemistry ', ' laboratory rat ', ' glucocorticoids ', ' ']",NHLBI,DUKE UNIVERSITY,R01,1989,161057,0.2304313376393357
"COMPUTER SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP A system for the objective analysis of physiological data (EEG, EMG, EOG, NPT, periodic leg movements, respiration, oxygen saturation level, and body temperature) occurring during sleep, is to be designed and evaluated.  The system will include a token generator (signal processor) interfaced to a host computer.  The token generator will detect and quantify the waveforms of interest and transmit the information to the host computer.  The host (a personal computer based system) will be designed using an expert system design shell and will include a knowledge base, knowledge base editor, user interface, interactive graphics and a data base management system.  The result will be a system easy to use by operators not familiar with computers or signal processing and one which can readily be expanded as more knowledge about the system and sleep analysis are acquired.  The research will include systematic studies, by two independent sleep laboratories, to demonstrate the utility and validity of the information obtained from automated analysis.  These studies will also provide information which will be used to further improve the system design.  The resulting system will provide a much more detailed description of the sleep process than is now possible, increase standardization of sleep studies, and provide a means for bringing sleep studies to a larger patient population.  ",COMPUTER SYSTEM FOR THE AUTOMATED ANALYSIS OF SLEEP,3508967,R44MH041679,"['sleep ', ' electromyography ', ' electrooculography ', ' computer graphics /printing ', ' computer system design /evaluation ', ' artificial intelligence ', ' electroencephalography ', ' patient monitoring device ', ' clinical biomedical equipment ', ' ']",NIMH,MICROTRONICS,R44,1989,293999,0.10675689138111545
"A COMPLETE SYSTEM FOR AUTOMATED ANALYSIS OF SLEEP DATA This project will develop a computer system for the automated analysis of sleep data including EEG, EOG, EMG, and respiration signals.  The system will include a data base management system for maintaining a library of processed records from which one can select records sorted for a particular parameter or parameters such as age.  The work will incorporate recent advances in Artificial Intelligence on the design of Expert Systems.  The system will include software which allows the user to communicate with the computer in human language form.  Much of the knowledge and expertise required for the operation of automated sleep analysis systems will be programmed into the computer.  The system will also serve as a repository for knowledge accumulated by many sleep specialists.  The computer will enable one to obtain a more detailed description of the sleep process than is currently obtained using visual scoring, and it will provide objective data which can be shared by all laboratories.  In addition, the system will provide objective data which can be shared by all laboratories.  In addition, the system will provide an economical method for providing sleep analysis to a large subject population.  The system is to be evaluated with sleep records, a magnetic tape, which has been hand scored by three independent laboratories.  In addition to EEG/EOG/EMG data the system will analyze respiration patterns, oxygen saturation levels, heart rate and leg myoclonus.  The study will assist the establishment of objective criteria for the diagnosis and treatment of sleep disorders.  The resulting system can provide a method for making sleep studies easily and economically available to a broad subject population.  ",A COMPLETE SYSTEM FOR AUTOMATED ANALYSIS OF SLEEP DATA,3400148,R01NS019996,"['respiratory gas level ', ' pulmonary respiration ', ' respiratory center dysfunction ', ' REM sleep ', ' sleep ', ' myoclonus ', ' sleep disorders ', ' electromyography ', ' heart rate ', ' electrooculography ', ' computer simulation ', ' computer graphics /printing ', ' online computer ', ' computer human interaction ', ' computer system design /evaluation ', ' artificial intelligence ', ' electroencephalography ', ' computer assisted diagnosis ', ' biomedical automation ', ' biomedical registry /referral center ', ' ']",NINDS,UNIVERSITY OF FLORIDA,R01,1989,78890,0.11984777288217045
"FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY During late fetal development, the lung must prepare for the transition to air breathing.  Maintaining alveolar stability becomes vital for survival. Therapy with glucocorticoids to enhance lung maturity may have immediate and long term consequences for lung structure and function.  This series of investigations is directed toward furthering our basic knowledge of lung secretory cell development.  We will use structural and biochemical methods to test hypotheses of secretory cell function and to test the probabilities that glucocorticoids damage fetal and newborn lung structure.  We intend to study biochemical and 3-dimensional morphologic changes during epithelial cell maturation in the last days of fetal development.  We will test hypotheses of the assembly of lamellar bodies and assess the changes in type II cell maturation induced by glucocorticoids.  This drug induced accelerated maturation is a relevant clinical concern as the effects are widespread within the lung and have not been shown to be entirely reversible during postnatal growth.  A detailed 3-dimensional morphologic study of groups of alveolar septa and of terminal bronchiolar structure will be conducted at allow magnification level that will test the microanatomic basis for theories of cell-cell interactions.  ",FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY,3343493,R01HL032188,"['stainings ', ' pulmonary surfactants ', ' lung alveolus ', ' lung ', ' bronchus ', ' respiratory function ', ' elastin ', ' collagen ', ' embryo /fetus drug adverse effect ', ' gestational age ', ' embryo /fetus ', ' longitudinal animal study ', ' density gradient ultracentrifugation ', ' thin layer chromatography ', ' phospholipids ', ' photography ', ' electron microscopy ', ' morphology ', ' postnatal growth disorder ', ' computer graphics /printing ', ' artificial intelligence ', ' cell morphology ', ' cell differentiation ', ' Golgi apparatus ', ' cell cell interaction ', ' secretion ', ' biochemistry ', ' laboratory rat ', ' glucocorticoids ', ' ']",NHLBI,DUKE UNIVERSITY,R01,1990,151746,0.2304313376393357
"FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY During late fetal development, the lung must prepare for the transition to air breathing.  Maintaining alveolar stability becomes vital for survival. Therapy with glucocorticoids to enhance lung maturity may have immediate and long term consequences for lung structure and function.  This series of investigations is directed toward furthering our basic knowledge of lung secretory cell development.  We will use structural and biochemical methods to test hypotheses of secretory cell function and to test the probabilities that glucocorticoids damage fetal and newborn lung structure.  We intend to study biochemical and 3-dimensional morphologic changes during epithelial cell maturation in the last days of fetal development.  We will test hypotheses of the assembly of lamellar bodies and assess the changes in type II cell maturation induced by glucocorticoids.  This drug induced accelerated maturation is a relevant clinical concern as the effects are widespread within the lung and have not been shown to be entirely reversible during postnatal growth.  A detailed 3-dimensional morphologic study of groups of alveolar septa and of terminal bronchiolar structure will be conducted at allow magnification level that will test the microanatomic basis for theories of cell-cell interactions.  ",FETAL LUNG BIOCHEMISTRY AND 3-DIMENSIONAL MICROANATOMY,3343494,R01HL032188,"['stainings ', ' pulmonary surfactants ', ' lung alveolus ', ' lung ', ' bronchus ', ' respiratory function ', ' elastin ', ' collagen ', ' embryo /fetus drug adverse effect ', ' gestational age ', ' embryo /fetus ', ' longitudinal animal study ', ' density gradient ultracentrifugation ', ' thin layer chromatography ', ' phospholipids ', ' photography ', ' electron microscopy ', ' morphology ', ' postnatal growth disorder ', ' computer graphics /printing ', ' artificial intelligence ', ' cell morphology ', ' cell differentiation ', ' Golgi apparatus ', ' cell cell interaction ', ' secretion ', ' biochemistry ', ' laboratory rat ', ' glucocorticoids ', ' ']",NHLBI,DUKE UNIVERSITY,R01,1991,155251,0.2304313376393357
"DEVELOPMENT OF A PORTABLE, UNATTENDED EEG/SLEEP DEVICE A portable, inexpensive EEG/Sleep Recorder with no moving parts that can be used in patients' homes and hospital rooms will be designed and validated. Phase I research will focus on software necessary for data compression and ""intelligent"" monitoring of input signals to assure the quality of data collected with unattended operation.  This technology will address the need of the growing field of sleep medicine to diagnose sleep disorders with greater efficiency and less expense.  The portable sleep monitor will have no moving parts and will rely on random access memory for digitized data storage.  The microprocessor-based device will be programmed to evaluate signals from transducers and to accept data only from the best of redundant sets.  This strategy will increase the useful data yield of unattended operation.  In addition, data compression techniques will reduce the amount of memory and battery power necessary to store 8 hours of polysomnographic data.  This technology can also be applied to psychophysiological monitoring of circadian rhythms and extended performance, to long-term evaluation of breathing disorders, and to studies of worker health and performance in critical industries.  ","DEVELOPMENT OF A PORTABLE, UNATTENDED EEG/SLEEP DEVICE",3504667,R43NS031062,"['respiratory gas analyzer ', ' respiratory airflow measurement ', ' sleep ', ' sleep disorders ', ' data collection ', ' electrocardiography ', ' electrooculography ', ' computer simulation ', ' computer program /software ', ' artificial intelligence ', ' electroencephalography ', ' patient monitoring device ', ' biomedical equipment development ', ' clinical biomedical equipment ', ' ']",NINDS,TELEFACTOR CORPORATION,R43,1992,49978,0.053360880164739964
"HYBRID LUNG NODULE DETECTION SYSTEM A hardware-based Hybrid Lung Nodule Detection System is proposed for improving diagnostic accuracy and speed for lung cancerous pulmonary radiology.  The configuration of the proposed system includes the following processing phases:  (1) data acquisition and pre-processing, in order to reduce and to enhance the figure-background contrast; (2) quick selection of nodule suspects based upon the most prominent feature of nodules, the disc shape; and (3) complete feature space determination and neural classification of nodules.  Our R&D work is aimed on extending existing digital processing techniques, developing new ones, and introducing robust Artificial Neural Network (ANN) architectures in the detection and classification of nodules.  In this project, we would like (1) to automate the feature extraction and lung texture analysis techniques in ways that will improve the speed and accuracy of selection of suspect nodules; (2) to analyze the detailed suspect nodules and to derive the additional relevant parameters and characteristic patterns, which subsequently are used for the classification task; and (3) to test and assess the performance of the developed hybrid (digital/neural) computation system.  A multistage ANN architecture involving early supervised learning processing stage (e.g., a back propagation stage) followed by self-adaptive output stage (e.g., a Kohonen feature map stage) is currently being investigated to serve as a basis for testing the proposed Hybrid Lung Nodule Detection System.  this project will eventually lead to an efficient, cost-effective, robust, and hardware-based system for improvement of the accuracy and speed in nodule detection.  It will also provide the basis for further development in other areas of diagnostic radiology.  ",HYBRID LUNG NODULE DETECTION SYSTEM,3493204,R43CA058116,"['digital imaging ', ' image processing ', ' image enhancement ', ' lung neoplasms ', ' neoplasm /cancer radiodiagnosis ', ' data collection ', ' automated data processing ', ' diagnosis design /evaluation ', ' computer system design /evaluation ', ' artificial intelligence ', ' computer assisted diagnosis ', ' ']",NCI,CAELUM RESEARCH CORPORATION,R43,1992,50000,0.15002582683629684
"RADIOGRAPHIC IMAGING FOR CANCER DIAGNOSIS The goal of the proposed research is to develop computer-aided diagnostic (CAD) schemes for detection of lung nodules, interstitial infiltrates, cardiomegaly and pneumothoraces in digital chest images.  We plan to develop advanced computerized schemes and software for improvements in sensitivities, specificities and efficiencies in order to implement and evaluate such schemes in a controlled clinical environment.  We believe that these computer-aided diagnostic schemes, which provide the radiologist with the location and/or quantitative measures of highly suspected lesions, have the potential to improve diagnostic accuracy in the detection of cancer by reducing human errors associated with radiologic diagnosis.  Specifically, we plan to (1)  develop an improved scheme for automated detection of lung nodules by (a) combinations of linear and nonlinear morphological filtering techniques based on a difference image method for enhancement and suppression of lung nodules, (b) reduction of false positive detections by detailed analysis of image features by chest radiologists and also use of artificial neural networks, and (c) observer performance studies for optimal use of CAD methods; (2) develop an improved scheme for automated lung texture analysis by (a) devising an automated technique for sampling numerous regions of interest (R01s) in lung fields, (b) investigation of new texture measures based on analysis of the shape and anisotropic properties of the power spectrum of lung textures, and (c) application of artificial neural networks for detection and classification of interstitial infiltrates; (3) develop an improved scheme for automated analysis of sizes of heart and lung by (a) employing an iterative fitting technique on cardiac contours, using a shift-variant cosine function as a model for the cardiac contour, and histogram analysis, and (b) comparison of radiologists' performances with and without the CAD scheme by means of receiver operating characteristic (ROC) analysis; (4) develop an automated scheme for detection of pneumothorax by (a) application of the Hough transform in conjunction with an edge enhancement technique for detection of subtle curved line, and (b) ROC analysis of radiologists' performances for evaluation of the usefulness of the CAD scheme; and (5) implement and evaluate the CAD schemes i a high-resolution, high-speed image processing system by (a) development of a prototype intelligent workstation with efficient algorithms and efficient man-machine interfaces, and (b) carrying out pilot studies on clinical evaluation of our chest CAD schemes in comparison with conventional readings in terms of the four types of abnormalities related to lung nodules, interstitial infiltrates, cardiomegaly and pneumothoraces.  ",RADIOGRAPHIC IMAGING FOR CANCER DIAGNOSIS,3166584,R01CA024806,"['digital imaging ', ' stereoradiography ', ' image processing ', ' image enhancement ', ' lung neoplasms ', ' neoplasm /cancer radiodiagnosis ', ' human subject ', ' heart dimension /size ', ' disease /disorder classification ', ' diagnosis design /evaluation ', ' diagnosis quality /standard ', ' computer simulation ', ' computer program /software ', ' artificial intelligence ', ' computer assisted diagnosis ', ' clinical biomedical equipment ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,1993,49999,0.19772102545779144
"RADIOGRAPHIC IMAGING FOR CANCER DIAGNOSIS The goal of the proposed research is to develop computer-aided diagnostic (CAD) schemes for detection of lung nodules, interstitial infiltrates, cardiomegaly and pneumothoraces in digital chest images.  We plan to develop advanced computerized schemes and software for improvements in sensitivities, specificities and efficiencies in order to implement and evaluate such schemes in a controlled clinical environment.  We believe that these computer-aided diagnostic schemes, which provide the radiologist with the location and/or quantitative measures of highly suspected lesions, have the potential to improve diagnostic accuracy in the detection of cancer by reducing human errors associated with radiologic diagnosis.  Specifically, we plan to (1)  develop an improved scheme for automated detection of lung nodules by (a) combinations of linear and nonlinear morphological filtering techniques based on a difference image method for enhancement and suppression of lung nodules, (b) reduction of false positive detections by detailed analysis of image features by chest radiologists and also use of artificial neural networks, and (c) observer performance studies for optimal use of CAD methods; (2) develop an improved scheme for automated lung texture analysis by (a) devising an automated technique for sampling numerous regions of interest (R01s) in lung fields, (b) investigation of new texture measures based on analysis of the shape and anisotropic properties of the power spectrum of lung textures, and (c) application of artificial neural networks for detection and classification of interstitial infiltrates; (3) develop an improved scheme for automated analysis of sizes of heart and lung by (a) employing an iterative fitting technique on cardiac contours, using a shift-variant cosine function as a model for the cardiac contour, and histogram analysis, and (b) comparison of radiologists' performances with and without the CAD scheme by means of receiver operating characteristic (ROC) analysis; (4) develop an automated scheme for detection of pneumothorax by (a) application of the Hough transform in conjunction with an edge enhancement technique for detection of subtle curved line, and (b) ROC analysis of radiologists' performances for evaluation of the usefulness of the CAD scheme; and (5) implement and evaluate the CAD schemes i a high-resolution, high-speed image processing system by (a) development of a prototype intelligent workstation with efficient algorithms and efficient man-machine interfaces, and (b) carrying out pilot studies on clinical evaluation of our chest CAD schemes in comparison with conventional readings in terms of the four types of abnormalities related to lung nodules, interstitial infiltrates, cardiomegaly and pneumothoraces.  ",RADIOGRAPHIC IMAGING FOR CANCER DIAGNOSIS,2087299,R01CA024806,"['digital imaging ', ' stereoradiography ', ' image processing ', ' image enhancement ', ' lung neoplasms ', ' neoplasm /cancer radiodiagnosis ', ' human subject ', ' heart dimension /size ', ' disease /disorder classification ', ' diagnosis design /evaluation ', ' diagnosis quality /standard ', ' computer simulation ', ' computer program /software ', ' artificial intelligence ', ' computer assisted diagnosis ', ' clinical biomedical equipment ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,1994,49685,0.19772102545779144
"CONSULTATION SYSTEM FOR LUNG NODULE DETECTION This project aims to develop a computer-assisted consultation system for clinical radiologists in the detection of lung nodules (cancer) on chest radiographs. An automated screening of digital chest radiographs can be further developed when this system is fully tested in various clinical settings. The success of this project will inspire revolutionary improvements in other cancer diagnostic procedures through further research and development. We have demonstrated that the newly developed ""vision type"" neural network and training methods for the detection of lung nodules are also applicable to the detection of microcalcifications on mammograms by presenting microcalcification patterns in the training.  The proposed pre-scan methods and vision type neural networks simulate radiologists' routine practices in reading chest radiographs. Radiologists' viewing patterns and decision making processes will be modeled and converted to computer readable form. Preliminary studies have shown the promise of this approach. The Phase I study will address issues related to the differentiation of end-on vessels from true nodules. The plan of the Phase H study is to (i) analyze the learning patterns of the vision type neural network, (ii) consolidate the research outcome of the neural network learning, and (iii) implement a prototype consultation system for clinical use.  ",CONSULTATION SYSTEM FOR LUNG NODULE DETECTION,3493681,R43CA062816,"['method development ', ' digital imaging ', ' thoracic radiography ', ' image processing ', ' lung neoplasms ', ' neoplasm /cancer diagnosis ', ' artificial intelligence ', ' computer assisted diagnosis ', ' ']",NCI,ADVANCED APPLICATIONS CORPORATION,R43,1994,53120,0.09760108449899299
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY The goal of the proposed research is to develop computer-aided diagnostic  (CAD) schemes for detection of lung nodules, interstitial infiltrates, and  pneumothoraces in digital chest images. We plan to develop advanced  computerized schemes and software for improvements in sensitivity,  specificity and efficiency in order to implement and evaluate such schemes  in a controlled clinical environment. We believe that these computer-aided  diagnostic schemes, which provide the radiologist with the location and/or  quantitative measures of highly suspected lesions, have the potential to  improve diagnostic accuracy in the detection of cancer by reducing human  errors associated with radiologic diagnoses.    Specifically, we plan to (l) develop an improved scheme for automated  detection of lung nodules by (a) combinations of linear and nonlinear  morphological filtering techniques based on a difference image method for  enhancement and suppression of lung nodules, (b) reduction of false  positive detections by detailed analysis of image features by chest  radiologists and also use of artificial neural networks, (c) analysis of  posterior ribs for reduction of false positives, (d) application of  wavelet transform for increasing the sensitivity, and (e) observer  performance studies for optimal use of CAD methods; (2) develop an  improved scheme for automated lung texture analysis by (a) devising an  automated technique for sampling numerous regions of interest (ROIs) in  the lung fields, (b) investigation of new texture measures based on  analysis of the shape and anisotropic properties of the power spectrum of  lung textures, and (c) application of artificial neural networks for  detection and classification of interstitial infiltrates; (3) develop an  automated scheme for detection of pneumothorax by (a) application of the  Hough transform in conjunction with an edge enhancement technique for  detection of subtle curved lines, and (b) ROC analysis of radiologists'  performances for evaluation of the usefulness of the CAD scheme; and (4)  implement and evaluate the CAD schemes in a high-resolution. high-speed  image processing system by (a) development of a prototype intelligent  workstation with efficient algorithms and efficient man-machine  interfaces, and (b) carrying out pilot studies on clinical evaluation of  our chest CAD schemes in comparison with conventional readings in terms of  the three types of abnormalities related to lung nodules, interstitial  infiltrates, and pneumothoraces.  ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,2104011,R01CA062625,"['human data ', ' digital imaging ', ' thoracic radiography ', ' image processing ', ' lung neoplasms ', ' neoplasm /cancer radiodiagnosis ', ' disease /disorder classification ', ' computer human interaction ', ' computer system design /evaluation ', ' artificial intelligence ', ' pneumothorax disorder ', ' computer assisted diagnosis ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,1995,336226,0.18673936384821674
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY The goal of the proposed research is to develop computer-aided diagnostic        (CAD) schemes for detection of lung nodules, interstitial infiltrates, and       pneumothoraces in digital chest images. We plan to develop advanced              computerized schemes and software for improvements in sensitivity,               specificity and efficiency in order to implement and evaluate such schemes       in a controlled clinical environment. We believe that these computer-aided       diagnostic schemes, which provide the radiologist with the location and/or       quantitative measures of highly suspected lesions, have the potential to         improve diagnostic accuracy in the detection of cancer by reducing human         errors associated with radiologic diagnoses.                                                                                                                      Specifically, we plan to (l) develop an improved scheme for automated            detection of lung nodules by (a) combinations of linear and nonlinear            morphological filtering techniques based on a difference image method for        enhancement and suppression of lung nodules, (b) reduction of false              positive detections by detailed analysis of image features by chest              radiologists and also use of artificial neural networks, (c) analysis of         posterior ribs for reduction of false positives, (d) application of              wavelet transform for increasing the sensitivity, and (e) observer               performance studies for optimal use of CAD methods; (2) develop an               improved scheme for automated lung texture analysis by (a) devising an           automated technique for sampling numerous regions of interest (ROIs) in          the lung fields, (b) investigation of new texture measures based on              analysis of the shape and anisotropic properties of the power spectrum of        lung textures, and (c) application of artificial neural networks for             detection and classification of interstitial infiltrates; (3) develop an         automated scheme for detection of pneumothorax by (a) application of the         Hough transform in conjunction with an edge enhancement technique for            detection of subtle curved lines, and (b) ROC analysis of radiologists'          performances for evaluation of the usefulness of the CAD scheme; and (4)         implement and evaluate the CAD schemes in a high-resolution. high-speed          image processing system by (a) development of a prototype intelligent            workstation with efficient algorithms and efficient man-machine                  interfaces, and (b) carrying out pilot studies on clinical evaluation of         our chest CAD schemes in comparison with conventional readings in terms of       the three types of abnormalities related to lung nodules, interstitial           infiltrates, and pneumothoraces.                                                  ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,2376914,R01CA062625,"['computer assisted diagnosis ', ' pneumothorax disorder ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' disease /disorder classification ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,1997,352153,0.18673936384821674
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY The goal of the proposed research is to develop computer-aided diagnostic        (CAD) schemes for detection of lung nodules, interstitial infiltrates, and       pneumothoraces in digital chest images. We plan to develop advanced              computerized schemes and software for improvements in sensitivity,               specificity and efficiency in order to implement and evaluate such schemes       in a controlled clinical environment. We believe that these computer-aided       diagnostic schemes, which provide the radiologist with the location and/or       quantitative measures of highly suspected lesions, have the potential to         improve diagnostic accuracy in the detection of cancer by reducing human         errors associated with radiologic diagnoses.                                                                                                                      Specifically, we plan to (l) develop an improved scheme for automated            detection of lung nodules by (a) combinations of linear and nonlinear            morphological filtering techniques based on a difference image method for        enhancement and suppression of lung nodules, (b) reduction of false              positive detections by detailed analysis of image features by chest              radiologists and also use of artificial neural networks, (c) analysis of         posterior ribs for reduction of false positives, (d) application of              wavelet transform for increasing the sensitivity, and (e) observer               performance studies for optimal use of CAD methods; (2) develop an               improved scheme for automated lung texture analysis by (a) devising an           automated technique for sampling numerous regions of interest (ROIs) in          the lung fields, (b) investigation of new texture measures based on              analysis of the shape and anisotropic properties of the power spectrum of        lung textures, and (c) application of artificial neural networks for             detection and classification of interstitial infiltrates; (3) develop an         automated scheme for detection of pneumothorax by (a) application of the         Hough transform in conjunction with an edge enhancement technique for            detection of subtle curved lines, and (b) ROC analysis of radiologists'          performances for evaluation of the usefulness of the CAD scheme; and (4)         implement and evaluate the CAD schemes in a high-resolution. high-speed          image processing system by (a) development of a prototype intelligent            workstation with efficient algorithms and efficient man-machine                  interfaces, and (b) carrying out pilot studies on clinical evaluation of         our chest CAD schemes in comparison with conventional readings in terms of       the three types of abnormalities related to lung nodules, interstitial           infiltrates, and pneumothoraces.                                                  ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,2667970,R01CA062625,"['computer assisted diagnosis ', ' pneumothorax disorder ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' disease /disorder classification ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,1998,362127,0.18673936384821674
"EXPERT-DRIVEN HYBRID LING NODULE DETECTION SYSTEM An Expert-Driven Lung Nodule Detection (E-HLND) System is proposed for           improving diagnostic accuracy and speed for lung cancerous pulmonary             radiology.  The research goal is to develop a robust, user-friendly, and         clinically useful system to assist radiologists in the detection and             analysis of lung tumor in an early and treatable stage. The detection and        treatment of lung nodule in the early stage of growth can results in a           better prognosis for survival.  The proposed E-HLND system configuration         include the following processing phases: (1) data acquisition of a large         clinical screening chest x-ray films and multiresolution pre-processing          to enhance object-to-background contrast, (2) quick selection of suspect         nodule areas, (3) features space determination and neural classification         of cancerous nodules as well as false positives, and (5) knowledge-based         registration and fusion processing to integrate follow-up, patient               history, radiologist's expertise, and other diagnosis reports.  This             proposal focuses on (l) improving system's sensitivity and specificity           with neural network, image registration, information fusion technologies,        and hardware design; and (2) validating system's performance with a              ""simulated"" clinical trials based on a large clinical x-ray film database        (Chinese Yunnan Tin Corp. Bio-Marker Specimen bank -YTC database). This          project will explore artificial neural network and computer vision               technologies in diagnostic radiology and provide a basis for other cancer        research in diagnostic radiology.  This R&D effort is not only consistent        with but its success will provide good tool in the NCI launched large-           scale study ""Prostate, Lung, Colorectal, and Ovarian Cancer Screen (PLCO)        Trial"".                                                                                                                                                           PROPOSED COMMERCIAL APPLICATIONS                                                 An expert-driven lung nodule detection system, which serves as a ""second         reader"" to assist pulmonary radiologists in detecting lung nodules, will         be of great clinical and commercial value. The system can increase               radiologists' sensitivity and specificity in the detection of early lung         cancer on screening chest radiographs. Early and accurate detection of           an early stage tumor will ensure patients get the best treatment                 available. The proposed R&D work will enhance current patient care               system, reduce the work load of radiologists, and improve the cancer             diagnostic procedure in diagnostic radiology.                                     ",EXPERT-DRIVEN HYBRID LING NODULE DETECTION SYSTEM,2542475,R44CA058116,"['human data ', ' thoracic radiography ', ' image processing ', ' lung neoplasms ', ' neoplasm /cancer diagnosis ', ' cancer information system ', ' diagnosis design /evaluation ', ' diagnosis quality /standard ', ' computer system design /evaluation ', ' artificial intelligence ', ' ']",NCI,CAELUM RESEARCH CORPORATION,R44,1998,336204,0.15260404771153938
"PORTABLE DROWSINESS MONITORING DEVICE DESCRIPTION: (Applicant's abstract) The feasibility of a Drowsiness              Monitoring Device (DMD) to detect EEG indices of drowsiness in real-             time, was demonstrated during Phase I with an analytical model correctly         classifying 97.1 percent of sleep episodes and 94.3 percent of awake             epochs in 20 sleep-deprived subjects. The model employs discriminant             function analysis (DFA) to characterize and classify one-sec epochs,             validated against a combination of visual scoring by polysomnographers           and/or a behavioral measure. Algorithms to detect artifacts in real-time         (EMG, 60-Hz and gross body/eye movements) were developed. This                   classification accuracy represents a significant advancement over                previously reported models and confirms the feasibility of                       distinguishing EEG characteristics of sleep and waking on a second-by-           second basis. Phase II will implement a three-level DFA classification           system to further refine the model, adding sub-class states for                  vigilance and drowsiness/sleep to improve system accuracy. The multi-            dimensional time-series DFA analyses will correlate EEG parameters with          behavioral measures of driving performance to provide quantitative               predictions of performance decrements associate with sleep onset.                The model will be validated using a population with demographics                 consistent with the target market for the DMD (e.g., truck drivers)              during Phase II. In addition, the system will be evaluated with the              introduction of commonly used legal drugs (caffeine, nicotine, and cold          medications) to determine the robustness of the model.                                                                                                            PROPOSED COMMERCIAL APPLICATION:                                                 The DMD provides three levels of user safety. When sleep onset is                approaching, the DMD will initiate a verbal warning alarm that must be           turned off by the user. Alternatively, the DMD can provide verbal                feedback to ensure the user maintains high levels of alertness during            activities that require sustained vigilance. The user can also select            the option for the DMD to recommend the optimal time to take a short             nap, monitor the length of the nap and awaken the user at the                    appropriate time.                                                                                                                                                 Currently, more that 10% of the U.S. workforce or an estimated 20                million people are engaged in night sift work. The transportation                industry, including airline, railroad, marine and highway transportation         companies, is the nation's third largest employer of shift workers. Long         haul truck drivers, in particular, are vulnerable to sleepiness because          they drive through the night, in most cases unaccompanied, and generally         sleep less than 6 hours per day at irregular intervals. In addition, an          estimated 6 million Americans suffer from chronic sleep disorders which          make them vulnerable to fatigue in the workplace.                                 ",PORTABLE DROWSINESS MONITORING DEVICE,2794305,R44NS035387,"['clinical biomedical equipment ', ' biomedical equipment development ', ' patient monitoring device ', ' electroencephalography ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer data analysis ', ' computer program /software ', ' human subject ', ' attention ', ' sleep ', ' wakefulness ', ' computer system hardware ', ' polysomnography ', ' portable biomedical equipment ', ' ']",NINDS,"ADVANCED BRAIN MONITORING, INC.",R44,1999,342050,0.06865860167942851
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY The goal of the proposed research is to develop computer-aided diagnostic        (CAD) schemes for detection of lung nodules, interstitial infiltrates, and       pneumothoraces in digital chest images. We plan to develop advanced              computerized schemes and software for improvements in sensitivity,               specificity and efficiency in order to implement and evaluate such schemes       in a controlled clinical environment. We believe that these computer-aided       diagnostic schemes, which provide the radiologist with the location and/or       quantitative measures of highly suspected lesions, have the potential to         improve diagnostic accuracy in the detection of cancer by reducing human         errors associated with radiologic diagnoses.                                                                                                                      Specifically, we plan to (l) develop an improved scheme for automated            detection of lung nodules by (a) combinations of linear and nonlinear            morphological filtering techniques based on a difference image method for        enhancement and suppression of lung nodules, (b) reduction of false              positive detections by detailed analysis of image features by chest              radiologists and also use of artificial neural networks, (c) analysis of         posterior ribs for reduction of false positives, (d) application of              wavelet transform for increasing the sensitivity, and (e) observer               performance studies for optimal use of CAD methods; (2) develop an               improved scheme for automated lung texture analysis by (a) devising an           automated technique for sampling numerous regions of interest (ROIs) in          the lung fields, (b) investigation of new texture measures based on              analysis of the shape and anisotropic properties of the power spectrum of        lung textures, and (c) application of artificial neural networks for             detection and classification of interstitial infiltrates; (3) develop an         automated scheme for detection of pneumothorax by (a) application of the         Hough transform in conjunction with an edge enhancement technique for            detection of subtle curved lines, and (b) ROC analysis of radiologists'          performances for evaluation of the usefulness of the CAD scheme; and (4)         implement and evaluate the CAD schemes in a high-resolution. high-speed          image processing system by (a) development of a prototype intelligent            workstation with efficient algorithms and efficient man-machine                  interfaces, and (b) carrying out pilot studies on clinical evaluation of         our chest CAD schemes in comparison with conventional readings in terms of       the three types of abnormalities related to lung nodules, interstitial           infiltrates, and pneumothoraces.                                                  ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,2882402,R01CA062625,"['computer assisted diagnosis ', ' pneumothorax disorder ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' disease /disorder classification ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,1999,372500,0.18673936384821674
"EXPERT-DRIVEN HYBRID LING NODULE DETECTION SYSTEM An Expert-Driven Lung Nodule Detection (E-HLND) System is proposed for           improving diagnostic accuracy and speed for lung cancerous pulmonary             radiology.  The research goal is to develop a robust, user-friendly, and         clinically useful system to assist radiologists in the detection and             analysis of lung tumor in an early and treatable stage. The detection and        treatment of lung nodule in the early stage of growth can results in a           better prognosis for survival.  The proposed E-HLND system configuration         include the following processing phases: (1) data acquisition of a large         clinical screening chest x-ray films and multiresolution pre-processing          to enhance object-to-background contrast, (2) quick selection of suspect         nodule areas, (3) features space determination and neural classification         of cancerous nodules as well as false positives, and (5) knowledge-based         registration and fusion processing to integrate follow-up, patient               history, radiologist's expertise, and other diagnosis reports.  This             proposal focuses on (l) improving system's sensitivity and specificity           with neural network, image registration, information fusion technologies,        and hardware design; and (2) validating system's performance with a              ""simulated"" clinical trials based on a large clinical x-ray film database        (Chinese Yunnan Tin Corp. Bio-Marker Specimen bank -YTC database). This          project will explore artificial neural network and computer vision               technologies in diagnostic radiology and provide a basis for other cancer        research in diagnostic radiology.  This R&D effort is not only consistent        with but its success will provide good tool in the NCI launched large-           scale study ""Prostate, Lung, Colorectal, and Ovarian Cancer Screen (PLCO)        Trial"".                                                                                                                                                           PROPOSED COMMERCIAL APPLICATIONS                                                 An expert-driven lung nodule detection system, which serves as a ""second         reader"" to assist pulmonary radiologists in detecting lung nodules, will         be of great clinical and commercial value. The system can increase               radiologists' sensitivity and specificity in the detection of early lung         cancer on screening chest radiographs. Early and accurate detection of           an early stage tumor will ensure patients get the best treatment                 available. The proposed R&D work will enhance current patient care               system, reduce the work load of radiologists, and improve the cancer             diagnostic procedure in diagnostic radiology.                                     ",EXPERT-DRIVEN HYBRID LING NODULE DETECTION SYSTEM,2894981,R44CA058116,"['artificial intelligence ', ' computer system design /evaluation ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' cancer information system ', ' neoplasm /cancer diagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,CAELUM RESEARCH CORPORATION,R44,1999,297883,0.15260404771153938
"COMPUTERIZED DETECTION OF PULMONARY NODULES   DESCRIPTION (Adapted from Applicant's Abstract): An essential factor in lung         cancer survival is early detection, with up to 50% long term survival among          patients whose tumors are detected at clinical stage I. Unfortunately, only 15%      of lung cancers are currently detected at this stage. A major problem in early       detection is the limitation of chest radiography, the initial procedure for          detection of pulmonary nodules; it is estimated that 30% of positive nodules         are currently missed. Therefore, the applicants proposed to develop an advanced      computer-aided diagnosis (CAD) scheme that assists radiologists in detecting         pulmonary nodules in chest radiographs by providing them with a ""second              opinion."" The main obstacle to achieving a clinically acceptable level of            performance in such schemes is the large number of false-positive detections.        Thus, this proposal focuses on improving the performance of pulmonary nodule         detection by substantially reducing the number of false positives detected. The      specific aims are: (1) To establish image databases of pulmonary nodules for         development and evaluation of a CAD scheme by (a)extracting regions of interest      containing nodule candidates from an existing database, and (b) developing a         new database of digital chest images for evaluation of the CAD schemes; (2) To       develop methods for removal of normal anatomic structures by implementing            radiologists' visual analysis strategy that (a) identify regions with similar        normal anatomic structures in the lung, and (b) remove anatomic structures           through non-linear registration and subtraction; (3) To develop methods to           select and combine image features for reduction of false positives by (a)            extracting image features characteristic of nodules from                             normal-structure-subtracted regions, (b) by applying adaptive rule-based tests,      (c) combining features by artificial neural networks to obtain a single index        for the reduction of false positives, and (d) using genetic algorithms to            select features that are most effective in distinguishing nodules from false         positives; and (4) To evaluate the benefit of the overall CAD scheme by (a)          performing observer studies to estimate improvement of radiologists' diagnostic      accuracy in the detection of pulmonary nodules without and with computer aid,        and (b) performing pilot prospective studies for preclinical evaluation. The         hypothesis is that a CAD scheme with a clinically acceptable sensitivity and         specificity will substantially improve radiologists' accuracy in the detection       of pulmonary nodules. Such a high-performance CAD scheme should advance the          early detection of pulmonary nodules, and therefore has the potential to             improve the prognosis for patients.                                                                                                                                       ",COMPUTERIZED DETECTION OF PULMONARY NODULES,6088420,R01CA085668,"['computer assisted diagnosis ', ' artificial intelligence ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' cancer information system ', ' neoplasm /cancer diagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2000,169875,0.06493352820621995
"PORTABLE DROWSINESS MONITORING DEVICE DESCRIPTION: (Applicant's abstract) The feasibility of a Drowsiness              Monitoring Device (DMD) to detect EEG indices of drowsiness in real-             time, was demonstrated during Phase I with an analytical model correctly         classifying 97.1 percent of sleep episodes and 94.3 percent of awake             epochs in 20 sleep-deprived subjects. The model employs discriminant             function analysis (DFA) to characterize and classify one-sec epochs,             validated against a combination of visual scoring by polysomnographers           and/or a behavioral measure. Algorithms to detect artifacts in real-time         (EMG, 60-Hz and gross body/eye movements) were developed. This                   classification accuracy represents a significant advancement over                previously reported models and confirms the feasibility of                       distinguishing EEG characteristics of sleep and waking on a second-by-           second basis. Phase II will implement a three-level DFA classification           system to further refine the model, adding sub-class states for                  vigilance and drowsiness/sleep to improve system accuracy. The multi-            dimensional time-series DFA analyses will correlate EEG parameters with          behavioral measures of driving performance to provide quantitative               predictions of performance decrements associate with sleep onset.                The model will be validated using a population with demographics                 consistent with the target market for the DMD (e.g., truck drivers)              during Phase II. In addition, the system will be evaluated with the              introduction of commonly used legal drugs (caffeine, nicotine, and cold          medications) to determine the robustness of the model.                                                                                                            PROPOSED COMMERCIAL APPLICATION:                                                 The DMD provides three levels of user safety. When sleep onset is                approaching, the DMD will initiate a verbal warning alarm that must be           turned off by the user. Alternatively, the DMD can provide verbal                feedback to ensure the user maintains high levels of alertness during            activities that require sustained vigilance. The user can also select            the option for the DMD to recommend the optimal time to take a short             nap, monitor the length of the nap and awaken the user at the                    appropriate time.                                                                                                                                                 Currently, more that 10% of the U.S. workforce or an estimated 20                million people are engaged in night sift work. The transportation                industry, including airline, railroad, marine and highway transportation         companies, is the nation's third largest employer of shift workers. Long         haul truck drivers, in particular, are vulnerable to sleepiness because          they drive through the night, in most cases unaccompanied, and generally         sleep less than 6 hours per day at irregular intervals. In addition, an          estimated 6 million Americans suffer from chronic sleep disorders which          make them vulnerable to fatigue in the workplace.                                 ",PORTABLE DROWSINESS MONITORING DEVICE,6139531,R44NS035387,"['portable biomedical equipment ', ' polysomnography ', ' computer system hardware ', ' wakefulness ', ' sleep ', ' attention ', ' human subject ', ' computer program /software ', ' computer data analysis ', ' computer system design /evaluation ', ' artificial intelligence ', ' electroencephalography ', ' patient monitoring device ', ' biomedical equipment development ', ' clinical biomedical equipment ', ' ']",NINDS,"ADVANCED BRAIN MONITORING, INC.",R44,2000,327260,0.06865860167942851
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY   DESCRIPTION (Adapted from Applicant's Abstract): The applicants proposed to          develop computer-aided diagnostic (CAD) schemes for detection and                    characterization of pulmonary nodules in digital chest images. For development       of reliable and predictable CAD schemes, they proposed to establish a large          database with 2,000 cases of chest radiographs, which include 1,000 nodule           cases and 1,000 non-nodule cases, in collaboration with Richard M. Slone, M.D.,      Mallinckrodt Institute of Radiology, Washington University, under a consortium       arrangement. An advanced CAD scheme for detection of lung nodules will be            developed by incorporating three subtraction techniques--temporal subtraction,       contralateral subtraction and energy subtraction--in order to achieve, on            average, a high sensitivity of 80-90% with a low false positive rate of              approximately 0.5 per chest image. They would investigate the usefulness of the      temporal subtraction technique in increasing the detection of subtle nodules         overlapped with ribs and also decreasing the number of false positives due to        rib-crossings, when a previous chest image of the same patient is available.         Contralateral subtraction, which is a novel technique for removal of peripheral      ribs in a single PA chest image, will be examined for enhancement in the             detection of overlapped nodules and reduction in the number of false positives.      They would also investigate the usefulness of energy subtraction soft-tissue         image for improved computerized detection of lung nodules in combination with        conventional chest images. In addition to the detection task, they would to          develop CAD schemes for characterization of nodules in order to distinguish          between benign and malignant nodules. This characterization task is to provide       the likelihood of malignance of lung nodules based on quantitative analysis of       image features of nodules detected by computer and/or by radiologists. With the      high level of detection performance that they expect to achieve, they propose        to develop a prototype CAD workstation and carry out a pilot study to examine        the clinical usefulness of CAD schemes on detection and characterization of          pulmonary nodules.                                                                                                                                                        ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,6044779,R01CA062625,"['computer assisted diagnosis ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' information system ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2000,380968,0.10379829548566011
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY   DESCRIPTION (Adapted from Applicant's Abstract): The applicants proposed to          develop computer-aided diagnostic (CAD) schemes for detection and                    characterization of pulmonary nodules in digital chest images. For development       of reliable and predictable CAD schemes, they proposed to establish a large          database with 2,000 cases of chest radiographs, which include 1,000 nodule           cases and 1,000 non-nodule cases, in collaboration with Richard M. Slone, M.D.,      Mallinckrodt Institute of Radiology, Washington University, under a consortium       arrangement. An advanced CAD scheme for detection of lung nodules will be            developed by incorporating three subtraction techniques--temporal subtraction,       contralateral subtraction and energy subtraction--in order to achieve, on            average, a high sensitivity of 80-90% with a low false positive rate of              approximately 0.5 per chest image. They would investigate the usefulness of the      temporal subtraction technique in increasing the detection of subtle nodules         overlapped with ribs and also decreasing the number of false positives due to        rib-crossings, when a previous chest image of the same patient is available.         Contralateral subtraction, which is a novel technique for removal of peripheral      ribs in a single PA chest image, will be examined for enhancement in the             detection of overlapped nodules and reduction in the number of false positives.      They would also investigate the usefulness of energy subtraction soft-tissue         image for improved computerized detection of lung nodules in combination with        conventional chest images. In addition to the detection task, they would to          develop CAD schemes for characterization of nodules in order to distinguish          between benign and malignant nodules. This characterization task is to provide       the likelihood of malignance of lung nodules based on quantitative analysis of       image features of nodules detected by computer and/or by radiologists. With the      high level of detection performance that they expect to achieve, they propose        to develop a prototype CAD workstation and carry out a pilot study to examine        the clinical usefulness of CAD schemes on detection and characterization of          pulmonary nodules.                                                                                                                                                        ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,6362584,R01CA062625,"['computer assisted diagnosis ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' information system ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2001,373412,0.10379829548566011
"COMPUTERIZED DETECTION OF PULMONARY NODULES   DESCRIPTION (Adapted from Applicant's Abstract): An essential factor in lung         cancer survival is early detection, with up to 50% long term survival among          patients whose tumors are detected at clinical stage I. Unfortunately, only 15%      of lung cancers are currently detected at this stage. A major problem in early       detection is the limitation of chest radiography, the initial procedure for          detection of pulmonary nodules; it is estimated that 30% of positive nodules         are currently missed. Therefore, the applicants proposed to develop an advanced      computer-aided diagnosis (CAD) scheme that assists radiologists in detecting         pulmonary nodules in chest radiographs by providing them with a ""second              opinion."" The main obstacle to achieving a clinically acceptable level of            performance in such schemes is the large number of false-positive detections.        Thus, this proposal focuses on improving the performance of pulmonary nodule         detection by substantially reducing the number of false positives detected. The      specific aims are: (1) To establish image databases of pulmonary nodules for         development and evaluation of a CAD scheme by (a)extracting regions of interest      containing nodule candidates from an existing database, and (b) developing a         new database of digital chest images for evaluation of the CAD schemes; (2) To       develop methods for removal of normal anatomic structures by implementing            radiologists' visual analysis strategy that (a) identify regions with similar        normal anatomic structures in the lung, and (b) remove anatomic structures           through non-linear registration and subtraction; (3) To develop methods to           select and combine image features for reduction of false positives by (a)            extracting image features characteristic of nodules from                             normal-structure-subtracted regions, (b) by applying adaptive rule-based tests,      (c) combining features by artificial neural networks to obtain a single index        for the reduction of false positives, and (d) using genetic algorithms to            select features that are most effective in distinguishing nodules from false         positives; and (4) To evaluate the benefit of the overall CAD scheme by (a)          performing observer studies to estimate improvement of radiologists' diagnostic      accuracy in the detection of pulmonary nodules without and with computer aid,        and (b) performing pilot prospective studies for preclinical evaluation. The         hypothesis is that a CAD scheme with a clinically acceptable sensitivity and         specificity will substantially improve radiologists' accuracy in the detection       of pulmonary nodules. Such a high-performance CAD scheme should advance the          early detection of pulmonary nodules, and therefore has the potential to             improve the prognosis for patients.                                                                                                                                       ",COMPUTERIZED DETECTION OF PULMONARY NODULES,6377798,R01CA085668,"['computer assisted diagnosis ', ' artificial intelligence ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' cancer information system ', ' neoplasm /cancer diagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2001,169875,0.06493352820621995
"Automated (AI) Analysis of Sleep Disordered Breathing DESCRIPTION (provided by applicant) This training grant is designed to advance the academic career of Dr. Indu Ayappa by building on the applicant?s strong biomedical engineering and computer background and providing comprehensive multi-disciplinary training which will allow her to become an independent investigator. The applicant?s career goals are to enter full time academic research in sleep physiology. Training activities proposed will include academic course work designed to support the research program and expose her to aspects of clinical research in sleep, neural science and artificial intelligence techniques. She will be mentored by David Rapoport, M.D., Joyce Walsleben, Ph.D., and Maurice Ohayon, M.D., Ph.D., as well as faculty in computer science and neurophysiology. The aims of the planned research are to develop an artificial intelligence system for the identification and quantification of sleep disordered breathing (SDB) based solely on non-invasive cardiopulmonary signals collected during routine polysomnography. This will simplify, standardize and improve the diagnosis of SDB and facilitate research in this area. With the long term goal of physiologic characterization of the spectrum of SDB in order to clinically diagnose upper airway resistance syndrome (UARS), the aims of this project are to: 1. Extract features from the nasal cannula airflow signal to characterize the state of resistance/collapsibility of individual breaths. These include amplitude, inspiratory flow contour, Ti/Ttot and presence of vibration which will be used as inputs to a neural network that will be trained and evaluated against breaths that have been classified by reference measurement of upper airway resistance (pressure/flow). 2A. Incorporate information from this classification of individual breaths to detect and classify respiratory events based on the flow signal alone using a trained neural network. 2B. Evaluate the utility of including additional cardiopulmonary signals like oxygen saturation, heart rate, pulse transit time and rib/abdominal movements (amplitude and phase) in the detection and classification of these events. Successful completion of the training and research program will allow Dr. Ayappa to contribute independently to research in the field of sleep physiology. ",Automated (AI) Analysis of Sleep Disordered Breathing,6320670,K25HL004420,"['electroencephalography ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' diagnosis quality /standard ', ' breath test ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' electrooculography ', ' electrocardiography ', ' human subject ', ' automated data processing ', ' electromyography ', ' sleep disorder ', ' cardiopulmonary disease ', ' respiratory airflow disorder ', ' respiratory disorder diagnosis ', ' respiratory airflow measurement ', ' polysomnography ', ' patient oriented research ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K25,2001,147450,0.08019430446497962
"COMPUTERIZED DETECTION OF PULMONARY NODULES   DESCRIPTION (Adapted from Applicant's Abstract): An essential factor in lung         cancer survival is early detection, with up to 50% long term survival among          patients whose tumors are detected at clinical stage I. Unfortunately, only 15%      of lung cancers are currently detected at this stage. A major problem in early       detection is the limitation of chest radiography, the initial procedure for          detection of pulmonary nodules; it is estimated that 30% of positive nodules         are currently missed. Therefore, the applicants proposed to develop an advanced      computer-aided diagnosis (CAD) scheme that assists radiologists in detecting         pulmonary nodules in chest radiographs by providing them with a ""second              opinion."" The main obstacle to achieving a clinically acceptable level of            performance in such schemes is the large number of false-positive detections.        Thus, this proposal focuses on improving the performance of pulmonary nodule         detection by substantially reducing the number of false positives detected. The      specific aims are: (1) To establish image databases of pulmonary nodules for         development and evaluation of a CAD scheme by (a)extracting regions of interest      containing nodule candidates from an existing database, and (b) developing a         new database of digital chest images for evaluation of the CAD schemes; (2) To       develop methods for removal of normal anatomic structures by implementing            radiologists' visual analysis strategy that (a) identify regions with similar        normal anatomic structures in the lung, and (b) remove anatomic structures           through non-linear registration and subtraction; (3) To develop methods to           select and combine image features for reduction of false positives by (a)            extracting image features characteristic of nodules from                             normal-structure-subtracted regions, (b) by applying adaptive rule-based tests,      (c) combining features by artificial neural networks to obtain a single index        for the reduction of false positives, and (d) using genetic algorithms to            select features that are most effective in distinguishing nodules from false         positives; and (4) To evaluate the benefit of the overall CAD scheme by (a)          performing observer studies to estimate improvement of radiologists' diagnostic      accuracy in the detection of pulmonary nodules without and with computer aid,        and (b) performing pilot prospective studies for preclinical evaluation. The         hypothesis is that a CAD scheme with a clinically acceptable sensitivity and         specificity will substantially improve radiologists' accuracy in the detection       of pulmonary nodules. Such a high-performance CAD scheme should advance the          early detection of pulmonary nodules, and therefore has the potential to             improve the prognosis for patients.                                                                                                                                       ",COMPUTERIZED DETECTION OF PULMONARY NODULES,6514433,R01CA085668,"['computer assisted diagnosis ', ' artificial intelligence ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' cancer information system ', ' neoplasm /cancer diagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2002,169875,0.06493352820621995
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY   DESCRIPTION (Adapted from Applicant's Abstract): The applicants proposed to          develop computer-aided diagnostic (CAD) schemes for detection and                    characterization of pulmonary nodules in digital chest images. For development       of reliable and predictable CAD schemes, they proposed to establish a large          database with 2,000 cases of chest radiographs, which include 1,000 nodule           cases and 1,000 non-nodule cases, in collaboration with Richard M. Slone, M.D.,      Mallinckrodt Institute of Radiology, Washington University, under a consortium       arrangement. An advanced CAD scheme for detection of lung nodules will be            developed by incorporating three subtraction techniques--temporal subtraction,       contralateral subtraction and energy subtraction--in order to achieve, on            average, a high sensitivity of 80-90% with a low false positive rate of              approximately 0.5 per chest image. They would investigate the usefulness of the      temporal subtraction technique in increasing the detection of subtle nodules         overlapped with ribs and also decreasing the number of false positives due to        rib-crossings, when a previous chest image of the same patient is available.         Contralateral subtraction, which is a novel technique for removal of peripheral      ribs in a single PA chest image, will be examined for enhancement in the             detection of overlapped nodules and reduction in the number of false positives.      They would also investigate the usefulness of energy subtraction soft-tissue         image for improved computerized detection of lung nodules in combination with        conventional chest images. In addition to the detection task, they would to          develop CAD schemes for characterization of nodules in order to distinguish          between benign and malignant nodules. This characterization task is to provide       the likelihood of malignance of lung nodules based on quantitative analysis of       image features of nodules detected by computer and/or by radiologists. With the      high level of detection performance that they expect to achieve, they propose        to develop a prototype CAD workstation and carry out a pilot study to examine        the clinical usefulness of CAD schemes on detection and characterization of          pulmonary nodules.                                                                                                                                                        ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,6512959,R01CA062625,"['computer assisted diagnosis ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' information system ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2002,381567,0.10379829548566011
"Automated (AI) Analysis of Sleep Disordered Breathing DESCRIPTION (provided by applicant) This training grant is designed to advance the academic career of Dr. Indu Ayappa by building on the applicant?s strong biomedical engineering and computer background and providing comprehensive multi-disciplinary training which will allow her to become an independent investigator. The applicant?s career goals are to enter full time academic research in sleep physiology. Training activities proposed will include academic course work designed to support the research program and expose her to aspects of clinical research in sleep, neural science and artificial intelligence techniques. She will be mentored by David Rapoport, M.D., Joyce Walsleben, Ph.D., and Maurice Ohayon, M.D., Ph.D., as well as faculty in computer science and neurophysiology. The aims of the planned research are to develop an artificial intelligence system for the identification and quantification of sleep disordered breathing (SDB) based solely on non-invasive cardiopulmonary signals collected during routine polysomnography. This will simplify, standardize and improve the diagnosis of SDB and facilitate research in this area. With the long term goal of physiologic characterization of the spectrum of SDB in order to clinically diagnose upper airway resistance syndrome (UARS), the aims of this project are to: 1. Extract features from the nasal cannula airflow signal to characterize the state of resistance/collapsibility of individual breaths. These include amplitude, inspiratory flow contour, Ti/Ttot and presence of vibration which will be used as inputs to a neural network that will be trained and evaluated against breaths that have been classified by reference measurement of upper airway resistance (pressure/flow). 2A. Incorporate information from this classification of individual breaths to detect and classify respiratory events based on the flow signal alone using a trained neural network. 2B. Evaluate the utility of including additional cardiopulmonary signals like oxygen saturation, heart rate, pulse transit time and rib/abdominal movements (amplitude and phase) in the detection and classification of these events. Successful completion of the training and research program will allow Dr. Ayappa to contribute independently to research in the field of sleep physiology. ",Automated (AI) Analysis of Sleep Disordered Breathing,6536655,K25HL004420,"['electroencephalography ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' diagnosis quality /standard ', ' breath test ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' electrooculography ', ' electrocardiography ', ' human subject ', ' automated data processing ', ' electromyography ', ' sleep disorder ', ' cardiopulmonary disease ', ' respiratory airflow disorder ', ' respiratory disorder diagnosis ', ' respiratory airflow measurement ', ' polysomnography ', ' patient oriented research ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K25,2002,147690,0.08019430446497962
"Serum Proteomic Biomarker Discovery in Lung Cancer DESCRIPTION (provided by applicant):  The applicant describes a five year program leading to independent translational research related to pulmonary and critical care medicine.  Although trained as a neuroscientist, the investigator is motivated by clinical experience to propose a career dedicated to the development of molecular diagnostic and targeted therapeutic approaches to medicine, in particular to lung cancer and critical illness.  Practical skills in functional genomics, proteomics, molecular biology, biostatistics, and machine learning will be fostered in the laboratory of Dr. Todd Golub, himself an accomplished clinical scientist with a vital independent research program.  Director of Cancer Genomics at the Whitehead Institute Center for Genome Research, Dr. Golub is a pioneer and internationally recognized leader in the application of genomics approaches to cancer biology, especially classification and prognosis.  This immersion will be complemented by formal instruction in genomics and computational biology, and reinforced by active advising from a team of domain experts.        The proposed research plan starts from the tenet that delayed or inaccurate diagnoses can be lethal.  Most lung cancer patients present with advanced disease, when the prognosis is grave; many of the critically ill can be given no better than phenomenological descriptions of their disease.  The Human Genome Project and other developments in biology and technology have advanced unbiased, whole-genome discovery efforts for improved markers of disease.  The principal investigator will undertake such an effort, by 1) creating datasets by mass spectrometry from serum samples of lung cancer patients and controls; 2) defining signatures of disease using machine learning approaches; and 3) identifying proteins and peptides comprising the diagnostic signatures.  While the investigator hopes to develop functional lung cancer biomarkers, the methodologies are intended to be applicable throughout medicine.        The combined resources of the Massachusetts General Hospital, the Dana Farber Cancer Institute, and the Whitehead Institute will be available to the applicant.  These rich environments will promote the success of the serum biomarker discovery project, and the larger cultivation of the investigator towards a goal of independence and productivity in academic medicine. ",Serum Proteomic Biomarker Discovery in Lung Cancer,6673550,K08CA102159,"['biomarker ', ' serum ', ' mass spectrometry ', ' human tissue ', ' information system ', ' adenocarcinoma ', ' squamous cell carcinoma ', ' lung neoplasm ', ' small cell lung cancer ', ' chromatography ', ' protein structure function ', ' clinical research ', ' protein protein interaction ', ' functional /structural genomics ', ' proteomics ', ' ']",NCI,DANA-FARBER CANCER INST,K08,2003,135837,0.13787459515359543
"Automated (AI) Analysis of Sleep Disordered Breathing DESCRIPTION (provided by applicant) This training grant is designed to advance the academic career of Dr. Indu Ayappa by building on the applicant?s strong biomedical engineering and computer background and providing comprehensive multi-disciplinary training which will allow her to become an independent investigator. The applicant?s career goals are to enter full time academic research in sleep physiology. Training activities proposed will include academic course work designed to support the research program and expose her to aspects of clinical research in sleep, neural science and artificial intelligence techniques. She will be mentored by David Rapoport, M.D., Joyce Walsleben, Ph.D., and Maurice Ohayon, M.D., Ph.D., as well as faculty in computer science and neurophysiology. The aims of the planned research are to develop an artificial intelligence system for the identification and quantification of sleep disordered breathing (SDB) based solely on non-invasive cardiopulmonary signals collected during routine polysomnography. This will simplify, standardize and improve the diagnosis of SDB and facilitate research in this area. With the long term goal of physiologic characterization of the spectrum of SDB in order to clinically diagnose upper airway resistance syndrome (UARS), the aims of this project are to: 1. Extract features from the nasal cannula airflow signal to characterize the state of resistance/collapsibility of individual breaths. These include amplitude, inspiratory flow contour, Ti/Ttot and presence of vibration which will be used as inputs to a neural network that will be trained and evaluated against breaths that have been classified by reference measurement of upper airway resistance (pressure/flow). 2A. Incorporate information from this classification of individual breaths to detect and classify respiratory events based on the flow signal alone using a trained neural network. 2B. Evaluate the utility of including additional cardiopulmonary signals like oxygen saturation, heart rate, pulse transit time and rib/abdominal movements (amplitude and phase) in the detection and classification of these events. Successful completion of the training and research program will allow Dr. Ayappa to contribute independently to research in the field of sleep physiology. ",Automated (AI) Analysis of Sleep Disordered Breathing,6638164,K25HL004420,"['electroencephalography ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' diagnosis quality /standard ', ' breath test ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' electrooculography ', ' electrocardiography ', ' human subject ', ' automated data processing ', ' electromyography ', ' sleep disorder ', ' cardiopulmonary disease ', ' respiratory airflow disorder ', ' respiratory disorder diagnosis ', ' respiratory airflow measurement ', ' polysomnography ', ' patient oriented research ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K25,2003,147690,0.08019430446497962
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY   DESCRIPTION (Adapted from Applicant's Abstract): The applicants proposed to          develop computer-aided diagnostic (CAD) schemes for detection and                    characterization of pulmonary nodules in digital chest images. For development       of reliable and predictable CAD schemes, they proposed to establish a large          database with 2,000 cases of chest radiographs, which include 1,000 nodule           cases and 1,000 non-nodule cases, in collaboration with Richard M. Slone, M.D.,      Mallinckrodt Institute of Radiology, Washington University, under a consortium       arrangement. An advanced CAD scheme for detection of lung nodules will be            developed by incorporating three subtraction techniques--temporal subtraction,       contralateral subtraction and energy subtraction--in order to achieve, on            average, a high sensitivity of 80-90% with a low false positive rate of              approximately 0.5 per chest image. They would investigate the usefulness of the      temporal subtraction technique in increasing the detection of subtle nodules         overlapped with ribs and also decreasing the number of false positives due to        rib-crossings, when a previous chest image of the same patient is available.         Contralateral subtraction, which is a novel technique for removal of peripheral      ribs in a single PA chest image, will be examined for enhancement in the             detection of overlapped nodules and reduction in the number of false positives.      They would also investigate the usefulness of energy subtraction soft-tissue         image for improved computerized detection of lung nodules in combination with        conventional chest images. In addition to the detection task, they would to          develop CAD schemes for characterization of nodules in order to distinguish          between benign and malignant nodules. This characterization task is to provide       the likelihood of malignance of lung nodules based on quantitative analysis of       image features of nodules detected by computer and/or by radiologists. With the      high level of detection performance that they expect to achieve, they propose        to develop a prototype CAD workstation and carry out a pilot study to examine        the clinical usefulness of CAD schemes on detection and characterization of          pulmonary nodules.                                                                                                                                                        ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,6633169,R01CA062625,"['computer assisted diagnosis ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' information system ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2003,388688,0.10379829548566011
"Serum Proteomic Biomarker Discovery in Lung Cancer DESCRIPTION (provided by applicant):  The applicant describes a five year program leading to independent translational research related to pulmonary and critical care medicine.  Although trained as a neuroscientist, the investigator is motivated by clinical experience to propose a career dedicated to the development of molecular diagnostic and targeted therapeutic approaches to medicine, in particular to lung cancer and critical illness.  Practical skills in functional genomics, proteomics, molecular biology, biostatistics, and machine learning will be fostered in the laboratory of Dr. Todd Golub, himself an accomplished clinical scientist with a vital independent research program.  Director of Cancer Genomics at the Whitehead Institute Center for Genome Research, Dr. Golub is a pioneer and internationally recognized leader in the application of genomics approaches to cancer biology, especially classification and prognosis.  This immersion will be complemented by formal instruction in genomics and computational biology, and reinforced by active advising from a team of domain experts.        The proposed research plan starts from the tenet that delayed or inaccurate diagnoses can be lethal.  Most lung cancer patients present with advanced disease, when the prognosis is grave; many of the critically ill can be given no better than phenomenological descriptions of their disease.  The Human Genome Project and other developments in biology and technology have advanced unbiased, whole-genome discovery efforts for improved markers of disease.  The principal investigator will undertake such an effort, by 1) creating datasets by mass spectrometry from serum samples of lung cancer patients and controls; 2) defining signatures of disease using machine learning approaches; and 3) identifying proteins and peptides comprising the diagnostic signatures.  While the investigator hopes to develop functional lung cancer biomarkers, the methodologies are intended to be applicable throughout medicine.        The combined resources of the Massachusetts General Hospital, the Dana Farber Cancer Institute, and the Whitehead Institute will be available to the applicant.  These rich environments will promote the success of the serum biomarker discovery project, and the larger cultivation of the investigator towards a goal of independence and productivity in academic medicine. ",Serum Proteomic Biomarker Discovery in Lung Cancer,6771670,K08CA102159,"['biomarker ', ' serum ', ' mass spectrometry ', ' human tissue ', ' information system ', ' adenocarcinoma ', ' squamous cell carcinoma ', ' lung neoplasm ', ' small cell lung cancer ', ' chromatography ', ' protein structure function ', ' clinical research ', ' protein protein interaction ', ' functional /structural genomics ', ' proteomics ', ' computational biology ', ' ']",NCI,DANA-FARBER CANCER INST,K08,2004,135837,0.13787459515359543
"Automated (AI) Analysis of Sleep Disordered Breathing DESCRIPTION (provided by applicant) This training grant is designed to advance the academic career of Dr. Indu Ayappa by building on the applicant?s strong biomedical engineering and computer background and providing comprehensive multi-disciplinary training which will allow her to become an independent investigator. The applicant?s career goals are to enter full time academic research in sleep physiology. Training activities proposed will include academic course work designed to support the research program and expose her to aspects of clinical research in sleep, neural science and artificial intelligence techniques. She will be mentored by David Rapoport, M.D., Joyce Walsleben, Ph.D., and Maurice Ohayon, M.D., Ph.D., as well as faculty in computer science and neurophysiology. The aims of the planned research are to develop an artificial intelligence system for the identification and quantification of sleep disordered breathing (SDB) based solely on non-invasive cardiopulmonary signals collected during routine polysomnography. This will simplify, standardize and improve the diagnosis of SDB and facilitate research in this area. With the long term goal of physiologic characterization of the spectrum of SDB in order to clinically diagnose upper airway resistance syndrome (UARS), the aims of this project are to: 1. Extract features from the nasal cannula airflow signal to characterize the state of resistance/collapsibility of individual breaths. These include amplitude, inspiratory flow contour, Ti/Ttot and presence of vibration which will be used as inputs to a neural network that will be trained and evaluated against breaths that have been classified by reference measurement of upper airway resistance (pressure/flow). 2A. Incorporate information from this classification of individual breaths to detect and classify respiratory events based on the flow signal alone using a trained neural network. 2B. Evaluate the utility of including additional cardiopulmonary signals like oxygen saturation, heart rate, pulse transit time and rib/abdominal movements (amplitude and phase) in the detection and classification of these events. Successful completion of the training and research program will allow Dr. Ayappa to contribute independently to research in the field of sleep physiology. ",Automated (AI) Analysis of Sleep Disordered Breathing,6721163,K25HL004420,"['electroencephalography ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' diagnosis quality /standard ', ' breath test ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' electrooculography ', ' electrocardiography ', ' human subject ', ' automated data processing ', ' electromyography ', ' sleep disorder ', ' cardiopulmonary disease ', ' respiratory airflow disorder ', ' respiratory disorder diagnosis ', ' respiratory airflow measurement ', ' polysomnography ', ' patient oriented research ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K25,2004,147690,0.08019430446497962
"COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY   DESCRIPTION (Adapted from Applicant's Abstract): The applicants proposed to          develop computer-aided diagnostic (CAD) schemes for detection and                    characterization of pulmonary nodules in digital chest images. For development       of reliable and predictable CAD schemes, they proposed to establish a large          database with 2,000 cases of chest radiographs, which include 1,000 nodule           cases and 1,000 non-nodule cases, in collaboration with Richard M. Slone, M.D.,      Mallinckrodt Institute of Radiology, Washington University, under a consortium       arrangement. An advanced CAD scheme for detection of lung nodules will be            developed by incorporating three subtraction techniques--temporal subtraction,       contralateral subtraction and energy subtraction--in order to achieve, on            average, a high sensitivity of 80-90% with a low false positive rate of              approximately 0.5 per chest image. They would investigate the usefulness of the      temporal subtraction technique in increasing the detection of subtle nodules         overlapped with ribs and also decreasing the number of false positives due to        rib-crossings, when a previous chest image of the same patient is available.         Contralateral subtraction, which is a novel technique for removal of peripheral      ribs in a single PA chest image, will be examined for enhancement in the             detection of overlapped nodules and reduction in the number of false positives.      They would also investigate the usefulness of energy subtraction soft-tissue         image for improved computerized detection of lung nodules in combination with        conventional chest images. In addition to the detection task, they would to          develop CAD schemes for characterization of nodules in order to distinguish          between benign and malignant nodules. This characterization task is to provide       the likelihood of malignance of lung nodules based on quantitative analysis of       image features of nodules detected by computer and/or by radiologists. With the      high level of detection performance that they expect to achieve, they propose        to develop a prototype CAD workstation and carry out a pilot study to examine        the clinical usefulness of CAD schemes on detection and characterization of          pulmonary nodules.                                                                                                                                                        ",COMPUTER AIDED DIAGNOSIS IN CHEST RADIOGRAPHY,6719070,R01CA062625,"['computer assisted diagnosis ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer human interaction ', ' diagnosis design /evaluation ', ' noninvasive diagnosis ', ' disease /disorder classification ', ' information system ', ' neoplasm /cancer radiodiagnosis ', ' lung neoplasm ', ' image processing ', ' pneumoradiography ', ' digital imaging ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF CHICAGO,R01,2004,397291,0.10379829548566011
"Novel Real-Time Algorithms:Quantifying Wake-Sleep States The overall goal of this project is to develop and clinically validate a novel class of computerized EEG-based algorithms and sophisticated signal processing methods designed for high temporal resolution characterization of the wake-sleep transition and fluctuations within sleep stages. In addition to their capability of profiling wakefulness and various sleep stages as a continuous process, these algorithms will be developed in a format such that they can be eventually implemented for real-time detection of wake-to sleep transitions. The new approach of this proposal is based on an innovative interaction of classically independent signal processing methods for quantifying EEG, including traditional Short-Term Fourier Transform, Recursive Auto-regressive Parameter Estimation, and Wavelet analysis. This new approach takes advantage of each method's relative strength and ""fuses"" the information obtained from each technique to provide a means of quantifying the entire wake-sleep transition with high temporal resolution (e.g., early detection of sleep onset) while being robust to factors that normally degrade EEG processing. The developed algorithms will be validated with an extensive set of clinical data including nocturnal polysomnography, and day-time tests of Sleepiness, MSLT (Multiple Sleep Latency Test) and MWT (Maintenance of Wakefulness Test). The dynamic events detected by these algorithms (e.g., micro-arousals and micro-sleeps) will be evaluated against standard R&K scoring of the same EEG data. Furthermore, the profile and characteristics of the events detected in PSG will be correlated with the daytime objective and subjective tests of sleepiness. ",Novel Real-Time Algorithms:Quantifying Wake-Sleep States,6838292,R43HL078442,"['bioengineering /biomedical engineering ', ' electroencephalography ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' human subject ', ' mathematics ', ' arousal ', ' sleep ', ' wakefulness ', ' clinical research ', ' polysomnography ', ' ']",NHLBI,"CLEVELAND MEDICAL DEVICES, INC.",R43,2004,165221,0.0807064358628637
"Clinical & Microarray Data Predict Lung Cancer Outcomes Patients with non-small cell lung carcinoma (NSCLC) have a poor prognosis. Our goal is to develop methods to translate gene expression profiles into knowledge that will lead to the identification of molecular targets for prediction and therapy in these patients. Current clinical (staging) models for prediction of survival in these patients with small, localized tumors (Stage I) fails to identify the subset that will die less than 2.5 years after ""curative"" surgery. Our preliminary research with rule-based models using Stage I lung adenocarcinoma patients demonstrates meaningful results for prediction of survival with models that combine gene expression data with clinical data. Our primary hypothesis is: Clinical and gene expression attributes combine in rule-based models to accurately predict patient outcomes (time to death or recurrence). We propose to test this hypothesis for patients with resectable NSCLC. The Specific Aims are to: 1. Test the accuracy of the rule-based models as a function of the data type. We will use several established algorithms for generating decision rule models. Leave-one-out-cross-validation (LOOCV) will be used to evaluate model accuracy, complexity, and stability. The ""gold standard"" for performance comparison is the AJCC staging model. 2. Compare the model performance for rule-based induction to other algorithms. We will use support vector machines and artificial neural networks. We will address the role of feature selection in model performance. We will also confirm the significance of model variables using a standard statistical metric, partial least squares. We will also experimentally evaluate (random and adaptive) subsampling methods (bagging and boosting, respectively), which vote multiple rule models produced by one rule-based system, C4.5. 3. Research rule induction to hypothesize causal mechanisms in survival. We will develop a novel extension to rule induction that we call backward-chaining rule induction, a form of ""semi-supervised"" learning, which we expect to better focus the search for variable interactions to ""interesting"" rules (i.e., those with mechanistic explanations), than purely unsupervised approaches. Knowledge discovery will be evaluated based on domain expertise in the molecular basis of cancer. ",Clinical & Microarray Data Predict Lung Cancer Outcomes,6778604,R01LM008000,"['artificial intelligence ', ' biopsy ', ' prognosis ', ' human subject ', ' statistics /biometry ', ' model design /development ', ' mathematical model ', ' neoplasm /cancer genetics ', ' nonsmall cell lung cancer ', ' clinical research ', ' outcomes research ', ' microarray technology ', ' patient oriented research ', ' gene expression profiling ', ' ']",NLM,VANDERBILT UNIVERSITY,R01,2004,208380,0.07490999880092236
"Clinical & Microarray Data Predict Lung Cancer Outcomes Patients with non-small cell lung carcinoma (NSCLC) have a poor prognosis. Our goal is to develop methods to translate gene expression profiles into knowledge that will lead to the identification of molecular targets for prediction and therapy in these patients. Current clinical (staging) models for prediction of survival in these patients with small, localized tumors (Stage I) fails to identify the subset that will die less than 2.5 years after ""curative"" surgery. Our preliminary research with rule-based models using Stage I lung adenocarcinoma patients demonstrates meaningful results for prediction of survival with models that combine gene expression data with clinical data. Our primary hypothesis is: Clinical and gene expression attributes combine in rule-based models to accurately predict patient outcomes (time to death or recurrence). We propose to test this hypothesis for patients with resectable NSCLC. The Specific Aims are to: 1. Test the accuracy of the rule-based models as a function of the data type. We will use several established algorithms for generating decision rule models. Leave-one-out-cross-validation (LOOCV) will be used to evaluate model accuracy, complexity, and stability. The ""gold standard"" for performance comparison is the AJCC staging model. 2. Compare the model performance for rule-based induction to other algorithms. We will use support vector machines and artificial neural networks. We will address the role of feature selection in model performance. We will also confirm the significance of model variables using a standard statistical metric, partial least squares. We will also experimentally evaluate (random and adaptive) subsampling methods (bagging and boosting, respectively), which vote multiple rule models produced by one rule-based system, C4.5. 3. Research rule induction to hypothesize causal mechanisms in survival. We will develop a novel extension to rule induction that we call backward-chaining rule induction, a form of ""semi-supervised"" learning, which we expect to better focus the search for variable interactions to ""interesting"" rules (i.e., those with mechanistic explanations), than purely unsupervised approaches. Knowledge discovery will be evaluated based on domain expertise in the molecular basis of cancer. ",Clinical & Microarray Data Predict Lung Cancer Outcomes,7214019,R01LM008000,"['artificial intelligence ', ' biopsy ', ' prognosis ', ' human subject ', ' statistics /biometry ', ' model design /development ', ' mathematical model ', ' neoplasm /cancer genetics ', ' nonsmall cell lung cancer ', ' clinical research ', ' outcomes research ', ' microarray technology ', ' patient oriented research ', ' gene expression profiling ', ' ']",NLM,H. LEE MOFFITT CANCER CTR & RES INST,R01,2005,180184,0.07490999880092236
"Clinical & Microarray Data Predict Lung Cancer Outcomes Patients with non-small cell lung carcinoma (NSCLC) have a poor prognosis. Our goal is to develop methods to translate gene expression profiles into knowledge that will lead to the identification of molecular targets for prediction and therapy in these patients. Current clinical (staging) models for prediction of survival in these patients with small, localized tumors (Stage I) fails to identify the subset that will die less than 2.5 years after ""curative"" surgery. Our preliminary research with rule-based models using Stage I lung adenocarcinoma patients demonstrates meaningful results for prediction of survival with models that combine gene expression data with clinical data. Our primary hypothesis is: Clinical and gene expression attributes combine in rule-based models to accurately predict patient outcomes (time to death or recurrence). We propose to test this hypothesis for patients with resectable NSCLC. The Specific Aims are to: 1. Test the accuracy of the rule-based models as a function of the data type. We will use several established algorithms for generating decision rule models. Leave-one-out-cross-validation (LOOCV) will be used to evaluate model accuracy, complexity, and stability. The ""gold standard"" for performance comparison is the AJCC staging model. 2. Compare the model performance for rule-based induction to other algorithms. We will use support vector machines and artificial neural networks. We will address the role of feature selection in model performance. We will also confirm the significance of model variables using a standard statistical metric, partial least squares. We will also experimentally evaluate (random and adaptive) subsampling methods (bagging and boosting, respectively), which vote multiple rule models produced by one rule-based system, C4.5. 3. Research rule induction to hypothesize causal mechanisms in survival. We will develop a novel extension to rule induction that we call backward-chaining rule induction, a form of ""semi-supervised"" learning, which we expect to better focus the search for variable interactions to ""interesting"" rules (i.e., those with mechanistic explanations), than purely unsupervised approaches. Knowledge discovery will be evaluated based on domain expertise in the molecular basis of cancer. ",Clinical & Microarray Data Predict Lung Cancer Outcomes,6888150,R01LM008000,"['artificial intelligence ', ' biopsy ', ' prognosis ', ' human subject ', ' statistics /biometry ', ' model design /development ', ' mathematical model ', ' neoplasm /cancer genetics ', ' nonsmall cell lung cancer ', ' clinical research ', ' outcomes research ', ' microarray technology ', ' patient oriented research ', ' gene expression profiling ', ' ']",NLM,VANDERBILT UNIVERSITY,R01,2005,28196,0.07490999880092236
"Serum Proteomic Biomarker Discovery in Lung Cancer DESCRIPTION (provided by applicant):  The applicant describes a five year program leading to independent translational research related to pulmonary and critical care medicine.  Although trained as a neuroscientist, the investigator is motivated by clinical experience to propose a career dedicated to the development of molecular diagnostic and targeted therapeutic approaches to medicine, in particular to lung cancer and critical illness.  Practical skills in functional genomics, proteomics, molecular biology, biostatistics, and machine learning will be fostered in the laboratory of Dr. Todd Golub, himself an accomplished clinical scientist with a vital independent research program.  Director of Cancer Genomics at the Whitehead Institute Center for Genome Research, Dr. Golub is a pioneer and internationally recognized leader in the application of genomics approaches to cancer biology, especially classification and prognosis.  This immersion will be complemented by formal instruction in genomics and computational biology, and reinforced by active advising from a team of domain experts.        The proposed research plan starts from the tenet that delayed or inaccurate diagnoses can be lethal.  Most lung cancer patients present with advanced disease, when the prognosis is grave; many of the critically ill can be given no better than phenomenological descriptions of their disease.  The Human Genome Project and other developments in biology and technology have advanced unbiased, whole-genome discovery efforts for improved markers of disease.  The principal investigator will undertake such an effort, by 1) creating datasets by mass spectrometry from serum samples of lung cancer patients and controls; 2) defining signatures of disease using machine learning approaches; and 3) identifying proteins and peptides comprising the diagnostic signatures.  While the investigator hopes to develop functional lung cancer biomarkers, the methodologies are intended to be applicable throughout medicine.        The combined resources of the Massachusetts General Hospital, the Dana Farber Cancer Institute, and the Whitehead Institute will be available to the applicant.  These rich environments will promote the success of the serum biomarker discovery project, and the larger cultivation of the investigator towards a goal of independence and productivity in academic medicine. ",Serum Proteomic Biomarker Discovery in Lung Cancer,6895904,K08CA102159,"['biomarker ', ' serum ', ' mass spectrometry ', ' human tissue ', ' information system ', ' adenocarcinoma ', ' squamous cell carcinoma ', ' lung neoplasm ', ' small cell lung cancer ', ' chromatography ', ' protein structure function ', ' clinical research ', ' protein protein interaction ', ' functional /structural genomics ', ' proteomics ', ' computational biology ', ' ']",NCI,DANA-FARBER CANCER INST,K08,2005,135837,0.13787459515359543
"Clinical & Microarray Data Predict Lung Cancer Outcomes Patients with non-small cell lung carcinoma (NSCLC) have a poor prognosis. Our goal is to develop methods to translate gene expression profiles into knowledge that will lead to the identification of molecular targets for prediction and therapy in these patients. Current clinical (staging) models for prediction of survival in these patients with small, localized tumors (Stage I) fails to identify the subset that will die less than 2.5 years after ""curative"" surgery. Our preliminary research with rule-based models using Stage I lung adenocarcinoma patients demonstrates meaningful results for prediction of survival with models that combine gene expression data with clinical data. Our primary hypothesis is: Clinical and gene expression attributes combine in rule-based models to accurately predict patient outcomes (time to death or recurrence). We propose to test this hypothesis for patients with resectable NSCLC. The Specific Aims are to: 1. Test the accuracy of the rule-based models as a function of the data type. We will use several established algorithms for generating decision rule models. Leave-one-out-cross-validation (LOOCV) will be used to evaluate model accuracy, complexity, and stability. The ""gold standard"" for performance comparison is the AJCC staging model. 2. Compare the model performance for rule-based induction to other algorithms. We will use support vector machines and artificial neural networks. We will address the role of feature selection in model performance. We will also confirm the significance of model variables using a standard statistical metric, partial least squares. We will also experimentally evaluate (random and adaptive) subsampling methods (bagging and boosting, respectively), which vote multiple rule models produced by one rule-based system, C4.5. 3. Research rule induction to hypothesize causal mechanisms in survival. We will develop a novel extension to rule induction that we call backward-chaining rule induction, a form of ""semi-supervised"" learning, which we expect to better focus the search for variable interactions to ""interesting"" rules (i.e., those with mechanistic explanations), than purely unsupervised approaches. Knowledge discovery will be evaluated based on domain expertise in the molecular basis of cancer. ",Clinical & Microarray Data Predict Lung Cancer Outcomes,7394041,R01LM008000,"['gene expression profiling ', ' patient oriented research ', ' microarray technology ', ' outcomes research ', ' clinical research ', ' nonsmall cell lung cancer ', ' neoplasm /cancer genetics ', ' mathematical model ', ' model design /development ', ' statistics /biometry ', ' human subject ', ' prognosis ', ' biopsy ', ' artificial intelligence ', ' ']",NLM,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2006,165017,0.07490999880092236
"Clinical & Microarray Data Predict Lung Cancer Outcomes Patients with non-small cell lung carcinoma (NSCLC) have a poor prognosis. Our goal is to develop methods to translate gene expression profiles into knowledge that will lead to the identification of molecular targets for prediction and therapy in these patients. Current clinical (staging) models for prediction of survival in these patients with small, localized tumors (Stage I) fails to identify the subset that will die less than 2.5 years after ""curative"" surgery. Our preliminary research with rule-based models using Stage I lung adenocarcinoma patients demonstrates meaningful results for prediction of survival with models that combine gene expression data with clinical data. Our primary hypothesis is: Clinical and gene expression attributes combine in rule-based models to accurately predict patient outcomes (time to death or recurrence). We propose to test this hypothesis for patients with resectable NSCLC. The Specific Aims are to: 1. Test the accuracy of the rule-based models as a function of the data type. We will use several established algorithms for generating decision rule models. Leave-one-out-cross-validation (LOOCV) will be used to evaluate model accuracy, complexity, and stability. The ""gold standard"" for performance comparison is the AJCC staging model. 2. Compare the model performance for rule-based induction to other algorithms. We will use support vector machines and artificial neural networks. We will address the role of feature selection in model performance. We will also confirm the significance of model variables using a standard statistical metric, partial least squares. We will also experimentally evaluate (random and adaptive) subsampling methods (bagging and boosting, respectively), which vote multiple rule models produced by one rule-based system, C4.5. 3. Research rule induction to hypothesize causal mechanisms in survival. We will develop a novel extension to rule induction that we call backward-chaining rule induction, a form of ""semi-supervised"" learning, which we expect to better focus the search for variable interactions to ""interesting"" rules (i.e., those with mechanistic explanations), than purely unsupervised approaches. Knowledge discovery will be evaluated based on domain expertise in the molecular basis of cancer. ",Clinical & Microarray Data Predict Lung Cancer Outcomes,7049523,R01LM008000,"['gene expression profiling ', ' patient oriented research ', ' microarray technology ', ' outcomes research ', ' clinical research ', ' nonsmall cell lung cancer ', ' neoplasm /cancer genetics ', ' mathematical model ', ' model design /development ', ' statistics /biometry ', ' human subject ', ' prognosis ', ' biopsy ', ' artificial intelligence ', ' ']",NLM,H. LEE MOFFITT CANCER CTR & RES INST,R01,2006,38466,0.07490999880092236
"Clinical & Microarray Data Predict Lung Cancer Outcomes Patients with non-small cell lung carcinoma (NSCLC) have a poor prognosis. Our goal is to develop methods to translate gene expression profiles into knowledge that will lead to the identification of molecular targets for prediction and therapy in these patients. Current clinical (staging) models for prediction of survival in these patients with small, localized tumors (Stage I) fails to identify the subset that will die less than 2.5 years after ""curative"" surgery. Our preliminary research with rule-based models using Stage I lung adenocarcinoma patients demonstrates meaningful results for prediction of survival with models that combine gene expression data with clinical data. Our primary hypothesis is: Clinical and gene expression attributes combine in rule-based models to accurately predict patient outcomes (time to death or recurrence). We propose to test this hypothesis for patients with resectable NSCLC. The Specific Aims are to: 1. Test the accuracy of the rule-based models as a function of the data type. We will use several established algorithms for generating decision rule models. Leave-one-out-cross-validation (LOOCV) will be used to evaluate model accuracy, complexity, and stability. The ""gold standard"" for performance comparison is the AJCC staging model. 2. Compare the model performance for rule-based induction to other algorithms. We will use support vector machines and artificial neural networks. We will address the role of feature selection in model performance. We will also confirm the significance of model variables using a standard statistical metric, partial least squares. We will also experimentally evaluate (random and adaptive) subsampling methods (bagging and boosting, respectively), which vote multiple rule models produced by one rule-based system, C4.5. 3. Research rule induction to hypothesize causal mechanisms in survival. We will develop a novel extension to rule induction that we call backward-chaining rule induction, a form of ""semi-supervised"" learning, which we expect to better focus the search for variable interactions to ""interesting"" rules (i.e., those with mechanistic explanations), than purely unsupervised approaches. Knowledge discovery will be evaluated based on domain expertise in the molecular basis of cancer. ",Clinical & Microarray Data Predict Lung Cancer Outcomes,7216647,R01LM008000,"['gene expression profiling ', ' patient oriented research ', ' microarray technology ', ' outcomes research ', ' clinical research ', ' nonsmall cell lung cancer ', ' neoplasm /cancer genetics ', ' mathematical model ', ' model design /development ', ' statistics /biometry ', ' human subject ', ' prognosis ', ' biopsy ', ' artificial intelligence ', ' ']",NLM,H. LEE MOFFITT CANCER CTR & RES INST,R01,2006,14319,0.07490999880092236
"Serum Proteomic Biomarker Discovery in Lung Cancer DESCRIPTION (provided by applicant):  The applicant describes a five year program leading to independent translational research related to pulmonary and critical care medicine.  Although trained as a neuroscientist, the investigator is motivated by clinical experience to propose a career dedicated to the development of molecular diagnostic and targeted therapeutic approaches to medicine, in particular to lung cancer and critical illness.  Practical skills in functional genomics, proteomics, molecular biology, biostatistics, and machine learning will be fostered in the laboratory of Dr. Todd Golub, himself an accomplished clinical scientist with a vital independent research program.  Director of Cancer Genomics at the Whitehead Institute Center for Genome Research, Dr. Golub is a pioneer and internationally recognized leader in the application of genomics approaches to cancer biology, especially classification and prognosis.  This immersion will be complemented by formal instruction in genomics and computational biology, and reinforced by active advising from a team of domain experts.        The proposed research plan starts from the tenet that delayed or inaccurate diagnoses can be lethal.  Most lung cancer patients present with advanced disease, when the prognosis is grave; many of the critically ill can be given no better than phenomenological descriptions of their disease.  The Human Genome Project and other developments in biology and technology have advanced unbiased, whole-genome discovery efforts for improved markers of disease.  The principal investigator will undertake such an effort, by 1) creating datasets by mass spectrometry from serum samples of lung cancer patients and controls; 2) defining signatures of disease using machine learning approaches; and 3) identifying proteins and peptides comprising the diagnostic signatures.  While the investigator hopes to develop functional lung cancer biomarkers, the methodologies are intended to be applicable throughout medicine.        The combined resources of the Massachusetts General Hospital, the Dana Farber Cancer Institute, and the Whitehead Institute will be available to the applicant.  These rich environments will promote the success of the serum biomarker discovery project, and the larger cultivation of the investigator towards a goal of independence and productivity in academic medicine. ",Serum Proteomic Biomarker Discovery in Lung Cancer,7087821,K08CA102159,"['computational biology ', ' proteomics ', ' functional /structural genomics ', ' protein protein interaction ', ' clinical research ', ' protein structure function ', ' chromatography ', ' small cell lung cancer ', ' lung neoplasms ', ' squamous cell carcinoma ', ' adenocarcinoma ', ' information systems ', ' human tissue ', ' mass spectrometry ', ' serum ', ' biomarker ', ' ']",NCI,DANA-FARBER CANCER INST,K08,2006,135837,0.13787459515359543
"Statistical Methods for Gene Environment Interactions In Lung Cancer    DESCRIPTION (provided by applicant):       Lung cancer is among the best known examples of a disease that reflects the interaction of genetic and environmental factors. While carcinogenic compounds in tobacco smoke constitute the major risk factor for lung cancer, only about 14% of long-time smokers will develop cancer. Family studies indicate the role that genetic susceptibility plays in determining lung cancer risk. The goal of this research proposal is to develop and apply methods to identify genetic susceptibility factors for lung cancer that are modulated by the effects of tobacco smoke. Toward this goal we are taking advantage of two extensive sources of data that reflect the efforts of teams of scientists who have been devoted to understanding the causes of lung cancer. The first source of data is from the Genetic Epidemiology of Lung Cancer Consortium, which has been collecting extended families with three or more relatives affected with lung cancer since 2000. Analytical results show evidence for a genetic susceptibility factor on chromosome 6q that strongly increases lung cancer risk, but that has a much more profound effect on risk among tobacco smokers. The other major source of data is an extremely large, case-control study developed by Dr. Margaret Spitz at the U.T. M.D. Anderson Cancer Center, starting in 1993. Currently, candidate gene studies to identify genetic risk factors of lung cancer susceptibility have been completed for 51 polymorphisms. In addition, data from a newly launched initiative to perform a genome-wide association analysis of 1200 ever-smoking Caucasian lung cancer cases and 1200 matched controls will become available within the next 3 months. A major goal of this proposal is to develop simulation-based approaches to evaluate the efficacy of many competing analytical approaches for characterizing the role of gene-environment interactions in disease causation. Our research involves a strong analytical team with extensive experience in gene-environment modeling, application of machine learning tools, and the study of family data. In addition, we have unique skills and methods for simulating data, which will be further refined through the proposed research funding. The simulation approaches and analytical discoveries from our research will be widely distributed. (End of Abstract)          ",Statistical Methods for Gene Environment Interactions In Lung Cancer,7348544,R01CA133996,"['Data Sources ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' Cancer Center ', ' Extended Family ', ' Family ', ' Affect ', ' Genes ', ' Population Genetics ', ' Genome ', ' Standards of Weights and Measures ', ' Natural History ', ' base ', ' Goals ', ' Procedures ', ' Head ', ' Family Study ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Predisposition ', ' Susceptibility ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' Methods ', ' Simulate ', ' Personal Satisfaction ', ' well-being ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' tool ', ' Smoker ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' Time ', ' Tobacco ', ' Caucasians ', ' Complex ', ' Tobacco smoke ', ' Behavior ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' skills ', ' simulation ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Relative (related person) ', ' Relative ', ' genetic risk factor ', ' inherited factor ', ' Statistical Methods ', ' abstracting ', ' Chromosome Mapping ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosomes ', ' Modeling ', ' case control ', ' genetic epidemiology ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Population ', ' analytical tool ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2007,263340,0.21059653839161882
"Serum Proteomic Biomarker Discovery in Lung Cancer DESCRIPTION (provided by applicant):  The applicant describes a five year program leading to independent translational research related to pulmonary and critical care medicine.  Although trained as a neuroscientist, the investigator is motivated by clinical experience to propose a career dedicated to the development of molecular diagnostic and targeted therapeutic approaches to medicine, in particular to lung cancer and critical illness.  Practical skills in functional genomics, proteomics, molecular biology, biostatistics, and machine learning will be fostered in the laboratory of Dr. Todd Golub, himself an accomplished clinical scientist with a vital independent research program.  Director of Cancer Genomics at the Whitehead Institute Center for Genome Research, Dr. Golub is a pioneer and internationally recognized leader in the application of genomics approaches to cancer biology, especially classification and prognosis.  This immersion will be complemented by formal instruction in genomics and computational biology, and reinforced by active advising from a team of domain experts.        The proposed research plan starts from the tenet that delayed or inaccurate diagnoses can be lethal.  Most lung cancer patients present with advanced disease, when the prognosis is grave; many of the critically ill can be given no better than phenomenological descriptions of their disease.  The Human Genome Project and other developments in biology and technology have advanced unbiased, whole-genome discovery efforts for improved markers of disease.  The principal investigator will undertake such an effort, by 1) creating datasets by mass spectrometry from serum samples of lung cancer patients and controls; 2) defining signatures of disease using machine learning approaches; and 3) identifying proteins and peptides comprising the diagnostic signatures.  While the investigator hopes to develop functional lung cancer biomarkers, the methodologies are intended to be applicable throughout medicine.        The combined resources of the Massachusetts General Hospital, the Dana Farber Cancer Institute, and the Whitehead Institute will be available to the applicant.  These rich environments will promote the success of the serum biomarker discovery project, and the larger cultivation of the investigator towards a goal of independence and productivity in academic medicine. ",Serum Proteomic Biomarker Discovery in Lung Cancer,7251530,K08CA102159,"['Critical Care ', ' Critical Illness ', ' Critically Ill ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Environment ', ' Epithelium ', ' lung small cell carcinoma ', ' lung small cell neuroendocrine carcinoma ', ' lung oat cell carcinoma ', ' Small Cell Lung Cancer ', ' Data Set ', ' Dataset ', ' Dana-Farber Cancer Institute ', ' DF/HCC ', ' Detection ', ' Development, Other ', ' Disease Marker ', ' Cancer Biology ', ' Cancer Etiology ', ' Cancer Cause ', ' Cancer Patient ', ' Carcinogenesis Mechanism ', ' Collection ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Limited Stage ', ' Translational Research ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Lung Adenocarcinoma ', ' Monitor ', ' Rate ', ' Principal Investigator ', ' Evolution ', ' Molecular ', ' Development ', ' developmental ', ' Gene Expression ', ' Genome ', ' base ', ' career ', ' Goals ', ' improved ', ' General Hospitals ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Human Genome Project ', ' Clinical ', ' Variant ', ' Variation ', ' Immersion Investigative Technique ', ' Immersion ', ' Institutes ', ' Training ', ' Laboratories ', ' Serum ', ' Blood Serum ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Fostering ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Massachusetts ', ' Medicine ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Neoplasm Metastasis ', ' tumor cell metastasis ', ' cancer metastasis ', ' Tumor Cell Migration ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastasize ', ' Metastasis ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Patients ', ' Peptides ', ' Genetic ', ' Probability ', ' Productivity ', ' outcome forecast ', ' Prognosis ', ' tool ', ' Proteins ', ' gene product ', ' Diagnostic ', ' Condition ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Serum Proteins ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Computational Biology ', ' programs ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' survivorship ', ' Localized ', ' Technology ', ' Scientist ', ' Tobacco smoke ', ' Class ', ' Back ', ' Dorsum ', ' Tumor Tissue ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Biological Markers ', ' Biologic Marker ', ' Biology ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Early Diagnosis ', ' early detection ', ' experience ', ' success ', ' bronchial epithelium ', ' Informatics ', ' Oligonucleotide Microarrays ', ' Oligonucleotide Array ', ' Primary Neoplasm ', ' Primary Tumor ', ' Structure ', ' skills ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carcinogens ', ' oncogenic agent ', ' Oncogens ', ' Cancer Causing Agents ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Proteome ', ' Sampling ', ' Proteomics ', ' functional genomics ', ' Genomics ', ' Classification ', ' Systematics ', ' cancer classification ', ' Complement ', ' Complement Proteins ', ' Instruction ', ' cancer genomics ', ' oncogenomics ', ' Small Cell Carcinoma ', ' Small Cell Cancer ', ' lung carcinogenesis ', ' Coupled ', ' therapeutic target ', ' ']",NCI,DANA-FARBER CANCER INST,K08,2007,135837,0.13787459515359543
"High Density Association Analysis of Lung Cancer    DESCRIPTION (provided by applicant):  The goal of this research is to identify novel susceptibility genes for lung cancer using a systematic genome- wide association-based approach. To achieve this goal, we are applying a two-stage design. This proposal builds upon an extensive resource of lung cancer cases and controls matched for smoking behavior, sex, and ethnicity who have been collected over many years at the U.T. M.D. Anderson Cancer Center, and on a recently approved proposal to the Center for Inherited Disease Research that is performing genotyping of 317,000 markers on 1200 Caucasian ever-smoking lung cancer cases and 1200 controls matched for ethnicity, age, smoking behavior, and sex. Our first aim is to analyze data from the completed first-stage of genotyping. For our second aim, we will complete the two-stage design, which is powered to detect associations with genotypic risk ratios of about 1.4 with a very stringent significance criterion of 1.7 x 10-7. We will genotype and analyze 3380 SNPs on 1200 lung cancer cases and 1200 controls. We will also analyze SNPs from 90 candidate genes identified through a systematic literature search as well as a limited number of SNPs in significant pathways. In our third aim we will genotype 400 never-smoking lung cancer cases and 400 controls for 946 SNP markers. To evaluate possible interethnic differences in the genetic control of lung cancer risk we will analyze 400 African-American lung cancer cases and 400 African- American controls (aim 4) for 946 SNP markers. In these 4 aims we are also including a panel of SNPs to estimate ancestry. In aim 5, we use machine learning approaches to develop models for characterizing gene-gene and gene-environment effects on lung cancer risk. Cases and controls have extensive epidemiological and family history data together with candidate gene and functional DNA repair measures. The end result of our analysis will substantively increase our understanding of the genetic etiology of lung cancer and gene-environment interactions that contribute to its causation. This is an experienced investigative team, using state of the art technology to perform a multistage genome-wide analysis on a large, uniquely well-characterized population of lung cancer cases and matched controls with rich functional data. We are collaborating with the International Lung Cancer Consortium so that it can further validate our findings for a variety of different populations, in future initiatives.                                                              ",High Density Association Analysis of Lung Cancer,7321441,R01CA121197,"['Data Analyses ', ' Data Analysis ', ' Inflammatory Response ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Data ', ' Direct Costs ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Applications Grants ', ' Grant Proposals ', ' International ', ' Subgroup ', ' Cancer Center ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' Collection ', ' Enrollment ', ' enroll ', ' Genetic Risk ', ' Genotypic Risk Ratio ', ' Newly Diagnosed ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Prevention ', ' Smoking Status ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Validation ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Future ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Behavioral Genetics ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Genome ', ' Genotype ', ' Age ', ' base ', ' density ', ' Goals ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Hypersensitivity ', ' Allergy ', ' repaired ', ' repair ', ' In Vitro ', ' Infection ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Individual ', ' Numbers ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Fostering ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Relative Risks ', ' Sample Size ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Persons ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Collaborations ', ' Occupational Exposure ', ' Oncogenes ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' Play ', ' Staging ', ' tool ', ' Smoker ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' medical specialties ', ' Specialty ', ' Arts ', ' Technology ', ' Tobacco ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Scanning ', ' Clinic ', ' Pattern ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' novel ', ' Participant ', ' Population Study ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Gender ', ' genetic analysis ', ' Genetic analyses ', ' Measures ', ' Statistical Methods ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Causations ', ' Modeling ', ' case control ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' Classification ', ' Systematics ', ' tobacco exposure ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' design ', ' designing ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' genome-wide analysis ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2007,584700,0.18238103681189097
"Genetic Polymorphisms in TRAIL Pathway as Susceptibility Markers for Lung Cancer    DESCRIPTION (provided by applicant):       Eighty-seven percent of lung cancers (LC) are attributed to tobacco exposure. However, only a fraction of smokers develop cancer. Genetically determined modulation of environmental exposures is an attractive possible mechanism for the variation in host susceptibility. Loss of apoptosis has been demonstrated to be an important mechanism for lung carcinogenesis. The activation of apoptosis signaling is through an intrinsic Bcl- 2 pathway and an extrinsic or TRAIL (TNF-related Apoptosis Inducing Ligand) pathway by activation of the death receptor. Although apoptosis is evolutionarily conserved, there may be interindividual variation in apoptotic capacity in general population. Polymorphic changes on genes of TRAIL pathway have been reported to be associated with modulated apoptosis. To date, there have been no studies on the role of genetic polymorphisms in the apoptotic pathway genes as predisposing factors for LC. In this application, we aim at examining polymorphisms in genes involved in the TRAIL pathway as predisposition factor for LC. The specific aims of this proposed study are: 1) To assess frequencies of SNPs in genes in the TRAIL apoptotic pathway (DR4, DR5, FADD, caspases -8, -10, -3, and -9, and BID) in 1000 cases and 1000 controls. Our working hypothesis is that adverse alleles on TRAIL pathway genes which are associated with modified apoptosis capacity may predispose individuals to increased lung cancer risk; 2) To Assess haplotypes and diplotypes as markers of susceptibility. We will implement haplotype-based analyses to identify any additional genetic factors; 3) To apply hierarchical model to refine the risk assessment and to apply novel machine- learning tools to identify any gene-environment and gene-gene interactions. Our hypothesis is that LC is a complex disease involving multiple genes in the apoptic pathway that have common, low penetrance polymorphisms, and that these polymorphisms interacting with each other and/or environmental factors. This application is designed to build upon a data and specimen repository from on ongoing funded lung-cancer case- control study in the Department of Epidemiology. Because relevant genotype data and epidemiologic profiles are available from the parent grant, this application is both time and cost effective. The goal of this study is to further our understanding of lung carcinogenesis. Polymorphic changes on TRAIL pathway may be useful risk biomarkers to identify high-risk populations.           ",Genetic Polymorphisms in TRAIL Pathway as Susceptibility Markers for Lung Cancer,7264915,R03CA128079,"['novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' General Population ', ' General Public ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' telomere ', ' Risk Assessment ', ' Modeling ', ' case control ', ' repository ', ' tobacco exposure ', ' design ', ' designing ', ' lung carcinogenesis ', ' cost effective ', ' cost-effective ', ' Population ', ' parent grant ', ' caspase ', ' cysteine endopeptidase ', ' cystein proteinase ', ' cystein protease ', ' ICE-like protease ', ' Cell-Death Protease ', ' Cessation of life ', ' Death ', ' Cell Cycle Checkpoint ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Dust ', ' TNFRSF10B gene ', ' ZTNFR9 ', ' TRICKB ', ' TRICK2B ', ' TRICK2A ', ' TRICK2 ', ' TRAILR2 ', ' TNFRSF10B ', ' KILLER/DR5 ', ' DR5 ', ' Environment ', ' Environmental Exposure ', ' Enzymes ', ' Length ', ' Build-it ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' lung small cell carcinoma ', ' lung small cell neuroendocrine carcinoma ', ' lung oat cell carcinoma ', ' Small Cell Lung Cancer ', ' human TNFRSF10A protein ', ' tumor necrosis factor receptor superfamily, member 10a protein, human ', ' tumor necrosis factor receptor superfamily member 10D ', ' Tumor Necrosis Factor Receptor Superfamily, Member 10A ', ' TRAIL Receptor 1 ', ' TNF-Related Apoptosis Inducing Ligand Receptor 1 ', ' Death Receptor 4 ', ' Cytotoxic TRAIL Receptor ', ' Data ', ' Death Domain ', ' Applications Grants ', ' Grant Proposals ', ' Stratification ', ' Apoptotic ', ' Cancer Patient ', ' Genetic Risk ', ' Characteristics ', ' Molecular ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genotype ', ' base ', ' Goals ', ' Haplotypes ', ' Hay fever ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Variant ', ' Variation ', ' Alleles ', ' Allelomorphs ', ' Inflammation ', ' Predisposition ', ' Susceptibility ', ' Individual ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' CD95 Antigens ', ' fas Receptors ', ' fas Antigens ', ' Tumor Necrosis Factor Receptor Superfamily, Member 6 ', ' TNFRSF6 Receptor ', ' CD95 molecule ', ' Apoptosis Antigen 1 ', ' APO-1 Cell Surface Antigen ', ' APO-1 Antigen ', ' Family Cancer History ', ' Micronutrients ', ' Metabolic ', ' Genetic ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Predisposing Factor ', ' tool ', ' Smoker ', ' Pulmonary Emphysema ', ' Emphysema ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Smoking ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' TNF-related apoptosis-inducing ligand ', ' Tumor Necrosis Factor Ligand Superfamily Member 10 ', ' TRAIL Protein ', ' TNFSF10 Protein ', ' TNF-Related Apoptosis Inducing Ligand TRAIL ', ' Apo-2 Ligand ', ' APO2 Ligand ', ' Asbestos ', ' Time ', ' Tobacco ', ' Asthma ', ' Bronchial Asthma ', ' Caucasians ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Pattern ', ' Penetrance ', ' death receptor-4 ', ' tumor necrosis factor receptor superfamily member 10A ', ' receptor TRAIL-4 ', ' TRAIL-R4 ', ' TNF-related apoptosis-inducing ligand receptor 1 ', ' Biological Markers ', ' Biologic Marker ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' cancer risk ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' receptor ', ' Receptor Protein ', ' caspase-8 ', ' Mch5 protease ', ' MACH protein ', ' FLICE protein ', ' FADD-homologous ICE/CED3-Like Protease ', ' FADD-Like ICE ', ' Caspase-8/Flice ', ' CASP8 Protein ', ' CAP4 protease ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R03,2007,77000,0.10431417137853966
"Statistical Model Building for High Dimensional Biomedical Data    DESCRIPTION (provided by applicant):  Typical of current large-scale biomedical data is the feature of small number of observed samples and the widely observed sample heterogeneity. Identifying differentially expressed genes related to the sample phenotye (e.g., cancer disease development) and predicting sample phenotype based on the gene expressions are some central research questions in the microarray data analysis. Most existing statistical methods have ignored sample heterogeneity and thus loss power.       This project proposes to develop novel statistical methods that explicitly address the small sample size and sampe heterogeneity issues, and can be applied very generally. The usefulness of these methods will be shown with the large-scale biomedical data originating from the lung and kidney transplant research projects. The transplant projects aimed to improve the molecular diagnosis and therapy of lung/kidney allograft rejection by identifying molecular biomarkers to predict the allograft rejection for critical early treatment and rapid, noninvasive, and economical testing.       The specific aims are 1) Develop novel statistical methods for differential gene expression detection that explicitly model sample heterogeneity. 2) Develop novel statistical methods for classifying high-dimensional biomedical data and incorporating sample heterogeneity. 3) Develop novel statistical methods for jointly analyzing a set of genes (e.g., genes in a pathway). 4) Use the developed models and methods to answer research questions relevant to public health in the lung and kidney transplant projects; and implement and validate the proposed methods in user-friendly and well-documented software, and distribute them to the scientific community at no charge.       It is very important to identify new biomarkers of allograft rejection in lung and kidney transplant recipients. The rapid and reliable detection and prediction of rejection in easily obtainable body fluids may allow the rapid advancement of clinical interventional trials. We propose to study novel methods for analyzing the large-scale biomedical data to realize their full potential of molecular diagnosis and prognosis of transplant rejection prediction for critical early treatment.          ",Statistical Model Building for High Dimensional Biomedical Data,7386333,R01GM083345,"['Data Analyses ', ' Data Analysis ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' None or Not Applicable ', ' Effectiveness ', ' Purpose ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Molecular Diagnosis ', ' Collection ', ' Oncogene Activation ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Characteristics ', ' Molecular ', ' Development ', ' developmental ', ' Experimental Designs ', ' Pathway interactions ', ' pathway ', ' Gene Expression ', ' Genes ', ' base ', ' method development ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' improved ', ' Procedures ', ' Heterogeneity ', ' Algorithms ', ' Clinical ', ' Joints ', ' Articulation ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Least-Squares Analysis ', ' Least-Squares Analyses ', ' Least Squares ', ' Individual ', ' Numbers ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Sample Size ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Minnesota ', ' Statistical Models ', ' Probabilistic Models ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Patients ', ' Personal Satisfaction ', ' well-being ', ' Phenotype ', ' Probability ', ' outcome forecast ', ' Prognosis ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Proposals ', ' Resources ', ' Research Resources ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' sound ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Transplantation ', ' transplant ', ' Universities ', ' Adopted ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Work ', ' Dimensions ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Allografting ', ' interest ', ' Biological Markers ', ' Biologic Marker ', ' kidney allograft ', ' renal allograft ', ' Body Fluids ', ' user friendly software ', ' user friendly computer software ', ' simulation ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cations ', ' Charge ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Outcome Measure ', ' Modeling ', ' Sampling ', ' desire ', ' theories ', ' software development ', ' developing computer software ', ' develop software ', ' Genomics ', ' Classification ', ' Systematics ', ' Communities ', ' cancer microarray ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' cancer type ', ' Coupled ', ' Early treatment ', ' early therapy ', ' early intervention ', ' user-friendly ', ' ']",NIGMS,UNIVERSITY OF MINNESOTA,R01,2008,255036,0.06301616635225511
"Inflammation Genes and Lung Cancer Risk    DESCRIPTION (provided by applicant): There is accumulating evidence that chronic injury and inflammation in the respiratory tract, such as that caused by cigarette smoking, predispose to lung cancer. We therefore propose to conduct an in depth pathway-based analysis of gene variants in the inflammatory pathway using test and validation sets of cases and controls. This proposal builds on a well-annotated specimen repository of lung cancer cases and controls enrolled in an ongoing risk factor study (CA55769, Spitz, PI). Cases are frequency-matched to controls on age, gender, ethnicity and smoking status recruited from a multi-specialty physician practice. Data collected include smoking history, dietary intake, cancer family history, specific occupational exposures (e.g., asbestos, dust), and previous medical history including chronic obstructive airway disease, asthma and hay fever. Genomic DNA and rich candidate genotype and phenotype data are available. Aim 1: To identify novel genetic variants influencing lung cancer risk in a test set of 1500 cases with non-small cell lung cancer and 1500 matched controls (all Caucasian), using the Illumina iSelect Infinium chip with 8.5 to 9K SNP's. Aim 2: In a replication set of an additional 1000 cases and 1000 controls, using a GoldenGate assay, we will evaluate the top 1500 SNPs identified from Aim1 as meeting the P<0.1 criterion, or selected by a rational prioritizing approach that incorporates published results, type of SNP, evolutionary biology, physico-chemical properties and haplotype tagging SNPs. Aim 3: To perform fine mapping in the flanking regions of 50 SNPs selected by the same approach as in Aim 2, combining prior information with in silico approaches for predicting functionality. For each of these 50 SNPs, we will select an average of 10 additional SNPs per gene region to regenotype in all 2500 cases and 2500 controls. Aim 4. To extend our epidemiologic risk prediction model by incorporating established epidemiologic risk factor and gene variant data. We will apply machine-learning tools to identify gene-environment and gene-gene interactions. Covariates will include prior emphysema, asthma, hay fever, dust and asbestos exposure, smoking characteristics, family history of cancer, and anti-inflammatory drug use. The International Lung Cancer Consortium will perform external validation in a proposal to be developed. Our approach to comprehensively evaluate variants in a candidate pathway in a large well- powered study will be applicable to a variety of other cancer sites where inflammation plays an important etiologic role, as well as in non-neoplastic diseases with a strong inflammatory component such as emphysema. The public health potential of a useful risk prediction modes for lung cancer is substantial. Public Health Relevance Statement Cigarette smoking results in inflammation in the respiratory tract and there is growing evidence that chronic inflammatory processes predispose to lung cancer. However, the molecular mechanisms underlying the causal nature of this association are unclear. We propose to conduct an in depth analysis of gene variants in the inflammatory pathway as susceptibility factors for lung cancer. This proposal builds upon an existing well annotated specimen repository. We will evaluate gene variants in a test set of lung cancer cases and matched controls and validate the findings in an independent dataset. Finally we will incorporate these findings into an extended risk prediction model for lung cancer.                      ",Inflammation Genes and Lung Cancer Risk,7371751,R01CA127219,"['Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Logistics ', ' Drug usage ', ' drug use ', ' Oxidative Stress ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' chemical property ', ' Maps ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Letters ', ' Occupational Exposure ', ' angiogenesis ', ' Phenotype ', ' Genetic ', ' Physicians ', ' Anti-Inflammatory Agents ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Probability ', ' Staging ', ' Inflammatory ', ' Antihistamines ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Pulmonary Emphysema ', ' Emphysema ', ' Receiver Operating Characteristics ', ' Condition ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Nature ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Research ', ' Resources ', ' Research Resources ', ' Respiratory System ', ' respiratory tract ', ' Respiratory system (all sites) ', ' Pulmonary Organ System ', ' Pulmonary Body System ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoking ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' medical specialties ', ' Specialty ', ' Asbestos ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Asthma ', ' Bronchial Asthma ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Adopted ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Score ', ' Host Defense ', ' Nucleotide Excision Repair ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' cancer risk ', ' carcinogenesis ', ' Cancer Induction ', ' gene interaction ', ' Proxy ', ' novel ', ' Participant ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' cigarette smoking ', ' smoke cigarette ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Cell Cycle ', ' Cell Division Cycle ', ' cell growth ', ' Cellular Growth ', ' Cellular Expansion ', ' Gender ', ' TP53 gene ', ' p53 Genes ', ' Tumor Protein p53 Gene ', ' TRP53 ', ' TP53 ', ' P53 ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Modeling ', ' response ', ' case control ', ' repository ', ' cancer site ', ' cancer location ', ' Genomics ', ' genetic variant ', ' Outcome ', ' aggregation pathway ', ' parent grant ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' Base Excision Repairs ', ' DNA Base Excision Repair ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' tumorigenesis ', ' Oncogenesis ', ' Dust ', ' Environment ', ' Data Set ', ' Dataset ', ' DNA Repair Pathway ', ' Data ', ' International ', ' Progress Review Group ', ' Range ', ' Anti-inflammatory ', ' Enrollment ', ' enroll ', ' Newly Diagnosed ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Status ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Pathway interactions ', ' pathway ', ' neoplastic ', ' Affect ', ' Genes ', ' Genotype ', ' Injury ', ' Age ', ' Glutathione S-Transferase ', ' glutathione aryltransferase ', ' glutathione aralkyltransferase ', ' S-Hydroxyalkyl Glutathione Lyase ', ' Ligandins ', ' Heme Transfer Protein ', ' Glutathione Transferase ', ' Glutathione S-Epoxidetransferase ', ' Glutathione S-Aryltransferase ', ' Glutathione S-Aralkyltransferase ', ' Glutathione S-Alkyltransferase ', ' Glutathione Organic Nitrate Ester Reductase ', ' EC 2.5.1.18 ', ' base ', ' Goals ', ' Growth Factor ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Haplotypes ', ' Hay fever ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Depth ', ' Area ', ' Chronic ', ' Variant ', ' Variation ', ' Molecular Epidemiology ', ' Link ', ' In Vitro ', ' Infection ', ' Inflammation ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Irritants ', ' Joints ', ' Articulation ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2008,549712,0.12530806534110406
"Statistical Methods for Gene Environment Interactions In Lung Cancer    DESCRIPTION (provided by applicant):       Lung cancer is among the best known examples of a disease that reflects the interaction of genetic and environmental factors. While carcinogenic compounds in tobacco smoke constitute the major risk factor for lung cancer, only about 14% of long-time smokers will develop cancer. Family studies indicate the role that genetic susceptibility plays in determining lung cancer risk. The goal of this research proposal is to develop and apply methods to identify genetic susceptibility factors for lung cancer that are modulated by the effects of tobacco smoke. Toward this goal we are taking advantage of two extensive sources of data that reflect the efforts of teams of scientists who have been devoted to understanding the causes of lung cancer. The first source of data is from the Genetic Epidemiology of Lung Cancer Consortium, which has been collecting extended families with three or more relatives affected with lung cancer since 2000. Analytical results show evidence for a genetic susceptibility factor on chromosome 6q that strongly increases lung cancer risk, but that has a much more profound effect on risk among tobacco smokers. The other major source of data is an extremely large, case-control study developed by Dr. Margaret Spitz at the U.T. M.D. Anderson Cancer Center, starting in 1993. Currently, candidate gene studies to identify genetic risk factors of lung cancer susceptibility have been completed for 51 polymorphisms. In addition, data from a newly launched initiative to perform a genome-wide association analysis of 1200 ever-smoking Caucasian lung cancer cases and 1200 matched controls will become available within the next 3 months. A major goal of this proposal is to develop simulation-based approaches to evaluate the efficacy of many competing analytical approaches for characterizing the role of gene-environment interactions in disease causation. Our research involves a strong analytical team with extensive experience in gene-environment modeling, application of machine learning tools, and the study of family data. In addition, we have unique skills and methods for simulating data, which will be further refined through the proposed research funding. The simulation approaches and analytical discoveries from our research will be widely distributed. (End of Abstract)          ",Statistical Methods for Gene Environment Interactions In Lung Cancer,7500250,R01CA133996,"['base ', ' Goals ', ' Procedures ', ' Head ', ' Family Study ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Predisposition ', ' Susceptibility ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' Methods ', ' Simulate ', ' Personal Satisfaction ', ' well-being ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' tool ', ' Smoker ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' Time ', ' Tobacco ', ' Caucasians ', ' Complex ', ' Tobacco smoke ', ' Behavior ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' skills ', ' simulation ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Relative (related person) ', ' Relative ', ' genetic risk factor ', ' inherited factor ', ' Statistical Methods ', ' abstracting ', ' Chromosome Mapping ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosomes ', ' Modeling ', ' case control ', ' genetic epidemiology ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Population ', ' analytical tool ', ' Data Sources ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' Cancer Center ', ' Extended Family ', ' Family ', ' Affect ', ' Genes ', ' Population Genetics ', ' Genome ', ' Standards of Weights and Measures ', ' Natural History ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2008,263340,0.21059653839161882
"Inflammation Genes and Lung Cancer Risk    DESCRIPTION (provided by applicant): There is accumulating evidence that chronic injury and inflammation in the respiratory tract, such as that caused by cigarette smoking, predispose to lung cancer. We therefore propose to conduct an in depth pathway-based analysis of gene variants in the inflammatory pathway using test and validation sets of cases and controls. This proposal builds on a well-annotated specimen repository of lung cancer cases and controls enrolled in an ongoing risk factor study (CA55769, Spitz, PI). Cases are frequency-matched to controls on age, gender, ethnicity and smoking status recruited from a multi-specialty physician practice. Data collected include smoking history, dietary intake, cancer family history, specific occupational exposures (e.g., asbestos, dust), and previous medical history including chronic obstructive airway disease, asthma and hay fever. Genomic DNA and rich candidate genotype and phenotype data are available. Aim 1: To identify novel genetic variants influencing lung cancer risk in a test set of 1500 cases with non-small cell lung cancer and 1500 matched controls (all Caucasian), using the Illumina iSelect Infinium chip with 8.5 to 9K SNP's. Aim 2: In a replication set of an additional 1000 cases and 1000 controls, using a GoldenGate assay, we will evaluate the top 1500 SNPs identified from Aim1 as meeting the P<0.1 criterion, or selected by a rational prioritizing approach that incorporates published results, type of SNP, evolutionary biology, physico-chemical properties and haplotype tagging SNPs. Aim 3: To perform fine mapping in the flanking regions of 50 SNPs selected by the same approach as in Aim 2, combining prior information with in silico approaches for predicting functionality. For each of these 50 SNPs, we will select an average of 10 additional SNPs per gene region to regenotype in all 2500 cases and 2500 controls. Aim 4. To extend our epidemiologic risk prediction model by incorporating established epidemiologic risk factor and gene variant data. We will apply machine-learning tools to identify gene-environment and gene-gene interactions. Covariates will include prior emphysema, asthma, hay fever, dust and asbestos exposure, smoking characteristics, family history of cancer, and anti-inflammatory drug use. The International Lung Cancer Consortium will perform external validation in a proposal to be developed. Our approach to comprehensively evaluate variants in a candidate pathway in a large well- powered study will be applicable to a variety of other cancer sites where inflammation plays an important etiologic role, as well as in non-neoplastic diseases with a strong inflammatory component such as emphysema. The public health potential of a useful risk prediction modes for lung cancer is substantial. Public Health Relevance Statement Cigarette smoking results in inflammation in the respiratory tract and there is growing evidence that chronic inflammatory processes predispose to lung cancer. However, the molecular mechanisms underlying the causal nature of this association are unclear. We propose to conduct an in depth analysis of gene variants in the inflammatory pathway as susceptibility factors for lung cancer. This proposal builds upon an existing well annotated specimen repository. We will evaluate gene variants in a test set of lung cancer cases and matched controls and validate the findings in an independent dataset. Finally we will incorporate these findings into an extended risk prediction model for lung cancer.                      ",Inflammation Genes and Lung Cancer Risk,7691628,R01CA127219,"['Probability ', ' Staging ', ' Inflammatory ', ' Antihistamines ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Pulmonary Emphysema ', ' Emphysema ', ' Receiver Operating Characteristics ', ' Condition ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Nature ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Research ', ' Resources ', ' Research Resources ', ' Respiratory System ', ' respiratory tract ', ' Respiratory system (all sites) ', ' Pulmonary Organ System ', ' Pulmonary Body System ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoking ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' medical specialties ', ' Specialty ', ' Asbestos ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Asthma ', ' Bronchial Asthma ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Adopted ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Score ', ' Host Defense ', ' Nucleotide Excision Repair ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' cancer risk ', ' carcinogenesis ', ' Cancer Induction ', ' gene interaction ', ' Proxy ', ' novel ', ' Participant ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' cigarette smoking ', ' smoke cigarette ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Cell Cycle ', ' Cell Division Cycle ', ' cell growth ', ' Cellular Growth ', ' Cellular Expansion ', ' Gender ', ' TP53 gene ', ' p53 Genes ', ' Tumor Protein p53 Gene ', ' TRP53 ', ' TP53 ', ' P53 ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Modeling ', ' response ', ' case control ', ' repository ', ' cancer site ', ' cancer location ', ' Genomics ', ' genetic variant ', ' Outcome ', ' aggregation pathway ', ' parent grant ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' Base Excision Repairs ', ' DNA Base Excision Repair ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' tumorigenesis ', ' Oncogenesis ', ' Dust ', ' Environment ', ' Data Set ', ' Dataset ', ' DNA Repair Pathway ', ' Data ', ' International ', ' Progress Review Group ', ' Range ', ' Anti-inflammatory ', ' Enrollment ', ' enroll ', ' Newly Diagnosed ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Status ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Pathway interactions ', ' pathway ', ' neoplastic ', ' Affect ', ' Genes ', ' Genotype ', ' Injury ', ' Age ', ' Glutathione S-Transferase ', ' glutathione aryltransferase ', ' glutathione aralkyltransferase ', ' S-Hydroxyalkyl Glutathione Lyase ', ' Ligandins ', ' Heme Transfer Protein ', ' Glutathione Transferase ', ' Glutathione S-Epoxidetransferase ', ' Glutathione S-Aryltransferase ', ' Glutathione S-Aralkyltransferase ', ' Glutathione S-Alkyltransferase ', ' Glutathione Organic Nitrate Ester Reductase ', ' EC 2.5.1.18 ', ' base ', ' Goals ', ' Growth Factor ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Haplotypes ', ' Hay fever ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Depth ', ' Area ', ' Chronic ', ' Variant ', ' Variation ', ' Molecular Epidemiology ', ' Link ', ' In Vitro ', ' Infection ', ' Inflammation ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Irritants ', ' Joints ', ' Articulation ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Logistics ', ' Drug usage ', ' drug use ', ' Oxidative Stress ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' chemical property ', ' Maps ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Letters ', ' Occupational Exposure ', ' angiogenesis ', ' Phenotype ', ' Genetic ', ' Physicians ', ' Anti-Inflammatory Agents ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2008,399774,0.12530806534110406
"Predicting Radiotherapy Outcomes by Combining Physical and Biological Factors    DESCRIPTION (provided by applicant):   Many radiotherapy (RT) treatments carry a significant risk of serious complications to normal tissues. Previously, efforts to predict outcome have used either physical factors (e.g., volume irradiated to high dose) or biological factors (e.g., inherent radiosensitivity), but not both. We hypothesize that combining physical treatment data with patient-specific biomarkers will increase the predictive power of RT outcomes models. We will test this hypothesis specifically for prediction of radiation pneumonitis (RP) for lung cancer patients. Because no appropriate dataset exists to test this hypothesis, under Specific Aim 1, we will conduct a prospective clinical trial for non-small-cell lung cancer patients and collect candidate physical and biological data for modeling. Biomarker families selected based on peer-reviewed literature will mainly include:  (a) the levels of DNA-end binding complexes of DNA damage detection and repair proteins, which has been well correlated with radiosensitivity; and (b) pretreatment blood levels of the interleukin family of inflammatory cytokines (IL-1 alpha and IL-6) and ACE enzymes, which have also been correlated to RP. Physical data to be collected includes volumes irradiated to varying doses of the normal lung (dose-volume histogram data, collected using 4-D methods to avoid breathing artifacts), and the spatial location of the high-dose regions, both of which have been correlated with risk of RP. We will also image tumor regression over the course of RT (mid-course and at the end of RT) in order to better characterize the high doses received by normal lung tissue after tumor regression. In SA2, we test the hypothesized improvement in outcome prediction by combining biological and physical data. To select the best mathematical model, we will adapt and validate a new form of statistical model-building known as kernel-based learning. Based on our preliminary results, the kernel-based methods will likely provide a natural framework for understanding the interactions among the different physical and biological variables resulting in an effectively optimal predictive model. In summary, we propose to test the combination of biological/biomarker data and dose data to improve our ability to predict radiotherapy complications. In particular, we will use detectable blood-based biomarkers as well as treatment dose distribution characteristics to potentially improve our ability to predict (or avoid) radiation pneumonitis.          ",Predicting Radiotherapy Outcomes by Combining Physical and Biological Factors,7470386,K25CA128809,"['data mining ', ' datamining ', ' Environment ', ' Address ', ' Enzymes ', ' Dose ', ' Data Set ', ' Dataset ', ' End Point ', ' Data ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Predictive Value ', ' Range ', ' in vitro Assay ', ' Cancer Patient ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Collection ', ' Common Terminology Criteria for Adverse Events ', ' Common Toxicity Criteria ', ' CTCAE ', ' Validation ', ' Principal Investigator ', ' prescription document ', ' Characteristics ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Radiotherapy Research ', ' Development ', ' developmental ', ' Family ', ' Image ', ' imaging ', ' Standards of Weights and Measures ', ' Age ', ' base ', ' Organ ', ' Blood specimen ', ' Blood Sample ', ' Goals ', ' Grant ', ' improved ', ' Histology ', ' Housing ', ' Algorithms ', ' Site ', ' Area ', ' Clinical ', ' repaired ', ' repair ', ' Phase ', ' Biological ', ' Logistic Regressions ', ' Radiation Pneumonitis ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonia ', ' Radiation Fibrosis ', ' Non-linear Models ', ' Nonlinear Models ', ' Link ', ' Inflammation ', ' Information Theory ', ' Interleukin-6 ', ' IFNB2 ', ' IFN-beta 2 ', ' Hybridoma Growth Factor ', ' Hepatocyte-Stimulating Factor ', ' HPGF ', ' BSF2 (B cell stimulating factor 2) ', ' BSF2 ', ' BSF-2 ', ' BCDF ', ' B-Cell Stimulatory Factor-2 ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Differentiation Factor ', ' B cell stimulating factor 2 ', ' B cell differentiation factor ', ' interferon beta 2 ', ' Plasmacytoma Growth Factor ', ' Myeloid Differentiation-Inducing Protein ', ' MGI-2 ', ' Interleukin 6 (Interferon, Beta 2) ', ' IL6 Protein ', ' IL-6 ', ' Interleukins ', ' Predisposition ', ' Susceptibility ', ' Peptidyl-Dipeptidase A ', ' Kininase II ', ' Kininase A ', ' Dipeptidyl Peptidase A ', ' Carboxycathepsin ', ' CD143 Antigens ', ' Angiotensin I-Converting Enzyme ', ' Angiotensin Converting Enzyme ', ' Serum ', ' Blood Serum ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' insight ', ' Numbers ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Pulmonary function tests ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Binding Proteins ', ' Ligand Binding Protein ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Measurement ', ' Relative Risks ', ' Radiation Oncology ', ' Funding ', ' Maps ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Motion ', ' Diagnostic Neoplasm Staging ', ' Tumor Staging ', ' Neoplasm Staging ', ' Cancer Staging ', ' Review Literature ', ' Pathology ', ' Patients ', ' Peer Review ', ' Personal Satisfaction ', ' well-being ', ' Genetic ', ' Physics ', ' Play ', ' Pneumonia ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Positron-Emission Tomography ', ' Rad.-PET ', ' Positron Emission Tomography Scan ', ' Positron Emission Tomography Medical Imaging ', ' PETT ', ' PETSCAN ', ' PET imaging ', ' PET Scan ', ' PET ', ' prescription procedure ', ' Daily ', ' Staging ', ' Normal tissue morphology ', ' Normal Tissue ', ' Shapes ', ' Inflammatory ', ' Proteins ', ' gene product ', ' Radiation Tolerance ', ' Radiosensitivity ', ' Radiation Sensitivity ', ' Radiation therapy ', ' Radiotherapy ', ' Radiotherapeutics ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Shorthand ', ' Archives ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Arts ', ' Sterilization for infection control ', ' Technology ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT X Ray ', ' CAT scan ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Transforming Growth Factor beta ', ' TGFbeta ', ' TGF-beta ', ' TGF B ', ' Platelet Transforming Growth Factor ', ' Milk Growth Factor ', ' Bone-Derived Transforming Growth Factor ', ' Transforming Growth Factors ', ' transforming growth factors Animal growth regulators ', ' Tumor Growth Factors ', ' Investigation ', ' Work ', ' Week ', ' Complex ', ' Event ', ' Scanning ', ' Clinic ', ' Source ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' 3-Dimensional ', ' 3-D ', ' Location ', ' Class ', ' size ', ' Tumor Tissue ', ' Nuclear ', ' Outcome Study ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Factors ', ' Natural Products ', ' Biologic Factor ', ' Biological Markers ', ' Biologic Marker ', ' Biology ', ' Adverse reactions ', ' Blood ', ' Blood Reticuloendothelial System ', ' success ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' treatment planning ', ' Interleukin-1 alpha ', ' Preinterleukin 1 Alpha ', ' Interleukin 1alpha ', ' IL1F1 ', ' IL1A Protein ', ' IL1-Alpha ', ' IL-1alpha ', ' IL-1A ', ' IL-1-a ', ' IL-1 alpha ', ' Toxic effect ', ' Toxicities ', ' Categories ', ' Disease regression ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Metric ', ' Reporting ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cultured Cells ', ' cytokine ', ' Gender ', ' Imaging Techniques ', ' Imaging Technics ', ' Imaging Procedures ', ' Measures ', ' Relative (related person) ', ' Relative ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Morphologic artifacts ', ' Artifacts ', ' Radiation ', ' ray (radiation) ', ' Case Study ', ' case report ', ' Modeling ', ' Sampling ', ' response ', ' Uncertainty ', ' doubt ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Three-Dimensional Imaging ', ' Three Dimensional Medical Imaging ', ' 3D imaging ', ' 3-D Imaging ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' clinical investigation ', ' Magnetic Resonance ', ' model design ', ' Accounting ', ' Electrophoretic Mobility Shift Assay ', ' gel shift assay ', ' Mobility Shift Assay ', ' Bandshift Mobility Assay ', ' Band Shift Mobility Assay ', ' Complication ', ' data modeling ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' Population ', ' prospective ', ' Resistance ', ' resistant ', ' open source ', ' tumor ', ' Data Analyses ', ' Data Analysis ', ' Data Collection ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA Damage ', ' DNA Injury ', ' Tumor stage ', ' T-Stage ', ' ']",NCI,WASHINGTON UNIVERSITY,K25,2008,131547,0.048113822971267435
"High Density Association Analysis of Lung Cancer    DESCRIPTION (provided by applicant):  The goal of this research is to identify novel susceptibility genes for lung cancer using a systematic genome- wide association-based approach. To achieve this goal, we are applying a two-stage design. This proposal builds upon an extensive resource of lung cancer cases and controls matched for smoking behavior, sex, and ethnicity who have been collected over many years at the U.T. M.D. Anderson Cancer Center, and on a recently approved proposal to the Center for Inherited Disease Research that is performing genotyping of 317,000 markers on 1200 Caucasian ever-smoking lung cancer cases and 1200 controls matched for ethnicity, age, smoking behavior, and sex. Our first aim is to analyze data from the completed first-stage of genotyping. For our second aim, we will complete the two-stage design, which is powered to detect associations with genotypic risk ratios of about 1.4 with a very stringent significance criterion of 1.7 x 10-7. We will genotype and analyze 3380 SNPs on 1200 lung cancer cases and 1200 controls. We will also analyze SNPs from 90 candidate genes identified through a systematic literature search as well as a limited number of SNPs in significant pathways. In our third aim we will genotype 400 never-smoking lung cancer cases and 400 controls for 946 SNP markers. To evaluate possible interethnic differences in the genetic control of lung cancer risk we will analyze 400 African-American lung cancer cases and 400 African- American controls (aim 4) for 946 SNP markers. In these 4 aims we are also including a panel of SNPs to estimate ancestry. In aim 5, we use machine learning approaches to develop models for characterizing gene-gene and gene-environment effects on lung cancer risk. Cases and controls have extensive epidemiological and family history data together with candidate gene and functional DNA repair measures. The end result of our analysis will substantively increase our understanding of the genetic etiology of lung cancer and gene-environment interactions that contribute to its causation. This is an experienced investigative team, using state of the art technology to perform a multistage genome-wide analysis on a large, uniquely well-characterized population of lung cancer cases and matched controls with rich functional data. We are collaborating with the International Lung Cancer Consortium so that it can further validate our findings for a variety of different populations, in future initiatives.                                                              ",High Density Association Analysis of Lung Cancer,7458843,R01CA121197,"['Genomics ', ' Classification ', ' Systematics ', ' tobacco exposure ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' design ', ' designing ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' genome-wide analysis ', ' Data Analyses ', ' Data Analysis ', ' Inflammatory Response ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Data ', ' Direct Costs ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Applications Grants ', ' Grant Proposals ', ' International ', ' Subgroup ', ' Cancer Center ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' Collection ', ' Enrollment ', ' enroll ', ' Genetic Risk ', ' Genotypic Risk Ratio ', ' Newly Diagnosed ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Prevention ', ' Smoking Status ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Validation ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Future ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Behavioral Genetics ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Genome ', ' Genotype ', ' Age ', ' base ', ' density ', ' Goals ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Hypersensitivity ', ' Allergy ', ' repaired ', ' repair ', ' In Vitro ', ' Infection ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Individual ', ' Numbers ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Fostering ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Relative Risks ', ' Sample Size ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Persons ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Collaborations ', ' Occupational Exposure ', ' Oncogenes ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' Play ', ' Staging ', ' tool ', ' Smoker ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' medical specialties ', ' Specialty ', ' Arts ', ' Technology ', ' Tobacco ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Scanning ', ' Clinic ', ' Pattern ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' novel ', ' Participant ', ' Population Study ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Gender ', ' genetic analysis ', ' Genetic analyses ', ' Measures ', ' Statistical Methods ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Causations ', ' Modeling ', ' case control ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2008,563540,0.18238103681189097
"Genetic Polymorphisms in TRAIL Pathway as Susceptibility Markers for Lung Cancer    DESCRIPTION (provided by applicant):       Eighty-seven percent of lung cancers (LC) are attributed to tobacco exposure. However, only a fraction of smokers develop cancer. Genetically determined modulation of environmental exposures is an attractive possible mechanism for the variation in host susceptibility. Loss of apoptosis has been demonstrated to be an important mechanism for lung carcinogenesis. The activation of apoptosis signaling is through an intrinsic Bcl- 2 pathway and an extrinsic or TRAIL (TNF-related Apoptosis Inducing Ligand) pathway by activation of the death receptor. Although apoptosis is evolutionarily conserved, there may be interindividual variation in apoptotic capacity in general population. Polymorphic changes on genes of TRAIL pathway have been reported to be associated with modulated apoptosis. To date, there have been no studies on the role of genetic polymorphisms in the apoptotic pathway genes as predisposing factors for LC. In this application, we aim at examining polymorphisms in genes involved in the TRAIL pathway as predisposition factor for LC. The specific aims of this proposed study are: 1) To assess frequencies of SNPs in genes in the TRAIL apoptotic pathway (DR4, DR5, FADD, caspases -8, -10, -3, and -9, and BID) in 1000 cases and 1000 controls. Our working hypothesis is that adverse alleles on TRAIL pathway genes which are associated with modified apoptosis capacity may predispose individuals to increased lung cancer risk; 2) To Assess haplotypes and diplotypes as markers of susceptibility. We will implement haplotype-based analyses to identify any additional genetic factors; 3) To apply hierarchical model to refine the risk assessment and to apply novel machine- learning tools to identify any gene-environment and gene-gene interactions. Our hypothesis is that LC is a complex disease involving multiple genes in the apoptic pathway that have common, low penetrance polymorphisms, and that these polymorphisms interacting with each other and/or environmental factors. This application is designed to build upon a data and specimen repository from on ongoing funded lung-cancer case- control study in the Department of Epidemiology. Because relevant genotype data and epidemiologic profiles are available from the parent grant, this application is both time and cost effective. The goal of this study is to further our understanding of lung carcinogenesis. Polymorphic changes on TRAIL pathway may be useful risk biomarkers to identify high-risk populations.           ",Genetic Polymorphisms in TRAIL Pathway as Susceptibility Markers for Lung Cancer,7491066,R03CA128079,"['Risk Assessment ', ' Modeling ', ' case control ', ' repository ', ' tobacco exposure ', ' design ', ' designing ', ' lung carcinogenesis ', ' cost effective ', ' cost-effective ', ' Population ', ' parent grant ', ' caspase ', ' cysteine endopeptidase ', ' cystein proteinase ', ' cystein protease ', ' ICE-like protease ', ' Cell-Death Protease ', ' Cessation of life ', ' Death ', ' Cell Cycle Checkpoint ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Dust ', ' TNFRSF10B gene ', ' ZTNFR9 ', ' TRICKB ', ' TRICK2B ', ' TRICK2A ', ' TRICK2 ', ' TRAILR2 ', ' TNFRSF10B ', ' KILLER/DR5 ', ' DR5 ', ' Environment ', ' Environmental Exposure ', ' Enzymes ', ' Length ', ' Build-it ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' lung small cell carcinoma ', ' lung small cell neuroendocrine carcinoma ', ' lung oat cell carcinoma ', ' Small Cell Lung Cancer ', ' human TNFRSF10A protein ', ' tumor necrosis factor receptor superfamily, member 10a protein, human ', ' tumor necrosis factor receptor superfamily member 10D ', ' Tumor Necrosis Factor Receptor Superfamily, Member 10A ', ' TRAIL Receptor 1 ', ' TNF-Related Apoptosis Inducing Ligand Receptor 1 ', ' Death Receptor 4 ', ' Cytotoxic TRAIL Receptor ', ' Data ', ' Death Domain ', ' Applications Grants ', ' Grant Proposals ', ' Stratification ', ' Apoptotic ', ' Cancer Patient ', ' Genetic Risk ', ' Characteristics ', ' Molecular ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genotype ', ' base ', ' Goals ', ' Haplotypes ', ' Hay fever ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Variant ', ' Variation ', ' Alleles ', ' Allelomorphs ', ' Inflammation ', ' Predisposition ', ' Susceptibility ', ' Individual ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' CD95 Antigens ', ' fas Receptors ', ' fas Antigens ', ' Tumor Necrosis Factor Receptor Superfamily, Member 6 ', ' TNFRSF6 Receptor ', ' CD95 molecule ', ' Apoptosis Antigen 1 ', ' APO-1 Cell Surface Antigen ', ' APO-1 Antigen ', ' Family Cancer History ', ' Micronutrients ', ' Metabolic ', ' Genetic ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Predisposing Factor ', ' tool ', ' Smoker ', ' Pulmonary Emphysema ', ' Emphysema ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Smoking ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' TNF-related apoptosis-inducing ligand ', ' Tumor Necrosis Factor Ligand Superfamily Member 10 ', ' TRAIL Protein ', ' TNFSF10 Protein ', ' TNF-Related Apoptosis Inducing Ligand TRAIL ', ' Apo-2 Ligand ', ' APO2 Ligand ', ' Asbestos ', ' Time ', ' Tobacco ', ' Asthma ', ' Bronchial Asthma ', ' Caucasians ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Pattern ', ' Penetrance ', ' death receptor-4 ', ' tumor necrosis factor receptor superfamily member 10A ', ' receptor TRAIL-4 ', ' TRAIL-R4 ', ' TNF-related apoptosis-inducing ligand receptor 1 ', ' Biological Markers ', ' Biologic Marker ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' cancer risk ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' receptor ', ' Receptor Protein ', ' caspase-8 ', ' Mch5 protease ', ' MACH protein ', ' FLICE protein ', ' FADD-homologous ICE/CED3-Like Protease ', ' FADD-Like ICE ', ' Caspase-8/Flice ', ' CASP8 Protein ', ' CAP4 protease ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' General Population ', ' General Public ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' telomere ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R03,2008,77000,0.10431417137853966
"High Density Association Analysis of Lung Cancer    DESCRIPTION (provided by applicant):  The goal of this research is to identify novel susceptibility genes for lung cancer using a systematic genome- wide association-based approach. To achieve this goal, we are applying a two-stage design. This proposal builds upon an extensive resource of lung cancer cases and controls matched for smoking behavior, sex, and ethnicity who have been collected over many years at the U.T. M.D. Anderson Cancer Center, and on a recently approved proposal to the Center for Inherited Disease Research that is performing genotyping of 317,000 markers on 1200 Caucasian ever-smoking lung cancer cases and 1200 controls matched for ethnicity, age, smoking behavior, and sex. Our first aim is to analyze data from the completed first-stage of genotyping. For our second aim, we will complete the two-stage design, which is powered to detect associations with genotypic risk ratios of about 1.4 with a very stringent significance criterion of 1.7 x 10-7. We will genotype and analyze 3380 SNPs on 1200 lung cancer cases and 1200 controls. We will also analyze SNPs from 90 candidate genes identified through a systematic literature search as well as a limited number of SNPs in significant pathways. In our third aim we will genotype 400 never-smoking lung cancer cases and 400 controls for 946 SNP markers. To evaluate possible interethnic differences in the genetic control of lung cancer risk we will analyze 400 African-American lung cancer cases and 400 African- American controls (aim 4) for 946 SNP markers. In these 4 aims we are also including a panel of SNPs to estimate ancestry. In aim 5, we use machine learning approaches to develop models for characterizing gene-gene and gene-environment effects on lung cancer risk. Cases and controls have extensive epidemiological and family history data together with candidate gene and functional DNA repair measures. The end result of our analysis will substantively increase our understanding of the genetic etiology of lung cancer and gene-environment interactions that contribute to its causation. This is an experienced investigative team, using state of the art technology to perform a multistage genome-wide analysis on a large, uniquely well-characterized population of lung cancer cases and matched controls with rich functional data. We are collaborating with the International Lung Cancer Consortium so that it can further validate our findings for a variety of different populations, in future initiatives.                                                              ",High Density Association Analysis of Lung Cancer,7934247,R01CA121197,"['Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' Play ', ' Staging ', ' tool ', ' Smoker ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' medical specialties ', ' Specialty ', ' Arts ', ' Technology ', ' Tobacco ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Scanning ', ' Clinic ', ' Pattern ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' meetings ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' novel ', ' Participant ', ' Population Study ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Gender ', ' genetic analysis ', ' Genetic analyses ', ' Measures ', ' Statistical Methods ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Modeling ', ' case control ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' Classification ', ' Systematics ', ' tobacco exposure ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' design ', ' designing ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' genome-wide analysis ', ' high risk ', ' genome-wide ', ' genomewide ', ' Data Analyses ', ' Data Analysis ', ' Inflammatory Response ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data ', ' Direct Costs ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Applications Grants ', ' Grant Proposals ', ' International ', ' Subgroup ', ' Cancer Center ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' Collection ', ' Enrollment ', ' enroll ', ' Genetic Risk ', ' Genotypic Risk Ratio ', ' Newly Diagnosed ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Prevention ', ' Smoking Status ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Validation ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Future ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Behavioral Genetics ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Genome ', ' Genotype ', ' Age ', ' base ', ' density ', ' Goals ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Hypersensitivity ', ' Allergy ', ' repaired ', ' repair ', ' In Vitro ', ' Infection ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Individual ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Fostering ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Relative Risks ', ' Sample Size ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Persons ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Collaborations ', ' Occupational Exposure ', ' Oncogenes ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Genetic ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2009,369994,0.18238103681189097
"Prediction of Physiological Events in People with Sleep Disordered Breathing    DESCRIPTION (provided by applicant): Sleep-disordered breathing (SDB) refers to a spectrum of disorders characterized by abnormal respiratory patterns or levels of ventilation during sleep. The most common is obstructive sleep apnea (OSA). People with OSA experience repetitive apnea (cessation of breathing) and hypopnea (marked decrease in tidal volume) during sleep in association with airway compromise and excessive daytime sleepiness (EDS). An arousal, or brief, often unnoticed, disruption of sleep is commonly associated with apnea. People with OSA also exhibit cognitive dysfunction, including impairment to memory, attention, and executive function. OSA- associated EDS and cognitive dysfunction are thought to significantly contribute to automobile accidents and workplace injuries. The first aim of this research is to predict the onset of nocturnal apnea, hypopnea, and arousal. Our proposal to accomplish this aim represents an entirely new approach to improving the effectiveness and tolerability of SBD therapy. The most common therapy is continuous positive airway pressure (CPAP), which is difficult for many patients to tolerate. Existing auto-adjusting PAP may be more tolerable but relies on detection of disordered breathing events and does not appear to improve quality of life compared with conventional CPAP. Predicting these events could lead to more effective titration of PAP levels and improved outcomes. Other therapies, such as the electrical stimulation of various cranial nerves or pharyngeal muscles, could also be improved by predicting disordered breathing. The second aim is to predict the onset of unintended daytime sleep while subjects undergo maintenance of wakefulness tests, which assess one's ability to resist sleep in a soporific condition. The third aim is to predict performance lapses during driving simulations. Accomplishing aims two and three could lead to the development of warning devices for at-risk individuals. Our novel prediction algorithms track the interactions between several physiological systems and reveal the most important predictors. The fourth aim is to contrast the key predictors between OSA, acutely sleep-deprived, and control subjects, and between men and women. By doing so, we expect to gain insight into the underlying pathophysiology of SDB and EDS, and will investigate sex differences in OSA and sleep deprivation. OSA is a major public health problem whose effects on society are comparable to those of smoking. The capability to predict its adverse consequences will be an invaluable tool to improve the quality of life of people with SDB, reduce the associated costs, and improve public health          ",Prediction of Physiological Events in People with Sleep Disordered Breathing,7745752,F30HL097403,"['Cranial Nerves ', ' Glean ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' automobile accident ', ' Electric Stimulation ', ' Electrical Stimulation ', ' Electroencephalography ', ' EEG ', ' Electronics ', ' Address ', ' Social Network ', ' Detection ', ' Measurable ', ' Predictive Value ', ' Retrieval ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Exhibits ', ' Behavioral ', ' Workplace ', ' work setting ', ' work environment ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' Job Environment ', ' Titrations ', ' Polysomnography ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Future ', ' Imagery ', ' Visualization ', ' Injury ', ' Goals ', ' improved ', ' Continuous Positive Airway Pressure ', ' CPAP Ventilation ', ' CPAP ', ' Algorithms ', ' Physiological ', ' Physiologic ', ' Medical ', ' Illinois ', ' Predisposition ', ' Susceptibility ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' insight ', ' Individual ', ' Maintenance ', ' Memory ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' neurophysiology ', ' neurophysiological ', ' Collaborations ', ' Patients ', ' Muscle structure of pharynx ', ' Pharyngeal Muscles ', ' Physiological Processes ', ' Physiologic Processes ', ' Organismal Process ', ' Organism-Level Process ', ' Zebra ', ' tool ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' public health medicine (field) ', ' Public Health ', ' Quality of life ', ' QOL ', ' Research ', ' Risk ', ' Apnea ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Sleep Deprivation ', ' Smoking ', ' Social Interaction ', ' Societies ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Arousal ', ' Systems Theory ', ' Testing ', ' Tidal Volume ', ' respiratory airway volume ', ' Scientist ', ' Time ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Universities ', ' Environmental air flow ', ' Ventilation ', ' Attention ', ' Wakefulness ', ' Woman ', ' Work ', ' Automobile Driving ', ' driving ', ' Complex ', ' Event ', ' Source ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' respiratory ', ' experience ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' simulation ', ' Cognitive deficits ', ' novel ', ' Graph ', ' Time Series Analysis ', ' Excessive Daytime Sleepiness ', ' Excessive daytime somnolence ', ' Devices ', ' Chicago ', ' Property ', ' LOINC Axis 2 Property ', ' sleep onset ', ' theories ', ' Adverse event ', ' Adverse Experience ', ' Accidents ', ' executive function ', ' executive control ', ' cost ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' Network-based ', ' heart rate variability ', ' Computers ', ' ']",NHLBI,UNIVERSITY OF ILLINOIS AT CHICAGO,F30,2009,42295,0.08917878920117636
"Statistical Methods for Gene Environment Interactions In Lung Cancer    DESCRIPTION (provided by applicant):       Lung cancer is among the best known examples of a disease that reflects the interaction of genetic and environmental factors. While carcinogenic compounds in tobacco smoke constitute the major risk factor for lung cancer, only about 14% of long-time smokers will develop cancer. Family studies indicate the role that genetic susceptibility plays in determining lung cancer risk. The goal of this research proposal is to develop and apply methods to identify genetic susceptibility factors for lung cancer that are modulated by the effects of tobacco smoke. Toward this goal we are taking advantage of two extensive sources of data that reflect the efforts of teams of scientists who have been devoted to understanding the causes of lung cancer. The first source of data is from the Genetic Epidemiology of Lung Cancer Consortium, which has been collecting extended families with three or more relatives affected with lung cancer since 2000. Analytical results show evidence for a genetic susceptibility factor on chromosome 6q that strongly increases lung cancer risk, but that has a much more profound effect on risk among tobacco smokers. The other major source of data is an extremely large, case-control study developed by Dr. Margaret Spitz at the U.T. M.D. Anderson Cancer Center, starting in 1993. Currently, candidate gene studies to identify genetic risk factors of lung cancer susceptibility have been completed for 51 polymorphisms. In addition, data from a newly launched initiative to perform a genome-wide association analysis of 1200 ever-smoking Caucasian lung cancer cases and 1200 matched controls will become available within the next 3 months. A major goal of this proposal is to develop simulation-based approaches to evaluate the efficacy of many competing analytical approaches for characterizing the role of gene-environment interactions in disease causation. Our research involves a strong analytical team with extensive experience in gene-environment modeling, application of machine learning tools, and the study of family data. In addition, we have unique skills and methods for simulating data, which will be further refined through the proposed research funding. The simulation approaches and analytical discoveries from our research will be widely distributed. (End of Abstract)          ",Statistical Methods for Gene Environment Interactions In Lung Cancer,7664511,R01CA133996,"['Data Sources ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' Cancer Center ', ' Extended Family ', ' Family ', ' Affect ', ' Genes ', ' Population Genetics ', ' Natural History ', ' base ', ' Goals ', ' Procedures ', ' Head ', ' Family Study ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Predisposition ', ' Susceptibility ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' Methods ', ' Simulate ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' tool ', ' Smoker ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' Time ', ' Tobacco ', ' Caucasians ', ' Complex ', ' Tobacco smoke ', ' Behavior ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' skills ', ' simulation ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Relative (related person) ', ' Relative ', ' genetic risk factor ', ' inherited factor ', ' Statistical Methods ', ' abstracting ', ' Chromosome Mapping ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosomes ', ' Modeling ', ' case control ', ' genetic epidemiology ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Population ', ' analytical tool ', ' genome-wide ', ' genomewide ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2009,263340,0.21059653839161882
"High Density Association Analysis of Lung Cancer    DESCRIPTION (provided by applicant):  The goal of this research is to identify novel susceptibility genes for lung cancer using a systematic genome- wide association-based approach. To achieve this goal, we are applying a two-stage design. This proposal builds upon an extensive resource of lung cancer cases and controls matched for smoking behavior, sex, and ethnicity who have been collected over many years at the U.T. M.D. Anderson Cancer Center, and on a recently approved proposal to the Center for Inherited Disease Research that is performing genotyping of 317,000 markers on 1200 Caucasian ever-smoking lung cancer cases and 1200 controls matched for ethnicity, age, smoking behavior, and sex. Our first aim is to analyze data from the completed first-stage of genotyping. For our second aim, we will complete the two-stage design, which is powered to detect associations with genotypic risk ratios of about 1.4 with a very stringent significance criterion of 1.7 x 10-7. We will genotype and analyze 3380 SNPs on 1200 lung cancer cases and 1200 controls. We will also analyze SNPs from 90 candidate genes identified through a systematic literature search as well as a limited number of SNPs in significant pathways. In our third aim we will genotype 400 never-smoking lung cancer cases and 400 controls for 946 SNP markers. To evaluate possible interethnic differences in the genetic control of lung cancer risk we will analyze 400 African-American lung cancer cases and 400 African- American controls (aim 4) for 946 SNP markers. In these 4 aims we are also including a panel of SNPs to estimate ancestry. In aim 5, we use machine learning approaches to develop models for characterizing gene-gene and gene-environment effects on lung cancer risk. Cases and controls have extensive epidemiological and family history data together with candidate gene and functional DNA repair measures. The end result of our analysis will substantively increase our understanding of the genetic etiology of lung cancer and gene-environment interactions that contribute to its causation. This is an experienced investigative team, using state of the art technology to perform a multistage genome-wide analysis on a large, uniquely well-characterized population of lung cancer cases and matched controls with rich functional data. We are collaborating with the International Lung Cancer Consortium so that it can further validate our findings for a variety of different populations, in future initiatives.                                                              ",High Density Association Analysis of Lung Cancer,7640930,R01CA121197,"['Data Analyses ', ' Data Analysis ', ' Inflammatory Response ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data ', ' Direct Costs ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Applications Grants ', ' Grant Proposals ', ' International ', ' Subgroup ', ' Cancer Center ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' Collection ', ' Enrollment ', ' enroll ', ' Genetic Risk ', ' Genotypic Risk Ratio ', ' Newly Diagnosed ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Prevention ', ' Smoking Status ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Validation ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Future ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Behavioral Genetics ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Genome ', ' Genotype ', ' Age ', ' base ', ' density ', ' Goals ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Hypersensitivity ', ' Allergy ', ' repaired ', ' repair ', ' In Vitro ', ' Infection ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Individual ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Fostering ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Relative Risks ', ' Sample Size ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Persons ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Collaborations ', ' Occupational Exposure ', ' Oncogenes ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' Play ', ' Staging ', ' tool ', ' Smoker ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' medical specialties ', ' Specialty ', ' Arts ', ' Technology ', ' Tobacco ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Scanning ', ' Clinic ', ' Pattern ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' meetings ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' novel ', ' Participant ', ' Population Study ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Gender ', ' genetic analysis ', ' Genetic analyses ', ' Measures ', ' Statistical Methods ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Modeling ', ' case control ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' Classification ', ' Systematics ', ' tobacco exposure ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' design ', ' designing ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' genome-wide analysis ', ' high risk ', ' genome-wide ', ' genomewide ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2009,568790,0.18238103681189097
"Inflammation Genes and Lung Cancer Risk    DESCRIPTION (provided by applicant): There is accumulating evidence that chronic injury and inflammation in the respiratory tract, such as that caused by cigarette smoking, predispose to lung cancer. We therefore propose to conduct an in depth pathway-based analysis of gene variants in the inflammatory pathway using test and validation sets of cases and controls. This proposal builds on a well-annotated specimen repository of lung cancer cases and controls enrolled in an ongoing risk factor study (CA55769, Spitz, PI). Cases are frequency-matched to controls on age, gender, ethnicity and smoking status recruited from a multi-specialty physician practice. Data collected include smoking history, dietary intake, cancer family history, specific occupational exposures (e.g., asbestos, dust), and previous medical history including chronic obstructive airway disease, asthma and hay fever. Genomic DNA and rich candidate genotype and phenotype data are available. Aim 1: To identify novel genetic variants influencing lung cancer risk in a test set of 1500 cases with non-small cell lung cancer and 1500 matched controls (all Caucasian), using the Illumina iSelect Infinium chip with 8.5 to 9K SNP's. Aim 2: In a replication set of an additional 1000 cases and 1000 controls, using a GoldenGate assay, we will evaluate the top 1500 SNPs identified from Aim1 as meeting the P<0.1 criterion, or selected by a rational prioritizing approach that incorporates published results, type of SNP, evolutionary biology, physico-chemical properties and haplotype tagging SNPs. Aim 3: To perform fine mapping in the flanking regions of 50 SNPs selected by the same approach as in Aim 2, combining prior information with in silico approaches for predicting functionality. For each of these 50 SNPs, we will select an average of 10 additional SNPs per gene region to regenotype in all 2500 cases and 2500 controls. Aim 4. To extend our epidemiologic risk prediction model by incorporating established epidemiologic risk factor and gene variant data. We will apply machine-learning tools to identify gene-environment and gene-gene interactions. Covariates will include prior emphysema, asthma, hay fever, dust and asbestos exposure, smoking characteristics, family history of cancer, and anti-inflammatory drug use. The International Lung Cancer Consortium will perform external validation in a proposal to be developed. Our approach to comprehensively evaluate variants in a candidate pathway in a large well- powered study will be applicable to a variety of other cancer sites where inflammation plays an important etiologic role, as well as in non-neoplastic diseases with a strong inflammatory component such as emphysema. The public health potential of a useful risk prediction modes for lung cancer is substantial. Public Health Relevance Statement Cigarette smoking results in inflammation in the respiratory tract and there is growing evidence that chronic inflammatory processes predispose to lung cancer. However, the molecular mechanisms underlying the causal nature of this association are unclear. We propose to conduct an in depth analysis of gene variants in the inflammatory pathway as susceptibility factors for lung cancer. This proposal builds upon an existing well annotated specimen repository. We will evaluate gene variants in a test set of lung cancer cases and matched controls and validate the findings in an independent dataset. Finally we will incorporate these findings into an extended risk prediction model for lung cancer.                      ",Inflammation Genes and Lung Cancer Risk,7536096,R01CA127219,"['Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' pathway ', ' Pathway interactions ', ' neoplastic ', ' Affect ', ' Genes ', ' Genotype ', ' Injury ', ' Age ', ' base ', ' Goals ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Growth Factor ', ' Haplotypes ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Hay fever ', ' History ', ' Recording of previous events ', ' Algorithms ', ' Area ', ' Chronic ', ' Variation ', ' Variant ', ' Logistic Regressions ', ' Link ', ' In Vitro ', ' Infection ', ' Inflammation ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Irritants ', ' Articulation ', ' Joints ', ' Literature ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' drug use ', ' Drug usage ', ' Oxidative Stress ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' chemical property ', ' Maps ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Family Cancer History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Respiratory Tracts ', ' Respiratory tract structure ', ' Letters ', ' Occupational Exposure ', ' angiogenesis ', ' Phenotype ', ' Genetic ', ' Physicians ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Anti-Inflammatory Agents ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Probability ', ' Staging ', ' Inflammatory ', ' Antihistamines ', ' tool ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Emphysema ', ' Pulmonary Emphysema ', ' Receiver Operating Characteristics ', ' Recommendation ', ' recruit ', ' Recruitment Activity ', ' Nature ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Research Resources ', ' Resources ', ' respiratory tract ', ' Respiratory system (all sites) ', ' Pulmonary Organ System ', ' Pulmonary Body System ', ' Respiratory System ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Research Specimen ', ' Specimen ', ' Smoking ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Specialty ', ' medical specialties ', ' Asbestos ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Bronchial Asthma ', ' Asthma ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Adopted ', ' Caucasians ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Host Defense ', ' Nucleotide Excision Repair ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biology ', ' meetings ', ' cancer risk ', ' Cancer Induction ', ' carcinogenesis ', ' gene interaction ', ' Proxy ', ' novel ', ' Participant ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' smoke cigarette ', ' cigarette smoking ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' Cell Division Cycle ', ' Cell Cycle ', ' Cellular Growth ', ' Cellular Expansion ', ' cell growth ', ' Gender ', ' p53 Genes ', ' Tumor Protein p53 Gene ', ' TRP53 ', ' TP53 ', ' P53 ', ' TP53 gene ', ' Lung Tissue ', ' Lung Parenchyma ', ' Structure of parenchyma of lung ', ' Modeling ', ' response ', ' case control ', ' repository ', ' cancer location ', ' cancer site ', ' Genomics ', ' genetic variant ', ' Outcome ', ' aggregation pathway ', ' parent grant ', ' public health relevance ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Bio-Informatics ', ' Bioinformatics ', ' Inflammatory Response ', ' Cell Cycle Control ', ' Cell Cycle Regulation ', ' DNA Base Excision Repair ', ' Base Excision Repairs ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Dietary intake ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Oncogenesis ', ' tumorigenesis ', ' Dust ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Dataset ', ' Data Set ', ' DNA Repair Pathway ', ' Data ', ' International ', ' Progress Review Group ', ' Anti-inflammatory ', ' enroll ', ' Enrollment ', ' Newly Diagnosed ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Status ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2009,602949,0.12530806534110406
"High Density Association Analysis of Lung Cancer    DESCRIPTION (provided by applicant):  The goal of this research is to identify novel susceptibility genes for lung cancer using a systematic genome- wide association-based approach. To achieve this goal, we are applying a two-stage design. This proposal builds upon an extensive resource of lung cancer cases and controls matched for smoking behavior, sex, and ethnicity who have been collected over many years at the U.T. M.D. Anderson Cancer Center, and on a recently approved proposal to the Center for Inherited Disease Research that is performing genotyping of 317,000 markers on 1200 Caucasian ever-smoking lung cancer cases and 1200 controls matched for ethnicity, age, smoking behavior, and sex. Our first aim is to analyze data from the completed first-stage of genotyping. For our second aim, we will complete the two-stage design, which is powered to detect associations with genotypic risk ratios of about 1.4 with a very stringent significance criterion of 1.7 x 10-7. We will genotype and analyze 3380 SNPs on 1200 lung cancer cases and 1200 controls. We will also analyze SNPs from 90 candidate genes identified through a systematic literature search as well as a limited number of SNPs in significant pathways. In our third aim we will genotype 400 never-smoking lung cancer cases and 400 controls for 946 SNP markers. To evaluate possible interethnic differences in the genetic control of lung cancer risk we will analyze 400 African-American lung cancer cases and 400 African- American controls (aim 4) for 946 SNP markers. In these 4 aims we are also including a panel of SNPs to estimate ancestry. In aim 5, we use machine learning approaches to develop models for characterizing gene-gene and gene-environment effects on lung cancer risk. Cases and controls have extensive epidemiological and family history data together with candidate gene and functional DNA repair measures. The end result of our analysis will substantively increase our understanding of the genetic etiology of lung cancer and gene-environment interactions that contribute to its causation. This is an experienced investigative team, using state of the art technology to perform a multistage genome-wide analysis on a large, uniquely well-characterized population of lung cancer cases and matched controls with rich functional data. We are collaborating with the International Lung Cancer Consortium so that it can further validate our findings for a variety of different populations, in future initiatives.                                                              ",High Density Association Analysis of Lung Cancer,7920556,R01CA121197,"['Data Analyses ', ' Data Analysis ', ' Inflammatory Response ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data ', ' Direct Costs ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Applications Grants ', ' Grant Proposals ', ' International ', ' Subgroup ', ' Cancer Center ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' Collection ', ' Enrollment ', ' enroll ', ' Genetic Risk ', ' Genotypic Risk Ratio ', ' Newly Diagnosed ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Prevention ', ' Smoking Status ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Validation ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Future ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Behavioral Genetics ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Genome ', ' Genotype ', ' Age ', ' base ', ' density ', ' Goals ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Hypersensitivity ', ' Allergy ', ' repaired ', ' repair ', ' In Vitro ', ' Infection ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Individual ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Fostering ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Relative Risks ', ' Sample Size ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Persons ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Collaborations ', ' Occupational Exposure ', ' Oncogenes ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' Play ', ' Staging ', ' tool ', ' Smoker ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' medical specialties ', ' Specialty ', ' Arts ', ' Technology ', ' Tobacco ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Scanning ', ' Clinic ', ' Pattern ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' meetings ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' novel ', ' Participant ', ' Population Study ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Gender ', ' genetic analysis ', ' Genetic analyses ', ' Measures ', ' Statistical Methods ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Modeling ', ' case control ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' Classification ', ' Systematics ', ' tobacco exposure ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' design ', ' designing ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' genome-wide analysis ', ' high risk ', ' genome-wide ', ' genomewide ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2009,531689,0.18238103681189097
"Statistical Model Building for High Dimensional Biomedical Data    DESCRIPTION (provided by applicant):  Typical of current large-scale biomedical data is the feature of small number of observed samples and the widely observed sample heterogeneity. Identifying differentially expressed genes related to the sample phenotye (e.g., cancer disease development) and predicting sample phenotype based on the gene expressions are some central research questions in the microarray data analysis. Most existing statistical methods have ignored sample heterogeneity and thus loss power.       This project proposes to develop novel statistical methods that explicitly address the small sample size and sampe heterogeneity issues, and can be applied very generally. The usefulness of these methods will be shown with the large-scale biomedical data originating from the lung and kidney transplant research projects. The transplant projects aimed to improve the molecular diagnosis and therapy of lung/kidney allograft rejection by identifying molecular biomarkers to predict the allograft rejection for critical early treatment and rapid, noninvasive, and economical testing.       The specific aims are 1) Develop novel statistical methods for differential gene expression detection that explicitly model sample heterogeneity. 2) Develop novel statistical methods for classifying high-dimensional biomedical data and incorporating sample heterogeneity. 3) Develop novel statistical methods for jointly analyzing a set of genes (e.g., genes in a pathway). 4) Use the developed models and methods to answer research questions relevant to public health in the lung and kidney transplant projects; and implement and validate the proposed methods in user-friendly and well-documented software, and distribute them to the scientific community at no charge.       It is very important to identify new biomarkers of allograft rejection in lung and kidney transplant recipients. The rapid and reliable detection and prediction of rejection in easily obtainable body fluids may allow the rapid advancement of clinical interventional trials. We propose to study novel methods for analyzing the large-scale biomedical data to realize their full potential of molecular diagnosis and prognosis of transplant rejection prediction for critical early treatment.          ",Statistical Model Building for High Dimensional Biomedical Data,7666186,R01GM083345,"['Data Analyses ', ' Data Analysis ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Molecular Diagnosis ', ' Collection ', ' Oncogene Activation ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Characteristics ', ' Molecular ', ' Development ', ' developmental ', ' Experimental Designs ', ' Pathway interactions ', ' pathway ', ' Gene Expression ', ' Genes ', ' base ', ' method development ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' improved ', ' Procedures ', ' Heterogeneity ', ' Algorithms ', ' Clinical ', ' Joints ', ' Articulation ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Least-Squares Analysis ', ' Least-Squares Analyses ', ' Least Squares ', ' Individual ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Sample Size ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Minnesota ', ' Statistical Models ', ' Probabilistic Models ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Patients ', ' Phenotype ', ' Probability ', ' outcome forecast ', ' Prognosis ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Proposals ', ' Resources ', ' Research Resources ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' sound ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Transplantation ', ' transplant ', ' Universities ', ' Adopted ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Work ', ' Dimensions ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Allografting ', ' interest ', ' kidney allograft ', ' renal allograft ', ' Body Fluids ', ' user friendly software ', ' user friendly computer software ', ' simulation ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cations ', ' Charge ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Outcome Measure ', ' Modeling ', ' Sampling ', ' theories ', ' software development ', ' developing computer software ', ' develop software ', ' Genomics ', ' Classification ', ' Systematics ', ' Communities ', ' cancer microarray ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' cancer type ', ' Coupled ', ' Early treatment ', ' early therapy ', ' early intervention ', ' user-friendly ', ' biomarker ', ' transplant database ', ' transplant data base ', ' biobank ', ' biorepository ', ' ']",NIGMS,UNIVERSITY OF MINNESOTA,R01,2009,256073,0.06301616635225511
"Genetic Susceptibility for Lung Cancer in African Americans    DESCRIPTION (provided by applicant):  Lung cancer is the leading cause of cancer death among African-Americans and this population has approximately 1/3 higher risk than Caucasians. Recently, collaborative studies that we and others have lead have identified regions on chromosomes 15q25, 5p15 and 6p21 that are highly significantly associated with lung cancer risk in Caucasians. The regions of association on chromosome 15q and 6p lie in areas of the genome that show very strong levels of linkage disequilibrium in Caucasians so that identifying the specific causal gene and causal variant(s) is problematic. In African- Americans, our preliminary study of the region on chromosome 15q25 shows a much more punctate pattern of linkage disequilbrium so that studies of the African-American population will provide a more precise localization of genetic variants. The preliminary data suggest the role of multiple genetic factors, but our initial studies conducted with a limited number of samples and SNPs are not yet sufficient to identify precisely the location(s) of causal variants. Our preliminary data show stronger effects on risks from SNPs on chromosomes 5p and 15q in African-Americans than in Caucasians. We therefore propose to genotype samples from three centers comprising over 1300 lung cancer cases and 1300 controls for 400 SNP loci in each of the three regions of interest. We will also genotype ancestry informative markers so that we can evaluate the ancestral background as a confounder. The first aim will perform dense SNP analysis in three genomic regions to sublocalize and characterize the impact on lung cancer risk in three genomic regions. The second aim will perform more detailed modeling to estimate joint effects of smoking, sex and genetic factors on lung cancer risk. This analysis will allow us to identify groups of African-American individuals at particularly higher risks for developing lung cancer.           Narrative African-Americans have particularly high risks of developing lung cancer, but genetic factors that influence their risk have not yet been studied. The goal of this research is to confirm and extent observations that SNPs in 3 genomic regions that associate with lung cancer risk in Caucasians also associate with lung cancer risk in African-Americans. To study enough African-Americans with lung cancer we are combining data from three research sites: the U.T. M.D. Anderson Cancer Center, the University of California - San Francisco, and Karmanos Institute. The first aim of our proposal will test that these three regions associate with lung cancer risk and estimate the risk associated with SNPs in this region. We will study 400 single nucleotide polymorphisms (genetic markers) in each of the three regions to precisely localize which region of the genome is involved in influencing disease risk. The second aim will model the differential roles of sex, genetic factors, and smoking for these regions to delineate the impacts of these factors on risk and to identify specific subsets of individuals at highest risk for developing lung cancer.",Genetic Susceptibility for Lung Cancer in African Americans,7743910,R01CA141716,"['cancer genetics ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Polymorphism Analysis ', ' Polymorphism Detection ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Chromosomes ', ' Modeling ', ' Sampling ', ' Telomerase ', ' case control ', ' Cisplatin ', ' cis-Platinum ', ' cis-Dichlorodiammineplatinum(II) ', ' cis-Diamminedichloroplatinum(II) ', ' cis-Diamminedichloroplatinum ', ' cis-Diaminedichloroplatinum ', ' cis platinum compound ', ' cis dichlorodiammineplatinum ', ' Platinum, diamminedichloro-, (SP-4-2)- ', ' Platinum, Diaminedichloro-, cis- (8CI) ', ' Platinum Diamminodichloride ', "" Peyrone's Salt "", "" Peyrone's Chloride "", ' Dichlorodiammineplatinum ', ' Cysplatyna ', ' Cisplatinum ', ' Cisplatina ', ' Cis-platinum II Diamine Dichloride ', ' Cis-platinum II ', ' Cis-platinous Diamine Dichloride ', ' Cis-dichloroammine Platinum (II) ', ' Cis-diamminedichloro Platinum (II) ', ' Cis-diamminedichloridoplatinum ', ' Cis-diammine-dichloroplatinum ', ' CDDP ', ' (SP-4-2)-Diamminedichloroplatinum ', ' Data Analyses ', ' Data Analysis ', ' Cessation of life ', ' Death ', ' Developing Countries ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' TERT gene ', ' hTERT Gene ', ' Telomerase Reverse Transcriptase Catalytic Subunit Gene ', ' Ethnic group ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' Population Attributable Risks ', ' attributable fraction ', ' Cancer Biology ', ' Cancer Center ', ' Cancer Etiology ', ' Cancer Cause ', ' Risk Estimate ', ' Scheme ', ' Validation ', ' 15q ', ' Chromosome 15 Long Arm ', ' Chromosome 15 Distal Arm ', ' 15q24 ', ' 15q25 ', ' 6p21 ', ' sex ', ' Development ', ' developmental ', ' Gender Role ', ' Sex Roles ', ' Genes ', ' Genetic Markers ', ' Genome ', ' Genotype ', ' Age ', ' density ', ' Goals ', ' Grant ', ' improved ', ' Procedures ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Site ', ' Area ', ' Variant ', ' Variation ', ' Death Rate ', ' Logistic Regressions ', ' Incidence ', ' Institutes ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' insight ', ' Individual ', ' Linkage Disequilibrium ', ' African ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' American Cancer Society ', ' male ', ' men ', "" men's "", ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Developed Countries ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Nation ', ' Developed Country ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' tool ', ' Smoker ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Risk ', ' Role ', ' social role ', ' San Francisco ', ' Smoking ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Survival Rate ', ' Testing ', ' Universities ', ' Caucasians ', ' Dependence ', ' Pattern ', ' Location ', ' interest ', ' cancer risk ', ' Tobacco Use Cessation ', ' Tobacco Cessation ', ' California ', ' disorder risk ', ' disease risk ', ' Genomics ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genetic variant ', ' Population ', ' Tobacco smoking ', ' parent grant ', ' high risk ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2009,397997,0.1861930459269944
"Predicting Radiotherapy Outcomes by Combining Physical and Biological Factors    DESCRIPTION (provided by applicant):   Many radiotherapy (RT) treatments carry a significant risk of serious complications to normal tissues. Previously, efforts to predict outcome have used either physical factors (e.g., volume irradiated to high dose) or biological factors (e.g., inherent radiosensitivity), but not both. We hypothesize that combining physical treatment data with patient-specific biomarkers will increase the predictive power of RT outcomes models. We will test this hypothesis specifically for prediction of radiation pneumonitis (RP) for lung cancer patients. Because no appropriate dataset exists to test this hypothesis, under Specific Aim 1, we will conduct a prospective clinical trial for non-small-cell lung cancer patients and collect candidate physical and biological data for modeling. Biomarker families selected based on peer-reviewed literature will mainly include:  (a) the levels of DNA-end binding complexes of DNA damage detection and repair proteins, which has been well correlated with radiosensitivity; and (b) pretreatment blood levels of the interleukin family of inflammatory cytokines (IL-1 alpha and IL-6) and ACE enzymes, which have also been correlated to RP. Physical data to be collected includes volumes irradiated to varying doses of the normal lung (dose-volume histogram data, collected using 4-D methods to avoid breathing artifacts), and the spatial location of the high-dose regions, both of which have been correlated with risk of RP. We will also image tumor regression over the course of RT (mid-course and at the end of RT) in order to better characterize the high doses received by normal lung tissue after tumor regression. In SA2, we test the hypothesized improvement in outcome prediction by combining biological and physical data. To select the best mathematical model, we will adapt and validate a new form of statistical model-building known as kernel-based learning. Based on our preliminary results, the kernel-based methods will likely provide a natural framework for understanding the interactions among the different physical and biological variables resulting in an effectively optimal predictive model. In summary, we propose to test the combination of biological/biomarker data and dose data to improve our ability to predict radiotherapy complications. In particular, we will use detectable blood-based biomarkers as well as treatment dose distribution characteristics to potentially improve our ability to predict (or avoid) radiation pneumonitis.          ",Predicting Radiotherapy Outcomes by Combining Physical and Biological Factors,7622168,K25CA128809,"['Pulmonary function tests ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Binding Proteins ', ' Ligand Binding Protein ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Relative Risks ', ' Maps ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Motion ', ' Diagnostic Neoplasm Staging ', ' Tumor Staging ', ' Neoplasm Staging ', ' Cancer Staging ', ' Review Literature ', ' Pathology ', ' Patients ', ' Peer Review ', ' Genetic ', ' Physics ', ' Play ', ' Pneumonia ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Staging ', ' Normal tissue morphology ', ' Normal Tissue ', ' Shapes ', ' Inflammatory ', ' Proteins ', ' gene product ', ' Radiation Tolerance ', ' Radiosensitivity ', ' Radiation Sensitivity ', ' Radiation therapy ', ' Radiotherapy ', ' Radiotherapeutics ', ' Risk ', ' Risk Factors ', ' Shorthand ', ' Archives ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Arts ', ' Technology ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT X Ray ', ' CAT scan ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Transforming Growth Factor beta ', ' TGFbeta ', ' TGF-beta ', ' TGF B ', ' Platelet Transforming Growth Factor ', ' Milk Growth Factor ', ' Bone-Derived Transforming Growth Factor ', ' Transforming Growth Factors ', ' transforming growth factors Animal growth regulators ', ' Tumor Growth Factors ', ' Investigation ', ' Work ', ' Complex ', ' Event ', ' Scanning ', ' Source ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' 3-Dimensional ', ' 3-D ', ' Location ', ' Nuclear ', ' Outcome Study ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Factors ', ' Natural Products ', ' Biologic Factor ', ' Biological Markers ', ' Biologic Marker ', ' Biology ', ' Blood ', ' Blood Reticuloendothelial System ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' treatment planning ', ' Interleukin-1 alpha ', ' Preinterleukin 1 Alpha ', ' Interleukin 1alpha ', ' IL1F1 ', ' IL1A Protein ', ' IL1-Alpha ', ' IL-1alpha ', ' IL-1A ', ' IL-1-a ', ' IL-1 alpha ', ' Categories ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Metric ', ' Reporting ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cell Culture Techniques ', ' cell culture ', ' cytokine ', ' Gender ', ' Imaging Techniques ', ' Imaging Technics ', ' Imaging Procedures ', ' Measures ', ' Relative (related person) ', ' Relative ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Morphologic artifacts ', ' Artifacts ', ' Radiation ', ' ray (radiation) ', ' Modeling ', ' Sampling ', ' response ', ' Uncertainty ', ' doubt ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Clinical Trials ', ' clinical investigation ', ' model design ', ' Electrophoretic Mobility Shift Assay ', ' gel shift assay ', ' Mobility Shift Assay ', ' Bandshift Mobility Assay ', ' Band Shift Mobility Assay ', ' Complication ', ' data modeling ', ' predictive modeling ', ' computer based prediction ', ' Outcome ', ' Population ', ' prospective ', ' Resistance ', ' resistant ', ' open source ', ' tumor ', ' high risk ', ' biomarker ', ' Data Collection ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' protein complex ', ' DNA Damage ', ' DNA Injury ', ' Tumor stage ', ' T-Stage ', ' data mining ', ' datamining ', ' Environment ', ' Address ', ' Enzymes ', ' Dose ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Cancer Patient ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Collection ', ' Common Terminology Criteria for Adverse Events ', ' Common Toxicity Criteria ', ' CTCAE ', ' Validation ', ' Characteristics ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Radiotherapy Research ', ' Development ', ' developmental ', ' Family ', ' Image ', ' imaging ', ' Age ', ' base ', ' Organ ', ' Blood specimen ', ' Blood Sample ', ' Goals ', ' Grant ', ' improved ', ' Histology ', ' Housing ', ' Algorithms ', ' Area ', ' Clinical ', ' repaired ', ' repair ', ' Phase ', ' Biological ', ' Logistic Regressions ', ' Radiation Pneumonitis ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonia ', ' Radiation Fibrosis ', ' Non-linear Models ', ' Nonlinear Models ', ' Link ', ' Inflammation ', ' Information Theory ', ' Interleukin-6 ', ' IFNB2 ', ' IFN-beta 2 ', ' Hybridoma Growth Factor ', ' Hepatocyte-Stimulating Factor ', ' HPGF ', ' BSF2 (B cell stimulating factor 2) ', ' BSF2 ', ' BSF-2 ', ' BCDF ', ' B-Cell Stimulatory Factor-2 ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Differentiation Factor ', ' B cell stimulating factor 2 ', ' B cell differentiation factor ', ' interferon beta 2 ', ' Plasmacytoma Growth Factor ', ' Myeloid Differentiation-Inducing Protein ', ' MGI-2 ', ' Interleukin 6 (Interferon, Beta 2) ', ' IL6 Protein ', ' IL-6 ', ' Interleukins ', ' Peptidyl-Dipeptidase A ', ' Kininase II ', ' Kininase A ', ' Dipeptidyl Peptidase A ', ' Carboxycathepsin ', ' CD143 Antigens ', ' Angiotensin I-Converting Enzyme ', ' Angiotensin Converting Enzyme ', ' Serum ', ' Blood Serum ', ' Learning ', ' insight ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' ']",NCI,WASHINGTON UNIVERSITY,K25,2009,131547,0.048113822971267435
"High Density Association Analysis of Lung Cancer    DESCRIPTION (provided by applicant):  The goal of this research is to identify novel susceptibility genes for lung cancer using a systematic genome- wide association-based approach. To achieve this goal, we are applying a two-stage design. This proposal builds upon an extensive resource of lung cancer cases and controls matched for smoking behavior, sex, and ethnicity who have been collected over many years at the U.T. M.D. Anderson Cancer Center, and on a recently approved proposal to the Center for Inherited Disease Research that is performing genotyping of 317,000 markers on 1200 Caucasian ever-smoking lung cancer cases and 1200 controls matched for ethnicity, age, smoking behavior, and sex. Our first aim is to analyze data from the completed first-stage of genotyping. For our second aim, we will complete the two-stage design, which is powered to detect associations with genotypic risk ratios of about 1.4 with a very stringent significance criterion of 1.7 x 10-7. We will genotype and analyze 3380 SNPs on 1200 lung cancer cases and 1200 controls. We will also analyze SNPs from 90 candidate genes identified through a systematic literature search as well as a limited number of SNPs in significant pathways. In our third aim we will genotype 400 never-smoking lung cancer cases and 400 controls for 946 SNP markers. To evaluate possible interethnic differences in the genetic control of lung cancer risk we will analyze 400 African-American lung cancer cases and 400 African- American controls (aim 4) for 946 SNP markers. In these 4 aims we are also including a panel of SNPs to estimate ancestry. In aim 5, we use machine learning approaches to develop models for characterizing gene-gene and gene-environment effects on lung cancer risk. Cases and controls have extensive epidemiological and family history data together with candidate gene and functional DNA repair measures. The end result of our analysis will substantively increase our understanding of the genetic etiology of lung cancer and gene-environment interactions that contribute to its causation. This is an experienced investigative team, using state of the art technology to perform a multistage genome-wide analysis on a large, uniquely well-characterized population of lung cancer cases and matched controls with rich functional data. We are collaborating with the International Lung Cancer Consortium so that it can further validate our findings for a variety of different populations, in future initiatives.                                                              ",High Density Association Analysis of Lung Cancer,7858483,R01CA121197,"['Data Analyses ', ' Data Analysis ', ' Inflammatory Response ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data ', ' Direct Costs ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Applications Grants ', ' Grant Proposals ', ' International ', ' Subgroup ', ' Cancer Center ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' Collection ', ' Enrollment ', ' enroll ', ' Genetic Risk ', ' Genotypic Risk Ratio ', ' Newly Diagnosed ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Prevention ', ' Smoking Status ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Validation ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Future ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Behavioral Genetics ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Genome ', ' Genotype ', ' Age ', ' base ', ' density ', ' Goals ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Hypersensitivity ', ' Allergy ', ' repaired ', ' repair ', ' In Vitro ', ' Infection ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Individual ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Fostering ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Relative Risks ', ' Sample Size ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Persons ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Collaborations ', ' Occupational Exposure ', ' Oncogenes ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Staging ', ' tool ', ' Smoker ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoke ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' medical specialties ', ' Specialty ', ' Arts ', ' Technology ', ' Tobacco ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Scanning ', ' Clinic ', ' Pattern ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' meetings ', ' cancer risk ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' novel ', ' Participant ', ' Population Study ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Gender ', ' genetic analysis ', ' Genetic analyses ', ' Measures ', ' Statistical Methods ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Modeling ', ' case control ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' tobacco exposure ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' design ', ' designing ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' genome-wide analysis ', ' high risk ', ' genome-wide ', ' genomewide ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2010,386698,0.18238103681189097
"Statistical Model Building for High Dimensional Biomedical Data    DESCRIPTION (provided by applicant):  Typical of current large-scale biomedical data is the feature of small number of observed samples and the widely observed sample heterogeneity. Identifying differentially expressed genes related to the sample phenotye (e.g., cancer disease development) and predicting sample phenotype based on the gene expressions are some central research questions in the microarray data analysis. Most existing statistical methods have ignored sample heterogeneity and thus loss power.       This project proposes to develop novel statistical methods that explicitly address the small sample size and sampe heterogeneity issues, and can be applied very generally. The usefulness of these methods will be shown with the large-scale biomedical data originating from the lung and kidney transplant research projects. The transplant projects aimed to improve the molecular diagnosis and therapy of lung/kidney allograft rejection by identifying molecular biomarkers to predict the allograft rejection for critical early treatment and rapid, noninvasive, and economical testing.       The specific aims are 1) Develop novel statistical methods for differential gene expression detection that explicitly model sample heterogeneity. 2) Develop novel statistical methods for classifying high-dimensional biomedical data and incorporating sample heterogeneity. 3) Develop novel statistical methods for jointly analyzing a set of genes (e.g., genes in a pathway). 4) Use the developed models and methods to answer research questions relevant to public health in the lung and kidney transplant projects; and implement and validate the proposed methods in user-friendly and well-documented software, and distribute them to the scientific community at no charge.       It is very important to identify new biomarkers of allograft rejection in lung and kidney transplant recipients. The rapid and reliable detection and prediction of rejection in easily obtainable body fluids may allow the rapid advancement of clinical interventional trials. We propose to study novel methods for analyzing the large-scale biomedical data to realize their full potential of molecular diagnosis and prognosis of transplant rejection prediction for critical early treatment.          ",Statistical Model Building for High Dimensional Biomedical Data,7858165,R01GM083345,"['Resources ', ' Research Resources ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' sound ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Transplantation ', ' transplant ', ' Universities ', ' Adopted ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Work ', ' Dimensions ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' interest ', ' kidney allograft ', ' renal allograft ', ' Body Fluids ', ' user friendly software ', ' user friendly computer software ', ' simulation ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cations ', ' Charge ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Outcome Measure ', ' Modeling ', ' Sampling ', ' theories ', ' software development ', ' developing computer software ', ' develop software ', ' Genomics ', ' Communities ', ' cancer microarray ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' cancer type ', ' Coupled ', ' Early treatment ', ' early therapy ', ' early intervention ', ' user-friendly ', ' biomarker ', ' transplant database ', ' transplant data base ', ' biobank ', ' biorepository ', ' allograft rejection ', ' Data Analyses ', ' Data Analysis ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Molecular Diagnosis ', ' Collection ', ' Oncogene Activation ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Characteristics ', ' Molecular ', ' Development ', ' developmental ', ' Experimental Designs ', ' Pathway interactions ', ' pathway ', ' Gene Expression ', ' Genes ', ' base ', ' method development ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' improved ', ' Procedures ', ' Heterogeneity ', ' Algorithms ', ' Clinical ', ' Joints ', ' Articulation ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Least-Squares Analysis ', ' Least-Squares Analyses ', ' Least Squares ', ' Individual ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Sample Size ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Minnesota ', ' Statistical Models ', ' Probabilistic Models ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Patients ', ' Phenotype ', ' Probability ', ' outcome forecast ', ' Prognosis ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Proposals ', ' ']",NIGMS,UNIVERSITY OF MINNESOTA,R01,2010,253269,0.06301616635225511
"Center for Nanobiology and Predictive Toxicology    DESCRIPTION (provided by applicant):  The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop ""nano-QSARs"" for probabilistic risk ranking (Project 3).        We propose a center to study how properties of engineered nanomaterials may lead to lung health effects by creating harmful interactions in cells and tissues that will come into contact with these materials. This will be accomplished by a multi-disciplinary team who will use their expertise in nanomaterial science, biology, toxicology, imaging, statistics and computer science to integrate above goals into a predictive model that projects from what is happening in cells to what may happen in the lung.",Center for Nanobiology and Predictive Toxicology,8016739,U19ES019528,[''],NIEHS,UNIVERSITY OF CALIFORNIA LOS ANGELES,U19,2010,1144284,0.06393576329664759
"Predictive Modeling with Clinical and Genomic Data in COPD    DESCRIPTION (provided by applicant):  Candidate: Dr. Peter Castaldi is a physician completing a period of F32-funded support. On July 1st, 2009 he will begin a full-time position at Tufts Medical Center and the Institute for Clinical Research and Health Policy Studies (ICRHPS). This position involves a 25% clinical commitment. His principal research interests are the genetic epidemiology of COPD and the translation of genomic discoveries into clinical practice and public health. His particular interests are genetic meta-analysis, gene-environment interaction, and predictive modeling with regression-based and machine-learning methods.  His immediate goals are 1.) to identify novel genetic associations with COPD susceptibility and COPD- related phenotypes through the combined analysis of multiple genome-wide association (GWA) studies, 2.) to identify epistatic and gene-by-smoking interactions, and 3.) to develop accurate predictive models in chronic obstructive pulmonary disease (COPD) using clinical and genomic information. His long-term goal is to be an independent investigator with expertise in bioinformatics. His vision for achieving this goal involves developing expertise in bioinformatics so as to be able to participate in and eventually lead multidisciplinary teams in the application of computational methods to genomic datasets in order to answer important clinical questions that will improve the care of patients and population health. Environment: Dr. Castaldi will receive training in a rich, interdisciplinary environment. His principal mentor, Dr. Joseph Lau, is the head of the Center for Clinical Evidence Synthesis in the ICRHPS, and he is a worldwide leader in the field of meta-analysis and evidence synthesis. At Tufts, in addition to regular meetings with Dr. Lau, Peter will receive training in genetic evidence synthesis from leaders in the field, including Drs. John Ioannidis and Tom Trikalinos. The co-mentor of this application, Dr. Edwin Silverman, is a leading researcher in COPD genetics at the Channing Laboratory. At the Channing Laboratory, Peter will receive excellent training in respiratory genetics and genetic epidemiology, and he will have resources to state of the art high-throughput genotyping, next-generation sequencing technologies, and bioinformatics support. Dr. Castaldi will also continue his collaboration with Dr. Donna Slonim in the Tufts Computer Science Department, who will provide assistance with application of computational algorithms to genomic data and guidance as Dr. Castaldi continues to build a practical and theoretical foundation in Bioinformatics. Research: COPD is a major cause of morbidity and mortality that is of increasing public health importance. While the principal risk factor for COPD, smoking, is well-established, there is variable susceptibility in the general population to the lung damage caused by cigarette smoke. There is strong evidence supporting a genetic component to COPD susceptibility. Understanding how genes and environment interact to produce clinical COPD will allow for more accurate diagnostic tools and open new avenues of investigation for the development of COPD therapies. We propose to 1.) identify novel genetic associations with COPD susceptibility and 4 COPD-related phenotypes by performing meta-analysis on patient-level data from 4 large COPD GWA studies, 2.) identify gene-by-smoking and gene-gene interactions, and 3.) develop predictive models for COPD susceptibility and COPD-related phenotypes. In order to maximize the information obtained from genomic data, we will combine data from multiple studies (the National Emphysema Treatment Trial Genetics Ancillary Study, the Norway Case-Control Study, COPDGene, and ECLIPSE - total sample size=7,962) to increase power and employ regression-based and machine-learning methods to identify complex patterns of interaction in genotype data. Our study is designed to both explore and subsequently rigorously validate discovered main effect and interaction associations. Using predictive models, we will quantify the incremental predictive benefit of including genetic main effects and genetic interaction data to traditional clinical variables. Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.      PUBLIC HEALTH RELEVANCE:  The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.           Project Narrative The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.",Predictive Modeling with Clinical and Genomic Data in COPD,7875053,K08HL102265,"['genetic epidemiology ', ' Genomics ', ' Clinical Research ', ' Clinical Study ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' treatment trial ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genetic variant ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' next generation ', ' Outcome ', ' Population ', ' multidisciplinary ', ' public health relevance ', ' clinical care ', ' patient population ', ' clinical practice ', ' population health ', ' Computational algorithm ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Bioinformatics ', ' Bio-Informatics ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Disease susceptibility ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' genetic association ', ' Environment ', ' Environmental Exposure ', ' Data Set ', ' Dataset ', ' Caring ', ' Data ', ' Disease Association ', ' Ancillary Study ', ' Validation ', ' Process ', ' Development ', ' developmental ', ' Foundations ', ' Future ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Genes ', ' Epistatic Gene ', ' Genotype ', ' base ', ' Goals ', ' improved ', ' Head ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Heart ', ' Hematological Disease ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hereditary Disease ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Area ', ' Clinical ', ' Biological ', ' Link ', ' Institutes ', ' Predisposition ', ' Susceptibility ', ' prognostic ', ' Training ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' insight ', ' Light ', ' Photoradiation ', ' Individual ', ' cigarette smoke ', ' smoke of cigarettes ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Sample Size ', ' Funding ', ' Mentors ', ' Methods ', ' Mission ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Persons ', ' Collaborations ', ' Norway ', ' Patients ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' Pulmonary Emphysema ', ' Emphysema ', ' Diagnostic ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Sampling Studies ', ' Smoke ', ' Smoking ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Arts ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' Training Programs ', ' Translating ', ' Translations ', ' Vision ', ' visual function ', ' Sight ', ' Investigation ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Pattern ', ' Techniques ', ' respiratory ', ' interest ', ' Biology ', ' Biomass ', ' meetings ', ' Medical center ', ' American ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' Performance ', ' success ', ' computer science ', ' cohort ', ' novel ', ' General Population ', ' General Public ', ' Prevention ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Positioning Attribute ', ' Position ', ' Cause of Death ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Relative (related person) ', ' Relative ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Modeling ', ' Sampling ', ' case control ', ' ']",NHLBI,TUFTS MEDICAL CENTER,K08,2010,128250,0.02304844678918864
"Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)    DESCRIPTION (provided by applicant): Preterm birth is associated with bronchopulmonary dysplasia (BPD), a form of chronic lung disease that impacts the pulmonary and overall health of more than 10,000 infants in the US each year. The long-term objective of this Clinical Research Center (CRC) is translation of biochemical, genetic and bioinformatics research into innovative interventions that improve outcomes of extremely preterm infants at risk for long- term pulmonary morbidity. Our proposal focuses specifically on the urea cycle-nitric oxide (UC-NO) and glutathione (GSH) pathways as pivotal and interrelated mechanisms in the response of the developing lung to the extrauterine environment. Overall hypotheses: (1) Biochemical immaturity and functional genetic variation in the UC-NO and GSH pathways modulate the BPD phenotype spectrum; (2) The duration and degree of NO insufficiency and free radical excess predicts BPD severity and correlates with pulmonary morbidity after NICU discharge. To investigate our hypothesis, our CRC will enroll 250 infants with birthweights 510-1250 grams and follow the survivors through 1 year of life. Our hypothesis invokes an immature hepatic and gut synthetic capacity to make citrulline and GSH, functional genetic variations in the UC-NO and GSH pathways, nutritional deficiencies and the physiologic and environmental stress of preterm birth. The resultant NO deficiency and free radical excess alters pulmonary vascular and alveolar development. Our biomarker discovery concept includes (a) collection of plasma, urine, red blood cells, DNA and tracheal aspirates for measurements of NO and GSH precursor sufficiency, production of NO metabolites and GSH, functional genetic variants in these pathways, and biomarkers of in vivo oxidative stress and (b) validation of these biomarkers for diagnosis and long term prognosis of patients with BPD. A bioinformatics approach using machine learning and predictive modeling has been developed for respiratory phenotyping and risk stratification at 36 weeks and 40 weeks postmenstrual age and at 12 months after hospital discharge. Accomplishment of these goals will promote novel clinical trials design to test new therapies to prevent BPD and improve long term pulmonary health of infants born preterm. (End of Abstract)      RELEVANCE: Each year in the US, more than 10,000 premature infants develop bronchopulmonary dysplasia (BPD), a chronic lung disease associated with prolonged and recurrent hospitalizations and lifelong alterations in lung function. This proposal will explore developmental, genetic and environmental interactions and identify biochemical markers to predict BPD development and severity, with the ultimate goal of designing new treatments to prevent BPD and improve long-term lung function in premature infants.              ",Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV),7867527,U01HL101456,"['Cysteine ', ' L-Cysteine ', ' Half-Cystine ', ' Data Collection ', ' Bioinformatics ', ' Bio-Informatics ', ' Diagnosis ', ' DNA ', ' Deoxyribonucleic Acid ', ' prevent ', ' preventing ', ' Alveolar ', ' Environment ', ' Erythrocytes ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' Data Set ', ' Dataset ', ' Data ', ' Predictive Value ', ' Stratification ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' in vivo ', ' Clinical Data ', ' Clinical Trials Design ', ' trial design ', ' Collection ', ' Enrollment ', ' enroll ', ' Validation ', ' Nutritional ', ' Principal Investigator ', ' Development ', ' developmental ', ' Malnutrition ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Free Radicals ', ' Pathway interactions ', ' pathway ', ' Gene Library ', ' genetic library ', ' Genes ', ' Biochemical Genetics ', ' Age ', ' Glutathione ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' base ', ' Goals ', ' improved ', ' Health ', ' Homocysteine ', ' L-Isomer Homocysteine ', ' 2-amino-4-mercaptobutyric acid ', ' Homocystine ', "" Butanoic acid, 4,4'-dithiobis(2-amino)- "", ' Hospitalization ', ' Hospitals ', ' County Hospitals ', ' Pediatric Hospitals ', "" Children's Hospital "", ' sample collection ', ' specimen collection ', ' Hepatic ', ' Clinical ', ' premature ', ' prematurity ', ' Specific qualifier value ', ' Specified ', ' Variant ', ' Variation ', ' Physiological ', ' Physiologic ', ' Biochemical ', ' Infant Health ', ' Biochemical Markers ', ' Survivors ', ' Infant ', ' Premature Infant ', ' preterm neonate ', ' preterm infant human ', ' preterm infant ', ' preterm baby ', ' premature infant human ', ' premature baby ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Measurement ', ' Oxidative Stress ', ' Amino Acids ', ' aminoacid ', ' Methionine ', ' L-Methionine ', ' L-Isomer Methionine ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Morbidity - disease rate ', ' Morbidity ', ' Nitric Oxide ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Ornithine ', ' 2,5-Diaminopentanoic Acid ', ' Oxides ', ' Patients ', ' Phenotype ', ' Genetic ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Production ', ' outcome forecast ', ' Prognosis ', ' Recruitment Activity ', ' recruit ', ' Recurrence ', ' Recurrent ', ' Research ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Risk ', ' Specimen ', ' Research Specimen ', ' Aspirate substance ', ' Aspirate ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Arginine ', ' L-Isomer Arginine ', ' L-Arginine ', ' Life ', ' Stress ', ' Testing ', ' Time ', ' Translations ', ' Urine ', ' Urine Urinary System ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Severities ', ' System ', ' LOINC Axis 4 System ', ' Beds ', ' respiratory ', ' gastrointestinal ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' developmental genetics ', ' urea cycle ', ' cohort ', ' Glutathione Disulfide ', ' Oxidized Glutathione ', ' GSSG ', ' Bis(gamma-Glutamyl-L-cysteinylglycine) Disulfide ', ' Bronchopulmonary Dysplasia ', ' newborn chronic lung disease ', ' neonatal chronic lung disease ', ' infant chronic lung disease ', ' chronic lung disease in prematurity ', ' chronic lung disease in newborns ', ' chronic lung disease in neonates ', ' chronic lung disease in neonatal infants ', ' chronic lung disease in infants ', ' BPD ', ' novel ', ' Study Subject ', ' Categories ', ' Pathogenesis ', ' Chronic lung disease ', ' Censuses ', ' Measures ', ' Admission activity ', ' Admission ', ' abstracting ', ' Modeling ', ' Sampling ', ' response ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Citrulline ', ' L-Ornithine, N5-(aminocarbonyl)- ', ' Clinical Research ', ' Clinical Study ', ' F2-Isoprostanes ', ' genetic variant ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' open source ', ' oxidant stress ', ' biomarker ', ' biobank ', ' biorepository ', ' Secure ', ' ']",NHLBI,VANDERBILT UNIVERSITY,U01,2010,227000,0.09218063307322696
"Predicting Radiotherapy Outcomes by Combining Physical and Biological Factors    DESCRIPTION (provided by applicant):   Many radiotherapy (RT) treatments carry a significant risk of serious complications to normal tissues. Previously, efforts to predict outcome have used either physical factors (e.g., volume irradiated to high dose) or biological factors (e.g., inherent radiosensitivity), but not both. We hypothesize that combining physical treatment data with patient-specific biomarkers will increase the predictive power of RT outcomes models. We will test this hypothesis specifically for prediction of radiation pneumonitis (RP) for lung cancer patients. Because no appropriate dataset exists to test this hypothesis, under Specific Aim 1, we will conduct a prospective clinical trial for non-small-cell lung cancer patients and collect candidate physical and biological data for modeling. Biomarker families selected based on peer-reviewed literature will mainly include:  (a) the levels of DNA-end binding complexes of DNA damage detection and repair proteins, which has been well correlated with radiosensitivity; and (b) pretreatment blood levels of the interleukin family of inflammatory cytokines (IL-1 alpha and IL-6) and ACE enzymes, which have also been correlated to RP. Physical data to be collected includes volumes irradiated to varying doses of the normal lung (dose-volume histogram data, collected using 4-D methods to avoid breathing artifacts), and the spatial location of the high-dose regions, both of which have been correlated with risk of RP. We will also image tumor regression over the course of RT (mid-course and at the end of RT) in order to better characterize the high doses received by normal lung tissue after tumor regression. In SA2, we test the hypothesized improvement in outcome prediction by combining biological and physical data. To select the best mathematical model, we will adapt and validate a new form of statistical model-building known as kernel-based learning. Based on our preliminary results, the kernel-based methods will likely provide a natural framework for understanding the interactions among the different physical and biological variables resulting in an effectively optimal predictive model. In summary, we propose to test the combination of biological/biomarker data and dose data to improve our ability to predict radiotherapy complications. In particular, we will use detectable blood-based biomarkers as well as treatment dose distribution characteristics to potentially improve our ability to predict (or avoid) radiation pneumonitis.          ",Predicting Radiotherapy Outcomes by Combining Physical and Biological Factors,7787116,K25CA128809,"['Disease ', ' disease/disorder ', ' Disorder ', ' DNA Damage ', ' DNA Injury ', ' Tumor stage ', ' T-Stage ', ' data mining ', ' datamining ', ' Environment ', ' Address ', ' Enzymes ', ' Dose ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Predictive Value ', ' in vitro Assay ', ' Cancer Patient ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Collection ', ' Common Terminology Criteria for Adverse Events ', ' Common Toxicity Criteria ', ' CTCAE ', ' therapy outcome ', ' Validation ', ' Principal Investigator ', ' Characteristics ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Radiotherapy Research ', ' Development ', ' developmental ', ' Family ', ' Image ', ' imaging ', ' Age ', ' base ', ' Organ ', ' Blood specimen ', ' Blood Sample ', ' Goals ', ' Grant ', ' improved ', ' Histology ', ' Housing ', ' Algorithms ', ' Site ', ' Area ', ' Clinical ', ' repaired ', ' repair ', ' Phase ', ' Biological ', ' Logistic Regressions ', ' Radiation Pneumonitis ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonia ', ' Radiation Fibrosis ', ' Non-linear Models ', ' Nonlinear Models ', ' Link ', ' Inflammation ', ' Information Theory ', ' Interleukin-6 ', ' IFNB2 ', ' IFN-beta 2 ', ' Hybridoma Growth Factor ', ' Hepatocyte-Stimulating Factor ', ' HPGF ', ' BSF2 (B cell stimulating factor 2) ', ' BSF2 ', ' BSF-2 ', ' BCDF ', ' B-Cell Stimulatory Factor-2 ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Differentiation Factor ', ' B cell stimulating factor 2 ', ' B cell differentiation factor ', ' interferon beta 2 ', ' Plasmacytoma Growth Factor ', ' Myeloid Differentiation-Inducing Protein ', ' MGI-2 ', ' Interleukin 6 (Interferon, Beta 2) ', ' IL6 Protein ', ' IL-6 ', ' Interleukins ', ' Predisposition ', ' Susceptibility ', ' Peptidyl-Dipeptidase A ', ' Kininase II ', ' Kininase A ', ' Dipeptidyl Peptidase A ', ' Carboxycathepsin ', ' CD143 Antigens ', ' Angiotensin I-Converting Enzyme ', ' Angiotensin Converting Enzyme ', ' Serum ', ' Blood Serum ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' insight ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Pulmonary function tests ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Binding Proteins ', ' Ligand Binding Protein ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Measurement ', ' Relative Risks ', ' Radiation Oncology ', ' Funding ', ' Maps ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Motion ', ' Diagnostic Neoplasm Staging ', ' Tumor Staging ', ' Neoplasm Staging ', ' Cancer Staging ', ' Review Literature ', ' Pathology ', ' Patients ', ' Peer Review ', ' Genetic ', ' Physics ', ' Play ', ' Pneumonia ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Positron-Emission Tomography ', ' Rad.-PET ', ' Positron Emission Tomography Scan ', ' Positron Emission Tomography Medical Imaging ', ' PETT ', ' PETSCAN ', ' PET imaging ', ' PET Scan ', ' PET ', ' Staging ', ' Normal tissue morphology ', ' Normal Tissue ', ' Shapes ', ' Inflammatory ', ' Proteins ', ' gene product ', ' Radiation Tolerance ', ' Radiosensitivity ', ' Radiation Sensitivity ', ' Radiation therapy ', ' Radiotherapy ', ' Radiotherapeutics ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Shorthand ', ' Archives ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Arts ', ' Technology ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT X Ray ', ' CAT scan ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Transforming Growth Factor beta ', ' TGFbeta ', ' TGF-beta ', ' TGF B ', ' Platelet Transforming Growth Factor ', ' Milk Growth Factor ', ' Bone-Derived Transforming Growth Factor ', ' Transforming Growth Factors ', ' transforming growth factors Animal growth regulators ', ' Tumor Growth Factors ', ' Investigation ', ' Work ', ' Complex ', ' Event ', ' Scanning ', ' Clinic ', ' Source ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' 3-Dimensional ', ' 3-D ', ' Location ', ' Tumor Tissue ', ' Nuclear ', ' Outcome Study ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Factors ', ' Natural Products ', ' Biologic Factor ', ' Biological Markers ', ' Biologic Marker ', ' Biology ', ' Adverse reactions ', ' Blood ', ' Blood Reticuloendothelial System ', ' success ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' treatment planning ', ' Interleukin-1 alpha ', ' Preinterleukin 1 Alpha ', ' Interleukin 1alpha ', ' IL1F1 ', ' IL1A Protein ', ' IL1-Alpha ', ' IL-1alpha ', ' IL-1A ', ' IL-1-a ', ' IL-1 alpha ', ' Toxic effect ', ' Toxicities ', ' Categories ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Metric ', ' Reporting ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cell Culture Techniques ', ' cell culture ', ' cytokine ', ' Gender ', ' Imaging Techniques ', ' Imaging Technics ', ' Imaging Procedures ', ' Measures ', ' Relative (related person) ', ' Relative ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Morphologic artifacts ', ' Artifacts ', ' Radiation ', ' ray (radiation) ', ' Case Study ', ' case report ', ' Modeling ', ' Sampling ', ' response ', ' Uncertainty ', ' doubt ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' clinical investigation ', ' Magnetic Resonance ', ' model design ', ' Accounting ', ' Electrophoretic Mobility Shift Assay ', ' gel shift assay ', ' Mobility Shift Assay ', ' Bandshift Mobility Assay ', ' Band Shift Mobility Assay ', ' Complication ', ' data modeling ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' Population ', ' prospective ', ' Resistance ', ' resistant ', ' open source ', ' tumor ', ' high risk ', ' patient population ', ' biomarker ', ' Sterilization ', ' Data Analyses ', ' Data Analysis ', ' Data Collection ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' protein complex ', ' Three-Dimensional Image ', ' 3D images ', ' 3D image ', ' 3-D image ', ' 3-D Images ', ' ']",NCI,WASHINGTON UNIVERSITY,K25,2010,131547,0.048113822971267435
"Center for Nanobiology and Predictive Toxicology    DESCRIPTION (provided by applicant):  The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop ""nano-QSARs"" for probabilistic risk ranking (Project 3).        We propose a center to study how properties of engineered nanomaterials may lead to lung health effects by creating harmful interactions in cells and tissues that will come into contact with these materials. This will be accomplished by a multi-disciplinary team who will use their expertise in nanomaterial science, biology, toxicology, imaging, statistics and computer science to integrate above goals into a predictive model that projects from what is happening in cells to what may happen in the lung.",Center for Nanobiology and Predictive Toxicology,8146748,U19ES019528,"['Play ', ' Pneumonia ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Risk ', ' Rodent ', ' Rodents Mammals ', ' Rodentia ', ' Role ', ' social role ', ' Science ', ' Signal Pathway ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' statistics ', ' Cellular biology ', ' cell biology ', ' Tissues ', ' Body Tissues ', ' Toxicology ', ' Lytic ', ' Inhalation Exposure ', ' Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biology ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' cytotoxicity ', ' Lytotoxicity ', ' Membrane ', ' membrane structure ', ' metal oxide ', ' Performance ', ' hazard ', ' computer science ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' Cells ', ' Generations ', ' Modeling ', ' Property ', ' LOINC Axis 2 Property ', ' high throughput screening ', ' High Throughput Assay ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' predictive modeling ', ' computer based prediction ', ' nanomaterials ', ' nano materials ', ' nanobiology ', ' nano biology ', ' nanoparticle ', ' nano particle ', ' Outcome ', ' combinatorial ', ' multidisciplinary ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Cytolysis ', ' Lysis ', ' Engineering ', ' Dose ', ' Data ', ' in vivo ', ' Molecular ', ' cellular imaging ', ' cell imaging ', ' nano ', ' Fibrosis ', ' Future ', ' Image ', ' imaging ', ' Pathway interactions ', ' pathway ', ' Injury ', ' base ', ' Organ ', ' Goals ', ' Health ', ' Link ', ' In Vitro ', ' Inflammation ', ' Screening procedure ', ' screenings ', ' screening ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Libraries ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Oxidative Stress ', ' Cellular Structures ', ' Cell Structure ', ' Cell Components ', ' chemical property ', ' Mathematics ', ' Metals ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA LOS ANGELES,U19,2010,27441,0.06393576329664759
"Inflammation Genes and Lung Cancer Risk DESCRIPTION (provided by applicant): There is accumulating evidence that chronic injury and inflammation in the respiratory tract, such as that caused by cigarette smoking, predispose to lung cancer. We therefore propose to conduct an in depth pathway-based analysis of gene variants in the inflammatory pathway using test and validation sets of cases and controls. This proposal builds on a well-annotated specimen repository of lung cancer cases and controls enrolled in an ongoing risk factor study (CA55769, Spitz, PI). Cases are frequency-matched to controls on age, gender, ethnicity and smoking status recruited from a multi-specialty physician practice. Data collected include smoking history, dietary intake, cancer family history, specific occupational exposures (e.g., asbestos, dust), and previous medical history including chronic obstructive airway disease, asthma and hay fever. Genomic DNA and rich candidate genotype and phenotype data are available. Aim 1: To identify novel genetic variants influencing lung cancer risk in a test set of 1500 cases with non-small cell lung cancer and 1500 matched controls (all Caucasian), using the Illumina iSelect Infinium chip with 8.5 to 9K SNP's. Aim 2: In a replication set of an additional 1000 cases and 1000 controls, using a GoldenGate assay, we will evaluate the top 1500 SNPs identified from Aim1 as meeting the P<0.1 criterion, or selected by a rational prioritizing approach that incorporates published results, type of SNP, evolutionary biology, physico-chemical properties and haplotype tagging SNPs. Aim 3: To perform fine mapping in the flanking regions of 50 SNPs selected by the same approach as in Aim 2, combining prior information with in silico approaches for predicting functionality. For each of these 50 SNPs, we will select an average of 10 additional SNPs per gene region to regenotype in all 2500 cases and 2500 controls. Aim 4. To extend our epidemiologic risk prediction model by incorporating established epidemiologic risk factor and gene variant data. We will apply machine-learning tools to identify gene-environment and gene-gene interactions. Covariates will include prior emphysema, asthma, hay fever, dust and asbestos exposure, smoking characteristics, family history of cancer, and anti-inflammatory drug use. The International Lung Cancer Consortium will perform external validation in a proposal to be developed. Our approach to comprehensively evaluate variants in a candidate pathway in a large well- powered study will be applicable to a variety of other cancer sites where inflammation plays an important etiologic role, as well as in non-neoplastic diseases with a strong inflammatory component such as emphysema. The public health potential of a useful risk prediction modes for lung cancer is substantial. Public Health Relevance Statement Cigarette smoking results in inflammation in the respiratory tract and there is growing evidence that chronic inflammatory processes predispose to lung cancer. However, the molecular mechanisms underlying the causal nature of this association are unclear. We propose to conduct an in depth analysis of gene variants in the inflammatory pathway as susceptibility factors for lung cancer. This proposal builds upon an existing well annotated specimen repository. We will evaluate gene variants in a test set of lung cancer cases and matched controls and validate the findings in an independent dataset. Finally we will incorporate these findings into an extended risk prediction model for lung cancer.",Inflammation Genes and Lung Cancer Risk,7746494,R01CA127219,"['Publishing ', ' Pulmonary Emphysema ', ' Emphysema ', ' Receiver Operating Characteristics ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Nature ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Research ', ' Resources ', ' Research Resources ', ' Respiratory System ', ' respiratory tract ', ' Respiratory system (all sites) ', ' Pulmonary Organ System ', ' Pulmonary Body System ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoking ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' medical specialties ', ' Specialty ', ' Asbestos ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Asthma ', ' Bronchial Asthma ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Adopted ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Host Defense ', ' Nucleotide Excision Repair ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' meetings ', ' cancer risk ', ' carcinogenesis ', ' Cancer Induction ', ' gene interaction ', ' Proxy ', ' novel ', ' Participant ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' cigarette smoking ', ' smoke cigarette ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Cell Cycle ', ' Cell Division Cycle ', ' cell growth ', ' Cellular Growth ', ' Cellular Expansion ', ' Gender ', ' TP53 gene ', ' p53 Genes ', ' Tumor Protein p53 Gene ', ' TRP53 ', ' TP53 ', ' P53 ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Modeling ', ' response ', ' case control ', ' repository ', ' cancer site ', ' cancer location ', ' Genomics ', ' genetic variant ', ' Outcome ', ' aggregation pathway ', ' parent grant ', ' public health relevance ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' Base Excision Repairs ', ' DNA Base Excision Repair ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Dietary intake ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' tumorigenesis ', ' Oncogenesis ', ' Dust ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' DNA Repair Pathway ', ' Data ', ' International ', ' Progress Review Group ', ' Anti-inflammatory ', ' Enrollment ', ' enroll ', ' Newly Diagnosed ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Status ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Pathway interactions ', ' pathway ', ' neoplastic ', ' Affect ', ' Genes ', ' Genotype ', ' Injury ', ' Age ', ' base ', ' Goals ', ' Growth Factor ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Haplotypes ', ' Hay fever ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Area ', ' Chronic ', ' Variant ', ' Variation ', ' Logistic Regressions ', ' Link ', ' In Vitro ', ' Infection ', ' Inflammation ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Irritants ', ' Joints ', ' Articulation ', ' Literature ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Drug usage ', ' drug use ', ' Oxidative Stress ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' chemical property ', ' Maps ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Family Cancer History ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Respiratory tract structure ', ' Respiratory Tracts ', ' Letters ', ' Occupational Exposure ', ' angiogenesis ', ' Phenotype ', ' Genetic ', ' Physicians ', ' Anti-Inflammatory Agents ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Probability ', ' Staging ', ' Inflammatory ', ' Antihistamines ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2010,532744,0.12530806534110406
"Prediction of Physiological Events in People with Sleep Disordered Breathing    DESCRIPTION (provided by applicant): Sleep-disordered breathing (SDB) refers to a spectrum of disorders characterized by abnormal respiratory patterns or levels of ventilation during sleep. The most common is obstructive sleep apnea (OSA). People with OSA experience repetitive apnea (cessation of breathing) and hypopnea (marked decrease in tidal volume) during sleep in association with airway compromise and excessive daytime sleepiness (EDS). An arousal, or brief, often unnoticed, disruption of sleep is commonly associated with apnea. People with OSA also exhibit cognitive dysfunction, including impairment to memory, attention, and executive function. OSA- associated EDS and cognitive dysfunction are thought to significantly contribute to automobile accidents and workplace injuries. The first aim of this research is to predict the onset of nocturnal apnea, hypopnea, and arousal. Our proposal to accomplish this aim represents an entirely new approach to improving the effectiveness and tolerability of SBD therapy. The most common therapy is continuous positive airway pressure (CPAP), which is difficult for many patients to tolerate. Existing auto-adjusting PAP may be more tolerable but relies on detection of disordered breathing events and does not appear to improve quality of life compared with conventional CPAP. Predicting these events could lead to more effective titration of PAP levels and improved outcomes. Other therapies, such as the electrical stimulation of various cranial nerves or pharyngeal muscles, could also be improved by predicting disordered breathing. The second aim is to predict the onset of unintended daytime sleep while subjects undergo maintenance of wakefulness tests, which assess one's ability to resist sleep in a soporific condition. The third aim is to predict performance lapses during driving simulations. Accomplishing aims two and three could lead to the development of warning devices for at-risk individuals. Our novel prediction algorithms track the interactions between several physiological systems and reveal the most important predictors. The fourth aim is to contrast the key predictors between OSA, acutely sleep-deprived, and control subjects, and between men and women. By doing so, we expect to gain insight into the underlying pathophysiology of SDB and EDS, and will investigate sex differences in OSA and sleep deprivation. OSA is a major public health problem whose effects on society are comparable to those of smoking. The capability to predict its adverse consequences will be an invaluable tool to improve the quality of life of people with SDB, reduce the associated costs, and improve public health          ",Prediction of Physiological Events in People with Sleep Disordered Breathing,7994232,F30HL097403,"['Cranial Nerves ', ' Glean ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' automobile accident ', ' Electric Stimulation ', ' Electrical Stimulation ', ' Electroencephalography ', ' EEG ', ' Electronics ', ' Address ', ' Social Network ', ' Detection ', ' Measurable ', ' Predictive Value ', ' Retrieval ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Exhibits ', ' Behavioral ', ' Workplace ', ' work setting ', ' work environment ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' Job Environment ', ' Titrations ', ' Polysomnography ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Future ', ' Imagery ', ' Visualization ', ' Injury ', ' Goals ', ' improved ', ' Continuous Positive Airway Pressure ', ' CPAP Ventilation ', ' CPAP ', ' Algorithms ', ' Physiological ', ' Physiologic ', ' Medical ', ' Illinois ', ' Predisposition ', ' Susceptibility ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' insight ', ' Individual ', ' Maintenance ', ' Memory ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' neurophysiology ', ' neurophysiological ', ' Collaborations ', ' Patients ', ' Muscle structure of pharynx ', ' Pharyngeal Muscles ', ' Physiological Processes ', ' Physiologic Processes ', ' Organismal Process ', ' Organism-Level Process ', ' Zebra ', ' tool ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' public health medicine (field) ', ' Public Health ', ' Quality of life ', ' QOL ', ' Research ', ' Risk ', ' Apnea ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Sleep Deprivation ', ' Smoking ', ' Social Interaction ', ' Societies ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Arousal ', ' Systems Theory ', ' Testing ', ' Tidal Volume ', ' respiratory airway volume ', ' Scientist ', ' Time ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Universities ', ' Environmental air flow ', ' Ventilation ', ' Attention ', ' Wakefulness ', ' Woman ', ' Work ', ' Automobile Driving ', ' driving ', ' Complex ', ' Event ', ' Source ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' respiratory ', ' experience ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' simulation ', ' Cognitive deficits ', ' novel ', ' Graph ', ' Time Series Analysis ', ' Excessive Daytime Sleepiness ', ' Excessive daytime somnolence ', ' Devices ', ' Chicago ', ' Property ', ' LOINC Axis 2 Property ', ' sleep onset ', ' theories ', ' Adverse event ', ' Adverse Experience ', ' Accidents ', ' executive function ', ' executive control ', ' cost ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' Network-based ', ' heart rate variability ', ' adverse outcome ', ' adverse consequence ', ' Computers ', ' ']",NHLBI,UNIVERSITY OF ILLINOIS AT CHICAGO,F30,2010,42499,0.08917878920117636
"Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)    DESCRIPTION (provided by applicant): Preterm birth is associated with bronchopulmonary dysplasia (BPD), a form of chronic lung disease that impacts the pulmonary and overall health of more than 10,000 infants in the US each year. The long-term objective of this Clinical Research Center (CRC) is translation of biochemical, genetic and bioinformatics research into innovative interventions that improve outcomes of extremely preterm infants at risk for long- term pulmonary morbidity. Our proposal focuses specifically on the urea cycle-nitric oxide (UC-NO) and glutathione (GSH) pathways as pivotal and interrelated mechanisms in the response of the developing lung to the extrauterine environment. Overall hypotheses: (1) Biochemical immaturity and functional genetic variation in the UC-NO and GSH pathways modulate the BPD phenotype spectrum; (2) The duration and degree of NO insufficiency and free radical excess predicts BPD severity and correlates with pulmonary morbidity after NICU discharge. To investigate our hypothesis, our CRC will enroll 250 infants with birthweights 510-1250 grams and follow the survivors through 1 year of life. Our hypothesis invokes an immature hepatic and gut synthetic capacity to make citrulline and GSH, functional genetic variations in the UC-NO and GSH pathways, nutritional deficiencies and the physiologic and environmental stress of preterm birth. The resultant NO deficiency and free radical excess alters pulmonary vascular and alveolar development. Our biomarker discovery concept includes (a) collection of plasma, urine, red blood cells, DNA and tracheal aspirates for measurements of NO and GSH precursor sufficiency, production of NO metabolites and GSH, functional genetic variants in these pathways, and biomarkers of in vivo oxidative stress and (b) validation of these biomarkers for diagnosis and long term prognosis of patients with BPD. A bioinformatics approach using machine learning and predictive modeling has been developed for respiratory phenotyping and risk stratification at 36 weeks and 40 weeks postmenstrual age and at 12 months after hospital discharge. Accomplishment of these goals will promote novel clinical trials design to test new therapies to prevent BPD and improve long term pulmonary health of infants born preterm. (End of Abstract)      RELEVANCE: Each year in the US, more than 10,000 premature infants develop bronchopulmonary dysplasia (BPD), a chronic lung disease associated with prolonged and recurrent hospitalizations and lifelong alterations in lung function. This proposal will explore developmental, genetic and environmental interactions and identify biochemical markers to predict BPD development and severity, with the ultimate goal of designing new treatments to prevent BPD and improve long-term lung function in premature infants.              ",Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV),8068785,U01HL101456,"['Clinical Data ', ' Stratification ', ' Predictive Value ', ' Categories ', ' Admission activity ', ' Admission ', ' gastrointestinal ', ' Beds ', ' Hospitalization ', ' Nitric Oxide ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Arginine ', ' L-Isomer Arginine ', ' L-Arginine ', ' Infant ', ' Clinical Trials Design ', ' trial design ', ' repository ', ' Alveolar ', ' Collection ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Erythrocytes ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' genetic variant ', ' Data Collection ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Severities ', ' Hepatic ', ' Principal Investigator ', ' Hospitals ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Recurrence ', ' Recurrent ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Blood ', ' Blood Reticuloendothelial System ', ' Oxidative Stress ', ' outcome forecast ', ' Prognosis ', ' Clinical Research ', ' Clinical Study ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variant ', ' Variation ', ' Libraries ', ' Bioinformatics ', ' Bio-Informatics ', ' Morbidity - disease rate ', ' Morbidity ', ' Recruitment Activity ', ' recruit ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Amino Acids ', ' aminoacid ', ' Specific qualifier value ', ' Specified ', ' Specimen ', ' Research Specimen ', ' Research ', ' Diagnosis ', ' cohort ', ' Validation ', ' Translations ', ' Blood Vessels ', ' vascular ', ' Patients ', ' Stress ', ' innovation ', ' innovative ', ' innovate ', ' abstracting ', ' Enrollment ', ' enroll ', ' Production ', ' premature ', ' prematurity ', ' Modeling ', ' prevent ', ' preventing ', ' DNA ', ' Deoxyribonucleic Acid ', ' Physiological ', ' Physiologic ', ' Environment ', ' Phenotype ', ' Clinical ', ' Secure ', ' Outcome ', ' Sampling ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Genes ', ' response ', ' Data ', ' Biochemical ', ' Urine ', ' Urine Urinary System ', ' Risk ', ' biomarker ', ' Pathogenesis ', ' Data Set ', ' Dataset ', ' Homocystine ', "" Butanoic acid, 4,4'-dithiobis(2-amino)- "", ' Methionine ', ' L-Methionine ', ' L-Isomer Methionine ', ' open source ', ' Oxides ', ' Measurement ', ' Testing ', ' Goals ', ' Genetic ', ' in vivo ', ' Health ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' design ', ' designing ', ' Pathway interactions ', ' pathway ', ' Age ', ' base ', ' Life ', ' Measures ', ' System ', ' LOINC Axis 4 System ', ' Development ', ' developmental ', ' improved ', ' respiratory ', ' Time ', ' novel ', ' biobank ', ' biorepository ', ' Chronic lung disease ', ' sample collection ', ' specimen collection ', ' F2-Isoprostanes ', ' Glutathione Disulfide ', ' Oxidized Glutathione ', ' GSSG ', ' Bis(gamma-Glutamyl-L-cysteinylglycine) Disulfide ', ' Ornithine ', ' 2,5-Diaminopentanoic Acid ', ' Biochemical Markers ', ' County Hospitals ', ' Homocysteine ', ' L-Isomer Homocysteine ', ' 2-amino-4-mercaptobutyric acid ', ' Isoprostanes ', ' Infant Health ', ' developmental genetics ', ' oxidant stress ', ' Survivors ', ' Pediatric Hospitals ', "" Children's Hospital "", ' Nutritional ', ' predictive modeling ', ' computer based prediction ', ' Citrulline ', ' L-Ornithine, N5-(aminocarbonyl)- ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Glutathione ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Premature Infant ', ' preterm neonate ', ' preterm infant human ', ' preterm infant ', ' preterm baby ', ' premature infant human ', ' premature baby ', ' Study Subject ', ' Aspirate substance ', ' Aspirate ', ' Biochemical Genetics ', ' Cysteine ', ' L-Cysteine ', ' Half-Cystine ', ' Censuses ', ' Malnutrition ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Bronchopulmonary Dysplasia ', ' newborn chronic lung disease ', ' neonatal chronic lung disease ', ' infant chronic lung disease ', ' chronic lung disease in prematurity ', ' chronic lung disease in newborns ', ' chronic lung disease in neonates ', ' chronic lung disease in neonatal infants ', ' chronic lung disease in infants ', ' BPD ', ' urea cycle ', ' Free Radicals ', ' ']",NHLBI,VANDERBILT UNIVERSITY,U01,2011,541780,0.09218063307322696
"Center for Nanobiology and Predictive Toxicology    DESCRIPTION (provided by applicant):  The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop ""nano-QSARs"" for probabilistic risk ranking (Project 3).        We propose a center to study how properties of engineered nanomaterials may lead to lung health effects by creating harmful interactions in cells and tissues that will come into contact with these materials. This will be accomplished by a multi-disciplinary team who will use their expertise in nanomaterial science, biology, toxicology, imaging, statistics and computer science to integrate above goals into a predictive model that projects from what is happening in cells to what may happen in the lung.",Center for Nanobiology and Predictive Toxicology,8147701,U19ES019528,[''],NIEHS,UNIVERSITY OF CALIFORNIA LOS ANGELES,U19,2011,1989357,0.06393576329664759
"Inflammation Genes and Lung Cancer Risk DESCRIPTION (provided by applicant): There is accumulating evidence that chronic injury and inflammation in the respiratory tract, such as that caused by cigarette smoking, predispose to lung cancer. We therefore propose to conduct an in depth pathway-based analysis of gene variants in the inflammatory pathway using test and validation sets of cases and controls. This proposal builds on a well-annotated specimen repository of lung cancer cases and controls enrolled in an ongoing risk factor study (CA55769, Spitz, PI). Cases are frequency-matched to controls on age, gender, ethnicity and smoking status recruited from a multi-specialty physician practice. Data collected include smoking history, dietary intake, cancer family history, specific occupational exposures (e.g., asbestos, dust), and previous medical history including chronic obstructive airway disease, asthma and hay fever. Genomic DNA and rich candidate genotype and phenotype data are available. Aim 1: To identify novel genetic variants influencing lung cancer risk in a test set of 1500 cases with non-small cell lung cancer and 1500 matched controls (all Caucasian), using the Illumina iSelect Infinium chip with 8.5 to 9K SNP's. Aim 2: In a replication set of an additional 1000 cases and 1000 controls, using a GoldenGate assay, we will evaluate the top 1500 SNPs identified from Aim1 as meeting the P<0.1 criterion, or selected by a rational prioritizing approach that incorporates published results, type of SNP, evolutionary biology, physico-chemical properties and haplotype tagging SNPs. Aim 3: To perform fine mapping in the flanking regions of 50 SNPs selected by the same approach as in Aim 2, combining prior information with in silico approaches for predicting functionality. For each of these 50 SNPs, we will select an average of 10 additional SNPs per gene region to regenotype in all 2500 cases and 2500 controls. Aim 4. To extend our epidemiologic risk prediction model by incorporating established epidemiologic risk factor and gene variant data. We will apply machine-learning tools to identify gene-environment and gene-gene interactions. Covariates will include prior emphysema, asthma, hay fever, dust and asbestos exposure, smoking characteristics, family history of cancer, and anti-inflammatory drug use. The International Lung Cancer Consortium will perform external validation in a proposal to be developed. Our approach to comprehensively evaluate variants in a candidate pathway in a large well- powered study will be applicable to a variety of other cancer sites where inflammation plays an important etiologic role, as well as in non-neoplastic diseases with a strong inflammatory component such as emphysema. The public health potential of a useful risk prediction modes for lung cancer is substantial. Public Health Relevance Statement Cigarette smoking results in inflammation in the respiratory tract and there is growing evidence that chronic inflammatory processes predispose to lung cancer. However, the molecular mechanisms underlying the causal nature of this association are unclear. We propose to conduct an in depth analysis of gene variants in the inflammatory pathway as susceptibility factors for lung cancer. This proposal builds upon an existing well annotated specimen repository. We will evaluate gene variants in a test set of lung cancer cases and matched controls and validate the findings in an independent dataset. Finally we will incorporate these findings into an extended risk prediction model for lung cancer.",Inflammation Genes and Lung Cancer Risk,8404111,R01CA127219,[''],NCI,BAYLOR COLLEGE OF MEDICINE,R01,2011,348026,0.12530806534110406
"Predictive Modeling with Clinical and Genomic Data in COPD    DESCRIPTION (provided by applicant):  Candidate: Dr. Peter Castaldi is a physician completing a period of F32-funded support. On July 1st, 2009 he will begin a full-time position at Tufts Medical Center and the Institute for Clinical Research and Health Policy Studies (ICRHPS). This position involves a 25% clinical commitment. His principal research interests are the genetic epidemiology of COPD and the translation of genomic discoveries into clinical practice and public health. His particular interests are genetic meta-analysis, gene-environment interaction, and predictive modeling with regression-based and machine-learning methods.  His immediate goals are 1.) to identify novel genetic associations with COPD susceptibility and COPD- related phenotypes through the combined analysis of multiple genome-wide association (GWA) studies, 2.) to identify epistatic and gene-by-smoking interactions, and 3.) to develop accurate predictive models in chronic obstructive pulmonary disease (COPD) using clinical and genomic information. His long-term goal is to be an independent investigator with expertise in bioinformatics. His vision for achieving this goal involves developing expertise in bioinformatics so as to be able to participate in and eventually lead multidisciplinary teams in the application of computational methods to genomic datasets in order to answer important clinical questions that will improve the care of patients and population health. Environment: Dr. Castaldi will receive training in a rich, interdisciplinary environment. His principal mentor, Dr. Joseph Lau, is the head of the Center for Clinical Evidence Synthesis in the ICRHPS, and he is a worldwide leader in the field of meta-analysis and evidence synthesis. At Tufts, in addition to regular meetings with Dr. Lau, Peter will receive training in genetic evidence synthesis from leaders in the field, including Drs. John Ioannidis and Tom Trikalinos. The co-mentor of this application, Dr. Edwin Silverman, is a leading researcher in COPD genetics at the Channing Laboratory. At the Channing Laboratory, Peter will receive excellent training in respiratory genetics and genetic epidemiology, and he will have resources to state of the art high-throughput genotyping, next-generation sequencing technologies, and bioinformatics support. Dr. Castaldi will also continue his collaboration with Dr. Donna Slonim in the Tufts Computer Science Department, who will provide assistance with application of computational algorithms to genomic data and guidance as Dr. Castaldi continues to build a practical and theoretical foundation in Bioinformatics. Research: COPD is a major cause of morbidity and mortality that is of increasing public health importance. While the principal risk factor for COPD, smoking, is well-established, there is variable susceptibility in the general population to the lung damage caused by cigarette smoke. There is strong evidence supporting a genetic component to COPD susceptibility. Understanding how genes and environment interact to produce clinical COPD will allow for more accurate diagnostic tools and open new avenues of investigation for the development of COPD therapies. We propose to 1.) identify novel genetic associations with COPD susceptibility and 4 COPD-related phenotypes by performing meta-analysis on patient-level data from 4 large COPD GWA studies, 2.) identify gene-by-smoking and gene-gene interactions, and 3.) develop predictive models for COPD susceptibility and COPD-related phenotypes. In order to maximize the information obtained from genomic data, we will combine data from multiple studies (the National Emphysema Treatment Trial Genetics Ancillary Study, the Norway Case-Control Study, COPDGene, and ECLIPSE - total sample size=7,962) to increase power and employ regression-based and machine-learning methods to identify complex patterns of interaction in genotype data. Our study is designed to both explore and subsequently rigorously validate discovered main effect and interaction associations. Using predictive models, we will quantify the incremental predictive benefit of including genetic main effects and genetic interaction data to traditional clinical variables. Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.      PUBLIC HEALTH RELEVANCE:  The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.          Project Narrative  The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.    Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.",Predictive Modeling with Clinical and Genomic Data in COPD,8063638,K08HL102265,"['respiratory ', ' multidisciplinary ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' clinical care ', ' Vision ', ' visual function ', ' Sight ', ' Environmental Exposure ', ' genetic association ', ' Genotype ', ' Smoking ', ' next generation ', ' Head ', ' Bioinformatics ', ' Bio-Informatics ', ' Institutes ', ' case control ', ' Sample Size ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Mission ', ' Translating ', ' Training Programs ', ' Smoke ', ' prognostic ', ' Cause of Death ', ' patient population ', ' Future ', ' Predisposition ', ' Susceptibility ', ' Caring ', ' Individual ', ' Medical center ', ' Training ', ' Translations ', ' Performance ', ' Validation ', ' Hereditary Disease ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Life ', ' genetic variant ', ' Diabetes Mellitus ', ' diabetes ', ' Mortality Vital Statistics ', ' Mortality ', ' improved ', ' Population ', ' Data Set ', ' Dataset ', ' Prevention ', ' interest ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Work ', ' Patients ', ' design ', ' designing ', ' Development ', ' developmental ', ' Pattern ', ' Morbidity - disease rate ', ' Morbidity ', ' General Population ', ' General Public ', ' insight ', ' American ', ' Investigation ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Relative (related person) ', ' Relative ', ' Mentors ', ' Environment ', ' Genomics ', ' Diagnostic ', ' clinical practice ', ' Risk Factors ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Persons ', ' Time ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Genes ', ' Area ', ' Laboratories ', ' Modeling ', ' Frequencies (time pattern) ', ' Frequency ', ' Pulmonary Emphysema ', ' Emphysema ', ' Techniques ', ' Data ', ' public health medicine (field) ', ' Public Health ', ' cohort ', ' public health relevance ', ' success ', ' Affect ', ' Research ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Link ', ' Outcome ', ' Architecture ', ' Engineering / Architecture ', ' Resources ', ' Research Resources ', ' Goals ', ' Positioning Attribute ', ' Position ', ' novel ', ' Pathway interactions ', ' pathway ', ' Clinical ', ' base ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Physicians ', ' Complex ', ' Technology ', ' Collaborations ', ' Sampling ', ' Testing ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Biology ', ' gene environment interaction ', ' environment effect on gene ', ' Genetic ', ' Phenotype ', ' tool ', ' Funding ', ' Foundations ', ' Clinical Research ', ' Clinical Study ', ' meetings ', ' Methods ', ' Health ', ' Biological ', ' Disease susceptibility ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Hematological Disease ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' cigarette smoke ', ' smoke of cigarettes ', ' treatment trial ', ' Computational algorithm ', ' computer algorithm ', ' Epistatic Gene ', ' computer science ', ' Biomass ', ' Norway ', ' population health ', ' Tobacco ', ' predictive modeling ', ' computer based prediction ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic epidemiology ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Ancillary Study ', ' Disease Association ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' gene interaction ', ' ']",NHLBI,TUFTS MEDICAL CENTER,K08,2011,128250,0.019092967376973143
"Prediction of Physiological Events in People with Sleep Disordered Breathing    DESCRIPTION (provided by applicant): Sleep-disordered breathing (SDB) refers to a spectrum of disorders characterized by abnormal respiratory patterns or levels of ventilation during sleep. The most common is obstructive sleep apnea (OSA). People with OSA experience repetitive apnea (cessation of breathing) and hypopnea (marked decrease in tidal volume) during sleep in association with airway compromise and excessive daytime sleepiness (EDS). An arousal, or brief, often unnoticed, disruption of sleep is commonly associated with apnea. People with OSA also exhibit cognitive dysfunction, including impairment to memory, attention, and executive function. OSA- associated EDS and cognitive dysfunction are thought to significantly contribute to automobile accidents and workplace injuries. The first aim of this research is to predict the onset of nocturnal apnea, hypopnea, and arousal. Our proposal to accomplish this aim represents an entirely new approach to improving the effectiveness and tolerability of SBD therapy. The most common therapy is continuous positive airway pressure (CPAP), which is difficult for many patients to tolerate. Existing auto-adjusting PAP may be more tolerable but relies on detection of disordered breathing events and does not appear to improve quality of life compared with conventional CPAP. Predicting these events could lead to more effective titration of PAP levels and improved outcomes. Other therapies, such as the electrical stimulation of various cranial nerves or pharyngeal muscles, could also be improved by predicting disordered breathing. The second aim is to predict the onset of unintended daytime sleep while subjects undergo maintenance of wakefulness tests, which assess one's ability to resist sleep in a soporific condition. The third aim is to predict performance lapses during driving simulations. Accomplishing aims two and three could lead to the development of warning devices for at-risk individuals. Our novel prediction algorithms track the interactions between several physiological systems and reveal the most important predictors. The fourth aim is to contrast the key predictors between OSA, acutely sleep-deprived, and control subjects, and between men and women. By doing so, we expect to gain insight into the underlying pathophysiology of SDB and EDS, and will investigate sex differences in OSA and sleep deprivation. OSA is a major public health problem whose effects on society are comparable to those of smoking. The capability to predict its adverse consequences will be an invaluable tool to improve the quality of life of people with SDB, reduce the associated costs, and improve public health          ",Prediction of Physiological Events in People with Sleep Disordered Breathing,8133670,F30HL097403,"['Sleep Deprivation ', ' Glean ', ' Workplace ', ' work setting ', ' work environment ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' Job Environment ', ' Environmental air flow ', ' Ventilation ', ' Social Network ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Titrations ', ' Computers ', ' Impairment ', ' respiratory ', ' Testing ', ' Memory ', ' Devices ', ' Electric Stimulation ', ' Electrical Stimulation ', ' Maintenance ', ' Complex ', ' Methods ', ' Predisposition ', ' Susceptibility ', ' Graph ', ' Techniques ', ' Societies ', ' Measurable ', ' Medical ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Physiological ', ' Physiologic ', ' Process ', ' Goals ', ' Outcome ', ' Smoking ', ' public health medicine (field) ', ' Public Health ', ' Development ', ' developmental ', ' Future ', ' Universities ', ' men ', "" men's "", ' Detection ', ' Behavioral ', ' Disease ', ' disease/disorder ', ' Disorder ', ' experience ', ' Laboratories ', ' Individual ', ' Exhibits ', ' theories ', ' Event ', ' Pattern ', ' improved ', ' System ', ' LOINC Axis 4 System ', ' design ', ' designing ', ' Quality of life ', ' QOL ', ' Effectiveness ', ' innovation ', ' innovative ', ' innovate ', ' Methodology ', ' Method LOINC Axis 6 ', ' Electronics ', ' Algorithms ', ' Behavior ', ' insight ', ' Automobile Driving ', ' driving ', ' Imagery ', ' Visualization ', ' Patients ', ' Population ', ' Attention ', ' Property ', ' LOINC Axis 2 Property ', ' Research ', ' Collaborations ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Risk ', ' Address ', ' adverse outcome ', ' adverse consequence ', ' novel ', ' Accidents ', ' Performance ', ' Work ', ' cost ', ' Predictive Value ', ' Excessive Daytime Sleepiness ', ' Excessive daytime somnolence ', ' Electroencephalography ', ' EEG ', ' Illinois ', ' Cognitive deficits ', ' executive function ', ' executive control ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' neurophysiology ', ' neurophysiological ', ' Physiological Processes ', ' Physiologic Processes ', ' Organismal Process ', ' Organism-Level Process ', ' Biological Neural Networks ', ' neural network ', ' simulation ', ' Sleep Apnea Syndromes ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Chicago ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Social Interaction ', ' Retrieval ', ' Sleep ', ' Adverse event ', ' Adverse Experience ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Arousal ', ' Zebra ', ' tool ', ' Apnea ', ' Source ', ' Injury ', ' Time ', ' Muscle structure of pharynx ', ' Pharyngeal Muscles ', ' Polysomnography ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Scientist ', ' Network-based ', ' Characteristics ', ' Woman ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' automobile accident ', ' Tidal Volume ', ' respiratory airway volume ', ' Cranial Nerves ', ' heart rate variability ', ' Systems Theory ', ' Time Series Analysis ', ' Continuous Positive Airway Pressure ', ' CPAP Ventilation ', ' CPAP ', ' sleep onset ', ' Wakefulness ', ' ']",NHLBI,UNIVERSITY OF ILLINOIS AT CHICAGO,F30,2011,42919,0.08917878920117636
"Statistical Model Building for High Dimensional Biomedical Data    DESCRIPTION (provided by applicant):  Typical of current large-scale biomedical data is the feature of small number of observed samples and the widely observed sample heterogeneity. Identifying differentially expressed genes related to the sample phenotye (e.g., cancer disease development) and predicting sample phenotype based on the gene expressions are some central research questions in the microarray data analysis. Most existing statistical methods have ignored sample heterogeneity and thus loss power.       This project proposes to develop novel statistical methods that explicitly address the small sample size and sampe heterogeneity issues, and can be applied very generally. The usefulness of these methods will be shown with the large-scale biomedical data originating from the lung and kidney transplant research projects. The transplant projects aimed to improve the molecular diagnosis and therapy of lung/kidney allograft rejection by identifying molecular biomarkers to predict the allograft rejection for critical early treatment and rapid, noninvasive, and economical testing.       The specific aims are 1) Develop novel statistical methods for differential gene expression detection that explicitly model sample heterogeneity. 2) Develop novel statistical methods for classifying high-dimensional biomedical data and incorporating sample heterogeneity. 3) Develop novel statistical methods for jointly analyzing a set of genes (e.g., genes in a pathway). 4) Use the developed models and methods to answer research questions relevant to public health in the lung and kidney transplant projects; and implement and validate the proposed methods in user-friendly and well-documented software, and distribute them to the scientific community at no charge.       It is very important to identify new biomarkers of allograft rejection in lung and kidney transplant recipients. The rapid and reliable detection and prediction of rejection in easily obtainable body fluids may allow the rapid advancement of clinical interventional trials. We propose to study novel methods for analyzing the large-scale biomedical data to realize their full potential of molecular diagnosis and prognosis of transplant rejection prediction for critical early treatment.          ",Statistical Model Building for High Dimensional Biomedical Data,8079474,R01GM083345,"['software development ', ' developing computer software ', ' develop software ', ' Statistical Models ', ' Probabilistic Models ', ' Experimental Designs ', ' user-friendly ', ' Probability ', ' Transplant Recipients ', ' transplant patient ', ' outcome forecast ', ' Prognosis ', ' Dimensions ', ' Charge ', ' Heterogeneity ', ' Research Proposals ', ' Outcome Measure ', ' Joints ', ' Articulation ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Data Analyses ', ' Data Analysis ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Data Set ', ' Dataset ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Pathway interactions ', ' pathway ', ' Testing ', ' sound ', ' Universities ', ' interest ', ' Literature ', ' Outcome ', ' Collection ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' public health medicine (field) ', ' Public Health ', ' simulation ', ' Sample Size ', ' Early treatment ', ' early therapy ', ' early intervention ', ' Sampling ', ' Coupled ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Adopted ', ' cancer type ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Development ', ' developmental ', ' Communities ', ' Algorithms ', ' base ', ' Address ', ' biomarker ', ' Detection ', ' Characteristics ', ' Procedures ', ' Statistical Methods ', ' Phenotype ', ' Data ', ' Relative (related person) ', ' Relative ', ' Gene Expression ', ' Work ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Patients ', ' Computer software ', ' computer program/software ', ' Software ', ' improved ', ' Modeling ', ' Research ', ' theories ', ' Genomics ', ' Transplantation ', ' transplant ', ' Individual ', ' Genes ', ' novel ', ' Molecular ', ' Clinical ', ' Effectiveness ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' design ', ' designing ', ' Diagnosis ', ' Technology ', ' Resources ', ' Research Resources ', ' biobank ', ' biorepository ', ' Minnesota ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' cancer microarray ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' kidney allograft ', ' renal allograft ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Body Fluids ', ' Least-Squares Analysis ', ' Least-Squares Analyses ', ' Least Squares ', ' transplant database ', ' transplant data base ', ' Molecular Diagnosis ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Cations ', ' predictive modeling ', ' computer based prediction ', ' allograft rejection ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' Oncogene Activation ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' method development ', ' user friendly software ', ' user friendly computer software ', ' ']",NIGMS,UNIVERSITY OF MINNESOTA,R01,2011,250488,0.06301616635225511
"Quantitative Analysis of PEM for REMBD Identification    DESCRIPTION (provided by applicant):    Rapid Eye Movement Behavior Disorder (RBD) refers to a condition in which patients act out their dreams and engage in potentially disruptive, injurious and even dangerous behavior while asleep[1-3]. Clinical reports of RBD have been shown to anticipate the development of neurodegenerative conditions like Parkinson's Disease by 20 years or more [4-6]. Despite this potential prognostic significance for human disease, the field of Sleep Medicine lacks an accepted computerized approach to quantify muscle activity in sleep. This proposed interdisciplinary research seeks to merge methods of computer engineering based computation with advanced neuroscience to establish a computerized clinical decision support system (CDSS) to detect RBD via measurement and analysis of the phasic electromyographic activity metric (PEM). The sponsor (Bliwise) has provided evidence based on traditional visual analyses from ""expert"" scorers that PEM recorded during sleep is a sensitive indicator a) to differentiate PD patients from controls [7]; b) to distinguish non-PD patients with a history of RBD from controls [8]; and c) to differentiate PD patients with early and late stage disease [9]. These data suggest that computer-aided PEM detection within a user-friendly CDSS will be vital for clinicians to determine prognosis, track disease course, and, possibly, even monitor treatment.      PUBLIC HEALTH RELEVANCE:    The proposed work is envisioned as a vital and integral component to establish standardized computerized bio-signal processing methods to detect phasic muscle activity in overnight human sleep polysomnograms for the identification and treatment of Rapid Eye Movement Behavior Disorder.                 The proposed work is envisioned as a vital and integral component to establish standardized computerized bio-signal processing methods to detect phasic muscle activity in overnight human sleep polysomnograms for the identification and treatment of Rapid Eye Movement Behavior Disorder.            ",Quantitative Analysis of PEM for REMBD Identification,8203202,F32NS070572,"['Clinical Protocols ', ' Parkinsonism ', ' Parkinsonian Syndrome ', ' Parkinsonian Diseases ', ' Parkinsonian Condition ', ' Parkinsonian ', ' Parkinsonian Disorders ', ' behavioral disorder ', ' Behavior Disorders ', ' Acting Out ', ' computer aided ', ' Computer Assisted ', ' dreaming ', ' Dreams ', ' computerized ', ' Morphologic artifacts ', ' Artifacts ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Dangerous Behavior ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' History ', ' Recording of previous events ', ' neurodegenerative illness ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Neurodegenerative Disorders ', ' Neurosciences ', ' signal processing ', ' data processing ', ' computerized data processing ', ' Measurement ', ' Research ', ' Reporting ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Bypass ', ' Techniques ', ' muscular ', ' Muscle Tissue ', ' Muscle ', ' innovative ', ' innovate ', ' innovation ', ' Motor ', ' Engineering ', ' Testing ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' novel ', ' Event ', ' Work ', ' Method LOINC Axis 6 ', ' Methodology ', ' Medicine ', ' evidence base ', ' meetings ', ' Quantitative Evaluations ', ' Evaluation ', ' human disease ', ' Monitor ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' user-friendly ', ' sensor ', ' Visual ', ' Methods ', ' Data ', ' Sleep ', ' Metric ', ' Clinical ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Lewy Body Parkinson Disease ', ' Idiopathic Parkinson Disease ', ' Parkinson Disease ', ' Detection ', ' Investigation ', ' Computers ', ' Process ', ' Location ', ' prognostic ', ' Algorithms ', ' Staging ', ' Site ', ' Patients ', ' Severities ', ' Performance ', ' base ', ' Characteristics ', ' Prognosis ', ' outcome forecast ', ' developmental ', ' Development ', ' Diffuse Lewy Body Disease ', ' Cortical Lewy Body Disease ', ' Lewy Body Disease ', ' Clinical Decision Support Systems ', ' rapid eye movement ', "" parkinson's disease dementia "", "" Parkinson's Dementia "", ' ']",NINDS,EMORY UNIVERSITY,F32,2011,53042,0.048193612224060184
"A New Approach to Compute PM2.5 for Health Impact Analysis    DESCRIPTION (provided by applicant): Environmental air quality impacts human well-being and disease, but the availability of air quality data is limited to selected locations because of the complexity involved in its measurement. Among air pollutants, PM2.5 is of the greatest concern. These particles are not captured by the lungs' natural defenses and can be inhaled deeply, where they can cause health problems ranging from asthma attacks to heart disease.  PM2.5 currently is measured primarily by ground monitoring stations located at approximately 320 EPA sites, providing limited local geographic coverage. However, there are satellites that make a variety of aerosol observations and provide a daily global picture of atmospheric particulates in the form of aerosol optical depth (AOD). Scientists have attempted to compute ground-level PM2.5 (GLP) from these AOD data. However, the multivariate nonlinear relationship between AOD and PM2.5 imposes limitations in computing GLP using satellite data. This project proposes to overcome these limitations by computing reliable GLP via a new methodology which has already been tested and validated.  The study has two specific aims: (1) develop satellite-derived daily GLP estimates for the contiguous U.S., and (2) examine spatial and temporal associations between GLP exposure and hospital visits for asthma exacerbation in Mississippi. Using our methodology, we will generate daily GLP data for a 12-month period at a resolution of 0.10x0.10 (~10x10km2), providing approximately 82,000 data points as opposed to about 300 data points available daily from EPA ground monitoring stations within the contiguous U.S. We will address the nonlinear relationship between PM2.5 and AOD which is a function of humidity, temperature, surface pressure, surface wind speed, surface type, boundary layer height, and AOD by accounting for these variables using a machine learning process. The AOD that will be used in this process will be generated by merging AOD data from multiple satellite sensors. Meteorological data will come from NOAA NCEP. Surface type data will be obtained from the satellite-identified vegetation index. Boundary layer height, which is the mixed layer of the atmosphere closest to the ground where people live and work, will come from CALIPSO data which provides vertical profiles of atmospheric aerosol extinction.  Information on GLP levels will allow the scientific community to better understand health impacts from exposure to low, moderate, or high levels of PM2.5. Moreover, in places where PM2.5 levels are elevated only occasionally, such as Mississippi, the short-term health impact of increases in PM2.5 can be studied more precisely. National GLP data will be made available to other researchers to facilitate future explorations of how PM2.5 exposure impacts a wide range of health conditions, thereby making possible more timely prophylactic treatment, improving healthcare system preparedness, and better informing public health policymaking.      PUBLIC HEALTH RELEVANCE:   Among air pollutants, particulates 2.5 micrometers in diameter and smaller (PM2.5) have the greatest impact on human health because they are small enough to be inhaled deeply into the lungs, making allergies, asthma, and other respiratory conditions worse. The proposed study will provide daily estimates of ground-level PM2.5 for the entire contiguous U.S. so that researchers can study how it affects disease at various locations in the country. The knowledge that results can be used to better inform people about the links between air pollution and disease, and to guide the development of air quality standards to improve public health.                Among air pollutants, particulates 2.5 micrometers in diameter and smaller (PM2.5) have the greatest impact on human health because they are small enough to be inhaled deeply into the lungs, making allergies, asthma, and other respiratory conditions worse. The proposed study will provide daily estimates of ground-level PM2.5 for the entire contiguous U.S. so that researchers can study how it affects disease at various locations in the country. The knowledge that results can be used to better inform people about the links between air pollution and disease, and to guide the development of air quality standards to improve public health.            ",A New Approach to Compute PM2.5 for Health Impact Analysis,8191561,R21ES019713,"['behavioral extinction ', ' Extinction ', ' Extinction (Psychology) ', ' Aerosols ', ' NIEHS ', ' National Institute of Environmental Health Sciences ', ' National Aeronautics and Space Administration ', ' NASA ', ' United States National Aeronautics and Space Administration ', ' Air Pollution ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' Data Quality ', ' Particulate ', ' web based interface ', ' Speed ', ' Speed (motion) ', ' Atmosphere ', ' planetary Atmosphere ', ' optical ', ' Optics ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Temperature ', ' particle ', ' respiratory ', ' Particulate Matter ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' well-being ', ' Personal Satisfaction ', ' Prophylaxis ', ' Prevention Measures ', ' Prophylactic treatment ', ' Diameter ', ' Caliber ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Breathing ', ' Health Care Systems ', ' Healthcare Systems ', ' Height ', ' statistics ', ' Data Sources ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Proxy ', ' Preparedness ', ' Readiness ', ' hazard ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Country ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Techniques ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Admission ', ' Admission activity ', ' Site ', ' Monitor ', ' Process ', ' Location ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' sensor ', ' LOINC Axis 4 System ', ' System ', ' Health ', ' novel ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Air ', ' Data ', ' Public Health ', ' public health medicine (field) ', ' Maps ', ' Method LOINC Axis 6 ', ' Methodology ', ' Hospitals ', ' Work ', ' Bronchial Asthma ', ' Asthma ', ' interest ', ' Source ', ' Scientist ', ' Surface ', ' Exposure to ', ' indexing ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Visit ', ' prototype ', ' Allergy ', ' Hypersensitivity ', ' Resolution ', ' Time ', ' Measurement ', ' Area ', ' pressure ', ' Future ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Link ', ' Mississippi ', ' Risk ', ' LOINC Axis 2 Property ', ' Property ', ' Accounting ', ' Address ', ' Variation ', ' Variant ', ' Communities ', ' Measures ', ' Modeling ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' developmental ', ' Development ', ' Goals ', ' designing ', ' design ', ' Humidity ', ' Testing ', ' Research ', ' Affect ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Life ', ' improved ', ' base ', ' Wind ', ' Environmental Wind ', ' Surveillance Program ', ' Birth Rate ', ' Air Pollutants ', ' knowledge of results ', ' Emergency Medicine ', ' ']",NIEHS,UNIVERSITY OF MISSISSIPPI MED CTR,R21,2011,219458,0.006314886445468728
"Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)    DESCRIPTION (provided by applicant): Preterm birth is associated with bronchopulmonary dysplasia (BPD), a form of chronic lung disease that impacts the pulmonary and overall health of more than 10,000 infants in the US each year. The long-term objective of this Clinical Research Center (CRC) is translation of biochemical, genetic and bioinformatics research into innovative interventions that improve outcomes of extremely preterm infants at risk for long- term pulmonary morbidity. Our proposal focuses specifically on the urea cycle-nitric oxide (UC-NO) and glutathione (GSH) pathways as pivotal and interrelated mechanisms in the response of the developing lung to the extrauterine environment. Overall hypotheses: (1) Biochemical immaturity and functional genetic variation in the UC-NO and GSH pathways modulate the BPD phenotype spectrum; (2) The duration and degree of NO insufficiency and free radical excess predicts BPD severity and correlates with pulmonary morbidity after NICU discharge. To investigate our hypothesis, our CRC will enroll 250 infants with birthweights 510-1250 grams and follow the survivors through 1 year of life. Our hypothesis invokes an immature hepatic and gut synthetic capacity to make citrulline and GSH, functional genetic variations in the UC-NO and GSH pathways, nutritional deficiencies and the physiologic and environmental stress of preterm birth. The resultant NO deficiency and free radical excess alters pulmonary vascular and alveolar development. Our biomarker discovery concept includes (a) collection of plasma, urine, red blood cells, DNA and tracheal aspirates for measurements of NO and GSH precursor sufficiency, production of NO metabolites and GSH, functional genetic variants in these pathways, and biomarkers of in vivo oxidative stress and (b) validation of these biomarkers for diagnosis and long term prognosis of patients with BPD. A bioinformatics approach using machine learning and predictive modeling has been developed for respiratory phenotyping and risk stratification at 36 weeks and 40 weeks postmenstrual age and at 12 months after hospital discharge. Accomplishment of these goals will promote novel clinical trials design to test new therapies to prevent BPD and improve long term pulmonary health of infants born preterm. (End of Abstract)      RELEVANCE: Each year in the US, more than 10,000 premature infants develop bronchopulmonary dysplasia (BPD), a chronic lung disease associated with prolonged and recurrent hospitalizations and lifelong alterations in lung function. This proposal will explore developmental, genetic and environmental interactions and identify biochemical markers to predict BPD development and severity, with the ultimate goal of designing new treatments to prevent BPD and improve long-term lung function in premature infants.              ",Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV),8278690,U01HL101456,"['abstracting ', ' Age ', ' aminoacid ', ' Amino Acids ', ' L-Isomer Arginine ', ' L-Arginine ', ' Arginine ', ' Beds ', ' Blood Reticuloendothelial System ', ' Blood ', ' vascular ', ' Blood Vessels ', ' newborn chronic lung disease ', ' neonatal chronic lung disease ', ' infant chronic lung disease ', ' chronic lung disease in prematurity ', ' chronic lung disease in newborns ', ' chronic lung disease in neonates ', ' chronic lung disease in neonatal infants ', ' chronic lung disease in infants ', ' BPD ', ' Bronchopulmonary Dysplasia ', ' Censuses ', ' L-Ornithine, N5-(aminocarbonyl)- ', ' Citrulline ', ' Clinical Study ', ' Clinical Research ', ' L-Cysteine ', ' Half-Cystine ', ' Cysteine ', ' Data Collection ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Environment ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' Erythrocytes ', ' Free Radicals ', ' Genes ', ' Biochemical Genetics ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Glutathione ', ' Goals ', ' Health ', ' L-Isomer Homocysteine ', ' 2-amino-4-mercaptobutyric acid ', ' Homocysteine ', "" Butanoic acid, 4,4'-dithiobis(2-amino)- "", ' Homocystine ', ' Hospitalization ', ' Hospitals ', ' County Hospitals ', "" Children's Hospital "", ' Pediatric Hospitals ', ' Infant ', ' preterm neonate ', ' preterm infant human ', ' preterm infant ', ' preterm baby ', ' premature infant human ', ' premature baby ', ' Premature Infant ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Morbidity ', ' Morbidity - disease rate ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Nitric Oxide ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' 2,5-Diaminopentanoic Acid ', ' Ornithine ', ' Oxides ', ' Patients ', ' Phenotype ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Production ', ' Prognosis ', ' outcome forecast ', ' recruit ', ' Recruitment Activity ', ' Recurrent ', ' Recurrence ', ' Research ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' Risk ', ' Stress ', ' Testing ', ' Time ', ' Translations ', ' Urine Urinary System ', ' Urine ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Oxidized Glutathione ', ' GSSG ', ' Bis(gamma-Glutamyl-L-cysteinylglycine) Disulfide ', ' Glutathione Disulfide ', ' Measures ', ' Dataset ', ' Data Set ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Premature Birth ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' base ', ' improved ', ' specimen collection ', ' sample collection ', ' Hepatic ', ' Clinical ', ' prematurity ', ' premature ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Infant Health ', ' Biochemical Markers ', ' Survivors ', ' Measurement ', ' Oxidative Stress ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' Research Specimen ', ' Specimen ', ' Aspirate ', ' Aspirate substance ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Severities ', ' LOINC Axis 4 System ', ' System ', ' respiratory ', ' gastrointestinal ', ' developmental genetics ', ' urea cycle ', ' cohort ', ' novel ', ' Study Subject ', ' Categories ', ' Pathogenesis ', ' Chronic lung disease ', ' Admission ', ' Admission activity ', ' Modeling ', ' Sampling ', ' response ', ' repository ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Isoprostanes ', ' F2-Isoprostanes ', ' Bio-Informatics ', ' Bioinformatics ', ' preventing ', ' prevent ', ' Alveolar ', ' Data ', ' Predictive Value ', ' Stratification ', ' in vivo ', ' Clinical Data ', ' trial design ', ' Clinical Trials Design ', ' Collection ', ' enroll ', ' Enrollment ', ' Validation ', ' nutritious ', ' Nutritional ', ' Principal Investigator ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' open source ', ' oxidant stress ', ' biomarker ', ' biorepository ', ' biobank ', ' Secure ', ' ']",NHLBI,VANDERBILT UNIVERSITY,U01,2012,546000,0.09218063307322696
"Transfer Rule Learning for Knowledge Based Biomarker Discovery and Predictive Bio     DESCRIPTION (provided by applicant): Predictive modeling of biomedical data arising from clinical studies for early detection, monitoring and prognosis of diseases is a crucial step in biomarker discovery. Since the data are typically measurements subject to error, and the sample size of any study is very small compared to the number of variables measured, the validity and verification of models arising from such datasets significantly impacts the discovery of reliable discriminatory markers for a disease. An important opportunity to make the most of these scarce data is to combine information from multiple related data sets for more effective biomarker discovery. Because the costs of creating large data sets for every disease of interest are likely to remain prohibitive, methods for more effectively making use of related biomarker discovery data sets continues to be important. Solution: This project develops and applies Transfer Rule Learning (TRL), a novel framework for integrative biomarker discovery from related but separate data sets, such as those generated from similar biomarker profiling studies. TRL alleviates the problem of data scarcity by providing automated ways to express, verify and use prior hypotheses generated from one data set while learning new knowledge via a related data set. This is the first study of transfer learning for biomarker discovery. Unlike other transfr learning approaches, TRL takes knowledge in the form of interpretable, modular classification rules, and uses them to seed learning of a rule model on a new data set. Classification rules simplify the extraction of discriminatory markers, and have been used successfully for biomarker discovery and verification in a non-integrative fashion. Specific Aims: This project tests the main hypothesis that TRL provides a mechanism for transfer learning of classification rules between related source and target data sets that improve performance on the target data, compared to learning without transfer. TRL will be evaluated using cross-validation performance of classification accuracy and transfer measures, on related groups of existing biomarker discovery datasets obtained from multiple experimental platforms for lung cancer detection and prognosis. A new set of independent validation data will be generated for early detection of lung cancer to test the models generated on pilot data. Insights into the impact of different modeling algorithms on transfer outcomes will be gleaned. Significance: The TRL framework and tool are important for combined analysis and interpretation of clinical data, as they support incremental building, verification and refinement of rule models for predictive biomedicine. The application of TRL to real-world biomarker discovery datasets can yield insights into novel interactions involving known markers, and the most reliable biomarkers for early detection of disease, particularly lung cancer. This project has the potential to help create new diagnostic screening tools for lung cancer detection. It allows foundational understanding of the use of transfer learning for integrative biomarker discovery that could lead to novel technologies for combining information from data and prior knowledge.        PUBLIC HEALTH RELEVANCE: This project will develop highly-needed computational methods for integrative biomarker discovery from related but separate data sets produced by predictive molecular profiling studies of disease. It will generate new experimental data for early detection of lung cancer, and has the potential to help create new diagnostic screening tools for lung cancer, a leading cause of death from cancer in the United States.                  This project will develop highly-needed computational methods for integrative biomarker discovery from related but separate data sets produced by predictive molecular profiling studies of disease. It will generate new experimental data for early detection of lung cancer, and has the potential to help create new diagnostic screening tools for lung cancer, a leading cause of death from cancer in the United States.                ",Transfer Rule Learning for Knowledge Based Biomarker Discovery and Predictive Bio,8373065,R01GM100387,"['Cause of Death ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Algorithms ', ' Gene Expression ', ' Goals ', ' Data Sources ', ' Systematics ', ' Classification ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Clinical Study ', ' Clinical Research ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Method LOINC Axis 6 ', ' Methodology ', ' Maps ', ' Methods ', ' Learning ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Sampling Studies ', ' Solutions ', ' Publishing ', ' Prognosis ', ' outcome forecast ', ' Glean ', ' Measures ', ' Clinical ', ' Outcomes Research ', ' Dataset ', ' Data Set ', ' base ', ' Biological ', ' training transfer ', ' learning transfer ', ' Transfer (Psychology) ', ' Psychological Transfer ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' United States ', ' Testing ', ' Work ', ' tool ', ' Source ', ' interest ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Protocol ', ' Protocols documentation ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' Collaborations ', ' Knowledge ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' insight ', ' Blood Serum ', ' Serum ', ' Screening procedure ', ' improved ', ' Measurement ', ' Sample Size ', ' Evaluation ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Sampling ', ' Institution ', ' novel technologies ', ' new technology ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Modeling ', ' Proteomics ', ' early detection ', ' Early Diagnosis ', ' knowledgebase ', ' knowledge base ', ' Performance ', ' novel ', ' Structure ', ' Cancer Detection ', ' computer based prediction ', ' predictive modeling ', ' developmental ', ' Development ', ' Cancer Prognosis ', ' Clinical Data ', ' Validation ', ' cost ', ' Characteristics ', ' Monitor ', ' Data ', ' miRNA ', ' Micro RNA ', ' MicroRNAs ', ' Address ', ' datamining ', ' data mining ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' cancer proteomics ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' designing ', ' design ', ' Outcome ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2012,299716,0.09020138957152676
"Center for Nanobiology and Predictive Toxicology    DESCRIPTION (provided by applicant):  The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop ""nano-QSARs"" for probabilistic risk ranking (Project 3).        We propose a center to study how properties of engineered nanomaterials may lead to lung health effects by creating harmful interactions in cells and tissues that will come into contact with these materials. This will be accomplished by a multi-disciplinary team who will use their expertise in nanomaterial science, biology, toxicology, imaging, statistics and computer science to integrate above goals into a predictive model that projects from what is happening in cells to what may happen in the lung.",Center for Nanobiology and Predictive Toxicology,8393965,U19ES019528,"['Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biological Availability ', ' Biology ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Cells ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Engineering ', ' Fibrosis ', ' Future ', ' Goals ', ' Health ', ' In Vitro ', ' Inflammation ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Mathematics ', ' Metals ', ' Methods ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Play ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Pneumonia ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Risk ', ' Rodents Mammals ', ' Rodentia ', ' Rodent ', ' social role ', ' Role ', ' Science ', ' Signal Pathway ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Silicon Dioxide ', ' statistics ', ' Body Tissues ', ' Tissues ', ' Toxicology ', ' Generations ', ' Injury ', ' base ', ' Organ ', ' Link ', ' screenings ', ' screening ', ' Screening procedure ', ' Oxidative Stress ', ' Cell Structure ', ' Cell Components ', ' Cellular Structures ', ' chemical property ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' cell biology ', ' Cellular biology ', ' Lytic ', ' Inhalation Exposure ', ' Lytotoxicity ', ' cytotoxicity ', ' membrane structure ', ' Membrane ', ' metal oxide ', ' Performance ', ' physical property ', ' hazard ', ' computer science ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' High Throughput Assay ', ' high throughput screening ', ' mathematical modeling ', ' Math Models ', ' mathematical model ', ' Lysis ', ' Cytolysis ', ' Dose ', ' Data ', ' in vivo ', ' Molecular ', ' cell imaging ', ' cellular imaging ', ' nano ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' computer based prediction ', ' predictive modeling ', ' nano materials ', ' nanomaterials ', ' nano biology ', ' nanobiology ', ' nano particle ', ' nanoparticle ', ' Outcome ', ' combinatorial ', ' multidisciplinary ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA LOS ANGELES,U19,2012,75559,0.06393576329664759
"Inflammation Genes and Lung Cancer Risk DESCRIPTION (provided by applicant): There is accumulating evidence that chronic injury and inflammation in the respiratory tract, such as that caused by cigarette smoking, predispose to lung cancer. We therefore propose to conduct an in depth pathway-based analysis of gene variants in the inflammatory pathway using test and validation sets of cases and controls. This proposal builds on a well-annotated specimen repository of lung cancer cases and controls enrolled in an ongoing risk factor study (CA55769, Spitz, PI). Cases are frequency-matched to controls on age, gender, ethnicity and smoking status recruited from a multi-specialty physician practice. Data collected include smoking history, dietary intake, cancer family history, specific occupational exposures (e.g., asbestos, dust), and previous medical history including chronic obstructive airway disease, asthma and hay fever. Genomic DNA and rich candidate genotype and phenotype data are available. Aim 1: To identify novel genetic variants influencing lung cancer risk in a test set of 1500 cases with non-small cell lung cancer and 1500 matched controls (all Caucasian), using the Illumina iSelect Infinium chip with 8.5 to 9K SNP's. Aim 2: In a replication set of an additional 1000 cases and 1000 controls, using a GoldenGate assay, we will evaluate the top 1500 SNPs identified from Aim1 as meeting the P<0.1 criterion, or selected by a rational prioritizing approach that incorporates published results, type of SNP, evolutionary biology, physico-chemical properties and haplotype tagging SNPs. Aim 3: To perform fine mapping in the flanking regions of 50 SNPs selected by the same approach as in Aim 2, combining prior information with in silico approaches for predicting functionality. For each of these 50 SNPs, we will select an average of 10 additional SNPs per gene region to regenotype in all 2500 cases and 2500 controls. Aim 4. To extend our epidemiologic risk prediction model by incorporating established epidemiologic risk factor and gene variant data. We will apply machine-learning tools to identify gene-environment and gene-gene interactions. Covariates will include prior emphysema, asthma, hay fever, dust and asbestos exposure, smoking characteristics, family history of cancer, and anti-inflammatory drug use. The International Lung Cancer Consortium will perform external validation in a proposal to be developed. Our approach to comprehensively evaluate variants in a candidate pathway in a large well- powered study will be applicable to a variety of other cancer sites where inflammation plays an important etiologic role, as well as in non-neoplastic diseases with a strong inflammatory component such as emphysema. The public health potential of a useful risk prediction modes for lung cancer is substantial. Public Health Relevance Statement Cigarette smoking results in inflammation in the respiratory tract and there is growing evidence that chronic inflammatory processes predispose to lung cancer. However, the molecular mechanisms underlying the causal nature of this association are unclear. We propose to conduct an in depth analysis of gene variants in the inflammatory pathway as susceptibility factors for lung cancer. This proposal builds upon an existing well annotated specimen repository. We will evaluate gene variants in a test set of lung cancer cases and matched controls and validate the findings in an independent dataset. Finally we will incorporate these findings into an extended risk prediction model for lung cancer.",Inflammation Genes and Lung Cancer Risk,8442397,R01CA127219,"['Affect ', ' Age ', ' Algorithms ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Anti-Inflammatory Agents ', ' Antihistamines ', ' Asbestos ', ' Bronchial Asthma ', ' Asthma ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' Cell Division Cycle ', ' Cell Cycle ', ' Cellular Growth ', ' Cellular Expansion ', ' cell growth ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Dust ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Genes ', ' Genotype ', ' Goals ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Growth Factor ', ' Haplotypes ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Hay fever ', ' History ', ' Recording of previous events ', ' In Vitro ', ' Infection ', ' Inflammation ', ' Irritants ', ' Articulation ', ' Joints ', ' Literature ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Maps ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Occupational Exposure ', ' Phenotype ', ' Physicians ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Emphysema ', ' Pulmonary Emphysema ', ' Receiver Operating Characteristics ', ' Recommendation ', ' recruit ', ' Recruitment Activity ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Research Resources ', ' Resources ', ' respiratory tract ', ' Respiratory system (all sites) ', ' Pulmonary Organ System ', ' Pulmonary Body System ', ' Respiratory System ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Smoking ', ' Specialty ', ' medical specialties ', ' Testing ', ' Body Tissues ', ' Tissues ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Caucasians ', ' Gender ', ' Dataset ', ' Data Set ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' Injury ', ' base ', ' Area ', ' Chronic ', ' Variation ', ' Variant ', ' Logistic Regressions ', ' Link ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' drug use ', ' Drug usage ', ' Oxidative Stress ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' chemical property ', ' Family Cancer History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Respiratory Tracts ', ' Respiratory tract structure ', ' Letters ', ' angiogenesis ', ' Genetic ', ' Staging ', ' Inflammatory ', ' tool ', ' Nature ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Adopted ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Host Defense ', ' Nucleotide Excision Repair ', ' meetings ', ' cancer risk ', ' Cancer Induction ', ' carcinogenesis ', ' gene interaction ', ' Proxy ', ' novel ', ' Participant ', ' smoke cigarette ', ' cigarette smoking ', ' Lung Tissue ', ' Lung Parenchyma ', ' Structure of parenchyma of lung ', ' Modeling ', ' response ', ' case control ', ' repository ', ' cancer location ', ' cancer site ', ' Genomics ', ' Bio-Informatics ', ' Bioinformatics ', ' Inflammatory Response ', ' Cell Cycle Control ', ' Cell Cycle Regulation ', ' DNA Base Excision Repair ', ' Base Excision Repairs ', ' Dietary intake ', ' Oncogenesis ', ' tumorigenesis ', ' DNA Repair Pathway ', ' Data ', ' International ', ' Progress Review Group ', ' Anti-inflammatory ', ' enroll ', ' Enrollment ', ' Newly Diagnosed ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Status ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' genetic variant ', ' Outcome ', ' aggregation pathway ', ' parent grant ', ' public health relevance ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R01,2012,510315,0.12530806534110406
"Understanding and enhancing visual search performance in complex scenes     DESCRIPTION (provided by applicant): Understanding and enhancing visual search performance in complex scenes Cancer screening saves lives (e.g. National Lung Screening Trial Research, 2011). Every day, radiologists are faced with difficult, time-consuming visual search tasks like in mammography and lung cancer screening. Oftentimes signs of cancer, e.g. lung nodules or little abnormalities in a breast, are very hard to find against heterogeneous backgrounds and obscured by overlapping tissues. Missing these signs of cancer can result in wrong diagnoses with life or death consequences. It is therefore of key interest to identify and tackle the problems posed in these crucial search tasks. The proposed studies aim to improve search performance in cancer screening in two ways: First, by enhancing the visibility of lung nodules embedded in 3D volumetric datasets. Radiologists usually search for lung nodules by scrolling through stacks of chest CT. Nodules are roughly spherical features, spanning a few slices in a CT stack. Anecdotally, experts report that the way that lung nodules 'pop' in and out of the changing view is a signal to their presence. We propose an innovative approach using saliency algorithms that harness this signal to enhance chest CTs in a way that directs attention to crucial regions of a scene. Second, we aim to improve search performance by understanding and utilizing non-selective, 'gist'-like processing of mammograms. Recent work has shown that expert radiologists can detect a global signal in mammograms that allows for above-chance categorization of normal and abnormal breasts after very short exposures to the stimulus. We will first train novices to become experts in closer approximation to the medical tasks. As expertise develops, we will investigate two different neural correlates that might evolve in the course of training using electroencephalography (EEG), namely the P300 and the N2pc. In other settings, these measures can signal attentional selection either across (P300) or within (N2pc) briefly presented images. We will adapt a new method that exploits machine learning for real-time decoding of brain signals. It allows neural signatures, elicited in response to a sequence of images, to be used to rank those images in order of their implicit 'interest' to the viewer. We hypothesize that this information can be fed back to the observer/radiologist as a source of information that might, for example, suggest that an image or region deserves more scrutiny. The main goals of this proposal are therefore to understand the guidance of attention in complex visual search tasks and to apply this knowledge to improvements in clinically relevant search tasks like cancer screening.        PUBLIC HEALTH RELEVANCE: Understanding and enhancing visual search performance in complex scenes Early detection of cancer can save lives, but error rates in cancer screening, both misses and false alarms, are still too high. We propose two ways of aiding cancer screening by radiologists: 1) We will enhance search displays by using saliency algorithms to direct attention to crucial regions of a scene. 2) We will utilize neural signals elicited by non-selective, 'gist'-like processing of medical images as a novel support for evaluation of mammograms.                  Understanding and enhancing visual search performance in complex scenes Early detection of cancer can save lives, but error rates in cancer screening, both misses and false alarms, are still too high. We propose two ways of aiding cancer screening by radiologists: 1) We will enhance search displays by using saliency algorithms to direct attention to crucial regions of a scene. 2) We will utilize neural signals elicited by non-selective, 'gist'-like processing of medical images as a novel support for evaluation of mammograms.                ",Understanding and enhancing visual search performance in complex scenes,8392371,F32EY022558,"['neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Dorsum ', ' Back ', ' vascular ', ' Blood Vessels ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Breast ', ' Algorithms ', ' Attention ', ' Eyeball ', ' Eye ', ' Eye Movements ', ' Evolution ', ' Goals ', ' EEG ', ' Electroencephalography ', ' Cues ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Methods ', ' Nodule ', ' Mammogram ', ' Mammography ', ' Medical Imaging ', ' Image Enhancement ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Learning ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Research Resources ', ' Resources ', ' Research ', ' ROC Analyses ', ' ROC Curve ', ' pulmonary nodule ', ' Lung nodule ', ' Dataset ', ' Data Set ', ' Measures ', ' Visualization ', ' Imagery ', ' base ', ' Phase ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Time ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Body Tissues ', ' Tissues ', ' X-Ray Medical Imaging ', ' X-Ray Imaging ', ' Roentgenography ', ' Radiography ', ' Diagnostic X-Ray Radiology ', ' Diagnostic X-Ray ', ' Diagnostic Radiology ', ' Conventional X-Ray ', ' Diagnostic radiologic examination ', ' Testing ', ' Breast Cancer Early Screening ', ' Breast Cancer Early Detection ', ' Life ', ' Complex ', ' Event ', ' Source ', ' RDST ', ' radiologist ', ' Pattern ', ' Knowledge ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' tool ', ' Exposure to ', ' improved ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Stimulus ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Training ', ' Medical ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Evaluation ', ' Screening procedure ', ' visual search ', ' Position ', ' Positioning Attribute ', ' Reporting ', ' response ', ' sorting ', ' Sorting - Cell Movement ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' Participant ', ' Stretching ', ' interest ', ' behavioral measurement ', ' behavioral measure ', ' behavior measurement ', ' Performance ', ' novel ', ' Techniques ', ' neural ', ' relating to nervous system ', ' directs attention ', ' directed attention ', ' feeding ', ' Slice ', ' imaging ', ' Image ', ' Process ', ' Data ', ' p300 ', ' EP300 ', ' EP300 gene ', ' Address ', ' Detection ', ' Reader ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer therapy ', ' clinical relevance ', ' clinically relevant ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' visual science ', ' vision science ', ' ']",NEI,BRIGHAM AND WOMEN'S HOSPITAL,F32,2012,53942,0.005346468914171802
"Center for Nanobiology and Predictive Toxicology    DESCRIPTION (provided by applicant):  The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop ""nano-QSARs"" for probabilistic risk ranking (Project 3).        We propose a center to study how properties of engineered nanomaterials may lead to lung health effects by creating harmful interactions in cells and tissues that will come into contact with these materials. This will be accomplished by a multi-disciplinary team who will use their expertise in nanomaterial science, biology, toxicology, imaging, statistics and computer science to integrate above goals into a predictive model that projects from what is happening in cells to what may happen in the lung.",Center for Nanobiology and Predictive Toxicology,8274480,U19ES019528,"['Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biological Availability ', ' Biology ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Cells ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Engineering ', ' Fibrosis ', ' Future ', ' Goals ', ' Health ', ' In Vitro ', ' Inflammation ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Mathematics ', ' Metals ', ' Methods ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Play ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Pneumonia ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Risk ', ' Rodents Mammals ', ' Rodentia ', ' Rodent ', ' social role ', ' Role ', ' Science ', ' Signal Pathway ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Silicon Dioxide ', ' statistics ', ' Body Tissues ', ' Tissues ', ' Toxicology ', ' Generations ', ' Injury ', ' base ', ' Organ ', ' Link ', ' screenings ', ' screening ', ' Screening procedure ', ' Oxidative Stress ', ' Cell Structure ', ' Cell Components ', ' Cellular Structures ', ' chemical property ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' cell biology ', ' Cellular biology ', ' Lytic ', ' Inhalation Exposure ', ' Lytotoxicity ', ' cytotoxicity ', ' membrane structure ', ' Membrane ', ' metal oxide ', ' Performance ', ' physical property ', ' hazard ', ' computer science ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' High Throughput Assay ', ' high throughput screening ', ' mathematical modeling ', ' Math Models ', ' mathematical model ', ' Lysis ', ' Cytolysis ', ' Dose ', ' Data ', ' in vivo ', ' Molecular ', ' cell imaging ', ' cellular imaging ', ' nano ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' computer based prediction ', ' predictive modeling ', ' nano materials ', ' nanomaterials ', ' nano biology ', ' nanobiology ', ' nano particle ', ' nanoparticle ', ' Outcome ', ' combinatorial ', ' multidisciplinary ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA LOS ANGELES,U19,2012,1784823,0.06393576329664759
"Predictive Modeling with Clinical and Genomic Data in COPD Candidate: Dr. Peter Castaldi is a physician completing a period of F32-funded support. On July 1st, 2009 he will begin a full-time position at Tufts Medical Center and the Institute for Clinical Research and Health Policy Studies (ICRHPS). This position involves a 25% clinical commitment. His principal research interests are the genetic epidemiology of COPD and the translation of genomic discoveries into clinical practice and public health. His particular interests are genetic meta-analysis, gene-environment interaction, and predictive modeling with regression-based and machine-learning methods.  His immediate goals are 1.) to identify novel genetic associations with COPD susceptibility and COPD- related phenotypes through the combined analysis of multiple genome-wide association (GWA) studies, 2.) to identify epistatic and gene-by-smoking interactions, and 3.) to develop accurate predictive models in chronic obstructive pulmonary disease (COPD) using clinical and genomic information. His long-term goal is to be an independent investigator with expertise in bioinformatics. His vision for achieving this goal involves developing expertise in bioinformatics so as to be able to participate in and eventually lead multidisciplinary teams in the application of computational methods to genomic datasets in order to answer important clinical questions that will improve the care of patients and population health.    Environment: Dr. Castaldi will receive training in a rich, interdisciplinary environment. His principal mentor, Dr. Joseph Lau, is the head of the Center for Clinical Evidence Synthesis in the ICRHPS, and he is a worldwide leader in the field of meta-analysis and evidence synthesis. At Tufts, in addition to regular meetings with Dr. Lau, Peter will receive training in genetic evidence synthesis from leaders in the field, including Drs. John Ioannidis and Tom Trikalinos. The co-mentor of this application, Dr. Edwin Silverman, is a leading researcher in COPD genetics at the Channing Laboratory. At the Channing Laboratory, Peter will receive excellent training in respiratory genetics and genetic epidemiology, and he will have resources to state of the art high-throughput genotyping, next-generation sequencing technologies, and bioinformatics support. Dr. Castaldi will also continue his collaboration with Dr. Donna Slonim in the Tufts Computer Science Department, who will provide assistance with application of computational algorithms to genomic data and guidance as Dr. Castaldi continues to build a practical and theoretical foundation in Bioinformatics.    Research: COPD is a major cause of morbidity and mortality that is of increasing public health importance. While the principal risk factor for COPD, smoking, is well-established, there is variable susceptibility in the general population to the lung damage caused by cigarette smoke. There is strong evidence supporting a genetic component to COPD susceptibility. Understanding how genes and environment interact to produce clinical COPD will allow for more accurate diagnostic tools and open new avenues of investigation for the development of COPD therapies. We propose to 1.) identify novel genetic associations with COPD susceptibility and 4 COPD-related phenotypes by performing meta-analysis on patient-level data from 4 large COPD GWA studies, 2.) identify gene-by-smoking and gene-gene interactions, and 3.) develop predictive models for COPD susceptibility and COPD-related phenotypes. In order to maximize the information obtained from genomic data, we will combine data from multiple studies (the National Emphysema Treatment Trial Genetics Ancillary Study, the Norway Case-Control Study, COPDGene, and ECLIPSE - total sample size=7,962) to increase power and employ regression-based and machine-learning methods to identify complex patterns of interaction in genotype data. Our study is designed to both explore and subsequently rigorously validate discovered main effect and interaction associations. Using predictive models, we will quantify the incremental predictive benefit of including genetic main effects and genetic interaction data to traditional clinical variables.    Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. Project Narrative  The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.    Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.",Predictive Modeling with Clinical and Genomic Data in COPD,8261100,K08HL102265,"['Affect ', ' Engineering / Architecture ', ' Architecture ', ' Biology ', ' Biomass ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cause of Death ', ' Clinical Study ', ' Clinical Research ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Disease susceptibility ', ' Environment ', ' Environmental Exposure ', ' Foundations ', ' Future ', ' Genes ', ' Epistatic Gene ', ' Genotype ', ' Goals ', ' Head ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Institutes ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' Mentors ', ' Methods ', ' Mission ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Persons ', ' Norway ', ' Patients ', ' Phenotype ', ' Physicians ', ' Public Health ', ' public health medicine (field) ', ' Emphysema ', ' Pulmonary Emphysema ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk Factors ', ' Smoke ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' Training Programs ', ' Translating ', ' Translations ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Biological ', ' Link ', ' Susceptibility ', ' Predisposition ', ' prognostic ', ' Training ', ' insight ', ' Individual ', ' smoke of cigarettes ', ' cigarette smoke ', ' Sample Size ', ' Funding ', ' Collaborations ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Investigation ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Pattern ', ' Techniques ', ' respiratory ', ' interest ', ' meetings ', ' Medical center ', ' American ', ' environment effect on gene ', ' gene environment interaction ', ' gene interaction ', ' Performance ', ' success ', ' computer science ', ' cohort ', ' novel ', ' General Public ', ' General Population ', ' Prevention ', ' Position ', ' Positioning Attribute ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' genetic association ', ' Data ', ' Disease Association ', ' Ancillary Study ', ' Validation ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' treatment trial ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' next generation ', ' Outcome ', ' Population ', ' multidisciplinary ', ' computer algorithm ', ' Computational algorithm ', ' clinical care ', ' patient population ', ' clinical practice ', ' population health ', ' ']",NHLBI,TUFTS MEDICAL CENTER,K08,2012,128250,0.02304844678918864
"Molecular, cellular and physiological mechanisms of the mammalian circadian clock     DESCRIPTION (provided by applicant): The circadian clock regulates physiology and behavior and impinges on many aspects of our daily life. Nowhere is this more obvious than control of the sleep wake cycle, where clock genes have been shown to play a role in both the timing of sleep and its quality. For example, mutations in PER2 cause familial advanced sleep phase syndrome (FASPS), while mutations in  CSNK1E and CSNK1D cause FASPS and delayed sleep phase syndrome (DSPS),  respectively. However, while we have learned much about the clock and how it regulates sleep, the picture is incomplete. Behavioral studies in mice and studies in human cells show that dozens to hundreds of loci impact circadian clock function. However, only a dozen genes have been investigated for their roles in regulating behavior. Testing dozens to hundreds of mice isn't practical, so a new approach is needed. Here we seek to address this gap with a novel strategy that uses, i) integrative bioinformatics to prioritize putative core clock factors, ii) new experimental methods to determine whether they interact with known clock genes and regulate clock function in several cellular or tissue slice models, and, finally, iii) for a subset of promising candidates, generate mouse models and test them for their roles in regulating circadian behavior and sleep. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.           PUBLIC HEALTH RELEVANCE: Our internal biological clocks control many important aspects of our physiology and behavior such as the sleep-wake cycle. Genetics and large-scale genomic studies have implicated the role of a dozen canonical and hundreds of additional new genes in the circadian clock.  However, almost none of the new genes have been studied in animal models for their ability to regulate sleep onset or quality. We will address this gap using bioinformatics, experimental biology, and finally through behavioral analysis. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.                   Our internal biological clocks control many important aspects of our physiology and behavior such as the sleep-wake cycle. Genetics and large-scale genomic studies have implicated the role of a dozen canonical and hundreds of additional new genes in the circadian clock.  However, almost none of the new genes have been studied in animal models for their ability to regulate sleep onset or quality. We will address this gap using bioinformatics, experimental biology, and finally through behavioral analysis. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.                 ","Molecular, cellular and physiological mechanisms of the mammalian circadian clock",8328020,R01NS054794,"['Cells ', ' Behavior ', ' Biology ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biological Clocks ', ' Goals ', ' Grant ', ' Genes ', ' Au element ', ' Gold ', ' Fibroblasts ', ' Data Analysis ', ' Data Analyses ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' disease/disorder ', ' Disorder ', ' Disease ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Methods ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Memory ', ' Literature ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' luminescence ', ' Learning ', ' social role ', ' Role ', ' Physiology ', ' Rhythmicity ', ' Cyclicity ', ' Periodicity ', ' Play ', ' Phenotype ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Probability ', ' Research ', ' improved ', ' Dataset ', ' Data Set ', ' Mutagenesis Molecular Biology ', ' Genetics-Mutagenesis ', ' Mutagenesis ', ' Generations ', ' Testing ', ' Time ', ' Work ', ' Sleep ', ' Body Tissues ', ' Tissues ', ' Life ', ' Pattern ', ' Delayed Sleep Phase Syndrome ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Neurological ', ' Neurologic ', ' gene function ', ' Screening procedure ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' mental ', ' Psyche structure ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Adipocytes ', ' Genetic ', ' Advanced Sleep Phase Syndrome (ASPS) ', ' Advanced Sleep Phase Syndrome ', ' behavioral test ', ' behavior test ', ' knockout animal ', ' sleep onset ', ' Proteomics ', ' Modeling ', ' intervention therapy ', ' Therapeutic Intervention ', ' Genomics ', ' Sleep Wake Cycle ', ' sleep problem ', ' Sleep Disorders ', ' LOINC Axis 4 System ', ' System ', ' mutant ', ' neural network ', ' Biological Neural Networks ', ' Informatics ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' neurogenetics ', ' Performance ', ' novel ', ' Neurosciences Research ', ' imaging ', ' Image ', ' Slice ', ' data integration ', ' Molecular ', ' Behavioral ', ' reverse genetics ', ' positional cloning ', ' Flies ', ' fly ', ' Behavioral Assay ', ' Data ', ' Quantitative Genetics ', ' Mammalian Cell ', ' Ortholog ', ' Orthologous Gene ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' Address ', ' Defect ', ' Animal Testing ', ' Bio-Informatics ', ' Bioinformatics ', ' mouse model ', ' discover genes ', ' gene discovery ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' therapeutic target ', ' circadian clock ', ' circadian pacemaker ', ' novel therapeutic target ', ' new therapeutic target ', ' Cellular model ', ' Cell model ', ' evidence base ', ' ']",NINDS,UNIVERSITY OF PENNSYLVANIA,R01,2012,622241,0.09569628336385132
"Transfer Rule Learning for Knowledge Based Biomarker Discovery and Predictive Bio     DESCRIPTION (provided by applicant): Predictive modeling of biomedical data arising from clinical studies for early detection, monitoring and prognosis of diseases is a crucial step in biomarker discovery. Since the data are typically measurements subject to error, and the sample size of any study is very small compared to the number of variables measured, the validity and verification of models arising from such datasets significantly impacts the discovery of reliable discriminatory markers for a disease. An important opportunity to make the most of these scarce data is to combine information from multiple related data sets for more effective biomarker discovery. Because the costs of creating large data sets for every disease of interest are likely to remain prohibitive, methods for more effectively making use of related biomarker discovery data sets continues to be important. Solution: This project develops and applies Transfer Rule Learning (TRL), a novel framework for integrative biomarker discovery from related but separate data sets, such as those generated from similar biomarker profiling studies. TRL alleviates the problem of data scarcity by providing automated ways to express, verify and use prior hypotheses generated from one data set while learning new knowledge via a related data set. This is the first study of transfer learning for biomarker discovery. Unlike other transfr learning approaches, TRL takes knowledge in the form of interpretable, modular classification rules, and uses them to seed learning of a rule model on a new data set. Classification rules simplify the extraction of discriminatory markers, and have been used successfully for biomarker discovery and verification in a non-integrative fashion. Specific Aims: This project tests the main hypothesis that TRL provides a mechanism for transfer learning of classification rules between related source and target data sets that improve performance on the target data, compared to learning without transfer. TRL will be evaluated using cross-validation performance of classification accuracy and transfer measures, on related groups of existing biomarker discovery datasets obtained from multiple experimental platforms for lung cancer detection and prognosis. A new set of independent validation data will be generated for early detection of lung cancer to test the models generated on pilot data. Insights into the impact of different modeling algorithms on transfer outcomes will be gleaned. Significance: The TRL framework and tool are important for combined analysis and interpretation of clinical data, as they support incremental building, verification and refinement of rule models for predictive biomedicine. The application of TRL to real-world biomarker discovery datasets can yield insights into novel interactions involving known markers, and the most reliable biomarkers for early detection of disease, particularly lung cancer. This project has the potential to help create new diagnostic screening tools for lung cancer detection. It allows foundational understanding of the use of transfer learning for integrative biomarker discovery that could lead to novel technologies for combining information from data and prior knowledge.          This project will develop highly-needed computational methods for integrative biomarker discovery from related but separate data sets produced by predictive molecular profiling studies of disease. It will generate new experimental data for early detection of lung cancer, and has the potential to help create new diagnostic screening tools for lung cancer, a leading cause of death from cancer in the United States.                ",Transfer Rule Learning for Knowledge Based Biomarker Discovery and Predictive Bio,8549840,R01GM100387,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cause of Death ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Sources ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Gene Expression ', ' Goals ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Maps ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Prognosis ', ' outcome forecast ', ' Publishing ', ' Sampling Studies ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Solutions ', ' Testing ', ' training transfer ', ' learning transfer ', ' Transfer (Psychology) ', ' Psychological Transfer ', ' United States ', ' Work ', ' Measures ', ' Outcomes Research ', ' Glean ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' insight ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Measurement ', ' Sample Size ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Protocol ', ' Protocols documentation ', ' Source ', ' interest ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' knowledgebase ', ' knowledge base ', ' Structure ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' novel technologies ', ' new technology ', ' Modeling ', ' Sampling ', ' Proteomics ', ' miRNA ', ' Micro RNA ', ' MicroRNAs ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Institution ', ' datamining ', ' data mining ', ' Address ', ' Data ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Cancer Detection ', ' Cancer Prognosis ', ' Clinical Data ', ' Validation ', ' Monitor ', ' Characteristics ', ' developmental ', ' Development ', ' cost ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' cancer proteomics ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' screening ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2013,289303,0.0753935636532694
"Center for Nanobiology and Predictive Toxicology    DESCRIPTION (provided by applicant):  The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop ""nano-QSARs"" for probabilistic risk ranking (Project 3).        We propose a center to study how properties of engineered nanomaterials may lead to lung health effects by creating harmful interactions in cells and tissues that will come into contact with these materials. This will be accomplished by a multi-disciplinary team who will use their expertise in nanomaterial science, biology, toxicology, imaging, statistics and computer science to integrate above goals into a predictive model that projects from what is happening in cells to what may happen in the lung.",Center for Nanobiology and Predictive Toxicology,8464703,U19ES019528,"['Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biological Availability ', ' Biology ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Cells ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Engineering ', ' Fibrosis ', ' Future ', ' Goals ', ' Health ', ' In Vitro ', ' Inflammation ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Mathematics ', ' Metals ', ' Methods ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Play ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Pneumonia ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Risk ', ' Rodents Mammals ', ' Rodentia ', ' Rodent ', ' social role ', ' Role ', ' Science ', ' Signal Pathway ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Silicon Dioxide ', ' statistics ', ' Body Tissues ', ' Tissues ', ' Toxicology ', ' Generations ', ' Injury ', ' base ', ' Organ ', ' Link ', ' Oxidative Stress ', ' Cell Structure ', ' Cell Components ', ' Cellular Structures ', ' chemical property ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' cell biology ', ' Cellular biology ', ' Lytic ', ' Inhalation Exposure ', ' Lytotoxicity ', ' cytotoxicity ', ' membrane structure ', ' Membrane ', ' metal oxide ', ' Performance ', ' physical property ', ' hazard ', ' computer science ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' High Throughput Assay ', ' high throughput screening ', ' mathematical modeling ', ' Math Models ', ' mathematical model ', ' Lysis ', ' Cytolysis ', ' Dose ', ' Data ', ' in vivo ', ' Molecular ', ' cell imaging ', ' cellular imaging ', ' nano ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' computer based prediction ', ' predictive modeling ', ' nano materials ', ' nanomaterials ', ' nano biology ', ' nanobiology ', ' nano particle ', ' nanoparticle ', ' Outcome ', ' combinatorial ', ' multidisciplinary ', ' screening ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA LOS ANGELES,U19,2013,1343177,0.06393576329664759
"Molecular, cellular and physiological mechanisms of the mammalian circadian clock     DESCRIPTION (provided by applicant): The circadian clock regulates physiology and behavior and impinges on many aspects of our daily life. Nowhere is this more obvious than control of the sleep wake cycle, where clock genes have been shown to play a role in both the timing of sleep and its quality. For example, mutations in PER2 cause familial advanced sleep phase syndrome (FASPS), while mutations in  CSNK1E and CSNK1D cause FASPS and delayed sleep phase syndrome (DSPS),  respectively. However, while we have learned much about the clock and how it regulates sleep, the picture is incomplete. Behavioral studies in mice and studies in human cells show that dozens to hundreds of loci impact circadian clock function. However, only a dozen genes have been investigated for their roles in regulating behavior. Testing dozens to hundreds of mice isn't practical, so a new approach is needed. Here we seek to address this gap with a novel strategy that uses, i) integrative bioinformatics to prioritize putative core clock factors, ii) new experimental methods to determine whether they interact with known clock genes and regulate clock function in several cellular or tissue slice models, and, finally, iii) for a subset of promising candidates, generate mouse models and test them for their roles in regulating circadian behavior and sleep. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.             Our internal biological clocks control many important aspects of our physiology and behavior such as the sleep-wake cycle. Genetics and large-scale genomic studies have implicated the role of a dozen canonical and hundreds of additional new genes in the circadian clock.  However, almost none of the new genes have been studied in animal models for their ability to regulate sleep onset or quality. We will address this gap using bioinformatics, experimental biology, and finally through behavioral analysis. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.                 ","Molecular, cellular and physiological mechanisms of the mammalian circadian clock",8434164,R01NS054794,"['Behavior ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biological Clocks ', ' Biology ', ' Cells ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Fibroblasts ', ' Genes ', ' Goals ', ' Au element ', ' Gold ', ' Grant ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Literature ', ' luminescence ', ' Memory ', ' Methods ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Rhythmicity ', ' Cyclicity ', ' Periodicity ', ' Phenotype ', ' Physiology ', ' Play ', ' Probability ', ' Research ', ' social role ', ' Role ', ' Sleep ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Work ', ' Generations ', ' Mutagenesis Molecular Biology ', ' Genetics-Mutagenesis ', ' Mutagenesis ', ' Dataset ', ' Data Set ', ' improved ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Neurological ', ' Neurologic ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Adipocytes ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' mental ', ' Psyche structure ', ' Genetic ', ' gene function ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Delayed Sleep Phase Syndrome ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' mutant ', ' neurogenetics ', ' Performance ', ' neural network ', ' Biological Neural Networks ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' Informatics ', ' novel ', ' behavioral test ', ' behavior test ', ' Advanced Sleep Phase Syndrome (ASPS) ', ' Advanced Sleep Phase Syndrome ', ' intervention therapy ', ' Therapeutic Intervention ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Sleep Wake Cycle ', ' sleep onset ', ' Proteomics ', ' Genomics ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' Bio-Informatics ', ' Bioinformatics ', ' knockout animal ', ' Ortholog ', ' Orthologous Gene ', ' Address ', ' Defect ', ' Animal Testing ', ' Data ', ' Mammalian Cell ', ' Quantitative Genetics ', ' Neurosciences Research ', ' Slice ', ' Molecular ', ' Behavioral ', ' reverse genetics ', ' positional cloning ', ' Flies ', ' fly ', ' imaging ', ' Image ', ' Behavioral Assay ', ' data integration ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' circadian clock ', ' circadian pacemaker ', ' Cellular model ', ' Cell model ', ' mouse model ', ' therapeutic target ', ' discover genes ', ' gene discovery ', ' novel therapeutic target ', ' new therapeutic target ', ' evidence base ', ' screening ', ' ']",NINDS,UNIVERSITY OF PENNSYLVANIA,R01,2013,538181,0.09251717179460534
"Quantitative Analysis of PEM for REMBD Identification    DESCRIPTION (provided by applicant):    Rapid Eye Movement Behavior Disorder (RBD) refers to a condition in which patients act out their dreams and engage in potentially disruptive, injurious and even dangerous behavior while asleep[1-3]. Clinical reports of RBD have been shown to anticipate the development of neurodegenerative conditions like Parkinson's Disease by 20 years or more [4-6]. Despite this potential prognostic significance for human disease, the field of Sleep Medicine lacks an accepted computerized approach to quantify muscle activity in sleep. This proposed interdisciplinary research seeks to merge methods of computer engineering based computation with advanced neuroscience to establish a computerized clinical decision support system (CDSS) to detect RBD via measurement and analysis of the phasic electromyographic activity metric (PEM). The sponsor (Bliwise) has provided evidence based on traditional visual analyses from ""expert"" scorers that PEM recorded during sleep is a sensitive indicator a) to differentiate PD patients from controls [7]; b) to distinguish non-PD patients with a history of RBD from controls [8]; and c) to differentiate PD patients with early and late stage disease [9]. These data suggest that computer-aided PEM detection within a user-friendly CDSS will be vital for clinicians to determine prognosis, track disease course, and, possibly, even monitor treatment.           The proposed work is envisioned as a vital and integral component to establish standardized computerized bio-signal processing methods to detect phasic muscle activity in overnight human sleep polysomnograms for the identification and treatment of Rapid Eye Movement Behavior Disorder.            ",Quantitative Analysis of PEM for REMBD Identification,8386725,F32NS070572,"['Acting Out ', ' Algorithms ', ' behavioral disorder ', ' Behavior Disorders ', ' Clinical Protocols ', ' Computers ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Dangerous Behavior ', ' disease/disorder ', ' Disorder ', ' Disease ', ' dreaming ', ' Dreams ', ' Engineering ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Medicine ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' muscular ', ' Muscle Tissue ', ' Muscle ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Neurosciences ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Lewy Body Parkinson Disease ', ' Idiopathic Parkinson Disease ', ' Parkinson Disease ', ' Patients ', ' Prognosis ', ' outcome forecast ', ' Quantitative Evaluations ', ' rapid eye movement ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Sleep ', ' Testing ', ' Work ', ' Artifacts ', ' Morphologic artifacts ', ' base ', ' sensor ', ' Site ', ' Clinical ', ' Evaluation ', ' prognostic ', ' Visual ', ' Parkinsonism ', ' Parkinsonian Syndrome ', ' Parkinsonian Diseases ', ' Parkinsonian Condition ', ' Parkinsonian ', ' Parkinsonian Disorders ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Investigation ', ' Severities ', ' Event ', ' Techniques ', ' Location ', ' neurodegenerative illness ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Neurodegenerative Disorders ', ' Clinical Decision Support Systems ', ' meetings ', ' Performance ', ' novel ', ' Metric ', ' Reporting ', ' Bypass ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' signal processing ', ' data processing ', ' computerized data processing ', ' Data ', ' Detection ', ' Motor ', ' Monitor ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' computerized ', ' computer aided ', ' Computer Assisted ', "" parkinson's disease dementia "", "" Parkinson's Dementia "", ' innovative ', ' innovate ', ' innovation ', ' user-friendly ', ' human disease ', ' evidence base ', ' Lewy Body Type Senile Dementia ', ' Dementia with Lewy Bodies ', ' Lewy Body Dementia ', ' ']",NINDS,EMORY UNIVERSITY,F32,2013,55670,0.05841671877005626
"EARLY DETECTION OF LUNG CANCER USING METABOLOMIC LIPID PROFILING     DESCRIPTION (provided by applicant): Our broad long-term goal is to develop a convenient, non-invasive, clinically-used blood biomarker test that can distinguish patients with lung cancer from patients with benign nodules for the early detection of lung cancer.  Lung cancer is often diagnosed at an advanced stage. Detecting lung cancer at earlier stages could reduce mortality rates 10- to 50-fold. The current CT scan approach has difficulty distinguishing benign from malignant pulmonary nodules. Patients are frequently over-diagnosed with poor specificity and require further invasive screening, which adds both to their psychological and to their financial burden. It is urgent to develop new non-invasive methods such as identifying blood molecular biomarkers for early detection of lung cancer.  Our immediate objective for this proposal is to identify blood lipid markers for the early detection of lung cancer. Lipids have numerous critical biological functions which include membrane structure, energy storage, and signal transduction. Lipids have also been implicated as playing roles in several human diseases, including lung cancer. However, studies generally have been focused on total levels of lipids in a class. Because individual species of a lipid class may have different functions, it is essential to measure their compositions. In the proposed study, we will adopt lipidomics technology which aims to quantify a cell's lipidome, identifying and quantifying individual lipid molecular species on a large scale using mass spectrometry. Our preliminary studies with lung and prostate cancer indicate this technology is robust and promising. We have identified a lipid profile difference between non-lung cancer and lung cancer plasma samples. The sensitivity and specificity of distinguishing non-cancer and lung cancer samples are over 90%. Our hypothesis is that lipidomics profiles will be different between lung cancer and non-malignant cancer plasma samples including benign pulmonary lesions and we will be able to define a lipid list as a predictive signature of lung cancer. To test this hypothesis, we propose to: 1) measure the levels of lipid species in human plasma from non-malignant and lung cancer biospecimens. 2) Mine lipid profile data to identify ""lipid markers"" that vary reproducibly between non-malignant samples and lung cancer samples. 3) Validate and test the predictive value of the lipid markers using independent samples.  Lipidomics is a rapidly developing novel technology that has not been applied to lung cancer studies. This work could lead to potentially new clinically used markers for early detection of lung cancer. Our findings may provide information that will lead to the development of novel lipid-related drugs to treat lung cancer. In the long term, linking our data with gene expression and proteomics data in lung cancer will give us a complete view of lipid metabolic pathways and networks, as well as new knowledge about their role in lung cancer development.         PUBLIC HEALTH RELEVANCE: We seek to identify lipid biomarkers in human blood for the early detection of lung cancer using a new technology called lipidomics, which aims to measure all the lipids in a human body. We suppose the composition and amount of lipids in early-stage lung cancer patients are different from non-lung cancer patients. Based on this, we can distinguish cancer from non-cancer samples. Detecting lung cancer at earlier stages could reduce mortality rates 10- to 50-fold. The current CT scan approach has difficulty distinguishing benign from malignant pulmonary nodules. Patients are frequently over- diagnosed with poor specificity and require further invasive screening. Results from the proposed work will be of significant value to public health because we can eventually develop an invasive, accurate test tool to be clinically used for the early detection of lung cancer, which can save thousands of lives.            ",EARLY DETECTION OF LUNG CANCER USING METABOLOMIC LIPID PROFILING,8445920,R21CA164764,"['Malignant Adenoma ', ' Adenocarcinoma ', ' Algorithms ', ' Blood Reticuloendothelial System ', ' Blood ', ' Bronchoscopy ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Squamous Cell Epithelioma ', ' Squamous Carcinoma ', ' Planocellular Carcinoma ', ' Epidermoid Carcinoma ', ' Squamous cell carcinoma ', ' Cells ', ' Systematics ', ' Classification ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Gene Expression ', ' Goals ', ' Granulomatous Lesion ', ' Granuloma ', ' Hamartoma ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lipids ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' Lysophosphatidic Acids ', ' Lysophospholipids ', ' Methods ', ' Mining ', ' Mortality ', ' Mortality Vital Statistics ', ' tumor cell metastasis ', ' cancer metastasis ', ' Tumor Cell Migration ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastasize ', ' Metastasis ', ' Neoplasm Metastasis ', ' Nodule ', ' Patients ', ' Phenotype ', ' Phosphatidylcholines ', ' Choline Phosphoglycerides ', ' Choline Glycerophospholipids ', ' Lecithin ', ' O-(1-beta-acyl-2-acyl-sn-glycero-3-phospho)-ethanolamine ', ' Ethanolamineglycerophospholipids ', ' Ethanolamine Phosphoglycerides ', ' Cephalins ', ' Phosphatidylethanolamine ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Play ', ' Predictive Value of Tests ', ' Public Health ', ' public health medicine (field) ', ' pulmonary nodule ', ' Lung nodule ', ' social role ', ' Role ', ' Sensitivity and Specificity ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Testing ', ' thorax radiography ', ' thoracic radiogram ', ' radiographic lung image ', ' radiographic chest image ', ' lung radiography ', ' chest radiography ', ' chest Xray ', ' chest X ray ', ' CXR ', ' Thoracic Radiography ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Work ', ' Measures ', ' base ', ' improved ', ' Procedures ', ' Benign ', ' Malignant ', ' Malignant - descriptor ', ' psychological ', ' psychologic ', ' Link ', ' Lesion ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Human Figure ', ' Human body ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Biological Function ', ' Biological Process ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' Staging ', ' Inflammatory ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Prostatic Cancer ', ' Prostate Cancer ', ' Prostate CA ', ' Malignant prostatic tumor ', ' Malignant Tumor of the Prostate ', ' Malignant neoplasm of prostate ', ' Knowledge ', ' Adopted ', ' blood lipid ', ' cancer risk ', ' membrane structure ', ' Membrane ', ' cohort ', ' novel ', ' novel technologies ', ' new technology ', ' Reporting ', ' Sampling ', ' Proteomics ', ' Metabolic Pathway ', ' preventing ', ' prevent ', ' metabolism measurement ', ' metabolomics ', ' Non-neoplastic Pulmonary Disease ', ' Non-Neoplastic Pulmonary Disorder ', ' Non-Neoplastic Lung Disorder ', ' Data ', ' Detection ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' Newly Diagnosed ', ' nonmalignant ', ' Non-Malignant ', ' Monitor ', ' Sputum Cytology ', ' Sputum Cytology Screening ', ' Molecular ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' mass spectrometer ', ' human disease ', ' tumor ', ' public health relevance ', ' minimally invasive ', ' new marker ', ' novel marker ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' screening ', ' ']",NCI,RUSH UNIVERSITY MEDICAL CENTER,R21,2013,166388,0.2283314265874188
"Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)    DESCRIPTION (provided by applicant): Preterm birth is associated with bronchopulmonary dysplasia (BPD), a form of chronic lung disease that impacts the pulmonary and overall health of more than 10,000 infants in the US each year. The long-term objective of this Clinical Research Center (CRC) is translation of biochemical, genetic and bioinformatics research into innovative interventions that improve outcomes of extremely preterm infants at risk for long- term pulmonary morbidity. Our proposal focuses specifically on the urea cycle-nitric oxide (UC-NO) and glutathione (GSH) pathways as pivotal and interrelated mechanisms in the response of the developing lung to the extrauterine environment. Overall hypotheses: (1) Biochemical immaturity and functional genetic variation in the UC-NO and GSH pathways modulate the BPD phenotype spectrum; (2) The duration and degree of NO insufficiency and free radical excess predicts BPD severity and correlates with pulmonary morbidity after NICU discharge. To investigate our hypothesis, our CRC will enroll 250 infants with birthweights 510-1250 grams and follow the survivors through 1 year of life. Our hypothesis invokes an immature hepatic and gut synthetic capacity to make citrulline and GSH, functional genetic variations in the UC-NO and GSH pathways, nutritional deficiencies and the physiologic and environmental stress of preterm birth. The resultant NO deficiency and free radical excess alters pulmonary vascular and alveolar development. Our biomarker discovery concept includes (a) collection of plasma, urine, red blood cells, DNA and tracheal aspirates for measurements of NO and GSH precursor sufficiency, production of NO metabolites and GSH, functional genetic variants in these pathways, and biomarkers of in vivo oxidative stress and (b) validation of these biomarkers for diagnosis and long term prognosis of patients with BPD. A bioinformatics approach using machine learning and predictive modeling has been developed for respiratory phenotyping and risk stratification at 36 weeks and 40 weeks postmenstrual age and at 12 months after hospital discharge. Accomplishment of these goals will promote novel clinical trials design to test new therapies to prevent BPD and improve long term pulmonary health of infants born preterm. (End of Abstract)      RELEVANCE: Each year in the US, more than 10,000 premature infants develop bronchopulmonary dysplasia (BPD), a chronic lung disease associated with prolonged and recurrent hospitalizations and lifelong alterations in lung function. This proposal will explore developmental, genetic and environmental interactions and identify biochemical markers to predict BPD development and severity, with the ultimate goal of designing new treatments to prevent BPD and improve long-term lung function in premature infants.              ",Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV),8468005,U01HL101456,"['abstracting ', ' Age ', ' aminoacid ', ' Amino Acids ', ' L-Isomer Arginine ', ' L-Arginine ', ' Arginine ', ' Beds ', ' Blood Reticuloendothelial System ', ' Blood ', ' vascular ', ' Blood Vessels ', ' newborn chronic lung disease ', ' neonatal chronic lung disease ', ' infant chronic lung disease ', ' chronic lung disease in prematurity ', ' chronic lung disease in newborns ', ' chronic lung disease in neonates ', ' chronic lung disease in neonatal infants ', ' chronic lung disease in infants ', ' BPD ', ' Bronchopulmonary Dysplasia ', ' Censuses ', ' L-Ornithine, N5-(aminocarbonyl)- ', ' Citrulline ', ' Clinical Study ', ' Clinical Research ', ' L-Cysteine ', ' Half-Cystine ', ' Cysteine ', ' Data Collection ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Environment ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' Erythrocytes ', ' Free Radicals ', ' Genes ', ' Biochemical Genetics ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Glutathione ', ' Goals ', ' Health ', ' L-Isomer Homocysteine ', ' 2-amino-4-mercaptobutyric acid ', ' Homocysteine ', "" Butanoic acid, 4,4'-dithiobis(2-amino)- "", ' Homocystine ', ' Hospitalization ', ' Hospitals ', ' County Hospitals ', "" Children's Hospital "", ' Pediatric Hospitals ', ' Infant ', ' preterm neonate ', ' preterm infant human ', ' preterm infant ', ' preterm baby ', ' premature infant human ', ' premature baby ', ' Premature Infant ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Morbidity ', ' Morbidity - disease rate ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Nitric Oxide ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' 2,5-Diaminopentanoic Acid ', ' Ornithine ', ' Oxides ', ' Patients ', ' Phenotype ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Production ', ' Prognosis ', ' outcome forecast ', ' recruit ', ' Recruitment Activity ', ' Recurrent ', ' Recurrence ', ' Research ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' Risk ', ' Stress ', ' Testing ', ' Time ', ' Translations ', ' Urine Urinary System ', ' Urine ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Oxidized Glutathione ', ' GSSG ', ' Bis(gamma-Glutamyl-L-cysteinylglycine) Disulfide ', ' Glutathione Disulfide ', ' Measures ', ' Dataset ', ' Data Set ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Premature Birth ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' base ', ' improved ', ' specimen collection ', ' sample collection ', ' Hepatic ', ' Clinical ', ' prematurity ', ' premature ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Infant Health ', ' Biochemical Markers ', ' Survivors ', ' Measurement ', ' Oxidative Stress ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' Research Specimen ', ' Specimen ', ' Aspirate ', ' Aspirate substance ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Severities ', ' LOINC Axis 4 System ', ' System ', ' respiratory ', ' gastrointestinal ', ' developmental genetics ', ' urea cycle ', ' cohort ', ' novel ', ' Study Subject ', ' Categories ', ' Pathogenesis ', ' Chronic lung disease ', ' Admission ', ' Admission activity ', ' Modeling ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Isoprostanes ', ' F2-Isoprostanes ', ' Bio-Informatics ', ' Bioinformatics ', ' preventing ', ' prevent ', ' Alveolar ', ' Data ', ' Predictive Value ', ' Stratification ', ' in vivo ', ' Clinical Data ', ' trial design ', ' Clinical Trials Design ', ' Collection ', ' enroll ', ' Enrollment ', ' Validation ', ' nutritious ', ' Nutritional ', ' Principal Investigator ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' open source ', ' oxidant stress ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' Secure ', ' DNA Repository ', ' ']",NHLBI,ALBERT EINSTEIN COLLEGE OF MEDICINE,U01,2013,519792,0.09218063307322696
"Predictive Modeling with Clinical and Genomic Data in COPD Candidate: Dr. Peter Castaldi is a physician completing a period of F32-funded support. On July 1st, 2009 he will begin a full-time position at Tufts Medical Center and the Institute for Clinical Research and Health Policy Studies (ICRHPS). This position involves a 25% clinical commitment. His principal research interests are the genetic epidemiology of COPD and the translation of genomic discoveries into clinical practice and public health. His particular interests are genetic meta-analysis, gene-environment interaction, and predictive modeling with regression-based and machine-learning methods.  His immediate goals are 1.) to identify novel genetic associations with COPD susceptibility and COPD- related phenotypes through the combined analysis of multiple genome-wide association (GWA) studies, 2.) to identify epistatic and gene-by-smoking interactions, and 3.) to develop accurate predictive models in chronic obstructive pulmonary disease (COPD) using clinical and genomic information. His long-term goal is to be an independent investigator with expertise in bioinformatics. His vision for achieving this goal involves developing expertise in bioinformatics so as to be able to participate in and eventually lead multidisciplinary teams in the application of computational methods to genomic datasets in order to answer important clinical questions that will improve the care of patients and population health.    Environment: Dr. Castaldi will receive training in a rich, interdisciplinary environment. His principal mentor, Dr. Joseph Lau, is the head of the Center for Clinical Evidence Synthesis in the ICRHPS, and he is a worldwide leader in the field of meta-analysis and evidence synthesis. At Tufts, in addition to regular meetings with Dr. Lau, Peter will receive training in genetic evidence synthesis from leaders in the field, including Drs. John Ioannidis and Tom Trikalinos. The co-mentor of this application, Dr. Edwin Silverman, is a leading researcher in COPD genetics at the Channing Laboratory. At the Channing Laboratory, Peter will receive excellent training in respiratory genetics and genetic epidemiology, and he will have resources to state of the art high-throughput genotyping, next-generation sequencing technologies, and bioinformatics support. Dr. Castaldi will also continue his collaboration with Dr. Donna Slonim in the Tufts Computer Science Department, who will provide assistance with application of computational algorithms to genomic data and guidance as Dr. Castaldi continues to build a practical and theoretical foundation in Bioinformatics.    Research: COPD is a major cause of morbidity and mortality that is of increasing public health importance. While the principal risk factor for COPD, smoking, is well-established, there is variable susceptibility in the general population to the lung damage caused by cigarette smoke. There is strong evidence supporting a genetic component to COPD susceptibility. Understanding how genes and environment interact to produce clinical COPD will allow for more accurate diagnostic tools and open new avenues of investigation for the development of COPD therapies. We propose to 1.) identify novel genetic associations with COPD susceptibility and 4 COPD-related phenotypes by performing meta-analysis on patient-level data from 4 large COPD GWA studies, 2.) identify gene-by-smoking and gene-gene interactions, and 3.) develop predictive models for COPD susceptibility and COPD-related phenotypes. In order to maximize the information obtained from genomic data, we will combine data from multiple studies (the National Emphysema Treatment Trial Genetics Ancillary Study, the Norway Case-Control Study, COPDGene, and ECLIPSE - total sample size=7,962) to increase power and employ regression-based and machine-learning methods to identify complex patterns of interaction in genotype data. Our study is designed to both explore and subsequently rigorously validate discovered main effect and interaction associations. Using predictive models, we will quantify the incremental predictive benefit of including genetic main effects and genetic interaction data to traditional clinical variables.    Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. Project Narrative  The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.    Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.",Predictive Modeling with Clinical and Genomic Data in COPD,8500430,K08HL102265,"['Affect ', ' Engineering / Architecture ', ' Architecture ', ' Biology ', ' Biomass ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cause of Death ', ' Clinical Study ', ' Clinical Research ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Disease susceptibility ', ' Environment ', ' Environmental Exposure ', ' Foundations ', ' Future ', ' Genes ', ' Epistatic Gene ', ' Genotype ', ' Goals ', ' Head ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Institutes ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' Mentors ', ' Methods ', ' Mission ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Persons ', ' Norway ', ' Patients ', ' Phenotype ', ' Physicians ', ' Public Health ', ' public health medicine (field) ', ' Emphysema ', ' Pulmonary Emphysema ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk Factors ', ' Smoke ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' Training Programs ', ' Translating ', ' Translations ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Biological ', ' Link ', ' Susceptibility ', ' Predisposition ', ' prognostic ', ' Training ', ' insight ', ' Individual ', ' smoke of cigarettes ', ' cigarette smoke ', ' Sample Size ', ' Funding ', ' Collaborations ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Investigation ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Pattern ', ' Techniques ', ' respiratory ', ' interest ', ' meetings ', ' Medical center ', ' American ', ' environment effect on gene ', ' gene environment interaction ', ' gene interaction ', ' Performance ', ' success ', ' computer science ', ' cohort ', ' novel ', ' General Public ', ' General Population ', ' Prevention ', ' Position ', ' Positioning Attribute ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' genetic association ', ' Data ', ' Disease Association ', ' Ancillary Study ', ' Validation ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' treatment trial ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' Population ', ' multidisciplinary ', ' computer algorithm ', ' Computational algorithm ', ' clinical care ', ' patient population ', ' clinical practice ', ' population health ', ' next generation sequencing ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,K08,2013,128250,0.02304844678918864
"Inflammation Genes and Lung Cancer Risk DESCRIPTION (provided by applicant): There is accumulating evidence that chronic injury and inflammation in the respiratory tract, such as that caused by cigarette smoking, predispose to lung cancer. We therefore propose to conduct an in depth pathway-based analysis of gene variants in the inflammatory pathway using test and validation sets of cases and controls. This proposal builds on a well-annotated specimen repository of lung cancer cases and controls enrolled in an ongoing risk factor study (CA55769, Spitz, PI). Cases are frequency-matched to controls on age, gender, ethnicity and smoking status recruited from a multi-specialty physician practice. Data collected include smoking history, dietary intake, cancer family history, specific occupational exposures (e.g., asbestos, dust), and previous medical history including chronic obstructive airway disease, asthma and hay fever. Genomic DNA and rich candidate genotype and phenotype data are available. Aim 1: To identify novel genetic variants influencing lung cancer risk in a test set of 1500 cases with non-small cell lung cancer and 1500 matched controls (all Caucasian), using the Illumina iSelect Infinium chip with 8.5 to 9K SNP's. Aim 2: In a replication set of an additional 1000 cases and 1000 controls, using a GoldenGate assay, we will evaluate the top 1500 SNPs identified from Aim1 as meeting the P<0.1 criterion, or selected by a rational prioritizing approach that incorporates published results, type of SNP, evolutionary biology, physico-chemical properties and haplotype tagging SNPs. Aim 3: To perform fine mapping in the flanking regions of 50 SNPs selected by the same approach as in Aim 2, combining prior information with in silico approaches for predicting functionality. For each of these 50 SNPs, we will select an average of 10 additional SNPs per gene region to regenotype in all 2500 cases and 2500 controls. Aim 4. To extend our epidemiologic risk prediction model by incorporating established epidemiologic risk factor and gene variant data. We will apply machine-learning tools to identify gene-environment and gene-gene interactions. Covariates will include prior emphysema, asthma, hay fever, dust and asbestos exposure, smoking characteristics, family history of cancer, and anti-inflammatory drug use. The International Lung Cancer Consortium will perform external validation in a proposal to be developed. Our approach to comprehensively evaluate variants in a candidate pathway in a large well- powered study will be applicable to a variety of other cancer sites where inflammation plays an important etiologic role, as well as in non-neoplastic diseases with a strong inflammatory component such as emphysema. The public health potential of a useful risk prediction modes for lung cancer is substantial. Public Health Relevance Statement Cigarette smoking results in inflammation in the respiratory tract and there is growing evidence that chronic inflammatory processes predispose to lung cancer. However, the molecular mechanisms underlying the causal nature of this association are unclear. We propose to conduct an in depth analysis of gene variants in the inflammatory pathway as susceptibility factors for lung cancer. This proposal builds upon an existing well annotated specimen repository. We will evaluate gene variants in a test set of lung cancer cases and matched controls and validate the findings in an independent dataset. Finally we will incorporate these findings into an extended risk prediction model for lung cancer.",Inflammation Genes and Lung Cancer Risk,8506981,R01CA127219,"['Affect ', ' Age ', ' Algorithms ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Anti-Inflammatory Agents ', ' Antihistamines ', ' Asbestos ', ' Bronchial Asthma ', ' Asthma ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' Cell Division Cycle ', ' Cell Cycle ', ' Cellular Growth ', ' Cellular Expansion ', ' cell growth ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Dust ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Genes ', ' Genotype ', ' Goals ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Growth Factor ', ' Haplotypes ', ' pollenosis ', ' Seasonal Rhinitis ', ' Rhinitis, Allergic, Seasonal ', ' Hayfever ', ' Hay fever ', ' History ', ' Recording of previous events ', ' In Vitro ', ' Infection ', ' Inflammation ', ' Irritants ', ' Articulation ', ' Joints ', ' Literature ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Maps ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Occupational Exposure ', ' Phenotype ', ' Physicians ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Emphysema ', ' Pulmonary Emphysema ', ' Receiver Operating Characteristics ', ' Recommendation ', ' recruit ', ' Recruitment Activity ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Research Resources ', ' Resources ', ' respiratory tract ', ' Respiratory system (all sites) ', ' Pulmonary Organ System ', ' Pulmonary Body System ', ' Respiratory System ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Smoking ', ' Specialty ', ' medical specialties ', ' Testing ', ' Body Tissues ', ' Tissues ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Caucasians ', ' Gender ', ' Dataset ', ' Data Set ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' Injury ', ' base ', ' Area ', ' Chronic ', ' Variation ', ' Variant ', ' Logistic Regressions ', ' Link ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' drug use ', ' Drug usage ', ' Oxidative Stress ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' chemical property ', ' Family Cancer History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Respiratory Tracts ', ' Respiratory tract structure ', ' Letters ', ' angiogenesis ', ' Genetic ', ' Staging ', ' Inflammatory ', ' tool ', ' Nature ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Adopted ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Host Defense ', ' Nucleotide Excision Repair ', ' meetings ', ' cancer risk ', ' Cancer Induction ', ' carcinogenesis ', ' gene interaction ', ' Proxy ', ' novel ', ' Participant ', ' smoke cigarette ', ' cigarette smoking ', ' Lung Tissue ', ' Lung Parenchyma ', ' Structure of parenchyma of lung ', ' Modeling ', ' response ', ' case control ', ' repository ', ' cancer location ', ' cancer site ', ' Genomics ', ' Bio-Informatics ', ' Bioinformatics ', ' Inflammatory Response ', ' Cell Cycle Control ', ' Cell Cycle Regulation ', ' DNA Base Excision Repair ', ' Base Excision Repairs ', ' Dietary intake ', ' Oncogenesis ', ' tumorigenesis ', ' DNA Repair Pathway ', ' Data ', ' International ', ' Progress Review Group ', ' Anti-inflammatory ', ' enroll ', ' Enrollment ', ' Newly Diagnosed ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Smoking Behavior ', ' Smoking History ', ' Smoking Status ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' genetic variant ', ' Outcome ', ' aggregation pathway ', ' parent grant ', ' public health relevance ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R01,2013,192450,0.12530806534110406
"Predictive Modeling with Clinical and Genomic Data in COPD Candidate: Dr. Peter Castaldi is a physician completing a period of F32-funded support. On July 1st, 2009 he will begin a full-time position at Tufts Medical Center and the Institute for Clinical Research and Health Policy Studies (ICRHPS). This position involves a 25% clinical commitment. His principal research interests are the genetic epidemiology of COPD and the translation of genomic discoveries into clinical practice and public health. His particular interests are genetic meta-analysis, gene-environment interaction, and predictive modeling with regression-based and machine-learning methods.  His immediate goals are 1.) to identify novel genetic associations with COPD susceptibility and COPD- related phenotypes through the combined analysis of multiple genome-wide association (GWA) studies, 2.) to identify epistatic and gene-by-smoking interactions, and 3.) to develop accurate predictive models in chronic obstructive pulmonary disease (COPD) using clinical and genomic information. His long-term goal is to be an independent investigator with expertise in bioinformatics. His vision for achieving this goal involves developing expertise in bioinformatics so as to be able to participate in and eventually lead multidisciplinary teams in the application of computational methods to genomic datasets in order to answer important clinical questions that will improve the care of patients and population health.    Environment: Dr. Castaldi will receive training in a rich, interdisciplinary environment. His principal mentor, Dr. Joseph Lau, is the head of the Center for Clinical Evidence Synthesis in the ICRHPS, and he is a worldwide leader in the field of meta-analysis and evidence synthesis. At Tufts, in addition to regular meetings with Dr. Lau, Peter will receive training in genetic evidence synthesis from leaders in the field, including Drs. John Ioannidis and Tom Trikalinos. The co-mentor of this application, Dr. Edwin Silverman, is a leading researcher in COPD genetics at the Channing Laboratory. At the Channing Laboratory, Peter will receive excellent training in respiratory genetics and genetic epidemiology, and he will have resources to state of the art high-throughput genotyping, next-generation sequencing technologies, and bioinformatics support. Dr. Castaldi will also continue his collaboration with Dr. Donna Slonim in the Tufts Computer Science Department, who will provide assistance with application of computational algorithms to genomic data and guidance as Dr. Castaldi continues to build a practical and theoretical foundation in Bioinformatics.    Research: COPD is a major cause of morbidity and mortality that is of increasing public health importance. While the principal risk factor for COPD, smoking, is well-established, there is variable susceptibility in the general population to the lung damage caused by cigarette smoke. There is strong evidence supporting a genetic component to COPD susceptibility. Understanding how genes and environment interact to produce clinical COPD will allow for more accurate diagnostic tools and open new avenues of investigation for the development of COPD therapies. We propose to 1.) identify novel genetic associations with COPD susceptibility and 4 COPD-related phenotypes by performing meta-analysis on patient-level data from 4 large COPD GWA studies, 2.) identify gene-by-smoking and gene-gene interactions, and 3.) develop predictive models for COPD susceptibility and COPD-related phenotypes. In order to maximize the information obtained from genomic data, we will combine data from multiple studies (the National Emphysema Treatment Trial Genetics Ancillary Study, the Norway Case-Control Study, COPDGene, and ECLIPSE - total sample size=7,962) to increase power and employ regression-based and machine-learning methods to identify complex patterns of interaction in genotype data. Our study is designed to both explore and subsequently rigorously validate discovered main effect and interaction associations. Using predictive models, we will quantify the incremental predictive benefit of including genetic main effects and genetic interaction data to traditional clinical variables.    Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. Project Narrative  The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.    Relevance: The proposed work will identify new genes associated with COPD and place them in a multivariate context so as to develop a better understanding of how genetic differences and environmental exposures contribute to the development of COPD. The models generated by this work will facilitate the translation of genomic discoveries to clinical practice and public health, in keeping with the NHLBI's mission to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.",Predictive Modeling with Clinical and Genomic Data in COPD,8668035,K08HL102265,"['Affect ', ' Engineering / Architecture ', ' Architecture ', ' Biology ', ' Biomass ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cause of Death ', ' Clinical Study ', ' Clinical Research ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Disease susceptibility ', ' Environment ', ' Environmental Exposure ', ' Foundations ', ' Future ', ' Genes ', ' Epistatic Gene ', ' Genotype ', ' Goals ', ' Head ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Institutes ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' Mentors ', ' Methods ', ' Mission ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Persons ', ' Norway ', ' Patients ', ' Phenotype ', ' Physicians ', ' Public Health ', ' public health medicine (field) ', ' Emphysema ', ' Pulmonary Emphysema ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk Factors ', ' Smoke ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' Training Programs ', ' Translating ', ' Translations ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Biological ', ' Link ', ' Susceptibility ', ' Predisposition ', ' prognostic ', ' Training ', ' insight ', ' Individual ', ' smoke of cigarettes ', ' cigarette smoke ', ' Sample Size ', ' Funding ', ' Collaborations ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Investigation ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Pattern ', ' Techniques ', ' respiratory ', ' interest ', ' meetings ', ' Medical center ', ' American ', ' environment effect on gene ', ' gene environment interaction ', ' gene interaction ', ' Performance ', ' success ', ' computer science ', ' cohort ', ' novel ', ' General Public ', ' General Population ', ' Prevention ', ' Position ', ' Positioning Attribute ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' genetic association ', ' Data ', ' Disease Association ', ' Ancillary Study ', ' Validation ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' treatment trial ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' Population ', ' multidisciplinary ', ' computer algorithm ', ' Computational algorithm ', ' clinical care ', ' patient population ', ' clinical practice ', ' population health ', ' next generation sequencing ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,K08,2014,128250,0.02304844678918864
"Center for Nanobiology and Predictive Toxicology    DESCRIPTION (provided by applicant):  The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop ""nano-QSARs"" for probabilistic risk ranking (Project 3).        We propose a center to study how properties of engineered nanomaterials may lead to lung health effects by creating harmful interactions in cells and tissues that will come into contact with these materials. This will be accomplished by a multi-disciplinary team who will use their expertise in nanomaterial science, biology, toxicology, imaging, statistics and computer science to integrate above goals into a predictive model that projects from what is happening in cells to what may happen in the lung.",Center for Nanobiology and Predictive Toxicology,8668954,U19ES019528,"['Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biological Availability ', ' Biology ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Cells ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Engineering ', ' Fibrosis ', ' Future ', ' Goals ', ' Health ', ' In Vitro ', ' Inflammation ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Math ', ' Mathematics ', ' Metals ', ' Methods ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Play ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' Pneumonia ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Risk ', ' Rodents Mammals ', ' Rodentia ', ' Rodent ', ' social role ', ' Role ', ' Science ', ' Signal Pathway ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Silicon Dioxide ', ' statistics ', ' Body Tissues ', ' Tissues ', ' Toxicology ', ' Generations ', ' Injury ', ' base ', ' Organ ', ' Link ', ' Oxidative Stress ', ' Cell Structure ', ' Cell Components ', ' Cellular Structures ', ' chemical property ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' cell biology ', ' Cellular biology ', ' Lytic ', ' Inhalation Exposure ', ' Lytotoxicity ', ' cytotoxicity ', ' membrane structure ', ' Membrane ', ' metal oxide ', ' Performance ', ' physical property ', ' hazard ', ' computer science ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' High Throughput Assay ', ' high throughput screening ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' mathematical model ', ' Lysis ', ' Cytolysis ', ' Dose ', ' Data ', ' in vivo ', ' Molecular ', ' cell imaging ', ' cellular imaging ', ' nano ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' computer based prediction ', ' predictive modeling ', ' nano materials ', ' nanomaterials ', ' nano biology ', ' nanobiology ', ' nano particle ', ' nanoparticle ', ' Outcome ', ' combinatorial ', ' multidisciplinary ', ' screening ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA LOS ANGELES,U19,2014,1124979,0.06393576329664759
"Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV) DESCRIPTION (provided by applicant): Preterm birth is associated with bronchopulmonary dysplasia (BPD), a form of chronic lung disease that impacts the pulmonary and overall health of more than 10,000 infants in the US each year. The long-term objective of this Clinical Research Center (CRC) is translation of biochemical, genetic and bioinformatics research into innovative interventions that improve outcomes of extremely preterm infants at risk for long- term pulmonary morbidity. Our proposal focuses specifically on the urea cycle-nitric oxide (UC-NO) and glutathione (GSH) pathways as pivotal and interrelated mechanisms in the response of the developing lung to the extrauterine environment. Overall hypotheses: (1) Biochemical immaturity and functional genetic variation in the UC-NO and GSH pathways modulate the BPD phenotype spectrum; (2) The duration and degree of NO insufficiency and free radical excess predicts BPD severity and correlates with pulmonary morbidity after NICU discharge. To investigate our hypothesis, our CRC will enroll 250 infants with birthweights 510-1250 grams and follow the survivors through 1 year of life. Our hypothesis invokes an immature hepatic and gut synthetic capacity to make citrulline and GSH, functional genetic variations in the UC-NO and GSH pathways, nutritional deficiencies and the physiologic and environmental stress of preterm birth. The resultant NO deficiency and free radical excess alters pulmonary vascular and alveolar development. Our biomarker discovery concept includes (a) collection of plasma, urine, red blood cells, DNA and tracheal aspirates for measurements of NO and GSH precursor sufficiency, production of NO metabolites and GSH, functional genetic variants in these pathways, and biomarkers of in vivo oxidative stress and (b) validation of these biomarkers for diagnosis and long term prognosis of patients with BPD. A bioinformatics approach using machine learning and predictive modeling has been developed for respiratory phenotyping and risk stratification at 36 weeks and 40 weeks postmenstrual age and at 12 months after hospital discharge. Accomplishment of these goals will promote novel clinical trials design to test new therapies to prevent BPD and improve long term pulmonary health of infants born preterm. (End of Abstract)      RELEVANCE: Each year in the US, more than 10,000 premature infants develop bronchopulmonary dysplasia (BPD), a chronic lung disease associated with prolonged and recurrent hospitalizations and lifelong alterations in lung function. This proposal will explore developmental, genetic and environmental interactions and identify biochemical markers to predict BPD development and severity, with the ultimate goal of designing new treatments to prevent BPD and improve long-term lung function in premature infants. ",Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV),9172438,U01HL101456,[''],NHLBI,"ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",U01,2014,197560,0.09218063307322696
"Molecular, cellular and physiological mechanisms of the mammalian circadian clock     DESCRIPTION (provided by applicant): The circadian clock regulates physiology and behavior and impinges on many aspects of our daily life. Nowhere is this more obvious than control of the sleep wake cycle, where clock genes have been shown to play a role in both the timing of sleep and its quality. For example, mutations in PER2 cause familial advanced sleep phase syndrome (FASPS), while mutations in  CSNK1E and CSNK1D cause FASPS and delayed sleep phase syndrome (DSPS),  respectively. However, while we have learned much about the clock and how it regulates sleep, the picture is incomplete. Behavioral studies in mice and studies in human cells show that dozens to hundreds of loci impact circadian clock function. However, only a dozen genes have been investigated for their roles in regulating behavior. Testing dozens to hundreds of mice isn't practical, so a new approach is needed. Here we seek to address this gap with a novel strategy that uses, i) integrative bioinformatics to prioritize putative core clock factors, ii) new experimental methods to determine whether they interact with known clock genes and regulate clock function in several cellular or tissue slice models, and, finally, iii) for a subset of promising candidates, generate mouse models and test them for their roles in regulating circadian behavior and sleep. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.             Our internal biological clocks control many important aspects of our physiology and behavior such as the sleep-wake cycle. Genetics and large-scale genomic studies have implicated the role of a dozen canonical and hundreds of additional new genes in the circadian clock.  However, almost none of the new genes have been studied in animal models for their ability to regulate sleep onset or quality. We will address this gap using bioinformatics, experimental biology, and finally through behavioral analysis. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.                 ","Molecular, cellular and physiological mechanisms of the mammalian circadian clock",8640983,R01NS054794,"['Behavior ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biological Clocks ', ' Biology ', ' Cells ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Fibroblasts ', ' Genes ', ' Goals ', ' Au element ', ' Gold ', ' Grant ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Literature ', ' luminescence ', ' Memory ', ' Methods ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Rhythmicity ', ' Cyclicity ', ' Periodicity ', ' Phenotype ', ' Physiology ', ' Play ', ' Probability ', ' Research ', ' social role ', ' Role ', ' Sleep ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Work ', ' Generations ', ' Mutagenesis Molecular Biology ', ' Genetics-Mutagenesis ', ' Mutagenesis ', ' Dataset ', ' Data Set ', ' improved ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Neurological ', ' Neurologic ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Adipocytes ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' mental ', ' Psyche structure ', ' Genetic ', ' gene function ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Delayed Sleep Phase Syndrome ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' mutant ', ' neurogenetics ', ' Performance ', ' neural network ', ' Biological Neural Networks ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' Informatics ', ' novel ', ' behavioral test ', ' behavior test ', ' Advanced Sleep Phase Syndrome (ASPS) ', ' Advanced Sleep Phase Syndrome ', ' intervention therapy ', ' Therapeutic Intervention ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Sleep Wake Cycle ', ' sleep onset ', ' Proteomics ', ' Genomics ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' Bio-Informatics ', ' Bioinformatics ', ' knockout animal ', ' Ortholog ', ' Orthologous Gene ', ' Address ', ' Defect ', ' Animal Testing ', ' Data ', ' Mammalian Cell ', ' Quantitative Genetics ', ' Neurosciences Research ', ' Slice ', ' Molecular ', ' Behavioral ', ' reverse genetics ', ' positional cloning ', ' Flies ', ' fly ', ' imaging ', ' Image ', ' Behavioral Assay ', ' data integration ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' circadian clock ', ' circadian pacemaker ', ' Cellular model ', ' Cell model ', ' mouse model ', ' therapeutic target ', ' discover genes ', ' gene discovery ', ' novel therapeutic target ', ' new therapeutic target ', ' evidence base ', ' screening ', ' ']",NINDS,UNIVERSITY OF PENNSYLVANIA,R01,2014,558658,0.09251717179460534
"Instrument to Co-register EEG and NIRS for Accurate Sleep Sorting     DESCRIPTION (provided by applicant):     PROJECT SUMMARY Sleep disorders are highly prevalent and are associated with substantial adverse consequences including motor vehicle and other accidents, impaired cognition, impaired immune function, altered mood, decreased quality of life, and increased mortality. The gold standard test for assessing the physiology of sleep is the polysomnogram suffers from a number of well-recognized limitations. These limitations decrease the capacity of sleep researchers to make advances in understanding sleep and diminish the capacity of clinicians to detect and treat patients suffering from sleep disorders. (PSG). Currently employed PSG technology Our long-term goal is to address the shortcomings of current PSG methodology by developing a low cost, low for automated assessment of sleep physiology. We hypothesize that this would be possible by expanding the types of brain assessments carried out to include near infrared spectroscopy (NIRS) where recent evidence suggests that the low frequency hemodynamic oscillation reflect sleep stage-related changes in brain function. NIRS also simultaneously provides cerebral oxygen saturation, heart rate and breathing rate estimates. In this application, we propose to design, build, and test power, low noise, ultra-miniaturized, wireless system a proof-of-principle prototype system combining diffuse optical spectroscopic, electrophysiological, and inertial . This system will have the form factor of an adhesive bandage which will disturb and limit subjects to a far lesser degree than traditional PSG systems. We will use supervised machine learning-based methods to explore NIRS features specific to sleep stages and clinically relevant events. Other innovations include recording inertial signals and incorporating adaptive signal processing in order to remove artifacts and improve the signal to noise ratio (SNR), and using commercial-off-the-shelf proximity sensor circuitry to support the NIRS front-end. measurement capabilities If successful, this project will lead to improved capacity to carry out sleep research and to detect and treat sleep disorders. The proposed methodology would test whether novel clinically relevant NIRS parameters can be explored enabling further understanding of sleep physiology. The miniaturization, low cost, and low power consumption of our new NIRS-based wireless system would pave the way for rapid adoption and deployment of these bandages for home-use in real-world settings. Given the high prevalence and substantial impairments associated with sleep disorders, this project has the potential to have a major positive impact on public health.         PUBLIC HEALTH RELEVANCE:     Project Narrative A review carried out by the Institute of Medicine concluded that 50-70 million people in the United States suffer from a chronic disorder of sleep and wakefulness which diminishes their ability to function, adversely impacts their health, and decreases longevity. Current systems for objectively monitoring sleep physiology and diagnosing sleep disorders suffer from a number of widely-recognized shortcomings that limit the capacity of researchers to make advances in understanding sleep and sleep disorders and diminish the capacity of clinicians to detect and treat patients suffering from these conditions. Our long term goal is to develop a low cost, low power, low noise, ultra-miniaturized, wireless system for automated assessment of sleep physiology which addresses these shortcomings. The specific objective of this proposal is to investigate the capability of a miniaturized, wireless near infrared spectroscopy ( NIRS ) system to achieve this. As such, the proposed project has the potential to improve the lives of the millions of people suffering from sleep disorders.            ",Instrument to Co-register EEG and NIRS for Accurate Sleep Sorting,8771722,R21NS085818,"['Accidents ', ' Adhesives ', ' Adoption ', ' Algorithms ', ' Apnea ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Breathing ', ' Bandage ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Systematics ', ' Classification ', ' Diagnosis ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' Fingers ', ' Goals ', ' Au element ', ' Gold ', ' Health ', ' Cardiac Chronotropism ', ' Heart Rate ', ' hemodynamics ', ' indexing ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Li+ element ', ' Lithium ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Miniaturisations ', ' Miniaturization ', ' Moods ', ' Mortality ', ' Mortality Vital Statistics ', ' body movement ', ' Movement ', ' Noise ', ' optical ', ' Optics ', ' O2 element ', ' O element ', ' Oxygen ', ' Patients ', ' Physiology ', ' Plethysmography ', ' Polymers ', ' Public Health ', ' public health medicine (field) ', ' Pulse Oximetry ', ' QOL ', ' Quality of life ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Scalp ', ' Scalp structure ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Sleep ', ' Sleep Stages ', ' Technology ', ' Testing ', ' Time ', ' United States ', ' Wakefulness ', ' Weight ', ' Artifacts ', ' Morphologic artifacts ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Polysomnography ', ' Motor Vehicles ', ' base ', ' sensor ', ' improved ', ' Clinical ', ' Diffuse ', ' Physiologic ', ' Physiological ', ' cerebral ', ' Cerebrum ', ' Measurement ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Near-Infrared Spectrometry ', ' NIR Spectroscopy ', ' Near-Infrared Spectroscopy ', ' Head Movements ', ' Hour ', ' Frequency ', ' Frequencies (time pattern) ', ' Event ', ' Home ', ' Home environment ', ' LOINC Axis 4 System ', ' System ', ' Syndrome, Sleep Apnea, Obstructive ', ' Obstructive Sleep Apnea ', ' respiratory ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' meetings ', ' experience ', ' novel ', ' sorting ', ' Sorting - Cell Movement ', ' Position ', ' Positioning Attribute ', ' sleep problem ', ' Sleep Disorders ', ' sleep onset ', ' miniaturize ', ' Insomnia Disorder ', ' Insomnia ', ' Sleeplessness ', ' Skin ', ' Cellular Immune Function ', ' immune function ', ' Address ', ' Data ', ' High Prevalence ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' cost ', ' designing ', ' design ', ' Consumption ', ' innovative ', ' innovate ', ' innovation ', ' Impairment ', ' clinical relevance ', ' clinically relevant ', ' prototype ', ' public health relevance ', ' adverse consequence ', ' adverse outcome ', ' signal processing ', ' ']",NINDS,NORTH CAROLINA STATE UNIVERSITY RALEIGH,R21,2014,265759,0.13297403579109804
"Quantitative Analysis of PEM for REMBD Identification    DESCRIPTION (provided by applicant):    Rapid Eye Movement Behavior Disorder (RBD) refers to a condition in which patients act out their dreams and engage in potentially disruptive, injurious and even dangerous behavior while asleep[1-3]. Clinical reports of RBD have been shown to anticipate the development of neurodegenerative conditions like Parkinson's Disease by 20 years or more [4-6]. Despite this potential prognostic significance for human disease, the field of Sleep Medicine lacks an accepted computerized approach to quantify muscle activity in sleep. This proposed interdisciplinary research seeks to merge methods of computer engineering based computation with advanced neuroscience to establish a computerized clinical decision support system (CDSS) to detect RBD via measurement and analysis of the phasic electromyographic activity metric (PEM). The sponsor (Bliwise) has provided evidence based on traditional visual analyses from ""expert"" scorers that PEM recorded during sleep is a sensitive indicator a) to differentiate PD patients from controls [7]; b) to distinguish non-PD patients with a history of RBD from controls [8]; and c) to differentiate PD patients with early and late stage disease [9]. These data suggest that computer-aided PEM detection within a user-friendly CDSS will be vital for clinicians to determine prognosis, track disease course, and, possibly, even monitor treatment.           The proposed work is envisioned as a vital and integral component to establish standardized computerized bio-signal processing methods to detect phasic muscle activity in overnight human sleep polysomnograms for the identification and treatment of Rapid Eye Movement Behavior Disorder.            ",Quantitative Analysis of PEM for REMBD Identification,8578112,F32NS070572,"['Acting Out ', ' Algorithms ', ' Clinical Protocols ', ' Computers ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Dangerous Behavior ', ' disease/disorder ', ' Disorder ', ' Disease ', ' dreaming ', ' Dreams ', ' Engineering ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Medicine ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' muscular ', ' Muscle Tissue ', ' Muscle ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Neurosciences ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Lewy Body Parkinson Disease ', ' Idiopathic Parkinson Disease ', ' Parkinson Disease ', ' Patients ', ' Prognosis ', ' outcome forecast ', ' Quantitative Evaluations ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Sleep ', ' Testing ', ' Work ', ' Artifacts ', ' Morphologic artifacts ', ' base ', ' sensor ', ' Site ', ' Clinical ', ' Evaluation ', ' prognostic ', ' Visual ', ' Parkinsonism ', ' Parkinsonian Syndrome ', ' Parkinsonian Diseases ', ' Parkinsonian Condition ', ' Parkinsonian ', ' Parkinsonian Disorders ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Investigation ', ' Severities ', ' Event ', ' Techniques ', ' Location ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neuro-degenerative Disorders ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Neurodegenerative Disorders ', ' Clinical Decision Support Systems ', ' meetings ', ' Performance ', ' novel ', ' Metric ', ' Reporting ', ' Bypass ', ' Rapid Eye Movement Sleep Behavior Disorder ', ' Rapid Eye Movement Behavior Disorder ', ' REM Behavior Disorder ', ' REM Sleep Behavior Disorder ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Data ', ' Detection ', ' Motor ', ' Monitor ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' computerized ', ' computer aided ', ' Computer Assisted ', "" parkinson's disease dementia "", "" Parkinson's disease with dementia "", ' PD with dementia ', "" Parkinson's Dementia "", ' innovative ', ' innovate ', ' innovation ', ' user-friendly ', ' human disease ', ' evidence base ', ' Lewy Body Type Senile Dementia ', ' Dementia with Lewy Bodies ', ' Lewy Body Dementia ', ' signal processing ', ' ']",NINDS,EMORY UNIVERSITY,F32,2014,58946,0.05841671877005626
"Transfer Rule Learning for Knowledge Based Biomarker Discovery and Predictive Bio     DESCRIPTION (provided by applicant): Predictive modeling of biomedical data arising from clinical studies for early detection, monitoring and prognosis of diseases is a crucial step in biomarker discovery. Since the data are typically measurements subject to error, and the sample size of any study is very small compared to the number of variables measured, the validity and verification of models arising from such datasets significantly impacts the discovery of reliable discriminatory markers for a disease. An important opportunity to make the most of these scarce data is to combine information from multiple related data sets for more effective biomarker discovery. Because the costs of creating large data sets for every disease of interest are likely to remain prohibitive, methods for more effectively making use of related biomarker discovery data sets continues to be important. Solution: This project develops and applies Transfer Rule Learning (TRL), a novel framework for integrative biomarker discovery from related but separate data sets, such as those generated from similar biomarker profiling studies. TRL alleviates the problem of data scarcity by providing automated ways to express, verify and use prior hypotheses generated from one data set while learning new knowledge via a related data set. This is the first study of transfer learning for biomarker discovery. Unlike other transfr learning approaches, TRL takes knowledge in the form of interpretable, modular classification rules, and uses them to seed learning of a rule model on a new data set. Classification rules simplify the extraction of discriminatory markers, and have been used successfully for biomarker discovery and verification in a non-integrative fashion. Specific Aims: This project tests the main hypothesis that TRL provides a mechanism for transfer learning of classification rules between related source and target data sets that improve performance on the target data, compared to learning without transfer. TRL will be evaluated using cross-validation performance of classification accuracy and transfer measures, on related groups of existing biomarker discovery datasets obtained from multiple experimental platforms for lung cancer detection and prognosis. A new set of independent validation data will be generated for early detection of lung cancer to test the models generated on pilot data. Insights into the impact of different modeling algorithms on transfer outcomes will be gleaned. Significance: The TRL framework and tool are important for combined analysis and interpretation of clinical data, as they support incremental building, verification and refinement of rule models for predictive biomedicine. The application of TRL to real-world biomarker discovery datasets can yield insights into novel interactions involving known markers, and the most reliable biomarkers for early detection of disease, particularly lung cancer. This project has the potential to help create new diagnostic screening tools for lung cancer detection. It allows foundational understanding of the use of transfer learning for integrative biomarker discovery that could lead to novel technologies for combining information from data and prior knowledge.          This project will develop highly-needed computational methods for integrative biomarker discovery from related but separate data sets produced by predictive molecular profiling studies of disease. It will generate new experimental data for early detection of lung cancer, and has the potential to help create new diagnostic screening tools for lung cancer, a leading cause of death from cancer in the United States.                ",Transfer Rule Learning for Knowledge Based Biomarker Discovery and Predictive Bio,8711497,R01GM100387,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cause of Death ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Sources ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Gene Expression ', ' Goals ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Maps ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Prognosis ', ' outcome forecast ', ' Publishing ', ' Sampling Studies ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Solutions ', ' Testing ', ' training transfer ', ' learning transfer ', ' Transfer (Psychology) ', ' Psychological Transfer ', ' United States ', ' Work ', ' Measures ', ' Outcomes Research ', ' Glean ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' insight ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Measurement ', ' Sample Size ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Protocol ', ' Protocols documentation ', ' Source ', ' interest ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' knowledgebase ', ' knowledge base ', ' Structure ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' novel technologies ', ' new technology ', ' Modeling ', ' Sampling ', ' Proteomics ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' MicroRNAs ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Institution ', ' datamining ', ' data mining ', ' Address ', ' Data ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Cancer Detection ', ' Cancer Prognosis ', ' Clinical Data ', ' Validation ', ' Monitor ', ' Characteristics ', ' developmental ', ' Development ', ' cost ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' cancer proteomics ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' screening ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2014,302234,0.0753935636532694
"Understanding and enhancing visual search performance in complex scenes     DESCRIPTION (provided by applicant): Understanding and enhancing visual search performance in complex scenes Cancer screening saves lives (e.g. National Lung Screening Trial Research, 2011). Every day, radiologists are faced with difficult, time-consuming visual search tasks like in mammography and lung cancer screening. Oftentimes signs of cancer, e.g. lung nodules or little abnormalities in a breast, are very hard to find against heterogeneous backgrounds and obscured by overlapping tissues. Missing these signs of cancer can result in wrong diagnoses with life or death consequences. It is therefore of key interest to identify and tackle the problems posed in these crucial search tasks. The proposed studies aim to improve search performance in cancer screening in two ways: First, by enhancing the visibility of lung nodules embedded in 3D volumetric datasets. Radiologists usually search for lung nodules by scrolling through stacks of chest CT. Nodules are roughly spherical features, spanning a few slices in a CT stack. Anecdotally, experts report that the way that lung nodules 'pop' in and out of the changing view is a signal to their presence. We propose an innovative approach using saliency algorithms that harness this signal to enhance chest CTs in a way that directs attention to crucial regions of a scene. Second, we aim to improve search performance by understanding and utilizing non-selective, 'gist'-like processing of mammograms. Recent work has shown that expert radiologists can detect a global signal in mammograms that allows for above-chance categorization of normal and abnormal breasts after very short exposures to the stimulus. We will first train novices to become experts in closer approximation to the medical tasks. As expertise develops, we will investigate two different neural correlates that might evolve in the course of training using electroencephalography (EEG), namely the P300 and the N2pc. In other settings, these measures can signal attentional selection either across (P300) or within (N2pc) briefly presented images. We will adapt a new method that exploits machine learning for real-time decoding of brain signals. It allows neural signatures, elicited in response to a sequence of images, to be used to rank those images in order of their implicit 'interest' to the viewer. We hypothesize that this information can be fed back to the observer/radiologist as a source of information that might, for example, suggest that an image or region deserves more scrutiny. The main goals of this proposal are therefore to understand the guidance of attention in complex visual search tasks and to apply this knowledge to improvements in clinically relevant search tasks like cancer screening.         PUBLIC HEALTH RELEVANCE: Understanding and enhancing visual search performance in complex scenes Early detection of cancer can save lives, but error rates in cancer screening, both misses and false alarms, are still too high. We propose two ways of aiding cancer screening by radiologists: 1) We will enhance search displays by using saliency algorithms to direct attention to crucial regions of a scene. 2) We will utilize neural signals elicited by non-selective, 'gist'-like processing of medical images as a novel support for evaluation of mammograms.                ",Understanding and enhancing visual search performance in complex scenes,8580179,F32EY022558,"['Algorithms ', ' Attention ', ' Dorsum ', ' Back ', ' vascular ', ' Blood Vessels ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Breast ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cues ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' EEG ', ' Electroencephalography ', ' Evolution ', ' Eyeball ', ' Eye ', ' Eye Movements ', ' Goals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Image Enhancement ', ' Learning ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Mammogram ', ' Mammography ', ' Medical Imaging ', ' Methods ', ' Nodule ', ' pulmonary nodule ', ' Lung nodule ', ' Research ', ' Research Resources ', ' Resources ', ' ROC Analyses ', ' ROC Curve ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' X-Ray Medical Imaging ', ' X-Ray Imaging ', ' Roentgenography ', ' Radiography ', ' Diagnostic X-Ray Radiology ', ' Diagnostic X-Ray ', ' Diagnostic Radiology ', ' Conventional X-Ray ', ' Diagnostic radiologic examination ', ' Measures ', ' Dataset ', ' Data Set ', ' Visualization ', ' Imagery ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Phase ', ' Medical ', ' Evaluation ', ' Training ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Stimulus ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' RDST ', ' radiologist ', ' Breast Cancer Early Screening ', ' Breast Cancer Early Detection ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' Exposure to ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Complex ', ' Event ', ' Source ', ' Pattern ', ' Techniques ', ' interest ', ' directs attention ', ' directed attention ', ' Performance ', ' behavioral measurement ', ' behavioral measure ', ' behavior measurement ', ' neural ', ' relating to nervous system ', ' Stretching ', ' novel ', ' Participant ', ' Reporting ', ' sorting ', ' Sorting - Cell Movement ', ' Position ', ' Positioning Attribute ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' response ', ' visual search ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer therapy ', ' p300 ', ' EP300 ', ' EP300 gene ', ' Address ', ' Data ', ' Detection ', ' Reader ', ' Slice ', ' Process ', ' imaging ', ' Image ', ' feeding ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' clinical relevance ', ' clinically relevant ', ' visual science ', ' vision science ', ' public health relevance ', ' screening ', ' ']",NEI,BRIGHAM AND WOMEN'S HOSPITAL,F32,2014,36508,0.022860113296636522
"Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)    DESCRIPTION (provided by applicant): Preterm birth is associated with bronchopulmonary dysplasia (BPD), a form of chronic lung disease that impacts the pulmonary and overall health of more than 10,000 infants in the US each year. The long-term objective of this Clinical Research Center (CRC) is translation of biochemical, genetic and bioinformatics research into innovative interventions that improve outcomes of extremely preterm infants at risk for long- term pulmonary morbidity. Our proposal focuses specifically on the urea cycle-nitric oxide (UC-NO) and glutathione (GSH) pathways as pivotal and interrelated mechanisms in the response of the developing lung to the extrauterine environment. Overall hypotheses: (1) Biochemical immaturity and functional genetic variation in the UC-NO and GSH pathways modulate the BPD phenotype spectrum; (2) The duration and degree of NO insufficiency and free radical excess predicts BPD severity and correlates with pulmonary morbidity after NICU discharge. To investigate our hypothesis, our CRC will enroll 250 infants with birthweights 510-1250 grams and follow the survivors through 1 year of life. Our hypothesis invokes an immature hepatic and gut synthetic capacity to make citrulline and GSH, functional genetic variations in the UC-NO and GSH pathways, nutritional deficiencies and the physiologic and environmental stress of preterm birth. The resultant NO deficiency and free radical excess alters pulmonary vascular and alveolar development. Our biomarker discovery concept includes (a) collection of plasma, urine, red blood cells, DNA and tracheal aspirates for measurements of NO and GSH precursor sufficiency, production of NO metabolites and GSH, functional genetic variants in these pathways, and biomarkers of in vivo oxidative stress and (b) validation of these biomarkers for diagnosis and long term prognosis of patients with BPD. A bioinformatics approach using machine learning and predictive modeling has been developed for respiratory phenotyping and risk stratification at 36 weeks and 40 weeks postmenstrual age and at 12 months after hospital discharge. Accomplishment of these goals will promote novel clinical trials design to test new therapies to prevent BPD and improve long term pulmonary health of infants born preterm. (End of Abstract)      RELEVANCE: Each year in the US, more than 10,000 premature infants develop bronchopulmonary dysplasia (BPD), a chronic lung disease associated with prolonged and recurrent hospitalizations and lifelong alterations in lung function. This proposal will explore developmental, genetic and environmental interactions and identify biochemical markers to predict BPD development and severity, with the ultimate goal of designing new treatments to prevent BPD and improve long-term lung function in premature infants.              ",Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV),8675906,U01HL101456,"['abstracting ', ' Age ', ' aminoacid ', ' Amino Acids ', ' L-Isomer Arginine ', ' L-Arginine ', ' Arginine ', ' Beds ', ' Blood Reticuloendothelial System ', ' Blood ', ' vascular ', ' Blood Vessels ', ' newborn chronic lung disease ', ' neonatal chronic lung disease ', ' infant chronic lung disease ', ' chronic lung disease in prematurity ', ' chronic lung disease in newborns ', ' chronic lung disease in neonates ', ' chronic lung disease in neonatal infants ', ' chronic lung disease in infants ', ' Bronchopulmonary Dysplasia ', ' Censuses ', ' L-Ornithine, N5-(aminocarbonyl)- ', ' Citrulline ', ' Clinical Study ', ' Clinical Research ', ' L-Cysteine ', ' Half-Cystine ', ' Cysteine ', ' Data Collection ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Environment ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' Erythrocytes ', ' Free Radicals ', ' Genes ', ' Biochemical Genetics ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Glutathione ', ' Goals ', ' Health ', ' L-Isomer Homocysteine ', ' 2-amino-4-mercaptobutyric acid ', ' Homocysteine ', "" Butanoic acid, 4,4'-dithiobis(2-amino)- "", ' Homocystine ', ' Hospitalization ', ' Hospitals ', ' County Hospitals ', "" Children's Hospital "", ' Pediatric Hospitals ', ' Infant ', ' preterm neonate ', ' preterm infant human ', ' preterm infant ', ' preterm baby ', ' premature infant human ', ' premature baby ', ' Premature Infant ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Morbidity ', ' Morbidity - disease rate ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Nitric Oxide ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' 2,5-Diaminopentanoic Acid ', ' Ornithine ', ' Oxides ', ' Patients ', ' Phenotype ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Production ', ' Prognosis ', ' outcome forecast ', ' recruit ', ' Recruitment Activity ', ' Recurrent ', ' Recurrence ', ' Research ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' Risk ', ' Stress ', ' Testing ', ' Time ', ' Translations ', ' Urine Urinary System ', ' Urine ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' Oxidized Glutathione ', ' GSSG ', ' Bis(gamma-Glutamyl-L-cysteinylglycine) Disulfide ', ' Glutathione Disulfide ', ' Measures ', ' Dataset ', ' Data Set ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Premature Birth ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' base ', ' improved ', ' specimen collection ', ' sample collection ', ' Hepatic ', ' Clinical ', ' prematurity ', ' premature ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Infant Health ', ' Biochemical Markers ', ' Survivors ', ' Measurement ', ' Oxidative Stress ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' Research Specimen ', ' Specimen ', ' Aspirate ', ' Aspirate substance ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Severities ', ' LOINC Axis 4 System ', ' System ', ' respiratory ', ' gastrointestinal ', ' developmental genetics ', ' urea cycle ', ' cohort ', ' novel ', ' Study Subject ', ' Categories ', ' Pathogenesis ', ' Chronic lung disease ', ' Admission ', ' Admission activity ', ' Modeling ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Isoprostanes ', ' F2-Isoprostanes ', ' Bio-Informatics ', ' Bioinformatics ', ' preventing ', ' prevent ', ' Alveolar ', ' Data ', ' Predictive Value ', ' Stratification ', ' in vivo ', ' Clinical Data ', ' trial design ', ' Clinical Trials Design ', ' Collection ', ' enroll ', ' Enrollment ', ' Validation ', ' nutritious ', ' Nutritional ', ' Principal Investigator ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' open source ', ' oxidant stress ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' Secure ', ' DNA Repository ', ' ']",NHLBI,ALBERT EINSTEIN COLLEGE OF MEDICINE,U01,2014,530584,0.09218063307322696
"EARLY DETECTION OF LUNG CANCER USING METABOLOMIC LIPID PROFILING     DESCRIPTION (provided by applicant): Our broad long-term goal is to develop a convenient, non-invasive, clinically-used blood biomarker test that can distinguish patients with lung cancer from patients with benign nodules for the early detection of lung cancer.  Lung cancer is often diagnosed at an advanced stage. Detecting lung cancer at earlier stages could reduce mortality rates 10- to 50-fold. The current CT scan approach has difficulty distinguishing benign from malignant pulmonary nodules. Patients are frequently over-diagnosed with poor specificity and require further invasive screening, which adds both to their psychological and to their financial burden. It is urgent to develop new non-invasive methods such as identifying blood molecular biomarkers for early detection of lung cancer.  Our immediate objective for this proposal is to identify blood lipid markers for the early detection of lung cancer. Lipids have numerous critical biological functions which include membrane structure, energy storage, and signal transduction. Lipids have also been implicated as playing roles in several human diseases, including lung cancer. However, studies generally have been focused on total levels of lipids in a class. Because individual species of a lipid class may have different functions, it is essential to measure their compositions. In the proposed study, we will adopt lipidomics technology which aims to quantify a cell's lipidome, identifying and quantifying individual lipid molecular species on a large scale using mass spectrometry. Our preliminary studies with lung and prostate cancer indicate this technology is robust and promising. We have identified a lipid profile difference between non-lung cancer and lung cancer plasma samples. The sensitivity and specificity of distinguishing non-cancer and lung cancer samples are over 90%. Our hypothesis is that lipidomics profiles will be different between lung cancer and non-malignant cancer plasma samples including benign pulmonary lesions and we will be able to define a lipid list as a predictive signature of lung cancer. To test this hypothesis, we propose to: 1) measure the levels of lipid species in human plasma from non-malignant and lung cancer biospecimens. 2) Mine lipid profile data to identify ""lipid markers"" that vary reproducibly between non-malignant samples and lung cancer samples. 3) Validate and test the predictive value of the lipid markers using independent samples.  Lipidomics is a rapidly developing novel technology that has not been applied to lung cancer studies. This work could lead to potentially new clinically used markers for early detection of lung cancer. Our findings may provide information that will lead to the development of novel lipid-related drugs to treat lung cancer. In the long term, linking our data with gene expression and proteomics data in lung cancer will give us a complete view of lipid metabolic pathways and networks, as well as new knowledge about their role in lung cancer development.         PUBLIC HEALTH RELEVANCE: We seek to identify lipid biomarkers in human blood for the early detection of lung cancer using a new technology called lipidomics, which aims to measure all the lipids in a human body. We suppose the composition and amount of lipids in early-stage lung cancer patients are different from non-lung cancer patients. Based on this, we can distinguish cancer from non-cancer samples. Detecting lung cancer at earlier stages could reduce mortality rates 10- to 50-fold. The current CT scan approach has difficulty distinguishing benign from malignant pulmonary nodules. Patients are frequently over- diagnosed with poor specificity and require further invasive screening. Results from the proposed work will be of significant value to public health because we can eventually develop an invasive, accurate test tool to be clinically used for the early detection of lung cancer, which can save thousands of lives.            ",EARLY DETECTION OF LUNG CANCER USING METABOLOMIC LIPID PROFILING,8617255,R21CA164764,"['Malignant Adenoma ', ' Adenocarcinoma ', ' Algorithms ', ' Blood Reticuloendothelial System ', ' Blood ', ' Bronchoscopy ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Squamous Cell Epithelioma ', ' Squamous Carcinoma ', ' Planocellular Carcinoma ', ' Epidermoid Carcinoma ', ' Squamous cell carcinoma ', ' Cells ', ' Systematics ', ' Classification ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Gene Expression ', ' Goals ', ' Granulomatous Lesion ', ' Granuloma ', ' Hamartoma ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lipids ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' Lysophosphatidic Acids ', ' Lysophospholipids ', ' Methods ', ' Mining ', ' Mortality ', ' Mortality Vital Statistics ', ' tumor cell metastasis ', ' cancer metastasis ', ' Tumor Cell Migration ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastasize ', ' Metastasis ', ' Neoplasm Metastasis ', ' Nodule ', ' Patients ', ' Phenotype ', ' Phosphatidylcholines ', ' Choline Phosphoglycerides ', ' Choline Glycerophospholipids ', ' Lecithin ', ' O-(1-beta-acyl-2-acyl-sn-glycero-3-phospho)-ethanolamine ', ' Ethanolamineglycerophospholipids ', ' Ethanolamine Phosphoglycerides ', ' Cephalins ', ' Phosphatidylethanolamine ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Play ', ' Predictive Value of Tests ', ' Public Health ', ' public health medicine (field) ', ' pulmonary nodule ', ' Lung nodule ', ' social role ', ' Role ', ' Sensitivity and Specificity ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Testing ', ' thorax radiography ', ' thoracic radiogram ', ' radiographic lung image ', ' radiographic chest image ', ' lung radiography ', ' chest radiography ', ' chest Xray ', ' chest X ray ', ' CXR ', ' Thoracic Radiography ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Work ', ' Measures ', ' base ', ' improved ', ' Procedures ', ' Benign ', ' Malignant ', ' Malignant - descriptor ', ' psychological ', ' psychologic ', ' Link ', ' Lesion ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Human Figure ', ' Human body ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Biological Function ', ' Biological Process ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' Staging ', ' Inflammatory ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Prostatic Cancer ', ' Prostate Cancer ', ' Prostate CA ', ' Malignant prostatic tumor ', ' Malignant Tumor of the Prostate ', ' Malignant neoplasm of prostate ', ' Knowledge ', ' Adopted ', ' blood lipid ', ' cancer risk ', ' membrane structure ', ' Membrane ', ' cohort ', ' novel ', ' novel technologies ', ' new technology ', ' Reporting ', ' Sampling ', ' Proteomics ', ' Metabolic Pathway ', ' preventing ', ' prevent ', ' metabolism measurement ', ' metabolomics ', ' Non-neoplastic Pulmonary Disease ', ' Non-Neoplastic Pulmonary Disorder ', ' Non-Neoplastic Lung Disorder ', ' Data ', ' Detection ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' Newly Diagnosed ', ' nonmalignant ', ' Non-Malignant ', ' Monitor ', ' Sputum Cytology ', ' Sputum Cytology Screening ', ' Molecular ', ' developmental ', ' Development ', ' mass spectrometer ', ' human disease ', ' tumor ', ' public health relevance ', ' minimally invasive ', ' new marker ', ' novel marker ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' screening ', ' ']",NCI,RUSH UNIVERSITY MEDICAL CENTER,R21,2014,193675,0.2283314265874188
"A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules     DESCRIPTION (provided by applicant): Primarily due to the lack of physical symptoms in the early stage, lung cancer remains the leading cause of cancer deaths in the United States and worldwide. Although high-resolution computed tomography (CT) has been proved to be a sensitive, non-invasive modality for visualizing small lung nodules, which could be the early manifestation of lung cancer, a considerable number of false positive detections are often resulted. Consequently, additional procedures, such as invasive biopsy / follow-up scans, are frequently needed to verify the nature of the indeterminate nodules. The negative effects associated with these over-diagnosis procedures, such as biopsy complications, exposure to additional radiation, patient anxiety, and economic cost, significantly limits the efficacy of CT screening for early diagnosis of lung cancer. In this project, we propose to develop a computer model to quantitatively assess the nature of indeterminate nodules using a longitudinal dataset. Unlike available investigations or lung cancer risk models, we will comprehensively quantify a wide variety of properties (features) of a nodule in an unprecedented detailed manner as well as their variations over time, and synergize them with patient demographic information (e.g., age, gender, smoke history) using machine learning techniques. Not only the image features of lung nodules but also their spatial relationship with respect to important lung landmarks as well as other smoke related lung abnormalities (e.g., emphysema) will be incorporated into this model. The output of this project, namely a novel computer tool, could aid clinicians to more accurately and efficiently assess the nature of indeterminate nodules, ultimately leading to the reduction of unnecessary harm and costs to patients and the healthcare system. All these will significantly improve the efficacy of CT for early lung cancer screening by maintaining its high sensitivity while reducing false positive findings. In terms of commercial potential, the developed tool could be easily integrated with the available image information systems at medical institutions by following the widely adopted Digital Imaging and Communications in Medicine (DICOM) standard.         PUBLIC HEALTH RELEVANCE: This project aims to develop a novel computer tool for aiding in accurate assessment of indeterminate nodules. Its novelty lies in the incorporation of a large variety of image features and patient demographic information using machine learning techniques and a longitudinal dataset. The availability of this tool would significantly improve th efficacy of CT by reducing false positive findings while maintaining its high sensitivity.            ",A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules,9043798,R43CA203058,"['Methods ', ' Mortality ', ' Mortality Vital Statistics ', ' Motivation ', ' Nodule ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' Patients ', ' Pulmonology ', ' Pulmonary Medicine ', ' Pneumonology ', ' Pneumology ', ' Pulmonary Disease (Specialty) ', ' Emphysema ', ' Pulmonary Emphysema ', ' pulmonary nodule ', ' Lung nodule ', ' study design ', ' Study Type ', ' Research Design ', ' Risk ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoke ', ' Testing ', ' thorax incision ', ' chest wall incision ', ' Thoracotomy ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Trees ', ' United States ', ' Work ', ' Gender ', ' Dataset ', ' Data Set ', ' calcification ', ' improved ', ' Procedures ', ' Benign ', ' Malignant ', ' Malignant - descriptor ', ' Phase ', ' Variation ', ' Variant ', ' Medical ', ' Evaluation ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' angiogenesis ', ' Exposure to ', ' Staging ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Adopted ', ' Investigation ', ' Frequency ', ' Frequencies (time pattern) ', ' Scanning ', ' Clinic ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' Outcome Study ', ' interest ', ' cancer risk ', ' computer imaging ', ' digital imaging ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' Structure ', ' novel ', ' economic cost ', ' Categories ', ' Modality ', ' Lobe ', ' ray (radiation) ', ' Radiation ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' Institution ', ' Symptoms ', ' Detection ', ' High Resolution Computed Tomography ', ' Predictive Value ', ' Resolution ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' Smoking History ', ' Validation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' cost ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' airway remodeling ', ' innovative ', ' innovate ', ' innovation ', ' spatial relationship ', ' public health relevance ', ' clinical practice ', ' screening ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' Affect ', ' Age ', ' Anxiety ', ' Biopsy ', ' needle biopsy ', ' Needle biopsy procedure ', ' vascular ', ' Blood Vessels ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communication ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Computers ', ' Confidence Intervals ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Goals ', ' Health Care Systems ', ' Healthcare Systems ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Medicine ', ' ']",NCI,INTERNATIONAL INTELLIGENT INFOR/SOLU/LAB,R43,2015,149970,0.16274381724282755
"Instrument to Co-register EEG and NIRS for Accurate Sleep Sorting DESCRIPTION (provided by applicant):     PROJECT SUMMARY Sleep disorders are highly prevalent and are associated with substantial adverse consequences including motor vehicle and other accidents, impaired cognition, impaired immune function, altered mood, decreased quality of life, and increased mortality. The gold standard test for assessing the physiology of sleep is the polysomnogram suffers from a number of well-recognized limitations. These limitations decrease the capacity of sleep researchers to make advances in understanding sleep and diminish the capacity of clinicians to detect and treat patients suffering from sleep disorders. (PSG). Currently employed PSG technology Our long-term goal is to address the shortcomings of current PSG methodology by developing a low cost, low for automated assessment of sleep physiology. We hypothesize that this would be possible by expanding the types of brain assessments carried out to include near infrared spectroscopy (NIRS) where recent evidence suggests that the low frequency hemodynamic oscillation reflect sleep stage-related changes in brain function. NIRS also simultaneously provides cerebral oxygen saturation, heart rate and breathing rate estimates. In this application, we propose to design, build, and test power, low noise, ultra-miniaturized, wireless system a proof-of-principle prototype system combining diffuse optical spectroscopic, electrophysiological, and inertial . This system will have the form factor of an adhesive bandage which will disturb and limit subjects to a far lesser degree than traditional PSG systems. We will use supervised machine learning-based methods to explore NIRS features specific to sleep stages and clinically relevant events. Other innovations include recording inertial signals and incorporating adaptive signal processing in order to remove artifacts and improve the signal to noise ratio (SNR), and using commercial-off-the-shelf proximity sensor circuitry to support the NIRS front-end. measurement capabilities If successful, this project will lead to improved capacity to carry out sleep research and to detect and treat sleep disorders. The proposed methodology would test whether novel clinically relevant NIRS parameters can be explored enabling further understanding of sleep physiology. The miniaturization, low cost, and low power consumption of our new NIRS-based wireless system would pave the way for rapid adoption and deployment of these bandages for home-use in real-world settings. Given the high prevalence and substantial impairments associated with sleep disorders, this project has the potential to have a major positive impact on public health. PUBLIC HEALTH RELEVANCE:     Project Narrative A review carried out by the Institute of Medicine concluded that 50-70 million people in the United States suffer from a chronic disorder of sleep and wakefulness which diminishes their ability to function, adversely impacts their health, and decreases longevity. Current systems for objectively monitoring sleep physiology and diagnosing sleep disorders suffer from a number of widely-recognized shortcomings that limit the capacity of researchers to make advances in understanding sleep and sleep disorders and diminish the capacity of clinicians to detect and treat patients suffering from these conditions. Our long term goal is to develop a low cost, low power, low noise, ultra-miniaturized, wireless system for automated assessment of sleep physiology which addresses these shortcomings. The specific objective of this proposal is to investigate the capability of a miniaturized, wireless near infrared spectroscopy ( NIRS ) system to achieve this. As such, the proposed project has the potential to improve the lives of the millions of people suffering from sleep disorders.",Instrument to Co-register EEG and NIRS for Accurate Sleep Sorting,8930756,R21NS085818,"['Accidents ', ' Adhesives ', ' Adoption ', ' Algorithms ', ' Apnea ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Breathing ', ' Bandage ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Systematics ', ' Classification ', ' Diagnosis ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' Fingers ', ' Goals ', ' Au element ', ' Gold ', ' Health ', ' Cardiac Chronotropism ', ' Heart Rate ', ' hemodynamics ', ' indexing ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Li+ element ', ' Lithium ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Miniaturisations ', ' Miniaturization ', ' Moods ', ' Mortality ', ' Mortality Vital Statistics ', ' body movement ', ' Movement ', ' Noise ', ' optical ', ' Optics ', ' O2 element ', ' O element ', ' Oxygen ', ' Patients ', ' Physiology ', ' Plethysmography ', ' Polymers ', ' Public Health ', ' public health medicine (field) ', ' Pulse Oximetry ', ' QOL ', ' Quality of life ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Scalp ', ' Scalp structure ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Sleep ', ' Sleep Stages ', ' Technology ', ' Testing ', ' Time ', ' United States ', ' Wakefulness ', ' Weight ', ' Morphologic artifacts ', ' Artifacts ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Polysomnography ', ' Motor Vehicles ', ' base ', ' sensor ', ' improved ', ' Clinical ', ' Diffuse ', ' Physiologic ', ' Physiological ', ' cerebral ', ' Cerebrum ', ' Measurement ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Near-Infrared Spectrometry ', ' NIR Spectroscopy ', ' Near-Infrared Spectroscopy ', ' Head Movements ', ' Hour ', ' Frequency ', ' Frequencies (time pattern) ', ' Event ', ' Home ', ' Home environment ', ' LOINC Axis 4 System ', ' System ', ' Syndrome, Sleep Apnea, Obstructive ', ' Obstructive Sleep Apnea ', ' respiratory ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' meetings ', ' experience ', ' novel ', ' sorting ', ' Sorting - Cell Movement ', ' Position ', ' Positioning Attribute ', ' sleep problem ', ' Sleep Disorders ', ' sleep onset ', ' miniaturize ', ' Insomnia Disorder ', ' Insomnia ', ' Sleeplessness ', ' Skin ', ' Cellular Immune Function ', ' immune function ', ' Address ', ' Data ', ' High Prevalence ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' cost ', ' designing ', ' design ', ' Consumption ', ' innovative ', ' innovate ', ' innovation ', ' Impairment ', ' clinical relevance ', ' clinically relevant ', ' prototype ', ' adverse consequence ', ' adverse outcome ', ' signal processing ', ' ']",NINDS,NORTH CAROLINA STATE UNIVERSITY RALEIGH,R21,2015,148458,0.13297403579109804
"Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer     DESCRIPTION (provided by applicant): Autophagy is a complex intracellular recycling program associated with tumor progression and cancer cell survival. Researchers still lack strategies to effectively target this process, and an understanding of when to apply such strategies. Oncogenic stress, such as that elicited by mutant KRAS, can activate autophagy to promote cancer cell survival. Importantly, KRAS mutations are linked to 40% of lung cancer deaths in the U.S. each year. Therefore, we propose an innovative, multidisciplinary research project that investigates autophagy in connection with KRAS: we will integrate predictive computational modeling and high-quality cell-based measurements to accurately model the autophagic process in KRAS-driven lung cancer. We anticipate that our model will help identify the most effective therapeutic strategies for targeting autophagy in cancer. Specific Aim #1: Validate a mechanistic model of the core autophagy pathway to predict targets for the effective inhibition of autophagy. We have specified a mechanistic model through ""rules"" that capture the key biological processes comprising the autophagy pathway. To validate this model, we measured how the individual steps of autophagy respond to physiological and oncogenic stressors, and systematic RNAi perturbations. Here, we propose to tune the model to align with quantitative data, and test predictions of the rate-limiting steps. This framework will explore the possibility that autophagy is controlled by a bistable switch, an intriguing model-derived hypothesis with therapeutic relevance. As part of this aim, we will identify effective autophagy inhibitors in wildtype and mutant KRAS backgrounds. Specific Aim #2: Model the relationship of autophagy and cell fate to test therapeutic predictions for KRAS-driven lung cancer. The autophagy model will be extended to investigate the relationship between autophagic flux and cell survival and death. For this effort, we will implement an innovative data-driven approach, which involves defining relationships between measured inputs (signaling readouts) and outputs (autophagic flux, survival, and death) in datasets. We will use this model and patient-derived cell lines to predict the therapeutic benefit of inhibiting autophagy in KRAS-driven lung cancer. Our collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer.""         PUBLIC HEALTH RELEVANCE: This collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer.""            ",Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer,8945228,R01CA197398,"['Achievement Attainment ', ' Achievement ', ' inhibitor ', ' inhibitor/antagonist ', ' assault ', ' autophagy ', ' Autophagocytosis ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' necrocytosis ', ' Cell Death ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Viability ', ' Cell Survival ', ' Cells ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Computers ', ' Death ', ' Cessation of life ', ' Digestion ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Engineering ', ' balance function ', ' balance ', ' Equilibrium ', ' Foundations ', ' Goals ', ' Kinetics ', ' Laboratories ', ' Lipids ', ' Monte Carlo simulation ', ' Monte Carlo procedure ', ' Monte Carlo calculation ', ' Monte Carlo algorithm ', ' Monte Carlo Method ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Nuclear Fission ', ' Patients ', ' Phenotype ', ' Physics ', ' Play ', ' gene product ', ' Proteins ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Starvation ', ' Stress ', ' Testing ', ' War ', ' Measures ', ' Mediating ', ' Dataset ', ' Data Set ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' base ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' tumor progression ', ' improved ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Individual ', ' Oxygen Deficiency ', ' Hypoxic ', ' Hypoxia ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Biological Function ', ' Biological Process ', ' Recycling ', ' Therapeutic ', ' Genetic ', ' Staging ', ' Malignant Cell ', ' cancer cell ', ' weapons ', ' Nuclear Weapon ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' cell biology ', ' Cellular biology ', ' Scientist ', ' Complex ', ' Reaction ', ' LOINC Axis 4 System ', ' System ', ' environmental stressor ', ' mutant ', ' stressor ', ' Structure ', ' Nutrient ', ' novel ', ' Second World War ', ' 2nd World War ', ' World War II ', ' model-based simulation ', ' models and simulation ', ' Devices ', ' Modeling ', ' response ', ' drug development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Ally ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog ', ' RASK2 ', ' Oncogene K-Ras ', ' Ki-RAS ', ' KRAS2 ', ' KRAS ', ' K-Ras-2 Oncogene ', ' K-Ras 2A ', ' K-RAS2B ', ' K-RAS2A ', ' C-K-RAS ', ' KRAS2 gene ', ' Address ', ' Data ', ' Molecular Target ', ' Resolution ', ' Cell Kinetics ', ' Cell Cycle Kinetics ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' Output ', ' designing ', ' design ', ' Cancer cell line ', ' innovative ', ' innovate ', ' innovation ', ' Oncogenic ', ' computer algorithm ', ' Computational algorithm ', ' cell behavior ', ' therapeutic target ', ' public health relevance ', ' inhibition of autophagy ', ' ']",NCI,VAN ANDEL RESEARCH INSTITUTE,R01,2015,538056,0.0880336127340645
"Clinical Evaluation of Lung Motion Tracker for Improved Diagnosis and Treatment     DESCRIPTION (provided by applicant): In dynamic image-guided radiotherapy for lung cancer, one of the major tasks is to provide the dynamic images and tumor shapes that reflect the patient's real-time anatomy as the roadmap for guiding the delivery of radiation beams. One fundamental question for these applications is how to estimate such dynamic images, as well location and shape changes of tumor using available sensors to capture the respiratory motion. This proposal focuses on solving such a lung motion tracking problem by using our newly proposed high- dimensional surface to lung motion prediction model and considering the difference of each individuals, such as gender, size, and respiratory pattern. Specifically, we wil optimize the statistical models that capture the motion distribution from training samples and the nonlinear prediction model for accurate lung motion tracking and conduct extensive evaluation for the lung motion tracking system developed to validate its feasibility in clinic practice. Our goal is to develop an efficient, effective and robust lung motion tracking system for dynamic image guidance of the radiotherapy procedures. After this clinical data validation, such a technique can also be applied to image-guided intervention.         PUBLIC HEALTH RELEVANCE: Lung motion tracking is essential for dynamic image-guided radiotherapy for lung cancer. We propose to estimate the dynamic lung motion for patient using the high-dimensional chest surface motion. Due individual variability (patient size, gender, and different respiratory patterns), in this proposal, we will optimize the newly proposed lung motion tracking by considering practical patient variability and evaluate the performance of the proposed system with a large number of dataset collected from radiotherapy planning.            ",Clinical Evaluation of Lung Motion Tracker for Improved Diagnosis and Treatment,8893187,R03EB018977,"['Abdominal ', ' Abdomen ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Algorithms ', ' Anatomical Sciences ', ' Anatomic ', ' Anatomy ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Breathing ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Goals ', ' Image Reconstructions ', ' Articulation ', ' Joints ', ' Least-Squares Analyses ', ' Least Squares ', ' Least-Squares Analysis ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' male ', ' Methods ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Motion ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' optical ', ' Optics ', ' Patients ', ' Radiotherapy ', ' Radiotherapeutics ', ' Radiation therapy ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' respiratory mechanism ', ' Respiration ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Time ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Work ', ' Gender ', ' Dataset ', ' Data Set ', ' base ', ' sensor ', ' improved ', ' Procedures ', ' Left ', ' Surface ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Evaluation ', ' Training ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Shapes ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Clinic ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' Tumor Volume ', ' respiratory ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' novel technologies ', ' new technology ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' ray (radiation) ', ' Radiation ', ' Modeling ', ' Sampling ', ' real time model ', ' Cancer Radiotherapy ', ' cancer radiation therapy ', ' Data ', ' Reproducibility ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' Clinical Data ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Validation ', ' Monitor ', ' imaging ', ' Image ', ' optical imaging ', ' optic imaging ', ' image guided intervention ', ' cancer imaging ', ' imaging Segmentation ', ' open source ', ' tumor ', ' public health relevance ', ' clinical practice ', ' image guided radiation therapy ', ' ']",NIBIB,METHODIST HOSPITAL RESEARCH INSTITUTE,R03,2015,79750,0.1184444103798059
"Autoimmunity as a Mechanism for Atherosclerosis in COPD     DESCRIPTION (provided by applicant): This project will facilitate the development of the principal investigator into an independent translational researcher investigating systemic vascular injury in Chronic obstructive pulmonary disease (COPD). This will be accomplished in the rich academic environment at the University of Pittsburgh, under the guidance of a highly accomplished team of mentors, and in the conduct of multidisciplinary research project that will develop autoimmunity as a novel mechanism for atherosclerosis in COPD. The increased risk of atherosclerosis in COPD is not explained by smoking, age, hypertension, and other established vascular disease risk factors. Chronic inflammation has recently been implicated as an atherogenic mechanism in COPD. We and others have reported that chronic inflammation in COPD may be propagated by humoral autoimmunity. Specifically, smokers with COPD have greatly increased levels of circulating autoantibodies that demonstrate in vitro pathogenic effects. Our subsequent studies also show that these autoantibodies target at least 50 different autoantigens and consistently target glucose regulated protein 78 (GRP78), particularly in patients with parenchymal lung destruction, i.e. emphysema. GRP78 is present in the endoplasmic reticulum, where it regulates the unfolded protein response, and is also a multifunction cell surface receptor. Studies in cancer patients suggest that ligation of the N-terminus of cell surface GRP78 by anti-GRP78 IgG transduces pro-inflammatory and pro-proliferative signals by activation of the AKT pathway, followed by NFB activation. Additional in vivo studies have identified anti-GRP78 IgG with affinity for the C-terminus of cell surface GRP78 that produce counteracting anti-inflammatory effects by suppressing AKT activation. Our preliminary work shows that circulating anti-GRP78 IgG in COPD patients binds to macrophages and leads to increased NFB activation and production of atherogenic inflammatory mediators by them. The macrophage is critical in the development of both atherosclerosis and COPD. Also, cross-sectional studies in our cohort find that levels of circulating anti-GRP78 IgG are strongly associated with carotid atherosclerosis in patients with emphysema, independent of established vascular risk factors. Therefore, we hypothesize that autoimmune responses against GRP78 are a mechanism for atherosclerosis in COPD. During this award, we will: (1) Test the hypothesis that elevated levels of circulating anti-GRP78 IgG predict progression of carotid atherosclerosis in patients with emphysema independent of established risk factors over 4 year follow up; (2) Test the hypothesis that anti-GRP78 IgG binds to the N-terminus of cell surface GRP78 and activates the AKT pathway followed by NFB activation and production of inflammatory mediators using a variety of cell function assays, and provide proof of concept for two potential therapeutic strategies; (3) Test the hypothesis that there are other antigen-specific immune responses associated with atherosclerosis in COPD by using machine learning to analyze high-throughput data on a large number of circulating autoantibody levels.         PUBLIC HEALTH RELEVANCE: Chronic obstructive pulmonary disease (COPD) is a lung disease caused by smoking that kills more and more Americans each year, and is now the third leading cause of death in the US. Although it is largely viewed as a disease of the lungs, the most common cause of death in patients with COPD are blockages in blood vessels. This research project will investigate why patients with COPD are so prone to develop these blood vessel blockages.            ",Autoimmunity as a Mechanism for Atherosclerosis in COPD,8860899,K23HL126912,"['Age ', ' Algorithms ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Anti-Inflammatory Agents ', ' Antibodies ', ' immunogen ', ' ATGN ', ' Antigens ', ' atherosclerotic vascular disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' Self-Antigens ', ' Autologous Antigens ', ' Autoantigens ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Autoimmune Responses ', ' self recognition (immune) ', ' Autoimmune Status ', ' Autoimmunity ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' vascular ', ' Blood Vessels ', ' protein blotting ', ' Western Immunoblotting ', ' Western Blotting ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cause of Death ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Ergastoplasm ', ' Endoplasmic Reticulum ', ' Environment ', ' ELISA ', ' Enzyme-Linked Immunosorbent Assay ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' IgG ', ' 7S Gamma Globulin ', ' Immunoglobulin G ', ' In Vitro ', ' Inflammation ', ' Closure by Ligation ', ' Ligation ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' macrophage ', ' Mentors ', ' Mentorship ', ' Morbidity ', ' Morbidity - disease rate ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Peptides ', ' Phenotype ', ' Protein Phosphorylation ', ' Phosphorylation ', ' Production ', ' gene product ', ' Proteins ', ' Emphysema ', ' Pulmonary Emphysema ', ' Cell Surface Receptors ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoking ', ' Testing ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Universities ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Vascular Diseases ', ' Work ', ' glucose-regulated proteins ', ' Measures ', ' Killings ', ' related to A and C-protein ', ' rac protein kinase ', ' proto-oncogene protein akt ', ' proto-oncogene protein RAC ', ' protein-serine-threonine kinase (rac) ', ' c-akt protein ', ' RAC-PK protein ', ' Protein Kinase B ', ' Akt protein ', ' AKT ', ' Proto-Oncogene Proteins c-akt ', ' Injury ', ' Chronic ', ' Clinical ', ' Link ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' immunoresponse ', ' host response ', ' Immune response ', ' Therapeutic ', ' Therapeutic Agents ', ' Inflammatory ', ' Smoker ', ' Figs ', ' Figs - dietary ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Investigation ', ' Event ', ' Carotid Atheroscleroses ', ' Carotid Atherosclerotic Disease ', ' American ', ' cohort ', ' novel ', ' disease risk ', ' disorder risk ', ' Cell surface ', ' Reporting ', ' carotid plaque ', ' Carotid Artery Plaque ', ' Carotid Artery Plaques ', ' response ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' preventing ', ' prevent ', ' Affinity ', ' Data ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' K-Series Research Career Programs ', ' in vivo ', ' Anti-inflammatory ', ' Cancer Patient ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' in vitro testing ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K23,2015,132192,0.06841134301101671
"Tensor-based Dictionary Learning for Imaging Biomarkers     DESCRIPTION (provided by applicant): As a central concept in systems biomedicine, biomarkers are multi-scale, diverse, and inter-connected indicators of physiological and pathological states and activities. Over the past decade, the research in this area has been active and exciting, including imaging informatics based on imaging biomarkers. In this context, the genome-wide association studies are being performed to establish fundamental links between genotypic and phenotypic biomarkers but a prime challenge is that progress along this direction has been far from what was widely expected. A critical observation is that while data are exploding from genome sequencing and epigenetic analysis, in most cases medical image features are still subjective or only defined in classic fashions, which seems an unreasonable imbalance between genotypic and phenotypic worlds. Lung cancer screening is an emerging CT application and an opportunity to identify imaging biomarkers. Like other cancers, lung cancer is not one but many diseases. It is different in each patient and even in each tumor site with overwhelming nonlinearity and dynamics. It is crystal-clear that comprehensive, adaptive and individualized therapies are needed to win the battle against lung cancer. Being consistent to this big picture, research on sophisticated, instead of simplistic, biomarkers is not only helpful but also necessary in cancer research, and imaging informatics must perform exclusive and intelligent mining through rich in vivo imaging data for biomarkers so that correlative and predictive models could be established. The general hypothesis behind this R21 project is that new phenotypic information can be unlocked in tomographic data to improve sensitivity and specificity significantly in lung cancer CT screening. The overall goal of this project is to develp a tensor-based dictionary learning approach for extraction of CT imaging biomarkers, and optimize a tensor-based locally linear embedding to use these biomarkers for differentiation between CT lung screening results. The major innovation of this project is to synergistically integrate tensor decomposition, dictionary learning, compressive sensing, low-dose reconstruction, machine learning, locally linear embedding, super-computing and big data mining into a brand-new imaging informatics approach, which can be viewed as ""phenome sequencing"" in analog of genome sequencing. Upon the successful completion of this project, the identified imaging biomarkers will have been demonstrated instrumental in reducing the false positive rate significantly for lung CT scans while the false negative rate is kept constant.It will also help accurately stage lung cancers and non-invasively monitor cancer progression and therapeutic response. Equally important is the technical significance of this project. If it is established, a lasting impact will be generated on the field of imaging informatics at large.         PUBLIC HEALTH RELEVANCE: The overall goal of this R21 project is to develop a tensor-based dictionary learning approach for extraction of CT imaging biomarkers, and optimize a tensor-based locally linear embedding to use these biomarkers for differentiation between true/false positive/negative CT lung screening results. Our methodology is highly innovative, and intended to be capable of unprecedented feature mining in big data via super-computing. If it is established, a lasting impact will be generated on the field of imaging informatics at large.           ",Tensor-based Dictionary Learning for Imaging Biomarkers,8968644,R21EB019074,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Chile ', ' clinical investigation ', ' Clinical Trials ', ' Dictionary ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Goals ', ' Grant ', ' Learning ', ' Medical Imaging ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mining ', ' Patients ', ' pilot study ', ' Pilot Projects ', ' Research ', ' Sensitivity and Specificity ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Diagnostic tests ', ' Dataset ', ' Data Set ', ' base ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' tumor progression ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' analog ', ' RDST ', ' radiologist ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' Therapeutic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Frequency ', ' Frequencies (time pattern) ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Speed ', ' Speed (motion) ', ' novel ', ' response ', ' developing computer software ', ' develop software ', ' software development ', ' datamining ', ' data mining ', ' genome sequencing ', ' Dose ', ' Data ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Low-Dose Spiral CT ', ' Screening Result ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' reconstruction ', ' cancer research ', ' anticancer research ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' imaging informatics ', ' innovative ', ' innovate ', ' innovation ', ' clinical applicability ', ' clinical application ', ' tumor ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' phenome ', ' screening ', ' Big Data ', ' in vivo imaging ', ' ']",NIBIB,UNIVERSITY OF MASSACHUSETTS LOWELL,R21,2015,208191,0.10708141898912629
"Molecular, cellular and physiological mechanisms of the mammalian circadian clock DESCRIPTION (provided by applicant): The circadian clock regulates physiology and behavior and impinges on many aspects of our daily life. Nowhere is this more obvious than control of the sleep wake cycle, where clock genes have been shown to play a role in both the timing of sleep and its quality. For example, mutations in PER2 cause familial advanced sleep phase syndrome (FASPS), while mutations in  CSNK1E and CSNK1D cause FASPS and delayed sleep phase syndrome (DSPS),  respectively. However, while we have learned much about the clock and how it regulates sleep, the picture is incomplete. Behavioral studies in mice and studies in human cells show that dozens to hundreds of loci impact circadian clock function. However, only a dozen genes have been investigated for their roles in regulating behavior. Testing dozens to hundreds of mice isn't practical, so a new approach is needed. Here we seek to address this gap with a novel strategy that uses, i) integrative bioinformatics to prioritize putative core clock factors, ii) new experimental methods to determine whether they interact with known clock genes and regulate clock function in several cellular or tissue slice models, and, finally, iii) for a subset of promising candidates, generate mouse models and test them for their roles in regulating circadian behavior and sleep. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans. Our internal biological clocks control many important aspects of our physiology and behavior such as the sleep-wake cycle. Genetics and large-scale genomic studies have implicated the role of a dozen canonical and hundreds of additional new genes in the circadian clock.  However, almost none of the new genes have been studied in animal models for their ability to regulate sleep onset or quality. We will address this gap using bioinformatics, experimental biology, and finally through behavioral analysis. Completion of this research will improve our understanding of circadian rhythms and sleep and may point the way to new therapeutic targets for related disorders in humans.","Molecular, cellular and physiological mechanisms of the mammalian circadian clock",8825538,R01NS054794,"['Behavior ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biological Clocks ', ' Biology ', ' Cells ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Fibroblasts ', ' Genes ', ' Goals ', ' Au element ', ' Gold ', ' Grant ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Literature ', ' luminescence ', ' Memory ', ' Methods ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Rhythmicity ', ' Cyclicity ', ' Periodicity ', ' Phenotype ', ' Physiology ', ' Play ', ' Probability ', ' Research ', ' social role ', ' Role ', ' Sleep ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Work ', ' Generations ', ' Mutagenesis Molecular Biology ', ' Genetics-Mutagenesis ', ' Mutagenesis ', ' Dataset ', ' Data Set ', ' improved ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Neurological ', ' Neurologic ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Adipocytes ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' mental ', ' Psyche structure ', ' Genetic ', ' gene function ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Delayed Sleep Phase Syndrome ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' mutant ', ' neurogenetics ', ' Performance ', ' neural network ', ' Biological Neural Networks ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' Informatics ', ' novel ', ' behavioral test ', ' behavior test ', ' Advanced Sleep Phase Syndrome (ASPS) ', ' Advanced Sleep Phase Syndrome ', ' intervention therapy ', ' Therapeutic Intervention ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Sleep Wake Cycle ', ' sleep onset ', ' Proteomics ', ' Genomics ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' Bio-Informatics ', ' Bioinformatics ', ' knockout animal ', ' Ortholog ', ' Orthologous Gene ', ' Address ', ' Defect ', ' Animal Testing ', ' Data ', ' Mammalian Cell ', ' Quantitative Genetics ', ' Neurosciences Research ', ' Slice ', ' Molecular ', ' Behavioral ', ' Flies ', ' fly ', ' imaging ', ' Image ', ' Behavioral Assay ', ' data integration ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' circadian clock ', ' circadian pacemaker ', ' Cellular model ', ' Cell model ', ' mouse model ', ' therapeutic target ', ' discover genes ', ' gene discovery ', ' novel therapeutic target ', ' new therapeutic target ', ' evidence base ', ' screening ', ' ']",NINDS,UNIVERSITY OF PENNSYLVANIA,R01,2015,557700,0.09251717179460534
"The Role of the Microbiome in the Acute Respiratory Distress Syndrome     DESCRIPTION (provided by applicant): This K23 proposal will complete Robert Dickson, MD's training towards his long-term career goal of improving our understanding and treatment of lung disease by investigation of the microbiome. Dr. Dickson is a Pulmonary and Critical Care physician and scientist at the University of Michigan with established success in the burgeoning field of lung microbiome studies. This proposal builds on Dr. Dickson's previously acquired expertise in pulmonary pathophysiology and microbial ecology with new training in clinical research methods and computational biology. These established and newly-acquired skills will be integrated to improve our understanding of the role of the microbiome in the pathogenesis of the Acute Respiratory Distress Syndrome (ARDS). This research will be conducted under the guidance of primary mentor Gary B. Huffnagle PhD, co- mentor Theodore J. Standiford MD and an advisory board of accomplished investigators with expertise in clinical research methods, computational biology and lung immunology as well as extensive mentoring success. This 5-year plan includes formal coursework, professional development, and progressively independent research, with defined milestones to ensure productivity and a successful transition to independence. The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year. Numerous studies have identified indirect evidence of translocation of bacteria from the gastrointestinal tract to the lung in patients at risk for ARDS, but to date no study has evaluated the role of microbiome in the pathogenesis of ARDS. This proposal will test the hypothesis that translocation of gut bacteria to the lung provokes the inflammation and injury of ARDS via two specific Scientific Aims. Aim 1 will determine if translocation of enteric bacteria to the lung microbiome precedes the clinical development of ARDS, and Aim 2 will determine the temporal relationship between respiratory dysbiosis, host inflammation and the clinical onset of ARDS. Inherent to completing these high-level aims, Dr. Dickson will execute a prospective cohort study of patients at high risk for ARDS, utilize modern culture-independent techniques of bacterial identification to describe the bacterial communities in the lungs and gastrointestinal tracts of high-risk patients, and apply novel techniques of advanced computational modeling to the complex nonlinear system of ARDS pathogenesis. This work will build to at least two R01 proposals: 1) to determine if the lung microbiome contributes to disease progression among patients with established ARDS and 2) to determine if the lung microbiome can be therapeutically manipulated in critically ill patients to prevent or modulate respiratory disease. n addition to building a foundation for a programmatic line of research to understand the role of the microbiome in lung disease, this proposal will provide Dr. Dickson with research skills applicable to additional domains of human microbiome and ARDS research. This K23 award will equip Dr. Dickson to establish himself as an independent investigator and international leader in this promising field.         PUBLIC HEALTH RELEVANCE: The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year; the National Institutes of Health have identified the prevention and early treatment of ARDS as a research priority. We lack an understanding of the pathogenesis of ARDS, impeding our ability to predict and prevent its onset. Determination of the role of the microbiome in the pathogenesis of ARDS would both 1) improve our ability to predict the onset of ARDS, enabling targeted preventive interventions and 2) identify novel therapeutic targets at the microbiome/host interface in patients at risk for ARDS.        ",The Role of the Microbiome in the Acute Respiratory Distress Syndrome,9013900,K23HL130641,"['Bacteria ', ' Sympathins ', ' Catecholamines ', ' Cell Body ', ' Cells ', ' Clinical Study ', ' Clinical Research ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' Complement Proteins ', ' Complement ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Critical Care ', ' Critically Ill ', ' Critical Illness ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Environmental Science ', ' Ecology ', ' Aerobacter ', ' Enterobacter ', ' Enterobacteria ', ' Enteric Bacteria ', ' Coliform Bacilli ', ' Enterobacteriaceae ', ' Therapeutic Epinephrine ', ' Adrenaline ', ' Epinephrine ', ' Foundations ', ' Future ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Gastrointestinal tract structure ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Immigrations ', ' In-Migration ', ' indexing ', ' Inflammation ', ' Preinterleukin 1 Beta ', ' Interleukin-1 ', ' Interleukin 1beta ', ' IL1 ', ' IL1F2 ', ' IL1B Protein ', ' IL1- ', ' IL1-Beta ', ' IL-1 ', ' IL-1-b ', ' IL-1  ', ' IL-1 beta ', ' Beta Proprotein Interleukin 1 ', ' Interleukin-1 beta ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Mentors ', ' Michigan ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Polymorphonuclear Neutrophils ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Cell ', ' Polymorph ', ' Neutrophilic Leukocyte ', ' Neutrophilic Granulocyte ', ' Marrow Neutrophil ', ' Heterophil Granulocyte ', ' Blood Segmented Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Blood Neutrophil ', ' neutrophil ', ' Noradrenaline ', ' Levonorepinephrine ', ' Levarterenol ', ' Norepinephrine ', ' Patients ', ' Physicians ', ' Productivity ', ' Prognosis ', ' outcome forecast ', ' Flavimonas ', ' Chrysemonas ', ' Pseudomonas ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' wet lung ', ' Stiff lung ', ' Shock Lung ', ' Da Nang Lung ', ' Adult RDS ', ' Acute Respiratory Distress Syndrome ', ' ARDS ', ' Adult Respiratory Distress Syndrome ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Testing ', ' Universities ', ' Work ', ' cytokine ', ' Research Methodology ', ' Research Methods ', ' Immunology ', ' Injury ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Logistic Regressions ', ' Nonlinear Models ', ' Non-linear Models ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Development Plans ', ' Disease Progression ', ' inflammatory mediator ', ' Inflammation Mediators ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Inflammatory ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Research Priority ', ' computer biology ', ' Computational Biology ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Complex ', ' Techniques ', ' System ', ' respiratory ', ' gastrointestinal ', ' success ', ' microbial ', ' skills ', ' novel ', ' member ', ' Prevention ', ' Pathogenesis ', ' -Proteobacteria ', ' gamma Proteobacteria ', ' Gammaproteobacteria ', ' Tumor Necrosis Factor-alpha ', ' Tumor Necrosis Factor ', ' TNF ', ' TNFA ', ' TNF- ', ' TNF Alpha ', ' TNF A ', ' TNF ', ' Monocyte-Derived TNF ', ' Macrophage-Derived TNF ', ' Cachectin ', ' TNF gene ', ' Modeling ', ' Sampling ', ' career development ', ' preventing ', ' prevent ', ' Enteric ', ' Enteral ', ' Alveolar ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' International ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' Mentored Patient-Oriented Research Career Development Award ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' Clinical Data ', ' developmental ', ' Development ', ' microbiome ', ' Human Microbiome ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' bloodstream infection ', ' Sepsis ', ' prospective ', ' Trauma ', ' Early treatment ', ' early therapy ', ' patient oriented ', ' patient centered ', ' high risk ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new drug target ', ' public health relevance ', ' gut microbiota ', ' intestinal tract microflora ', ' intestinal microbiota ', ' gut microflora ', ' gut microbiotic ', ' clinical risk ', ' microbiota ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K23,2016,171176,0.11607683332915562
"Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting     DESCRIPTION (provided by applicant): Disrupted circadian timing has emerged as a serious health and safety issue, yet there are no objective means of easily assessing circadian timing or alignment without performing a highly controlled, multiple-day in- patient study. Altered circadian timing can cause both sleep loss and sleepiness, cause performance errors such as motor vehicle accidents, and impair memory/learning. Thus, despite the obvious need to recognize an individual's circadian phase/alignment, we cannot assess circadian timing clinically or in retrospective studies. Not surprisingly, the first goal of the 2011 NIH Sleep Disorders Research Plan is to identify: ""...metabolic... biomarkers of sleep deficiency and biological timing...and circadian disorders that will facilitate personalized treatments, and clarify the risk associated with untreated sleep and circadian disorders and disturbances."" We are aware that major challenges face biomarker development, including multi-factorial causes of metabolite shifts normally controlled across multiple time-points. Because circadian time is associated with profound metabolic, immune and cardiovascular changes, however, we hypothesize that a biomarker signature for circadian phase derived from -omic markers can be obtained from a single blood sample. We therefore propose to utilize the analytical and bioinformatics platforms and experience in population-level metabolomics studies in the PIs lab to study banked plasma samples from the well-characterized individuals in six tightly controlled circadian rhythm studies run by the four co-investigators.The Aims are:  Aim 1: To identify, to optimize, to validate, and t cross-validate a set of nested plasma lipidomics-  based biomarker profiles that report circadian phase and alignment using well-characterized samples drawn from three constant routine protocols Aim 2: To identify, to optimize, to validate, and to cross-validate a set of nested plasma lipidomics based biomarker profiles that report circadian phase and alignment using well-characterized samples  drawn from four forced desynchrony protocols  Aim 3: To systematically evaluate the validated profiles from Aims 1 and 2 and their mathematical  similarities and differences so as to improve accuracy and precision of the biomarkers  Aim 4: To test the markers identified above under poorly controlled real world applications Identification of biomarker panels will impact multiple aspects of science and health: (i) contribute to clinical recognition and treatment on circadian disorders; (ii) advance personalized medicine through individualized treatment timing to enhance efficacy/reduce side effects of medications (e.g., chemotherapy); (iii) creating epidemiologic tools to relate circadian with disease risk; and aiding development of other disease biomarkers, and; (iv) contribute to research on circadian biology and its implications for human health.         PUBLIC HEALTH RELEVANCE: We propose to identify blood-based markers that can inform a clinician or researcher about an individual's internal biological clock. At the broad levels of society and public health research, the work has the potential direct benefit of identifying individuals with ""off-set"" clocks (enabling diagnosis and potential therapy), increasing accuracy and precision of studies of blood lipids, facilitating understanding of certain sleep disorders, increasing understanding of the role of biological clocks in chronic disease processes (e.g., cancer, diabetes, cardiovascular disease), and potentially improving the administration of certain pharmaceuticals, eg, chemotherapy agents.        ","Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting",9083622,R01HL132556,"['Age ', ' Algorithms ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biological Clocks ', ' Biology ', ' Avian ', ' Aves ', ' Birds ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' facial ', ' faces ', ' Face ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Inpatients ', ' Learning ', ' Memory ', "" men's "", ' men ', ' Methods ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retrospective Studies ', ' Risk ', ' social role ', ' Role ', ' Running ', ' Safety ', ' Sleep ', ' Smoking ', ' Societies ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Testing ', ' Time ', ' Work ', ' Gender ', ' Generations ', ' base ', ' human population study ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Clinical ', ' Phase ', ' Biological ', ' Link ', ' Individual ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Metabolic ', ' Owls ', ' Strigiformes ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Hour ', ' Immune ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' meetings ', ' blood lipid ', ' experience ', ' Performance ', ' disease risk ', ' disorder risk ', ' motor vehicle accident ', ' Motor carrier accident ', ' vehicular accident ', ' Reporting ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Sampling ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' Bio-Informatics ', ' Bioinformatics ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Data ', ' Health Sciences ', ' Resolution ', ' Pattern Recognition ', ' Process ', ' developmental ', ' Development ', ' Population ', ' older women ', ' combinatorial ', ' chemotherapy ', ' real world application ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' public health research ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' biomarker development ', ' biomarker panel ', ' marker panel ', ' blood-based biomarker ', ' blood-based marker ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,R01,2016,848973,0.0718518910897693
"Clinical Evaluation of Lung Motion Tracker for Improved Diagnosis and Treatment     DESCRIPTION (provided by applicant): In dynamic image-guided radiotherapy for lung cancer, one of the major tasks is to provide the dynamic images and tumor shapes that reflect the patient's real-time anatomy as the roadmap for guiding the delivery of radiation beams. One fundamental question for these applications is how to estimate such dynamic images, as well location and shape changes of tumor using available sensors to capture the respiratory motion. This proposal focuses on solving such a lung motion tracking problem by using our newly proposed high- dimensional surface to lung motion prediction model and considering the difference of each individuals, such as gender, size, and respiratory pattern. Specifically, we wil optimize the statistical models that capture the motion distribution from training samples and the nonlinear prediction model for accurate lung motion tracking and conduct extensive evaluation for the lung motion tracking system developed to validate its feasibility in clinic practice. Our goal is to develop an efficient, effective and robust lung motion tracking system for dynamic image guidance of the radiotherapy procedures. After this clinical data validation, such a technique can also be applied to image-guided intervention. PUBLIC HEALTH RELEVANCE: Lung motion tracking is essential for dynamic image-guided radiotherapy for lung cancer. We propose to estimate the dynamic lung motion for patient using the high-dimensional chest surface motion. Due individual variability (patient size, gender, and different respiratory patterns), in this proposal, we will optimize the newly proposed lung motion tracking by considering practical patient variability and evaluate the performance of the proposed system with a large number of dataset collected from radiotherapy planning.",Clinical Evaluation of Lung Motion Tracker for Improved Diagnosis and Treatment,9050674,R03EB018977,"['image-guided radiotherapy ', ' image guided radiation treatment ', ' IGRT ', ' image guided ', ' image guidance ', ' imaging biomarker ', ' imaging marker ', ' dynamic system ', ' dynamical system ', ' individual patient ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' Abdominal ', ' Abdomen ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Algorithms ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Breathing ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Goals ', ' Health ', ' image construction ', ' Image Reconstructions ', ' Articulation ', ' Joints ', ' Least-Squares Analyses ', ' Least Squares ', ' Least-Squares Analysis ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' male ', ' Methods ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Motion ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' optical ', ' Optics ', ' Patients ', ' treatment with radiation ', ' radio-therapy ', ' radiation treatment ', ' Radiotherapy ', ' Radiotherapeutics ', ' Radiation therapy ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' respiratory mechanism ', ' Respiration ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Time ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Work ', ' Gender ', ' Data Set ', ' Dataset ', ' base ', ' sensor ', ' improved ', ' Procedures ', ' Left ', ' Surface ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Evaluation ', ' Training ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Shapes ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Clinic ', ' Pattern ', ' Techniques ', ' System ', ' Location ', ' Tumor Volume ', ' respiratory ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' novel technologies ', ' new technology ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' Radiation ', ' Modeling ', ' Sampling ', ' real time model ', ' Cancer Radiotherapy ', ' cancer radiation therapy ', ' Data ', ' Reproducibility ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' Clinical Data ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Validation ', ' Monitor ', ' imaging ', ' Image ', ' optical imaging ', ' optic imaging ', ' image guided intervention ', ' cancer imaging ', ' tumor imaging ', ' imaging Segmentation ', ' open source ', ' tumor ', ' clinical practice ', ' image guided radiation therapy ', ' ']",NIBIB,METHODIST HOSPITAL RESEARCH INSTITUTE,R03,2016,79750,0.1184444103798059
"Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)     DESCRIPTION (provided by applicant): It is estimated that neurodegenerative diseases causing dementia will surpass cancer as the leading cause of death by the year 2040. Alzheimer's disease (AD) is the leading cause of dementia, followed by synucleinopathies, such as dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). Among clinical researchers focused on investigating the varying etiologies, genetic associations, biomarkers, and treatment options for these neurodengenerative diseases, there is an urgent need for effective tools to aid in the classification of dementia subtypes, in the earliest detectable stages of the pathophysiological process. To address this unmet need Advanced Brain Monitoring (ABM) proposes to leverage two previously developed technologies to create an Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS). The core components of the INSPECDS platform will be a previously developed Alertness and Memory Profiler (AMP), a recently developed Sleep Profiler, and integrated machine-learning, classification algorithms, hosted on a secure, cloud-based, infrastructure for automated data processing, analysis, and reporting. The AMP was developed and validated during a previous NIH-funded SBIR Phase I/II project for the purpose of detecting the neurocognitive effects of sleep deprivation in adults diagnosed with obstructive sleep apnea. The AMP is truly unique among neurocognitive testing platforms in that it is the only one which integrates advanced, electrophysiological measures (e.g., 24-channel, wireless EEG and ECG) during the performance of computerized neurocognitive tasks. This advanced capability permits researchers to explore real-time relations between fluctuations in alertness, discrete cognitive functions, and specific neural processes believed to subserve observed performance deficits. The Sleep Profiler is an FDA-cleared, easily applied, wireless-EEG device that was developed and validated to measure sleep architecture for in-home sleep studies. With integrated measures of submental (chin) EMG and wireless accelerometers to monitor head and limb movements, the Sleep Profiler is an ideal device for quantifying the characteristics of REM-sleep behavior disorder (RBD), which is considered to be a prodromal expression of synucleinopathy. Furthermore, the application of sophisticated, machine-learning, classification algorithms will streamline the processing and analyses of these data to derive statistical probabilities of various dementia subtypes. The overarching goal of the current, Direct-to-Phase II, SBIR project is to develop a secure, cloud-based infrastructure to compile the data obtained from the AMP and Sleep Profiler, train classification algorithms to discriminate among dementia subtypes, validate diagnostic accuracy, and integrate optimized classifiers within the cloud-based architecture. Once completed, the INSPECDS system will be the first clinical research tool of its kind and find immediate application in both university-based research settings and pharmaceutical industry clinical trials to aid in the endophenotypic stratification of research participants.         PUBLIC HEALTH RELEVANCE: Among clinical researchers focused on investigating the varying etiologies, genetic associations, clinical course, and treatment options for neurodengenerative diseases, there is an urgent need for effective tools to aid in the classification of dementia subtypes, in the earliest detectable stages of the pathophysiological process. To address this unmet need, Advanced Brain Monitoring (Carlsbad, CA) is developing Integrated Neurocognitive and Sleep-Behavior Profilers for the Endophenotypic Classification of Dementia Subtypes (INSPECDS), which will provide an inexpensive, non-invasive solution combining neurocognitive, electrophysiological (EEG, ECG, EMG), and sleep-behavior assessment into a single, integrated system featuring automated scoring and classification algorithms. Once completed, the INSPECDS system will be the first clinical research tool of its kind and find immediate application in university-based research settings and pharmaceutical industry clinical trials to aid in the endophenotypic stratification of research participants.                ",Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS),9046620,R44AG050326,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Engineering / Architecture ', ' Architecture ', ' automated data processing ', ' Electronic Data Processing ', ' Computer Data Processing ', ' Automatic Data Processing ', ' Behavior ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' California ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cause of Death ', ' Mentum ', ' Chin ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Drug Industry ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' electrophysiological ', ' Neurophysiology / Electrophysiology ', ' Electrophysiology ', ' Electrophysiology (science) ', ' Goals ', ' General Hospitals ', ' Massachusetts ', ' Memory ', ' Minor ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Neuropsychologic Tests ', ' Neuropsychological Tests ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Parkinson Disease ', ' Patients ', ' Probability ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Sleep ', ' Sleep Deprivation ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Technology ', ' Time ', ' Universities ', ' Measures ', ' Blinded ', ' base ', ' human subject ', ' Clinical ', ' Phase ', ' Training ', ' Individual ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Disease Progression ', ' Funding ', ' Staging ', ' tool ', ' sadness ', ' depressed ', ' Depressed mood ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Head Movements ', ' cognitive function ', ' Home ', ' Home environment ', ' Clinic ', ' System ', ' Amentia ', ' Dementia ', ' Neurocognitive ', ' Syndrome, Sleep Apnea, Obstructive ', ' Obstructive Sleep Apnea ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neuro-degenerative Disorders ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Neurodegenerative Disorders ', ' limb movement ', ' Performance ', ' Accuracy of Diagnosis ', ' diagnostic accuracy ', ' cohort ', ' neural ', ' relating to nervous system ', ' Participant ', ' Devices ', ' Reporting ', ' Rapid Eye Movement Sleep Behavior Disorder ', ' Rapid Eye Movement Behavior Disorder ', ' REM Behavior Disorder ', ' REM Sleep Behavior Disorder ', ' Sampling ', ' neurocognitive test ', ' behavioral assessment ', ' Behavior assessment ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Address ', ' alertness ', ' Data ', ' Economic Burden ', ' Infrastructure ', ' Research Infrastructure ', ' Stratification ', ' enroll ', ' Enrollment ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Characteristics ', ' Process ', ' Modification ', ' computerized ', ' Sleep Architecture ', "" parkinson's disease dementia "", ' dementia in Parkinson disease ', ' dementia in PD ', "" Parkinson's disease with dementia "", ' PD with dementia ', "" Parkinson's Dementia "", ' data acquisition ', ' brain behavior ', ' synucleinopathy ', ' public health relevance ', ' FDA approved ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Secure ', ' mild cognitive impairment ', ' mild cognitive disorder ', ' Lewy Body Dementia ', ' Lewy Body Type Senile Dementia ', ' Dementia with Lewy Bodies ', ' cloud based ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' ']",NIA,"ADVANCED BRAIN MONITORING, INC.",R44,2016,664813,-0.005408286358404966
"Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer     DESCRIPTION (provided by applicant): Autophagy is a complex intracellular recycling program associated with tumor progression and cancer cell survival. Researchers still lack strategies to effectively target this process, and an understanding of when to apply such strategies. Oncogenic stress, such as that elicited by mutant KRAS, can activate autophagy to promote cancer cell survival. Importantly, KRAS mutations are linked to 40% of lung cancer deaths in the U.S. each year. Therefore, we propose an innovative, multidisciplinary research project that investigates autophagy in connection with KRAS: we will integrate predictive computational modeling and high-quality cell-based measurements to accurately model the autophagic process in KRAS-driven lung cancer. We anticipate that our model will help identify the most effective therapeutic strategies for targeting autophagy in cancer. Specific Aim #1: Validate a mechanistic model of the core autophagy pathway to predict targets for the effective inhibition of autophagy. We have specified a mechanistic model through ""rules"" that capture the key biological processes comprising the autophagy pathway. To validate this model, we measured how the individual steps of autophagy respond to physiological and oncogenic stressors, and systematic RNAi perturbations. Here, we propose to tune the model to align with quantitative data, and test predictions of the rate-limiting steps. This framework will explore the possibility that autophagy is controlled by a bistable switch, an intriguing model-derived hypothesis with therapeutic relevance. As part of this aim, we will identify effective autophagy inhibitors in wildtype and mutant KRAS backgrounds. Specific Aim #2: Model the relationship of autophagy and cell fate to test therapeutic predictions for KRAS-driven lung cancer. The autophagy model will be extended to investigate the relationship between autophagic flux and cell survival and death. For this effort, we will implement an innovative data-driven approach, which involves defining relationships between measured inputs (signaling readouts) and outputs (autophagic flux, survival, and death) in datasets. We will use this model and patient-derived cell lines to predict the therapeutic benefit of inhibiting autophagy in KRAS-driven lung cancer. Our collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer."" PUBLIC HEALTH RELEVANCE: This collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer.""",Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer,9139424,R01CA197398,"['Achievement Attainment ', ' Achievement ', ' inhibitor ', ' inhibitor/antagonist ', ' assault ', ' autophagy ', ' Autophagocytosis ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' necrocytosis ', ' Cell Death ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Viability ', ' Cell Survival ', ' Cell Body ', ' Cells ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Computers ', ' Death ', ' Cessation of life ', ' Digestion ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Engineering ', ' balance function ', ' balance ', ' Equilibrium ', ' Foundations ', ' Goals ', ' Health ', ' Kinetics ', ' Laboratories ', ' Lipids ', ' Monte Carlo simulation ', ' Monte Carlo procedure ', ' Monte Carlo calculation ', ' Monte Carlo algorithm ', ' Monte Carlo Method ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Nuclear Fission ', ' Patients ', ' Phenotype ', ' Physics ', ' Play ', ' Proteins ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Starvation ', ' Stress ', ' Testing ', ' War ', ' Measures ', ' Mediating ', ' Data Set ', ' Dataset ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' base ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' tumor progression ', ' improved ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Individual ', ' Oxygen Deficiency ', ' Hypoxic ', ' Hypoxia ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Biological Function ', ' Biological Process ', ' Recycling ', ' Therapeutic ', ' Genetic ', ' Staging ', ' Malignant Cell ', ' cancer cell ', ' weapons ', ' Nuclear Weapon ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' cell biology ', ' Cellular biology ', ' Scientist ', ' Complex ', ' Reaction ', ' System ', ' environmental stressor ', ' mutant ', ' stressor ', ' Structure ', ' Nutrient ', ' novel ', ' Second World War ', ' 2nd World War ', ' World War II ', ' model-based simulation ', ' models and simulation ', ' Devices ', ' Modeling ', ' response ', ' drug development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Ally ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog ', ' RASK2 ', ' Oncogene K-Ras ', ' Ki-RAS ', ' KRAS2 ', ' KRAS ', ' K-Ras-2 Oncogene ', ' K-Ras 2A ', ' K-Ras ', ' K-RAS2B ', ' K-RAS2A ', ' C-K-RAS ', ' KRAS2 gene ', ' Address ', ' Data ', ' Molecular Target ', ' Resolution ', ' Cell Kinetics ', ' Cell Cycle Kinetics ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' Output ', ' designing ', ' design ', ' Cancer cell line ', ' innovation ', ' innovative ', ' innovate ', ' Oncogenic ', ' Computational algorithm ', ' computer algorithm ', ' cell behavior ', ' therapeutic target ', ' inhibition of autophagy ', ' ']",NCI,VAN ANDEL RESEARCH INSTITUTE,R01,2016,515556,0.0880336127340645
"Tensor-based Dictionary Learning for Imaging Biomarkers     DESCRIPTION (provided by applicant): As a central concept in systems biomedicine, biomarkers are multi-scale, diverse, and inter-connected indicators of physiological and pathological states and activities. Over the past decade, the research in this area has been active and exciting, including imaging informatics based on imaging biomarkers. In this context, the genome-wide association studies are being performed to establish fundamental links between genotypic and phenotypic biomarkers but a prime challenge is that progress along this direction has been far from what was widely expected. A critical observation is that while data are exploding from genome sequencing and epigenetic analysis, in most cases medical image features are still subjective or only defined in classic fashions, which seems an unreasonable imbalance between genotypic and phenotypic worlds. Lung cancer screening is an emerging CT application and an opportunity to identify imaging biomarkers. Like other cancers, lung cancer is not one but many diseases. It is different in each patient and even in each tumor site with overwhelming nonlinearity and dynamics. It is crystal-clear that comprehensive, adaptive and individualized therapies are needed to win the battle against lung cancer. Being consistent to this big picture, research on sophisticated, instead of simplistic, biomarkers is not only helpful but also necessary in cancer research, and imaging informatics must perform exclusive and intelligent mining through rich in vivo imaging data for biomarkers so that correlative and predictive models could be established. The general hypothesis behind this R21 project is that new phenotypic information can be unlocked in tomographic data to improve sensitivity and specificity significantly in lung cancer CT screening. The overall goal of this project is to develp a tensor-based dictionary learning approach for extraction of CT imaging biomarkers, and optimize a tensor-based locally linear embedding to use these biomarkers for differentiation between CT lung screening results. The major innovation of this project is to synergistically integrate tensor decomposition, dictionary learning, compressive sensing, low-dose reconstruction, machine learning, locally linear embedding, super-computing and big data mining into a brand-new imaging informatics approach, which can be viewed as ""phenome sequencing"" in analog of genome sequencing. Upon the successful completion of this project, the identified imaging biomarkers will have been demonstrated instrumental in reducing the false positive rate significantly for lung CT scans while the false negative rate is kept constant.It will also help accurately stage lung cancers and non-invasively monitor cancer progression and therapeutic response. Equally important is the technical significance of this project. If it is established, a lasting impact will be generated on the field of imaging informatics at large. PUBLIC HEALTH RELEVANCE: The overall goal of this R21 project is to develop a tensor-based dictionary learning approach for extraction of CT imaging biomarkers, and optimize a tensor-based locally linear embedding to use these biomarkers for differentiation between true/false positive/negative CT lung screening results. Our methodology is highly innovative, and intended to be capable of unprecedented feature mining in big data via super-computing. If it is established, a lasting impact will be generated on the field of imaging informatics at large.",Tensor-based Dictionary Learning for Imaging Biomarkers,9143765,R21EB019074,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Chile ', ' Clinical Trials ', ' Dictionary ', ' Disorder ', ' Disease ', ' Goals ', ' Grant ', ' Health ', ' Learning ', ' Medical Imaging ', ' Methods ', ' Methodology ', ' Mining ', ' Patients ', ' pilot study ', ' Pilot Projects ', ' Research ', ' Sensitivity and Specificity ', ' Software ', ' Computer software ', ' Testing ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Diagnostic tests ', ' Data Set ', ' Dataset ', ' base ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' tumor progression ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' analog ', ' RDST ', ' radiologist ', ' lung cancer early detection ', ' Lung Cancer screening ', ' Screening for Lung Cancer ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Frequencies ', ' Techniques ', ' System ', ' Speed ', ' novel ', ' developing computer software ', ' develop software ', ' software development ', ' datamining ', ' data mining ', ' genome sequencing ', ' Dose ', ' Data ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Low dose CT ', ' Low-Dose Spiral CT ', ' Screening Result ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' reconstruction ', ' cancer research ', ' anticancer research ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' imaging informatics ', ' innovation ', ' innovative ', ' innovate ', ' clinical application ', ' clinical applicability ', ' tumor ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' phenome ', ' screening ', ' Big Data ', ' BigData ', ' in vivo imaging ', ' Lung CAT Scan ', ' Lung CT scan ', ' Lung CT ', ' CT Lung Screening ', ' imaging biomarker ', ' imaging marker ', ' learning strategy ', ' learning method ', ' learning activity ', ' phenotypic biomarker ', ' phenotypic marker ', ' ']",NIBIB,UNIVERSITY OF MASSACHUSETTS LOWELL,R21,2016,233224,0.10708141898912629
"Dose-distribution radiomics to predict morbidity risk in radiotherapy     DESCRIPTION (provided by applicant):  Lung cancer remains the leading cause of cancer deaths in the U.S., and definitive radiotherapy is the standard of care for locally advanced, inoperable cases. Radiation therapy is also highly flexible, and can be adapted for variations in tumor volume and location. However, decision support models to optimize treatment planning and avoid morbidity on a patient-by-patient basis are lacking. Recently, the randomized phase III trial, RTOG 0617, compared high dose (74 Gy) treatments to standard (60 Gy) treatments for non-small cell lung cancer (NSCLC), and demonstrated an unexpectedly higher rate of mortality in the high-dose arm. We hypothesize that this was primarily due to heart irradiation, in combination with lung irradiation factors. The goal of this project is to determine and validate predictive models of morbidity following thoracic RT, in order to achieve safer and more optimal tradeoffs between local control and morbidity. We will jointly analyze three large, high-quality datasets using innovative image-registration, machine learning, and dose characteristics (dose-based radiomics), to develop mathematical models that could be used to predict and avoid key morbidity endpoints in radiotherapy treatment planning. All endpoints will use dose-distribution comparison methods to examine the correlation between dose and morbidity as a function of anatomic location, thus providing greater assurance that the source of radiotherapy toxicity is correctly identified. Under Specific Aim 1 (SA1), we will use innovative deformable image registration methods to map all patient dose distributions to a segmented reference case anatomy (including heart, lungs, bronchii, and blood vessels). The accuracy of the deformations will be mapped carefully using an innovative non-parametric estimation methodology. Tissue regions with high correlations to morbidity will be extracted for machine learning under SAs 2 and 3. Under SA2, we will apply innovative machine learning with the goal of relating dose factors extracted under SA1 with treatment-related death hazard. Under SA3, we will apply the same methodology to the risk of severe pneumonitis. We hypothesize that treatment related death hazard and radiation pneumonitis form a single predictable continuum of increasing risk, and we will attempt to bring together the results of SA2 and SA3 in a single predictive model. Innovative post-modeling analyses of mutually exclusive predictors will be used to make the machine learning models interpretable. The overall goals of this grant are: (1) to advance the state of science in the field of personally-optimized radiation oncology, and (2) to provide decision support tools to guide patient-specific tradeoffs between local control and toxicity in lung cancer radiotherapy.         PUBLIC HEALTH RELEVANCE:  Lung cancer for locally advanced, inoperable disease is usually treated with radiotherapy, but the cause of severe treatment morbidity is not well understood. Using advanced data analysis methods, we will produce mathematical models that can be used to compare the risks of alternative treatment plans for individual patients, thereby avoiding unnecessary treatment morbidity.        ",Dose-distribution radiomics to predict morbidity risk in radiotherapy,9107070,R01CA198121,"['Accounting ', ' Age ', ' Algorithms ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' vascular ', ' Blood Vessels ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' Cause of Death ', ' Systematics ', ' Classification ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Death ', ' Cessation of life ', ' Disorder ', ' Disease ', ' Fractionation Radiotherapy ', ' FRACN ', ' Chemical Fractionation ', ' Fractionation ', ' Goals ', ' Grant ', ' Heart ', ' cardiac failure ', ' Heart failure ', ' Modern Man ', ' Human ', ' Incidence ', ' indexing ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Maps ', ' Methods ', ' Methodology ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Patients ', ' treatment with radiation ', ' radio-therapy ', ' radiation treatment ', ' Radiotherapy ', ' Radiotherapeutics ', ' Radiation therapy ', ' Research ', ' Risk ', ' Risk Factors ', ' Science ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Trees ', ' Universities ', ' Washington ', ' forest ', ' Decision Support Model ', ' Uncertainty ', ' doubt ', ' Data Set ', ' Dataset ', ' base ', ' quality assurance ', ' Clinical ', ' Variation ', ' Variant ', ' Death Rate ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonia ', ' Radiation Pneumonitis ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Logistics ', ' Radiation Oncology ', ' Normal Tissue ', ' Normal tissue morphology ', ' Shapes ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Source ', ' Pattern ', ' Techniques ', ' Location ', ' Tumor Volume ', ' Tumor Tissue ', ' hazard ', ' treatment planning ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' Radiation ', ' Modeling ', ' Sampling ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' mathematical model ', ' Cancer Radiotherapy ', ' cancer radiation therapy ', ' irradiation ', ' Dose ', ' Data ', ' Dose-Limiting ', ' RTOG ', ' Radiation Therapy Oncology Group ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Cancer Cause ', ' Cancer Etiology ', ' Characteristics ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' image registration ', ' software systems ', ' conditioning ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' public health relevance ', ' alternative treatment ', ' standard of care ', ' flexibility ', ' flexible ', ' arm ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' phase III trial ', ' image guided ', ' image guidance ', ' learning strategy ', ' learning method ', ' learning activity ', ' support tools ', ' individual patient ', ' unnecessary treatment ', ' radiomics ', ' ']",NCI,SLOAN-KETTERING INST CAN RESEARCH,R01,2016,602108,0.1184215278682198
"Machine Learning Development for Subtyping COPD Project Summary Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. To date, researchers have attempted to use standard machine learning methodology to identify more meaningful subtypes of COPD, but these methods often make general assumptions about the data, limiting their ability to penetrate more complex patterns in some data sets. Thus, a meaningful reclassification of COPD subtypes that could lead to more targeted therapies and interventions has been elusive. The applicant introduces a new way of looking at the COPD subtyping problem by recasting it in terms of discovering associations of individuals to disease trajectories  i.e., grouping individuals based on their similarity in response to environmental and/or disease causing variables. The machine learning methods proposed build on the most recent advances in Bayesian nonparametrics, a collection of theoretical ideas and techniques that permit very flexible data representations. In this career development proposal, the applicant hypothesizes that these machine learning methods and extensions thereof  together with data sources not previously leveraged for COPD subtyping  will produce more biologically meaningful sub-groupings of patients, leading to a better understanding of the genetic and biological underpinnings of the disease and ultimately improved patient management. Aim 1 of this application involves evaluating the utility of CT-assessed lung mass  a potentially more discriminative measure of emphysema than conventionally used measures  for defining COPD subtypes using both K-means clustering and our disease trajectory algorithm. The goal of Aim 2 is to evaluate the utility of comorbidity data for defining COPD subtypes using our trajectory clustering algorithm. Novel computed tomography based measures of muscle wasting (cachexia) and pulmonary vascular pruning will be explored to determine their efficacy in subtype determination. Additionally, we will extend and test the trajectory algorithm in order to model discrete outputs (such as physician-diagnosed comorbidities), count data (e.g. exacerbations), and time-to-event data (death). In Aim 3, the applicant will extend our trajectory clustering algorithms to directly incorporate genetic and omics data for subtype discovery. Together, the research proposed in the aims of this award will take full advantage of the comprehensive data set available through the COPDGene study. Execution of the aims in this proposal will be possible through active collaboration with Dr. Ron Kikinis, M.D., a renowned leader in the field of medical image analysis, and Dr. Ed Silverman, an internationally recognized expert in the genetic epidemiology of COPD. Project Narrative Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. In carrying out the research outlined in the following proposal, we plan to develop and apply machine learning methods to better identify subpopulations of individuals who have similar forms of COPD, potentially enabling better, targeted therapies.",Machine Learning Development for Subtyping COPD,9180344,K25HL130637,"['Affect ', ' Algorithms ', ' Award ', ' vascular ', ' Blood Vessels ', ' Cachectic ', ' Cachexia ', ' Cause of Death ', ' co-morbidity ', ' Comorbidity ', ' data representation ', ' Data Reporting ', ' Data Sources ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Disorder ', ' Disease ', ' liability to disease ', ' Diathesis ', ' Disease susceptibility ', ' Breathlessness ', ' Dyspnea ', ' Environment ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' Health ', ' Heterogeneity ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' Medical Imaging ', ' Methods ', ' Methodology ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' mortality ', ' muscle wasting ', ' muscle loss ', ' muscle deterioration ', ' muscle degradation ', ' muscle breakdown ', ' Muscle Atrophy ', ' Muscular Atrophy ', ' Patients ', ' Physicians ', ' Publishing ', ' emphysematous ', ' Emphysema ', ' Pulmonary Emphysema ', ' QOL ', ' Quality of life ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' Smoke ', ' Syndrome ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Measures ', ' Pulmonary Mass ', ' Lung Mass ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Biological ', ' peripheral blood ', ' Failure ', ' Individual ', ' smoke of cigarettes ', ' cigarette smoke ', ' Bayesian statistics ', ' Bayesian statistical inference ', ' Bayesian statistical analysis ', ' Bayesian spatial analysis ', ' Bayesian network analysis ', ' Bayesian inference ', ' Bayesian Analysis ', ' Disease Progression ', ' Collaborations ', ' Descriptor ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' particle ', ' novel ', ' disorder model ', ' Disease model ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Modeling ', ' career development ', ' response ', ' genetic epidemiologic study ', ' genetic epidemiology ', ' disease subtype ', ' disorder subtype ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Inflammatory Response ', ' genetic association ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' Subgroup ', ' Collection ', ' Physiologic Imaging ', ' Functional Imaging ', ' Scheme ', ' Characteristics ', ' Process ', ' groupings ', ' Grouping ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' flexibility ', ' flexible ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning strategy ', ' learning method ', ' learning activity ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,K25,2016,188040,0.09184403757293304
"Autoimmunity as a Mechanism for Atherosclerosis in COPD     DESCRIPTION (provided by applicant): This project will facilitate the development of the principal investigator into an independent translational researcher investigating systemic vascular injury in Chronic obstructive pulmonary disease (COPD). This will be accomplished in the rich academic environment at the University of Pittsburgh, under the guidance of a highly accomplished team of mentors, and in the conduct of multidisciplinary research project that will develop autoimmunity as a novel mechanism for atherosclerosis in COPD. The increased risk of atherosclerosis in COPD is not explained by smoking, age, hypertension, and other established vascular disease risk factors. Chronic inflammation has recently been implicated as an atherogenic mechanism in COPD. We and others have reported that chronic inflammation in COPD may be propagated by humoral autoimmunity. Specifically, smokers with COPD have greatly increased levels of circulating autoantibodies that demonstrate in vitro pathogenic effects. Our subsequent studies also show that these autoantibodies target at least 50 different autoantigens and consistently target glucose regulated protein 78 (GRP78), particularly in patients with parenchymal lung destruction, i.e. emphysema. GRP78 is present in the endoplasmic reticulum, where it regulates the unfolded protein response, and is also a multifunction cell surface receptor. Studies in cancer patients suggest that ligation of the N-terminus of cell surface GRP78 by anti-GRP78 IgG transduces pro-inflammatory and pro-proliferative signals by activation of the AKT pathway, followed by NFB activation. Additional in vivo studies have identified anti-GRP78 IgG with affinity for the C-terminus of cell surface GRP78 that produce counteracting anti-inflammatory effects by suppressing AKT activation. Our preliminary work shows that circulating anti-GRP78 IgG in COPD patients binds to macrophages and leads to increased NFB activation and production of atherogenic inflammatory mediators by them. The macrophage is critical in the development of both atherosclerosis and COPD. Also, cross-sectional studies in our cohort find that levels of circulating anti-GRP78 IgG are strongly associated with carotid atherosclerosis in patients with emphysema, independent of established vascular risk factors. Therefore, we hypothesize that autoimmune responses against GRP78 are a mechanism for atherosclerosis in COPD. During this award, we will: (1) Test the hypothesis that elevated levels of circulating anti-GRP78 IgG predict progression of carotid atherosclerosis in patients with emphysema independent of established risk factors over 4 year follow up; (2) Test the hypothesis that anti-GRP78 IgG binds to the N-terminus of cell surface GRP78 and activates the AKT pathway followed by NFB activation and production of inflammatory mediators using a variety of cell function assays, and provide proof of concept for two potential therapeutic strategies; (3) Test the hypothesis that there are other antigen-specific immune responses associated with atherosclerosis in COPD by using machine learning to analyze high-throughput data on a large number of circulating autoantibody levels. PUBLIC HEALTH RELEVANCE: Chronic obstructive pulmonary disease (COPD) is a lung disease caused by smoking that kills more and more Americans each year, and is now the third leading cause of death in the US. Although it is largely viewed as a disease of the lungs, the most common cause of death in patients with COPD are blockages in blood vessels. This research project will investigate why patients with COPD are so prone to develop these blood vessel blockages.",Autoimmunity as a Mechanism for Atherosclerosis in COPD,9024612,K23HL126912,"['Age ', ' Algorithms ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Anti-Inflammatory Agents ', ' Antibodies ', ' immunogen ', ' ATGN ', ' Antigens ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' Self-Antigens ', ' Autologous Antigens ', ' Autoantigens ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Autoimmune Responses ', ' Autoimmune Status ', ' Autoimmunity ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' vascular ', ' Blood Vessels ', ' protein blotting ', ' Western Immunoblotting ', ' Western Blotting ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cause of Death ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Ergastoplasm ', ' Endoplasmic Reticulum ', ' Environment ', ' ELISA ', ' Enzyme-Linked Immunosorbent Assay ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Health ', ' Modern Man ', ' Human ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' IgG ', ' 7S Gamma Globulin ', ' Immunoglobulin G ', ' In Vitro ', ' Inflammation ', ' Closure by Ligation ', ' Ligation ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' macrophage ', ' Mentors ', ' Mentorship ', ' Morbidity ', ' Morbidity - disease rate ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Phenotype ', ' Protein Phosphorylation ', ' Phosphorylation ', ' Production ', ' Proteins ', ' emphysematous ', ' Emphysema ', ' Pulmonary Emphysema ', ' Cell Surface Receptors ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoking ', ' Testing ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Universities ', ' Vascular Diseases ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Work ', ' glucose-regulated proteins ', ' Measures ', ' Killings ', ' related to A and C-protein ', ' rac protein kinase ', ' proto-oncogene protein akt ', ' proto-oncogene protein RAC ', ' c-akt protein ', ' RAC-PK protein ', ' Protein Kinase B ', ' Akt protein ', ' AKT ', ' Proto-Oncogene Proteins c-akt ', ' Injury ', ' Chronic ', ' Clinical ', ' Link ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' immunoresponse ', ' host response ', ' Immune response ', ' Therapeutic ', ' Therapeutic Agents ', ' Inflammatory ', ' Smoker ', ' Figs ', ' Figs - dietary ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Investigation ', ' Event ', ' Carotid Atheroscleroses ', ' Carotid Atherosclerotic Disease ', ' American ', ' cohort ', ' novel ', ' disease risk ', ' disorder risk ', ' Cell surface ', ' Reporting ', ' carotid plaque ', ' Carotid Artery Plaque ', ' Carotid Artery Plaques ', ' response ', ' Molecular Interaction ', ' Binding ', ' preventing ', ' prevent ', ' Affinity ', ' Data ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' K-Series Research Career Programs ', ' in vivo ', ' Anti-inflammatory ', ' Cancer Patient ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' peptidomimetics ', ' peptide mimic ', ' peptide mimetic ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' in vitro testing ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K23,2016,166104,0.06841134301101671
"Low Cost Mobile Platform for Pulmonary Disease Screening     DESCRIPTION (provided by applicant): Pulmonary disease (including primarily asthma, Chronic Obstructive Pulmonary Disease (COPD), pneumonia, lung cancer, and tuberculosis) is an increasingly large portion of the global health burden. Developing countries with large low-income populations are disproportionately affected, due to increased risk factors (e.g. biomass cooking stoves) as well as poor access to health care and lack of affordable screening tools for early detection. Chronic Obstructive Pulmonary Disease (COPD) alone is currently the third leading cause of death in the world and second leading cause of death in India after ischemic heart disease. In the younger population, pneumonia is a particular concern, being the leading cause of death for children under 5 years of age. Tuberculosis (TB) has also reached alarming proportions in India (24% of all cases worldwide). Despite this great prevalence of pulmonary disease in India, access to modern diagnostics instruments is not possible; furthermore, approximately 60% of general practice (GP) clinic doctors in India are primarily trained in Ayurvedic medicine with little or no training for diagnosing respiratory disease. As a result, many of the patients with lung disease are underdiagnosed or misdiagnosed (often confused with cardiovascular disease). As a result, there is a great need to provide health workers in India with simple tools that can be used to diagnose or screen for respiratory disease in the primary care setting. Addressing this need, our team has been developing a mobile diagnostic platform consisting of a digital stethoscope, peak flow meter, and mobile phone that can be used to screen for symptoms of lung disease and provide a guide for diagnosis. The present study extends this work and has the following aims: (1) To validate and test a low-cost mobile diagnostic platform for the purpose of identifying symptoms of lung disease and providing diagnostic guidance. (2) To assess the acceptance and usability of the mobile diagnostic platform by the local general practitioner (GP) doctors in rural India. We propose to deploy and test a low-cost mobile diagnostic platform, making use of machine learning algorithms that will detect specific symptoms of lung disease and help guide diagnosis. In the first year of the project, we shall create and train the mobile software algorithm using data collected in the field from patients (N=250) that have been previously diagnosed with specific lung diseases. Then year 2, we shall evaluate and test our mobile platform with Indian patients (N=250) recruited from four GP clinic sites in the Pune, India region. The automated mobile phone diagnosis result shall then be compared with the diagnosis from trained pulmonologists, using a traditional stethoscope as well as standard lung function testing instruments. A preliminary diagnosis and qualitative feedback shall also be collected from non-trained GP doctors using the mobile tools in order to ascertain usability and diagnostic value.         PUBLIC HEALTH RELEVANCE: Pulmonary disease is a very large public health concern in India, as well as in most developing countries. Relatively few general practitioner (GP) doctors are trained to properly diagnose pulmonary disease, and affordable tools for diagnostic support simply do not exist. This proposal seeks to validate and test the use of low-cost mobile phone-based diagnostic tools for pulmonary disease.            ",Low Cost Mobile Platform for Pulmonary Disease Screening,9018346,R21TW010245,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Air Pollution ', ' Algorithms ', ' Bronchial Asthma ', ' Asthma ', ' Bacteria ', ' Behavioral Medicine ', ' Biomass ', ' Bronchitis ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cause of Death ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Countries ', ' Diagnosis ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Feedback ', ' Generalists ', ' General Practitioners ', ' Health ', ' India ', ' Low Income Population ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Chronic Obstructive Airway Disease ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Pulmonary function tests ', ' ayurvedic ', ' ayurveda ', ' Ayurvedic Medicine ', ' Patients ', ' Pneumonia ', ' Public Health ', ' emphysematous ', ' Emphysema ', ' Pulmonary Emphysema ', ' QOL ', ' Quality of life ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Research ', ' Risk Factors ', ' Testing ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' Work ', ' General Practices ', ' Myocardial Ischemia ', ' myocardium ischemia ', ' myocardial ischemia/hypoxia ', ' heart ischemia ', ' cardiac ischemia ', ' Ischemic myocardium ', ' Ischemic Heart Disease ', ' Ischemic Heart ', ' base ', ' Stethoscopes ', ' improved ', ' Site ', ' Area ', ' Chronic ', ' Clinical ', ' Medical ', ' Interstitial Lung Diseases ', ' Training ', ' Rural ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Staging ', ' tool ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Clinic ', ' meter ', ' respiratory ', ' early detection ', ' Early Diagnosis ', ' Categories ', ' smoke cigarette ', ' cigarette smoking ', ' Chronic lung disease ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Mobile Phones ', ' Car Phone ', ' Low income ', ' Address ', ' global health ', ' Symptoms ', ' Data ', ' cost ', ' digital ', ' Population ', ' Prevalence ', ' 5 year old ', ' five year old ', ' age 5 years ', ' usability ', ' inclusion criteria ', ' public health relevance ', ' primary care setting ', ' screening ', ' Algorithmic Software ', ' Software Algorithm ', ' Algorithmic Tools ', ' mHealth ', ' mobile health ', ' m-Health ', ' Cookstove ', ' traditional stove ', ' elemental stove ', ' Cook stove ', ' Household Air Pollution ', ' accurate diagnosis ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' health care availability ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' ']",FIC,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R21,2016,181365,0.09835854276763951
"Machine Learning Development for Subtyping COPD Project Summary Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. To date, researchers have attempted to use standard machine learning methodology to identify more meaningful subtypes of COPD, but these methods often make general assumptions about the data, limiting their ability to penetrate more complex patterns in some data sets. Thus, a meaningful reclassification of COPD subtypes that could lead to more targeted therapies and interventions has been elusive. The applicant introduces a new way of looking at the COPD subtyping problem by recasting it in terms of discovering associations of individuals to disease trajectories  i.e., grouping individuals based on their similarity in response to environmental and/or disease causing variables. The machine learning methods proposed build on the most recent advances in Bayesian nonparametrics, a collection of theoretical ideas and techniques that permit very flexible data representations. In this career development proposal, the applicant hypothesizes that these machine learning methods and extensions thereof  together with data sources not previously leveraged for COPD subtyping  will produce more biologically meaningful sub-groupings of patients, leading to a better understanding of the genetic and biological underpinnings of the disease and ultimately improved patient management. Aim 1 of this application involves evaluating the utility of CT-assessed lung mass  a potentially more discriminative measure of emphysema than conventionally used measures  for defining COPD subtypes using both K-means clustering and our disease trajectory algorithm. The goal of Aim 2 is to evaluate the utility of comorbidity data for defining COPD subtypes using our trajectory clustering algorithm. Novel computed tomography based measures of muscle wasting (cachexia) and pulmonary vascular pruning will be explored to determine their efficacy in subtype determination. Additionally, we will extend and test the trajectory algorithm in order to model discrete outputs (such as physician-diagnosed comorbidities), count data (e.g. exacerbations), and time-to-event data (death). In Aim 3, the applicant will extend our trajectory clustering algorithms to directly incorporate genetic and omics data for subtype discovery. Together, the research proposed in the aims of this award will take full advantage of the comprehensive data set available through the COPDGene study. Execution of the aims in this proposal will be possible through active collaboration with Dr. Ron Kikinis, M.D., a renowned leader in the field of medical image analysis, and Dr. Ed Silverman, an internationally recognized expert in the genetic epidemiology of COPD. Project Narrative Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. In carrying out the research outlined in the following proposal, we plan to develop and apply machine learning methods to better identify subpopulations of individuals who have similar forms of COPD, potentially enabling better, targeted therapies.",Machine Learning Development for Subtyping COPD,9316700,K25HL130637,"['Affect ', ' Algorithms ', ' Award ', ' vascular ', ' Blood Vessels ', ' Cachectic ', ' Cachexia ', ' Cause of Death ', ' co-morbidity ', ' Comorbidity ', ' data representation ', ' Data Reporting ', ' Data Sources ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Disorder ', ' Disease ', ' liability to disease ', ' Diathesis ', ' Disease susceptibility ', ' Breathlessness ', ' Dyspnea ', ' Environment ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' Health ', ' Heterogeneity ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Medical Imaging ', ' Methods ', ' Methodology ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' mortality ', ' Muscular Atrophy ', ' muscle wasting ', ' muscle loss ', ' muscle deterioration ', ' muscle degradation ', ' muscle breakdown ', ' Muscle Atrophy ', ' Patients ', ' Physicians ', ' Publishing ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Quality of life ', ' QOL ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Smoke ', ' Syndrome ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Measures ', ' Lung Mass ', ' Pulmonary Mass ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Biological ', ' peripheral blood ', ' Failure ', ' Individual ', ' smoke of cigarettes ', ' cigarette smoke ', ' Bayesian statistics ', ' Bayesian statistical inference ', ' Bayesian statistical analysis ', ' Bayesian spatial analysis ', ' Bayesian network analysis ', ' Bayesian inference ', ' Bayesian Analysis ', ' Disease Progression ', ' Collaborations ', ' Descriptor ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' particle ', ' novel ', ' Disease model ', ' disorder model ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Modeling ', ' career development ', ' response ', ' genetic epidemiology ', ' genetic epidemiologic study ', ' disorder subtype ', ' disease subtype ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Inflammatory Response ', ' genetic association ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' International ', ' Subgroup ', ' Collection ', ' physiological imaging ', ' Physiologic Imaging ', ' Functional Imaging ', ' Scheme ', ' Characteristics ', ' Process ', ' groupings ', ' Grouping ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' flexibility ', ' flexible ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning strategy ', ' learning method ', ' learning activity ', ' clinical imaging ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,K25,2017,187400,0.09184403757293304
"Omics Data Integration to Identify Disease Pathways in COPD Project Summary Although chronic obstructive pulmonary disease (COPD) occurs predominantly in smokers, it is unknown why only a minority of smokers (~20-40%) develops chronic airflow limitation and/or destruction of distal airspaces (emphysema). Using several NIH and foundation grants, we have systematically generated genetic, genomics, proteomic, and metabolomics profiles from the NHLBI supported COPDGene cohort, which includes 10,300 current and former smokers age 45-80. This proposal will focus on integrating the omics data generated in the five-year followup (Phase II) of the COPDgene study to identify molecular subtypes of COPD across a broad range of blood profiles (Specific Aim 1). Biomarkers and pathways discriminating the molecular subtypes, in addition to other COPD phenotypes will then be identified (Specific Aim 2). These results will identify markers that are specific to smoking-related lung disease and can be used to develop novel diagnostic tests and therapies for early prevention and treatment of COPD. Relevance to Public Health Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in the United States. The major risk factor is smoking; however, most smokers do not develop COPD and the factors that identify who goes from normal to abnormal lung function are unknown. This proposal will use already collected data on existing NHLBI cohorts to identify blood signatures that can identify who will be at risk for developing smoking related lung disease. The knowledge gained will help guide treatment strategies and improve prognosis assessments.",Omics Data Integration to Identify Disease Pathways in COPD,9440672,R21HL140376,"['ages ', ' Age ', ' Biology ', ' Blood Reticuloendothelial System ', ' Blood ', ' Cause of Death ', ' Complement Proteins ', ' Complement ', ' Computers ', ' Disorder ', ' Disease ', ' Foundations ', ' Gene Expression ', ' Goals ', ' Grant ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Proteins ', ' Public Health ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Risk ', ' Risk Factors ', ' Smoking ', ' Supervision ', ' Time ', ' United States ', ' Work ', ' Diagnostic tests ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Distal ', ' Chronic ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Individual ', ' Sample Size ', ' Disease Progression ', ' Funding ', ' Genetic ', ' Smoker ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Complex ', ' Source ', ' System ', ' Severity of illness ', ' disease severity ', ' cohort ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' novel ', ' Prevention ', ' Sleep Disorders ', ' sleep problem ', ' Sampling ', ' response ', ' Proteomics ', ' disorder subtype ', ' disease subtype ', ' Genomics ', ' disorder control ', ' disease control ', ' computerized data processing ', ' data processing ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' data mining ', ' datamining ', ' Data ', ' Disease Pathway ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Molecular Target ', ' Classification Scheme ', ' Preparation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' clinical phenotype ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' data integration ', ' Minority ', ' multidisciplinary ', ' Early treatment ', ' early therapy ', ' data space ', ' human disease ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' novel therapeutic intervention ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' treatment strategy ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' learning strategy ', ' learning method ', ' learning activity ', ' multiple omics ', ' molecular subtypes ', ' molecular subsets ', ' molecular sub-types ', ' secondary analysis ', ' Disease stratification ', ' high dimensionality ', ' ']",NHLBI,UNIVERSITY OF COLORADO DENVER,R21,2017,117278,0.10961996718985918
"Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting     DESCRIPTION (provided by applicant): Disrupted circadian timing has emerged as a serious health and safety issue, yet there are no objective means of easily assessing circadian timing or alignment without performing a highly controlled, multiple-day in- patient study. Altered circadian timing can cause both sleep loss and sleepiness, cause performance errors such as motor vehicle accidents, and impair memory/learning. Thus, despite the obvious need to recognize an individual's circadian phase/alignment, we cannot assess circadian timing clinically or in retrospective studies. Not surprisingly, the first goal of the 2011 NIH Sleep Disorders Research Plan is to identify: ""...metabolic... biomarkers of sleep deficiency and biological timing...and circadian disorders that will facilitate personalized treatments, and clarify the risk associated with untreated sleep and circadian disorders and disturbances."" We are aware that major challenges face biomarker development, including multi-factorial causes of metabolite shifts normally controlled across multiple time-points. Because circadian time is associated with profound metabolic, immune and cardiovascular changes, however, we hypothesize that a biomarker signature for circadian phase derived from -omic markers can be obtained from a single blood sample. We therefore propose to utilize the analytical and bioinformatics platforms and experience in population-level metabolomics studies in the PIs lab to study banked plasma samples from the well-characterized individuals in six tightly controlled circadian rhythm studies run by the four co-investigators.The Aims are:  Aim 1: To identify, to optimize, to validate, and t cross-validate a set of nested plasma lipidomics-  based biomarker profiles that report circadian phase and alignment using well-characterized samples drawn from three constant routine protocols Aim 2: To identify, to optimize, to validate, and to cross-validate a set of nested plasma lipidomics based biomarker profiles that report circadian phase and alignment using well-characterized samples  drawn from four forced desynchrony protocols  Aim 3: To systematically evaluate the validated profiles from Aims 1 and 2 and their mathematical  similarities and differences so as to improve accuracy and precision of the biomarkers  Aim 4: To test the markers identified above under poorly controlled real world applications Identification of biomarker panels will impact multiple aspects of science and health: (i) contribute to clinical recognition and treatment on circadian disorders; (ii) advance personalized medicine through individualized treatment timing to enhance efficacy/reduce side effects of medications (e.g., chemotherapy); (iii) creating epidemiologic tools to relate circadian with disease risk; and aiding development of other disease biomarkers, and; (iv) contribute to research on circadian biology and its implications for human health. PUBLIC HEALTH RELEVANCE: We propose to identify blood-based markers that can inform a clinician or researcher about an individual's internal biological clock. At the broad levels of society and public health research, the work has the potential direct benefit of identifying individuals with ""off-set"" clocks (enabling diagnosis and potential therapy), increasing accuracy and precision of studies of blood lipids, facilitating understanding of certain sleep disorders, increasing understanding of the role of biological clocks in chronic disease processes (e.g., cancer, diabetes, cardiovascular disease), and potentially improving the administration of certain pharmaceuticals, eg, chemotherapy agents.","Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting",9264015,R01HL132556,"['ages ', ' Age ', ' Algorithms ', ' Awareness ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biological Clocks ', ' Biology ', ' Avian ', ' Aves ', ' Birds ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' sleepiness ', ' Somnolence ', ' Drowsiness ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' facial ', ' faces ', ' Face ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Inpatients ', ' Learning ', ' Mathematics ', ' Math ', ' men ', "" men's "", ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Patients ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Retrospective Studies ', ' Risk ', ' Role ', ' social role ', ' Running ', ' Safety ', ' Science ', ' Sleep ', ' Smoking ', ' Societies ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' Time ', ' Woman ', ' Work ', ' Gender ', ' Generations ', ' base ', ' human population study ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Clinical ', ' Phase ', ' Biological ', ' Link ', ' memory dysfunction ', ' Memory Deficit ', ' Memory impairment ', ' Individual ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Metabolic ', ' Strigiformes ', ' Owls ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Hour ', ' Immune ', ' Immunes ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' blood lipid ', ' experience ', ' Performance ', ' disorder risk ', ' disease risk ', ' vehicular accident ', ' motor vehicle accident ', ' Motor carrier accident ', ' Reporting ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' Sampling ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Bioinformatics ', ' Bio-Informatics ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Data ', ' Resolution ', ' Pattern Recognition ', ' Process ', ' developmental ', ' Development ', ' Population ', ' prospective ', ' combinatorial ', ' chemotherapy ', ' real world application ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' public health research ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' biomarker development ', ' biomarker panel ', ' marker panel ', ' biomarker identification ', ' marker identification ', ' blood-based biomarker ', ' blood-based marker ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,R01,2017,877276,0.0718518910897693
"The Role of the Microbiome in the Acute Respiratory Distress Syndrome     DESCRIPTION (provided by applicant): This K23 proposal will complete Robert Dickson, MD's training towards his long-term career goal of improving our understanding and treatment of lung disease by investigation of the microbiome. Dr. Dickson is a Pulmonary and Critical Care physician and scientist at the University of Michigan with established success in the burgeoning field of lung microbiome studies. This proposal builds on Dr. Dickson's previously acquired expertise in pulmonary pathophysiology and microbial ecology with new training in clinical research methods and computational biology. These established and newly-acquired skills will be integrated to improve our understanding of the role of the microbiome in the pathogenesis of the Acute Respiratory Distress Syndrome (ARDS). This research will be conducted under the guidance of primary mentor Gary B. Huffnagle PhD, co- mentor Theodore J. Standiford MD and an advisory board of accomplished investigators with expertise in clinical research methods, computational biology and lung immunology as well as extensive mentoring success. This 5-year plan includes formal coursework, professional development, and progressively independent research, with defined milestones to ensure productivity and a successful transition to independence. The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year. Numerous studies have identified indirect evidence of translocation of bacteria from the gastrointestinal tract to the lung in patients at risk for ARDS, but to date no study has evaluated the role of microbiome in the pathogenesis of ARDS. This proposal will test the hypothesis that translocation of gut bacteria to the lung provokes the inflammation and injury of ARDS via two specific Scientific Aims. Aim 1 will determine if translocation of enteric bacteria to the lung microbiome precedes the clinical development of ARDS, and Aim 2 will determine the temporal relationship between respiratory dysbiosis, host inflammation and the clinical onset of ARDS. Inherent to completing these high-level aims, Dr. Dickson will execute a prospective cohort study of patients at high risk for ARDS, utilize modern culture-independent techniques of bacterial identification to describe the bacterial communities in the lungs and gastrointestinal tracts of high-risk patients, and apply novel techniques of advanced computational modeling to the complex nonlinear system of ARDS pathogenesis. This work will build to at least two R01 proposals: 1) to determine if the lung microbiome contributes to disease progression among patients with established ARDS and 2) to determine if the lung microbiome can be therapeutically manipulated in critically ill patients to prevent or modulate respiratory disease. n addition to building a foundation for a programmatic line of research to understand the role of the microbiome in lung disease, this proposal will provide Dr. Dickson with research skills applicable to additional domains of human microbiome and ARDS research. This K23 award will equip Dr. Dickson to establish himself as an independent investigator and international leader in this promising field. PUBLIC HEALTH RELEVANCE: The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year; the National Institutes of Health have identified the prevention and early treatment of ARDS as a research priority. We lack an understanding of the pathogenesis of ARDS, impeding our ability to predict and prevent its onset. Determination of the role of the microbiome in the pathogenesis of ARDS would both 1) improve our ability to predict the onset of ARDS, enabling targeted preventive interventions and 2) identify novel therapeutic targets at the microbiome/host interface in patients at risk for ARDS.",The Role of the Microbiome in the Acute Respiratory Distress Syndrome,9199225,K23HL130641,"['Bacteria ', ' Sympathins ', ' Catecholamines ', ' Cell Body ', ' Cells ', ' Clinical Study ', ' Clinical Research ', ' Communities ', ' Complement Proteins ', ' Complement ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Critical Care ', ' Critically Ill ', ' Critical Illness ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Environmental Science ', ' Ecology ', ' Aerobacter ', ' Enterobacter ', ' Enterobacteria ', ' Enteric Bacteria ', ' Coliform Bacilli ', ' Enterobacteriaceae ', ' Therapeutic Epinephrine ', ' Adrenaline ', ' Epinephrine ', ' Foundations ', ' Future ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Gastrointestinal tract structure ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Immigration ', ' indexing ', ' Inflammation ', ' Interleukin-1 beta ', ' Preinterleukin 1 Beta ', ' Interleukin-1 ', ' Interleukin 1beta ', ' IL1 ', ' IL1F2 ', ' IL1B Protein ', ' IL1- ', ' IL1-Beta ', ' IL-1 ', ' IL-1-b ', ' IL-1  ', ' IL-1 beta ', ' Beta Proprotein Interleukin 1 ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Mentors ', ' Michigan ', ' Modernization ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' neutrophil ', ' Polymorphonuclear Neutrophils ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Cell ', ' Neutrophilic Leukocyte ', ' Neutrophilic Granulocyte ', ' Marrow Neutrophil ', ' Heterophil Granulocyte ', ' Blood Segmented Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Blood Neutrophil ', ' Norepinephrine ', ' Noradrenaline ', ' Levonorepinephrine ', ' Levarterenol ', ' Patients ', ' Physicians ', ' Productivity ', ' outcome forecast ', ' Prognosis ', ' Pseudomonas ', ' Flavimonas ', ' Chrysemonas ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Adult Respiratory Distress Syndrome ', ' wet lung ', ' Stiff lung ', ' Shock Lung ', ' Da Nang Lung ', ' Adult RDS ', ' Acute Respiratory Distress Syndrome ', ' ARDS ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Testing ', ' Universities ', ' Work ', ' cytokine ', ' Research Methods ', ' Research Methodology ', ' Immunology ', ' Injury ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Logistic Regressions ', ' Nonlinear Models ', ' Non-linear Models ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Development Plans ', ' Disease Progression ', ' inflammatory mediator ', ' Inflammation Mediators ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Therapeutic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' Computational Biology ', ' computer biology ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Complex ', ' Techniques ', ' System ', ' respiratory ', ' gastrointestinal ', ' success ', ' gastrointestinal bacteria ', ' microbial ', ' skills ', ' novel ', ' member ', ' Prevention ', ' Pathogenesis ', ' Gammaproteobacteria ', ' -Proteobacteria ', ' gamma Proteobacteria ', ' TNF gene ', ' Tumor Necrosis Factor-alpha ', ' Tumor Necrosis Factor ', ' TNF ', ' TNFA ', ' TNF- ', ' TNF Alpha ', ' TNF A ', ' TNF ', ' Monocyte-Derived TNF ', ' Macrophage-Derived TNF ', ' Cachectin ', ' Modeling ', ' Sampling ', ' career development ', ' prevent ', ' preventing ', ' Enteral ', ' Enteric ', ' Alveolar ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' International ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Clinical Data ', ' Computational Technique ', ' developmental ', ' Development ', ' microbiome ', ' Human Microbiome ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' bloodstream infection ', ' blood infection ', ' Sepsis ', ' Trauma ', ' Early treatment ', ' early therapy ', ' patient oriented ', ' patient centered ', ' spatiotemporal ', ' high risk ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' public health relevance ', ' gut microbiota ', ' intestinal tract microflora ', ' intestinal microbiota ', ' gut microflora ', ' gut microbiotic ', ' clinical risk ', ' Patient risk ', ' microbiota ', ' Prospective cohort study ', ' clinical development ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K23,2017,171176,0.11607683332915562
"Low Cost Mobile Platform for Pulmonary Disease Screening     DESCRIPTION (provided by applicant): Pulmonary disease (including primarily asthma, Chronic Obstructive Pulmonary Disease (COPD), pneumonia, lung cancer, and tuberculosis) is an increasingly large portion of the global health burden. Developing countries with large low-income populations are disproportionately affected, due to increased risk factors (e.g. biomass cooking stoves) as well as poor access to health care and lack of affordable screening tools for early detection. Chronic Obstructive Pulmonary Disease (COPD) alone is currently the third leading cause of death in the world and second leading cause of death in India after ischemic heart disease. In the younger population, pneumonia is a particular concern, being the leading cause of death for children under 5 years of age. Tuberculosis (TB) has also reached alarming proportions in India (24% of all cases worldwide). Despite this great prevalence of pulmonary disease in India, access to modern diagnostics instruments is not possible; furthermore, approximately 60% of general practice (GP) clinic doctors in India are primarily trained in Ayurvedic medicine with little or no training for diagnosing respiratory disease. As a result, many of the patients with lung disease are underdiagnosed or misdiagnosed (often confused with cardiovascular disease). As a result, there is a great need to provide health workers in India with simple tools that can be used to diagnose or screen for respiratory disease in the primary care setting. Addressing this need, our team has been developing a mobile diagnostic platform consisting of a digital stethoscope, peak flow meter, and mobile phone that can be used to screen for symptoms of lung disease and provide a guide for diagnosis. The present study extends this work and has the following aims: (1) To validate and test a low-cost mobile diagnostic platform for the purpose of identifying symptoms of lung disease and providing diagnostic guidance. (2) To assess the acceptance and usability of the mobile diagnostic platform by the local general practitioner (GP) doctors in rural India. We propose to deploy and test a low-cost mobile diagnostic platform, making use of machine learning algorithms that will detect specific symptoms of lung disease and help guide diagnosis. In the first year of the project, we shall create and train the mobile software algorithm using data collected in the field from patients (N=250) that have been previously diagnosed with specific lung diseases. Then year 2, we shall evaluate and test our mobile platform with Indian patients (N=250) recruited from four GP clinic sites in the Pune, India region. The automated mobile phone diagnosis result shall then be compared with the diagnosis from trained pulmonologists, using a traditional stethoscope as well as standard lung function testing instruments. A preliminary diagnosis and qualitative feedback shall also be collected from non-trained GP doctors using the mobile tools in order to ascertain usability and diagnostic value.         PUBLIC HEALTH RELEVANCE: Pulmonary disease is a very large public health concern in India, as well as in most developing countries. Relatively few general practitioner (GP) doctors are trained to properly diagnose pulmonary disease, and affordable tools for diagnostic support simply do not exist. This proposal seeks to validate and test the use of low-cost mobile phone-based diagnostic tools for pulmonary disease.            ",Low Cost Mobile Platform for Pulmonary Disease Screening,9356362,R21TW010245,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' ages ', ' Age ', ' Air Pollution ', ' Algorithms ', ' Bronchial Asthma ', ' Asthma ', ' Bacteria ', ' Behavioral Medicine ', ' Biomass ', ' Bronchitis ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cause of Death ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Countries ', ' Diagnosis ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Feedback ', ' Generalists ', ' General Practitioners ', ' Health ', ' Health Resources ', ' India ', ' Low Income Population ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Pulmonary function tests ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Ayurvedic Medicine ', ' ayurvedic ', ' ayurveda ', ' Modernization ', ' Patients ', ' Pneumonia ', ' Public Health ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Quality of life ', ' QOL ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Risk Factors ', ' Savings ', ' Testing ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' MTB infection ', ' M.tuberculosis infection ', ' M.tb infection ', ' M. tuberculosis infection ', ' M. tb infection ', ' M tuberculosis infection ', ' Tuberculosis ', ' Work ', ' General Practices ', ' myocardium ischemia ', ' myocardial ischemia/hypoxia ', ' heart ischemia ', ' cardiac ischemia ', ' Ischemic myocardium ', ' Ischemic Heart Disease ', ' Ischemic Heart ', ' Myocardial Ischemia ', ' base ', ' rural area ', ' Stethoscopes ', ' improved ', ' Site ', ' Chronic ', ' Clinical ', ' Medical ', ' Interstitial Lung Diseases ', ' Training ', ' Rural ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' tool ', ' instrument ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Clinic ', ' meter ', ' Early Diagnosis ', ' early detection ', ' Categories ', ' cigarette smoking ', ' smoke cigarette ', ' Chronic lung disease ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Car Phone ', ' Mobile Phones ', ' Low income ', ' Address ', ' global health ', ' Symptoms ', ' Data ', ' cost ', ' digital ', ' Population ', ' Prevalence ', ' 5 year old ', ' five years of age ', ' five year old ', ' age 5 years ', ' 5 years of age ', ' usability ', ' inclusion criteria ', ' public health relevance ', ' primary care setting ', ' screening ', ' Algorithmic Software ', ' Software Algorithm ', ' Algorithmic Tools ', ' mHealth ', ' mobile health ', ' m-Health ', ' Cookstove ', ' traditional stove ', ' elemental stove ', ' Cook stove ', ' Household Air Pollution ', ' accurate diagnosis ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' health care availability ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' ']",FIC,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R21,2017,164421,0.09835854276763951
"Autoimmunity as a Mechanism for Atherosclerosis in COPD     DESCRIPTION (provided by applicant): This project will facilitate the development of the principal investigator into an independent translational researcher investigating systemic vascular injury in Chronic obstructive pulmonary disease (COPD). This will be accomplished in the rich academic environment at the University of Pittsburgh, under the guidance of a highly accomplished team of mentors, and in the conduct of multidisciplinary research project that will develop autoimmunity as a novel mechanism for atherosclerosis in COPD. The increased risk of atherosclerosis in COPD is not explained by smoking, age, hypertension, and other established vascular disease risk factors. Chronic inflammation has recently been implicated as an atherogenic mechanism in COPD. We and others have reported that chronic inflammation in COPD may be propagated by humoral autoimmunity. Specifically, smokers with COPD have greatly increased levels of circulating autoantibodies that demonstrate in vitro pathogenic effects. Our subsequent studies also show that these autoantibodies target at least 50 different autoantigens and consistently target glucose regulated protein 78 (GRP78), particularly in patients with parenchymal lung destruction, i.e. emphysema. GRP78 is present in the endoplasmic reticulum, where it regulates the unfolded protein response, and is also a multifunction cell surface receptor. Studies in cancer patients suggest that ligation of the N-terminus of cell surface GRP78 by anti-GRP78 IgG transduces pro-inflammatory and pro-proliferative signals by activation of the AKT pathway, followed by NFB activation. Additional in vivo studies have identified anti-GRP78 IgG with affinity for the C-terminus of cell surface GRP78 that produce counteracting anti-inflammatory effects by suppressing AKT activation. Our preliminary work shows that circulating anti-GRP78 IgG in COPD patients binds to macrophages and leads to increased NFB activation and production of atherogenic inflammatory mediators by them. The macrophage is critical in the development of both atherosclerosis and COPD. Also, cross-sectional studies in our cohort find that levels of circulating anti-GRP78 IgG are strongly associated with carotid atherosclerosis in patients with emphysema, independent of established vascular risk factors. Therefore, we hypothesize that autoimmune responses against GRP78 are a mechanism for atherosclerosis in COPD. During this award, we will: (1) Test the hypothesis that elevated levels of circulating anti-GRP78 IgG predict progression of carotid atherosclerosis in patients with emphysema independent of established risk factors over 4 year follow up; (2) Test the hypothesis that anti-GRP78 IgG binds to the N-terminus of cell surface GRP78 and activates the AKT pathway followed by NFB activation and production of inflammatory mediators using a variety of cell function assays, and provide proof of concept for two potential therapeutic strategies; (3) Test the hypothesis that there are other antigen-specific immune responses associated with atherosclerosis in COPD by using machine learning to analyze high-throughput data on a large number of circulating autoantibody levels. PUBLIC HEALTH RELEVANCE: Chronic obstructive pulmonary disease (COPD) is a lung disease caused by smoking that kills more and more Americans each year, and is now the third leading cause of death in the US. Although it is largely viewed as a disease of the lungs, the most common cause of death in patients with COPD are blockages in blood vessels. This research project will investigate why patients with COPD are so prone to develop these blood vessel blockages.",Autoimmunity as a Mechanism for Atherosclerosis in COPD,9238793,K23HL126912,"['ages ', ' Age ', ' Algorithms ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Anti-Inflammatory Agents ', ' Antibodies ', ' immunogen ', ' ATGN ', ' Antigens ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' Self-Antigens ', ' Autologous Antigens ', ' Autoantigens ', ' autoimmune disorder ', ' auto-immune disorder ', ' auto-immune disease ', ' Autoimmune Diseases ', ' Autoimmune Responses ', ' Autoimmune Status ', ' Autoimmunity ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' vascular ', ' Blood Vessels ', ' protein blotting ', ' Western Immunoblotting ', ' Western Blotting ', ' Cause of Death ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Ergastoplasm ', ' Endoplasmic Reticulum ', ' Environment ', ' ELISA ', ' Enzyme-Linked Immunosorbent Assay ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Modern Man ', ' Human ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Immunoglobulin G ', ' IgG ', ' 7S Gamma Globulin ', ' In Vitro ', ' Inflammation ', ' Ligation ', ' Closure by Ligation ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' macrophage ', ' Mentors ', ' Mentorship ', ' Morbidity - disease rate ', ' Morbidity ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Patients ', ' Phenotype ', ' Phosphorylation ', ' Protein Phosphorylation ', ' Production ', ' Proteins ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Cell Surface Receptors ', ' Risk ', ' Risk Factors ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Smoking ', ' Testing ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Universities ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Vascular Diseases ', ' Work ', ' glucose-regulated proteins ', ' Measures ', ' Killings ', ' related to A and C-protein ', ' rac protein kinase ', ' proto-oncogene protein akt ', ' proto-oncogene protein RAC ', ' c-akt protein ', ' RAC-PK protein ', ' Protein Kinase B ', ' Akt protein ', ' AKT ', ' Proto-Oncogene Proteins c-akt ', ' Injury ', ' Chronic ', ' Link ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Therapeutic Agents ', ' Inflammatory ', ' Smoker ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Event ', ' Carotid Atherosclerotic Disease ', ' Carotid Atheroscleroses ', ' American ', ' cohort ', ' novel ', ' Cell surface ', ' Reporting ', ' Carotid Artery Plaques ', ' carotid plaque ', ' Carotid Artery Plaque ', ' response ', ' Pathogenicity ', ' Binding ', ' Molecular Interaction ', ' prevent ', ' preventing ', ' Affinity ', ' Data ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' in vivo ', ' Anti-inflammatory ', ' Cancer Patient ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' peptidomimetics ', ' peptide mimic ', ' peptide mimetic ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' in vitro testing ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' cancer clinical trial ', ' translational scientist ', ' translational researcher ', ' translational investigator ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K23,2017,166104,0.06841134301101671
"DEVELOPMENT OF A RAPID METHOD FOR IMAGING REGIONAL VENTILATION IN SMALL ANIMALS W/O CONTRAST AGENTS The objective of this R01 application is to develop a rapid method for imaging regional ventilation and lung compliance in small animals without contrast agents. Much of our current understanding of the normal functioning of the lung and mechanisms of lung disease comes from small animal studies. However, lung function imaging in small animal models is technically challenging due to motion and the relatively small size of the lungs. Pulmonary function testing using plethysmography has been employed to assess lung function and injury with limited validity and utility, particularly in small animals. Additionally, only aggregate measures of functional performance are produced and no regional lung changes can be assessed. An improved imaging method that could provide spatially- and temporally-resolved information regarding ventilation would be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases. It would also facilitate drug discovery and efficacy studies aimed to mitigate respiratory pathology. The ideal method would provide quantitative regional functional information, be applicable to longitudinal studies (low radiation dose), and have a simple and affordable implementation that permits widespread use. Currently available imaging methods including micro-CT or MRI fall short in one or more of these requirements.  To address this need, we will establish and evaluate a novel, easy to implement, and highly effective X- ray phase-contrast (XPC) method for ventilation imaging in small animal models. The lung is ideally suited to XPC imaging because it is comprised mainly of air spaces separated by thin tissue structures. The air-tissue interfaces cause the X-ray beam to experience numerous and strong refractions that produce a distinctive texture in the intensity measured over the lungs known as speckle. Detailed information regarding the regional lung air volume (RLAV) distribution is encoded in the speckle. The benefits of exploiting lung speckle for detecting and monitoring lung function are numerous but remain entirely unexplored for benchtop imaging.  Our approach involves a high degree of technical innovation regarding image formation methods and will significantly extend the current boundaries of functional lung imaging in small animals. The proposed method, referred to as parametric XPC (P-XPC) imaging, will produce 2D parametric images that depict the projected RLAV distribution. When differential images are computed for any given two points in the breathing cycle, ventilation or lung compliance imaging will be achieved. Preliminary in vivo and computational studies have been conducted in support of the proposed research. The specific aims of the project are as follows. Aim 1: Develop P-XPC image formation methods for estimating the projected RLAV distribution; Aim 2: Optimize an XPC imaging system for P-XPC imaging. Aim 3: Evaluate the diagnostic capability of P-XPC imaging in two pre-clinical animal models of disease in vivo. The proposed research will result in a novel, easy to implement, and highly effective X-ray phase-contrast (XPC) method for functional lung imaging in small animal models. It will provide spatially- and temporally- resolved information regarding lung ventilation that will be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases.",DEVELOPMENT OF A RAPID METHOD FOR IMAGING REGIONAL VENTILATION IN SMALL ANIMALS W/O CONTRAST AGENTS,9309904,R01EB023045,"['Air ', ' Animals ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Inhaling ', ' Inhalation ', ' Breathing ', ' Communities ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Contrast Media ', ' Animal Disease Models ', ' Learning ', ' Longitudinal Studies ', ' long-term study ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung Compliance ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Pulmonary function tests ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Maps ', ' Methods ', ' Motion ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Pathology ', ' Physics ', ' Physiology ', ' Plethysmography ', ' pressure ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Research ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Supervision ', ' Thinness ', ' Leanness ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Ventilation ', ' Environmental air flow ', ' Xrays ', ' X-Rays Radiation ', ' X-Rays ', ' X-Radiation ', ' Roentgen Rays ', ' Measures ', ' falls ', ' base ', ' detector ', ' improved ', ' lung scanning ', ' Pulmonary imaging ', ' lung imaging ', ' Phase ', ' Evaluation ', ' lung volume ', ' lung injury ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Source ', ' Texture ', ' Techniques ', ' System ', ' respiratory ', ' experience ', ' Performance ', ' drug efficacy ', ' lung pressure ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Structure ', ' novel ', ' Radiation ', ' rapid technique ', ' rapid method ', ' drug discovery ', ' imaging modality ', ' imaging method ', ' image-based method ', ' Address ', ' Dose ', ' Resolution ', ' Resource Sharing ', ' in vivo ', ' physiological imaging ', ' Physiologic Imaging ', ' Functional Imaging ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' preclinical ', ' pre-clinical ', ' cost ', ' computational studies ', ' computer studies ', ' Imaging technology ', ' innovation ', ' innovative ', ' innovate ', ' mouse model ', ' murine model ', ' microCT ', ' micro CT ', ' animal imaging ', ' imaging system ', ' contrast imaging ', ' learning strategy ', ' learning method ', ' learning activity ', ' Technical Degree ', ' technical certificate ', ' efficacy study ', ' parametric imaging ', ' ']",NIBIB,WASHINGTON UNIVERSITY,R01,2017,489676,0.181852624679404
"Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer     DESCRIPTION (provided by applicant): Autophagy is a complex intracellular recycling program associated with tumor progression and cancer cell survival. Researchers still lack strategies to effectively target this process, and an understanding of when to apply such strategies. Oncogenic stress, such as that elicited by mutant KRAS, can activate autophagy to promote cancer cell survival. Importantly, KRAS mutations are linked to 40% of lung cancer deaths in the U.S. each year. Therefore, we propose an innovative, multidisciplinary research project that investigates autophagy in connection with KRAS: we will integrate predictive computational modeling and high-quality cell-based measurements to accurately model the autophagic process in KRAS-driven lung cancer. We anticipate that our model will help identify the most effective therapeutic strategies for targeting autophagy in cancer. Specific Aim #1: Validate a mechanistic model of the core autophagy pathway to predict targets for the effective inhibition of autophagy. We have specified a mechanistic model through ""rules"" that capture the key biological processes comprising the autophagy pathway. To validate this model, we measured how the individual steps of autophagy respond to physiological and oncogenic stressors, and systematic RNAi perturbations. Here, we propose to tune the model to align with quantitative data, and test predictions of the rate-limiting steps. This framework will explore the possibility that autophagy is controlled by a bistable switch, an intriguing model-derived hypothesis with therapeutic relevance. As part of this aim, we will identify effective autophagy inhibitors in wildtype and mutant KRAS backgrounds. Specific Aim #2: Model the relationship of autophagy and cell fate to test therapeutic predictions for KRAS-driven lung cancer. The autophagy model will be extended to investigate the relationship between autophagic flux and cell survival and death. For this effort, we will implement an innovative data-driven approach, which involves defining relationships between measured inputs (signaling readouts) and outputs (autophagic flux, survival, and death) in datasets. We will use this model and patient-derived cell lines to predict the therapeutic benefit of inhibiting autophagy in KRAS-driven lung cancer. Our collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer."" PUBLIC HEALTH RELEVANCE: This collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer.""",Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer,9547104,R01CA197398,"['Achievement Attainment ', ' Achievement ', ' inhibitor ', ' inhibitor/antagonist ', ' assault ', ' autophagy ', ' Autophagocytosis ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' necrocytosis ', ' Cell Death ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Viability ', ' Cell Survival ', ' Cell Body ', ' Cells ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Computers ', ' Death ', ' Cessation of life ', ' Digestion ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Engineering ', ' balance function ', ' balance ', ' Equilibrium ', ' Foundations ', ' Goals ', ' Kinetics ', ' Laboratories ', ' Lipids ', ' Monte Carlo Method ', ' Monte Carlo simulation ', ' Monte Carlo procedure ', ' Monte Carlo calculation ', ' Monte Carlo algorithm ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Nuclear Fission ', ' Patients ', ' Phenotype ', ' Physics ', ' Play ', ' Proteins ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Starvation ', ' Stress ', ' Testing ', ' War ', ' Measures ', ' Mediating ', ' Dataset ', ' Data Set ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' base ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' tumor progression ', ' improved ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Individual ', ' Oxygen Deficiency ', ' Hypoxic ', ' Hypoxia ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Biological Function ', ' Biological Process ', ' Recycling ', ' Therapeutic ', ' Genetic ', ' cancer cell ', ' Malignant Cell ', ' weapons ', ' Nuclear Weapon ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Cellular biology ', ' cell biology ', ' Scientist ', ' Complex ', ' Reaction ', ' System ', ' environmental stressor ', ' mutant ', ' stressor ', ' Structure ', ' Nutrient ', ' novel ', ' World War II ', ' Second World War ', ' 2nd World War ', ' models and simulation ', ' model-based simulation ', ' Devices ', ' Modeling ', ' response ', ' drug development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Ally ', ' RNA Interference ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' therapeutic evaluation ', ' therapeutic testing ', ' KRAS2 gene ', ' v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog ', ' RASK2 ', ' Oncogene K-Ras ', ' Ki-RAS ', ' KRAS2 ', ' KRAS ', ' K-Ras-2 Oncogene ', ' K-Ras 2A ', ' K-Ras ', ' K-RAS2B ', ' K-RAS2A ', ' C-K-RAS ', ' Address ', ' Data ', ' Molecular Target ', ' Resolution ', ' Cell Kinetics ', ' Cell Cycle Kinetics ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' Output ', ' designing ', ' design ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Cancer cell line ', ' innovation ', ' innovative ', ' innovate ', ' Oncogenic ', ' Computational algorithm ', ' computer algorithm ', ' cell behavior ', ' therapeutic target ', ' public health relevance ', ' inhibition of autophagy ', ' genetic predictors ', ' ']",NCI,MICHIGAN STATE UNIVERSITY,R01,2017,484156,0.0880336127340645
"Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)     DESCRIPTION (provided by applicant): It is estimated that neurodegenerative diseases causing dementia will surpass cancer as the leading cause of death by the year 2040. Alzheimer's disease (AD) is the leading cause of dementia, followed by synucleinopathies, such as dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). Among clinical researchers focused on investigating the varying etiologies, genetic associations, biomarkers, and treatment options for these neurodengenerative diseases, there is an urgent need for effective tools to aid in the classification of dementia subtypes, in the earliest detectable stages of the pathophysiological process. To address this unmet need Advanced Brain Monitoring (ABM) proposes to leverage two previously developed technologies to create an Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS). The core components of the INSPECDS platform will be a previously developed Alertness and Memory Profiler (AMP), a recently developed Sleep Profiler, and integrated machine-learning, classification algorithms, hosted on a secure, cloud-based, infrastructure for automated data processing, analysis, and reporting. The AMP was developed and validated during a previous NIH-funded SBIR Phase I/II project for the purpose of detecting the neurocognitive effects of sleep deprivation in adults diagnosed with obstructive sleep apnea. The AMP is truly unique among neurocognitive testing platforms in that it is the only one which integrates advanced, electrophysiological measures (e.g., 24-channel, wireless EEG and ECG) during the performance of computerized neurocognitive tasks. This advanced capability permits researchers to explore real-time relations between fluctuations in alertness, discrete cognitive functions, and specific neural processes believed to subserve observed performance deficits. The Sleep Profiler is an FDA-cleared, easily applied, wireless-EEG device that was developed and validated to measure sleep architecture for in-home sleep studies. With integrated measures of submental (chin) EMG and wireless accelerometers to monitor head and limb movements, the Sleep Profiler is an ideal device for quantifying the characteristics of REM-sleep behavior disorder (RBD), which is considered to be a prodromal expression of synucleinopathy. Furthermore, the application of sophisticated, machine-learning, classification algorithms will streamline the processing and analyses of these data to derive statistical probabilities of various dementia subtypes. The overarching goal of the current, Direct-to-Phase II, SBIR project is to develop a secure, cloud-based infrastructure to compile the data obtained from the AMP and Sleep Profiler, train classification algorithms to discriminate among dementia subtypes, validate diagnostic accuracy, and integrate optimized classifiers within the cloud-based architecture. Once completed, the INSPECDS system will be the first clinical research tool of its kind and find immediate application in both university-based research settings and pharmaceutical industry clinical trials to aid in the endophenotypic stratification of research participants.         PUBLIC HEALTH RELEVANCE: Among clinical researchers focused on investigating the varying etiologies, genetic associations, clinical course, and treatment options for neurodengenerative diseases, there is an urgent need for effective tools to aid in the classification of dementia subtypes, in the earliest detectable stages of the pathophysiological process. To address this unmet need, Advanced Brain Monitoring (Carlsbad, CA) is developing Integrated Neurocognitive and Sleep-Behavior Profilers for the Endophenotypic Classification of Dementia Subtypes (INSPECDS), which will provide an inexpensive, non-invasive solution combining neurocognitive, electrophysiological (EEG, ECG, EMG), and sleep-behavior assessment into a single, integrated system featuring automated scoring and classification algorithms. Once completed, the INSPECDS system will be the first clinical research tool of its kind and find immediate application in university-based research settings and pharmaceutical industry clinical trials to aid in the endophenotypic stratification of research participants.                ",Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS),9360534,R44AG050326,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Engineering / Architecture ', ' Architecture ', ' automated data processing ', ' Electronic Data Processing ', ' Computer Data Processing ', ' Automatic Data Processing ', ' Behavior ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' California ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cause of Death ', ' Mentum ', ' Chin ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Drug Industry ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' EEG ', ' Electroencephalography ', ' electrophysiological ', ' Neurophysiology / Electrophysiology ', ' Electrophysiology ', ' Electrophysiology (science) ', ' Goals ', ' General Hospitals ', ' Massachusetts ', ' Memory ', ' Minor ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neuropsychological Tests ', ' Neuropsychologic Tests ', ' Patients ', ' Probability ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Sleep ', ' Sleep Deprivation ', ' stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Technology ', ' Time ', ' Universities ', ' Measures ', ' Blinded ', ' base ', ' human subject ', ' Clinical ', ' Phase ', ' Training ', ' Individual ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Disease Progression ', ' Funding ', ' tool ', ' Depressed mood ', ' sadness ', ' depressed ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Head Movements ', ' cognitive function ', ' Home environment ', ' Home ', ' Clinic ', ' System ', ' Dementia ', ' Amentia ', ' Neurocognitive ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neuro-degenerative Disorders ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' limb movement ', ' Performance ', ' diagnostic accuracy ', ' Accuracy of Diagnosis ', ' cohort ', ' relating to nervous system ', ' neural ', ' Participant ', ' Study Subject ', ' Devices ', ' Reporting ', ' REM Sleep Behavior Disorder ', ' Rapid Eye Movement Sleep Behavior Disorder ', ' Rapid Eye Movement Behavior Disorder ', ' REM Behavior Disorder ', ' Sampling ', ' neurocognitive test ', ' Behavior assessment ', ' behavioral assessment ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Address ', ' alertness ', ' Data ', ' Economic Burden ', ' Research Infrastructure ', ' Infrastructure ', ' Stratification ', ' enroll ', ' Enrollment ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Characteristics ', ' Process ', ' Modification ', ' computerized ', ' Sleep Architecture ', "" parkinson's disease dementia "", ' dementia in Parkinson disease ', ' dementia in PD ', "" Parkinson's disease with dementia "", ' PD with dementia ', "" Parkinson's Dementia "", ' data acquisition ', ' brain behavior ', ' synucleinopathy ', ' public health relevance ', ' FDA approved ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Secure ', ' mild cognitive impairment ', ' mild cognitive disorder ', ' Lewy Body Dementia ', ' Lewy Body Type Senile Dementia ', ' Dementia with Lewy Bodies ', ' cloud based ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' ']",NIA,"ADVANCED BRAIN MONITORING, INC.",R44,2017,681391,-0.005408286358404966
"Sleep Health Profiles and Mortality Risk in Older Adults: A Multi-Cohort Application of Novel Statistical Methods PROJECT SUMMARY / ABSTRACT Individual sleep disorders and characteristics are known to be associated with adverse health outcomes. However, few studies consider sleep in a multivariate context. Therefore, we propose a paradigmatic shift in sleep research towards sleep health. Conducting research through a sleep health lens can change health practice by clarifying which sleep characteristics are most important to treat, enhancing screening efforts, and facilitating the generalization of findings to all individuals, not just those with specific sleep disorders or complaints. Before achieving these long-term goals, however, the crucial first steps in the study of sleep health are to determine which sleep profiles predict health outcomes (Aim 1), and develop predictive algorithms that can identify individuals at risk of adverse health outcomes based on their sleep and other risk factors (Aim 2). These aims can only be achieved with an awareness of the statistical challenges related to the inherent multidimensionality of sleep health (e.g. multiple domains of sleep, multiple characteristics to represent each domain, multiple data sources, etc.). This multidimensionality generates substantial methodological barriers regarding variable and model selection and threatens researchers' abilities to develop transparent and reproducible models. In this R01, investigators will apply rigorous, sophisticated statistical methods to a large aggregated sample of adults aged >60 with self-report and polysomnographic characterization and over 10 years of longitudinal follow-up from three parent studies: Osteoporotic Fractures in Men Sleep Study (MrOS), Study of Osteoporotic Fractures (SOF), and the Sleep Heart Health Study (SHHS). In Aim 1, investigators will determine which multidimensional sleep profiles predict time to mortality in older adults using Cox-proportional hazards models, tree-structured survival analysis, and clustering. In Aim 2, investigators will develop powerful machine learning algorithms that incorporate sleep and other risk factors to identify which older adults have the greatest risk for early mortality. Within each aim, the impact of sex and race will be rigorously investigated, and models will be internally validated in independent samples to ensure reproducibility. The Secondary Aim is to investigate generalizability to studies with different demographic profiles and sleep protocols (Wisconsin Sleep Cohort Study, Honolulu Asia Aging Study of Sleep America) and different data types (sleep diary, actigraphy). All models will be developed in the context of other important known risk factors, including but not limited to age, gender, race, sleep apnea, cardiovascular disease, smoking, and BMI. Findings from Aim 1 will jumpstart subsequent mechanistic research focused on sleep-related causal factors of mortality, leading to identification of targeted treatments for sleep problems that could reduce risk of mortality and morbidity. Findings from Aim 2 will provide important preliminary evidence for enhanced screening tools that can more accurately identify which individuals are at risk for adverse health outcomes. PROJECT NARRATIVE This project initiates a paradigmatic research shift by studying multivariate sleep health in older adults. Cutting- edge statistical methods will be applied to a large, multi-cohort sample, and replicability of findings will be rigorously investigated. Achieving the proposed aims will improve health practice by: (1) determining which multivariate sleep profiles predict mortality in older adults, thereby jumpstarting subsequent mechanistic research on sleep-related causal factors of mortality and targeted treatments to reduce mortality; and (2) suggesting prediction algorithms that incorporate sleep to enhance health screening for adverse health outcomes in older adults.",Sleep Health Profiles and Mortality Risk in Older Adults: A Multi-Cohort Application of Novel Statistical Methods,9360318,R01AG056331,"['developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' Outcome ', ' Population ', ' aged ', ' health practice ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' lens ', ' lenses ', ' flexibility ', ' flexible ', ' screening ', ' cardiovascular health ', ' nonlinear regression ', ' non-linear regression ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' Cardiac health ', ' Heart health ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' ages ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Algorithms ', ' Americas ', ' Asia ', ' Attention ', ' Awareness ', ' Beds ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cognition ', ' Concurrent Studies ', ' Cohort Studies ', ' Cox Proportional Hazards Models ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Sources ', ' depression ', ' Mental Depression ', ' sleepiness ', ' Somnolence ', ' Drowsiness ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Maps ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Parents ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Sleep ', ' Sleep Apnea Syndromes ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Smoking ', ' Survival Analysis ', ' Survival Analyses ', ' Testing ', ' Time ', ' Trees ', ' visual function ', ' Sight ', ' Vision ', ' Wakefulness ', ' Wisconsin ', ' Woman ', ' Gender ', ' falls ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Polysomnography ', ' base ', ' improved ', ' Ensure ', ' Individual ', ' satisfaction ', ' Sample Size ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' diaries ', ' Well in self ', ' self wellness ', ' psychological wellness ', ' mental wellbeing ', ' mental well-being ', ' Sense of well-being ', ' Psychological Well Being ', ' Normal psyche ', ' Normal mental state ', ' Normal mental condition ', ' Feels well ', ' Emotional well being ', ' Dimensions ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Techniques ', ' osteoporosis with pathological fracture ', ' Osteoporotic fracture ', ' Osteoporosis with fracture ', ' Fracture due to osteoporosis ', ' cohort ', ' Structure ', ' novel ', ' Patient Self-Report ', ' Self-Report ', ' Statistical Methods ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' actigraphy ', ' Data ', ' Reproducibility ', ' Subgroup ', ' Characteristics ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' ']",NIA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2017,353303,0.08245349062012627
"The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites Project Summary/Abstract Background: Blacks have higher rates of cardiovascular disease (CVD), CVD risk markers (elevated blood pressure, cholesterol, and unhealthy glucose levels), and CVD mortality, compared to whites. Despite advances in understanding how CVD disparity is engendered and preventing CVD, blacks compared to whites are still disproportionately burdened by CVD, particularly CVD risk markers. Therefore, more novel targets that drive racial disparity in CVD risk markers must be investigated in order to reduce and eliminate CVD disparity. Evidence indicating that insufficient sleep (sleep duration 6hrs/24 hr. cycle), which disproportionately affects blacks, is linked to concurrent and future CVD risk may offer a potentially novel mechanism explaining CVD risk disparity between blacks and whites. However, it is unclear whether insufficient sleep directly or indirectly drives disparity in CVD risk between blacks and whites? Therefore, the purpose of the proposed K01 study is to investigate whether insufficient sleep independently explains a significant portion of racial disparity in CVD risk markers, while adjusting for the confounding effects of sleep apnea and insomnia (two sleep disorders that cause insufficient sleep). Additionally, since 55% of insufficient sleepers are obese and blacks are twice as likely to be obese compared to whites, the candidate will investigate the independent and combined effects of insufficient sleep and obesity on the disparity in CVD risk markers between blacks and whites. Research: In the proposed K01, the candidate, Dr. Azizi Seixas, will investigate: 1) whether insufficient sleep and/or obesity play an important role in the relationship between race/ethnicity and CVD risk, controlling for sleep apnea and insomnia; and 2) what sleep duration and body mass index profile is associated with lowest probability of CVD risk among blacks and whites, using advanced mathematical analytic methods and complex system simulation modeling. Training: The training plan builds upon the candidate's background and experience in conducting research in sleep disorders and cardiovascular disease (e.g. hypertension and stroke), among minority populations. During the K01, the candidate will receive training in sleep science and physiology, cardiovascular disease and advanced analytical, machine learning, and simulation modeling. He will perform secondary analyses of data from the Sleep Heart Health Study, a NHLBI-funded study. The pedagogical approach includes one-on-one mentorship, course work, mentored laboratory training (practicum), and attendance to targeted conferences and seminars, with the common goal of supporting his transition to being an independent scientist. Project Narrative The overarching objective of this K01 career development award is to foster the transition of Dr. Azizi Seixas into an independent scientist in the area of sleep and cardiovascular disease and health disparities. The proposed study will investigate a novel mechanism underlying associations between insufficient sleep, obesity, and disparity in CVD risk markers between blacks and whites. Findings from the study will be the basis of sleep and obesity interventions to reduce CVD risk, especially among diverse groups burdened by cardiovascular disease.",The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites,9228453,K01HL135452,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' ages ', ' Age ', ' Blood Pressure ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' Cholesterol ', ' Concurrent Studies ', ' Cohort Studies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Future ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Glucose Intolerance ', ' Goals ', ' services research ', ' Medical Care Research ', ' Health Services Evaluation ', ' Health Services Research ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Life Style ', ' Lifestyle ', ' Mathematics ', ' Math ', ' Mentors ', ' Mentorship ', ' Methodology ', ' mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Physiology ', ' Play ', ' Probability ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' Role ', ' social role ', ' Science ', ' Sleep ', ' Sleep Apnea Syndromes ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Work ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' Mediating ', ' Caring ', ' advisory team ', ' Task Forces ', ' Advisory Committees ', ' analytical method ', ' base ', ' Site ', ' Area ', ' Biological ', ' Medical ', ' Link ', ' Training ', ' Failure ', ' Bayesian statistics ', ' Bayesian statistical inference ', ' Bayesian statistical analysis ', ' Bayesian spatial analysis ', ' Bayesian network analysis ', ' Bayesian inference ', ' Bayesian Analysis ', ' Fostering ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Complex ', ' System ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' Equation ', ' experience ', ' Disease Outcome ', ' novel ', ' models and simulation ', ' model-based simulation ', ' Reporting ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Risk Reduction ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' Body mass index ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Address ', ' Data ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Risk Marker ', ' developmental ', ' Development ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' poststroke ', ' post stroke ', ' effectiveness research ', ' underserved people ', ' under served population ', ' Underserved Population ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' comparative effectiveness ', ' fasting glucose ', ' social health determinants ', ' Bayesian Modeling ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' cardiovascular health ', ' pedagogical content ', ' pedagogical method ', ' pedagogical development ', ' pedagogical approach ', ' laboratory experience ', ' laboratory training ', ' lab experience ', ' stroke survivor ', ' disparity reduction ', ' reduce disparity ', ' Cardiac health ', ' Heart health ', ' secondary analysis ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K01,2017,179820,0.13071578339539583
"Dose-distribution radiomics to predict morbidity risk in radiotherapy     DESCRIPTION (provided by applicant):  Lung cancer remains the leading cause of cancer deaths in the U.S., and definitive radiotherapy is the standard of care for locally advanced, inoperable cases. Radiation therapy is also highly flexible, and can be adapted for variations in tumor volume and location. However, decision support models to optimize treatment planning and avoid morbidity on a patient-by-patient basis are lacking. Recently, the randomized phase III trial, RTOG 0617, compared high dose (74 Gy) treatments to standard (60 Gy) treatments for non-small cell lung cancer (NSCLC), and demonstrated an unexpectedly higher rate of mortality in the high-dose arm. We hypothesize that this was primarily due to heart irradiation, in combination with lung irradiation factors. The goal of this project is to determine and validate predictive models of morbidity following thoracic RT, in order to achieve safer and more optimal tradeoffs between local control and morbidity. We will jointly analyze three large, high-quality datasets using innovative image-registration, machine learning, and dose characteristics (dose-based radiomics), to develop mathematical models that could be used to predict and avoid key morbidity endpoints in radiotherapy treatment planning. All endpoints will use dose-distribution comparison methods to examine the correlation between dose and morbidity as a function of anatomic location, thus providing greater assurance that the source of radiotherapy toxicity is correctly identified. Under Specific Aim 1 (SA1), we will use innovative deformable image registration methods to map all patient dose distributions to a segmented reference case anatomy (including heart, lungs, bronchii, and blood vessels). The accuracy of the deformations will be mapped carefully using an innovative non-parametric estimation methodology. Tissue regions with high correlations to morbidity will be extracted for machine learning under SAs 2 and 3. Under SA2, we will apply innovative machine learning with the goal of relating dose factors extracted under SA1 with treatment-related death hazard. Under SA3, we will apply the same methodology to the risk of severe pneumonitis. We hypothesize that treatment related death hazard and radiation pneumonitis form a single predictable continuum of increasing risk, and we will attempt to bring together the results of SA2 and SA3 in a single predictive model. Innovative post-modeling analyses of mutually exclusive predictors will be used to make the machine learning models interpretable. The overall goals of this grant are: (1) to advance the state of science in the field of personally-optimized radiation oncology, and (2) to provide decision support tools to guide patient-specific tradeoffs between local control and toxicity in lung cancer radiotherapy. PUBLIC HEALTH RELEVANCE:  Lung cancer for locally advanced, inoperable disease is usually treated with radiotherapy, but the cause of severe treatment morbidity is not well understood. Using advanced data analysis methods, we will produce mathematical models that can be used to compare the risks of alternative treatment plans for individual patients, thereby avoiding unnecessary treatment morbidity.",Dose-distribution radiomics to predict morbidity risk in radiotherapy,9271942,R01CA198121,"['ages ', ' Age ', ' Algorithms ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' vascular ', ' Blood Vessels ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' Cause of Death ', ' Systematics ', ' Classification ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Death ', ' Cessation of life ', ' Disorder ', ' Disease ', ' Fractionation Radiotherapy ', ' FRACN ', ' Chemical Fractionation ', ' Fractionation ', ' Goals ', ' Grant ', ' Heart ', ' cardiac failure ', ' Heart failure ', ' Modern Man ', ' Human ', ' Incidence ', ' indexing ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Maps ', ' Mathematics ', ' Math ', ' Methods ', ' Methodology ', ' Modernization ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patients ', ' Radiation therapy ', ' treatment with radiation ', ' radio-therapy ', ' radiation treatment ', ' Radiotherapy ', ' Radiotherapeutics ', ' Research ', ' Risk ', ' Risk Factors ', ' Science ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Trees ', ' Universities ', ' Washington ', ' forest ', ' Decision Support Model ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' quality assurance ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Variation ', ' Variant ', ' Death Rate ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonia ', ' Radiation Pneumonitis ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Logistics ', ' Radiation Oncology ', ' Normal tissue morphology ', ' Normal Tissue ', ' Shapes ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Source ', ' Pattern ', ' Techniques ', ' Location ', ' Tumor Volume ', ' Tumor Tissue ', ' hazard ', ' treatment planning ', ' Toxic effect ', ' Toxicities ', ' Locally Advanced Malignant Neoplasm ', ' Locally Advanced Cancer ', ' Structure ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Radiation ', ' Modeling ', ' Sampling ', ' preconditioning ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' cancer radiation therapy ', ' Cancer Radiotherapy ', ' irradiation ', ' Dose ', ' Data ', ' Dose-Limiting ', ' Radiation Therapy Oncology Group ', ' RTOG ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cancer Cause ', ' Cancer Etiology ', ' Characteristics ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' image registration ', ' software systems ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' public health relevance ', ' alternative treatment ', ' standard of care ', ' flexibility ', ' flexible ', ' arm ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' phase III trial ', ' image guided ', ' image guidance ', ' learning strategy ', ' learning method ', ' learning activity ', ' support tools ', ' individual patient ', ' unnecessary treatment ', ' radiomics ', ' ']",NCI,SLOAN-KETTERING INST CAN RESEARCH,R01,2017,577764,0.1184215278682198
"An automated and massively scalable platform for organismal and developmental genetics Project Summary Sleep regulation plays a critical role in proper neurological development. During sleep, there is enhanced synaptic plasticity in the nervous system in addition to often extensive neural remodeling. Although we know that sleep regulation is important to neurological development, many aspects of sleep regulation are poorly understood. In particular, the mechanisms of how we compensate for missed sleep in future sleep cycles are mysterious, despite general knowledge of how circadian rhythms are established. It is likely that these mechanisms involve neuropeptide signaling in the brain. However, current tools to study the roles these peptides play in sleep homeostasis, even with the use of simple model organisms like C. elegans, are low- throughput, qualitative, and subjective. In order to study sleep-like behavior in C. elegans, there is an unmet need for a tool for continuously monitoring and perturbing long-term behavior of the worm, as well as an automated and un-biased method for quantifying behavioral data. In this proposal, we will first develop the enabling technology, and use it to identify the roles of neuropeptides in homeostasis of the nematodes sleep- like state. In Aim I, we will engineer and validate a scalable microscopy platform for monitoring and perturbing C. elegans behavior, decreasing the cost of long-term candidate screens by ~ 100 fold. In Aim 2, we will quantify behavior of wild-type animals via an automated and bias-free quantitative analysis to establish baseline behavior and prioritize behaviors that are linked to sleep homeostasis. In Aim 3, we will use the technology developed in Aims I and 2 to quantify differences in behavior of C. elegans neuropeptide mutants using a candidate approach. Because of the strong preliminary data we have gathered so far and the experience of the sponsors laboratory, this proposed work is likely to identify the roles of these candidate neuropeptides in sleep homeostasis, contributing to our mechanistic understanding of sleep regulation. Furthermore, the tools we develop for this particular study will also have broad utilities in many other problems, such as developmental programming, aging, and neurobehavioral studies. Project Narrative Sleep regulation plays a critical role in proper brain development and is linked to a variety of neurological and behavioral disorders. In particular, how animals correct for interrupted sleep cycles in future cycles could lead to therapeutic targets, but apart from a few implicated neuropeptides, little is known about the mechanisms behind this aspect of sleep. The objective of this proposal is to identify the roles of neuropeptides in sleep homeostasis by screening C. elegans mutants for behavioral defects.",An automated and massively scalable platform for organismal and developmental genetics,9396432,F31GM123662,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Aging ', ' Animals ', ' Automation ', ' Behavior ', ' behavioral disorder ', ' Behavior Disorders ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Communities ', ' computer vision ', ' Computer Vision Systems ', ' Disorder ', ' Disease ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Pre-clinical Drug Evaluation ', ' Drug Screening ', ' Preclinical Drug Evaluation ', ' Engineering ', ' artificial environment ', ' Controlled Environment ', ' Future ', ' Genes ', ' Goals ', ' Health ', ' Heterogeneity ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Modern Man ', ' Human ', ' Insulin ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Maps ', ' Methods ', ' Microscopy ', ' Study models ', ' Nematoda ', ' roundworm ', ' Nematodes ', ' Nervous system structure ', ' Neurologic Organ System ', ' Neurologic Body System ', ' Nervous System ', ' nervous system disorder ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' Neuropeptides ', ' Organism ', ' living system ', ' Peptides ', ' Physiology ', ' Play ', ' Reproduction ', ' Role ', ' social role ', ' Signal Pathway ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Sleep ', ' Synapses ', ' synapse ', ' Synaptic ', ' Technology ', ' Work ', ' Zebra Fish ', ' Zebra Danio ', ' Danio rerio ', ' Brachydanio rerio ', ' Zebrafish ', ' C.elegans ', ' C. elegans ', ' C elegans ', ' Caenorhabditis elegans ', ' improved ', ' Neurological ', ' Neurologic ', ' Link ', ' Individual ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Middle Insomnia ', ' Sleep maintenance insomnia ', ' Night waking ', ' Interrupted sleep ', ' Fitful sleep ', ' Difficulty staying asleep ', ' Difficulty in sleep maintenance ', ' Broken sleep ', ' Complex ', ' Source ', ' Pattern ', ' Techniques ', ' System ', ' developmental genetics ', ' experience ', ' mutant ', ' success ', ' sleep regulation ', ' sleep control ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' relating to nervous system ', ' neural ', ' Emotional ', ' Regulation ', ' Modeling ', ' software development ', ' developing computer software ', ' develop software ', ' Microfluidics ', ' Microfluidic ', ' Address ', ' Microfluidic Microchips ', ' microfluidic chip ', ' Microfluidic Lab-On-A-Chip ', ' Microfluidic Device ', ' Defect ', ' Data ', ' Interruption ', ' Monitor ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' age dependent ', ' age related ', ' cost ', ' behavioral monitoring ', ' Behavior monitoring ', ' neurobehavioral ', ' Synaptic plasticity ', ' innovation ', ' innovative ', ' innovate ', ' circadian pacemaker ', ' circadian clock ', ' therapeutic target ', ' screening ', ' behavioral study ', ' behavior study ', ' ']",NIGMS,GEORGIA INSTITUTE OF TECHNOLOGY,F31,2017,44044,0.12164657749771916
"Pre-clinic model for sleep deprivation-induced obesity and hedonic intake due to noise exposure Easy access to calories and poor sleep independently increase eating and weight gain. Sleep deprivation (SD) increases hedonic intake (eating palatable food for pleasure) and in humans environmental noise exposure causes SD, is detrimental to health and increases obesity risk. We have shown that noise (pre-recorded random city sounds) causes SD, hyperphagia and weight gain in male rats, which is novel and replicates human data. Yet this methodology must be established in female rodents as sex is a critical biological variable. The overall goal is to establish the method of SD by noise to induce obesity in female rodents, use the model to define the contribution of hedonic intake to SD-induced obesity and use these data to develop a non- invasive method to distinguish types of sleep (REM vs. non-REM). Aim 1 will use statistical learning methods and data mining to quantify REM and non-REM based on data collected from studies in this proposal (food intake, physical activity energy expenditure, EEG, EMG) and will establish SD by noise in females as a pre- clinical model for obesity due to SD. We will compare sleep disruption caused by noise exposure and the gentle handling technique; test whether sex moderates the effect of noise exposure on sleep, weight gain and food intake and whether Suvorexant (used clinically for insomnia) normalizes sleep in noise-exposed rats. Finally, data mining will be completed to address a critical need in the sleep field: to develop a high-throughput, non-invasive technique to distinguish REM vs. non-REM in rats. In humans, SD increases hedonic intake, which promotes obesity. Taste preference is highly variable and may modulate hedonic intake caused by SD. We show clear individual taste preferences for snacks using a cafeteria (CAF) diet protocol (i.e. rotating selection of palatable human snacks plus rodent chow ad lib). We also show SD by noise increases chocolate intake in sated rats with low initial preference for chocolate and maintains intake in rats with high preference. Thus, SD by noise may increase intake of palatable foods that would normally be avoided during adequate sleep. Aim 2 will test if the effects of SD by noise on hedonic intake and obesity are dependent upon sex and individual taste preferences in rats. We will test whether SD increases binge chocolate intake and intake of CAF diet snacks. The scientific premise is: SD in increases hedonic intake and promotes obesity in humans; environmental noise promotes SD in humans; and our pre-clinical model mirrors the human response to SD. We hypothesize that like male rats, SD due to noise will cause obesity in females and increase hedonic intake despite individual preference to in turn worsen obesity. The innovation lies in establishing a simple method of SD that replicates human SD-induced obesity; developing a non-surgical method to measure sleep types; and identifying how individual preferences affects hedonic intake and obesity caused by SD. Its significance lies in establishing a translational model of SD independent of sex to identify mechanisms underlying reward behavior and obesity propensity due to SD, with the ultimate goal of developing novel anti-obesity therapies. The goal of these studies is to establish our method of sleep deprivation by environmental noise to induce obesity, and use this model to define the contribution of hedonic intake to obesity due to sleep deprivation in humans. Studies will employ a novel method of partial sleep deprivation by noise, which mimics weight gain in sleep deprived humans. We propose to establish sleep deprivation by noise in females rats, as we have shown in males, as a pre-clinical model for obesity due to sleep deprivation, develop a non-invasive method to distinguish REM from non-REM sleep based on food intake, physical activity, energy expenditure, EEG and EMG data, in lieu of EEG/EMG recordings, and define the effects of sleep deprivation by noise on hedonic intake and its influence on obesity in males and female rats. Completing these studies will provide a valid translational pre-clinical model of sleep deprivation to identify how sleep deprivation alters reward behavior, eating and obesity propensity, with the ultimate goal of developing new therapies against obesity.",Pre-clinic model for sleep deprivation-induced obesity and hedonic intake due to noise exposure,9386535,R21NS099468,"['Affect ', ' Animal Welfare ', ' driving ', ' Automobile Driving ', ' Behavior ', ' Body Weight ', ' caloric dietary content ', ' Caloric Intake ', ' Energy Intake ', ' Chocolate ', ' Cities ', ' Communities ', ' dietary ', ' Diet ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Food Intake ', ' Eating ', ' EEG ', ' Electroencephalography ', ' Energy Expenditure ', ' Energy Metabolism ', ' Female ', ' Food or Food Product ', ' Food ', ' Food Preferences ', ' Goals ', ' Gold ', ' Health ', ' Modern Man ', ' Human ', ' polyphagia ', ' Overeating ', ' Hyperphagia ', ' male ', ' Manuals ', ' Methods ', ' Methodology ', ' Study models ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Noise ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Publishing ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rewards ', ' Rodent ', ' Rodents Mammals ', ' Rodentia ', ' Sex Characteristics ', ' Sex Differences ', ' Sleep ', ' Sleep Deprivation ', ' REM Sleep ', ' rapid eye movement sleep ', ' dreaming sleep ', ' Rhombencephalic Sleep ', ' Paradoxical Sleep ', ' Fast-Wave Sleep ', ' sound ', ' Stress ', ' Testing ', ' Hydrogen Oxide ', ' Water ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' Weight ', ' Measures ', ' Mediating ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' base ', ' urban area ', ' improved ', ' Clinical ', ' Biological ', ' Physical activity ', ' Individual ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Mechanics ', ' mechanical ', ' Middle Insomnia ', ' Sleep maintenance insomnia ', ' Night waking ', ' Interrupted sleep ', ' Fitful sleep ', ' Difficulty staying asleep ', ' Difficulty in sleep maintenance ', ' Broken sleep ', ' Calories ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' preference ', ' experience ', ' human data ', ' pleasure ', ' novel ', ' noise pollution ', ' Reporting ', ' Palate ', ' Touch sensation ', ' tactile sensation ', ' Touch ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' response ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' data mining ', ' datamining ', ' Address ', ' Data ', ' Intake ', ' Pre-Clinical Model ', ' Preclinical Models ', ' Rodent Model ', ' sex ', ' Behavioral ', ' food consumption ', ' feeding ', ' nonrapid eye movement ', ' non-rapid eye movement ', ' non-REM ', ' NREM (non rapid eye movement) ', ' non rapid eye movement ', ' Outcome ', ' Consumption ', ' hedonic ', ' innovation ', ' innovative ', ' innovate ', ' defined contribution ', ' obesity risk ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' Taste preferences ', ' learning strategy ', ' learning method ', ' learning activity ', ' ']",NINDS,UNIVERSITY OF ARIZONA,R21,2017,227208,0.11514217236796777
"Precision Medicine in Sarcoidosis ABSTRACT Sarcoidosis is a systemic inflammatory disease of unknown etiology characterized by non-caseating granulomas in affected organs, primarily in the lungs. Approximately 30% of patients with sarcoidosis progress to debilitating disease; however, the drivers of susceptibility or resilience to disease remain poorly understood. An inflammatory response to an undefined antigen is postulated as the etiology of granuloma formation, and the pathogenesis has been suggested to involve gene-pathogen interaction, yet analysis of single genes or microbes has not proven applicable to diagnosis of all forms of sarcoidosis. Indeed, rather than a single organism, the disease may represent an interaction between the community of organisms that comprise the lung microbiome (community of organisms that live in and on us) and the host immune response. We propose that understanding the microbiome/host interaction will suggest strategies for precision medicine approaches to sarcoidosis. This proposal addresses this significant gap by investigating interactions between the lung microbiome, host immune and clinical responses in sarcoidosis using multiomics approaches  a critically innovative strategy. Our preliminary data support our novel hypotheses. First, we identified distinct lung microbiomes that differentiated patients with sarcoidosis versus controls. Second, our results identified biomarkers of disease severity that were associated with decreased lung function. Third, a recurrent analytic theme that emerged, regardless of the type of -omic analysis, was that sarcoidosis is characterized by pathways related to apoptosis and autophagy, which is consistent with our observation of decreased abundance of peripheral lymphocytes and functional immune anergy. These data led us to our Overall Hypothesis: Lung microbiome and host immune interactions characterized by apoptosis and autophagy pathways influence sarcoidosis clinical course. This hypothesis will be tested by an observational prospective and validation study of sarcoidosis patients at 5 time points to facilitate time series analyses. Aims 1 and 2 focus on lung microbiome or host immune responses, respectively, in relation to clinical course of sarcoidosis. Using these data in Aim 3, predictive models will be constructed based on integrated data of metagenomic and host-immune interactions. The novelty and significance of our multiomics strategy is to construct models for precision medicine therapies to harness bioinformatic strategies into focused, patient-specific approaches. The long-term significance of this study is to define pathways for sarcoidosis progression or resolution, and to develop database of these findings to further develop more precise, testable, models. PROJECT NARRATIVE Sarcoidosis is a disease of unknown etiology that predominately affects the lung and may affect other organs. We propose to construct a model to predict sarcoidosis progression or resolution by identifying microbial and immune interactions. We postulate that these models will be helpful in designing therapeutic options.",Precision Medicine in Sarcoidosis,9708373,R01HL138628,"['Affect ', ' Algorithms ', ' Antigens ', ' immunogen ', ' ATGN ', ' Autophagocytosis ', ' autophagy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Communities ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Feces ', ' stool ', ' Genes ', ' Granuloma ', ' Granulomatous Lesion ', ' Immunity ', ' indexing ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Methods ', ' Organism ', ' living system ', ' Patients ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Prospective Studies ', ' Recurrence ', ' Recurrent ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Messenger RNA ', ' mRNA ', ' Sarcoidosis ', "" Schaumann's Disease "", "" Boeck's Sarcoid "", ' Besnier-Boeck Disease ', ' Technology ', ' Testing ', ' Time ', ' cytokine ', ' Taxonomy ', ' General Taxonomy ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' base ', ' Organ ', ' bronchopulmonary lavage therapy ', ' Lung Lavage ', ' Bronchopulmonary Lavage ', ' Bronchioalveolar Lavage ', ' Bronchoalveolar Lavage ', ' Peripheral ', ' Clinical ', ' Susceptibility ', ' Predisposition ', ' anergy ', ' data base ', ' Data Bases ', ' Databases ', ' Disease Progression ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Immune ', ' Immunes ', ' Severity of illness ', ' disease severity ', ' microbial ', ' novel ', ' validation studies ', ' Time Series Analysis ', ' Disease model ', ' disorder model ', ' Pathogenesis ', ' Modeling ', ' response ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Address ', ' Data ', ' Resolution ', ' Apoptotic ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' pathway ', ' Pathway interactions ', ' microbiome ', ' metagenome ', ' deep sequencing ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' resilience ', ' pathogen ', ' innovative ', ' innovate ', ' innovation ', ' transcriptomics ', ' Microbe ', ' metagenome sequencing ', ' metagenomic sequencing ', ' clinical relevance ', ' clinically relevant ', ' Functional Metagenomics ', ' Metagenomics ', ' inflammation marker ', ' inflammatory marker ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' precision-based medicine ', ' precision medicine ', ' clinical predictors ', ' global transcription profile ', ' global gene expression ', ' transcriptome ', ' pulmonary microbiome ', ' lung microbiome ', ' host microbiome ', ' ']",NHLBI,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2018,143095,0.14183780501413243
"Mentorship in the Endocrinology of Sleep The overarching goal of this application for a K24 Midcareer Investigator Award in Patient-Oriented Research is to foster training of promising junior investigators in cutting edge patient-oriented research related to how sleep biology influences cardiometabolic health. It capitalizes on the established network and resources of the recently renewed UCLA CTSI that includes a highly successful KL2 program. Dr. Liu led a competitively- funded Endocrine and Cardiometabolic Program in Sleep Biology at the University of Sydney, and since 2012, he has led a similar interdisciplinary research program in Los Angeles supported by a 5 year NHLBI R01 Hormonal mechanisms of sleep restriction that is currently in its 3rd year. During his 10 years of mentoring, he has trained 16 individuals: 10 remaining in academic medicine and 2 others in industry-related patient orientated research. Three of his trainees won major US young investigator awards under his supervision. He continues to support, mentor, and publish with former trainees, often long after they left his laboratory.  Disturbed sleep causes insulin resistance, promotes poor food choices, and curtails fat loss while dieting, thereby reducing the effectiveness of standard weight loss programs. However, the cardiometabolic consequences of disturbed sleep are not well recognized by the community, and the evidential bases to justify widespread changes to community sleeping patterns for cardiometabolic health reasons are evolving. Showing the mechanisms by which sleep restriction leads to cardiometabolic ill-health, particularly in older adults according to sex, are critical steps in providing these data. Dr. Liu's goal is to mentor the next cadre of independent clinical scientists focused on placing sleep alongside diet and exercise as part of healthy lifestyle, by understanding hormonal mechanisms and consequences of disrupted, inadequate or misaligned sleep.  The work proposed in this application fulfill these goals. Aim 1 will reveal the hypothalmo-pituitary-adrenal and hypothalamo-pituitary-gonadal mechanisms that cause testosterone-cortisol imbalance when sleep is restricted in older men and women (20 in each group). In doing so, trainees will learn endocrine physiology and chronobiological study design, IRB processes, recruitment skills, and hands-on study management. Aim 2 will identify sex differences in these mechanisms, trainees will learn statistical methods and abstract/presentation/ manuscript preparation. Aim 3 requires trainees to discover new mechanisms by which sleep restriction causes insulin resistance and alters appetite or food intake. Certain inflammatory mediators, hormones, or factors related to ethnicity or age could be studied. Aim 3 fulfils broader expectations for trainees to have a second project that is faster to accomplish, more exploratory, and driven by their interests and available resources, to develop a line of research that complements and is separate from that of the mentors. Taken together, these experiments will generate new knowledge of the relationship between sleep and hormonal cardiometabolic and reproductive health, provide wide-ranging training opportunities, and generate future R and K proposals. Narrative Insufficient sleep is common, and leads to insulin resistance, a major factor in the development of type 2 diabetes mellitus. This proposal attempts to reveal the hormonal mechanisms underlying the link between insufficient sleep with insulin resistance in older adults, the population at greatest risk for disordered sleep and metabolic disorders as a vehicle to provide outstanding mentorship opportunities.",Mentorship in the Endocrinology of Sleep,9522654,K24HL138632,"['Adrenal Glands ', ' suprarenal gland ', ' Adrenals ', ' Corticotropin ', ' Adrenocorticotropin ', ' Adrenocorticotropic Hormone ', ' ACTH ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Amino Acids ', ' aminoacid ', ' Analysis of Variance ', ' Variance Analyses ', ' ANOVA ', ' Desire for food ', ' Appetite ', ' Award ', ' Biology ', ' Carbohydrates ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Corticotropin-Releasing Hormone ', ' corticotropin releasing hormone ', ' Corticotropin-Releasing Hormone-41 ', ' Corticotropin-Releasing Factor-41 ', ' Corticotropin-Releasing Factor ', ' Corticoliberin ', ' CRF-41 ', ' ACTH-Releasing Factor ', ' Cosyntropin ', ' alpha1-24-Corticotropin ', ' alpha-1,24-Corticotropin ', ' Tetracosapeptide ', ' Tetracosactrin ', ' Tetracosactide ', ' Synthetic ACTH ', ' Corticotropin (1-24)-Tetracosapeptide ', ' Corticotropin (1-24)-Peptide ', ' ACTH 1-24 ', ' 1-24-Corticotropin ', ' Couples ', ' Dexamethasone ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Diet ', ' dietary ', ' Eating ', ' Food Intake ', ' Endocrinology ', ' Metabolism and Endocrinology ', ' Environment ', ' Equilibrium ', ' balance function ', ' balance ', ' Fatty acid glycerol esters ', ' Fats ', ' Fatty Acids ', ' Feedback ', ' Female ', ' Food ', ' Food or Food Product ', ' Freezing ', ' Future ', ' Goals ', ' Gonadal structure ', ' gonads ', ' gonad ', ' Grant ', ' Health ', ' Hormones ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hunger ', ' Hydrocortisone ', ' Proctocort ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hypothalamic structure ', ' hypothalamic ', ' Hypothalamus ', ' Industry ', ' Insulin Resistance ', ' insulin resistant ', ' Ketoconazole ', ' Laboratories ', ' Learning ', ' Luteinizing Hormone ', ' Therapeutic LH ', ' Recombinant Luteinizing Hormone ', ' Pituitary Lutenizing Hormone ', ' Lutropin ', ' Leuteinizing Hormone ', ' Interstitial Cell-Stimulating Hormone ', ' Interstitial Cell Stimulating Hormone ', ' Gonadotropin Hormone Releasing Hormone ', ' gonadotropin releasing factor ', ' follicle stimulating hormone-releasing factor ', ' Therapeutic GRH ', ' Recombinant Gonadorelin ', ' Pulsti ', ' Luteinizing Hormone-Releasing Factor ', ' Luliberin ', ' LHFSH Releasing Hormone ', ' LH-Releasing Hormone ', ' LH-FSH Releasing Hormone ', ' Gonadotropin-Releasing Hormone ', ' Gonadorelinum ', ' Gonadoliberin ', ' FSH-Releasing Hormone ', ' Los Angeles ', ' male ', ' Medicine ', ' men ', "" men's "", ' Menopause ', ' menopausal ', ' Female Change of Life ', ' Mentors ', ' Mentorship ', ' Metabolic Diseases ', ' metabolism disorder ', ' Thesaurismosis ', ' Metabolic Disorder ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Moods ', ' Muscle ', ' muscular ', ' Muscle Tissue ', ' Muscular Atrophy ', ' muscle wasting ', ' muscle loss ', ' muscle deterioration ', ' muscle degradation ', ' muscle breakdown ', ' Muscle Atrophy ', ' Osteoporosis ', ' Ovary ', ' Patients ', ' Pituitary Gland ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Pituitary-Adrenal System ', ' pituitary adrenal axis ', ' Production ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Sex Characteristics ', ' Sex Differences ', ' Sleep ', ' Stress ', ' Supervision ', ' Testing ', ' Testosterone ', ' Trans-Testosterone ', ' Therapeutic Testosterone ', ' Universities ', ' Weight Gain ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Woman ', ' Work ', ' ganirelix ', ' Measures ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' base ', ' Left ', ' Clinical ', ' Physiologic ', ' Physiological ', ' postmenopausal ', ' post-menopausal ', ' Postmenopausal Period ', ' Post-menopausal Period ', ' Post-Menopause ', ' Postmenopause ', ' Link ', ' biosynthesis ', ' Anabolism ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Blood Serum ', ' Serum ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Reproductive Health ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Metabolism Studies ', ' Metabolic Studies ', ' Abnormal Assessment of Metabolism ', ' metabolic abnormality assessment ', ' Metabolic ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Prediabetes syndrome ', ' syndrome x ', ' prediabetic ', ' pre-diabetic ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Scientist ', ' bone age ', ' Pattern ', ' Hormonal ', ' Endocrine ', ' interest ', ' Infusion procedures ', ' Infusion ', ' pituitary gonadal axis ', ' Steroid biosynthesis ', ' steroidogenesis ', ' Manuscripts ', ' skills ', ' Endocrine Physiology ', ' expectation ', ' disorder risk ', ' disease risk ', ' Catabolism ', ' Statistical Methods ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' response ', ' sarcopenia ', ' sarcopenic ', ' patient oriented research ', ' patient oriented study ', ' insulin sensitivity ', ' Metabolic syndrome ', ' Virulence Factors ', ' Pathogenicity Factors ', ' diabetes risk ', ' Effectiveness ', ' prevent ', ' preventing ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Dose ', ' Data ', ' Midcareer Investigator Award in Patient-Oriented Research ', ' Midcareer Investigator Award in Patient-Oriented Research (K24) ', ' K24 Program ', ' K24 Mechanism ', ' Research Training ', ' Preparation ', ' Process ', ' sex ', ' developmental ', ' Development ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' age dependent ', ' age related ', ' diet and exercise ', ' Population ', ' aged ', ' older women ', ' older men ', ' IRBs ', ' IRB ', ' Institutional Review Boards ', ' healthy lifestyle ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' training opportunity ', ' experimental research ', ' experiment ', ' experimental study ', ' recruit ', ' hormonal secretion ', ' Hormone secretion ', ' hormone signals ', ' hormonal signals ', ' weight loss programming ', ' weight loss program ', ' hormonal imbalance ', ' Hormone imbalance ', ' cardiometabolic ', ' cardiometabolism ', ' ']",NHLBI,LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER,K24,2018,119586,0.09683163010563556
"The Health and Behavioral Effects of Sleep Deprivation Among the Urban Poor in India Project Summary/Abstract Evidence demonstrates that sleep deprivation causes impaired cognitive function and is associated with impaired health (e.g. altered immune and cardiovascular function). Yet these conclusions largely derive from correlational relationships or studies of acute sleep deprivation lasting only a few days in sleep labs. Further, research on sleep in disadvantaged populations and sleep disparities is limited, despite severe environmental challenges to sleep among the poor. Moreover, the potentially bi-directional relationship between poor sleep and poor decision-making, a possible mediator of the income-health gradient, remains largely unexplored. In short, while poor sleep could be an important contributor to health disparities and accelerated aging, we know relatively little about the causes and impacts of sleep deprivation in low SES populations and how to address these disparities, a gap that is especially acute in real-world settings with extended time frames. This K01 application will provide key training for career advancement and begin to close this gap in knowledge. To accomplish this goal, a randomized field experiment with 400 participants, each enrolled for over one month, in Chennai, India, will (1) objectively measure sleep and key environmental factors to provide preliminary evidence on the role of environmental causes of sleep deprivation in an urban environment, (2) rigorously evaluate two simple scalable interventions to reduce sleep deprivation among low-income adults in their natural environments, (3) estimate the causal effect of improved sleep on cognitive function, decision- making, health outcomes and behaviors (e.g. blood pressure, alcohol consumption), and earnings, and (4) utilizing questions regarding sleep asked of both RCT participants and a 50,000 person nationally-representative sample, estimate the extent of sleep deprivation and its impacts more broadly in urban India. The training aims underpinning the research aims and the applicant's long-term research goals are to expand knowledge and skills in: (1) cognitive psychology and the measurement of cognitive function, (2) aging, and (3) machine learning and predictive modeling. This training, accomplished through multiple avenues including coursework, directed study, and mentorship, will directly facilitate the proposed research and extend the scope and impact of the applicant's long-term research career studying health disparities and interactions between health and decision-making which may impact both cognitive and physical health as individuals age. Notably, while this application focuses on the impacts of sleep deprivation, the potential for health to shape decision-making is much broader. Constant exposure to other aspects of poor health associated with poverty, such as pain, also have the potential to exert a mental tax, leading to impaired cognition and poor decisions. Such a negative feedback loop between these factors and decision-making has the potential to further exacerbate health disparities. The far-reaching applicability of this idea beyond the direct scope of this proposal opens the door to high public-health significance through a wide variety of channels. Project narrative Although sleep has significant potential to impair cognition and impede health, relatively little is known about the causes and impacts of sleep deprivation in low SES populations and how to address these disparities, a gap that is especially acute in real-world settings with extended time frames. This research will begin to close this gap in knowledge through a 400 person randomized trial in Chennai, India, which will objectively and rigorously measure sleep and key environmental factors impacting sleep, evaluate the impact of two simple and scalable interventions to improve sleep, and estimate the causal effect of improved sleep on cognitive function, decision-making, health outcomes and behaviors (e.g. blood pressure, tobacco consumption), and earnings. Providing rigorous evidence on these relationships and improving our collective understanding of the causes and costs to sleep deprivation, including not just direct health outcomes, but also shifts in preferences and decision-making directly relevant to health, will provide policy-relevant information important to improving health and healthy behaviors as well as promoting heathy and economically-secure aging.",The Health and Behavioral Effects of Sleep Deprivation Among the Urban Poor in India,9452529,K01AG055691,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Aging ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Attention ', ' Behavior ', ' Blood Pressure ', ' Cardiovascular Physiology ', ' cardiovascular function ', ' Career Mobility ', ' career transition ', ' career advancement ', ' Cognition ', ' Cost Measures ', ' cost measurement ', ' Cost metrics ', ' Decision Making ', ' Developing Countries ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Disease ', ' Disorder ', ' Economic Models ', ' Environment ', ' Feedback ', ' Food ', ' Food or Food Product ', ' Goals ', ' Health ', ' Health behavior ', ' Health Promotion ', ' promoting health ', ' Salutogenesis ', ' Incidence ', ' Income ', ' Economical Income ', ' Economic Income ', ' India ', ' Insecta ', ' Insects Invertebrates ', ' Insects ', ' Investments ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Light ', ' Photoradiation ', ' Mentorship ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Morbidity - disease rate ', ' Morbidity ', ' Persons ', ' Noise ', ' Pain ', ' Painful ', ' Personal Satisfaction ', ' wellbeing ', ' well-being ', ' Poverty ', ' Psychomotor Performance ', ' psychomotor function ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Role ', ' social role ', ' Running ', ' Savings ', ' Sleep ', ' Sleep Deprivation ', ' Surveys ', ' Survey Instrument ', ' Taxes ', ' Testing ', ' Time ', ' Tobacco ', ' Translating ', ' Measures ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' career ', ' improved ', ' Acute ', ' Chronic ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Training ', ' mental ', ' Psyche structure ', ' Individual ', ' Logistics ', ' Policies ', ' Measurement ', ' Exposure to ', ' Shapes ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Cognitive Science ', ' cognitive psychology ', ' Knowledge ', ' programs ', ' cognitive function ', ' Dimensions ', ' physical conditioning ', ' physical health ', ' respiratory ', ' Tobacco use ', ' Tobacco Consumption ', ' preference ', ' skills training ', ' skills ', ' Participant ', ' research study ', ' Patient Self-Report ', ' Self-Report ', ' Impaired health ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Inflammatory Response ', ' health disparity ', ' disparity in health ', ' immune function ', ' Cellular Immune Function ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' low SES ', ' Low income ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' cognitive change ', ' Address ', ' global health ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cognitive ', ' enroll ', ' Enrollment ', ' Observational research ', ' Observation study ', ' Observation research ', ' Observational Study ', ' discount ', ' Behavioral ', ' cost ', ' health economics ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' Outcome ', ' Population ', ' healthy aging ', ' Randomization trial ', ' randomized trial ', ' Secure ', ' adverse consequence ', ' adverse outcome ', ' cognitive ability ', ' behavioral economics ', ' reduction in blood pressure ', ' reduction in BP ', ' reduce blood pressure ', ' reduce BP ', ' lowers blood pressure ', ' lower blood pressure ', ' lower BP ', ' BP reduction ', ' blood pressure reduction ', ' disadvantaged population ', ' experimental research ', ' experiment ', ' experimental study ', ' sleep health ', ' ']",NIA,UNIVERSITY OF PENNSYLVANIA,K01,2018,127872,0.12356008834777311
"Imaging Biomarkers of Severe Respiratory Infections in Premature Infants ABSTRACT  Prematurity is the largest single cause of death in children under five in the world and lower respiratory tract infections (LRTI) are the top cause of hospitalization and mortality in premature infants. Clinical tools to predict and prevent severe LRTI in premature pediatric patients are critically needed to allow early interventions to decrease the high morbidity and mortality in this patient group. Although imaging biomarkers of lung disease from computed tomography have been successfully used in adults, they entail heightened risks for children due to cumulative radiation and the need for sedation. Our goal is to address these gaps and improve clinical practice by developing an objective imaging biomarker framework to assess the risk of severe respiratory disease in premature babies using non-invasive low-radiation X-ray imaging.  Previous efforts lead by Dr. Linguraru (Principal Investigator) at Children's National Health System (CNHS) have focused on developing technical components to quantify lung structural data from chest X-ray (CXR) in children. The image processing pipeline developed at CNHS integrates three novel technical components: a) automatic lung segmentation, b) obtrusive object removal in CXR, and c) severity quantification of lung pathology. These innovations enabled the development of a quantitative imaging software technology to quantify Lung Air trapping and Irregular opacities Radiological analyzer (LungAIR).  This Phase I project builds on the methodology developed in preliminary work. We will analyze a large database (n=200) of retrospective CXR images from premature infants with known clinical outcomes, and further develop and validate lung imaging biomarkers. In Specific Aim 1 we will design and implement a prototype of the software technology (LungAIR) for the localization and quantification of heterogeneous aeration patterns in each lung quadrant through quantitative imaging algorithms. A graphical user interface will also be developed for the simple clinical use of the technology. In Specific Aim 2 we will perform clinical outcome analysis to correlate these biomarkers with the severity of lung disease. We will also combine our new imaging biomarkers with clinical parameters to design and evaluate a predictive model of LRTI risk in the first year of life to optimize the clinical management and improve the outcomes for premature babies.  In this project, CNHS partners with Kitware to translate our research into a clinical software application and lay the groundwork for further developments and clinical studies in Phase II. In summary, our approach will enable better clinical management of diseases of prematurity leading to novel diagnostic strategies to improve treatment and outcomes for the highly vulnerable population of premature infants. PROJECT NARRATIVE  Prematurity is the largest single cause of death in children under five in the world and lower respiratory tract infections (LRTI) are the top cause of hospitalization and mortality in premature infants. Clinical tools to predict and prevent severe LRTI in premature pediatric patients are critically needed to allow early interventions to decrease the high morbidity and mortality in this patient group. In this project, we will develop and evaluate a quantitative imaging technology to assess the risk for severe respiratory disease in premature babies using non-invasive low-radiation X-ray imaging.",Imaging Biomarkers of Severe Respiratory Infections in Premature Infants,9549210,R41HL145669,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Air ', ' Algorithms ', ' Bronchopulmonary Dysplasia ', ' newborn chronic lung disease ', ' neonatal chronic lung disease ', ' infant chronic lung disease ', ' chronic lung disease in prematurity ', ' chronic lung disease in newborns ', ' chronic lung disease in neonates ', ' chronic lung disease in neonatal infants ', ' chronic lung disease in infants ', ' Cause of Death ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Clinical Markers ', ' Clinical Research ', ' Clinical Study ', ' Complement ', ' Complement Proteins ', ' Complication ', ' Goals ', ' Heterogeneity ', ' Hospitalization ', ' Pediatric Hospitals ', "" Children's Hospital "", ' Infant Mortality ', ' Infant Mortality Total ', ' Premature Infant ', ' preterm neonate ', ' preterm infant human ', ' preterm infant ', ' preterm baby ', ' premature infant human ', ' premature baby ', ' pre-term neonate ', ' pre-term infant ', ' pre-term baby ', ' pre-mature baby ', ' infants born prematurely ', ' infants born premature ', ' infants born pre-mature ', ' Neonatal Intensive Care Units ', ' neonatal ICU ', ' Newborn Intensive Care Units ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Neonatology ', ' Patients ', ' Pregnancy ', ' Gestation ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Research ', ' Respiratory Tract Infections ', ' Respiratory Infections ', ' Risk ', ' Computer software ', ' Software ', ' Software Engineering ', ' Computer Software Engineering ', ' Computer Software Development ', ' Technology ', ' Thoracic Radiography ', ' thorax radiography ', ' thoracic radiogram ', ' radiographic lung image ', ' radiographic chest image ', ' lung radiography ', ' chest radiography ', ' chest Xray ', ' chest X ray ', ' CXR ', ' Time ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' Translating ', ' Work ', ' Diagnostic radiologic examination ', ' X-Ray Medical Imaging ', ' X-Ray Imaging ', ' Roentgenography ', ' Radiography ', ' Diagnostic X-Ray Radiology ', ' Diagnostic X-Ray ', ' Diagnostic Radiology ', ' Conventional X-Ray ', ' Roentgen Rays ', ' Xrays ', ' X-Rays Radiation ', ' X-Rays ', ' X-Radiation ', ' Measures ', ' Treatment outcome ', ' Healthcare ', ' health care ', ' Risk Assessment ', ' Specialist ', ' Lower Respiratory Tract Infection ', ' Lower respiratory infection ', ' base ', ' image processing ', ' improved ', ' lung scanning ', ' Pulmonary imaging ', ' lung imaging ', ' Chronic ', ' Clinical ', ' prematurity ', ' premature ', ' Phase ', ' lung base ', ' lung basal segment ', ' data base ', ' Data Bases ', ' Databases ', ' Early Intervention ', ' Collaborations ', ' news ', ' Shapes ', ' tool ', ' Sedation procedure ', ' sedation ', ' Life ', ' Disease Management ', ' Disorder Management ', ' programs ', ' Severities ', ' Pattern ', ' Country ', ' Lower respiratory tract structure ', ' lower respiratory tract ', ' Severity of illness ', ' disease severity ', ' respiratory ', ' novel ', ' Graph ', ' Reporting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Pulmonary Pathology ', ' lung pathology ', ' Early identification ', ' Radiation ', ' Sampling ', ' Vulnerable Populations ', ' vulnerable group ', ' prevent ', ' preventing ', ' Address ', ' Health system ', ' Data ', ' Imaging Device ', ' Imaging Tool ', ' Imaging Instrument ', ' Clinical Management ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Therapy Clinical Trials ', ' STTR ', ' Small Business Technology Transfer Research ', ' Validation ', ' Monitor ', ' Principal Investigator ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cost ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' infant measurement ', ' infant monitoring ', ' Outcome ', ' Imaging technology ', ' innovative ', ' innovate ', ' innovation ', ' multidisciplinary ', ' clinical applicability ', ' clinical application ', ' graphic user interface ', ' Graphical interface ', ' graphical user interface ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' prototype ', ' high risk ', ' standard of care ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' clinical practice ', ' clinical decision-making ', ' child patients ', ' pediatric patients ', ' imaging software ', ' quantitative imaging ', ' imaging marker ', ' imaging biomarker ', ' improved outcome ', ' Risk stratification ', ' clinical translation ', ' deep learning ', ' ']",NHLBI,"KITWARE, INC.",R41,2018,210105,0.09486549617130505
"Dose-distribution radiomics to predict morbidity risk in radiotherapy     DESCRIPTION (provided by applicant):  Lung cancer remains the leading cause of cancer deaths in the U.S., and definitive radiotherapy is the standard of care for locally advanced, inoperable cases. Radiation therapy is also highly flexible, and can be adapted for variations in tumor volume and location. However, decision support models to optimize treatment planning and avoid morbidity on a patient-by-patient basis are lacking. Recently, the randomized phase III trial, RTOG 0617, compared high dose (74 Gy) treatments to standard (60 Gy) treatments for non-small cell lung cancer (NSCLC), and demonstrated an unexpectedly higher rate of mortality in the high-dose arm. We hypothesize that this was primarily due to heart irradiation, in combination with lung irradiation factors. The goal of this project is to determine and validate predictive models of morbidity following thoracic RT, in order to achieve safer and more optimal tradeoffs between local control and morbidity. We will jointly analyze three large, high-quality datasets using innovative image-registration, machine learning, and dose characteristics (dose-based radiomics), to develop mathematical models that could be used to predict and avoid key morbidity endpoints in radiotherapy treatment planning. All endpoints will use dose-distribution comparison methods to examine the correlation between dose and morbidity as a function of anatomic location, thus providing greater assurance that the source of radiotherapy toxicity is correctly identified. Under Specific Aim 1 (SA1), we will use innovative deformable image registration methods to map all patient dose distributions to a segmented reference case anatomy (including heart, lungs, bronchii, and blood vessels). The accuracy of the deformations will be mapped carefully using an innovative non-parametric estimation methodology. Tissue regions with high correlations to morbidity will be extracted for machine learning under SAs 2 and 3. Under SA2, we will apply innovative machine learning with the goal of relating dose factors extracted under SA1 with treatment-related death hazard. Under SA3, we will apply the same methodology to the risk of severe pneumonitis. We hypothesize that treatment related death hazard and radiation pneumonitis form a single predictable continuum of increasing risk, and we will attempt to bring together the results of SA2 and SA3 in a single predictive model. Innovative post-modeling analyses of mutually exclusive predictors will be used to make the machine learning models interpretable. The overall goals of this grant are: (1) to advance the state of science in the field of personally-optimized radiation oncology, and (2) to provide decision support tools to guide patient-specific tradeoffs between local control and toxicity in lung cancer radiotherapy. PUBLIC HEALTH RELEVANCE:  Lung cancer for locally advanced, inoperable disease is usually treated with radiotherapy, but the cause of severe treatment morbidity is not well understood. Using advanced data analysis methods, we will produce mathematical models that can be used to compare the risks of alternative treatment plans for individual patients, thereby avoiding unnecessary treatment morbidity.",Dose-distribution radiomics to predict morbidity risk in radiotherapy,9477682,R01CA198121,"['Age ', ' ages ', ' Algorithms ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Blood Vessels ', ' vascular ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cause of Death ', ' Classification ', ' Systematics ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Fractionation ', ' Fractionation Radiotherapy ', ' FRACN ', ' Chemical Fractionation ', ' Goals ', ' Grant ', ' Heart ', ' Heart failure ', ' cardiac failure ', ' Human ', ' Modern Man ', ' Incidence ', ' indexing ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Maps ', ' Mathematics ', ' Math ', ' Methods ', ' Methodology ', ' Modernization ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patients ', ' Radiation therapy ', ' treatment with radiation ', ' radio-therapy ', ' radiation treatment ', ' Radiotherapy ', ' Radiotherapeutics ', ' Research ', ' Risk ', ' Risk Factors ', ' Science ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Trees ', ' Universities ', ' Washington ', ' forest ', ' Decision Support Model ', ' Uncertainty ', ' doubt ', ' Data Set ', ' Dataset ', ' Custom ', ' base ', ' quality assurance ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Variation ', ' Variant ', ' Death Rate ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonia ', ' Radiation Pneumonitis ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Logistics ', ' Radiation Oncology ', ' Normal tissue morphology ', ' Normal Tissue ', ' Shapes ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Source ', ' Pattern ', ' Techniques ', ' Location ', ' Tumor Volume ', ' Tumor Tissue ', ' hazard ', ' treatment planning ', ' Toxic effect ', ' Toxicities ', ' Locally Advanced Malignant Neoplasm ', ' Locally Advanced Cancer ', ' Structure ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Radiation ', ' Modeling ', ' Sampling ', ' preconditioning ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' cancer radiation therapy ', ' Cancer Radiotherapy ', ' irradiation ', ' Dose ', ' Data ', ' Dose-Limiting ', ' Radiation Therapy Oncology Group ', ' RTOG ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cancer Cause ', ' Cancer Etiology ', ' Characteristics ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' image registration ', ' software systems ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' public health relevance ', ' alternative treatment ', ' standard of care ', ' flexible ', ' flexibility ', ' arm ', ' Pneumonitis ', ' Pulmonary Inflammation ', ' phase III trial ', ' image guidance ', ' image guided ', ' learning method ', ' learning activity ', ' learning strategy ', ' support tools ', ' individual patient ', ' unnecessary treatment ', ' radiomics ', ' therapy optimization ', ' treatment optimization ', ' ']",NCI,SLOAN-KETTERING INST CAN RESEARCH,R01,2018,577261,0.1184215278682198
"Using natural language processing and machine learning to identify potentially preventable hospital admissions among outpatients with chronic lung diseases Project Summary Patients living with chronic lung diseases (CLDs) are frequently admitted to the hospital for potentially preventable causes. Such admissions may be discordant with patient preferences and/or represent a low-value allocation of health system resources. To anticipate such admissions, existing clinical prediction models in this eld typically produce an all-cause risk estimate which, even if accurate, overlooks the actionable mechanisms behind admis- sion risk and therefore fails to identify a prescribed response. This limitation may explain the only modest  at best  reductions in hospital admissions and readmissions seen in most intervention bundles that have been tested in this population. An opportunity exists, therefore, to predict hospitalization risk while simultaneously identifying patient phenotypes (i.e. some constellation of social, demographic, clinical, and other characteristics) for which known preventive interventions exist. The proposed study seeks to overcome these limitations and capitalize on this opportunity by (1) conducting semi-structured interviews with hospitalized patients with CLDs, and their caregivers and clinicians, to directly identify modiable risks and their associated phenotypes driving hospital ad- missions; (2) using natural language processing techniques (NLP) to build classication models that will leverage nuanced narrative, social, and clinical information in the unstructured text of clinical encounter notes to identify patients with these phenotypes; and (3) building risk prediction model focused on actionable phenotypes with a wide-array of traditional regression and machine learning approaches while also incorporating large numbers of predictor variables from text data and accounting for time-varying trends. The candidate's preliminary work using basic NLP techniques to signicantly improve the discrimination of clinical prediction models in an inpatient population has motivated this methodologic approach. The rising burden and costs of hospitalizations associated with CLDs, and the increasing attention from federal payers, highlights the critical nature of this work. Completion of this research will build upon the candidate's past training, which includes a Masters of Science in Health Policy Research obtained with NHLBI T32 support, and will provide the experience, education, and mentorship to allow the candidate to become a fully independent investigator. Based on the candidate's tailored training plan, he will acquire advanced skills in mixed-methods research, NLP, and trial design all through coursework, close men- toring and supervision, and direct practice. The skills will position him ideally to submit successful R01s testing the deployment of the proposed clinical prediction models in real-world settings. The candidate's primary mentor, collaborators, and advisors will ensure adherence to the proposed timeline and goals and provide a support- ive environment for him to develop an independent research career testing the real-world deployment of clinical prediction models to reduce low-value and preference-discordant care for patients with CLDs. Project Narrative Every year many people living with chronic lung diseases are admitted to the hospital despite the fact that some of these admissions may have been prevented with early identication and intervention prior to the hospitalization. Previous attempts at preventing such hospitalizations have been limited by their ability to both accurately identify those at risk, and because most risk models do not provide a reason for the likely admission. The proposed work draws directly on the experiences of patients with chronic lung diseases who are admitted to a hospital, and then uses cutting edge statistical and computer science techniques to use information in the electronic health record to accurately predict the risk and the likely reason for future hospital admissions.",Using natural language processing and machine learning to identify potentially preventable hospital admissions among outpatients with chronic lung diseases,9505570,K23HL141639,"['Accounting ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Ambulatory Care ', ' outpatient treatment ', ' Outpatient Care ', ' Attention ', ' Automobile Driving ', ' driving ', ' Classification ', ' Systematics ', ' Communities ', ' Comorbidity ', ' co-morbidity ', ' Data Sources ', ' Diagnosis ', ' Discrimination ', ' Cognitive Discrimination ', ' Education ', ' Educational aspects ', ' Future ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Hospitalization ', ' Hospitals ', ' Inpatients ', ' Interview ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Mentors ', ' Mentorship ', ' Methods ', ' Methodology ', ' Mission ', ' Natural Language Processing ', ' natural language understanding ', ' Nurses ', ' nurse ', ' Outpatients ', ' Out-patients ', ' Palliative Care ', ' comfort care ', ' Palliative Treatment ', ' Palliative Therapy ', ' Patients ', ' Pennsylvania ', ' Phenotype ', ' Physicians ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Social support ', ' social support network ', ' Supervision ', ' Testing ', ' Time ', ' United States ', ' Universities ', ' Work ', ' Measures ', ' Caregivers ', ' Care Givers ', ' Research Methodology ', ' Research Methods ', ' TimeLine ', ' Data Set ', ' Dataset ', ' Caring ', ' base ', ' career ', ' improved ', ' Acute ', ' Clinical ', ' Interstitial Lung Diseases ', ' Hospitalization cost ', ' Hospital Costs ', ' Ensure ', ' Training ', ' Early Intervention ', ' instrument ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Patient Preferences ', ' Home environment ', ' Home ', ' Techniques ', ' interest ', ' preference ', ' experience ', ' Performance ', ' computer science ', ' Hospital Readmission ', ' readmission ', ' Structure ', ' skills ', ' novel ', ' social ', ' Positioning Attribute ', ' Position ', ' Chronic lung disease ', ' Admission activity ', ' Admission ', ' Early identification ', ' Modeling ', ' career development ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' model development ', ' Bioinformatics ', ' Bio-Informatics ', ' prevent ', ' preventing ', ' Address ', ' Health system ', ' end of life ', ' end-of-life ', ' Symptoms ', ' Adherence ', ' Data ', ' Master of Science ', ' Policy Research ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Risk Estimate ', ' Validation ', ' Monitor ', ' trend ', ' Characteristics ', ' Text ', ' Electronic Health Record ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' cost ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Population ', ' administrative data base ', ' administrative database ', ' innovative ', ' innovate ', ' innovation ', ' modifiable risk ', ' discrete data ', ' Randomization trial ', ' randomized trial ', ' Patient risk ', ' trial design ', ' workplace environment ', ' workplace climate ', ' work environment ', ' supportive environment ', ' peer-group environment ', ' job environment ', ' interdisciplinary environment ', ' interactive environment ', ' informal environment ', ' enthusiastic environment ', ' competitive environment ', ' business-friendly environment ', ' collaborative environment ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,K23,2018,195205,0.046404892478558876
"Cardiac genetic effects across HLBS phenotypes Forward genetic genome-wide association studies (GWAS) have successfully mapped thousands of loci regulating disorders of the heart, lung, blood and sleep (HLBS), implicating widespread sequence variation within the non-coding genome. However, their functions, mechanisms of action and how they impact disease is still unclear. To solve this new and important GWAS bottleneck, we use a functional genomics-inspired reverse genetics strategy to identify the `transcriptional machinery' (transcription factors (TF), cis-regulatory elements (CRE), target genes) controlling HLBS-relevant tissue functions and how DNA variants in them affect HLBS diseases. Taking advantage of our long-standing expertise and successes in complex, cardiovascular disorders, and novel computational methods we have recently developed, we propose novel genomics analyses of the Trans-Omics for Precision Medicine (TOPMed) Program phenotypes and their whole genome sequences, together with publicly available epigenomics data, to identify the molecular bases of HLBS disease. We will first focus on the transcriptional machinery controlling heart physiology and its disorders before exploring other HLBS-relevant tissues and disorders in collaboration with other TOPMed investigators. Our specific aims are: (1) Identifying the transcriptional machinery in the heart and other HLBS relevant tissues; and, (2) Connecting genomic variation in the transcriptional machinery to HLBS traits. Our approach will enable identification of the core molecular components that control HLBS tissues and how they are compromised in HLBS disorders. The major hypothesis explaining the results of heart, lung, blood and sleep (HLBS) genome-wide association studies (GWAS) is that sequence variants at specific cis-regulatory elements (CRE or enhancer) affect the binding of their cognate transcription factors (TF) to alter expression of specific HLBS genes and, thereby, modulate variation in the phenotype and disorders. In this proposal, we advance new computational approaches to identify the `transcriptional machinery' (TF, CRE, target genes) controlling HLBS-relevant tissue functions so that the effects of causal genetic variation can be identified within identified trait loci genome- wide. This tissue-based view provides an alternative, complementary approach for understanding HLBS trait and disease variation, a major public health challenge.",Cardiac genetic effects across HLBS phenotypes,9521873,R01HL141980,"['Affect ', ' Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Chromatin ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Family ', ' Gene Expression ', ' Gene Frequency ', ' allelic frequency ', ' Allele Frequency ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genome ', ' Genotype ', ' Heart ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Hematological Disease ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Maps ', ' Minor ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Phenotype ', ' Physiology ', ' Public Health ', ' Publishing ', ' Quality Control ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Sleep ', ' Testing ', ' Tissues ', ' Body Tissues ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Variation ', ' Genetic Diversity ', ' Weight ', ' Enhancers ', ' base ', ' improved ', ' Peripheral ', ' Variation ', ' Variant ', ' Link ', ' Individual ', ' Gene Targeting ', ' Sample Size ', ' Collaborations ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Complex ', ' success ', ' trait ', ' Base Pairing ', ' novel ', ' Code ', ' Coding System ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' functional genomics ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' histone modification ', ' Binding ', ' Molecular Interaction ', ' Data ', ' Regulatory Element ', ' Molecular ', ' Cardiac ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' epigenomics ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' genome-wide identification ', ' genome wide studies ', ' genome wide analysis ', ' genome-wide analysis ', ' discover genes ', ' gene discovery ', ' genomewide ', ' genome scale ', ' genome-wide ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' rare allele ', ' rare variant ', ' DNaseI-seq ', ' DNase-seq ', ' DNase I hypersensitive sites sequencing ', ' genomic variation ', ' reverse genetics ', ' ATACseq ', ' ATAC-seq ', ' GTEx ', ' Genotype-Tissue Expression Project ', ' full genome ', ' entire genome ', ' whole genome ', ' genomic data ', ' TOPMed ', ' Trans-Omics for Precision Medicine ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2018,438051,0.0011146360333239595
"Pre-clinic model for sleep deprivation-induced obesity and hedonic intake due to noise exposure Easy access to calories and poor sleep independently increase eating and weight gain. Sleep deprivation (SD) increases hedonic intake (eating palatable food for pleasure) and in humans environmental noise exposure causes SD, is detrimental to health and increases obesity risk. We have shown that noise (pre-recorded random city sounds) causes SD, hyperphagia and weight gain in male rats, which is novel and replicates human data. Yet this methodology must be established in female rodents as sex is a critical biological variable. The overall goal is to establish the method of SD by noise to induce obesity in female rodents, use the model to define the contribution of hedonic intake to SD-induced obesity and use these data to develop a non- invasive method to distinguish types of sleep (REM vs. non-REM). Aim 1 will use statistical learning methods and data mining to quantify REM and non-REM based on data collected from studies in this proposal (food intake, physical activity energy expenditure, EEG, EMG) and will establish SD by noise in females as a pre- clinical model for obesity due to SD. We will compare sleep disruption caused by noise exposure and the gentle handling technique; test whether sex moderates the effect of noise exposure on sleep, weight gain and food intake and whether Suvorexant (used clinically for insomnia) normalizes sleep in noise-exposed rats. Finally, data mining will be completed to address a critical need in the sleep field: to develop a high-throughput, non-invasive technique to distinguish REM vs. non-REM in rats. In humans, SD increases hedonic intake, which promotes obesity. Taste preference is highly variable and may modulate hedonic intake caused by SD. We show clear individual taste preferences for snacks using a cafeteria (CAF) diet protocol (i.e. rotating selection of palatable human snacks plus rodent chow ad lib). We also show SD by noise increases chocolate intake in sated rats with low initial preference for chocolate and maintains intake in rats with high preference. Thus, SD by noise may increase intake of palatable foods that would normally be avoided during adequate sleep. Aim 2 will test if the effects of SD by noise on hedonic intake and obesity are dependent upon sex and individual taste preferences in rats. We will test whether SD increases binge chocolate intake and intake of CAF diet snacks. The scientific premise is: SD in increases hedonic intake and promotes obesity in humans; environmental noise promotes SD in humans; and our pre-clinical model mirrors the human response to SD. We hypothesize that like male rats, SD due to noise will cause obesity in females and increase hedonic intake despite individual preference to in turn worsen obesity. The innovation lies in establishing a simple method of SD that replicates human SD-induced obesity; developing a non-surgical method to measure sleep types; and identifying how individual preferences affects hedonic intake and obesity caused by SD. Its significance lies in establishing a translational model of SD independent of sex to identify mechanisms underlying reward behavior and obesity propensity due to SD, with the ultimate goal of developing novel anti-obesity therapies. The goal of these studies is to establish our method of sleep deprivation by environmental noise to induce obesity, and use this model to define the contribution of hedonic intake to obesity due to sleep deprivation in humans. Studies will employ a novel method of partial sleep deprivation by noise, which mimics weight gain in sleep deprived humans. We propose to establish sleep deprivation by noise in females rats, as we have shown in males, as a pre-clinical model for obesity due to sleep deprivation, develop a non-invasive method to distinguish REM from non-REM sleep based on food intake, physical activity, energy expenditure, EEG and EMG data, in lieu of EEG/EMG recordings, and define the effects of sleep deprivation by noise on hedonic intake and its influence on obesity in males and female rats. Completing these studies will provide a valid translational pre-clinical model of sleep deprivation to identify how sleep deprivation alters reward behavior, eating and obesity propensity, with the ultimate goal of developing new therapies against obesity.",Pre-clinic model for sleep deprivation-induced obesity and hedonic intake due to noise exposure,9525441,R21NS099468,"['Affect ', ' Animal Welfare ', ' Automobile Driving ', ' driving ', ' Behavior ', ' Body Weight ', ' Energy Intake ', ' caloric dietary content ', ' Caloric Intake ', ' Chocolate ', ' Cities ', ' Communities ', ' Diet ', ' dietary ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Eating ', ' Food Intake ', ' Electroencephalography ', ' EEG ', ' Energy Metabolism ', ' Energy Expenditure ', ' Female ', ' Food ', ' Food or Food Product ', ' Food Preferences ', ' Goals ', ' Gold ', ' Health ', ' Human ', ' Modern Man ', ' Hyperphagia ', ' polyphagia ', ' Overeating ', ' male ', ' Manuals ', ' Methods ', ' Methodology ', ' Study models ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Noise ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Publishing ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rewards ', ' Rodent ', ' Rodents Mammals ', ' Rodentia ', ' Sex Characteristics ', ' Sex Differences ', ' Sleep ', ' Sleep Deprivation ', ' REM Sleep ', ' rapid eye movement sleep ', ' dreaming sleep ', ' Rhombencephalic Sleep ', ' Paradoxical Sleep ', ' Fast-Wave Sleep ', ' sound ', ' Stress ', ' Testing ', ' Water ', ' Hydrogen Oxide ', ' Weight Gain ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight ', ' Measures ', ' Mediating ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' base ', ' urban area ', ' improved ', ' Clinical ', ' Biological ', ' Physical activity ', ' Individual ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Mechanics ', ' mechanical ', ' Middle Insomnia ', ' Sleep maintenance insomnia ', ' Night waking ', ' Interrupted sleep ', ' Fitful sleep ', ' Difficulty staying asleep ', ' Difficulty in sleep maintenance ', ' Broken sleep ', ' Calories ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' preference ', ' experience ', ' human data ', ' pleasure ', ' novel ', ' noise pollution ', ' Reporting ', ' Palate ', ' Touch sensation ', ' tactile sensation ', ' Touch ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' response ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' data mining ', ' datamining ', ' Address ', ' Data ', ' Intake ', ' Pre-Clinical Model ', ' Preclinical Models ', ' Rodent Model ', ' sex ', ' Behavioral ', ' food consumption ', ' feeding ', ' nonrapid eye movement ', ' non-rapid eye movement ', ' non-REM ', ' NREM (non rapid eye movement) ', ' non rapid eye movement ', ' Outcome ', ' Consumption ', ' hedonic ', ' innovative ', ' innovate ', ' innovation ', ' defined contribution ', ' obesity risk ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' Taste preferences ', ' learning method ', ' learning activity ', ' learning strategy ', ' adequate sleep ', ' sleep quality ', ' translational model ', ' ']",NINDS,UNIVERSITY OF ARIZONA,R21,2018,188446,0.11514217236796777
"An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD ! Abstract  Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death worldwide with a devastating socio-economic burden impacting more than three million individuals per year in the US. The primary environmental risk factor in the susceptible population is smoking, which causes an exaggerated inflammatory response. However, many factors including several genetic risk variants substantially influence the susceptibility. Twin-based studies show that families with emphysema have a higher risk for the disease. The two different major phenotypes of COPD are small airway remodeling (airway disease) and alveolar destruction (emphysema). Although these two major phenotypes result in a similar deficiency in global lung function, the relationship between them is complicated and likely involves feedback mechanisms. Developing an objective method to characterize lung phenotypes is critical since treatment candidates vary based on phenotype. Measurements from High-Resolution Computed Tomography (HRCT) images are increasingly used to describe COPD since they can quantitatively describe the contribution of the phenotypes. To discover the genetic risk variants, Genome-Association Studies (GWAS) have focused on either the physiological lung function or a simple threshold-based measurement from lung CT, neither of which fully characterizes phenotypic subtypes or the distribution pattern of disease. The proposed studies will take advantage of the rich image and genetic data jointly to build a genetically-informed imaging biomarker to characterize each patient. For each patient, our method summarizes the CT image to a vector representation that accurately describes the severity of the disease. Also, a method to link the representation back to the genetic risk variants will be developed. If successful, these methods can be used to monitor the efficacy of treatment or progression of the disease using imaging data. Successful execution of the second aim will result in better understanding of the etiology of different disease subtypes and discovery of novel genetic pathways that could be used as potential drug targets. Furthermore, the patient representation enables the use of image data to construct a more powerful model to predict the so-called acute exacerbation event. Predicting the exacerbations is clinically important since they cause further damage to the lung.  In Aim 1, we develop and implement a novel image biomarker that is mutually informed by imaging and genetic data from each patient. Our statistical method in Aim 2 elucidates the underlying genetic pathways behind the abnormal anatomical variations explained by the biomarker. We validate our method on data from 10,300 patients in the COPDGene dataset. ! Narrative  Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death worldwide with a devastating socio-economic burden impacting more than three million individuals per year in the US. Measurements from High-Resolution Computed Tomography (HRCT) images are increasingly used to describe COPD. Many factors including several genetic risk variants substantially influence the susceptibility. We propose to take advantage of the rich image and genetic data jointly to understand the underlying biological causes of the disease and discovery of novel genetic pathways that could be used as potential drug targets.",An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD,9499218,R01HL141813,"['Affect ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Back ', ' Dorsum ', ' Cause of Death ', ' Chronic Bronchitis ', ' Computers ', ' Disease ', ' Disorder ', ' Disease Vectors ', ' Family ', ' Feedback ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genome ', ' Genotype ', ' Goals ', ' Joints ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Mathematics ', ' Math ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Obstruction ', ' Patients ', ' Phenotype ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Risk Factors ', ' Smoking ', ' Spirometry ', ' Time ', ' tomography ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' Twin Multiple Birth ', ' Twins ', ' Measures ', ' Data Set ', ' Dataset ', ' Caring ', ' base ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Area ', ' Acute ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Susceptibility ', ' Predisposition ', ' lung lobe ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Descriptor ', ' Deformity ', ' Anatomical Abnormality ', ' Anatomic Abnormality ', ' Genetic ', ' clinical Diagnosis ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Pollution ', ' Dimensions ', ' Complex ', ' Event ', ' Pattern ', ' Severity of illness ', ' disease severity ', ' small airways disease ', ' Biological Neural Networks ', ' neural network ', ' attenuation ', ' novel ', ' economic cost ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' Statistical Methods ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Modeling ', ' drug development ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Pathogenicity ', ' Inflammatory Response ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Address ', ' Data ', ' Economic Burden ', ' High Resolution Computed Tomography ', ' high resolution CT ', ' Resolution ', ' Genetic Risk ', ' Pathologic ', ' Monitor ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' vector ', ' designing ', ' design ', ' airway remodeling ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Population ', ' alveolar destruction ', ' Heritability ', ' endophenotype ', ' high risk ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' Drug Targeting ', ' Radiogenomics ', ' noninvasive imaging ', ' non-invasive imaging ', ' Lung CT scan ', ' Lung CT ', ' CT Lung Screening ', ' Lung CAT Scan ', ' imaging marker ', ' imaging biomarker ', ' genotyped patients ', ' imaging genetics ', ' high dimensionality ', ' Airway Disease ', ' deep learning ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2018,570906,0.07328307427471549
"Machine Learning Development for Subtyping COPD Project Summary Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. To date, researchers have attempted to use standard machine learning methodology to identify more meaningful subtypes of COPD, but these methods often make general assumptions about the data, limiting their ability to penetrate more complex patterns in some data sets. Thus, a meaningful reclassification of COPD subtypes that could lead to more targeted therapies and interventions has been elusive. The applicant introduces a new way of looking at the COPD subtyping problem by recasting it in terms of discovering associations of individuals to disease trajectories  i.e., grouping individuals based on their similarity in response to environmental and/or disease causing variables. The machine learning methods proposed build on the most recent advances in Bayesian nonparametrics, a collection of theoretical ideas and techniques that permit very flexible data representations. In this career development proposal, the applicant hypothesizes that these machine learning methods and extensions thereof  together with data sources not previously leveraged for COPD subtyping  will produce more biologically meaningful sub-groupings of patients, leading to a better understanding of the genetic and biological underpinnings of the disease and ultimately improved patient management. Aim 1 of this application involves evaluating the utility of CT-assessed lung mass  a potentially more discriminative measure of emphysema than conventionally used measures  for defining COPD subtypes using both K-means clustering and our disease trajectory algorithm. The goal of Aim 2 is to evaluate the utility of comorbidity data for defining COPD subtypes using our trajectory clustering algorithm. Novel computed tomography based measures of muscle wasting (cachexia) and pulmonary vascular pruning will be explored to determine their efficacy in subtype determination. Additionally, we will extend and test the trajectory algorithm in order to model discrete outputs (such as physician-diagnosed comorbidities), count data (e.g. exacerbations), and time-to-event data (death). In Aim 3, the applicant will extend our trajectory clustering algorithms to directly incorporate genetic and omics data for subtype discovery. Together, the research proposed in the aims of this award will take full advantage of the comprehensive data set available through the COPDGene study. Execution of the aims in this proposal will be possible through active collaboration with Dr. Ron Kikinis, M.D., a renowned leader in the field of medical image analysis, and Dr. Ed Silverman, an internationally recognized expert in the genetic epidemiology of COPD. Project Narrative Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. In carrying out the research outlined in the following proposal, we plan to develop and apply machine learning methods to better identify subpopulations of individuals who have similar forms of COPD, potentially enabling better, targeted therapies.",Machine Learning Development for Subtyping COPD,9480874,K25HL130637,"['Affect ', ' Algorithms ', ' Award ', ' Blood Vessels ', ' vascular ', ' Cachexia ', ' Cachectic ', ' Cause of Death ', ' Comorbidity ', ' co-morbidity ', ' Data Reporting ', ' data representation ', ' Data Sources ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Disease susceptibility ', ' liability to disease ', ' Diathesis ', ' Dyspnea ', ' Breathlessness ', ' Environment ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Health ', ' Heterogeneity ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Medical Imaging ', ' Methods ', ' Methodology ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' mortality ', ' Muscular Atrophy ', ' muscle wasting ', ' muscle loss ', ' muscle deterioration ', ' muscle degradation ', ' muscle breakdown ', ' Muscle Atrophy ', ' Patients ', ' Physicians ', ' Publishing ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Quality of life ', ' QOL ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Smoke ', ' Syndrome ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' Measures ', ' Pulmonary Mass ', ' Lung Mass ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Biological ', ' peripheral blood ', ' Failure ', ' Individual ', ' Bayesian statistics ', ' Bayesian statistical inference ', ' Bayesian statistical analysis ', ' Bayesian spatial analysis ', ' Bayesian network analysis ', ' Bayesian inference ', ' Bayesian Analysis ', ' Disease Progression ', ' Collaborations ', ' Descriptor ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' particle ', ' novel ', ' Disease model ', ' disorder model ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Modeling ', ' career development ', ' response ', ' genetic epidemiology ', ' genetic epidemiologic study ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Inflammatory Response ', ' genetic association ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' International ', ' Subgroup ', ' Collection ', ' physiological imaging ', ' Physiologic Imaging ', ' Functional Imaging ', ' Scheme ', ' Characteristics ', ' Process ', ' groupings ', ' Grouping ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' flexible ', ' flexibility ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' learning method ', ' learning activity ', ' learning strategy ', ' cigarette smoke ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,K25,2018,187699,0.09184403757293304
"A Systems Biology Approach to Mapping Aging in the lung PROJECT SUMMARY This proposal for an NRSA Individual Fellowship is motivated by two overarching goals: 1) to provide a rich environment for learning and growth to support the candidate's development into an effective physician- scientist, and 2) to generate a molecular map of aging in the lung by applying a systems biology approach to the analysis of transcriptomic data obtained over the lifespan of the laboratory mouse. The candidate and his mentors have designed a specific training plan that includes a rigorous research component and lays the foundation for a successful career. Aging is a key risk factor for morbidity and mortality related to diseases that affect the lung, however, the biological mechanisms contributing to this are not understood. The candidate will employ a systems biology approach to analyze already generated datasets to identify molecular pathways of aging in the lung. A better understanding of aging in the lung may ultimately lead to the development of novel therapies for lung diseases in older adults. Gene expression profiling using RNA-Seq has been used to generate maps of tissues by depicting tissues and purified constituent cellular populations on a molecular level. Transcriptional profiles from individuals with disease have been compared to those from healthy individuals in an attempt to develop signatures for a given disease. These signatures can be useful for disease diagnosis as well as for identifying targets for therapy. This proposal focuses on the contributions of two abundant cell populations in the lung, alveolar macrophages and alveolar type II cells (AT2), to the transcriptional signatures of aging in the lung. The candidate has preliminary data demonstrating evidence of an aging signature in alveolar macrophages and AT2 cells purified from mice at 18 months compared with 3 months. This signature persists during an influenza A virus infection challenge. The purpose of this proposal is to employ a systems biology approach to analyze transcriptomic data already obtained by investigators in the candidate's laboratory that includes whole lung tissue, alveolar macrophages, and AT2 cells harvested from mice over the lifespan (2 weeks, and 6,12,18 and 24 months of age). In Specific Aim 1, the candidate will generate a transcriptional map of aging in murine whole lung and purified cellular populations of alveolar macrophages and AT2 cells. In Specific Aim 2, the candidate will determine whether the transcriptional signature of aging in alveolar macrophages is cell autonomous or is driven by changes in the alveolar local microenvironment. Over the course of this award, the candidate will learn new systems biology approaches to analyzing large time-series genomic datasets and will develop a comprehensive understanding of the age-related changes in the innate immune system of the lung. The skills developed as part of this project will serve as a guide for the analysis of similar genomic data harvested from aging humans with lung disease. PROJECT NARRATIVE Aging is a key risk factor for morbidity and mortality related to diseases that affect the lung, including lung cancer, chronic obstructive pulmonary disease, lung fibrosis, and lung infections. The mechanisms contributing to the increased susceptibility of older adults to these diseases are unknown. We hope to identify novel mechanisms of aging in the lung that ultimately lead to new therapeutic options for diseases of the lung in older adults.",A Systems Biology Approach to Mapping Aging in the lung,9598302,F32HL136111,"['Affect ', ' Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aging ', ' Algorithms ', ' Animals ', ' Award ', ' Cells ', ' Cell Body ', ' Chronology ', ' Disease ', ' Disorder ', ' Epithelial Cells ', ' Fellowship ', ' Flow Cytometry ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Foundations ', ' Future ', ' Genes ', ' Biochemical Genetics ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Homeostasis ', ' Physiological Homeostasis ', ' Autoregulation ', ' Human ', ' Modern Man ', ' Infection ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Linear Regressions ', ' Longevity ', ' lifespan ', ' life span ', ' Length of Life ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Maps ', ' Mentors ', ' Laboratory mice ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Physicians ', ' Play ', ' Publishing ', ' Pulmonary Fibrosis ', ' lung fibrosis ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Supervision ', ' Time ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Fluorescence-Activated Cell Sorting ', ' Fluorescence-Activated Cell Sortings ', ' Fluorescence Activated Cell Sorting Fractionation ', ' Alveolar Macrophages ', ' Pulmonary Macrophages ', ' forest ', ' Data Set ', ' Dataset ', ' base ', ' career ', ' Surface ', ' Biological ', ' Series ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Type II Pneumocyte ', ' alveolar type II cell ', ' insight ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Adoptive Transfer ', ' Scientist ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Immune ', ' Immunes ', ' cell type ', ' juvenile animal ', ' young animal ', ' cohort ', ' skills ', ' novel ', ' Gene Expression Profiling ', ' transcriptional profiling ', ' gene expression assay ', ' gene expression analysis ', ' Transcript Expression Analysis ', ' Transcript Expression Analyses ', ' Gene Expression Pattern Analysis ', ' Gene Expression Monitoring ', ' Therapeutic Intervention ', ' intervention therapy ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' Influenza A virus ', ' Orthomyxovirus Type A ', ' Influenzavirus A ', ' Influenza Viruses Type A ', ' Influenza A ', ' lung development ', ' Alveolar ', ' Address ', ' Systems Biology ', ' Age-Months ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Harvest ', ' National Research Service Awards ', ' NRSA ', ' C57BL/6 Mouse ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' transcriptional signature ', ' gene expression signature ', ' gene expression pattern ', ' Expression Signature ', ' Gene Expression Profile ', ' age dependent ', ' age related ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Population ', ' aged ', ' prospective ', ' surfactant ', ' Coupled ', ' transcriptomics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' murine model ', ' mouse model ', ' network models ', ' disease diagnosis ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' university atmosphere ', ' training atmosphere ', ' school atmosphere ', ' learning environment ', ' learning atmosphere ', ' intellectual atmosphere ', ' educational environment ', ' education atmosphere ', ' collegiate atmosphere ', ' collegial atmosphere ', ' college atmosphere ', ' classroom environment ', ' educational atmosphere ', ' multi-omics ', ' multiple omics ', ' GTEx ', ' Genotype-Tissue Expression Project ', ' genomic data ', ' Innate Immune System ', ' pulmonary infections ', ' Lung infections ', ' unsupervised machine learning ', ' unsupervised learning ', ' ']",NHLBI,NORTHWESTERN UNIVERSITY AT CHICAGO,F32,2018,58282,0.07891212296677198
"The Role of the Microbiome in the Acute Respiratory Distress Syndrome     DESCRIPTION (provided by applicant): This K23 proposal will complete Robert Dickson, MD's training towards his long-term career goal of improving our understanding and treatment of lung disease by investigation of the microbiome. Dr. Dickson is a Pulmonary and Critical Care physician and scientist at the University of Michigan with established success in the burgeoning field of lung microbiome studies. This proposal builds on Dr. Dickson's previously acquired expertise in pulmonary pathophysiology and microbial ecology with new training in clinical research methods and computational biology. These established and newly-acquired skills will be integrated to improve our understanding of the role of the microbiome in the pathogenesis of the Acute Respiratory Distress Syndrome (ARDS). This research will be conducted under the guidance of primary mentor Gary B. Huffnagle PhD, co- mentor Theodore J. Standiford MD and an advisory board of accomplished investigators with expertise in clinical research methods, computational biology and lung immunology as well as extensive mentoring success. This 5-year plan includes formal coursework, professional development, and progressively independent research, with defined milestones to ensure productivity and a successful transition to independence. The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year. Numerous studies have identified indirect evidence of translocation of bacteria from the gastrointestinal tract to the lung in patients at risk for ARDS, but to date no study has evaluated the role of microbiome in the pathogenesis of ARDS. This proposal will test the hypothesis that translocation of gut bacteria to the lung provokes the inflammation and injury of ARDS via two specific Scientific Aims. Aim 1 will determine if translocation of enteric bacteria to the lung microbiome precedes the clinical development of ARDS, and Aim 2 will determine the temporal relationship between respiratory dysbiosis, host inflammation and the clinical onset of ARDS. Inherent to completing these high-level aims, Dr. Dickson will execute a prospective cohort study of patients at high risk for ARDS, utilize modern culture-independent techniques of bacterial identification to describe the bacterial communities in the lungs and gastrointestinal tracts of high-risk patients, and apply novel techniques of advanced computational modeling to the complex nonlinear system of ARDS pathogenesis. This work will build to at least two R01 proposals: 1) to determine if the lung microbiome contributes to disease progression among patients with established ARDS and 2) to determine if the lung microbiome can be therapeutically manipulated in critically ill patients to prevent or modulate respiratory disease. n addition to building a foundation for a programmatic line of research to understand the role of the microbiome in lung disease, this proposal will provide Dr. Dickson with research skills applicable to additional domains of human microbiome and ARDS research. This K23 award will equip Dr. Dickson to establish himself as an independent investigator and international leader in this promising field. PUBLIC HEALTH RELEVANCE: The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year; the National Institutes of Health have identified the prevention and early treatment of ARDS as a research priority. We lack an understanding of the pathogenesis of ARDS, impeding our ability to predict and prevent its onset. Determination of the role of the microbiome in the pathogenesis of ARDS would both 1) improve our ability to predict the onset of ARDS, enabling targeted preventive interventions and 2) identify novel therapeutic targets at the microbiome/host interface in patients at risk for ARDS.",The Role of the Microbiome in the Acute Respiratory Distress Syndrome,9413355,K23HL130641,"['Bacteria ', ' Catecholamines ', ' Sympathins ', ' Cells ', ' Cell Body ', ' Clinical Research ', ' Clinical Study ', ' Complement ', ' Complement Proteins ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Critical Care ', ' Critical Illness ', ' Critically Ill ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Ecology ', ' Environmental Science ', ' Enterobacter ', ' Aerobacter ', ' Enterobacteriaceae ', ' Enterobacteria ', ' Enteric Bacteria ', ' Coliform Bacilli ', ' Epinephrine ', ' Therapeutic Epinephrine ', ' Adrenaline ', ' Foundations ', ' Future ', ' Gastrointestinal tract structure ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Immigration ', ' indexing ', ' Inflammation ', ' Interleukin-1 beta ', ' Preinterleukin 1 Beta ', ' Interleukin-1 ', ' Interleukin 1beta ', ' IL1 ', ' IL1F2 ', ' IL1B Protein ', ' IL1- ', ' IL1-Beta ', ' IL-1 ', ' IL-1-b ', ' IL-1  ', ' IL-1 beta ', ' Beta Proprotein Interleukin 1 ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Mentors ', ' Michigan ', ' Modernization ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' neutrophil ', ' Polymorphonuclear Neutrophils ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Cell ', ' Neutrophilic Leukocyte ', ' Neutrophilic Granulocyte ', ' Marrow Neutrophil ', ' Heterophil Granulocyte ', ' Blood Segmented Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Blood Neutrophil ', ' Norepinephrine ', ' Noradrenaline ', ' Levonorepinephrine ', ' Levarterenol ', ' Patients ', ' Physicians ', ' Productivity ', ' outcome forecast ', ' Prognosis ', ' Pseudomonas ', ' Flavimonas ', ' Chrysemonas ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Adult Respiratory Distress Syndrome ', ' wet lung ', ' Stiff lung ', ' Shock Lung ', ' Da Nang Lung ', ' Adult RDS ', ' Acute Respiratory Distress Syndrome ', ' ARDS ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Testing ', ' Universities ', ' Work ', ' cytokine ', ' Research Methodology ', ' Research Methods ', ' Immunology ', ' Injury ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Logistic Regressions ', ' Nonlinear Models ', ' Non-linear Models ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Development Plans ', ' Disease Progression ', ' inflammatory mediator ', ' Inflammation Mediators ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Therapeutic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' Computational Biology ', ' computer biology ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Complex ', ' Techniques ', ' System ', ' respiratory ', ' gastrointestinal ', ' success ', ' gastrointestinal bacteria ', ' microbial ', ' skills ', ' novel ', ' member ', ' Prevention ', ' Pathogenesis ', ' Gammaproteobacteria ', ' -Proteobacteria ', ' gamma Proteobacteria ', ' TNF gene ', ' Tumor Necrosis Factor-alpha ', ' Tumor Necrosis Factor ', ' TNF ', ' TNFA ', ' TNF- ', ' TNF Alpha ', ' TNF A ', ' TNF ', ' Monocyte-Derived TNF ', ' Macrophage-Derived TNF ', ' Cachectin ', ' Modeling ', ' Sampling ', ' career development ', ' prevent ', ' preventing ', ' Alveolar ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' International ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Clinical Data ', ' Computational Technique ', ' developmental ', ' Development ', ' microbiome ', ' human-associated microbiome ', ' Human Microbiome ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' bloodstream infection ', ' blood infection ', ' Sepsis ', ' Trauma ', ' early therapy ', ' Early treatment ', ' patient centered ', ' patient oriented ', ' spatiotemporal ', ' high risk ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' new therapeutic target ', ' public health relevance ', ' intestinal tract microflora ', ' intestinal microflora ', ' intestinal microbiota ', ' intestinal microbes ', ' intestinal flora ', ' gut microflora ', ' gut microbiotic ', ' gut microbial consortia ', ' gut microbial composition ', ' gut microbial community ', ' gut microbe community ', ' gut flora ', ' gut community ', ' gut commensal ', ' gastrointestinal microbial flora ', ' enteric microbiota ', ' enteric microbial community ', ' Gastrointestinal microbiota ', ' GI microbiota ', ' gut microbiota ', ' clinical risk ', ' Patient risk ', ' Prospective cohort study ', ' clinical development ', ' bacterial microbiome ', ' bacteriome ', ' microbiome studies ', ' microbiome science ', ' Microbiomics ', ' microbiome research ', ' culture-independent techniques ', ' culture-independent molecular techniques ', ' culture-independent approaches ', ' culture-independent analyses ', ' Culture-independent methods ', ' bacteria in the gut ', ' gut bacteria ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' dysbiosis ', ' pulmonary microbiome ', ' lung microbiome ', ' pulmonary microbiota ', ' pulmonary microbial community ', ' lung microbial community ', ' lung microbiota ', ' bacterial community ', ' respiratory tract microbiome ', ' airway microbiome ', ' respiratory microbiome ', ' host microbiome ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K23,2018,171176,0.11607683332915562
"Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study ABSTRACT Short sleep duration, insomnia disorder, and sleep apnea are all highly prevalent in the US population and are associated with significant morbidity, including poor mental health, impaired neurocognitive function, metabolic dysregulation, and cardiovascular disease. In the context of the high prevalence of pernicious sleep disturbances, there is evidence that sleep disparities exist in the population, such that racial/ethnic minorities  including Mexican-Americans  are at increased risk of sleep disturbances. This is alarming, since this group is also at increased risk for many of the adverse cardiometabolic and functional outcomes linked to sleep disturbances. These associations may be influenced by economic hardship, psychosocial stress, unhealthy behaviors (diet, exercise, alcohol, and smoking), and acculturation  the degree to which an individual adopts (in this case) traditional Mexican versus American culture. The first goal of this project is to examine sleep duration, insomnia symptoms, and sleep apnea severity among Mexican-Americans and examine the role of these social-behavioral factors in this relationship. Second, this study aims to examine the role of sleep and cardiometabolic disease risk in this population and explore the role of acculturation, psychosocial stress, economic hardship, and/or unhealthy behaviors in these associations. To accomplish this, this project will partner with the Mariposa Community Health Center, the federally qualified clinic in the Nogales, AZ area. Nogales is a small city on the US/Mexico border that is an ideal location for studying non-urban Mexican- Americans, as it is made up of 83% Hispanics/Latinos, 33% immigrants, and 77% who primarily speak Spanish at home. This community-engaged project will partner with Mariposa and their Platicamos Salud program that uses experienced Community Health Workers (promotoras de salud) to collect data and perform home visits. The study will recruit N=900 Mexican-Americans and N=200 Non-Hispanic Whites to complete a battery of assessments from a clinic visit (questionnaires, interviews, exam for anthropometry and arterial stiffness, and collection of biomarkers), a 1-night home sleep apnea assessment, a 24-hour ambulatory blood pressure recording, and a 2-week home monitoring period with sleep diary and actigraphy. This will result in a rich dataset that can help to identify and reduce sleep disparities in the population and point to potential intervention approaches to reducing cardiometabolic disease disparities. The analytic plan will take advantage of a machine-learning analytic approach, which will be used to evaluate the complex relationships among all of these variables. This project will address many relevant issues in sleep medicine, health disparities research, and border health. The partnership with Mariposa will enhance recruitment, promote research integrity (or ensure appropriateness of research methods), and facilitate dissemination of the study results into the community through education programs associated with Platicamos Salud and other community outreach efforts. PROJECT NARRATIVE The primary goal of this study is to assess sleep health among Mexican-Americans at the US/Mexico border, characterize relationships with cardiometabolic disease risk, and investigate the role of social-environmental factors including acculturation, stress, socioeconomics, and health behaviors. Short sleep duration, insomnia disorder, and sleep apnea are highly prevalent in the population. These conditions are associated with cardiovascular disease, diabetes, daytime functioning problems, and poor mental health. Disparities in sleep health in racial/ethnic minorities exist, including Mexican-Americans. In particular, social-environmental factors at the US-Mexico border may play an important role in sleep health disparities. This project will not only allow for increased understanding of the complex relationship among sleep, health, and social-environmental pressures, but through a community partnership it can maximize our ability to reduce these disparities. Also, this project has the added benefit of providing information about the role of sleep as a potentially modifiable factor in cardiovascular disease and diabetes disparities as well.",Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study,9523633,R01MD011600,"['Acculturation ', ' Cultural Assimilation ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Anthropometry ', ' Behavior ', ' Blood Pressure ', ' Blood Vessels ', ' vascular ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cities ', ' Clinic Visits ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Community Developments ', ' Community Health Aides ', ' community health worker ', ' Community Health Centers ', ' Satellite Centers ', ' Diabetes Mellitus ', ' diabetes ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Economics ', ' Education ', ' Educational aspects ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Goals ', ' Habits ', ' Health ', ' Health behavior ', ' Glycosylated hemoglobin A ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' indexing ', ' Inflammation ', ' Interview ', ' Lipids ', ' High Density Lipoproteins ', ' alpha-Lipoproteins ', ' High density lipoprotein ', ' Heavy Lipoproteins ', ' HDL Lipoproteins ', ' HDL ', ' LDL Cholesterol Lipoproteins ', ' beta-Lipoprotein Cholesterol ', ' Low Density Lipoprotein Cholesterol ', ' LDL Cholesterol ', ' Medicine ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mexican Americans ', ' Chicanos ', ' Chicanas ', ' Mexico ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Phenotype ', ' Play ', ' Poverty ', ' pressure ', ' Questionnaires ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Sleep ', ' Sleep Apnea Syndromes ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Sleep disturbances ', ' Smoking ', ' Social support ', ' social support network ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Weight Gain ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Work ', ' low density lipoprotein triglyceride ', ' triacylglycerol LDL ', ' LDL triglyceride lipoprotein ', ' LDL triglyceride ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Latino ', ' Research Methodology ', ' Research Methods ', ' Data Set ', ' Dataset ', ' base ', ' specimen collection ', ' sample collection ', ' Area ', ' Link ', ' Ensure ', ' Physical activity ', ' white American ', ' caucasian American ', ' Blood Serum ', ' Serum ', ' Individual ', ' Mexican ', ' Ethnicity ', ' Ethnic Origin ', ' Community Outreach ', ' Immigrant ', ' Metabolic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' diaries ', ' programs ', ' Adopted ', ' Hour ', ' Severities ', ' Complex ', ' Home environment ', ' Home ', ' Clinic ', ' Location ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' American ', ' experience ', ' stressor ', ' arterial stiffness ', ' artery stiffness ', ' artery stiffening ', ' arterial stiffening ', ' Participant ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' social ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Regulation ', ' Modeling ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' actigraphy ', ' health disparity ', ' disparity in health ', ' Address ', ' Symptoms ', ' Data ', ' High Prevalence ', ' Intake ', ' Collection ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Monitor ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' Behavioral ', ' home visit ', ' House Call ', ' Home visitation ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' Neurocognitive Deficit ', ' food security ', ' diet and exercise ', ' functional outcomes ', ' Outcome ', ' Population ', ' Prevalence ', ' Psychosocial Stress ', ' modifiable risk ', ' ethnic minority ', ' ethnic minority population ', ' racial and ethnic ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' community partnership ', ' reduce disparity ', ' disparity reduction ', ' recruit ', ' health assessment ', ' sleep health ', ' cardiometabolic ', ' cardiometabolism ', ' ']",NIMHD,UNIVERSITY OF ARIZONA,R01,2018,772060,0.14299264733359784
"Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer     DESCRIPTION (provided by applicant): Autophagy is a complex intracellular recycling program associated with tumor progression and cancer cell survival. Researchers still lack strategies to effectively target this process, and an understanding of when to apply such strategies. Oncogenic stress, such as that elicited by mutant KRAS, can activate autophagy to promote cancer cell survival. Importantly, KRAS mutations are linked to 40% of lung cancer deaths in the U.S. each year. Therefore, we propose an innovative, multidisciplinary research project that investigates autophagy in connection with KRAS: we will integrate predictive computational modeling and high-quality cell-based measurements to accurately model the autophagic process in KRAS-driven lung cancer. We anticipate that our model will help identify the most effective therapeutic strategies for targeting autophagy in cancer. Specific Aim #1: Validate a mechanistic model of the core autophagy pathway to predict targets for the effective inhibition of autophagy. We have specified a mechanistic model through ""rules"" that capture the key biological processes comprising the autophagy pathway. To validate this model, we measured how the individual steps of autophagy respond to physiological and oncogenic stressors, and systematic RNAi perturbations. Here, we propose to tune the model to align with quantitative data, and test predictions of the rate-limiting steps. This framework will explore the possibility that autophagy is controlled by a bistable switch, an intriguing model-derived hypothesis with therapeutic relevance. As part of this aim, we will identify effective autophagy inhibitors in wildtype and mutant KRAS backgrounds. Specific Aim #2: Model the relationship of autophagy and cell fate to test therapeutic predictions for KRAS-driven lung cancer. The autophagy model will be extended to investigate the relationship between autophagic flux and cell survival and death. For this effort, we will implement an innovative data-driven approach, which involves defining relationships between measured inputs (signaling readouts) and outputs (autophagic flux, survival, and death) in datasets. We will use this model and patient-derived cell lines to predict the therapeutic benefit of inhibiting autophagy in KRAS-driven lung cancer. Our collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer."" PUBLIC HEALTH RELEVANCE: This collaborative research brings mechanistic modeling and cell biology experts together for a project that is highly relevant and valuable to public health. Mechanistic modeling was used by Los Alamos National Laboratory after World War II to assist with complex nuclear fission devices like the atomic bomb. We will use modeling to predict complex cancer cell behavior, with the ultimate goal of contributing a valuable weapon to the ""war on cancer.""",Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer,9552097,R01CA197398,"['Achievement ', ' Achievement Attainment ', ' inhibitor/antagonist ', ' inhibitor ', ' assault ', ' Autophagocytosis ', ' autophagy ', ' Biology ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cell Death ', ' necrocytosis ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Survival ', ' Cell Viability ', ' Cells ', ' Cell Body ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computers ', ' Cessation of life ', ' Death ', ' Digestion ', ' Drug resistance ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Engineering ', ' Equilibrium ', ' balance function ', ' balance ', ' Foundations ', ' Goals ', ' Kinetics ', ' Laboratories ', ' Lipids ', ' Monte Carlo Method ', ' Monte Carlo simulation ', ' Monte Carlo procedure ', ' Monte Carlo calculation ', ' Monte Carlo algorithm ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Nuclear Fission ', ' Patients ', ' Phenotype ', ' Physics ', ' Play ', ' Proteins ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Starvation ', ' Stress ', ' Testing ', ' War ', ' Measures ', ' Mediating ', ' Data Set ', ' Dataset ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' base ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' tumor progression ', ' improved ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Individual ', ' Oxygen Deficiency ', ' Hypoxic ', ' Hypoxia ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Biological Function ', ' Biological Process ', ' Recycling ', ' Therapeutic ', ' Genetic ', ' cancer cell ', ' Malignant Cell ', ' weapons ', ' Nuclear Weapon ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Cellular biology ', ' cell biology ', ' Scientist ', ' Complex ', ' Reaction ', ' System ', ' environmental stressor ', ' mutant ', ' stressor ', ' Structure ', ' Nutrient ', ' novel ', ' World War II ', ' Second World War ', ' 2nd World War ', ' models and simulation ', ' model-based simulation ', ' Devices ', ' Modeling ', ' response ', ' drug development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Ally ', ' RNA Interference ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' therapeutic evaluation ', ' therapeutic testing ', ' KRAS2 gene ', ' v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog ', ' RASK2 ', ' Oncogene K-Ras ', ' Ki-RAS ', ' KRAS2 ', ' KRAS ', ' K-Ras-2 Oncogene ', ' K-Ras 2A ', ' K-Ras ', ' K-RAS2B ', ' K-RAS2A ', ' C-K-RAS ', ' Address ', ' Data ', ' Molecular Target ', ' Resolution ', ' Cell Kinetics ', ' Cell Cycle Kinetics ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' Output ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Cancer cell line ', ' innovative ', ' innovate ', ' innovation ', ' Oncogenic ', ' computer algorithm ', ' Computational algorithm ', ' cell behavior ', ' therapeutic target ', ' public health relevance ', ' inhibition of autophagy ', ' genetic predictors ', ' ']",NCI,MICHIGAN STATE UNIVERSITY,R01,2018,470406,0.0880336127340645
"Precision Medicine in Sarcoidosis ABSTRACT Sarcoidosis is a systemic inflammatory disease of unknown etiology characterized by non-caseating granulomas in affected organs, primarily in the lungs. Approximately 30% of patients with sarcoidosis progress to debilitating disease; however, the drivers of susceptibility or resilience to disease remain poorly understood. An inflammatory response to an undefined antigen is postulated as the etiology of granuloma formation, and the pathogenesis has been suggested to involve gene-pathogen interaction, yet analysis of single genes or microbes has not proven applicable to diagnosis of all forms of sarcoidosis. Indeed, rather than a single organism, the disease may represent an interaction between the community of organisms that comprise the lung microbiome (community of organisms that live in and on us) and the host immune response. We propose that understanding the microbiome/host interaction will suggest strategies for precision medicine approaches to sarcoidosis. This proposal addresses this significant gap by investigating interactions between the lung microbiome, host immune and clinical responses in sarcoidosis using multiomics approaches  a critically innovative strategy. Our preliminary data support our novel hypotheses. First, we identified distinct lung microbiomes that differentiated patients with sarcoidosis versus controls. Second, our results identified biomarkers of disease severity that were associated with decreased lung function. Third, a recurrent analytic theme that emerged, regardless of the type of -omic analysis, was that sarcoidosis is characterized by pathways related to apoptosis and autophagy, which is consistent with our observation of decreased abundance of peripheral lymphocytes and functional immune anergy. These data led us to our Overall Hypothesis: Lung microbiome and host immune interactions characterized by apoptosis and autophagy pathways influence sarcoidosis clinical course. This hypothesis will be tested by an observational prospective and validation study of sarcoidosis patients at 5 time points to facilitate time series analyses. Aims 1 and 2 focus on lung microbiome or host immune responses, respectively, in relation to clinical course of sarcoidosis. Using these data in Aim 3, predictive models will be constructed based on integrated data of metagenomic and host-immune interactions. The novelty and significance of our multiomics strategy is to construct models for precision medicine therapies to harness bioinformatic strategies into focused, patient-specific approaches. The long-term significance of this study is to define pathways for sarcoidosis progression or resolution, and to develop database of these findings to further develop more precise, testable, models. PROJECT NARRATIVE Sarcoidosis is a disease of unknown etiology that predominately affects the lung and may affect other organs. We propose to construct a model to predict sarcoidosis progression or resolution by identifying microbial and immune interactions. We postulate that these models will be helpful in designing therapeutic options.",Precision Medicine in Sarcoidosis,9530040,R01HL138628,"['Affect ', ' Algorithms ', ' Antigens ', ' immunogen ', ' ATGN ', ' Autophagocytosis ', ' autophagy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Communities ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Feces ', ' stool ', ' Genes ', ' Granuloma ', ' Granulomatous Lesion ', ' Immunity ', ' indexing ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Methods ', ' Organism ', ' living system ', ' Patients ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Prospective Studies ', ' Recurrence ', ' Recurrent ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Messenger RNA ', ' mRNA ', ' Sarcoidosis ', "" Schaumann's Disease "", "" Boeck's Sarcoid "", ' Besnier-Boeck Disease ', ' Technology ', ' Testing ', ' Time ', ' cytokine ', ' Taxonomy ', ' General Taxonomy ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' base ', ' Organ ', ' bronchopulmonary lavage therapy ', ' Lung Lavage ', ' Bronchopulmonary Lavage ', ' Bronchioalveolar Lavage ', ' Bronchoalveolar Lavage ', ' Peripheral ', ' Clinical ', ' Susceptibility ', ' Predisposition ', ' anergy ', ' data base ', ' Data Bases ', ' Databases ', ' Disease Progression ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Immune ', ' Immunes ', ' Severity of illness ', ' disease severity ', ' microbial ', ' novel ', ' validation studies ', ' Time Series Analysis ', ' Disease model ', ' disorder model ', ' Pathogenesis ', ' Modeling ', ' response ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Address ', ' Data ', ' Resolution ', ' Apoptotic ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' pathway ', ' Pathway interactions ', ' microbiome ', ' metagenome ', ' deep sequencing ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' resilience ', ' pathogen ', ' innovative ', ' innovate ', ' innovation ', ' transcriptomics ', ' Microbe ', ' metagenome sequencing ', ' metagenomic sequencing ', ' clinical relevance ', ' clinically relevant ', ' Functional Metagenomics ', ' Metagenomics ', ' inflammation marker ', ' inflammatory marker ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' precision-based medicine ', ' precision medicine ', ' clinical predictors ', ' global transcription profile ', ' global gene expression ', ' transcriptome ', ' pulmonary microbiome ', ' lung microbiome ', ' host microbiome ', ' ']",NHLBI,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2018,680760,0.14183780501413243
"Sleep Health Profiles and Mortality Risk in Older Adults: A Multi-Cohort Application of Novel Statistical Methods PROJECT SUMMARY / ABSTRACT Individual sleep disorders and characteristics are known to be associated with adverse health outcomes. However, few studies consider sleep in a multivariate context. Therefore, we propose a paradigmatic shift in sleep research towards sleep health. Conducting research through a sleep health lens can change health practice by clarifying which sleep characteristics are most important to treat, enhancing screening efforts, and facilitating the generalization of findings to all individuals, not just those with specific sleep disorders or complaints. Before achieving these long-term goals, however, the crucial first steps in the study of sleep health are to determine which sleep profiles predict health outcomes (Aim 1), and develop predictive algorithms that can identify individuals at risk of adverse health outcomes based on their sleep and other risk factors (Aim 2). These aims can only be achieved with an awareness of the statistical challenges related to the inherent multidimensionality of sleep health (e.g. multiple domains of sleep, multiple characteristics to represent each domain, multiple data sources, etc.). This multidimensionality generates substantial methodological barriers regarding variable and model selection and threatens researchers' abilities to develop transparent and reproducible models. In this R01, investigators will apply rigorous, sophisticated statistical methods to a large aggregated sample of adults aged >60 with self-report and polysomnographic characterization and over 10 years of longitudinal follow-up from three parent studies: Osteoporotic Fractures in Men Sleep Study (MrOS), Study of Osteoporotic Fractures (SOF), and the Sleep Heart Health Study (SHHS). In Aim 1, investigators will determine which multidimensional sleep profiles predict time to mortality in older adults using Cox-proportional hazards models, tree-structured survival analysis, and clustering. In Aim 2, investigators will develop powerful machine learning algorithms that incorporate sleep and other risk factors to identify which older adults have the greatest risk for early mortality. Within each aim, the impact of sex and race will be rigorously investigated, and models will be internally validated in independent samples to ensure reproducibility. The Secondary Aim is to investigate generalizability to studies with different demographic profiles and sleep protocols (Wisconsin Sleep Cohort Study, Honolulu Asia Aging Study of Sleep America) and different data types (sleep diary, actigraphy). All models will be developed in the context of other important known risk factors, including but not limited to age, gender, race, sleep apnea, cardiovascular disease, smoking, and BMI. Findings from Aim 1 will jumpstart subsequent mechanistic research focused on sleep-related causal factors of mortality, leading to identification of targeted treatments for sleep problems that could reduce risk of mortality and morbidity. Findings from Aim 2 will provide important preliminary evidence for enhanced screening tools that can more accurately identify which individuals are at risk for adverse health outcomes. PROJECT NARRATIVE This project initiates a paradigmatic research shift by studying multivariate sleep health in older adults. Cutting- edge statistical methods will be applied to a large, multi-cohort sample, and replicability of findings will be rigorously investigated. Achieving the proposed aims will improve health practice by: (1) determining which multivariate sleep profiles predict mortality in older adults, thereby jumpstarting subsequent mechanistic research on sleep-related causal factors of mortality and targeted treatments to reduce mortality; and (2) suggesting prediction algorithms that incorporate sleep to enhance health screening for adverse health outcomes in older adults.",Sleep Health Profiles and Mortality Risk in Older Adults: A Multi-Cohort Application of Novel Statistical Methods,9534484,R01AG056331,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aging ', ' Algorithms ', ' Americas ', ' Asia ', ' Attention ', ' Awareness ', ' Beds ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cognition ', ' Cohort Studies ', ' Concurrent Studies ', ' Cox Proportional Hazards Models ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Data Sources ', ' Mental Depression ', ' depression ', ' Drowsiness ', ' sleepiness ', ' Somnolence ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Goals ', ' Health ', ' Maps ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Parents ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Sleep ', ' Sleep Apnea Syndromes ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Smoking ', ' Survival Analysis ', ' Survival Analyses ', ' Testing ', ' Time ', ' Trees ', ' Vision ', ' visual function ', ' Sight ', ' Wakefulness ', ' Wisconsin ', ' Woman ', ' Gender ', ' falls ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Polysomnography ', ' base ', ' improved ', ' Ensure ', ' screening tools ', ' Screening procedure ', ' Individual ', ' satisfaction ', ' Sample Size ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' diaries ', ' Well in self ', ' sense of wellbeing ', ' self wellness ', ' psychological wellness ', ' psychological wellbeing ', ' mental wellbeing ', ' mental well-being ', ' emotional wellbeing ', ' Sense of well-being ', ' Psychological Well Being ', ' Normal psyche ', ' Normal mental state ', ' Normal mental condition ', ' Feels well ', ' Emotional well being ', ' Dimensions ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Techniques ', ' osteoporosis with pathological fracture ', ' Osteoporotic fracture ', ' Osteoporosis with fracture ', ' Fracture due to osteoporosis ', ' cohort ', ' Structure ', ' novel ', ' Patient Self-Report ', ' Self-Report ', ' Statistical Methods ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' actigraphy ', ' Data ', ' Reproducibility ', ' Subgroup ', ' Characteristics ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' Outcome ', ' Population ', ' aged ', ' health practice ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' lenses ', ' lens ', ' flexible ', ' flexibility ', ' screening ', ' cardiovascular health ', ' non-linear regression ', ' nonlinear regression ', ' predictor algorithm ', ' predictive algorithm ', ' prediction algorithm ', ' Heart health ', ' Cardiac health ', ' sleep health ', ' ']",NIA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2018,298548,0.08245349062012627
"Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer Lung cancer is a leading cause of death in the United States. The National Lung Screening Trial (NLST) showed that more lung cancers can be detected at an early stage with low dose CT screening. However, over-diagnosis of indolent lung cancer and benign nodules is one of the major limitations of screening, resulting in unnecessary treatment, biopsy, follow-up, increased radiation exposure, patient anxiety, and cost. Due to a lack of in-depth knowledge of the correlation of structural image features and histologic findings of lung nodules and the absence of validated diagnostic biomarkers for accurate disease categorization, the current diagnosis and management of the screen-detected nodules remains challenging.  The goal of this proposed project is to develop a decision support system (DSS) based on quantitative histopathology correlated CT descriptor (q-PCD) of pulmonary nodules using advanced computer vision and machine learning techniques to characterize the histopathologic features of nodules and analyze their correlations with CT image features for improvement of early detection of lung cancer. We hypothesize that the proposed q-PCD analysis will have strong association with histopathologic characterization, and therefore will be a more effective biomarker for differentiation of invasive, pre-invasive, and benign nodules than conventional image-based features or radiologists' visual judgement. Accurate characterization of the nodule types will assist radiologists in making decision for management of the detected nodules; e.g., enabling early detection and treatment of invasive lung cancer, safe surveillance or replacing lobectomy with limited sublobar resection for pre-invasive lung cancer, and sparing biopsy of benign nodules, thereby reducing morbidity and costs in lung cancer screening programs. Our major specific aims are to 1) collect a large database of LDCT screening cases from NLST project and our institute to develop automated image analysis methods, 2) to develop a new DSS based on quantitative pathologic correlated CT descriptors (q-PCD) of lung nodules, 3) validate the effectiveness of DSS in lung cancer diagnosis. To achieve these aims, we will collect a large data set from the National Lung Screening Trial (NLST) and our institute. The collected database will include the baseline and follow up scans, pathology data, demographic information and other information provided by NLST. We will develop automated segmentation methods to extract the volumes of the solid and sub-solid components of detected lung nodules, develop quantitative methods to characterize the radiologic and pathologic features of lung nodules as well as the surrounding lung parenchyma, develop a novel radiopathomics strategy to correlate pathomics with radiomics, and to identify new imaging biomarkers. We will develop a clinically-translatable DSS with a joint biomarker combining both image and patient information, and evaluate its performance in lung cancer diagnosis, including its effectiveness in baseline screening CT exams and in follow up exams. Narrative: Lung cancer is the second most commonly diagnosed cancer in both men and women in the United States. If successful, we will have developed an automated low dose CT-based quantitative histopathology correlated CT descriptor (q-PCD) which can be included as an independent factor to improve the diagnosis of screening detected nodules. It will not only provide a useful imaging biomarker to assist in lung nodule management for individuals, but also constitute a strong foundation to meet our long-term goal of developing clinically- translatable decision support system (DSS) to facilitate personalized medicine in early detection of lung cancer, optimizing treatment strategies and reducing health care costs",Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer,9526145,U01CA216459,"['Anxiety ', ' Archives ', ' Biopsy ', ' Cause of Death ', ' Computer Vision Systems ', ' computer vision ', ' Database Management Systems ', ' relational database management systems ', ' Data Base Management Systems ', ' Decision Making ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Foundations ', ' Goals ', ' Institutes ', ' Joints ', ' Lobectomy ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Maps ', ' men ', "" men's "", ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Nodule ', ' Pathology ', ' Patients ', ' Lung nodule ', ' pulmonary nodule ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Reference Standards ', ' Risk Factors ', ' Testing ', ' Thoracic Radiography ', ' thorax radiography ', ' thoracic radiogram ', ' radiographic lung image ', ' radiographic chest image ', ' lung radiography ', ' chest radiography ', ' chest Xray ', ' chest X ray ', ' CXR ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' United States ', ' Woman ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Decision Aid ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Benign ', ' Solid ', ' Histologically ', ' Histologic ', ' Evaluation ', ' Indolent ', ' Visual ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' radiologist ', ' lung cancer early detection ', ' lung cancer screening ', ' Descriptor ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scanning ', ' Techniques ', ' Early Diagnosis ', ' early detection ', ' Performance ', ' attenuation ', ' Histopathology ', ' novel ', ' Reporting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Decision Support Systems ', ' Property ', ' cancer diagnosis ', ' Effectiveness ', ' Advocate ', ' Data ', ' Reproducibility ', ' Collection ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' low-dose spiral CT ', ' Screening Result ', ' Pathologic ', ' Characteristics ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cost ', ' early therapy ', ' Early treatment ', ' high risk ', ' treatment strategy ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' screening ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' Patient risk ', ' imaging marker ', ' imaging biomarker ', ' diagnostic marker ', ' diagnostic biomarker ', ' unnecessary treatment ', ' radiomics ', ' Radiation exposure ', ' clinically translatable ', ' screening program ', ' therapy optimization ', ' treatment optimization ', ' CT screening ', ' computed tomography screening ', ' pathology imaging ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2018,480528,0.21436115699374778
"Automated coronary artery calcification scoring for cardiovascular risk screening ABSTRACT The World Health Organization lists cardiovascular disease as the most common cause of death worldwide at 31% of all deaths. Coronary artery calcium (CAC) scoring has become the most reliable predictor of future coronary artery disease (CAD) events in the asymptomatic population. CAC scores are currently only reported on ECG-gated CT examinations that are ordered when the primary indication is cardiac in nature. However, in 2007 there were 7.1 million non-cardiac thoracic CT scans ordered with lungs as the primary indication where CAC scores could have been reported. An additional 7-10 million CT lung screening scans are expected to be ordered per year as lung screening programs grow. Because lung cancer risk factors and CAD risk factors overlap significantly, most these patients could benefit greatly from having their CAC score reported as part of their non-cardiac CT examination. This could dramatically improve decision making, quality of care, and lower expenses due to future CAD interventions and cardiac specific CT scans. The goal of this project is to develop a fully automated software application that can report CAC scores on both gated and ungated thoracic CT scans with seamless integration into the Radiology workflow. A successful completion of this project will deliver a product capable of dramatically increasing the number of people that receive early intervention for CAD, thereby increasing quality of care and lowering costs. This Phase I application proposes first creating an algorithm capable of automatically calculating global CAC scores from both ECG-gated and ungated CT scans using CAC segmentations performed by an expert physician. If successful, the Phase II project will perform robust clinical validation adequate for an FDA 510(k) submission. NARRATIVE The goal of this project is to develop a fully automated software application that can report CAC scores on both gated and ungated thoracic CT scans with seamless integration into the Radiology workflow. A successful completion of this project will deliver a product capable of dramatically increasing the number of people that receive early intervention for CAD, thereby increasing quality of care and lowering costs.",Automated coronary artery calcification scoring for cardiovascular risk screening,9555974,R43HL139273,"['Algorithms ', ' Bone Density ', ' Bone Mineral Density ', ' Calcium ', ' Factor IV ', ' Coagulation Factor IV ', ' Ca++ element ', ' Blood Coagulation Factor IV ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cause of Death ', ' Coronary Arteriosclerosis ', ' coronary arterial disease ', ' atherosclerotic coronary disease ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Correlation Studies ', ' Statistical Correlation ', ' Cessation of life ', ' Death ', ' Decision Making ', ' Electrocardiogram ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Future ', ' Goals ', ' Human ', ' Modern Man ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Manuals ', ' Patients ', ' Physicians ', ' Lung nodule ', ' pulmonary nodule ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Risk Factors ', ' Computer software ', ' Software ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' Vision ', ' visual function ', ' Sight ', ' World Health Organization ', ' Measures ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Data Set ', ' Dataset ', ' base ', ' Label ', ' improved ', ' Heart artery ', ' Cardiac artery ', ' Coronary artery ', ' Clinical ', ' Phase ', ' Interstitial Lung Diseases ', ' Training ', ' Lesion ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Early Intervention ', ' Diagnostic ', ' Nature ', ' Event ', ' Scanning ', ' Techniques ', ' Performance ', ' success ', ' Categories ', ' Reporting ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Modeling ', ' Quality of Care ', ' QOC ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Compliance behavior ', ' therapy cooperation ', ' therapy compliance ', ' patient adherence ', ' compliance cooperation ', ' Treatment Compliance ', ' Patient Cooperation ', ' Patient Compliance ', ' Dose ', ' Data ', ' Detection ', ' Predictive Value ', ' Validation ', ' Cardiac ', ' developmental ', ' Development ', ' coronary calcification ', ' coronary artery calcification ', ' imaging ', ' Image ', ' cost ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' clinical relevance ', ' clinically relevant ', ' clinical effect ', ' multi-task ', ' multitask ', ' screening ', ' Lung CT scan ', ' Lung CT ', ' CT Lung Screening ', ' Lung CAT Scan ', ' quantitative imaging ', ' imaging marker ', ' imaging biomarker ', ' learning method ', ' learning activity ', ' learning strategy ', ' Preventative measure ', ' Preventive measure ', ' Multi-Ethnic Study of Atherosclerosis ', ' screening program ', ' coronary calcium ', ' coronary artery calcium ', ' coronary artery calcium scoring ', ' coronary calcium scoring ', ' Agatston ', ' Agatston Score ', ' deep learning ', ' ']",NHLBI,"IMBIO, LLC",R43,2018,214629,0.03434116037487223
"2018 International Molecular and Functional Pulmonary Imaging Workshop SUMMARY This application requests funding to support the 2018 International Workshop on Pulmonary Imaging, a three- day meeting scheduled for December 6-8, 2018, which will be the sixth of its kind hosted by the University of Pennsylvania. The requested funds will primarily be used to cover travel and housing expenses for undergraduate, graduate and junior faculty speakers. Some may also be used to support live webcasting and publication of the workshop proceedings. As in the past, it is our intention to broadcast each session of the meeting online in real-time, enabling interested parties who cannot physically attend to access them free of charge. Pulmonary diseases constitute a significant and rising cause of morbidity and mortality worldwide, and imaging is becoming an increasingly important source of innovative techniques for both diagnosing and treating these pathologies. The field of pulmonary imaging currently encompasses a wider range of techniques for the functional, structural and molecular assessment of lung disorders than ever before, which are being developed and refined by investigators across a diverse set of fields such as biology, physics, chemistry, medicine and engineering, computer science and machine learning. Given the rapidly-developing nature of the pulmonary imaging field, it is of the utmost importance that a regular forum exists for scientists and clinicians to communicate and debate their ideas with one another. In the absence of other meetings with a similar focus, our previous workshops have provided such a forum, bringing together the diverse components of the field into the kind of rigorous, focused exchange needed to advance the field. The specific aims of the proposed workshop are as follows: (1) keep the pulmonary imaging community informed about the latest developments in structural, functional and molecular lung imaging; (2) examine the use of pulmonary imaging to assess therapeutic response, including strategies for overcoming the challenges inherent in this objective; (3) explore the integration of machine learning with pulmonary imaging techniques to more accurately phenotype disease and predict injury progression; (4) broadcast the entire proceedings live over the web, allowing non-attendees to freely access the proceedings, and enabling the online audience to participate in workshop discussions in real-time. Based on feedback from participants that previous meetings tended to be overly dense and predominantly didactic in nature, we have also implemented a significant format change for proposed 2018 meeting. With the exception of a few keynote presentations, we plan to limit the percentage of formal lecture in each invited speakers talk to one-third of their allotted time, with the rest dedicated to a period of discussion that will be driven by a panel of moderators as well as audience questions. For each presentation, the moderators will prepare a list of questions focusing on three main points: 1) the translatability of the research being presented, 2) the scientific gap which this research aims to address, and 3) the necessity of identifying lung disorders that are suitable for longitudinal studies, as well as which imaging parameters are best suited to the longitudinal study of lung disease. In addition to this change in format, the 2018 workshop will continue efforts to strike a more even balance between functional, structural and molecular imaging approaches to pulmonary disease. Finally, we will also continue to foreground the important issue of using imaging techniques to assess treatment response, which was first introduced at the 2017 pulmonary imaging workshop. NARRATIVE This application requests funding to support the 2018 International Workshop on Pulmonary Imaging at the University of Pennsylvania. The proposed meeting will provide a valuable opportunity for researchers engaged in the development of functional, structural, and molecular imaging techniques for assessing lung diseasessuch as COPD, ARDS, IPF and lung cancerto meet and discuss their work with one another. The entirety of the workshop will be broadcast live online, giving interested individuals who are not able to attend in person the ability to both view and participate in its proceedings.",2018 International Molecular and Functional Pulmonary Imaging Workshop,9613494,R13HL144010,"['Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Biology ', ' Charge ', ' Chemistry ', ' Communication ', ' Communities ', ' Diagnosis ', ' Engineering ', ' Equilibrium ', ' balance function ', ' balance ', ' Faculty ', ' Feedback ', ' Future ', ' Gases ', ' Heart ', ' Housing ', ' Learning ', ' Longitudinal Studies ', ' long-term study ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Medicine ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Movement ', ' body movement ', ' Persons ', ' Pathology ', ' Pennsylvania ', ' Phenotype ', ' Physics ', ' Physiology ', ' Positron-Emission Tomography ', ' positron emitting tomography ', ' positron emission tomographic imaging ', ' positron emission tomographic (PET) imaging ', ' Rad.-PET ', ' Positron Emission Tomography Scan ', ' Positron Emission Tomography Medical Imaging ', ' PETT ', ' PETSCAN ', ' PET imaging ', ' PET Scan ', ' PET ', ' Protons ', ' Hydrogen Ions ', ' H+ element ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Pulmonology ', ' Pulmonary Medicine ', ' Pneumonology ', ' Pneumology ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Adult Respiratory Distress Syndrome ', ' wet lung ', ' Stiff lung ', ' Shock Lung ', ' Da Nang Lung ', ' Adult RDS ', ' Acute Respiratory Distress Syndrome ', ' ARDS ', ' Rest ', ' Students ', ' Time ', ' single photon emission computed tomography ', ' Single-Photon Emission-Computed Radionuclide Tomography ', ' SPECT imaging ', ' SPECT ', ' Travel ', ' Universities ', ' Work ', ' Imaging Techniques ', ' Imaging Technics ', ' Imaging Procedures ', ' Schedule ', ' Intention ', ' Injury ', ' base ', ' density ', ' improved ', ' lung scanning ', ' Pulmonary imaging ', ' lung imaging ', ' Area ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Individual ', ' Workshop ', ' Educational workshop ', ' Fostering ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Disease Progression ', ' Funding ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' Metabolic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' lectures ', ' Scientist ', ' Source ', ' Techniques ', ' Location ', ' interest ', ' meetings ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' computer science ', ' novel ', ' Participant ', ' Address ', ' Data ', ' International ', ' Request for Applications ', ' NIH RFA ', ' physiological imaging ', ' Physiologic Imaging ', ' Functional Imaging ', ' Molecular ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' disease phenotype ', ' innovative ', ' innovate ', ' innovation ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' undergraduate ', ' undergraduate student ', ' noninvasive imaging ', ' non-invasive imaging ', ' imaging marker ', ' imaging biomarker ', ' imaging approach ', ' responsive patient ', ' patient response ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,R13,2018,29805,0.14583375753215141
"A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules Low dose CT screening (LDCT) has been approved by the Centers for Medicare & Medicaid Services  (CMS) for Medicare coverage. However, the primary problem associated with CT is the high false positive  detections (~96%). This issue often leads to unpleasant and costly unintended consequences (e.g.,  follow-up scans and/or invasive biopsies). In this project, we propose to develop and commercialize  a novel computer tool to aid in accurate assessment of indeterminate lung nodules. The goal is to  accurately and efficiently quantify the potential risk of developing lung cancer and its future  prognosis, thereby facilitating precise / personalized lung cancer screening and optimal patient  management. During Phase I of this project, we have accomplished the proposed milestones and  developed a prototype system that is now publicly accessible. Our preliminary validation of the  prototype system demonstrates very promising performance. In Phase II, we will continue our effort  to make this tool available to serve clinical community with the following specific aims: (1)  develop a generalized framework that supports the incorporation of both image and patient  information as well as other biological tests related to lung cancer; (2) fully optimize the  computer algorithms to efficiently analyze chest CT scans and in particular synergize our  algorithms with the deep learning technology to improve training efficiency and benign/malignance  classification accuracy; and (3) comprehensively validate and optimize the system in clinical  environment at the University of Pittsburgh Medical Center (UPMC). We believe that the proposed  system is extremely timely and important in light of the CMS decision to cover annual LDCT lung  cancer screening. Its availability will significantly reduce the over-diagnosis associated with  LDCT for lung cancer screening and relieve the economic burden on healthcare system. Project Narrative: The project aims to develop an online computer tool to aid in efficacious early  lung cancer screening and diagnosis based on LDCT. This tool will not only locate the pulmonary  nodules automatically, but also quantitatively assess the malignancy of a suspicious nodule and its  prognosis.",A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules,9463945,R44CA203058,"['Affect ', ' Age ', ' ages ', ' Algorithms ', ' Anxiety ', ' Biopsy ', ' Needle biopsy procedure ', ' needle biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Classification ', ' Systematics ', ' Communities ', ' Computer Systems ', ' computing system ', ' Computers ', ' Statistical Data Interpretation ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Environment ', ' Future ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Medicare ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Learning ', ' Light ', ' Photoradiation ', ' Literature ', ' Manuals ', ' Methods ', ' mortality ', ' Nodule ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Patients ', ' outcome forecast ', ' Prognosis ', ' Lung nodule ', ' pulmonary nodule ', ' Receiver Operating Characteristics ', ' Receiver Operator Characteristics ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sputum ', ' Technology ', ' Testing ', ' Thoracotomy ', ' thorax incision ', ' chest wall incision ', ' Time ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' United States ', ' United States Centers for Medicare and Medicaid Services ', ' United States Health Care Financing Administration ', ' Health Care Financing Administration ', ' Centers for Medicare and Medicaid Services ', ' Universities ', ' Work ', ' Uncertainty ', ' doubt ', ' Data Set ', ' Dataset ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Benign ', ' Solid ', ' Clinical ', ' Malignant ', ' Malignant - descriptor ', ' Phase ', ' Death Rate ', ' Training ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' radiologist ', ' lung cancer early detection ', ' lung cancer screening ', ' tool ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Malignant neoplasm of prostate ', ' Prostatic Cancer ', ' Prostate Cancer ', ' Prostate CA ', ' Malignant prostatic tumor ', ' Malignant Tumor of the Prostate ', ' Frequencies ', ' Scanning ', ' System ', ' Medical center ', ' cancer risk ', ' Performance ', ' success ', ' novel ', ' Agreement ', ' new technology ', ' novel technologies ', ' Modality ', ' Colon Carcinoma ', ' cancer in the colon ', ' Colonic Carcinoma ', ' Colon Cancer ', ' Reporting ', ' cancer diagnosis ', ' Biological Testing ', ' Data ', ' Detection ', ' Economic Burden ', ' Resolution ', ' Cancer Cause ', ' Cancer Etiology ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' low-dose spiral CT ', ' Smoking History ', ' Validation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cost ', ' innovative ', ' innovate ', ' innovation ', ' computer algorithm ', ' Computational algorithm ', ' prototype ', ' clinical practice ', ' Systems Development ', ' image guidance ', ' image guided ', ' imaging system ', ' physical symptom ', ' Radiation exposure ', ' chest CT ', ' chest computed tomography ', ' CT screening ', ' computed tomography screening ', ' deep learning ', ' ']",NCI,INTERNATIONAL INTELLIGENT INFOR/SOLU/LAB,R44,2018,494965,0.17523477002884585
"Autoimmunity as a Mechanism for Atherosclerosis in COPD     DESCRIPTION (provided by applicant): This project will facilitate the development of the principal investigator into an independent translational researcher investigating systemic vascular injury in Chronic obstructive pulmonary disease (COPD). This will be accomplished in the rich academic environment at the University of Pittsburgh, under the guidance of a highly accomplished team of mentors, and in the conduct of multidisciplinary research project that will develop autoimmunity as a novel mechanism for atherosclerosis in COPD. The increased risk of atherosclerosis in COPD is not explained by smoking, age, hypertension, and other established vascular disease risk factors. Chronic inflammation has recently been implicated as an atherogenic mechanism in COPD. We and others have reported that chronic inflammation in COPD may be propagated by humoral autoimmunity. Specifically, smokers with COPD have greatly increased levels of circulating autoantibodies that demonstrate in vitro pathogenic effects. Our subsequent studies also show that these autoantibodies target at least 50 different autoantigens and consistently target glucose regulated protein 78 (GRP78), particularly in patients with parenchymal lung destruction, i.e. emphysema. GRP78 is present in the endoplasmic reticulum, where it regulates the unfolded protein response, and is also a multifunction cell surface receptor. Studies in cancer patients suggest that ligation of the N-terminus of cell surface GRP78 by anti-GRP78 IgG transduces pro-inflammatory and pro-proliferative signals by activation of the AKT pathway, followed by NFB activation. Additional in vivo studies have identified anti-GRP78 IgG with affinity for the C-terminus of cell surface GRP78 that produce counteracting anti-inflammatory effects by suppressing AKT activation. Our preliminary work shows that circulating anti-GRP78 IgG in COPD patients binds to macrophages and leads to increased NFB activation and production of atherogenic inflammatory mediators by them. The macrophage is critical in the development of both atherosclerosis and COPD. Also, cross-sectional studies in our cohort find that levels of circulating anti-GRP78 IgG are strongly associated with carotid atherosclerosis in patients with emphysema, independent of established vascular risk factors. Therefore, we hypothesize that autoimmune responses against GRP78 are a mechanism for atherosclerosis in COPD. During this award, we will: (1) Test the hypothesis that elevated levels of circulating anti-GRP78 IgG predict progression of carotid atherosclerosis in patients with emphysema independent of established risk factors over 4 year follow up; (2) Test the hypothesis that anti-GRP78 IgG binds to the N-terminus of cell surface GRP78 and activates the AKT pathway followed by NFB activation and production of inflammatory mediators using a variety of cell function assays, and provide proof of concept for two potential therapeutic strategies; (3) Test the hypothesis that there are other antigen-specific immune responses associated with atherosclerosis in COPD by using machine learning to analyze high-throughput data on a large number of circulating autoantibody levels. PUBLIC HEALTH RELEVANCE: Chronic obstructive pulmonary disease (COPD) is a lung disease caused by smoking that kills more and more Americans each year, and is now the third leading cause of death in the US. Although it is largely viewed as a disease of the lungs, the most common cause of death in patients with COPD are blockages in blood vessels. This research project will investigate why patients with COPD are so prone to develop these blood vessel blockages.",Autoimmunity as a Mechanism for Atherosclerosis in COPD,9460547,K23HL126912,"['Age ', ' ages ', ' Algorithms ', ' Antibodies ', ' Antigens ', ' immunogen ', ' ATGN ', ' Atherosclerosis ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Autoantibodies ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantigens ', ' Self-Antigens ', ' Autologous Antigens ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Autoimmune Responses ', ' Autoimmunity ', ' Autoimmune Status ', ' Award ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood Vessels ', ' vascular ', ' Western Blotting ', ' Western Immunoblotting ', ' protein blotting ', ' Cause of Death ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Endoplasmic Reticulum ', ' Ergastoplasm ', ' Environment ', ' Enzyme-Linked Immunosorbent Assay ', ' ELISA ', ' Flow Cytometry ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Human ', ' Modern Man ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Immunoglobulin G ', ' IgG ', ' 7S Gamma Globulin ', ' In Vitro ', ' Inflammation ', ' Ligation ', ' Closure by Ligation ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' macrophage ', ' Mentors ', ' Mentorship ', ' Morbidity - disease rate ', ' Morbidity ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Patients ', ' Phenotype ', ' Phosphorylation ', ' Protein Phosphorylation ', ' Production ', ' Proteins ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Cell Surface Receptors ', ' Risk ', ' Risk Factors ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Smoking ', ' Testing ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Universities ', ' Vascular Diseases ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Work ', ' glucose-regulated proteins ', ' Measures ', ' related to A and C-protein ', ' rac protein kinase ', ' proto-oncogene protein akt ', ' proto-oncogene protein RAC ', ' c-akt protein ', ' RAC-PK protein ', ' Protein Kinase B ', ' Akt protein ', ' AKT ', ' Proto-Oncogene Proteins c-akt ', ' Injury ', ' Chronic ', ' Link ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Therapeutic Agents ', ' Exposure to ', ' Inflammatory ', ' Smoker ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Event ', ' Carotid Atherosclerotic Disease ', ' Carotid Atheroscleroses ', ' American ', ' cohort ', ' novel ', ' Cell surface ', ' Reporting ', ' Carotid Artery Plaques ', ' carotid plaque ', ' Carotid Artery Plaque ', ' response ', ' Pathogenicity ', ' Binding ', ' Molecular Interaction ', ' prevent ', ' preventing ', ' Affinity ', ' Data ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' in vivo ', ' anti-inflammatory effect ', ' Antiinflammatory Effect ', ' Cancer Patient ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' peptide mimic ', ' peptide mimetic ', ' peptidomimetics ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' in vitro testing ', ' vascular risk factor ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' predictive marker ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' cancer clinical trial ', ' translational researcher ', ' translational investigator ', ' translational scientist ', ' atherosclerotic risk ', ' atherosclerosis risk ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K23,2018,166104,0.06841134301101671
"DEVELOPMENT OF A RAPID METHOD FOR IMAGING REGIONAL VENTILATION IN SMALL ANIMALS W/O CONTRAST AGENTS The objective of this R01 application is to develop a rapid method for imaging regional ventilation and lung compliance in small animals without contrast agents. Much of our current understanding of the normal functioning of the lung and mechanisms of lung disease comes from small animal studies. However, lung function imaging in small animal models is technically challenging due to motion and the relatively small size of the lungs. Pulmonary function testing using plethysmography has been employed to assess lung function and injury with limited validity and utility, particularly in small animals. Additionally, only aggregate measures of functional performance are produced and no regional lung changes can be assessed. An improved imaging method that could provide spatially- and temporally-resolved information regarding ventilation would be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases. It would also facilitate drug discovery and efficacy studies aimed to mitigate respiratory pathology. The ideal method would provide quantitative regional functional information, be applicable to longitudinal studies (low radiation dose), and have a simple and affordable implementation that permits widespread use. Currently available imaging methods including micro-CT or MRI fall short in one or more of these requirements.  To address this need, we will establish and evaluate a novel, easy to implement, and highly effective X- ray phase-contrast (XPC) method for ventilation imaging in small animal models. The lung is ideally suited to XPC imaging because it is comprised mainly of air spaces separated by thin tissue structures. The air-tissue interfaces cause the X-ray beam to experience numerous and strong refractions that produce a distinctive texture in the intensity measured over the lungs known as speckle. Detailed information regarding the regional lung air volume (RLAV) distribution is encoded in the speckle. The benefits of exploiting lung speckle for detecting and monitoring lung function are numerous but remain entirely unexplored for benchtop imaging.  Our approach involves a high degree of technical innovation regarding image formation methods and will significantly extend the current boundaries of functional lung imaging in small animals. The proposed method, referred to as parametric XPC (P-XPC) imaging, will produce 2D parametric images that depict the projected RLAV distribution. When differential images are computed for any given two points in the breathing cycle, ventilation or lung compliance imaging will be achieved. Preliminary in vivo and computational studies have been conducted in support of the proposed research. The specific aims of the project are as follows. Aim 1: Develop P-XPC image formation methods for estimating the projected RLAV distribution; Aim 2: Optimize an XPC imaging system for P-XPC imaging. Aim 3: Evaluate the diagnostic capability of P-XPC imaging in two pre-clinical animal models of disease in vivo. The proposed research will result in a novel, easy to implement, and highly effective X-ray phase-contrast (XPC) method for functional lung imaging in small animal models. It will provide spatially- and temporally- resolved information regarding lung ventilation that will be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases.",DEVELOPMENT OF A RAPID METHOD FOR IMAGING REGIONAL VENTILATION IN SMALL ANIMALS W/O CONTRAST AGENTS,9474118,R01EB023045,"['Air ', ' Animals ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Communities ', ' Contrast Media ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Animal Disease Models ', ' Learning ', ' Longitudinal Studies ', ' long-term study ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung Compliance ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Pulmonary function tests ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Maps ', ' Methods ', ' Motion ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Pathology ', ' Physics ', ' Physiology ', ' Plethysmography ', ' pressure ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Research ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Supervision ', ' Thinness ', ' Leanness ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Environmental air flow ', ' Ventilation ', ' Roentgen Rays ', ' Xrays ', ' X-Rays Radiation ', ' X-Rays ', ' X-Radiation ', ' Measures ', ' falls ', ' base ', ' detector ', ' improved ', ' lung scanning ', ' Pulmonary imaging ', ' lung imaging ', ' Phase ', ' Evaluation ', ' lung volume ', ' Lung damage ', ' lung injury ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Source ', ' Texture ', ' Techniques ', ' System ', ' respiratory ', ' experience ', ' Performance ', ' drug efficacy ', ' lung pressure ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Structure ', ' novel ', ' Radiation ', ' rapid technique ', ' rapid method ', ' drug discovery ', ' imaging modality ', ' imaging method ', ' image-based method ', ' Address ', ' Dose ', ' Resolution ', ' Resource Sharing ', ' in vivo ', ' physiological imaging ', ' Physiologic Imaging ', ' Functional Imaging ', ' Low Dose Radiation ', ' Monitor ', ' Process ', ' imaging ', ' Image ', ' preclinical ', ' pre-clinical ', ' cost ', ' computational studies ', ' computer studies ', ' Imaging technology ', ' innovative ', ' innovate ', ' innovation ', ' murine model ', ' mouse model ', ' micro CT ', ' microCT ', ' animal imaging ', ' imaging system ', ' contrast imaging ', ' learning method ', ' learning activity ', ' learning strategy ', ' technical certificate ', ' Technical Degree ', ' efficacy study ', ' parametric imaging ', ' in vivo monitoring ', ' ']",NIBIB,WASHINGTON UNIVERSITY,R01,2018,408541,0.181852624679404
"Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting     DESCRIPTION (provided by applicant): Disrupted circadian timing has emerged as a serious health and safety issue, yet there are no objective means of easily assessing circadian timing or alignment without performing a highly controlled, multiple-day in- patient study. Altered circadian timing can cause both sleep loss and sleepiness, cause performance errors such as motor vehicle accidents, and impair memory/learning. Thus, despite the obvious need to recognize an individual's circadian phase/alignment, we cannot assess circadian timing clinically or in retrospective studies. Not surprisingly, the first goal of the 2011 NIH Sleep Disorders Research Plan is to identify: ""...metabolic... biomarkers of sleep deficiency and biological timing...and circadian disorders that will facilitate personalized treatments, and clarify the risk associated with untreated sleep and circadian disorders and disturbances."" We are aware that major challenges face biomarker development, including multi-factorial causes of metabolite shifts normally controlled across multiple time-points. Because circadian time is associated with profound metabolic, immune and cardiovascular changes, however, we hypothesize that a biomarker signature for circadian phase derived from -omic markers can be obtained from a single blood sample. We therefore propose to utilize the analytical and bioinformatics platforms and experience in population-level metabolomics studies in the PIs lab to study banked plasma samples from the well-characterized individuals in six tightly controlled circadian rhythm studies run by the four co-investigators.The Aims are:  Aim 1: To identify, to optimize, to validate, and t cross-validate a set of nested plasma lipidomics-  based biomarker profiles that report circadian phase and alignment using well-characterized samples drawn from three constant routine protocols Aim 2: To identify, to optimize, to validate, and to cross-validate a set of nested plasma lipidomics based biomarker profiles that report circadian phase and alignment using well-characterized samples  drawn from four forced desynchrony protocols  Aim 3: To systematically evaluate the validated profiles from Aims 1 and 2 and their mathematical  similarities and differences so as to improve accuracy and precision of the biomarkers  Aim 4: To test the markers identified above under poorly controlled real world applications Identification of biomarker panels will impact multiple aspects of science and health: (i) contribute to clinical recognition and treatment on circadian disorders; (ii) advance personalized medicine through individualized treatment timing to enhance efficacy/reduce side effects of medications (e.g., chemotherapy); (iii) creating epidemiologic tools to relate circadian with disease risk; and aiding development of other disease biomarkers, and; (iv) contribute to research on circadian biology and its implications for human health. PUBLIC HEALTH RELEVANCE: We propose to identify blood-based markers that can inform a clinician or researcher about an individual's internal biological clock. At the broad levels of society and public health research, the work has the potential direct benefit of identifying individuals with ""off-set"" clocks (enabling diagnosis and potential therapy), increasing accuracy and precision of studies of blood lipids, facilitating understanding of certain sleep disorders, increasing understanding of the role of biological clocks in chronic disease processes (e.g., cancer, diabetes, cardiovascular disease), and potentially improving the administration of certain pharmaceuticals, eg, chemotherapy agents.","Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting",9457491,R01HL132556,"['Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Retrospective Studies ', ' Risk ', ' Role ', ' social role ', ' Running ', ' Safety ', ' Science ', ' Sleep ', ' Smoking ', ' Societies ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' Time ', ' Woman ', ' Work ', ' Gender ', ' Generations ', ' base ', ' human population study ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Clinical ', ' Phase ', ' Biological ', ' Link ', ' memory dysfunction ', ' Memory Deficit ', ' Memory impairment ', ' Individual ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Metabolic ', ' Strigiformes ', ' Owls ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Hour ', ' Immune ', ' Immunes ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' blood lipid ', ' experience ', ' Performance ', ' disorder risk ', ' disease risk ', ' vehicular accident ', ' motor vehicle accident ', ' Motor carrier accident ', ' Reporting ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' Sampling ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Bioinformatics ', ' Bio-Informatics ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Data ', ' Resolution ', ' Pattern Recognition ', ' Process ', ' developmental ', ' Development ', ' Population ', ' prospective ', ' combinatorial ', ' chemotherapy ', ' real world application ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' public health research ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' biomarker development ', ' marker panel ', ' biomarker panel ', ' marker identification ', ' biomarker identification ', ' blood-based marker ', ' blood-based biomarker ', ' Age ', ' ages ', ' Algorithms ', ' Awareness ', ' Biological Clocks ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biology ', ' Birds ', ' Avian ', ' Aves ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Circadian Rhythms ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Diabetes Mellitus ', ' diabetes ', ' Diagnosis ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Drowsiness ', ' sleepiness ', ' Somnolence ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Face ', ' facial ', ' faces ', ' Goals ', ' Health ', ' Human ', ' Modern Man ', ' Inpatients ', ' Learning ', ' Mathematics ', ' Math ', ' men ', "" men's "", ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Patients ', ' Plasma ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,R01,2018,863172,0.0718518910897693
"The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites Project Summary/Abstract Background: Blacks have higher rates of cardiovascular disease (CVD), CVD risk markers (elevated blood pressure, cholesterol, and unhealthy glucose levels), and CVD mortality, compared to whites. Despite advances in understanding how CVD disparity is engendered and preventing CVD, blacks compared to whites are still disproportionately burdened by CVD, particularly CVD risk markers. Therefore, more novel targets that drive racial disparity in CVD risk markers must be investigated in order to reduce and eliminate CVD disparity. Evidence indicating that insufficient sleep (sleep duration 6hrs/24 hr. cycle), which disproportionately affects blacks, is linked to concurrent and future CVD risk may offer a potentially novel mechanism explaining CVD risk disparity between blacks and whites. However, it is unclear whether insufficient sleep directly or indirectly drives disparity in CVD risk between blacks and whites? Therefore, the purpose of the proposed K01 study is to investigate whether insufficient sleep independently explains a significant portion of racial disparity in CVD risk markers, while adjusting for the confounding effects of sleep apnea and insomnia (two sleep disorders that cause insufficient sleep). Additionally, since 55% of insufficient sleepers are obese and blacks are twice as likely to be obese compared to whites, the candidate will investigate the independent and combined effects of insufficient sleep and obesity on the disparity in CVD risk markers between blacks and whites. Research: In the proposed K01, the candidate, Dr. Azizi Seixas, will investigate: 1) whether insufficient sleep and/or obesity play an important role in the relationship between race/ethnicity and CVD risk, controlling for sleep apnea and insomnia; and 2) what sleep duration and body mass index profile is associated with lowest probability of CVD risk among blacks and whites, using advanced mathematical analytic methods and complex system simulation modeling. Training: The training plan builds upon the candidate's background and experience in conducting research in sleep disorders and cardiovascular disease (e.g. hypertension and stroke), among minority populations. During the K01, the candidate will receive training in sleep science and physiology, cardiovascular disease and advanced analytical, machine learning, and simulation modeling. He will perform secondary analyses of data from the Sleep Heart Health Study, a NHLBI-funded study. The pedagogical approach includes one-on-one mentorship, course work, mentored laboratory training (practicum), and attendance to targeted conferences and seminars, with the common goal of supporting his transition to being an independent scientist. Project Narrative The overarching objective of this K01 career development award is to foster the transition of Dr. Azizi Seixas into an independent scientist in the area of sleep and cardiovascular disease and health disparities. The proposed study will investigate a novel mechanism underlying associations between insufficient sleep, obesity, and disparity in CVD risk markers between blacks and whites. Findings from the study will be the basis of sleep and obesity interventions to reduce CVD risk, especially among diverse groups burdened by cardiovascular disease.",The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites,9412518,K01HL135452,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Blood Pressure ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cholesterol ', ' Cohort Studies ', ' Concurrent Studies ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Future ', ' Glucose ', ' Dextrose ', ' D-Glucose ', ' Glucose Intolerance ', ' Goals ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Health Services Evaluation ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Life Style ', ' Lifestyle ', ' Mathematics ', ' Math ', ' Mentors ', ' Mentorship ', ' Methodology ', ' mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Physiology ', ' Play ', ' Probability ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' Role ', ' social role ', ' Science ', ' Sleep ', ' Sleep Apnea Syndromes ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Work ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' Mediating ', ' Caring ', ' advisory team ', ' Task Forces ', ' Advisory Committees ', ' analytical method ', ' base ', ' Site ', ' Area ', ' Biological ', ' Medical ', ' Link ', ' Training ', ' Failure ', ' Bayesian statistics ', ' Bayesian statistical inference ', ' Bayesian statistical analysis ', ' Bayesian spatial analysis ', ' Bayesian network analysis ', ' Bayesian inference ', ' Bayesian Analysis ', ' Fostering ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Complex ', ' System ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' Equation ', ' experience ', ' Disease Outcome ', ' novel ', ' models and simulation ', ' model-based simulation ', ' Reporting ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Risk Reduction ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' Body mass index ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Address ', ' Data ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Risk Marker ', ' developmental ', ' Development ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' poststroke ', ' post stroke ', ' effectiveness research ', ' underserved people ', ' under served population ', ' Underserved Population ', ' Minority ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' comparative effectiveness ', ' fasting glucose ', ' social health determinants ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' race disparity ', ' disparities in race ', ' racial disparity ', ' cardiovascular health ', ' pedagogical method ', ' pedagogical development ', ' pedagogical approach ', ' pedagogical content ', ' laboratory training ', ' lab experience ', ' laboratory experience ', ' stroke survivor ', ' reduce disparity ', ' disparity reduction ', ' Heart health ', ' Cardiac health ', ' secondary analysis ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K01,2018,179820,0.13071578339539583
"An automated and massively scalable platform for organismal and developmental genetics Project Summary Sleep regulation plays a critical role in proper neurological development. During sleep, there is enhanced synaptic plasticity in the nervous system in addition to often extensive neural remodeling. Although we know that sleep regulation is important to neurological development, many aspects of sleep regulation are poorly understood. In particular, the mechanisms of how we compensate for missed sleep in future sleep cycles are mysterious, despite general knowledge of how circadian rhythms are established. It is likely that these mechanisms involve neuropeptide signaling in the brain. However, current tools to study the roles these peptides play in sleep homeostasis, even with the use of simple model organisms like C. elegans, are low- throughput, qualitative, and subjective. In order to study sleep-like behavior in C. elegans, there is an unmet need for a tool for continuously monitoring and perturbing long-term behavior of the worm, as well as an automated and un-biased method for quantifying behavioral data. In this proposal, we will first develop the enabling technology, and use it to identify the roles of neuropeptides in homeostasis of the nematodes sleep- like state. In Aim I, we will engineer and validate a scalable microscopy platform for monitoring and perturbing C. elegans behavior, decreasing the cost of long-term candidate screens by ~ 100 fold. In Aim 2, we will quantify behavior of wild-type animals via an automated and bias-free quantitative analysis to establish baseline behavior and prioritize behaviors that are linked to sleep homeostasis. In Aim 3, we will use the technology developed in Aims I and 2 to quantify differences in behavior of C. elegans neuropeptide mutants using a candidate approach. Because of the strong preliminary data we have gathered so far and the experience of the sponsors laboratory, this proposed work is likely to identify the roles of these candidate neuropeptides in sleep homeostasis, contributing to our mechanistic understanding of sleep regulation. Furthermore, the tools we develop for this particular study will also have broad utilities in many other problems, such as developmental programming, aging, and neurobehavioral studies. Project Narrative Sleep regulation plays a critical role in proper brain development and is linked to a variety of neurological and behavioral disorders. In particular, how animals correct for interrupted sleep cycles in future cycles could lead to therapeutic targets, but apart from a few implicated neuropeptides, little is known about the mechanisms behind this aspect of sleep. The objective of this proposal is to identify the roles of neuropeptides in sleep homeostasis by screening C. elegans mutants for behavioral defects.",An automated and massively scalable platform for organismal and developmental genetics,9545566,F31GM123662,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Aging ', ' Animals ', ' Automation ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Circadian Rhythms ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Communities ', ' Computer Vision Systems ', ' computer vision ', ' Disease ', ' Disorder ', ' Drosophila genus ', ' fruit fly ', ' Drosophila ', ' Engineering ', ' Environment ', ' Future ', ' Genes ', ' Goals ', ' Health ', ' Heterogeneity ', ' Homeostasis ', ' Physiological Homeostasis ', ' Autoregulation ', ' Human ', ' Modern Man ', ' Insulin ', ' Regular Insulin ', ' Novolin R ', ' Humulin R ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Maps ', ' Methods ', ' Microscopy ', ' Study models ', ' Nematoda ', ' roundworm ', ' Nematodes ', ' Nervous system structure ', ' Neurologic Organ System ', ' Neurologic Body System ', ' Nervous System ', ' nervous system disorder ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' Neuropeptides ', ' Organism ', ' living system ', ' Peptides ', ' Physiology ', ' Play ', ' Reproduction ', ' Role ', ' social role ', ' Signal Pathway ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Sleep ', ' Synapses ', ' synapse ', ' Synaptic ', ' Technology ', ' Work ', ' Zebrafish ', ' Zebra Fish ', ' Zebra Danio ', ' Danio rerio ', ' Brachydanio rerio ', ' C.elegans ', ' C. elegans ', ' C elegans ', ' Caenorhabditis elegans ', ' improved ', ' Neurological ', ' Neurologic ', ' Link ', ' Individual ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Middle Insomnia ', ' Sleep maintenance insomnia ', ' Night waking ', ' Interrupted sleep ', ' Fitful sleep ', ' Difficulty staying asleep ', ' Difficulty in sleep maintenance ', ' Broken sleep ', ' Complex ', ' Source ', ' Pattern ', ' Techniques ', ' System ', ' developmental genetics ', ' experience ', ' mutant ', ' success ', ' sleep regulation ', ' sleep control ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' relating to nervous system ', ' neural ', ' Emotional ', ' Regulation ', ' Modeling ', ' software development ', ' developing computer software ', ' develop software ', ' Microfluidics ', ' Microfluidic ', ' Address ', ' Microfluidic Microchips ', ' microfluidic chip ', ' Microfluidic Lab-On-A-Chip ', ' Microfluidic Device ', ' Defect ', ' Data ', ' Interruption ', ' Monitor ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' age dependent ', ' age related ', ' cost ', ' behavioral monitoring ', ' Behavior monitoring ', ' neurobehavioral ', ' Synaptic plasticity ', ' innovative ', ' innovate ', ' innovation ', ' circadian clock ', ' circadian pacemaker ', ' therapeutic target ', ' screening ', ' behavior study ', ' behavioral study ', ' Drug Screening ', ' ']",NIGMS,GEORGIA INSTITUTE OF TECHNOLOGY,F31,2018,44524,0.12164657749771916
"Microtemporal Processes Underlying Health Behavior Adoption and Maintenance SUMMARY Emerging adulthood (ages 18-24 years) is marked by substantial weight gain, leading to increased lifetime risks of cancer and other chronic diseases. Engaging in sufficient levels of physical activity and sleep, and limiting sedentary time are important contributors to the prevention of weight gain. However, engaging in these healthy behaviors peaks during the childhood and adolescent years, and steeply deteriorates into emerging adulthood. Interventions promoting physical activity, reduced sedentary time, and sufficient sleep typically focus on the adoption of these behaviors. Yet, when these interventions are successful, new patterns of behavior are not maintained and typically regress back to baseline levels. Traditional health behavior theories provide limited guidance regarding factors underlying behavior maintenance. To address this gap, our work suggests that dual-process models of decision-making and behavior can shed light on differences in the mechanisms underlying adoption versus maintenance. Reflective processes (e.g., efficacy, deliberations, self-control) may be activated to a greater extent during behavior adoption. In contrast, reactive processes (e.g., contextual cues, automaticity, habits) may play a greater role in behavior maintenance. However, reactive processes are difficult to measure using retrospective methods because they can unfold on a micro-timescale (i.e., change across minutes or hours). To solve this problem, we propose to use real-time mobile technologies to collect intensive longitudinal data examining differences in the micro-temporal processes underlying the adoption and maintenance of physical activity, low sedentary time, and sufficient sleep duration. We will conduct a prospective within- subject case-crossover observational study across a 12-month period. Ethnically-diverse, emerging adults (ages 18-24, N=300) will be recruited from the Happiness & Health Cohort (R01DA033296). We will conduct intermittent self-report (i.e., ecological momentary assessment) of reflective variables; and continuous, sensor- based passive monitoring of reactive variables (e.g., location, social proximity, voice/text communication) and behaviors (i.e., physical activity, sedentary time, sleep) using smartwatches and smartphones. These data will be used to predict within-subject variation (within-days, between-days) in the likelihood of behavior episodes (e.g., 10 min of physical activity, 120 min sedentary time, 7 hr sleep) and lapses (i.e., failure to achieve recommended levels 7 days). The specific aims are to (1) idiographically use machine learning to identify person-specific combinations of time-varying reflective and reactive factors that predict behavior episodes and lapse; and (2) nomothetically determine whether there are general, group-level patterns of time-varying predictors, and whether those patterns predict successful behavior maintenance outcomes. The data and methods from this project will contribute to the U01/U24 Intensive Longitudinal Behavior Initiatives collective goal to build more predictive health behavior theories that specify targets for personalized interventions. PROJECT NARRATIVE Weight gain increases dramatically emerging adulthood, increasing risk of cancer and chronic disease later in life. This study will use mobile technologies to collect intensive longitudinal data on micro-temporal mechanisms underlying the adoption and maintenance of physical activity, limited sedentary time, and sufficient sleep duration in emerging adults. Results will be used to build more predictive health behavior theories and inform personalized behavior interventions to reduce obesity and improve public health.",Microtemporal Processes Underlying Health Behavior Adoption and Maintenance,9576883,U01HL146327,"['Adoption ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Cues ', ' Decision Making ', ' Exhibits ', ' Goals ', ' Habits ', ' Happiness ', ' positive attitude ', ' Health ', ' Health behavior ', ' Light ', ' Photoradiation ', ' Maintenance ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Methodology ', ' Persons ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Play ', ' Problem Solving ', ' Public Health ', ' Relapse ', ' Research ', ' Role ', ' social role ', ' Sleep ', ' Specificity ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Vision ', ' visual function ', ' Sight ', ' Voice ', ' Weight Gain ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Work ', ' Measures ', ' base ', ' communication behavior ', ' sensor ', ' improved ', ' sedentary ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Variation ', ' Variant ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Physical activity ', ' Failure ', ' pediatric ', ' Childhood ', ' Individual ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Adopted ', ' Hour ', ' Pattern ', ' Location ', ' cancer risk ', ' cohort ', ' Structure ', ' Patient Self-Report ', ' Self-Report ', ' Predictive Factor ', ' Self-control as a personality trait ', ' self control ', ' social ', ' Modeling ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' prevent ', ' preventing ', ' Address ', ' Data ', ' Lifetime Risk ', ' Observational research ', ' Observation study ', ' Observation research ', ' Observational Study ', ' Monitor ', ' trend ', ' Characteristics ', ' Process ', ' Text ', ' developmental ', ' Development ', ' Behavioral ', ' weight gain prevention ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' prospective ', ' demographics ', ' successful intervention ', ' early adulthood ', ' emerging adult ', ' emerging adulthood ', ' precision interventions ', ' personalized intervention ', ' Ecological momentary assessment ', ' mobile technology ', ' mobile platform ', ' mobile computing ', ' predictors of outcomes ', ' predictive outcomes ', ' outcome prediction ', ' ethnically diverse ', ' ethnic diversity ', ' recruit ', ' ']",NHLBI,UNIVERSITY OF SOUTHERN CALIFORNIA,U01,2018,694652,0.04711646592084497
"Omics Data Integration to Identify Disease Pathways in COPD Project Summary Although chronic obstructive pulmonary disease (COPD) occurs predominantly in smokers, it is unknown why only a minority of smokers (~20-40%) develops chronic airflow limitation and/or destruction of distal airspaces (emphysema). Using several NIH and foundation grants, we have systematically generated genetic, genomics, proteomic, and metabolomics profiles from the NHLBI supported COPDGene cohort, which includes 10,300 current and former smokers age 45-80. This proposal will focus on integrating the omics data generated in the five-year followup (Phase II) of the COPDgene study to identify molecular subtypes of COPD across a broad range of blood profiles (Specific Aim 1). Biomarkers and pathways discriminating the molecular subtypes, in addition to other COPD phenotypes will then be identified (Specific Aim 2). These results will identify markers that are specific to smoking-related lung disease and can be used to develop novel diagnostic tests and therapies for early prevention and treatment of COPD. Relevance to Public Health Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in the United States. The major risk factor is smoking; however, most smokers do not develop COPD and the factors that identify who goes from normal to abnormal lung function are unknown. This proposal will use already collected data on existing NHLBI cohorts to identify blood signatures that can identify who will be at risk for developing smoking related lung disease. The knowledge gained will help guide treatment strategies and improve prognosis assessments.",Omics Data Integration to Identify Disease Pathways in COPD,9562961,R21HL140376,"['Age ', ' ages ', ' Biology ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cause of Death ', ' Complement ', ' Complement Proteins ', ' Computers ', ' Disease ', ' Disorder ', ' Foundations ', ' Gene Expression ', ' Goals ', ' Grant ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Hematological Disease ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Proteins ', ' Public Health ', ' Pulmonary Emphysema ', ' emphysematous ', ' Emphysema ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Risk ', ' Risk Factors ', ' Smoking ', ' Supervision ', ' Time ', ' United States ', ' Work ', ' Diagnostic tests ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Distal ', ' Chronic ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Individual ', ' Sample Size ', ' Disease Progression ', ' Funding ', ' Genetic ', ' Smoker ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Complex ', ' Source ', ' System ', ' Severity of illness ', ' disease severity ', ' cohort ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' novel ', ' Prevention ', ' Sleep Disorders ', ' sleep problem ', ' Sampling ', ' response ', ' Proteomics ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Genomics ', ' disorder control ', ' disease control ', ' computerized data processing ', ' data processing ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' data mining ', ' datamining ', ' Data ', ' Disease Pathway ', ' Molecular Target ', ' Classification Scheme ', ' Preparation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' clinical phenotype ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' data integration ', ' Minority ', ' multidisciplinary ', ' early therapy ', ' Early treatment ', ' data space ', ' human disease ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' new therapeutic target ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' novel therapeutic intervention ', ' treatment strategy ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' learning method ', ' learning activity ', ' learning strategy ', ' multi-omics ', ' multiple omics ', ' molecular subsets ', ' molecular sub-types ', ' expression subtypes ', ' molecular subtypes ', ' secondary analysis ', ' Disease stratification ', ' high dimensionality ', ' Expression Profiling ', ' unsupervised machine learning ', ' unsupervised learning ', ' ']",NHLBI,UNIVERSITY OF COLORADO DENVER,R21,2018,117464,0.10961996718985918
"Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood PROJECT SUMMARY Substantial improvements in cancer survival rates could be achieved by developing better tools to detect occult malignancies at an earlier, more curable stage. Unfortunately, efforts to identify serum protein biomarkers that are sufficiently cancer-specific to be used for screening have found little success. Here, we pursue an alternative strategy based on detection of exceptionally tumor-specific mutant DNA fragments in the circulation of patients with early-stage lung cancer. Because these tumor-derived DNA fragments harbor genetic signatures that would be uncommon in healthy individuals, they hold great promise for screening applications where a high frequency of false-positive results would be unacceptable. However, it is a formidable challenge to create an assay that is able to detect trace quantities of mutant DNA released into the bloodstream from a small, early-stage tumor, without knowing the tumors mutation profile beforehand. Additional challenges are posed by economic factors as well as the presence of low-level mutations in the healthy population. To address these challenges, we have assembled a multidisciplinary team with highly complementary expertise from Microsoft Research and from Yale, Rice, and Harvard Universities. In this proposal, we describe innovative solutions in which we apply tools of biochemistry, thermodynamics, machine learning, and biostatistics to develop and validate an ultrasensitive, cost-efficient assay for detecting rare mutant DNA fragments in blood as markers of early-stage lung cancer. PROJECT NARRATIVE Lung cancer has a high fatality rate because most patients are diagnosed at a late stage, when the disease is more difficult to cure. A screening test that finds lung tumor DNA in blood could help to improve survival outcomes.",Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood,9631134,U01CA233364,"['Age ', ' ages ', ' Algorithms ', ' Alleles ', ' Allelomorphs ', ' Back ', ' Dorsum ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Colonoscopy ', ' Diagnosis ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Blood Tests ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' Hematopoiesis ', ' Hematopoietic Cellular Control Mechanisms ', ' Libraries ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung Neoplasms ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Mammography ', ' mammographic exams ', ' mammographic examinations ', ' Mammogram ', ' Medicine ', ' Methods ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Patients ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Probability ', ' Research ', ' Rice ', ' Sensitivity and Specificity ', ' Serum Proteins ', ' Skates ', ' Rajidae ', ' Specificity ', ' Survival Rate ', ' Technology ', ' Temperature ', ' Testing ', ' Thermodynamics ', ' Thermodynamic ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' Universities ', ' Work ', ' Pap smear ', ' cervical/vaginal smear ', ' Vaginal Smears ', ' Papanicolaou Test ', ' Papanicolaou Smear ', ' Pap Test ', ' Cervical Smears ', ' Morphologic artifacts ', ' Artifacts ', ' Tube ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Economical Factors ', ' Economic Factors ', ' Training ', ' Lesion ', ' lung base ', ' lung basal segment ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' lung cancer early detection ', ' lung cancer screening ', ' tool ', ' Smoker ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Somatic Mutation ', ' mutant ', ' Performance ', ' success ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' purge ', ' purging ', ' purges ', ' Sampling ', ' repository ', ' Tumor stage ', ' T-Stage ', ' Fatality rate ', ' Address ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effectiveness analyses ', ' cost effective analysis ', ' Cost Effective Analyses ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Data ', ' Detection ', ' Predictive Value ', ' Premalignant ', ' precancerous ', ' Pre-Malignant ', ' genomic region ', ' Genomic Segment ', ' Nucleic Acid Biochemistry ', ' Tumor-Derived ', ' developmental ', ' Development ', ' neoplastic ', ' cost ', ' designing ', ' design ', ' cost efficient ', ' Population ', ' cancer type ', ' prospective ', ' innovative ', ' innovate ', ' innovation ', ' multidisciplinary ', ' tumor ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' next generation sequencing ', ' exome-seq ', ' exome sequencing ', ' screening ', ' tumor-specific DNA ', ' tumor cell DNA ', ' tumor DNA ', ' variant of undetermined significance ', ' variant of uncertain significance ', ' variant of uncertain clinical significance ', ' unclassified variant ', ' variant of unknown significance ', ' cell free circulating DNA ', ' cell free DNA ', ' biochemistry tools ', ' biochemical tools ', ' biomarker development ', ' gene signatures ', ' genetic signature ', ' cancer markers ', ' cancer biomarkers ', ' protein markers ', ' protein biomarkers ', ' survival outcome ', ' cancer survival ', ' high risk group ', ' high risk population ', ' ']",NCI,YALE UNIVERSITY,U01,2018,520236,0.020759932163057816
"Lung Navigation System for Localizing and Resecting Nodules Project Abstract  Although Wedge Resection Surgery results in better lung function, tumor recurrence rate is almost double that of lobectomy, with significantly poorer 5-year survival rates. This may be attributed to the difficulty in accurately localizing and resecting the nodules in a deflated lung. Currently, there is no effective method of accurately localizing the nodules and guiding the surgical stapling device to the optimal resection margin. The long-term goal of this research is to investigate algorithms and technologies to manage lung nodules from diagnosis to surgical resection. The objective of this proposal is to design and develop a lung navigation (LungNav) system to localize and excise, with sufficient margin, small and early malignant lung nodules. The experimental methods will be to design and develop the LungNav system integrated with an active nodule tracker called J-bar, machine learning algorithms for determining the optimal resection margin, and tracked surgical stapling device for accurately excising the nodule. Tumor deformation algorithms and augmented reality displays will be developed to visualize the nodule on thoracosopy videos and guide the surgical stapler in real-time to the optimal margin. The hypothesis is that by anchoring the J-bar close to the nodule, the nodule position can be accurately tracked in real-time despite significant tissue deformation when the lung is collapsed and manipulated during surgery. To achieve the goals of this project, we will pursue the following specific aims: 1) Design and develop the nodule tracker (J-bar) and deformation algorithms to estimate the real-time position of the nodule. 2) Investigate a machine-learning approach based on convolutional neural networks (CNN) to determine the optimal resection margin. 3) Design and develop a software navigation module, called LungNav, for visualizing the tumor and navigating the surgical stapler to the optimal resection margin. 4) Validate the design and performance of the LungNav system using ex-vivo lung tissue and live porcine models. The proposed research is significant since it addresses an important problem, which potentially affects several thousand patients each year, of accurately localizing and resecting lung nodules while preserving healthy lung function. The research is innovative since it builds on state-of-the-art machine learning algorithms, navigation systems and augmented reality methods to accurately diagnose and localize the nodule in presence of significant tissue deformation. The expected outcome of the project is the development of CNN-based machine learning algorithms for lung nodule classification and a LungNav system with tumor deformation algorithms and augmented reality methods to localize and guide complete surgical resection of lung nodules. Project Narrative ! The proposed research is significant since it addresses an important problem, which potentially affects several thousand patients each year, of accurately localizing and resecting lung nodules while preserving healthy lung function. The research is innovative since it builds on state-of-the-art machine learning algorithms, navigation systems and augmented reality methods to accurately diagnose and localize the nodule in presence of significant tissue deformation. !",Lung Navigation System for Localizing and Resecting Nodules,9596800,R01EB025964,"['Affect ', ' Algorithms ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' Diagnosis ', ' Electromagnetics ', ' Electromagnetic ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Lobectomy ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Methods ', ' Nodule ', ' Legal patent ', ' Patents ', ' Patients ', ' Lung nodule ', ' pulmonary nodule ', ' Recurrence ', ' Recurrent ', ' Research ', ' Respiratory physiology ', ' respiratory function ', ' lung function ', ' Computer software ', ' Software ', ' Surgical Staplers ', ' Survival Rate ', ' Family suidae ', ' suid ', ' porcine ', ' Swine ', ' Suidae ', ' Pigs ', ' Technology ', ' Thoracoscopy ', ' TRSCPY ', ' Pleuroscopy ', ' Pleural Endoscopy ', ' Time ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' Measures ', ' Visualization ', ' Imagery ', ' base ', ' sensor ', ' Pleuroscopes ', ' Thoracoscopes ', ' Surface ', ' Malignant ', ' Malignant - descriptor ', ' Phase ', ' Surgical margins ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' lung cancer early detection ', ' lung cancer screening ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' System ', ' Surgical Staples ', ' Surgical Stapling ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Surgeon ', ' particle ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' novel ', ' Devices ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Positioning Attribute ', ' Position ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Modeling ', ' cancer diagnosis ', ' Address ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' low-dose spiral CT ', ' developmental ', ' Development ', ' cost ', ' designing ', ' design ', ' Outcome ', ' Navigation System ', ' innovative ', ' innovate ', ' innovation ', ' early therapy ', ' Early treatment ', ' open source ', ' Network-based ', ' tumor ', ' minimally invasive ', ' arm ', ' screening ', ' accurate diagnosis ', ' Augmented Reality ', ' deep learning ', ' ']",NIBIB,BRIGHAM AND WOMEN'S HOSPITAL,R01,2018,395640,0.10601535364540948
"Genetic interaction analysis involving oncogenesis-related genes in lung cancer PROJECT SUMMARY  The development of cancer diseases is driven by the accumulation of many oncogenesis-related genetic alterations and tumorigenesis is triggered by complex networks of involved genes rather than independent actions. The interactions among genetic factors are believed to play important roles in carcinogenesis and contribute to the missing heritability. In this proposal, we designed a filtered gene-gene interaction analysis aiming to identify the epistasis involving important oncogenesis-related genes. Besides the advantage of dimensional reduction and increased power, this filtered interaction analysis will help us identify novel oncogenes or tumor suppressor genes implicated in lung cancer development that will not be revealed in main effect association analysis. It will also identify novel susceptibility variants, including those in intergenic and non-coding regions, affecting lung cancer risk by interacting/modulating with oncogenesis-related genes. Lung cancer is a heterogeneous disease and researchers have identified vast differences in genomic attributes. However, the knowledge about epistatic features in lung cancer subtypes is limited. We will conduct a stratified epistasis analysis by lung cancer histology subtype in the proposed study to reveal subtype-specific genetic interactions and gene networks. The stratified analysis by histology will enhance our understanding about this complicated disease mechanism in lung cancer and has the potential to contribute to precision medicine in lung cancer treatment.  A main challenge in genetic association studies is to understand the functional consequences of identified genetic variants. In this study, we proposed functional annotation analysis including eQTL gene expression analysis, pathway and gene network analysis, and functional annotation of epistasis-involved SNPs. This integrative epistasis and functional annotation analysis will help us pinpoint the causal epistasis and characterize the epistasis-involved genes or regions in lung cancer risk development. It will be a pilot study to explore how the regulatory non-coding variants impact lung cancer risk by interacting with oncogenesis-related genes.  The proposed study will provide insights about the complicated biological interactions that are critical for gene regulation, biochemical networks, and developmental pathways implicated in lung carcinogenesis. In order to finish the proposed study, we collected the genotype data from three independent GWAS studies including 24,037 lung cancer patients and 20,401 healthy controls from the Caucasian population. The genotype and gene expression data in lung tissues from 409 individuals will be applied for eQTL gene expression analysis. NARRATIVE The interactions among genetic factors are believed to play important roles in carcinogenesis and contribute to the missing heritability. In this proposal, we designed an integrative filtered epistasis and functional annotation analysis to identify the genetic interactions involving important oncogenesis-related genes in lung cancer development. Besides the advantage of dimensional reduction and increased power, this filtered interaction analysis will help us identify novel variants, including the regulatory elements in non-coding regions, implicated in lung cancer development that will not be revealed in main effect association analysis.",Genetic interaction analysis involving oncogenesis-related genes in lung cancer,9825016,R21CA235464,"['Adenocarcinoma ', ' Malignant Adenoma ', ' Affect ', ' Canada ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Squamous cell carcinoma ', ' Squamous Cell Epithelioma ', ' Squamous Carcinoma ', ' Planocellular Carcinoma ', ' Epidermoid Carcinoma ', ' Cities ', ' Disorder ', ' Disease ', ' genetic epistases ', ' gene x gene interaction ', ' epistatic relationship ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' Genotype ', ' Histology ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Oncogenes ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Quantitative Evaluations ', ' Quebec ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Testing ', ' Translating ', ' Universities ', ' white race ', ' Occidental ', ' Caucasoid Race ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasians ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Tumor Suppressor Genes ', ' Dataset ', ' Data Set ', ' Lung Adenocarcinoma ', ' base ', ' Variant ', ' Variation ', ' Biological ', ' Biochemical ', ' insight ', ' Individual ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Patient Recruitments ', ' participant recruitment ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Dimensions ', ' Complex ', ' cancer risk ', ' carcinogenesis ', ' Cancer Induction ', ' gene interaction ', ' novel ', ' Reporting ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Gene Expression Profiling ', ' transcriptional profiling ', ' gene expression assay ', ' gene expression analysis ', ' Transcript Expression Analysis ', ' Transcript Expression Analyses ', ' Gene Expression Pattern Analysis ', ' Gene Expression Monitoring ', ' genetic analysis ', ' Genetic analyses ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Pathway Analysis ', ' Network Analysis ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-translated RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' Meta-Analysis ', ' Data Pooling ', ' Clinical Trial Overviews ', ' cancer therapy ', ' anticancer therapy ', ' anti-cancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' Oncogenesis ', ' tumorigenesis ', ' genetic association ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Data ', ' Regulatory Element ', ' Cancer Histology ', ' Cancer Patient ', ' Smoking Status ', ' Characteristics ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' design ', ' designing ', ' lung carcinogenesis ', ' Population ', ' Heritability ', ' Susceptibility Gene ', ' susceptibility variant ', ' susceptibility locus ', ' susceptibility allele ', ' predisposing gene ', ' Predisposition gene ', ' precision medicine ', ' precision-based medicine ', ' cancer subtypes ', ' cancer sub-types ', ' causal variant ', ' causative variant ', ' causative mutation ', ' causal mutation ', ' causal gene ', ' causal allele ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R21,2019,210597,0.17514202458012365
"Development of a Rapid Method for Imaging Regional Ventilation in Small Animals w/o Contrast Agents The objective of this R01 application is to develop a rapid method for imaging regional ventilation and lung compliance in small animals without contrast agents. Much of our current understanding of the normal functioning of the lung and mechanisms of lung disease comes from small animal studies. However, lung function imaging in small animal models is technically challenging due to motion and the relatively small size of the lungs. Pulmonary function testing using plethysmography has been employed to assess lung function and injury with limited validity and utility, particularly in small animals. Additionally, only aggregate measures of functional performance are produced and no regional lung changes can be assessed. An improved imaging method that could provide spatially- and temporally-resolved information regarding ventilation would be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases. It would also facilitate drug discovery and efficacy studies aimed to mitigate respiratory pathology. The ideal method would provide quantitative regional functional information, be applicable to longitudinal studies (low radiation dose), and have a simple and affordable implementation that permits widespread use. Currently available imaging methods including micro-CT or MRI fall short in one or more of these requirements.  To address this need, we will establish and evaluate a novel, easy to implement, and highly effective X- ray phase-contrast (XPC) method for ventilation imaging in small animal models. The lung is ideally suited to XPC imaging because it is comprised mainly of air spaces separated by thin tissue structures. The air-tissue interfaces cause the X-ray beam to experience numerous and strong refractions that produce a distinctive texture in the intensity measured over the lungs known as speckle. Detailed information regarding the regional lung air volume (RLAV) distribution is encoded in the speckle. The benefits of exploiting lung speckle for detecting and monitoring lung function are numerous but remain entirely unexplored for benchtop imaging.  Our approach involves a high degree of technical innovation regarding image formation methods and will significantly extend the current boundaries of functional lung imaging in small animals. The proposed method, referred to as parametric XPC (P-XPC) imaging, will produce 2D parametric images that depict the projected RLAV distribution. When differential images are computed for any given two points in the breathing cycle, ventilation or lung compliance imaging will be achieved. Preliminary in vivo and computational studies have been conducted in support of the proposed research. The specific aims of the project are as follows. Aim 1: Develop P-XPC image formation methods for estimating the projected RLAV distribution; Aim 2: Optimize an XPC imaging system for P-XPC imaging. Aim 3: Evaluate the diagnostic capability of P-XPC imaging in two pre-clinical animal models of disease in vivo. The proposed research will result in a novel, easy to implement, and highly effective X-ray phase-contrast (XPC) method for functional lung imaging in small animal models. It will provide spatially- and temporally- resolved information regarding lung ventilation that will be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases.",Development of a Rapid Method for Imaging Regional Ventilation in Small Animals w/o Contrast Agents,9927856,R01EB023045,"['Air ', ' Animals ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Communities ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Contrast Media ', ' Animal Disease Models ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Lung Compliance ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Respiratory Function Tests ', ' Lung Function Tests ', ' Pulmonary function tests ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Maps ', ' Methods ', ' Motion ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Pathology ', ' Physics ', ' Physiology ', ' Plethysmography ', ' pressure ', ' emphysematous ', ' Emphysema ', ' Pulmonary Emphysema ', ' Research ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' Leanness ', ' Thinness ', ' Time ', ' Body Tissues ', ' Tissues ', ' Translating ', ' Ventilation ', ' Environmental air flow ', ' Xrays ', ' X-Rays Radiation ', ' X-Rays ', ' X-Radiation ', ' Roentgen Rays ', ' Measures ', ' falls ', ' base ', ' detector ', ' improved ', ' lung imaging ', ' lung scanning ', ' Pulmonary imaging ', ' Phase ', ' Evaluation ', ' lung volume ', ' lung injury ', ' Lung damage ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Source ', ' Texture ', ' Techniques ', ' System ', ' respiratory ', ' Radiation Dose Unit ', ' Radiation Dose ', ' experience ', ' Performance ', ' drug efficacy ', ' lung pressure ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Structure ', ' novel ', ' Radiation ', ' rapid technique ', ' rapid method ', ' drug discovery ', ' imaging method ', ' image-based method ', ' imaging modality ', ' Address ', ' Resolution ', ' Resource Sharing ', ' in vivo ', ' Functional Imaging ', ' physiological imaging ', ' Physiologic Imaging ', ' Low Dose Radiation ', ' Monitor ', ' Process ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' pre-clinical ', ' preclinical ', ' cost ', ' computer studies ', ' computational studies ', ' Imaging technology ', ' innovation ', ' innovative ', ' innovate ', ' mouse model ', ' murine model ', ' microCT ', ' micro CT ', ' animal imaging ', ' imaging system ', ' contrast imaging ', ' learning strategy ', ' learning method ', ' learning activity ', ' Technical Degree ', ' technical certificate ', ' efficacy study ', ' parametric imaging ', ' in vivo monitoring ', ' supervised learning ', ' supervised machine learning ', ' ']",NIBIB,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,R01,2019,408514,0.181852624679404
"A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules Low dose CT screening (LDCT) has been approved by the Centers for Medicare & Medicaid Services  (CMS) for Medicare coverage. However, the primary problem associated with CT is the high false positive  detections (~96%). This issue often leads to unpleasant and costly unintended consequences (e.g.,  follow-up scans and/or invasive biopsies). In this project, we propose to develop and commercialize  a novel computer tool to aid in accurate assessment of indeterminate lung nodules. The goal is to  accurately and efficiently quantify the potential risk of developing lung cancer and its future  prognosis, thereby facilitating precise / personalized lung cancer screening and optimal patient  management. During Phase I of this project, we have accomplished the proposed milestones and  developed a prototype system that is now publicly accessible. Our preliminary validation of the  prototype system demonstrates very promising performance. In Phase II, we will continue our effort  to make this tool available to serve clinical community with the following specific aims: (1)  develop a generalized framework that supports the incorporation of both image and patient  information as well as other biological tests related to lung cancer; (2) fully optimize the  computer algorithms to efficiently analyze chest CT scans and in particular synergize our  algorithms with the deep learning technology to improve training efficiency and benign/malignance  classification accuracy; and (3) comprehensively validate and optimize the system in clinical  environment at the University of Pittsburgh Medical Center (UPMC). We believe that the proposed  system is extremely timely and important in light of the CMS decision to cover annual LDCT lung  cancer screening. Its availability will significantly reduce the over-diagnosis associated with  LDCT for lung cancer screening and relieve the economic burden on healthcare system. Project Narrative: The project aims to develop an online computer tool to aid in efficacious early  lung cancer screening and diagnosis based on LDCT. This tool will not only locate the pulmonary  nodules automatically, but also quantitatively assess the malignancy of a suspicious nodule and its  prognosis.",A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules,9624736,R44CA203058,"['Affect ', ' Age ', ' ages ', ' Algorithms ', ' Anxiety ', ' Biopsy ', ' Needle biopsy procedure ', ' needle biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Systematics ', ' Classification ', ' Communities ', ' computing system ', ' Computer Systems ', ' Computers ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Environment ', ' Future ', ' Goals ', ' Health Care Systems ', ' Healthcare Systems ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' Learning ', ' Photoradiation ', ' Light ', ' Literature ', ' Manuals ', ' Methods ', ' mortality ', ' Nodule ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Patients ', ' Prognosis ', ' outcome forecast ', ' pulmonary nodule ', ' Lung nodule ', ' Receiver Operator Characteristics ', ' Receiver Operating Characteristics ', ' R&D ', ' R & D ', ' Development and Research ', ' research and development ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Sputum ', ' Technology ', ' Testing ', ' thorax incision ', ' chest wall incision ', ' Thoracotomy ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' United States Health Care Financing Administration ', ' Health Care Financing Administration ', ' Centers for Medicare and Medicaid Services ', ' United States Centers for Medicare and Medicaid Services ', ' Universities ', ' Work ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Benign ', ' Solid ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Phase ', ' Death Rate ', ' Training ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' radiologist ', ' lung cancer screening ', ' lung cancer early detection ', ' tool ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Malignant neoplasm of prostate ', ' Prostatic Cancer ', ' Prostate Cancer ', ' Prostate CA ', ' Malignant prostatic tumor ', ' Malignant Tumor of the Prostate ', ' Frequencies ', ' Scanning ', ' System ', ' Medical center ', ' cancer risk ', ' Performance ', ' success ', ' novel ', ' Agreement ', ' new technology ', ' novel technologies ', ' Modality ', ' Colon Carcinoma ', ' cancer in the colon ', ' Colonic Carcinoma ', ' Colon Cancer ', ' Reporting ', ' cancer diagnosis ', ' Biological Testing ', ' Data ', ' Detection ', ' Economic Burden ', ' Resolution ', ' Cancer Etiology ', ' Cancer Cause ', ' low-dose spiral CT ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' Smoking History ', ' Validation ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' cost ', ' innovation ', ' innovative ', ' innovate ', ' Computational algorithm ', ' computer algorithm ', ' prototype ', ' multimodality ', ' multi-modality ', ' clinical practice ', ' Systems Development ', ' image guided ', ' image guidance ', ' imaging system ', ' physical symptom ', ' Radiation exposure ', ' chest computed tomography ', ' chest CT ', ' computed tomography screening ', ' CT screening ', ' deep learning ', ' Digital Imaging and Communications in Medicine ', ' DICOM ', ' ']",NCI,INTERNATIONAL INTELLIGENT INFOR/SOLU/LAB,R44,2019,430933,0.17523477002884585
"The role of the lung microbiome in oxygen-induced lung injury PROJECT SUMMARY/ABSTRACT Background and long-term objectives: This proposed research will advance our understanding of how the lung microbiome contributes to the pathogenesis and perpetuation of oxygen-induced lung injury. Inhaled oxygen is among our most commonly administered therapies. Yet hyperoxia - elevated inspired oxygen - causes lethal lung injury in animals, and in humans is associated with increased mortality and development of the acute respiratory distress syndrome. We have recently discovered that hyperoxia acutely alters lung microbiota. This oxygen-induced dysbiosis is strongly and temporally correlated with alveolar inflammation. We have discovered that germ-free mice - experimental mice devoid of microbiota - are protected from oxygen- induced lung injury, an observation that cannot be explained via our conventional model of oxygen-induced lung injury. Conversely, lung injury alters lung microbiota by changing bacterial growth conditions within the lung microenvironment. We have discovered that germ-free mice are protected from non-resolving lung injury (bleomycin), indicating that the microbiome is necessary for perpetuation of lung injury. The discovery of the lung microbiome has thus broadened our model of pathogenesis. The mechanisms by which lung microbiota mediate oxygen-induced lung injury, and are in turn altered by lung injury, are undetermined. The central hypothesis of this proposal is that specific bacteria within the lung ecosystem propel alveolar inflammation in oxygen-induced lung injury, and these bacteria are enriched within the lung microbiome both by hyperoxia itself and by the altered ecology of injured lungs. The rationale is that these discoveries will facilitate the development of therapies for the prevention and treatment of oxygen-related human lung disease. Specific Aim 1: To determine the microbial and molecular pathways by which oxygen therapy alters lung microbiota, mediating host inflammation and injury. We will accomplish this Aim by integrating complementary experimental approaches: in vivo heterogeneity analysis of host-microbiome interactions in mice; in vivo germ-free, gnotobiotic, and antibiotic-treated hyperoxia modeling in mice; data science interrogation of observational human data using a validated machine-learning algorithm. Specific Aim 2: To determine the molecular pathways by which oxygen-induced host inflammation and injury alter lung microbiota, perpetuating respiratory dysbiosis and lung injury. We will accomplish this Aim by integrating complementary experimental approaches: a novel ex vivo culture assay that identifies host- derived mediators of bacterial growth; in vivo augmentation and inhibition of the host response in hyperoxia. This translational research approach will determine 1) the key members of the lung microbiome that mediate oxygen-induced lung injury, 2) the pathways by which these bacteria promote alveolar inflammation, and 3) the ecologic factors within the injured lung environment that promote their growth. PROJECT NARRATIVE Inhaled oxygen is among our most commonly administered therapies, yet hyperoxia - elevated inspired oxygen - causes lethal lung injury in animals, and in humans is associated with increased mortality and severe lung disease. We have recently discovered that the lung microbiome - the communities of microbes living in the respiratory tract - are altered by inhaled oxygen and necessary for the development of oxygen-induced lung injury. This proposed research plan will reveal how the lung microbiome contributes to oxygen-induced lung injury, and provide us with new ways to prevent and treat this common clinical problem.",The role of the lung microbiome in oxygen-induced lung injury,9754347,R01HL144599,"['Animals ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Bacteria ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Bleomycin ', ' Bleo ', ' Disorder ', ' Disease ', ' Environmental Science ', ' Ecology ', ' Environment ', ' Feedback ', ' Gnotobiotics ', ' Gnotobiotic ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Inflammation ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' mortality ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' O2 element ', ' O element ', ' Oxygen ', ' Publishing ', ' Research ', ' wet lung ', ' Stiff lung ', ' Shock Lung ', ' Da Nang Lung ', ' Adult RDS ', ' Adult ARDS ', ' Acute Respiratory Distress Syndrome ', ' Acute Respiratory Distress ', ' ARDS ', ' Adult Respiratory Distress Syndrome ', ' Respiratory tract structure ', ' Respiratory Tracts ', ' Pulmonary Organ System ', ' Pulmonary Body System ', ' Respiratory System ', ' social role ', ' Role ', ' Experimental Models ', ' Mediating ', ' Ecosystem ', ' Ecological Systems ', ' Ecologic Systems ', ' Injury ', ' Oxygen Therapy Care ', ' oxygen therapy ', ' oxygen administration ', ' Warburg Therapy ', ' Oxygen Inhalation Therapy ', ' Acute ', ' Clinical ', ' Oxidative Stress ', ' Hyperoxia ', ' lung injury ', ' Lung damage ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Nature ', ' Severities ', ' respiratory ', ' human data ', ' microbial ', ' Sterility ', ' sterile ', ' novel ', ' member ', ' Prevention ', ' Pathogenesis ', ' Modeling ', ' preventing ', ' prevent ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Alveolar ', ' in vivo ', ' Germ-Free ', ' Observational Study ', ' Observational research ', ' Observation study ', ' Observation research ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Molecular ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' microbiome ', ' injured ', ' Outcome ', ' Prevention therapy ', ' microbial community ', ' community microbes ', ' therapeutic target ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' Data Science ', ' microbiota ', ' multispecies consortia ', ' microflora ', ' microbial flora ', ' microbial consortia ', ' Inhalation ', ' Inhaling ', ' host microbiota ', ' resident microflora ', ' resident microbes ', ' host microflora ', ' dysbiosis ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' lung microbiome ', ' pulmonary microbiome ', ' lung microbiota ', ' pulmonary microbiota ', ' pulmonary microbial community ', ' lung microbial community ', ' host microbiome ', ' machine learning algorithm ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2019,422565,0.13374521240940032
"Autoimmunity as a Mechanism for Atherosclerosis in COPD     DESCRIPTION (provided by applicant): This project will facilitate the development of the principal investigator into an independent translational researcher investigating systemic vascular injury in Chronic obstructive pulmonary disease (COPD). This will be accomplished in the rich academic environment at the University of Pittsburgh, under the guidance of a highly accomplished team of mentors, and in the conduct of multidisciplinary research project that will develop autoimmunity as a novel mechanism for atherosclerosis in COPD. The increased risk of atherosclerosis in COPD is not explained by smoking, age, hypertension, and other established vascular disease risk factors. Chronic inflammation has recently been implicated as an atherogenic mechanism in COPD. We and others have reported that chronic inflammation in COPD may be propagated by humoral autoimmunity. Specifically, smokers with COPD have greatly increased levels of circulating autoantibodies that demonstrate in vitro pathogenic effects. Our subsequent studies also show that these autoantibodies target at least 50 different autoantigens and consistently target glucose regulated protein 78 (GRP78), particularly in patients with parenchymal lung destruction, i.e. emphysema. GRP78 is present in the endoplasmic reticulum, where it regulates the unfolded protein response, and is also a multifunction cell surface receptor. Studies in cancer patients suggest that ligation of the N-terminus of cell surface GRP78 by anti-GRP78 IgG transduces pro-inflammatory and pro-proliferative signals by activation of the AKT pathway, followed by NFB activation. Additional in vivo studies have identified anti-GRP78 IgG with affinity for the C-terminus of cell surface GRP78 that produce counteracting anti-inflammatory effects by suppressing AKT activation. Our preliminary work shows that circulating anti-GRP78 IgG in COPD patients binds to macrophages and leads to increased NFB activation and production of atherogenic inflammatory mediators by them. The macrophage is critical in the development of both atherosclerosis and COPD. Also, cross-sectional studies in our cohort find that levels of circulating anti-GRP78 IgG are strongly associated with carotid atherosclerosis in patients with emphysema, independent of established vascular risk factors. Therefore, we hypothesize that autoimmune responses against GRP78 are a mechanism for atherosclerosis in COPD. During this award, we will: (1) Test the hypothesis that elevated levels of circulating anti-GRP78 IgG predict progression of carotid atherosclerosis in patients with emphysema independent of established risk factors over 4 year follow up; (2) Test the hypothesis that anti-GRP78 IgG binds to the N-terminus of cell surface GRP78 and activates the AKT pathway followed by NFB activation and production of inflammatory mediators using a variety of cell function assays, and provide proof of concept for two potential therapeutic strategies; (3) Test the hypothesis that there are other antigen-specific immune responses associated with atherosclerosis in COPD by using machine learning to analyze high-throughput data on a large number of circulating autoantibody levels. PUBLIC HEALTH RELEVANCE: Chronic obstructive pulmonary disease (COPD) is a lung disease caused by smoking that kills more and more Americans each year, and is now the third leading cause of death in the US. Although it is largely viewed as a disease of the lungs, the most common cause of death in patients with COPD are blockages in blood vessels. This research project will investigate why patients with COPD are so prone to develop these blood vessel blockages.",Autoimmunity as a Mechanism for Atherosclerosis in COPD,9668180,K23HL126912,"['Age ', ' ages ', ' Antibodies ', ' Antigens ', ' immunogen ', ' ATGN ', ' Atherosclerosis ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Autoantibodies ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantigens ', ' Self-Antigens ', ' Autologous Antigens ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Autoimmune Responses ', ' Autoimmunity ', ' Autoimmune Status ', ' Award ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood Vessels ', ' vascular ', ' Western Blotting ', ' protein blotting ', ' Western Immunoblotting ', ' Cause of Death ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Ergastoplasm ', ' Endoplasmic Reticulum ', ' Environment ', ' ELISA ', ' Enzyme-Linked Immunosorbent Assay ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Modern Man ', ' Human ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' IgG ', ' 7S Gamma Globulin ', ' Immunoglobulin G ', ' In Vitro ', ' Inflammation ', ' Closure by Ligation ', ' Ligation ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' Chronic Obstructive Airway Disease ', ' macrophage ', ' Mentors ', ' Mentorship ', ' Morbidity ', ' Morbidity - disease rate ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Phenotype ', ' Protein Phosphorylation ', ' Phosphorylation ', ' Production ', ' Proteins ', ' emphysematous ', ' Emphysema ', ' Pulmonary Emphysema ', ' Cell Surface Receptors ', ' Risk ', ' Risk Factors ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoking ', ' Testing ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Universities ', ' vasculopathy ', ' vascular dysfunction ', ' blood vessel disorder ', ' Vascular Disorder ', ' Vascular Diseases ', ' Work ', ' glucose-regulated proteins ', ' Measures ', ' Proto-Oncogene Proteins c-akt ', ' related to A and C-protein ', ' rac protein kinase ', ' proto-oncogene protein akt ', ' proto-oncogene protein RAC ', ' c-akt protein ', ' RAC-PK protein ', ' Protein Kinase B ', ' Akt protein ', ' AKT ', ' Injury ', ' Chronic ', ' Link ', ' Fostering ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Inflammation Mediators ', ' inflammatory mediator ', ' Funding ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Therapeutic Agents ', ' Exposure to ', ' Inflammatory ', ' Smoker ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Event ', ' Carotid Atherosclerotic Disease ', ' Carotid Atheroscleroses ', ' American ', ' cohort ', ' novel ', ' Cell surface ', ' Reporting ', ' Carotid Artery Plaques ', ' carotid plaque ', ' Carotid Artery Plaque ', ' response ', ' Pathogenicity ', ' Molecular Interaction ', ' Binding ', ' preventing ', ' prevent ', ' Affinity ', ' Data ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' in vivo ', ' Antiinflammatory Effect ', ' anti-inflammatory effect ', ' Cancer Patient ', ' Principal Investigator ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' peptidomimetics ', ' peptide mimic ', ' peptide mimetic ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' in vitro testing ', ' vascular risk factor ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' cancer clinical trial ', ' translational scientist ', ' translational researcher ', ' translational investigator ', ' atherosclerosis risk ', ' atherosclerotic risk ', ' machine learning algorithm ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K23,2019,166104,0.06841134301101671
"Cardiac genetic effects across HLBS phenotypes Forward genetic genome-wide association studies (GWAS) have successfully mapped thousands of loci regulating disorders of the heart, lung, blood and sleep (HLBS), implicating widespread sequence variation within the non-coding genome. However, their functions, mechanisms of action and how they impact disease is still unclear. To solve this new and important GWAS bottleneck, we use a functional genomics-inspired reverse genetics strategy to identify the `transcriptional machinery' (transcription factors (TF), cis-regulatory elements (CRE), target genes) controlling HLBS-relevant tissue functions and how DNA variants in them affect HLBS diseases. Taking advantage of our long-standing expertise and successes in complex, cardiovascular disorders, and novel computational methods we have recently developed, we propose novel genomics analyses of the Trans-Omics for Precision Medicine (TOPMed) Program phenotypes and their whole genome sequences, together with publicly available epigenomics data, to identify the molecular bases of HLBS disease. We will first focus on the transcriptional machinery controlling heart physiology and its disorders before exploring other HLBS-relevant tissues and disorders in collaboration with other TOPMed investigators. Our specific aims are: (1) Identifying the transcriptional machinery in the heart and other HLBS relevant tissues; and, (2) Connecting genomic variation in the transcriptional machinery to HLBS traits. Our approach will enable identification of the core molecular components that control HLBS tissues and how they are compromised in HLBS disorders. The major hypothesis explaining the results of heart, lung, blood and sleep (HLBS) genome-wide association studies (GWAS) is that sequence variants at specific cis-regulatory elements (CRE or enhancer) affect the binding of their cognate transcription factors (TF) to alter expression of specific HLBS genes and, thereby, modulate variation in the phenotype and disorders. In this proposal, we advance new computational approaches to identify the `transcriptional machinery' (TF, CRE, target genes) controlling HLBS-relevant tissue functions so that the effects of causal genetic variation can be identified within identified trait loci genome- wide. This tissue-based view provides an alternative, complementary approach for understanding HLBS trait and disease variation, a major public health challenge.",Cardiac genetic effects across HLBS phenotypes,9692018,R01HL141980,"['Affect ', ' Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Chromatin ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Gene Expression ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Genotype ', ' Heart ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Maps ', ' Minor ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Phenotype ', ' Physiology ', ' Public Health ', ' Publishing ', ' Quality Control ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Sleep ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Genetic Diversity ', ' Genetic Variation ', ' Weight ', ' Enhancers ', ' base ', ' improved ', ' Peripheral ', ' Variant ', ' Variation ', ' Link ', ' Individual ', ' Sample Size ', ' Collaborations ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Complex ', ' success ', ' trait ', ' Base Pairing ', ' novel ', ' Code ', ' Coding System ', ' Sleep Disorders ', ' sleep problem ', ' sleep dysregulation ', ' sleep dysfunction ', ' Modeling ', ' functional genomics ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-translated RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Data ', ' Regulatory Element ', ' Molecular ', ' Cardiac ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' epigenomics ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' genome-wide analysis ', ' genome-wide identification ', ' genome wide studies ', ' genome wide analysis ', ' gene discovery ', ' discover genes ', ' genome-wide ', ' genomewide ', ' genome scale ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' rare variant ', ' rare allele ', ' DNase I hypersensitive sites sequencing ', ' DNaseI-seq ', ' DNase-seq ', ' genomic variation ', ' reverse genetics ', ' ATAC-seq ', ' ATACseq ', ' Genotype-Tissue Expression Project ', ' GTEx ', ' whole genome ', ' full genome ', ' entire genome ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' Trans-Omics for Precision Medicine ', ' TOPMed ', ' causal variant ', ' causative variant ', ' causative mutation ', ' causal mutation ', ' causal gene ', ' causal allele ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2019,436249,0.0011146360333239595
"The Detection, Quantification, and Management of Ventilator Dyssynchrony Project Summary/Abstract Despite significant advances in ventilator management, mortality from the acute respiratory distress syn- drome (ARDS) remains unacceptably high. Mechanical ventilation with large tidal volume, high pressure ven- tilation, and repeated alveolar collapse can injure the lung, called ventilator induced lung injury (VILI). Defined as the inappropriate timing and delivery of a breath in response to a patient effort, ventilator dyssynchrony (VD) may potentiate VILI. This proposal outlines a 5-year training programing including mentoring, formal didactics, and practical research experiences which positions Dr. Sottile for a successful clinical research career examining ventilator dyssynchrony (VD), its impact on ventilator induced lung injury (VILI), and its optimal management. An integrated curriculum will optimize an automated VD detection algorithm, delineate which types of VD are deleterious, and determine the ideal ventilator and sedation strategies to minimize VD and improve patient outcomes. This experience will provide Dr. Sottile with the necessary tools to be a leader in signal analysis, ventilator dyssynchrony, advanced mathematical modeling, and critical care research. This program will consist of formal mentoring from four renowned experts in machine learning, mechanical ventilation, critical care research, and modeling of dynamic systems. In addition, coursework in clinical sciences, machine learning, and advanced mathematical modeling will build the theoretical foundation to apply these techniques. This structured curriculum will help Dr. Sottile gain expertise in the computerized detection of VD from real-time ventilator data, the pathophysiology of VD, and the modeling of complex, temporally dynamic, biological systems. The formal curriculum will coincide with three practical experiences. First, Dr. Sottile will optimize his already developed VD identification algorithm to detect additional types of VD that may be injurious to the lung. Second, he will identify which types of VD are associated with deleterious ventilator mechanics. Finally, he will deter- mine the personalized ventilator and sedation strategies to minimize VD, VILI, and the negative consequences of over sedation using linear optimization and lagged linear correlation to account for the dynamic nature of patient physiology. The result of the proposed studies will develop a computerized algorithm to detect seven types of VD, identify which types of VD are most likely to propagate VILI, and determine the optimal ventilator and sedation strategies to improve individual patient outcomes. This will leave Dr. Sottile and the study team positioned to conduct a randomized clinical trial comparing computer-predicted individualized ventilator and se- dation strategies compared to the current standard of care. If successful, this will potentially to revolutionize the use of mechanical ventilation by tailoring evidenced-based therapies to the individual patient. Project Narrative Despite over 50 years of research, the acute respiratory distress syndrome (ARDS) accounts of over 10% of ICU admissions. Despite current treatment strategies focused on reducing ventilator induced lung injury through low tidal volume ventilation or prone position, mortality remains over 30%. This proposal seeks to understand how patient-ventilator interactions may propagate lung injury and will determine optimal treatment strategies to improve patient- ventilator interactions, decrease lung injury, and improve patient outcomes.","The Detection, Quantification, and Management of Ventilator Dyssynchrony",9646106,K23HL145011,"['Accounting ', ' Algorithms ', ' Dysbarism ', ' Barotrauma ', ' Clinical Study ', ' Clinical Research ', ' Computers ', ' Critical Care ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' Endothelium ', ' Foundations ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Manometry Biochemistry ', ' Manometry ', ' Math ', ' Mathematics ', ' Mentors ', ' mortality ', ' Patients ', ' Physiology ', ' pressure ', ' Prone Position ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' wet lung ', ' Stiff lung ', ' Shock Lung ', ' Da Nang Lung ', ' Adult RDS ', ' Adult ARDS ', ' Acute Respiratory Distress Syndrome ', ' Acute Respiratory Distress ', ' ARDS ', ' Adult Respiratory Distress Syndrome ', ' Risk ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Technology ', ' respiratory airway volume ', ' Tidal Volume ', ' Time ', ' Training Programs ', ' Ventilation ', ' Environmental air flow ', ' Measures ', ' surrogate biomarkers ', ' surrogate bio-markers ', ' Surrogate Markers ', ' Outcomes Research ', ' Ventilator ', ' Injury ', ' career ', ' improved ', ' Mechanical ventilation ', ' mechanical respiratory assist ', ' Clinical ', ' Randomized Clinical Trials ', ' Epithelial ', ' esophagus pressure ', ' esophageal pressure ', ' Induction of neuromuscular blockade ', ' Neuromuscular Blockade ', ' Neuromuscular Block ', ' Individual ', ' lung injury ', ' Lung damage ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' tool ', ' Sedation procedure ', ' sedation ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Mechanics ', ' mechanical ', ' Complex ', ' Techniques ', ' System ', ' interest ', ' experience ', ' Structure ', ' Time Series Analysis ', ' Positioning Attribute ', ' Position ', ' Admission activity ', ' Admission ', ' Modeling ', ' response ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' Alveolar ', ' Data ', ' Detection ', ' Research Infrastructure ', ' Clinical Data ', ' Clinical Sciences ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Monitor ', ' Esophageal ', ' injured ', ' computerized ', ' Ventilator-induced lung injury ', ' Outcome ', ' multidisciplinary ', ' trial comparing ', ' evidence base ', ' standard of care ', ' treatment strategy ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' biological systems ', ' dynamic system ', ' dynamical system ', ' individual patient ', ' personalized strategies ', ' individualized strategies ', ' improved outcome ', ' personalized predictions ', ' personalized predictors ', ' individualized predictions ', ' Individualized Predictors ', ' optimal treatments ', ' optimal therapies ', ' machine learning algorithm ', ' ']",NHLBI,UNIVERSITY OF COLORADO DENVER,K23,2019,170640,0.05824601796995617
"Using natural language processing and machine learning to identify potentially preventable hospital admissions among outpatients with chronic lung diseases Project Summary Patients living with chronic lung diseases (CLDs) are frequently admitted to the hospital for potentially preventable causes. Such admissions may be discordant with patient preferences and/or represent a low-value allocation of health system resources. To anticipate such admissions, existing clinical prediction models in this eld typically produce an all-cause risk estimate which, even if accurate, overlooks the actionable mechanisms behind admis- sion risk and therefore fails to identify a prescribed response. This limitation may explain the only modest  at best  reductions in hospital admissions and readmissions seen in most intervention bundles that have been tested in this population. An opportunity exists, therefore, to predict hospitalization risk while simultaneously identifying patient phenotypes (i.e. some constellation of social, demographic, clinical, and other characteristics) for which known preventive interventions exist. The proposed study seeks to overcome these limitations and capitalize on this opportunity by (1) conducting semi-structured interviews with hospitalized patients with CLDs, and their caregivers and clinicians, to directly identify modiable risks and their associated phenotypes driving hospital ad- missions; (2) using natural language processing techniques (NLP) to build classication models that will leverage nuanced narrative, social, and clinical information in the unstructured text of clinical encounter notes to identify patients with these phenotypes; and (3) building risk prediction model focused on actionable phenotypes with a wide-array of traditional regression and machine learning approaches while also incorporating large numbers of predictor variables from text data and accounting for time-varying trends. The candidate's preliminary work using basic NLP techniques to signicantly improve the discrimination of clinical prediction models in an inpatient population has motivated this methodologic approach. The rising burden and costs of hospitalizations associated with CLDs, and the increasing attention from federal payers, highlights the critical nature of this work. Completion of this research will build upon the candidate's past training, which includes a Masters of Science in Health Policy Research obtained with NHLBI T32 support, and will provide the experience, education, and mentorship to allow the candidate to become a fully independent investigator. Based on the candidate's tailored training plan, he will acquire advanced skills in mixed-methods research, NLP, and trial design all through coursework, close men- toring and supervision, and direct practice. The skills will position him ideally to submit successful R01s testing the deployment of the proposed clinical prediction models in real-world settings. The candidate's primary mentor, collaborators, and advisors will ensure adherence to the proposed timeline and goals and provide a support- ive environment for him to develop an independent research career testing the real-world deployment of clinical prediction models to reduce low-value and preference-discordant care for patients with CLDs. Project Narrative Every year many people living with chronic lung diseases are admitted to the hospital despite the fact that some of these admissions may have been prevented with early identication and intervention prior to the hospitalization. Previous attempts at preventing such hospitalizations have been limited by their ability to both accurately identify those at risk, and because most risk models do not provide a reason for the likely admission. The proposed work draws directly on the experiences of patients with chronic lung diseases who are admitted to a hospital, and then uses cutting edge statistical and computer science techniques to use information in the electronic health record to accurately predict the risk and the likely reason for future hospital admissions.",Using natural language processing and machine learning to identify potentially preventable hospital admissions among outpatients with chronic lung diseases,9681485,K23HL141639,"['Accounting ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Ambulatory Care ', ' outpatient treatment ', ' Outpatient Care ', ' Attention ', ' Automobile Driving ', ' driving ', ' Systematics ', ' Classification ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Data Sources ', ' Diagnosis ', ' Cognitive Discrimination ', ' Discrimination ', ' Educational aspects ', ' Education ', ' Future ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' Hospital Admission ', ' Hospitalization ', ' Hospitals ', ' Inpatients ', ' Interview ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' Chronic Obstructive Airway Disease ', ' Mentors ', ' Mentorship ', ' Methods ', ' Methodology ', ' Mission ', ' natural language understanding ', ' Natural Language Processing ', ' nurse ', ' Nurses ', ' Out-patients ', ' Outpatients ', ' comfort care ', ' Palliative Treatment ', ' Palliative Therapy ', ' Palliative Care ', ' Patients ', ' Pennsylvania ', ' Phenotype ', ' Physicians ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social support network ', ' Social support ', ' Supervision ', ' Testing ', ' Time ', ' United States ', ' Universities ', ' Work ', ' Measures ', ' Care Givers ', ' Caregivers ', ' Research Methods ', ' Research Methodology ', ' TimeLine ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' career ', ' improved ', ' Acute ', ' Clinical ', ' Interstitial Lung Diseases ', ' Hospital Costs ', ' Hospitalization cost ', ' Ensure ', ' Training ', ' Early Intervention ', ' instrument ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Patient Preferences ', ' Home environment ', ' Home ', ' Techniques ', ' interest ', ' preference ', ' experience ', ' Performance ', ' computer science ', ' hospital readmission ', ' rehospitalization ', ' readmission ', ' re-hospitalization ', ' re-admission ', ' hospital re-admission ', ' Structure ', ' skills ', ' novel ', ' social ', ' Positioning Attribute ', ' Position ', ' Chronic lung disease ', ' Admission activity ', ' Admission ', ' Early identification ', ' Modeling ', ' career development ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' model development ', ' Bioinformatics ', ' Bio-Informatics ', ' preventing ', ' prevent ', ' Address ', ' Health system ', ' end of life ', ' end-of-life ', ' Symptoms ', ' Adherence ', ' Data ', ' Master of Science ', ' Policy Research ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Risk Estimate ', ' Validation ', ' Monitor ', ' trend ', ' Characteristics ', ' Text ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' National Heart, Lung, and Blood Institute ', ' NHLBI ', ' cost ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' Population ', ' administrative database ', ' administrative data base ', ' innovation ', ' innovative ', ' innovate ', ' modifiable risk ', ' discrete data ', ' randomized trial ', ' Randomization trial ', ' trial design ', ' supportive environment ', ' supportive atmosphere ', ' enthusiastic environment ', ' enthusiastic atmosphere ', ' risk prediction model ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,K23,2019,195076,0.046404892478558876
"CRCNS: Unsupervised Learning of Hippocampal Sequence Dynamic in Sleep   In unit recordings from large populations of neurons, fast compressed sequential firing of neurons during rest and early sleep have been found to replay patterns first observed in active awake experience. These remarkable patterns have sparked widespread interest in the scientific community and beyond. Sequence  replay is now considered to play a critical role in the long-term stabilization and storage of mnemonically  important information. However, despite the general acknowledgement of the importance of the sequential structure, very little is known about the null background against which replay is compared. Specifically, are apparently 'non-replaying' spike patterns, as seen in late sleep, just simply noise? Because replay is typically assessed by comparison against a fixed known template, most methods can only determine whether the resemblance to the template is more than what might be expected from  random spike trains. But these methods cannot appraise whether other patterns remain in the nonsignificant events. Recently, the Diba and Kemere labs successfully collaborated to address precisely  this issue. We developed methods based on hidden Markov models (HMMs) to uncover temporal structure in spike trains of neurons in an unsupervised template-free manner. In this proposal, we aim to further improve these methods and to evaluate the hidden structure of spike trains in hippocampal  neuronal populations during sleep. In our second specific aim, we will use HMMs to determine both co-active ensemble (""contextual"") and temporal patterns (""sequential"") structure in hippocampal spike trains in both pre- and post-task sleep. In the third specific aim, we will probe the essence of sleep replay further, by exposing animals to multiple novel and familiar maze environments prior to long durations of sleep. In the fourth specific aim, we will perform closed-loop disruption of neuronal population patterns to  examine the causal interplay and reverberation of these patterns from early to late sleep. In summary, our  proposal is designed to provide strongest characterization to date of the structure of ""noise"" in replay events. RELEVANCE (See instructions):  This study will provide an opening to evaluate the role of sleep in reorganizing information in the brain and  help to identify critical time windows and neuronal activities during sleep which are particularly important  for information storage and stabilization. Our assumptions and deductions about the nature and purpose  of sleep implicitly inform all manner of public policy, from the durations of shifts for hospital and relief  workers, to morning start times of public schools. Understanding the function and mechanisms of sleep H ",CRCNS: Unsupervised Learning of Hippocampal Sequence Dynamic in Sleep  ,9916188,R01NS115233,"['Animals ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cell Body ', ' Cells ', ' Cognition ', ' Communities ', ' Deductibles ', ' electrostimulation ', ' Electrical Stimulation ', ' Electric Stimulation ', ' Environment ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' Hospitals ', ' Learning ', ' Memory ', ' Methods ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Neurosciences ', ' Noise ', ' Play ', ' Public Policy ', ' Rest ', ' social role ', ' Role ', ' Schools ', ' Sleep ', ' sound ', ' Time ', ' base ', ' improved ', ' Evaluation ', ' Training ', ' Memory impairment ', ' memory dysfunction ', ' Memory Deficit ', ' awake ', ' Information Storage ', ' Nature ', ' Hour ', ' Event ', ' Pattern ', ' Techniques ', ' interest ', ' Visit ', ' experience ', ' Structure ', ' memory process ', ' memory processing ', ' novel ', ' Reporting ', ' Modeling ', ' theories ', ' Address ', ' Data ', ' Pathway interactions ', ' pathway ', ' Instruction ', ' markov model ', ' design ', ' designing ', ' Population ', ' optogenetics ', ' memory consolidation ', ' unsupervised learning ', ' unsupervised machine learning ', ' ']",NINDS,RICE UNIVERSITY,R01,2019,348066,0.09775043564350816
"STAN-CT: Standardization and Normalization of CT images for Lung Cancer Patients Project Summary/Abstract Lung cancer is the leading cause of cancer death and one of the most common cancers among both men and women in the United States. Recent advances in high-resolution imaging set the stage for radiomics to become an active emerging field in cancer research. However, the promise of radiomics is limited by a lack of image standardization tools, because computed tomography (CT) images are often acquired using scanners from different vendors with customized acquisition parameters, posing a fundamental challenge to radiomic studies across sites. To overcome this challenge, especially for large-scale, multi-site radiomic studies, advanced algorithms are required to integrate, standardize, and normalize CT images from multiple sources. We propose to develop STAN-CT, a deep learning software package that can automatically standardize and normalize a large volume of diagnostic images to facilitate cross-site large-scale image feature extraction for lung cancer characterization and stratification. By precisely mitigating the differences in advanced radiomic features of CT images, STAN-CT will overcome research silos and promote medical image resource sharing, ultimately improving the diagnosis and treatment of lung cancer. Our goal will be achieved through two Aims. In Aim 1, we will develop a working prototype to standardize CT images. First, we will collect raw image data from lung cancer patients and reconstruct CT images using multiple image reconstruction parameters, and we will scan a multipurpose chest phantom along with five different nodule inserts. Then, we will develop and train STAN-CT for CT image standardization. An alternative training architecture will be developed to achieve the improved model training stability. In Aim 2. We will deploy and test STAN-CT for image standardization locally and across three medical centers. First, we will make the STAN-CT software package available to the public by providing a menu-driven web-interface so that that users can conveniently convert medical images that were taken using non-standard protocols to one or multiple standards that they specify. Second, we will deploy STAN-CT at the University of Kentucky for local performance validation. We will test the functionality, reliability, and performance of STAN-CT using both patient chest CT image data collected at large-scale and the phantom image data, both independent to training. Third, we will deploy and test STAN-CT at the University of Kentucky as well as the University of Texas Southwestern Medical Center and Emory University for cross- center performance validation. We will use the same multipurpose chest phantom and both standard and non- standard protocols to validate STAN-CT at the three centers. We will test the generalizability of STAN-CT using clinical CT images of human patients and will determine whether a model trained using the data from one medical center are applicable for images collected at another place. Finally, we will distribute the software package of STAN-CT for public use. STAN-CT will enable a wide range of radiomic researches to identify diagnostic image features that strongly associated with lung cancer prognosis. Project Narrative Computed tomography (CT) is one of the most popular diagnostic image modalities routinely used for assessing anatomical tissue characteristics for disease management. However, CT images are often acquired using scanners from different vendors with different imaging standards, posing a fundamental challenge to radiomic studies across sites. The goal of the Standardization and Normalization of CT images for lung cancer patients (STAN-CT) project is to develop a deep learning software package that can automatically standardize and normalize a large volume of chest CT images to facilitate cross-site large-scale image feature extraction for lung cancer characterization and stratification.",STAN-CT: Standardization and Normalization of CT images for Lung Cancer Patients,9827910,R21CA231911,"['Algorithms ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Architecture ', ' Engineering / Architecture ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Nonsmall Cell Lung Carcinoma ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Communities ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Diagnostic Imaging ', ' Evolution ', ' Faculty ', ' Goals ', ' Modern Man ', ' Human ', ' image generation ', ' image construction ', ' image reconstruction ', ' Kentucky ', ' Medical Imaging ', "" men's "", ' men ', ' Anatomical Models ', ' Anatomic Models ', ' Names ', ' Nodule ', ' Patients ', ' Phenotype ', ' Prognosis ', ' outcome forecast ', ' Quality Control ', ' Radiology ', ' General Radiology ', ' Radiology Specialty ', ' Research ', ' Software ', ' Computer software ', ' Standardization ', ' Survival Rate ', ' Testing ', ' Texas ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Universities ', ' Vendor ', ' Woman ', ' Custom ', ' base ', ' improved ', ' lung imaging ', ' lung scanning ', ' Pulmonary imaging ', ' Site ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' Phase ', ' Training ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Imaging Phantoms ', ' tool ', ' Life ', ' Disease Management ', ' Disorder Management ', ' Scanning ', ' Protocols documentation ', ' Protocol ', ' Source ', ' System ', ' Medical center ', ' Performance ', ' trait ', ' member ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Modeling ', ' response ', ' cancer therapy ', ' anticancer therapy ', ' anti-cancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer diagnosis ', ' Tomography, Computed, Scanners ', ' imaging method ', ' image-based method ', ' imaging modality ', ' Data ', ' Multi-Institutional Clinical Trial ', ' Multisite clinical trial ', ' Multisite clinical study ', ' Multicenter clinical trial ', ' Multicenter clinical study ', ' Multi-site clinical trial ', ' Multi-site clinical study ', ' Multi-center clinical trial ', ' Multi-center clinical study ', ' Resource Sharing ', ' Stratification ', ' Cancer Etiology ', ' Cancer Cause ', ' Cancer Patient ', ' Cancer Prognosis ', ' Validation ', ' Characteristics ', ' Image ', ' imaging ', ' anticancer research ', ' cancer research ', ' anti-cancer research ', ' Outcome ', ' cancer imaging ', ' tumor imaging ', ' oncology imaging ', ' oncologic imaging ', ' Imaging technology ', ' web interface ', ' spatial temporal variation ', ' prototype ', ' tumor ', ' quantitative imaging ', ' data to knowledge ', ' data into knowledge ', ' radiomics ', ' chest computed tomography ', ' chest CT ', ' high resolution imaging ', ' human imaging ', ' deep learning ', ' computational platform ', ' computing platform ', ' ']",NCI,UNIVERSITY OF KENTUCKY,R21,2019,213271,0.06407178479722458
"The Role of the Microbiome in the Acute Respiratory Distress Syndrome     DESCRIPTION (provided by applicant): This K23 proposal will complete Robert Dickson, MD's training towards his long-term career goal of improving our understanding and treatment of lung disease by investigation of the microbiome. Dr. Dickson is a Pulmonary and Critical Care physician and scientist at the University of Michigan with established success in the burgeoning field of lung microbiome studies. This proposal builds on Dr. Dickson's previously acquired expertise in pulmonary pathophysiology and microbial ecology with new training in clinical research methods and computational biology. These established and newly-acquired skills will be integrated to improve our understanding of the role of the microbiome in the pathogenesis of the Acute Respiratory Distress Syndrome (ARDS). This research will be conducted under the guidance of primary mentor Gary B. Huffnagle PhD, co- mentor Theodore J. Standiford MD and an advisory board of accomplished investigators with expertise in clinical research methods, computational biology and lung immunology as well as extensive mentoring success. This 5-year plan includes formal coursework, professional development, and progressively independent research, with defined milestones to ensure productivity and a successful transition to independence. The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year. Numerous studies have identified indirect evidence of translocation of bacteria from the gastrointestinal tract to the lung in patients at risk for ARDS, but to date no study has evaluated the role of microbiome in the pathogenesis of ARDS. This proposal will test the hypothesis that translocation of gut bacteria to the lung provokes the inflammation and injury of ARDS via two specific Scientific Aims. Aim 1 will determine if translocation of enteric bacteria to the lung microbiome precedes the clinical development of ARDS, and Aim 2 will determine the temporal relationship between respiratory dysbiosis, host inflammation and the clinical onset of ARDS. Inherent to completing these high-level aims, Dr. Dickson will execute a prospective cohort study of patients at high risk for ARDS, utilize modern culture-independent techniques of bacterial identification to describe the bacterial communities in the lungs and gastrointestinal tracts of high-risk patients, and apply novel techniques of advanced computational modeling to the complex nonlinear system of ARDS pathogenesis. This work will build to at least two R01 proposals: 1) to determine if the lung microbiome contributes to disease progression among patients with established ARDS and 2) to determine if the lung microbiome can be therapeutically manipulated in critically ill patients to prevent or modulate respiratory disease. n addition to building a foundation for a programmatic line of research to understand the role of the microbiome in lung disease, this proposal will provide Dr. Dickson with research skills applicable to additional domains of human microbiome and ARDS research. This K23 award will equip Dr. Dickson to establish himself as an independent investigator and international leader in this promising field. PUBLIC HEALTH RELEVANCE: The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year; the National Institutes of Health have identified the prevention and early treatment of ARDS as a research priority. We lack an understanding of the pathogenesis of ARDS, impeding our ability to predict and prevent its onset. Determination of the role of the microbiome in the pathogenesis of ARDS would both 1) improve our ability to predict the onset of ARDS, enabling targeted preventive interventions and 2) identify novel therapeutic targets at the microbiome/host interface in patients at risk for ARDS.",The Role of the Microbiome in the Acute Respiratory Distress Syndrome,9619605,K23HL130641,"['Bacteria ', ' Sympathins ', ' Catecholamines ', ' Cell Body ', ' Cells ', ' Clinical Study ', ' Clinical Research ', ' Complement Proteins ', ' Complement ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Critical Care ', ' Critically Ill ', ' Critical Illness ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Environmental Science ', ' Ecology ', ' Aerobacter ', ' Enterobacter ', ' Enterobacteria ', ' Enteric Bacteria ', ' Coliform Bacilli ', ' Enterobacteriaceae ', ' Therapeutic Epinephrine ', ' Adrenaline ', ' Epinephrine ', ' Foundations ', ' Future ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Gastrointestinal tract structure ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Immigration ', ' indexing ', ' Inflammation ', ' Preinterleukin 1 Beta ', ' Interleukin-1 ', ' Interleukin 1beta ', ' IL1 ', ' IL1F2 ', ' IL1B Protein ', ' IL1- ', ' IL1-Beta ', ' IL-1 ', ' IL-1-b ', ' IL-1  ', ' IL-1 beta ', ' Beta Proprotein Interleukin 1 ', ' Interleukin-1 beta ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Mentors ', ' Michigan ', ' Modernization ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Polymorphonuclear Neutrophils ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Cell ', ' Neutrophilic Leukocyte ', ' Neutrophilic Granulocyte ', ' Marrow Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Blood Neutrophil ', ' neutrophil ', ' Noradrenaline ', ' Levonorepinephrine ', ' Levarterenol ', ' Norepinephrine ', ' Patients ', ' Physicians ', ' Productivity ', ' Prognosis ', ' outcome forecast ', ' Flavimonas ', ' Chrysemonas ', ' Pseudomonas ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' wet lung ', ' Stiff lung ', ' Shock Lung ', ' Da Nang Lung ', ' Adult RDS ', ' Adult ARDS ', ' Acute Respiratory Distress Syndrome ', ' Acute Respiratory Distress ', ' ARDS ', ' Adult Respiratory Distress Syndrome ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Testing ', ' Universities ', ' Work ', ' cytokine ', ' Research Methods ', ' Research Methodology ', ' Immunology ', ' Injury ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Logistic Regressions ', ' Non-linear Models ', ' Nonlinear Models ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Development Plans ', ' Disease Progression ', ' Inflammation Mediators ', ' inflammatory mediator ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Therapeutic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' Computational Biology ', ' computer biology ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Complex ', ' Techniques ', ' System ', ' respiratory ', ' gastrointestinal ', ' success ', ' gastrointestinal bacteria ', ' microbial ', ' skills ', ' novel ', ' member ', ' Prevention ', ' Pathogenesis ', ' Gammaproteobacteria ', ' -Proteobacteria ', ' gamma Proteobacteria ', ' TNF gene ', ' Tumor Necrosis Factor-alpha ', ' Tumor Necrosis Factor ', ' TNF ', ' TNFA ', ' TNF- ', ' TNF Alpha ', ' TNF A ', ' TNF ', ' Monocyte-Derived TNF ', ' Macrophage-Derived TNF ', ' Cachectin ', ' (TNF)- ', ' Modeling ', ' Sampling ', ' career development ', ' preventing ', ' prevent ', ' Alveolar ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' International ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Clinical Data ', ' Computational Technique ', ' Development ', ' developmental ', ' microbiome ', ' Human Microbiome ', ' human-associated microbiome ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Sepsis ', ' bloodstream infection ', ' blood infection ', ' Trauma ', ' Early treatment ', ' early therapy ', ' patient oriented ', ' patient centered ', ' spatiotemporal ', ' high risk ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' public health relevance ', ' gut microbiota ', ' intestinal tract microflora ', ' intestinal microflora ', ' intestinal microbiota ', ' intestinal microbes ', ' intestinal flora ', ' gut microflora ', ' gut microbiotic ', ' gut microbial consortia ', ' gut microbial composition ', ' gut microbial community ', ' gut microbe community ', ' gut flora ', ' gut community ', ' gut commensal ', ' gastrointestinal microbial flora ', ' enteric microbiota ', ' enteric microbial community ', ' Gastrointestinal microbiota ', ' GI microbiota ', ' clinical risk ', ' Prospective cohort study ', ' clinical development ', ' bacteriome ', ' bacterial microbiome ', ' microbiome research ', ' microbiome studies ', ' microbiome science ', ' Microbiomics ', ' Culture-independent methods ', ' culture-independent techniques ', ' culture-independent molecular techniques ', ' culture-independent approaches ', ' culture-independent analyses ', ' gut bacteria ', ' bacteria in the gut ', ' dysbiosis ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' lung microbiome ', ' pulmonary microbiome ', ' lung microbiota ', ' pulmonary microbiota ', ' pulmonary microbial community ', ' lung microbial community ', ' bacterial community ', ' respiratory microbiome ', ' respiratory tract microbiome ', ' airway microbiome ', ' host microbiome ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K23,2019,172256,0.11607683332915562
"Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS Chronic obstructive pulmonary disease (COPD) and emphysema, jointly, are the fourth leading cause of death in the US and globally. Decades of research have not found disease-modifying therapies except for a1 antitrypsin deficiency, a rare disease found by improved phenotyping, characterized by a specific emphysema subtype and caused by gene variants in SERPINA1. This renewal builds on the successful discovery of six new quantitative emphysema subtypes (QES), which were associated independently with greater symptoms, impaired function and increased mortality in addition to several genome-wide significant associations for gene variants. In the renewal, we propose to leverage over 27,000 CTs acquired over 5-7 years of follow-up from 4,500 highly phenotyped and genotyped participants to test if deep and unsupervised learning on new state-of- the-art CTs and CT angiograms will reveal additional deep-learned and molecular QES that suggest mechanistic pathways to treatment. Further, we will collect 60 explanted lungs and use state-of-the art microCT to test if QES have distinct histology and structure. Finally, we will recruit 100 patients undergoing lung cancer CT screening to test if QES will be translatable to clinical low-dose lung cancer screening CT scans acquired on contemporary scanners. Successful completion of these aims will discover new deep QES and molecular QES and validate and translate QES to further subphenotype emphysema and facilitate testing of personalize molecular therapies and, hopefully, replicate the success of therapy for a1-antitrypsin deficiency for more common emphysema subtypes. Project Narrative In the first funding period, we discovered six QES, which are independently associated with morbidity, mortality and distinct gene variants that suggest targetable molecular pathways. This renewal builds upon our successful UML approach with integration of DL, greatly increased CT and genetic data; validates QES with histology; and translates QES to the clinic in order to facilitate testing of molecular therapies of specific QES and to redefine emphysema subtypes in clinical practice.",Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS,9740637,R01HL121270,"['Algorithms ', ' Angiography ', ' angiographic imaging ', ' Angiogram ', ' Blood Vessels ', ' vascular ', ' Cause of Death ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Endothelium ', ' Fibrosis ', ' Genotype ', ' Histology ', ' Learning ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' Chronic Obstructive Airway Disease ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Patients ', ' Phenotype ', ' Physiology ', ' emphysematous ', ' Emphysema ', ' Pulmonary Emphysema ', ' lung fibrosis ', ' Pulmonary Fibrosis ', ' Research ', ' Smoking ', ' Testing ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Translating ', ' improved ', ' Apical ', ' Clinical ', ' Diffuse ', ' Biological ', ' Histologic ', ' Histologically ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' lung cancer screening ', ' lung cancer early detection ', ' Genetic ', ' Smoker ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scanning ', ' Clinic ', ' Pattern ', ' Techniques ', ' success ', ' c new ', ' Rare Diseases ', ' orphan disorder ', ' Rare Disorder ', ' Orphan Disease ', ' Structure ', ' novel ', ' Participant ', ' disorder control ', ' disease control ', ' Tomography, Computed, Scanners ', ' genome sequencing ', ' Dose ', ' Symptoms ', ' Data ', ' Molecular Target ', ' Reproducibility ', ' Characteristics ', ' Molecular ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Text ', ' Image ', ' imaging ', ' Pathway interactions ', ' pathway ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' clinical care ', ' population based ', ' genome-wide ', ' genomewide ', ' genome scale ', ' clinical practice ', ' microCT ', ' micro CT ', ' contrast enhanced ', ' whole genome ', ' full genome ', ' entire genome ', ' symptomatology ', ' recruit ', ' computed tomography screening ', ' CT screening ', ' deep learning ', ' unsupervised learning ', ' unsupervised machine learning ', ' Bayesian learning ', ' Bayesian machine learning ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2019,790346,0.05101174030051399
"Enhanced Measurement and Modeling of Sleep Electrophysiology to Better Understand Sleep Disparities Project Summary Health disparities associated with race and ethnicity are a major public health issue in the United States. Multiple lines of evidence suggest that differences in people's quality and quantity of sleep may account for part of this problem. Here we wish to study patterns of sleep, using full polysomnography data in a large and diverse cohort, to better understand what causes some individuals and groups to differ in their typical sleep, and to link this variation in sleep to relevant health outcomes. In order to study sleep as a mediator of health disparities associated with race/ethnicity, we propose to first unpack the sleep term into profiles of quantitative traits (Aim 1). Second, we will test for demographic moderators of the associations between race/ethnicity and sleep traits, which can point to likely socioeconomic and social/environmental contextual mediators (Aim 2). Finally, we will demonstrate the relevance of these findings by testing for association with health outcomes  primarily cardiovascular disease risk and measures of allostatic load  and estimating the extent to which sleep accounts for racial/ethnic health disparities (Aim 3). We will apply a targeted array of data-driven analytic methods, from data science, machine learning, computational neuroscience and causal modeling, to characterize individual differences in patterns of sleep. A more nuanced understanding of what constitutes poor sleep is important because different aspects of sleep are likely to have qualitatively different links to demographic and biomedical factors, including age, sex, lifestyle factors, inherited genetic makeup, circadian rhythms, medication effects and current state of physical and mental health. By disentangling this network of inter-related variables, we will be better positioned to understand  and ameliorate  the effects of the numerous factors that can induce racial/ethnic disparities in sleep, and consequently, in health too. Project Narrative Health disparities associated with race and ethnicity are a major public health issue in the United States. Multiple lines of evidence suggest that differences in peoples quality and quantity of sleep may account for part of this problem. We wish to study patterns of sleep in a large and diverse set of people, to better understand what causes some individuals and groups to differ in their typical sleep, and how this might in turn influence important health outcomes.",Enhanced Measurement and Modeling of Sleep Electrophysiology to Better Understand Sleep Disparities,9742577,R21MD012738,"['Age ', ' ages ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' daily biorhythm ', ' circadian process ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Circadian Rhythms ', ' Communities ', ' Complement Proteins ', ' Complement ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' electrophysiological ', ' Neurophysiology / Electrophysiology ', ' Electrophysiology ', ' Electrophysiology (science) ', ' ethnicity group ', ' Ethnic group ', ' Family ', ' Health ', ' indexing ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Lifestyle ', ' Life Style ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Phenotype ', ' Public Health ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Sleep ', ' sleep disruption ', ' poor sleep ', ' impaired sleep ', ' disturbed sleep ', ' disrupted sleep ', ' aberrant sleep ', ' Sleep disturbances ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Testing ', ' United States ', ' Gender ', ' Measures ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Mediating ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' Polysomnography ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' analytical method ', ' base ', ' computational neuroscience ', ' density ', ' improved ', ' Variant ', ' Variation ', ' Physiological ', ' Physiologic ', ' Link ', ' Slow-Wave Sleep ', ' Delta Wave sleep ', ' Delta Wave ', ' Individual ', ' Measurement ', ' Ethnic Origin ', ' Ethnicity ', ' Attenuated ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Inherited ', ' Hereditary ', ' Complex ', ' Techniques ', ' physical conditioning ', ' physical health ', ' psychosocial ', ' contextual factors ', ' Application Context ', ' physical state ', ' cohort ', ' trait ', ' attenuation ', ' novel ', ' Patient Self-Report ', ' Self-Report ', ' racial difference ', ' race differences ', ' ethnic difference ', ' ethnicity difference ', ' Reporting ', ' social ', ' Positioning Attribute ', ' Position ', ' Modeling ', ' Sampling ', ' behavioral pharmacology ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' disparity in health ', ' health disparity ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Data ', ' Cognitive ', ' lifestyle factors ', ' life-style factor ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' Development ', ' developmental ', ' allostatic load ', ' age related ', ' age dependent ', ' age effect ', ' aging effect ', ' Sleep Architecture ', ' Outcome ', ' social disparities ', ' Individual Differences ', ' Coupling ', ' ethnic minority population ', ' ethnic minority ', ' racial and ethnic ', ' demographics ', ' racial and ethnic disparities ', ' healthy aging ', ' primary outcome ', ' population health ', ' signal processing ', ' genetic makeup ', ' genetic make-up ', ' causal model ', ' causal diagram ', ' Data Science ', ' ethnic health disparity ', ' gender difference ', ' gender-associated difference ', ' racial minority ', ' intersectionality ', ' sleep quality ', ' quality of sleep ', ' sleep behavior ', ' sleep habit ', ' sleep pattern ', ' sleep physiology ', ' sleep spindle ', ' ']",NIMHD,BRIGHAM AND WOMEN'S HOSPITAL,R21,2019,282410,0.14086460874302653
"Administrative Supplement for Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study ABSTRACT This application is in response to NOT-MD-19-023, which calls for proposals for expanding recruitment of projects to include Native Hawaiians / Other Pacific Islanders (NH/OPIs). Sleep disturbances, including short sleep duration, sleep apnea, and insomnia disorder, are highly prevalent among adults in the US and are associated with an increased risk for mental and physical health consequences including cardiometabolic disease. Comparative research studies indicate that sleep disparities are present in some minority populations; however, the extent to which sleep disparities exist across different racial/ethnic groups is not well known. Both Mexican-Americans and individuals from Native Hawaiian/Other Pacific Islander (NH/OPI) populations are at an increased risk for adverse sleep and corresponding cardiometabolic health outcomes, yet the role of potential mechanisms linking such deficiencies in these comparative minority groups is understudied. Factors that impact sleep functioning in one population may differentially impact another population. The overall goal of this project is to support and strengthen two aims of the parent grant by specifically including NH/OPI into the Nogales Cardiometabolic Health and Sleep study to further evaluate how acculturation, psychosocial stressors, and other social, environmental, and behavioral factors impact relationships between sleep disturbances and cardiometabolic disease risk similarly and uniquely, as compared to Mexican-Americans at the US/Mexico border. This project aims to determine how acculturation, economic hardship, psychosocial stress, and unhealthy behaviors (diet, exercise, alcohol, and smoking) are related to sleep disturbance by type in NH/OPI and in comparison to these relationships in Mexican-Americans. The second goal of this project is to determine how sleep and/or social-behavioral factors predict cardiometabolic disease risk among NH/OPI, as well as determine how these same factors are different in NH/OPI when compared to Mexican-Americans at the US/Mexico border. To accomplish these goals, this project will partner with researchers at the University of Hawaii to recruit and enroll N=100 NH/OPI to complete a battery of assessments from a clinic visit (questionnaires, interviews, exam for anthropometry, collection of biomarkers), a 1-night home sleep apnea assessment, a 24-hour ambulatory blood pressure recording, and a 2-week home monitoring period with sleep diary and actigraphy. Inclusion of NH/OPI into the larger dataset will facilitate a better understanding of sleep disturbances and the impact of factors that regulate sleep, including duration, insomnia symptoms, and obstructive sleep apnea, in relation to cardiometabolic disease risk within this population and in comparison to Mexican-Americans. The analytic plan will utilize a machine-learning analytic approach, which will be used to evaluate the complex relationships among all of these variables. This project will further address efforts at reducing sleep-cardiometabolic health disparities in minority populations by identifying potentially modifiable areas associated with community-based intervention programs. PROJECT NARRATIVE Sleep disturbances are common and related to important health outcomes. This project expands the parent project by adding additional information regarding how sleep plays an important role in linking social/ environmental factors such as acculturation, stress, and health behaviors to cardiometabolic risk factors. Specifically, by expanding this project to include Native Hawaiians / Other Pacific Islanders, we can obtain new information about these relationships.",Administrative Supplement for Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study,9978525,R01MD011600,"['Acculturation ', ' Cultural Assimilation ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Anthropometry ', ' Behavior ', ' Blood Pressure ', ' Blood Vessels ', ' vascular ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Clinic Visits ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' Economics ', ' Educational aspects ', ' Education ', ' ethnicity group ', ' Ethnic group ', ' Goals ', ' Hawaii ', ' Health ', ' Health behavior ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Inflammation ', ' Interview ', ' Lipids ', ' alpha-Lipoproteins ', ' High density lipoprotein ', ' Heavy Lipoproteins ', ' HDL Lipoproteins ', ' HDL ', ' High Density Lipoproteins ', ' beta-Lipoprotein Cholesterol ', ' Low Density Lipoprotein Cholesterol ', ' LDL Cholesterol ', ' LDL Cholesterol Lipoproteins ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Mexico ', ' Minority Groups ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Play ', ' Poverty ', ' Questionnaires ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Sleep ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Sleep Apnea Syndromes ', ' sleep disruption ', ' poor sleep ', ' impaired sleep ', ' disturbed sleep ', ' disrupted sleep ', ' aberrant sleep ', ' Sleep disturbances ', ' Smoking ', ' social support network ', ' Social support ', ' Stress ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Universities ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' Work ', ' triacylglycerol LDL ', ' LDL triglyceride lipoprotein ', ' LDL triglyceride ', ' low density lipoprotein triglyceride ', ' Community Health Care ', ' Community Healthcare ', ' Dataset ', ' Data Set ', ' base ', ' Area ', ' Link ', ' Physical activity ', ' Serum ', ' Blood Serum ', ' Individual ', ' Mexican ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Hawaiian population ', ' Hawaiian ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' diaries ', ' Hour ', ' Severities ', ' Complex ', ' Home environment ', ' Home ', ' physical conditioning ', ' physical health ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' psychosocial ', ' environmental stressor ', ' experience ', ' stressor ', ' intervention program ', ' Participant ', ' Exclusion ', ' research study ', ' disorder risk ', ' disease risk ', ' Predictive Factor ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Regulation ', ' Modeling ', ' Sampling ', ' response ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' actigraph ', ' actigraphy ', ' disparity in health ', ' health disparity ', ' Address ', ' Symptoms ', ' Administrative Supplement ', ' Data ', ' High Prevalence ', ' Collection ', ' Enrollment ', ' enroll ', ' Monitor ', ' Behavioral ', ' design ', ' designing ', ' Minority ', ' food security ', ' diet and exercise ', ' Outcome ', ' Population ', ' Psychosocial Stress ', ' racial and ethnic ', ' comparative ', ' parent grant ', ' parent project ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' cardiometabolic risk ', ' ethnic identity ', ' Native Hawaiian ', ' recruit ', ' health assessment ', ' sleep health ', ' sleep hygiene ', ' cardiometabolism ', ' cardiometabolic ', ' perceived stress ', ' ']",NIMHD,UNIVERSITY OF ARIZONA,R01,2019,124869,0.1398316683196534
"Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood PROJECT SUMMARY Substantial improvements in cancer survival rates could be achieved by developing better tools to detect occult malignancies at an earlier, more curable stage. Unfortunately, efforts to identify serum protein biomarkers that are sufficiently cancer-specific to be used for screening have found little success. Here, we pursue an alternative strategy based on detection of exceptionally tumor-specific mutant DNA fragments in the circulation of patients with early-stage lung cancer. Because these tumor-derived DNA fragments harbor genetic signatures that would be uncommon in healthy individuals, they hold great promise for screening applications where a high frequency of false-positive results would be unacceptable. However, it is a formidable challenge to create an assay that is able to detect trace quantities of mutant DNA released into the bloodstream from a small, early-stage tumor, without knowing the tumors mutation profile beforehand. Additional challenges are posed by economic factors as well as the presence of low-level mutations in the healthy population. To address these challenges, we have assembled a multidisciplinary team with highly complementary expertise from Microsoft Research and from Yale, Rice, and Harvard Universities. In this proposal, we describe innovative solutions in which we apply tools of biochemistry, thermodynamics, machine learning, and biostatistics to develop and validate an ultrasensitive, cost-efficient assay for detecting rare mutant DNA fragments in blood as markers of early-stage lung cancer. PROJECT NARRATIVE Lung cancer has a high fatality rate because most patients are diagnosed at a late stage, when the disease is more difficult to cure. A screening test that finds lung tumor DNA in blood could help to improve survival outcomes.",Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood,9778791,U01CA233364,"['Age ', ' ages ', ' Algorithms ', ' Alleles ', ' Allelomorphs ', ' Back ', ' Dorsum ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Colonoscopy ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' Blood Tests ', ' blood cell formation ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoiesis ', ' Libraries ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' mammographic exams ', ' mammographic examinations ', ' Mammogram ', ' Mammography ', ' Medicine ', ' Methods ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Patients ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Probability ', ' Research ', ' Rice ', ' Sensitivity and Specificity ', ' Serum Proteins ', ' Rajidae ', ' Skates ', ' Specificity ', ' Survival Rate ', ' Technology ', ' Temperature ', ' Testing ', ' Thermodynamic ', ' Thermodynamics ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Universities ', ' Work ', ' cervical/vaginal smear ', ' Vaginal Smears ', ' Papanicolaou Test ', ' Papanicolaou Smear ', ' Pap Test ', ' Cervical Smears ', ' Pap smear ', ' Artifacts ', ' Morphologic artifacts ', ' Tube ', ' base ', ' improved ', ' Screening for cancer ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Area ', ' Clinical ', ' Variant ', ' Variation ', ' Biological ', ' Economic Factors ', ' Economical Factors ', ' Training ', ' Lesion ', ' lung basal segment ', ' lung base ', ' Individual ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' lung cancer screening ', ' lung cancer early detection ', ' tool ', ' Smoker ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Somatic Mutation ', ' mutant ', ' Performance ', ' success ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' purge ', ' purging ', ' purges ', ' Sampling ', ' repository ', ' T-Stage ', ' Tumor stage ', ' Fatality rate ', ' Address ', ' Cost Effectiveness Analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Data ', ' Detection ', ' Predictive Value ', ' Premalignant ', ' precancerous ', ' Pre-Malignant ', ' Genomic Segment ', ' genomic region ', ' Nucleic Acid Biochemistry ', ' Tumor-Derived ', ' Development ', ' developmental ', ' neoplastic ', ' cost ', ' design ', ' designing ', ' cost efficient ', ' Population ', ' cancer type ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' tumor ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' exome sequencing ', ' exome-seq ', ' screening ', ' tumor DNA ', ' tumor-specific DNA ', ' tumor cell DNA ', ' variant of unknown significance ', ' variant of undetermined significance ', ' variant of uncertain significance ', ' variant of uncertain clinical significance ', ' unclassified variant ', ' cell free DNA ', ' cell free circulating DNA ', ' biochemical tools ', ' biochemistry tools ', ' biomarker development ', ' genetic signature ', ' gene signatures ', ' cancer biomarkers ', ' cancer markers ', ' protein biomarkers ', ' protein markers ', ' survival outcome ', ' cancer survival ', ' high risk population ', ' high risk group ', ' preservation ', ' machine learning algorithm ', ' ']",NCI,YALE UNIVERSITY,U01,2019,504629,0.020759932163057816
"Individually-tailored clinical decision support for management of indeterminate pulmonary nodules ABSTRACT (PROJECT DESCRIPTION) The rollout of low-dose computed tomography (LDCT) lung screening programs is accelerating in the United States, aiming for earlier detection of lung cancer to improve long-term survival. However, a consequence of such imaging programs is the increased discovery of indeterminate pulmonary nodules (IPNs). Significant ques- tions remain around the effective management of screen- and incidentally-detected IPNs: while many are benign, a fraction will go on to become cancerous. Diagnostic models for IPNs and associated management guidelines have been described previously, but their real-world validation is limited. Moreover, the majority of models only use a snapshot of the IPN at a single point in time and fail to take into consideration progressive changes. Opportunities now exist to advance such predictive models by encompassing the patient's evolving medical history, combining clinical and imaging biomarkers to improve prediction and individually-tailor the management of IPNs over time. The objective of this imaging informatics proposal is the development of a clinical decision support tool for the management of screen- and incidentally-detected IPNs. We address two key challenges: 1) the development of a continuous-time model for predicting how the IPN will evolve; and 2) the use of this prediction to determine a series of actions over time that will optimize (screening) outcomes for the individual. We first explore the devel- opment of a continuous time belief network (CTBN), a temporal probabilistic model to predict the likelihood of a patient to develop lung cancer. Unlike traditional approaches, CTBNs do not require fixed sampling frequency of the data over time (e.g., all observations made annually) and are thus more amenable to real-world clinical settings and observational datasets. The probabilities computed through the CTBN are subsequently input into a partially-observable Markov decision process (POMDP) to guide IPN management decisions. From the POMDP, policies (sequences of actions over time) can be chosen to achieve a desired goal (e.g., minimizing time to diagnosis), given past and current observations/decisions for an individual. For both the CTBN and POMDP, we explore novel methods in the design and implementation, overcoming computational challenges to realize translation of these models into practice. A web-based interface is implemented, providing a clinical de- cision making tool for physicians to understand the models' recommendations. Evaluation focuses on assessing the performance of the CTBN and POMDP relative to known outcomes and compared to other conventional methods (e.g., logistic regression, decision trees, dynamic belief networks); as well as the overall impact of the system to influence decision-making. This effort advances our past research in probabilistic models and capital- izes on expertise in lung cancer screening, including past leadership of the National Lung Screening Trial (NLST). The result of this effort will be a set of informatics-driven modeling tools and new temporal predictive models informing IPN management. PROGRAM NARRATIVE Low-dose computed tomography (LDCT) lung screening is being implemented nationwide, aiming to reduce mortality due to lung cancer. But questions have been raised regarding false positives, with concerns about the attendant discovery of indeterminate pulmonary nodules (IPNs) and their ensuing long-term surveillance. This project develops new predictive models for the management of IPNs using clinical and imaging information ac- crued over time, providing individually-tailored clinical decision support.",Individually-tailored clinical decision support for management of indeterminate pulmonary nodules,9668004,R01CA226079,"['Belief ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Capital ', ' Decision Making ', ' Decision Trees ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Evolution ', ' Future ', ' Goals ', ' History ', ' Recording of previous events ', ' Leadership ', ' Life Expectancy ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Methods ', ' Methodology ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' mortality ', ' Nodule ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Patients ', ' Physicians ', ' Probability ', ' pulmonary nodule ', ' Lung nodule ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Software ', ' Computer software ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Translating ', ' Translations ', ' United States ', ' Dataset ', ' Data Set ', ' Custom ', ' Guidelines ', ' Practice Guidelines ', ' base ', ' improved ', ' Benign ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Series ', ' Logistic Regressions ', ' Evaluation ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Policies ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' lung cancer screening ', ' lung cancer early detection ', ' tool ', ' Smoker ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Dependence ', ' Event ', ' System ', ' Medical center ', ' Early Diagnosis ', ' early detection ', ' Performance ', ' Informatics ', ' novel ', ' Disease model ', ' disorder model ', ' Modeling ', ' Sampling ', ' Address ', ' Data ', ' Clinical Data ', ' low-dose spiral CT ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' Update ', ' Validation ', ' Process ', ' Development ', ' developmental ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' Image ', ' imaging ', ' cost ', ' time use ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' imaging informatics ', ' design ', ' designing ', ' Outcome ', ' Population ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' Cancerous ', ' web based interface ', ' high risk ', ' database structure ', ' data base structure ', ' arm ', ' screening ', ' imaging biomarker ', ' imaging-based marker ', ' imaging-based biomarker ', ' imaging-based biological marker ', ' imaging marker ', ' learning strategy ', ' learning method ', ' learning activity ', ' support tools ', ' discrete time ', ' individual patient ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' imaging program ', ' screening program ', ' clinical decision support ', ' computed tomography screening ', ' CT screening ', ' screening policy ', ' screening guidelines ', ' screening recommendations ', ' recommended screening ', ' ']",NCI,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2019,464766,0.15351243067658366
"Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting     DESCRIPTION (provided by applicant): Disrupted circadian timing has emerged as a serious health and safety issue, yet there are no objective means of easily assessing circadian timing or alignment without performing a highly controlled, multiple-day in- patient study. Altered circadian timing can cause both sleep loss and sleepiness, cause performance errors such as motor vehicle accidents, and impair memory/learning. Thus, despite the obvious need to recognize an individual's circadian phase/alignment, we cannot assess circadian timing clinically or in retrospective studies. Not surprisingly, the first goal of the 2011 NIH Sleep Disorders Research Plan is to identify: ""...metabolic... biomarkers of sleep deficiency and biological timing...and circadian disorders that will facilitate personalized treatments, and clarify the risk associated with untreated sleep and circadian disorders and disturbances."" We are aware that major challenges face biomarker development, including multi-factorial causes of metabolite shifts normally controlled across multiple time-points. Because circadian time is associated with profound metabolic, immune and cardiovascular changes, however, we hypothesize that a biomarker signature for circadian phase derived from -omic markers can be obtained from a single blood sample. We therefore propose to utilize the analytical and bioinformatics platforms and experience in population-level metabolomics studies in the PIs lab to study banked plasma samples from the well-characterized individuals in six tightly controlled circadian rhythm studies run by the four co-investigators.The Aims are:  Aim 1: To identify, to optimize, to validate, and t cross-validate a set of nested plasma lipidomics-  based biomarker profiles that report circadian phase and alignment using well-characterized samples drawn from three constant routine protocols Aim 2: To identify, to optimize, to validate, and to cross-validate a set of nested plasma lipidomics based biomarker profiles that report circadian phase and alignment using well-characterized samples  drawn from four forced desynchrony protocols  Aim 3: To systematically evaluate the validated profiles from Aims 1 and 2 and their mathematical  similarities and differences so as to improve accuracy and precision of the biomarkers  Aim 4: To test the markers identified above under poorly controlled real world applications Identification of biomarker panels will impact multiple aspects of science and health: (i) contribute to clinical recognition and treatment on circadian disorders; (ii) advance personalized medicine through individualized treatment timing to enhance efficacy/reduce side effects of medications (e.g., chemotherapy); (iii) creating epidemiologic tools to relate circadian with disease risk; and aiding development of other disease biomarkers, and; (iv) contribute to research on circadian biology and its implications for human health. PUBLIC HEALTH RELEVANCE: We propose to identify blood-based markers that can inform a clinician or researcher about an individual's internal biological clock. At the broad levels of society and public health research, the work has the potential direct benefit of identifying individuals with ""off-set"" clocks (enabling diagnosis and potential therapy), increasing accuracy and precision of studies of blood lipids, facilitating understanding of certain sleep disorders, increasing understanding of the role of biological clocks in chronic disease processes (e.g., cancer, diabetes, cardiovascular disease), and potentially improving the administration of certain pharmaceuticals, eg, chemotherapy agents.","Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting",9666966,R01HL132556,"['Age ', ' ages ', ' Algorithms ', ' Awareness ', ' Biological Clocks ', ' internal clock ', ' body clock ', ' Biologic Clock ', ' Biology ', ' Birds ', ' Avian ', ' Aves ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' daily biorhythm ', ' circadian process ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Circadian Rhythms ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' sleepiness ', ' Somnolence ', ' Drowsiness ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' facial ', ' faces ', ' Face ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Inpatients ', ' Learning ', ' Math ', ' Mathematics ', "" men's "", ' men ', ' Methods ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retrospective Studies ', ' Risk ', ' social role ', ' Role ', ' Running ', ' Safety ', ' Science ', ' Sleep ', ' sleep loss ', ' sleep insufficiency ', ' sleep deficit ', ' sleep deficiency ', ' sleep debt ', ' insufficient sleep ', ' inadequate sleep ', ' deficient sleep ', ' Sleep Deprivation ', ' Smoking ', ' Societies ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Testing ', ' Time ', ' Woman ', ' Work ', ' Gender ', ' Generations ', ' base ', ' human population study ', ' Blood specimen ', ' Blood Sample ', ' improved ', ' Clinical ', ' Phase ', ' Biological ', ' Link ', ' Memory impairment ', ' memory dysfunction ', ' Memory Deficit ', ' Individual ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Metabolic ', ' Strigiformes ', ' Owls ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Hour ', ' Immune ', ' Immunes ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' blood lipid ', ' experience ', ' Performance ', ' disorder risk ', ' disease risk ', ' vehicular accident ', ' motor vehicle accident ', ' Motor carrier accident ', ' Reporting ', ' Sleep Disorders ', ' sleep problem ', ' sleep dysregulation ', ' sleep dysfunction ', ' Modeling ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Data ', ' Resolution ', ' Pattern Recognition ', ' Process ', ' Development ', ' developmental ', ' Population ', ' prospective ', ' combinatorial ', ' chemotherapy ', ' real world application ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' public health research ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' biomarker development ', ' biomarker panel ', ' marker panel ', ' biomarker identification ', ' marker identification ', ' blood-based biomarker ', ' blood-based marker ', ' circadian ', ' side effect ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,R01,2019,862336,0.0718518910897693
"The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites Project Summary/Abstract Background: Blacks have higher rates of cardiovascular disease (CVD), CVD risk markers (elevated blood pressure, cholesterol, and unhealthy glucose levels), and CVD mortality, compared to whites. Despite advances in understanding how CVD disparity is engendered and preventing CVD, blacks compared to whites are still disproportionately burdened by CVD, particularly CVD risk markers. Therefore, more novel targets that drive racial disparity in CVD risk markers must be investigated in order to reduce and eliminate CVD disparity. Evidence indicating that insufficient sleep (sleep duration 6hrs/24 hr. cycle), which disproportionately affects blacks, is linked to concurrent and future CVD risk may offer a potentially novel mechanism explaining CVD risk disparity between blacks and whites. However, it is unclear whether insufficient sleep directly or indirectly drives disparity in CVD risk between blacks and whites? Therefore, the purpose of the proposed K01 study is to investigate whether insufficient sleep independently explains a significant portion of racial disparity in CVD risk markers, while adjusting for the confounding effects of sleep apnea and insomnia (two sleep disorders that cause insufficient sleep). Additionally, since 55% of insufficient sleepers are obese and blacks are twice as likely to be obese compared to whites, the candidate will investigate the independent and combined effects of insufficient sleep and obesity on the disparity in CVD risk markers between blacks and whites. Research: In the proposed K01, the candidate, Dr. Azizi Seixas, will investigate: 1) whether insufficient sleep and/or obesity play an important role in the relationship between race/ethnicity and CVD risk, controlling for sleep apnea and insomnia; and 2) what sleep duration and body mass index profile is associated with lowest probability of CVD risk among blacks and whites, using advanced mathematical analytic methods and complex system simulation modeling. Training: The training plan builds upon the candidate's background and experience in conducting research in sleep disorders and cardiovascular disease (e.g. hypertension and stroke), among minority populations. During the K01, the candidate will receive training in sleep science and physiology, cardiovascular disease and advanced analytical, machine learning, and simulation modeling. He will perform secondary analyses of data from the Sleep Heart Health Study, a NHLBI-funded study. The pedagogical approach includes one-on-one mentorship, course work, mentored laboratory training (practicum), and attendance to targeted conferences and seminars, with the common goal of supporting his transition to being an independent scientist. Project Narrative The overarching objective of this K01 career development award is to foster the transition of Dr. Azizi Seixas into an independent scientist in the area of sleep and cardiovascular disease and health disparities. The proposed study will investigate a novel mechanism underlying associations between insufficient sleep, obesity, and disparity in CVD risk markers between blacks and whites. Findings from the study will be the basis of sleep and obesity interventions to reduce CVD risk, especially among diverse groups burdened by cardiovascular disease.",The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites,9618589,K01HL135452,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Blood Pressure ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cholesterol ', ' Concurrent Studies ', ' Cohort Studies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Future ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Glucose Intolerance ', ' Goals ', ' services research ', ' Medical Care Research ', ' Health Services Evaluation ', ' Health Services Research ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Math ', ' Mathematics ', ' Mentors ', ' Mentorship ', ' Methodology ', ' mortality ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Physiology ', ' Play ', ' Probability ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk Factors ', ' social role ', ' Role ', ' Science ', ' Sleep ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Sleep Apnea Syndromes ', ' sleep loss ', ' sleep insufficiency ', ' sleep deficit ', ' sleep deficiency ', ' sleep debt ', ' insufficient sleep ', ' inadequate sleep ', ' deficient sleep ', ' Sleep Deprivation ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Work ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' Mediating ', ' Caring ', ' Advisory Committees ', ' advisory team ', ' Task Forces ', ' analytical method ', ' base ', ' Site ', ' Area ', ' Biological ', ' Medical ', ' Link ', ' Training ', ' Failure ', ' Bayesian Analysis ', ' Bayesian statistics ', ' Bayesian statistical inference ', ' Bayesian statistical analysis ', ' Bayesian spatial analysis ', ' Bayesian network analysis ', ' Bayesian inference ', ' Bayesian computation ', ' Fostering ', ' Funding ', ' Ethnic Origin ', ' Ethnicity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Complex ', ' System ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' Equation ', ' experience ', ' Structure ', ' Disease Outcome ', ' novel ', ' models and simulation ', ' model-based simulation ', ' Reporting ', ' Sleep Disorders ', ' sleep problem ', ' sleep dysregulation ', ' sleep dysfunction ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' Risk Reduction ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' Address ', ' Data ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Risk Marker ', ' Development ', ' developmental ', ' National Heart, Lung, and Blood Institute ', ' NHLBI ', ' post stroke ', ' poststroke ', ' after stroke ', ' effectiveness research ', ' Underserved Population ', ' underserved people ', ' under served population ', ' Minority ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' comparative effectiveness ', ' fasting glucose ', ' social health determinants ', ' Bayesian Modeling ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' cardiovascular health ', ' pedagogical content ', ' pedagogical method ', ' pedagogical development ', ' pedagogical approach ', ' laboratory experience ', ' laboratory training ', ' lab experience ', ' stroke survivor ', ' disparity reduction ', ' reduce disparity ', ' Cardiac health ', ' Heart health ', ' secondary analysis ', ' sleep physiology ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K01,2019,179820,0.13071578339539583
"Determinants of insufficient sleep among blacks and effects on disparities in health outcomes Project Summary Insufficient sleep (IS), stemming from sleep apnea, shift work, insomnia, working over 40 hr./week, unfavorable sleep environments and/or volitional reduction of bedtime, is associated with increased risk of cardiovascular disease (CVD) markers (elevated blood pressure, insulin resistance, dyslipidemia and arterial stiffness), inflammatory markers (interleukin-6, tumor necrosis factor-, and C-reactive protein) as well as with brain injury. Compelling evidence shows racial/ethnic disparities in insufficient sleep (IS), with blacks exhibiting a three-fold greater risk of IS relative to whites. Disparities might arise from physiologic and genetic factors, but recent evidence suggests environmental and psychosocial factors are also critical determinants. This study will utilize innovative dynamic modeling in a multi-level framework to delineate the psychosocial and environmental determinants (associative factors) of actigraphic IS and its putative associations with adverse health outcomes among blacks. Individual- and contextual-level data will be captured using novel home-based recordings and GIS data to model the environmental context where sleep occurs. The proposed study will leverage success of the NYU Sleep Disparity Workgroup led by Dr. Jean- Louis (PI), who has been conducting community-engaged sleep research for over 10 years. The workgroup comprises outstanding investigators with expertise in sleep and circadian rhythm, CVD, brain health, health disparities, translational behavioral medicine, and multi-level dynamic modeling. The study will benefit from experience of our standing Community Steering Committee, enabling recruitment of 560 blacks in various venues to participate in weeklong home studies to achieve proposed study aims. The multidisciplinary team will: 1) identify psychosocial (social support, discrimination, and attitudes/beliefs) and environmental (household [density, noise, light, and temperature], socioeconomic position, social capital, and neighborhood [built environment]) factors that are associated with IS; ascertain effects of IS on (a) markers of CVD (obesity, BP, lipid profile, and glucose/ HbA1C) and inflammation (IL-6, IL-10, and TNF-) and on (b) markers of brain injury (tau, amyloid-, neurofilament light, homocysteine, and glial fibrillary acidic protein; and develop profiles of blacks with IS-related adverse health outcomes using individual- and environmental-level data applying innovative multi-level dynamic modeling tools (Bayesia Belief Network and Agent-Based Simulation). This study will provide evidence to delineate factors underlying greater rates of IS among blacks and explain putative associations with markers of CVD, inflammation, and brain injury. These data will provide the foundation for longitudinal studies assessing causal effects of IS on these novel markers and interventions to mitigate adverse effects of IS on health outcomes. Project Narrative This proposal is predicated upon compelling data that blacks exhibit a three-fold greater risk of insufficient sleep (<7 hours) compared with whites, and that insufficient sleep is associated with increased risk of cardiovascular disease and brain injury. It will provide multi-level evidence on the impact of the psychosocial and environmental factors on insufficient sleep among blacks. These data will provide the foundation for interventions to mitigate adverse effects of insufficient sleep on health outcomes among blacks.",Determinants of insufficient sleep among blacks and effects on disparities in health outcomes,9742641,R01HL142066,"['Attitude ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavioral Medicine ', ' Behavioral Sciences ', ' Belief ', ' Blood Pressure ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' daily biorhythm ', ' circadian process ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Circadian Rhythms ', ' Communities ', ' Cognitive Discrimination ', ' Discrimination ', ' Environment ', ' Exhibits ', ' Foundations ', ' Glial Intermediate Filament Protein ', ' Glial Fibrillary Acid Protein ', ' GFAP ', ' GFA-Protein ', ' Astroprotein ', ' Glial Fibrillary Acidic Protein ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' Health ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' Homocysteine ', ' Household ', ' Inflammation ', ' insulin resistant ', ' Insulin Resistance ', ' interferon beta 2 ', ' Plasmacytoma Growth Factor ', ' Myeloid Differentiation-Inducing Protein ', ' MGI-2 ', ' IL6 Protein ', ' IL-6 ', ' IFNB2 ', ' IFN-beta 2 ', ' Hybridoma Growth Factor ', ' Hepatocyte-Stimulating Factor ', ' HPGF ', ' BSF2 ', ' BSF-2 ', ' BCDF ', ' B-Cell Stimulatory Factor-2 ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Differentiation Factor ', ' B cell stimulating factor 2 ', ' B cell differentiation factor ', ' Interleukin-6 ', ' Laboratories ', ' Photoradiation ', ' Light ', ' Lipids ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' Morbidity ', ' Morbidity - disease rate ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Neighborhoods ', ' neurofilament ', ' Noise ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' psychosocial variables ', ' Psychosocial Factor ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' Sleep ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Sleep Apnea Syndromes ', ' sleep loss ', ' sleep insufficiency ', ' sleep deficit ', ' sleep deficiency ', ' sleep debt ', ' insufficient sleep ', ' inadequate sleep ', ' deficient sleep ', ' Sleep Deprivation ', ' sleep disruption ', ' poor sleep ', ' impaired sleep ', ' disturbed sleep ', ' disrupted sleep ', ' aberrant sleep ', ' Sleep disturbances ', ' social support network ', ' Social support ', ' Temperature ', ' Time ', ' Volition ', ' soluble amyloid precursor protein ', ' beta amyloid fibril ', ' amyloid-b protein ', ' amyloid beta ', ' abeta ', ' a beta peptide ', ' A ', ' Amyloid -Protein ', ' Amyloid -Peptide ', ' Amyloid  ', ' Amyloid Protein A4 ', ' Amyloid Beta-Peptide ', "" Amyloid Alzheimer's Dementia Amyloid Protein "", "" Alzheimer's amyloid "", "" Alzheimer's Amyloid beta-Protein "", ' Alzheimer beta-Protein ', ' Amyloid beta-Protein ', ' Interleukin 10 Precursor ', ' IL10A ', ' IL10 ', ' IL-10 ', ' Cytokine Synthesis Inhibitory Factor ', ' CSIF-10 ', ' CSIF ', ' Interleukin-10 ', '  Proteins ', ' tau factor ', ' tau ', ' microtubule-bound tau ', ' microtubule bound tau ', ' MT-bound tau ', ' tau Proteins ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' base ', ' density ', ' Area ', ' Physiological ', ' Physiologic ', ' Individual ', ' Dyslipidemias ', ' Brain Injuries ', ' brain-injured ', ' brain damage ', ' Acquired brain injury ', ' Genetic ', ' Exposure to ', ' Inflammatory ', ' tool ', ' Level of Evidence ', ' Hour ', ' Home environment ', ' Home ', ' psychosocial ', ' environmental stressor ', ' experience ', ' success ', ' arterial stiffness ', ' artery stiffness ', ' artery stiffening ', ' arterial stiffening ', ' simulation ', ' novel ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Devices ', ' Reporting ', ' social ', ' TNF gene ', ' Tumor Necrosis Factor-alpha ', ' Tumor Necrosis Factor ', ' TNF ', ' TNFA ', ' TNF- ', ' TNF Alpha ', ' TNF A ', ' TNF ', ' Monocyte-Derived TNF ', ' Macrophage-Derived TNF ', ' Cachectin ', ' (TNF)- ', ' Emotional ', ' Sleep Disorders ', ' sleep problem ', ' sleep dysregulation ', ' sleep dysfunction ', ' Modeling ', ' Adverse effects ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' Metabolic syndrome ', ' Vulnerable Populations ', ' vulnerable group ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' disparity in health ', ' health disparity ', ' Low income ', ' Address ', ' social capital ', ' Data ', ' Disease Marker ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Monitor ', ' Modification ', ' shift work ', ' shiftwork ', ' night work ', ' night shift ', ' day shift ', ' Underserved Population ', ' underserved people ', ' under served population ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' multidisciplinary ', ' racial and ethnic ', ' stem ', ' racial and ethnic disparities ', ' high risk ', ' inflammatory marker ', ' inflammation marker ', ' novel marker ', ' novel biomarker ', ' new marker ', ' Healthy People 2020 ', ' built environment ', ' brain health ', ' disparity reduction ', ' reduce disparity ', ' Circadian desynchrony ', ' circadian misalignment ', ' circadian desynchronization ', ' recruit ', ' Bayesian learning ', ' Bayesian machine learning ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2019,840599,0.08449226091599091
"Leveraging National Sleep Research Resource Data for Personalized Sleep Profiling PROJECT SUMMARY People vary in both the quantity and the quality of their sleep. Traditional sleep stages (for example, slow- wave sleep or REM sleep) can exhibit different neural correlates (as measured by electroencephalography, EEG) in different people and at different times during the night. Standard approaches for characterizing sleep (staging) do not take this variability into account, however. Here we suggest that attempts to use EEG and other data to infer sleep stages should in fact tackle the heterogeneity between and within individuals explicitly, to yield more accurate classification not just of an individuals minute-by-minute sleep, but of the sleepers typical characteristics more generally. Quantitative, data-driven individual sleep profiles will be important prerequisites for emerging large-scale molecular genetics and other omics studies of sleep, and for driving personalized sleep medicine more generally. Specifically, we propose to leverage more than ten thousand whole-night polysomnography (PSG) studies from the demographically diverse National Sleep Research Resource (NSRR), in order to optimally apply machine-learning methods to sleep signals. Most importantly, the NSRR dataset will enable approaches that take the fundamental heterogeneity of sleep into account: this is a rate-limiting step that has not been tackled by previous approaches. We hypothesize that it is not the large training set per se, but rather the increased prospects for better-matched training data, combined with the methods developed here, that will be beneficial. To this end, we will build and disseminate a novel, multi-level automated sleep classifier based on the worlds largest dataset of sleep signals. PROJECT NARRATIVE People vary considerably not just in how much they sleep, but also in the types of sleep they typically have. Standard approaches to describing sleep, primarily developed in the 1960s, only partially capture this variability: we propose to use a range of measures, including brain activity, on over ten thousand sleeping individuals to generate more accurate, data-driven, personalized profiles of how a person's sleep varies over a night. Sleep factors are associated with multiple physical and neuropsychiatric illnesses, and so better measurement of the underlying processes will be critical for future genetic and biomarker studies aimed at understanding the links between sleep, health and disease.",Leveraging National Sleep Research Resource Data for Personalized Sleep Profiling,9687195,R01HL146339,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Automobile Driving ', ' driving ', ' Awareness ', ' Beds ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Systematics ', ' Classification ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' EEG ', ' Electroencephalography ', ' Exhibits ', ' Future ', ' genetic biomarker ', ' Genetic Markers ', ' Genome ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Manuals ', ' Maps ', ' Medicine ', ' Methods ', ' Mythology ', ' Persons ', ' Phenotype ', ' Physiology ', ' Research Resources ', ' Resources ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Sleep ', ' Sleep Stages ', ' rapid eye movement sleep ', ' dreaming sleep ', ' Rhombencephalic Sleep ', ' Paradoxical Sleep ', ' Fast-Wave Sleep ', ' REM Sleep ', ' Supervision ', ' Testing ', ' Time ', ' Work ', ' Measures ', ' Artifacts ', ' Morphologic artifacts ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' Polysomnography ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Guidelines ', ' base ', ' Label ', ' Link ', ' Training ', ' Slow-Wave Sleep ', ' Delta Wave sleep ', ' Delta Wave ', ' Individual ', ' Measurement ', ' Funding ', ' Genetic ', ' Staging ', ' Morphology ', ' tool ', ' Greek ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Neurocognitive ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' heuristics ', ' trait ', ' Stretching ', ' novel ', ' Reporting ', ' Modeling ', ' Sampling ', ' neuropsychiatry ', ' neuropsychiatric ', ' Property ', ' sleep onset ', ' genetic epidemiology ', ' genetic epidemiologic study ', ' Data ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' National Heart, Lung, and Blood Institute ', ' NHLBI ', ' molecular scale ', ' Sleep Architecture ', ' Stage I Sleep ', ' Stage 1 Sleep ', ' Stage II Sleep ', ' Stage 2 Sleep ', ' non rapid eye movement ', ' nonrapid eye movement ', ' nonREM ', ' non-rapid eye movement ', ' non-REM ', ' NREM ', ' Outcome ', ' Individual Differences ', ' open source ', ' demographics ', ' real world application ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' neural correlate ', ' learning strategy ', ' learning method ', ' learning activity ', ' implicit bias ', ' data resource ', ' sleep health ', ' sleep hygiene ', ' analysis pipeline ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,R01,2019,451078,0.1473452953485527
"Dose-distribution radiomics to predict morbidity risk in radiotherapy     DESCRIPTION (provided by applicant):  Lung cancer remains the leading cause of cancer deaths in the U.S., and definitive radiotherapy is the standard of care for locally advanced, inoperable cases. Radiation therapy is also highly flexible, and can be adapted for variations in tumor volume and location. However, decision support models to optimize treatment planning and avoid morbidity on a patient-by-patient basis are lacking. Recently, the randomized phase III trial, RTOG 0617, compared high dose (74 Gy) treatments to standard (60 Gy) treatments for non-small cell lung cancer (NSCLC), and demonstrated an unexpectedly higher rate of mortality in the high-dose arm. We hypothesize that this was primarily due to heart irradiation, in combination with lung irradiation factors. The goal of this project is to determine and validate predictive models of morbidity following thoracic RT, in order to achieve safer and more optimal tradeoffs between local control and morbidity. We will jointly analyze three large, high-quality datasets using innovative image-registration, machine learning, and dose characteristics (dose-based radiomics), to develop mathematical models that could be used to predict and avoid key morbidity endpoints in radiotherapy treatment planning. All endpoints will use dose-distribution comparison methods to examine the correlation between dose and morbidity as a function of anatomic location, thus providing greater assurance that the source of radiotherapy toxicity is correctly identified. Under Specific Aim 1 (SA1), we will use innovative deformable image registration methods to map all patient dose distributions to a segmented reference case anatomy (including heart, lungs, bronchii, and blood vessels). The accuracy of the deformations will be mapped carefully using an innovative non-parametric estimation methodology. Tissue regions with high correlations to morbidity will be extracted for machine learning under SAs 2 and 3. Under SA2, we will apply innovative machine learning with the goal of relating dose factors extracted under SA1 with treatment-related death hazard. Under SA3, we will apply the same methodology to the risk of severe pneumonitis. We hypothesize that treatment related death hazard and radiation pneumonitis form a single predictable continuum of increasing risk, and we will attempt to bring together the results of SA2 and SA3 in a single predictive model. Innovative post-modeling analyses of mutually exclusive predictors will be used to make the machine learning models interpretable. The overall goals of this grant are: (1) to advance the state of science in the field of personally-optimized radiation oncology, and (2) to provide decision support tools to guide patient-specific tradeoffs between local control and toxicity in lung cancer radiotherapy. PUBLIC HEALTH RELEVANCE:  Lung cancer for locally advanced, inoperable disease is usually treated with radiotherapy, but the cause of severe treatment morbidity is not well understood. Using advanced data analysis methods, we will produce mathematical models that can be used to compare the risks of alternative treatment plans for individual patients, thereby avoiding unnecessary treatment morbidity.",Dose-distribution radiomics to predict morbidity risk in radiotherapy,9685174,R01CA198121,"['Age ', ' ages ', ' Algorithms ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Blood Vessels ', ' vascular ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Nonsmall Cell Lung Carcinoma ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cause of Death ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Death ', ' Cessation of life ', ' Disorder ', ' Disease ', ' Fractionation Radiotherapy ', ' FRACN ', ' Chemical Fractionation ', ' Fractionation ', ' Goals ', ' Grant ', ' Heart ', ' cardiac failure ', ' Heart failure ', ' Modern Man ', ' Human ', ' Incidence ', ' indexing ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Maps ', ' Math ', ' Mathematics ', ' Methods ', ' Methodology ', ' Modernization ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Patients ', ' treatment with radiation ', ' radio-therapy ', ' radiation treatment ', ' Radiotherapy ', ' Radiotherapeutics ', ' Radiation therapy ', ' Research ', ' Risk ', ' Risk Factors ', ' Science ', ' Smoking ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Universities ', ' Washington ', ' Decision Support Model ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' quality assurance ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' Clinical ', ' Variant ', ' Variation ', ' Death Rate ', ' Radiation Pneumonitis ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonia ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Logistics ', ' Radiation Oncology ', ' Normal tissue morphology ', ' Normal Tissue ', ' Shapes ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Source ', ' Pattern ', ' Techniques ', ' Location ', ' Tumor Volume ', ' Tumor Tissue ', ' Radiation Dose Unit ', ' Radiation Dose ', ' hazard ', ' treatment planning ', ' Toxic effect ', ' Toxicities ', ' Locally Advanced Malignant Neoplasm ', ' Locally Advanced Cancer ', ' Structure ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Modeling ', ' Sampling ', ' preconditioning ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' cancer radiation therapy ', ' Cancer Radiotherapy ', ' irradiation ', ' Dose ', ' Data ', ' Dose-Limiting ', ' Radiation Therapy Oncology Group ', ' RTOG ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cancer Etiology ', ' Cancer Cause ', ' Characteristics ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' image registration ', ' software systems ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' public health relevance ', ' alternative treatment ', ' standard of care ', ' flexibility ', ' flexible ', ' arm ', ' Pulmonary Inflammation ', ' Pneumonitis ', ' phase III trial ', ' image guided ', ' image guidance ', ' learning strategy ', ' learning method ', ' learning activity ', ' support tools ', ' individual patient ', ' unnecessary treatment ', ' radiomics ', ' treatment optimization ', ' therapy optimization ', ' random forest ', ' classification trees ', ' ']",NCI,SLOAN-KETTERING INST CAN RESEARCH,R01,2019,579921,0.1184215278682198
"Precision Medicine in Sarcoidosis ABSTRACT Sarcoidosis is a systemic inflammatory disease of unknown etiology characterized by non-caseating granulomas in affected organs, primarily in the lungs. Approximately 30% of patients with sarcoidosis progress to debilitating disease; however, the drivers of susceptibility or resilience to disease remain poorly understood. An inflammatory response to an undefined antigen is postulated as the etiology of granuloma formation, and the pathogenesis has been suggested to involve gene-pathogen interaction, yet analysis of single genes or microbes has not proven applicable to diagnosis of all forms of sarcoidosis. Indeed, rather than a single organism, the disease may represent an interaction between the community of organisms that comprise the lung microbiome (community of organisms that live in and on us) and the host immune response. We propose that understanding the microbiome/host interaction will suggest strategies for precision medicine approaches to sarcoidosis. This proposal addresses this significant gap by investigating interactions between the lung microbiome, host immune and clinical responses in sarcoidosis using multiomics approaches  a critically innovative strategy. Our preliminary data support our novel hypotheses. First, we identified distinct lung microbiomes that differentiated patients with sarcoidosis versus controls. Second, our results identified biomarkers of disease severity that were associated with decreased lung function. Third, a recurrent analytic theme that emerged, regardless of the type of -omic analysis, was that sarcoidosis is characterized by pathways related to apoptosis and autophagy, which is consistent with our observation of decreased abundance of peripheral lymphocytes and functional immune anergy. These data led us to our Overall Hypothesis: Lung microbiome and host immune interactions characterized by apoptosis and autophagy pathways influence sarcoidosis clinical course. This hypothesis will be tested by an observational prospective and validation study of sarcoidosis patients at 5 time points to facilitate time series analyses. Aims 1 and 2 focus on lung microbiome or host immune responses, respectively, in relation to clinical course of sarcoidosis. Using these data in Aim 3, predictive models will be constructed based on integrated data of metagenomic and host-immune interactions. The novelty and significance of our multiomics strategy is to construct models for precision medicine therapies to harness bioinformatic strategies into focused, patient-specific approaches. The long-term significance of this study is to define pathways for sarcoidosis progression or resolution, and to develop database of these findings to further develop more precise, testable, models. PROJECT NARRATIVE Sarcoidosis is a disease of unknown etiology that predominately affects the lung and may affect other organs. We propose to construct a model to predict sarcoidosis progression or resolution by identifying microbial and immune interactions. We postulate that these models will be helpful in designing therapeutic options.",Precision Medicine in Sarcoidosis,9632837,R01HL138628,"['Affect ', ' Antigens ', ' immunogen ', ' ATGN ', ' Autophagocytosis ', ' autophagy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Communities ', ' Diagnosis ', ' Disorder ', ' Disease ', ' stool ', ' Feces ', ' Genes ', ' Granulomatous Lesion ', ' Granuloma ', ' Immunity ', ' indexing ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Methods ', ' living system ', ' Organism ', ' Patients ', ' Phenotype ', ' Prognosis ', ' outcome forecast ', ' Prospective Studies ', ' Recurrent ', ' Recurrence ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' mRNA ', ' Messenger RNA ', "" Schaumann's Disease "", "" Boeck's Sarcoid "", ' Besnier-Boeck Disease ', ' Sarcoidosis ', ' Technology ', ' Testing ', ' Time ', ' cytokine ', ' General Taxonomy ', ' Taxonomy ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' base ', ' Organ ', ' Bronchoalveolar Lavage ', ' bronchopulmonary lavage therapy ', ' Lung Lavage ', ' Bronchopulmonary Lavage ', ' Bronchioalveolar Lavage ', ' Peripheral ', ' Clinical ', ' Predisposition ', ' Susceptibility ', ' anergy ', ' Databases ', ' data base ', ' Data Bases ', ' Disease Progression ', ' Biological Process ', ' Biological Function ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Inflammatory ', ' Immune ', ' Immunes ', ' Severity of illness ', ' disease severity ', ' microbial ', ' novel ', ' validation studies ', ' Time Series Analysis ', ' Disease model ', ' disorder model ', ' Pathogenesis ', ' Modeling ', ' response ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Address ', ' Data ', ' Resolution ', ' Apoptotic ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Pathway interactions ', ' pathway ', ' microbiome ', ' metagenome ', ' deep sequencing ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' resilience ', ' pathogen ', ' innovation ', ' innovative ', ' innovate ', ' transcriptomics ', ' Microbe ', ' metagenomic sequencing ', ' metagenome sequencing ', ' clinically relevant ', ' clinical relevance ', ' Metagenomics ', ' Functional Metagenomics ', ' inflammatory marker ', ' inflammation marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' precision medicine ', ' precision-based medicine ', ' clinical predictors ', ' multiple omics ', ' multiomics ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' lung microbiome ', ' pulmonary microbiome ', ' host microbiome ', ' machine learning algorithm ', ' ']",NHLBI,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2019,914660,0.14183780501413243
"Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer Lung cancer is a leading cause of death in the United States. The National Lung Screening Trial (NLST) showed that more lung cancers can be detected at an early stage with low dose CT screening. However, over-diagnosis of indolent lung cancer and benign nodules is one of the major limitations of screening, resulting in unnecessary treatment, biopsy, follow-up, increased radiation exposure, patient anxiety, and cost. Due to a lack of in-depth knowledge of the correlation of structural image features and histologic findings of lung nodules and the absence of validated diagnostic biomarkers for accurate disease categorization, the current diagnosis and management of the screen-detected nodules remains challenging.  The goal of this proposed project is to develop a decision support system (DSS) based on quantitative histopathology correlated CT descriptor (q-PCD) of pulmonary nodules using advanced computer vision and machine learning techniques to characterize the histopathologic features of nodules and analyze their correlations with CT image features for improvement of early detection of lung cancer. We hypothesize that the proposed q-PCD analysis will have strong association with histopathologic characterization, and therefore will be a more effective biomarker for differentiation of invasive, pre-invasive, and benign nodules than conventional image-based features or radiologists' visual judgement. Accurate characterization of the nodule types will assist radiologists in making decision for management of the detected nodules; e.g., enabling early detection and treatment of invasive lung cancer, safe surveillance or replacing lobectomy with limited sublobar resection for pre-invasive lung cancer, and sparing biopsy of benign nodules, thereby reducing morbidity and costs in lung cancer screening programs. Our major specific aims are to 1) collect a large database of LDCT screening cases from NLST project and our institute to develop automated image analysis methods, 2) to develop a new DSS based on quantitative pathologic correlated CT descriptors (q-PCD) of lung nodules, 3) validate the effectiveness of DSS in lung cancer diagnosis. To achieve these aims, we will collect a large data set from the National Lung Screening Trial (NLST) and our institute. The collected database will include the baseline and follow up scans, pathology data, demographic information and other information provided by NLST. We will develop automated segmentation methods to extract the volumes of the solid and sub-solid components of detected lung nodules, develop quantitative methods to characterize the radiologic and pathologic features of lung nodules as well as the surrounding lung parenchyma, develop a novel radiopathomics strategy to correlate pathomics with radiomics, and to identify new imaging biomarkers. We will develop a clinically-translatable DSS with a joint biomarker combining both image and patient information, and evaluate its performance in lung cancer diagnosis, including its effectiveness in baseline screening CT exams and in follow up exams. Narrative: Lung cancer is the second most commonly diagnosed cancer in both men and women in the United States. If successful, we will have developed an automated low dose CT-based quantitative histopathology correlated CT descriptor (q-PCD) which can be included as an independent factor to improve the diagnosis of screening detected nodules. It will not only provide a useful imaging biomarker to assist in lung nodule management for individuals, but also constitute a strong foundation to meet our long-term goal of developing clinically- translatable decision support system (DSS) to facilitate personalized medicine in early detection of lung cancer, optimizing treatment strategies and reducing health care costs",Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer,9693200,U01CA216459,"['Anxiety ', ' Archives ', ' Biopsy ', ' Cause of Death ', ' computer vision ', ' Computer Vision Systems ', ' relational database management systems ', ' database systems ', ' Data Base Management Systems ', ' Database Management Systems ', ' Decision Making ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Foundations ', ' Goals ', ' Institutes ', ' Joints ', ' Lobectomy ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Maps ', "" men's "", ' men ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Nodule ', ' Pathology ', ' Patients ', ' pulmonary nodule ', ' Lung nodule ', ' Radiology ', ' General Radiology ', ' Radiology Specialty ', ' Reference Standards ', ' Risk Factors ', ' Testing ', ' thorax radiography ', ' thoracic radiogram ', ' radiographic lung image ', ' radiographic chest image ', ' lung radiography ', ' chest radiography ', ' chest Xray ', ' chest X ray ', ' CXR ', ' Thoracic Radiography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Woman ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Decision Aid ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Benign ', ' Solid ', ' Histologic ', ' Histologically ', ' Evaluation ', ' Indolent ', ' Visual ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' radiologist ', ' lung cancer screening ', ' lung cancer early detection ', ' Descriptor ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scanning ', ' Techniques ', ' Early Diagnosis ', ' early detection ', ' Performance ', ' attenuation ', ' Histopathology ', ' Structure ', ' novel ', ' Reporting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Decision Support Systems ', ' Property ', ' cancer diagnosis ', ' Effectiveness ', ' Advocate ', ' Data ', ' Reproducibility ', ' Collection ', ' low-dose spiral CT ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' Screening Result ', ' Pathologic ', ' Characteristics ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' cost ', ' Early treatment ', ' early therapy ', ' high risk ', ' treatment strategy ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' screening ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' Patient risk ', ' imaging biomarker ', ' imaging-based marker ', ' imaging-based biomarker ', ' imaging-based biological marker ', ' imaging marker ', ' diagnostic biomarker ', ' diagnostic marker ', ' unnecessary treatment ', ' radiomics ', ' Radiation exposure ', ' clinically translatable ', ' screening program ', ' treatment optimization ', ' therapy optimization ', ' computed tomography screening ', ' CT screening ', ' pathology imaging ', ' automated image analysis ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2019,591449,0.21436115699374778
"Deep Radiomic Analysis of Coronary Heart Disease with Lung Screening CT Cardiovascular diseases (CVDs) caused 17.7 million deaths in 2015, accounting for one third of all deaths globally. Amongst 8.8 million cancer-deaths in 2015, lung cancer contributed to 1.69 million deaths worldwide. In the United States, lung cancer will claim 154,050 lives in 2018, representing a quarter of all cancer deaths. Both CVDs and lung cancer share several risk factors, including unhealthy dietary patterns, obesity, and tobacco use. Low-dose Computed Tomography (LDCT), an effective lung cancer screening technique, reduces the cancer-related mortality rate by 20% in those with history of heavy smoking. Such subjects have substantially higher risk of CVDs than lung cancer. Indeed, most subjects undergoing lung cancer screening with LDCT have an intermediate to high risk for CVDs. Concomitant CVD screening will have profound benefits for these subjects at no additional time, cost, or radiation dose to the patient. The goal of the project is to develop an automated workflow of cardiovascular morbidity and mortality risk (CARMOR) evaluation with lung cancer screening LDCT data to provide high-risk subjects a radiation-free CVD screening without cost or time constraints. Our central hypothesis is that deep radiomics from LDCT follow-up scans and across different reconstructions can effectively improve the performance of CARMOR estimation. To validate our hypothesis, we will perform radiomics analysis on CARMOR with lung cancer screening LDCT scans, and then further enhance the CARMOR features with complementary image reconstructions from the same scan and serial LDCT scans for optimized prognostic performance. The CARMOR quantification methods in lung screening LDCT will be validated retrospectively against multiple subspecialty radiologists with Coronary Computed Tomography Angiogram (CCTA) as the standard of reference. The project requires us to perform analyses over serial LDCT exams and different reconstruction techniques and settings. Therefore, major innovations and improvements need to be made for this challenging deep radiomic analysis task. Since the risk factors of CVDs and lung cancer are closely related with lifestyle, the findings of the project can also be used to create teachable moments for patients to change towards healthier lifestyles. In context of the Center for Medicare & Medicaid Services (CMS) reimbursement of LDCT for lung cancer screening and stress on the importance of considering co-morbidities, our timely project will have a significant impact on the healthcare of a large population. At the end of the project, we will have developed an automated workflow of assessing CARMOR for lung screening LDCT with zero radiation added. We will also have acquired study results to enable personalized patient education to address the long-term health crisis caused by unhealthy lifestyles. Our studies will lead to new understanding of deep radiomics in CVD screening and the impact of LDCT reconstructions in clinical practice. Low-dose Computed Tomography (LDCT) is effective in lung cancer screening and can reduce the mortality rate by 20% for the high-risk population. However, heavy smokers are affected by cardiovascular diseases (CVDs) even more than by lung cancer and most high-risk subjects undergoing lung cancer screening with LDCT have an intermediate to high risk for CVDs. The goal of the project is to develop an automated workflow to provide high-risk subjects a radiation-free CVD screening using lung cancer screening LDCT data.",Deep Radiomic Analysis of Coronary Heart Disease with Lung Screening CT,10009810,R56HL145172,"['Accounting ', ' Affect ', ' Algorithms ', ' Angiography ', ' angiographic imaging ', ' Angiogram ', ' Calcium ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' coronary disorder ', ' atherosclerotic heart disease ', ' Coronary Disease ', ' Coronary heart disease ', ' Death ', ' Cessation of life ', ' Goals ', ' Health ', ' History ', ' Recording of previous events ', ' image generation ', ' image construction ', ' image reconstruction ', ' Lifestyle ', ' Life Style ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patient Training ', ' Patient Instruction ', ' Patient Education ', ' Patients ', ' Recurrent ', ' Recurrence ', ' Reference Standards ', ' Risk ', ' Risk Factors ', ' Semantics ', ' Smoking ', ' Stress ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' United States Health Care Financing Administration ', ' Health Care Financing Administration ', ' Centers for Medicare and Medicaid Services ', ' United States Centers for Medicare and Medicaid Services ', ' Vendor ', ' health care ', ' Healthcare ', ' calcification ', ' Calcified ', ' improved ', ' Series ', ' Evaluation ', ' prognostic ', ' muscle form ', ' muscle mass ', ' muscle bulk ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Funding ', ' radiologist ', ' lung cancer screening ', ' lung cancer early detection ', ' Smoker ', ' Body fat ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Scanning ', ' Source ', ' Techniques ', ' Tobacco use ', ' Tobacco Consumption ', ' Radiation Dose Unit ', ' Radiation Dose ', ' Performance ', ' cohort ', ' Graph ', ' Reporting ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Radiation ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Dietary Practices ', ' dietary pattern ', ' low-dose spiral CT ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' Validation ', ' Coronary ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' coronary artery calcification ', ' coronary calcification ', ' Image ', ' imaging ', ' National Heart, Lung, and Blood Institute ', ' NHLBI ', ' cost ', ' reconstruction ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' task analysis ', ' spatiotemporal ', ' high risk ', ' clinical practice ', ' screening ', ' unhealthy lifestyle ', ' healthy lifestyle ', ' healthy life-style ', ' Lung CAT Scan ', ' Lung CT scan ', ' Lung CT ', ' CT Lung Screening ', ' prognostic performance ', ' radiomics ', ' high risk population ', ' high risk group ', ' deep neural network ', ' deep neural net ', ' deep learning neural network ', ' deep learning based neural network ', ' deep learning ', ' mortality risk ', ' death risk ', ' ']",NHLBI,RENSSELAER POLYTECHNIC INSTITUTE,R56,2019,369682,0.18310219612175824
"A diagnostic model for malignant pulmonary nodules The early detection of lung cancer by low-dose computed tomography (LDCT) followed by effective treatments, including immunotherapy, can reduce the mortality. LDCT is now recommended for lung cancer screening in smokers. However, more than 25% of smokers screened by LDCT have indeterminate pulmonary nodules (PNs), of which only 4% are finally diagnosed to be lung cancers, whereas more than 95% are benign diseases, resulting in over-diagnosis. As a result, large numbers of smokers with indeterminate PNs are referred for invasive biopsies and expensive 2-year multiple follow-up examinations, which carry their own morbidity and mortality. Therefore, there is an unmet clinical need for accurately distinguishing malignant PN (lung cancer) from benign PN in smokers with LDCT-found PNs. However, none of biomarkers and radiological features of PNs provides sufficient diagnostic values required in the clinics for accurately identifying malignant PNs. The objective of this proposed project is to develop a test for specifically differentiating malignant from benign PN. The target population of this test will be smokers with LDCT-found PNs. Its future use in the clinics will spare smokers with benign PNs from invasive biopsies and expensive multiple follow-up examinations, while facilitating effective treatments to be instantly initiated for lung cancer. Therefore, the test could complement LDCT for the early detection lung cancer, and thereby reduce the mortality and cost. Here we propose to develop an easy and cost-effective test for accurately distinguishing malignant from benign lung nodules. Future use of the test will complement CT screening for the early detection of lung cancer, and ultimately reduce lung cancer-associated deaths.",A diagnostic model for malignant pulmonary nodules,9805358,R21CA240556,"['Biometry ', ' Biostatistics ', ' Biometrics ', ' Biopsy ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell Body ', ' Cells ', ' Complement Proteins ', ' Complement ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Female ', ' Future ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' immuno therapy ', ' immune-based treatments ', ' immune-based therapies ', ' immune therapy ', ' immune therapeutic strategy ', ' immune therapeutic regimens ', ' immune therapeutic interventions ', ' immune therapeutic approach ', ' immune drugs ', ' Immunologically Directed Therapy ', ' Immunotherapy ', ' male ', ' Marriage ', "" men's "", ' men ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Pathology ', ' Physics ', ' Prospective Studies ', ' Pulmonary Medicine ', ' Pneumonology ', ' Pneumology ', ' Pulmonology ', ' pulmonary nodule ', ' Lung nodule ', ' Radiology ', ' General Radiology ', ' Radiology Specialty ', ' Research Resources ', ' Resources ', ' Sensitivity and Specificity ', ' Target Populations ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Woman ', ' Molecular Genetics ', ' Immunologic Markers ', ' immunological markers ', ' immunological biomarkers ', ' immune-based biomarkers ', ' Immune Markers ', ' base ', ' Procedures ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' Benign ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Medical ', ' Ensure ', ' peripheral blood ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' oncology ', ' Oncology Cancer ', ' lung cancer screening ', ' lung cancer early detection ', ' Smoker ', ' non-smoker ', ' nonsmoker ', ' Diagnostic ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Clinic ', ' success ', ' cohort ', ' novel ', ' Modeling ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Data ', ' Emerging Technologies ', ' Emergent Technologies ', ' low-dose spiral CT ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' cost ', ' digital ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' cost effective ', ' multidisciplinary ', ' effective therapy ', ' effective treatment ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' never smoker ', ' whole genome ', ' full genome ', ' entire genome ', ' radiomics ', ' microRNA biomarkers ', ' microRNA markers ', ' miRNA markers ', ' miRNA biomarkers ', ' radiological imaging ', ' radiologic imaging ', ' high dimensionality ', ' screening program ', ' computed tomography screening ', ' CT screening ', ' ']",NCI,UNIVERSITY OF MARYLAND BALTIMORE,R21,2019,201623,0.2068211842569885
"The Health and Behavioral Effects of Sleep Deprivation Among the Urban Poor in India Project Summary/Abstract Evidence demonstrates that sleep deprivation causes impaired cognitive function and is associated with impaired health (e.g. altered immune and cardiovascular function). Yet these conclusions largely derive from correlational relationships or studies of acute sleep deprivation lasting only a few days in sleep labs. Further, research on sleep in disadvantaged populations and sleep disparities is limited, despite severe environmental challenges to sleep among the poor. Moreover, the potentially bi-directional relationship between poor sleep and poor decision-making, a possible mediator of the income-health gradient, remains largely unexplored. In short, while poor sleep could be an important contributor to health disparities and accelerated aging, we know relatively little about the causes and impacts of sleep deprivation in low SES populations and how to address these disparities, a gap that is especially acute in real-world settings with extended time frames. This K01 application will provide key training for career advancement and begin to close this gap in knowledge. To accomplish this goal, a randomized field experiment with 400 participants, each enrolled for over one month, in Chennai, India, will (1) objectively measure sleep and key environmental factors to provide preliminary evidence on the role of environmental causes of sleep deprivation in an urban environment, (2) rigorously evaluate two simple scalable interventions to reduce sleep deprivation among low-income adults in their natural environments, (3) estimate the causal effect of improved sleep on cognitive function, decision- making, health outcomes and behaviors (e.g. blood pressure, alcohol consumption), and earnings, and (4) utilizing questions regarding sleep asked of both RCT participants and a 50,000 person nationally-representative sample, estimate the extent of sleep deprivation and its impacts more broadly in urban India. The training aims underpinning the research aims and the applicant's long-term research goals are to expand knowledge and skills in: (1) cognitive psychology and the measurement of cognitive function, (2) aging, and (3) machine learning and predictive modeling. This training, accomplished through multiple avenues including coursework, directed study, and mentorship, will directly facilitate the proposed research and extend the scope and impact of the applicant's long-term research career studying health disparities and interactions between health and decision-making which may impact both cognitive and physical health as individuals age. Notably, while this application focuses on the impacts of sleep deprivation, the potential for health to shape decision-making is much broader. Constant exposure to other aspects of poor health associated with poverty, such as pain, also have the potential to exert a mental tax, leading to impaired cognition and poor decisions. Such a negative feedback loop between these factors and decision-making has the potential to further exacerbate health disparities. The far-reaching applicability of this idea beyond the direct scope of this proposal opens the door to high public-health significance through a wide variety of channels. Project narrative Although sleep has significant potential to impair cognition and impede health, relatively little is known about the causes and impacts of sleep deprivation in low SES populations and how to address these disparities, a gap that is especially acute in real-world settings with extended time frames. This research will begin to close this gap in knowledge through a 400 person randomized trial in Chennai, India, which will objectively and rigorously measure sleep and key environmental factors impacting sleep, evaluate the impact of two simple and scalable interventions to improve sleep, and estimate the causal effect of improved sleep on cognitive function, decision-making, health outcomes and behaviors (e.g. blood pressure, tobacco consumption), and earnings. Providing rigorous evidence on these relationships and improving our collective understanding of the causes and costs to sleep deprivation, including not just direct health outcomes, but also shifts in preferences and decision-making directly relevant to health, will provide policy-relevant information important to improving health and healthy behaviors as well as promoting heathy and economically-secure aging.",The Health and Behavioral Effects of Sleep Deprivation Among the Urban Poor in India,9614849,K01AG055691,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Aging ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Attention ', ' Behavior ', ' Blood Pressure ', ' cardiovascular function ', ' Cardiovascular Physiology ', ' career transition ', ' career advancement ', ' Career Mobility ', ' Cognition ', ' cost measurement ', ' Cost metrics ', ' Cost Measures ', ' Decision Making ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Countries ', ' Disorder ', ' Disease ', ' Economic Models ', ' Environment ', ' Feedback ', ' Food or Food Product ', ' Food ', ' Goals ', ' Health ', ' Health behavior ', ' promoting health ', ' Salutogenesis ', ' Health Promotion ', ' Incidence ', ' Economical Income ', ' Economic Income ', ' Income ', ' India ', ' Insects Invertebrates ', ' Insects ', ' Insecta ', ' Investments ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Photoradiation ', ' Light ', ' Mentorship ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Morbidity ', ' Morbidity - disease rate ', ' Persons ', ' Noise ', ' Painful ', ' Pain ', ' wellbeing ', ' well-being ', ' Personal Satisfaction ', ' Poverty ', ' psychomotor function ', ' Psychomotor Performance ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' Running ', ' Savings ', ' Sleep ', ' sleep loss ', ' sleep insufficiency ', ' sleep deficit ', ' sleep deficiency ', ' sleep debt ', ' insufficient sleep ', ' inadequate sleep ', ' deficient sleep ', ' Sleep Deprivation ', ' sleep disruption ', ' poor sleep ', ' impaired sleep ', ' disturbed sleep ', ' disrupted sleep ', ' aberrant sleep ', ' Sleep disturbances ', ' Survey Instrument ', ' Surveys ', ' Taxes ', ' Testing ', ' Time ', ' Tobacco ', ' Translating ', ' Measures ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' career ', ' improved ', ' Acute ', ' Chronic ', ' Biological ', ' Physiological ', ' Physiologic ', ' Link ', ' Training ', ' Psyche structure ', ' mental ', ' Individual ', ' Logistics ', ' Policies ', ' Measurement ', ' Exposure to ', ' Shapes ', ' Impaired cognition ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Cognitive Science ', ' cognitive psychology ', ' Knowledge ', ' programs ', ' cognitive function ', ' Dimensions ', ' physical conditioning ', ' physical health ', ' respiratory ', ' Tobacco use ', ' Tobacco Consumption ', ' preference ', ' skills training ', ' skills ', ' Participant ', ' research study ', ' Patient Self-Report ', ' Self-Report ', ' Impaired health ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Inflammatory Response ', ' disparity in health ', ' health disparity ', ' Cellular Immune Function ', ' immune function ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' low SES ', ' low socioeconomic status ', ' Low income ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' cognitive change ', ' Address ', ' global health ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cognitive ', ' Enrollment ', ' enroll ', ' Observational Study ', ' Observational research ', ' Observation study ', ' Observation research ', ' discount ', ' Behavioral ', ' cost ', ' health economics ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Outcome ', ' Population ', ' healthy aging ', ' randomized trial ', ' Randomization trial ', ' Secure ', ' adverse outcome ', ' adverse consequence ', ' cognitive ability ', ' behavioral economics ', ' blood pressure reduction ', ' reduction in blood pressure ', ' reduction in BP ', ' reduce blood pressure ', ' reduce BP ', ' lowers blood pressure ', ' lower blood pressure ', ' lower BP ', ' BP reduction ', ' disadvantaged population ', ' experimental study ', ' experimental research ', ' experiment ', ' sleep health ', ' sleep hygiene ', ' diarrheal disease ', ' diarrheal illness ', ' econometrics ', ' ']",NIA,UNIVERSITY OF PENNSYLVANIA,K01,2019,127872,0.12356008834777311
"Identification of immune cell-cell communication networks and inflammatory pulmonary microenvironments associated with the progression of COPD PROJECT SUMMARY Chronic obstructive pulmonary disease (COPD) is a fatal lung disease that is the fourth leading cause of death in the U.S. Despite an estimated $50 billion in yearly healthcare costs, it has no current cure and only palliat- ive treatments. COPD is clearly characterized by chronic lung inflammation that likely arises from dysregulat- ion of complex networks of immune factors and cells across multiple tissue compartments. Although multiple individual genes and proteins have been associated with COPD risk and progression, global mechanistic understanding of its pathophysiology is lacking, particularly regarding the marked heterogeneity in COPD phenotypes. The overall objective of our study is to gain systems-level insight into complex inflammatory and immune mechanisms underlying COPD, by applying data-driven (also called machine learning) modeling approaches to clinical samples collected from human pulmonary microenvironments and matched immune cell networks from peripheral blood. Our central hypothesis is that immune networks will be more predictive of COPD phenotype, progression, and exacerbation than individual factors. We will test this hypothesis in three Specific Aims, using matched brochoalveolar lavage (BAL) and blood samples collected in SPIROMICS I and II clinical trials. Aim 1 will identify changes in immune cell-cell communication networks, by high-throughput cytokine measurements from stimulated systems of peripheral blood immune cells from smokers with and without COPD and never-smoking controls (collected from the upcoming SPIROMICS II visit; n=150). Aim 2 will determine systems-level changes that occur in the inflamed lung microenvironment, using high-throughput cytokine measurements in BAL samples (both archival from SPIROMICS I, n=200, and collected during upcoming SPIROMICS II bronchoscopies) from smokers with and without COPD and never-smoking controls. We will identify networks associated with longitudinal clinical progression and exacerbation frequency. Aim 3 will integrate measurements across lung and blood tissue compartments to define key combinatorial relationships associated with progression and exacerbation events. Overall, this project will provide systems- level insight into COPD pathogenesis and progression, and create a new paradigm for the study of other pulmonary conditions involving chronic inflammation, including idiopathic pulmonary fibrosis, asthma, and lung transplant. Results will aid in the future development of new non-invasive diagnostic assays and will guide systems-level mechanistic studies that could result in new combinatorial therapies. PROJECT NARRATIVE The goal of this proposal is to gain new systems-level insight into chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide and an enormous cost burden in the U.S. yearly (~50 billion). Despite progress in identifying individual immune factors associated with COPD, there are only palliative treatment options and no cure. New insight generated by this project into how immune cell communication networks and inflammatory pulmonary microenvironments are altered in COPD could be used to identify diagnostic biomarkers and to guide the design of combinatorial therapies.",Identification of immune cell-cell communication networks and inflammatory pulmonary microenvironments associated with the progression of COPD,9640679,R01HL144849,"['Accounting ', ' Archives ', ' Asthma ', ' Bronchial Asthma ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood ', ' Blood Reticuloendothelial System ', ' Bronchoscopy ', ' Cause of Death ', ' Cell-to-Cell Interaction ', ' Cell Interaction ', ' Cell Communication ', ' Cell Body ', ' Cells ', ' Clinical Trials ', ' Concurrent Studies ', ' Cohort Studies ', ' Death Records ', ' Disorder ', ' Disease ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Future ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' immunological substance ', ' immunologic substance ', ' Immunological Factors ', ' Immunologic Factors ', ' In Vitro ', ' Inflammation ', ' other than vaginal Irrigation ', ' other than vaginal Douching ', ' lavage therapy ', ' irrigation therapy ', ' Nonvaginal lavage ', ' Nonvaginal irrigation ', ' Lavage ', ' Irrigation ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' Chronic Obstructive Airway Disease ', ' lung transplant ', ' Lung Grafting ', ' Lung Transplantation ', ' Methods ', ' Mucosal Tissue ', ' Mucosa ', ' Mucous Membrane ', ' comfort care ', ' Palliative Treatment ', ' Palliative Therapy ', ' Palliative Care ', ' Patients ', ' Radiology ', ' General Radiology ', ' Radiology Specialty ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Spirometry ', ' Testing ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' visual function ', ' Sight ', ' Vision ', ' cytokine ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' Outcome Measure ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Caring ', ' Blood specimen ', ' Blood Sample ', ' detector ', ' Bronchoalveolar Lavage ', ' bronchopulmonary lavage therapy ', ' Lung Lavage ', ' Bronchopulmonary Lavage ', ' Bronchioalveolar Lavage ', ' Chronic ', ' Clinical ', ' Physiological ', ' Physiologic ', ' prognostic ', ' Epithelial ', ' peripheral blood ', ' insight ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Funding ', ' noninvasive diagnosis ', ' noninvasive diagnostic ', ' non-invasive diagnostic ', ' non-invasive diagnosis ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Inflammatory ', ' Smoker ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Immune ', ' Immunes ', ' Severities ', ' Complex ', ' Event ', ' System ', ' Visit ', ' experience ', ' cohort ', ' Participant ', ' disorder risk ', ' disease risk ', ' Pathogenesis ', ' Positioning Attribute ', ' Position ', ' Gene Proteins ', ' Protein Gene Products ', ' Proteome ', ' Modeling ', ' Sampling ', ' Data ', ' Clinical Data ', ' Enrollment ', ' enroll ', ' Process ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' disease phenotype ', ' cost ', ' design ', ' designing ', ' adjudicate ', ' Outcome ', ' Lung Inflammation ', ' prospective ', ' combinatorial ', ' clinically relevant ', ' clinical relevance ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' novel therapeutic intervention ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' diagnostic assay ', ' diagnostic biomarker ', ' diagnostic marker ', ' idiopathic pulmonary fibrosis ', ' diffuse interstitial pulmonary fibrosis ', ' never smoking ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2019,322937,0.0747921906345567
"Predicting tuberculosis outcomes using genotypic and biomarker signatures PROJECT SUMMARY/ABSTRACT Tuberculosis (TB) is caused by an infectious pathogen, Mycobacterium tuberculosis (M.tb) in susceptible individuals, but we cannot yet classify or predict outcomes in those prone to pulmonary TB disease versus those prone to resistance. In part, this reflects knowledge gaps regarding genotypes that may increase susceptibility, and in validated disease correlates (e.g. serum of lung protein biomarkers) measured individually, or combined signatures. We address these knowledge gaps by using Diversity Outbred (DO) mice, a population with abundant genetic diversity and heterozygosity, like the human population. Also, like humans, a low dose M.tb infection of DO mice produces a spectrum of outcomes, from highly susceptible to highly resistant, and many intermediate outcomes. In this proposal, we use the DO population to: 1) Identify and test the capacity of genotypic (alleles and statistically significant loci) to predict outcomes such as diagnostic category (class); and 2) To identify and test lung and serum biomarker (protein) and granuloma signatures to determine diagnostic category (class); and 3) To identify and test serum biomarker (protein) signatures that can forecast disease onset, within a 3-week window before illness manifests clinically. The best performing signatures will be tested using samples from humans. Collectively, results from these studies will generate new translatable knowledge regarding correlates of pulmonary TB (useful for diagnostics), and genotypic and serum protein signatures (useful for prognostics). PROJECT NARRATIVE Mycobacterium tuberculosis (M.tb) causes tuberculosis (TB) in millions of susceptible humans each year. It is well known that humans respond variably to M.tb infection, yet we are unable to predict outcomes with accuracy. Here, we use the Diversity Outbred (DO) mouse population to identify and test genotypic, serum, and lung biomarker signatures to accurately predict outcomes. Findings are also validated in samples from humans.",Predicting tuberculosis outcomes using genotypic and biomarker signatures,9642291,R01HL145411,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Aerosols ', ' Alleles ', ' Allelomorphs ', ' Bacillus (bacterium) ', ' Bacillus ', ' Blood ', ' Blood Reticuloendothelial System ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Systematics ', ' Classification ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Patient Care Delivery ', ' Patient Care ', ' Genotype ', ' Granulomatous Lesion ', ' Granuloma ', ' heterozygosity ', ' Heterozygote ', ' Modern Man ', ' Human ', ' Infection ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Plasmodium Infections ', ' Paludism ', ' Malaria ', ' Morbidity ', ' Morbidity - disease rate ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' mtb ', ' M.tuberculosis ', ' M.tb ', ' M. tuberculosis ', ' M. tb ', ' M tuberculosis ', ' M tb ', ' Mycobacterium tuberculosis ', ' Necrotic ', ' Necrosis ', ' Patients ', ' Production ', ' Prognosis ', ' outcome forecast ', ' Proteins ', ' Serum Proteins ', ' Testing ', ' Time ', ' tuberculous spondyloarthropathy ', ' tuberculosis infection ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' TB infection ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' MTB infection ', ' M.tuberculosis infection ', ' M.tb infection ', ' M. tuberculosis infection ', ' M. tb infection ', ' M tuberculosis infection ', ' Tuberculosis ', ' Pulmonary TB ', ' Lung Tuberculosis ', ' Lung TB ', ' Pulmonary Tuberculosis ', ' Genetic Diversity ', ' Genetic Variation ', ' Measures ', ' Diagnostic tests ', ' base ', ' improved ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' Clinical ', ' Predisposition ', ' Susceptibility ', ' prognostic ', ' Training ', ' Serum ', ' Blood Serum ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' tool ', ' Diagnostic ', ' Consensus ', ' Knowledge ', ' Quantitative Trait Loci ', ' QTL ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Structure ', ' Disease Outcome ', ' Categories ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Modeling ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' model development ', ' Address ', ' Dose ', ' Data ', ' Harvest ', ' Inbred Strain ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' transmission process ', ' Transmission ', ' Process ', ' Image ', ' imaging ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Minority ', ' Outcome ', ' pathogen ', ' Population ', ' Vehicle crash ', ' Vehicular crash ', ' Vehicular collision ', ' Motor vehicle crash ', ' Motor vehicle collision ', ' Car crash ', ' Car collision ', ' Automobile crash ', ' Automobile collision ', ' Resistance ', ' resistant ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' novel marker ', ' novel biomarker ', ' new marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' public health intervention ', ' individual patient ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' protein biomarkers ', ' protein markers ', ' survival outcome ', ' tuberculosis diagnostics ', ' TB diagnostics ', ' supervised learning ', ' supervised machine learning ', ' human pathogen ', ' learning algorithm ', ' ']",NHLBI,TUFTS UNIVERSITY BOSTON,R01,2019,617451,0.0565443966182408
"Mentorship in the Endocrinology of Sleep The overarching goal of this application for a K24 Midcareer Investigator Award in Patient-Oriented Research is to foster training of promising junior investigators in cutting edge patient-oriented research related to how sleep biology influences cardiometabolic health. It capitalizes on the established network and resources of the recently renewed UCLA CTSI that includes a highly successful KL2 program. Dr. Liu led a competitively- funded Endocrine and Cardiometabolic Program in Sleep Biology at the University of Sydney, and since 2012, he has led a similar interdisciplinary research program in Los Angeles supported by a 5 year NHLBI R01 Hormonal mechanisms of sleep restriction that is currently in its 3rd year. During his 10 years of mentoring, he has trained 16 individuals: 10 remaining in academic medicine and 2 others in industry-related patient orientated research. Three of his trainees won major US young investigator awards under his supervision. He continues to support, mentor, and publish with former trainees, often long after they left his laboratory.  Disturbed sleep causes insulin resistance, promotes poor food choices, and curtails fat loss while dieting, thereby reducing the effectiveness of standard weight loss programs. However, the cardiometabolic consequences of disturbed sleep are not well recognized by the community, and the evidential bases to justify widespread changes to community sleeping patterns for cardiometabolic health reasons are evolving. Showing the mechanisms by which sleep restriction leads to cardiometabolic ill-health, particularly in older adults according to sex, are critical steps in providing these data. Dr. Liu's goal is to mentor the next cadre of independent clinical scientists focused on placing sleep alongside diet and exercise as part of healthy lifestyle, by understanding hormonal mechanisms and consequences of disrupted, inadequate or misaligned sleep.  The work proposed in this application fulfill these goals. Aim 1 will reveal the hypothalmo-pituitary-adrenal and hypothalamo-pituitary-gonadal mechanisms that cause testosterone-cortisol imbalance when sleep is restricted in older men and women (20 in each group). In doing so, trainees will learn endocrine physiology and chronobiological study design, IRB processes, recruitment skills, and hands-on study management. Aim 2 will identify sex differences in these mechanisms, trainees will learn statistical methods and abstract/presentation/ manuscript preparation. Aim 3 requires trainees to discover new mechanisms by which sleep restriction causes insulin resistance and alters appetite or food intake. Certain inflammatory mediators, hormones, or factors related to ethnicity or age could be studied. Aim 3 fulfils broader expectations for trainees to have a second project that is faster to accomplish, more exploratory, and driven by their interests and available resources, to develop a line of research that complements and is separate from that of the mentors. Taken together, these experiments will generate new knowledge of the relationship between sleep and hormonal cardiometabolic and reproductive health, provide wide-ranging training opportunities, and generate future R and K proposals. Narrative Insufficient sleep is common, and leads to insulin resistance, a major factor in the development of type 2 diabetes mellitus. This proposal attempts to reveal the hormonal mechanisms underlying the link between insufficient sleep with insulin resistance in older adults, the population at greatest risk for disordered sleep and metabolic disorders as a vehicle to provide outstanding mentorship opportunities.",Mentorship in the Endocrinology of Sleep,9692343,K24HL138632,"['Adrenal Glands ', ' suprarenal gland ', ' Adrenals ', ' Corticotropin ', ' Adrenocorticotropin ', ' Adrenocorticotropic Hormone ', ' ACTH ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Amino Acids ', ' aminoacid ', ' Analysis of Variance ', ' Variance Analyses ', ' ANOVA ', ' Desire for food ', ' Appetite ', ' Award ', ' Biology ', ' Carbohydrates ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communities ', ' Complement Proteins ', ' Complement ', ' corticotropin releasing hormone ', ' Corticotropin-Releasing Hormone-41 ', ' Corticotropin-Releasing Factor-41 ', ' Corticotropin-Releasing Factor ', ' Corticoliberin ', ' CRF-41 ', ' ACTH-Releasing Factor ', ' Corticotropin-Releasing Hormone ', ' alpha1-24-Corticotropin ', ' alpha-1,24-Corticotropin ', ' Tetracosapeptide ', ' Tetracosactrin ', ' Tetracosactide ', ' Synthetic ACTH ', ' Corticotropin (1-24)-Tetracosapeptide ', ' Corticotropin (1-24)-Peptide ', ' ACTH 1-24 ', ' 1-24-Corticotropin ', ' Cosyntropin ', ' Couples ', ' Dexamethasone ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' dietary ', ' Diet ', ' Food Intake ', ' Eating ', ' Metabolism and Endocrinology ', ' Endocrinology ', ' Environment ', ' balance function ', ' balance ', ' Equilibrium ', ' Fats ', ' Fatty acid glycerol esters ', ' Fatty Acids ', ' Feedback ', ' Female ', ' Food or Food Product ', ' Food ', ' Freezing ', ' Future ', ' Goals ', ' gonads ', ' gonad ', ' Gonadal structure ', ' Grant ', ' Health ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Hormones ', ' Hunger ', ' Proctocort ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' hypothalamic ', ' Hypothalamus ', ' Hypothalamic structure ', ' Industry ', ' insulin resistant ', ' Insulin Resistance ', ' Ketoconazole ', ' Laboratories ', ' Learning ', ' Therapeutic LH ', ' Recombinant Luteinizing Hormone ', ' Pituitary Lutenizing Hormone ', ' Lutropin ', ' Leuteinizing Hormone ', ' Interstitial Cell-Stimulating Hormone ', ' Interstitial Cell Stimulating Hormone ', ' Luteinizing Hormone ', ' gonadotropin releasing factor ', ' follicle stimulating hormone-releasing factor ', ' Therapeutic GRH ', ' Recombinant Gonadorelin ', ' Pulsti ', ' Luteinizing Hormone-Releasing Factor ', ' Luliberin ', ' LHFSH Releasing Hormone ', ' LH-Releasing Hormone ', ' LH-FSH Releasing Hormone ', ' Gonadotropin-Releasing Hormone ', ' Gonadorelinum ', ' Gonadoliberin ', ' FSH-Releasing Hormone ', ' Gonadotropin Hormone Releasing Hormone ', ' Los Angeles ', ' male ', ' Medicine ', "" men's "", ' men ', ' menopausal ', ' Female Change of Life ', ' Menopause ', ' Mentors ', ' Mentorship ', ' metabolism disorder ', ' Thesaurismosis ', ' Metabolic Disorder ', ' Metabolic Diseases ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Moods ', ' muscular ', ' Muscle Tissue ', ' Muscle ', ' muscle wasting ', ' muscle loss ', ' muscle deterioration ', ' muscle degradation ', ' muscle breakdown ', ' Muscle Atrophy ', ' Muscular Atrophy ', ' Osteoporosis ', ' Ovary ', ' Patients ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Pituitary Gland ', ' pituitary adrenal axis ', ' Pituitary-Adrenal System ', ' Production ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Sleep ', ' sleep loss ', ' sleep insufficiency ', ' sleep deficit ', ' sleep deficiency ', ' sleep debt ', ' insufficient sleep ', ' inadequate sleep ', ' deficient sleep ', ' Sleep Deprivation ', ' sleep disruption ', ' poor sleep ', ' impaired sleep ', ' disturbed sleep ', ' disrupted sleep ', ' aberrant sleep ', ' Sleep disturbances ', ' Stress ', ' Supervision ', ' Testing ', ' Trans-Testosterone ', ' Therapeutic Testosterone ', ' Testosterone ', ' Universities ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' Woman ', ' Work ', ' ganirelix ', ' Measures ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' base ', ' Left ', ' Clinical ', ' Physiological ', ' Physiologic ', ' Postmenopause ', ' postmenopausal ', ' post-menopausal ', ' Postmenopausal Period ', ' Post-menopausal Period ', ' Post-Menopause ', ' Link ', ' Anabolism ', ' biosynthesis ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Serum ', ' Blood Serum ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Fostering ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Reproductive Health ', ' Inflammation Mediators ', ' inflammatory mediator ', ' Funding ', ' Ethnic Origin ', ' Ethnicity ', ' metabolic abnormality assessment ', ' Metabolism Studies ', ' Metabolic Studies ', ' Abnormal Assessment of Metabolism ', ' Metabolic ', ' Impaired cognition ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Prediabetes syndrome ', ' prediabetic ', ' pre-diabetic ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Scientist ', ' bone age ', ' Hormonal ', ' Endocrine ', ' interest ', ' Infusion procedures ', ' Infusion ', ' pituitary gonadal axis ', ' Steroid biosynthesis ', ' steroidogenesis ', ' Manuscripts ', ' skills ', ' Endocrine Physiology ', ' expectation ', ' disorder risk ', ' disease risk ', ' Catabolism ', ' Statistical Methods ', ' Sleep Disorders ', ' sleep problem ', ' sleep dysregulation ', ' sleep dysfunction ', ' Modeling ', ' response ', ' sarcopenia ', ' sarcopenic ', ' patient oriented research ', ' patient oriented study ', ' insulin sensitivity ', ' Metabolic syndrome ', ' Virulence Factors ', ' Pathogenicity Factors ', ' diabetes risk ', ' Effectiveness ', ' preventing ', ' prevent ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Dose ', ' Data ', ' Midcareer Investigator Award in Patient-Oriented Research ', ' Midcareer Investigator Award in Patient-Oriented Research (K24) ', ' K24 Program ', ' K24 Mechanism ', ' Research Training ', ' Preparation ', ' Process ', ' sex ', ' Development ', ' developmental ', ' National Heart, Lung, and Blood Institute ', ' NHLBI ', ' age related ', ' age dependent ', ' diet and exercise ', ' Population ', ' aged ', ' older women ', ' older men ', ' Institutional Review Boards ', ' IRBs ', ' IRB ', ' healthy lifestyle ', ' healthy life-style ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' training opportunity ', ' experimental study ', ' experimental research ', ' experiment ', ' recruit ', ' Hormone secretion ', ' hormonal secretion ', ' hormonal signals ', ' hormone signals ', ' weight loss program ', ' weight loss programming ', ' Hormone imbalance ', ' hormonal imbalance ', ' cardiometabolism ', ' cardiometabolic ', ' sleep pattern ', ' Sex Differences ', ' sex-specific differences ', ' sex-related differences ', ' sex-dependent differences ', ' ']",NHLBI,LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER,K24,2019,119586,0.09683163010563556
"Lung-on-a-chip pulmonary fibrosis model for drug discovery LUNG-ON-A-CHIP PULMONARY FIBROSIS MODEL FOR DRUG DISCOVERY PROJECT SUMMARY Pulmonary fibrosis (PF) is a devastating disease characterized by excessive extracellular matrix (ECM) accumulation and associated scar formation that compromises breathing function and often leads to respiratory failure and death. There are multiple etiologies of PF, including environmental particles, radiation, and even certain antibiotics, but in most cases patients are diagnosed with idiopathic pulmonary fibrosis (IPF) where the specific trigger is unknown. There is no cure for IPF as current treatments are only capable of slowing lung damage, and prognosis is poor, with a median survival time of 2.5 to 3.5 years after diagnosis. A significant barrier to the development of PF therapeutics is interspecies differences in lung physiology and associated inflammatory and immune responses such that animal models do not sufficiently recapitulate certain aspects of the disease. Recent advances in human organs-on-chip (Organ Chip) microfluidic culture systems that recapitulate the multicellular architecture, tissue-tissue interfaces, mechanical environment (e.g., cyclic breathing motions), and vascular perfusion of major organ functional units have allowed for physiologically based evaluation of cell, environmental, and drug interactions within an organ-level context in vitro. We can utilize these Organ Chips to gain complementary data to animal models about the role of specific cellular contributions to PF development. Thus, the main goal of this proposal is to develop a human Organ Chip model of PF to better understand the mechanism of fibrosis development and progression, and to discover potential new therapeutics that could slow disease progression or reverse this deadly disease. This goal will be achieved with the following two aims: human PF Chips will be engineered with myofibroblasts from healthy donors and PF patients, with the addition of various environmental stimuli as well as potential inflammatory and immune contributors implicated in PF development (Aim 1), and transcriptomics data from these PF Chips will be compared to existing genomics literature data to identify drugs to use as potential PF therapeutics, prioritizing for clinically approved drugs that can be repurposed (Aim 2). This approach is innovative because it will be the first to incorporate all the major components of a human lung microenvironment critical for fibrosis development (human tissue-tissue interactions, breathing motions, perfusion, and environmental stimuli). Completion of these aims will enable analysis of the mechanism of PF development, with the capability to rapidly repurpose existing FDA- approved drugs as potentially life-saving PF therapeutics. PROJECT NARRATIVE Pulmonary fibrosis is a common and devastating disorder without effective pharmacological treatment options, leading to a median survival time of only 2.5 to 3.5 years after diagnosis. To complement animal research models for screening of potential therapeutics, we propose the development of a pulmonary fibrosis model using a cell-based platform that recapitulates the human lung microenvironment. The goals of this project are to determine the mechanisms of pulmonary fibrosis through characterization of the contribution of donor fibroblasts, environmental factors, and immune and inflammatory cell mediators, then use the knowledge of mechanistic elements to aid in the discovery of new therapeutics for treating pulmonary fibrosis.",Lung-on-a-chip pulmonary fibrosis model for drug discovery,9682914,F32HL146070,"['Animal Experimentation ', ' Animal Research ', ' Animal Experimental Use ', ' inhibitor/antagonist ', ' inhibitor ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Architecture ', ' Engineering / Architecture ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Bleomycin ', ' Bleo ', ' Blood Vessels ', ' vascular ', ' Cell Body ', ' Cells ', ' Scars ', ' Cicatrix ', ' Collagen ', ' Complement Proteins ', ' Complement ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Drug Modelings ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Elements ', ' Engineering ', ' Environment ', ' Epithelial Cells ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Fibroblasts ', ' Fibrosis ', ' -Ray ', ' -Radiation ', ' Gamma Radiation ', ' Gamma Rays ', ' Goals ', ' Modern Man ', ' Human ', ' In Vitro ', ' Institutes ', ' Literature ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' macrophage ', ' Fluorescence Light Microscopy ', ' Fluorescence Microscopy ', ' Motion ', ' Polymorphonuclear Neutrophils ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Cell ', ' Neutrophilic Leukocyte ', ' Neutrophilic Granulocyte ', ' Marrow Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Blood Neutrophil ', ' neutrophil ', ' Patients ', ' Perfusion ', ' Rhythmicity ', ' Cyclicity ', ' Periodicity ', ' Phenotype ', ' Physiology ', ' Prognosis ', ' outcome forecast ', ' Proteins ', ' lung alveolus ', ' Pulmonary Alveoli ', ' Pulmonary alveolar structure ', ' lung fibrosis ', ' Pulmonary Fibrosis ', ' social role ', ' Role ', ' Savings ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Upregulation ', ' Up-Regulation ', ' cytokine ', ' Measures ', ' Mediating ', ' Stromal Cells ', ' base ', ' Organ ', ' Clinical ', ' Physiological ', ' Physiologic ', ' Biochemical ', ' Evaluation ', ' Endothelial Cells ', ' Myofibroblast ', ' Stimulus ', ' Databases ', ' data base ', ' Data Bases ', ' Disease Progression ', ' lung injury ', ' Lung damage ', ' chemokine ', ' chemoattractant cytokine ', ' SIS cytokines ', ' Intercrines ', ' Homologous Chemotactic Cytokines ', ' Chemotactic Cytokines ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Exposure to ', ' Inflammatory ', ' Deposition ', ' Deposit ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Life ', ' Mechanics ', ' mechanical ', ' Immune ', ' Immunes ', ' human tissue ', ' System ', ' Particulate ', ' particle ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Drug Interactions ', ' Radiation ', ' Modeling ', ' response ', ' Genomics ', ' drug discovery ', ' Bioinformatics ', ' Bio-Informatics ', ' Respiratory Failure ', ' respiratory insufficiency/failure ', ' pulmonary failure ', ' Inflammatory Response ', ' fluidic ', ' Microfluidics ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Alveolar ', ' Systems Biology ', ' Data ', ' in vitro Model ', ' Pharmacological Treatment ', ' Development ', ' developmental ', ' innovation ', ' innovative ', ' innovate ', ' transcriptomics ', ' combinatorial ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' FDA approved ', ' screening ', ' human model ', ' idiopathic pulmonary fibrosis ', ' diffuse interstitial pulmonary fibrosis ', ' organ on a chip ', ' organ on chip ', ' ']",NHLBI,HARVARD UNIVERSITY,F32,2019,34725,0.052836580735895124
"An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD ! Abstract  Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death worldwide with a devastating socio-economic burden impacting more than three million individuals per year in the US. The primary environmental risk factor in the susceptible population is smoking, which causes an exaggerated inflammatory response. However, many factors including several genetic risk variants substantially influence the susceptibility. Twin-based studies show that families with emphysema have a higher risk for the disease. The two different major phenotypes of COPD are small airway remodeling (airway disease) and alveolar destruction (emphysema). Although these two major phenotypes result in a similar deficiency in global lung function, the relationship between them is complicated and likely involves feedback mechanisms. Developing an objective method to characterize lung phenotypes is critical since treatment candidates vary based on phenotype. Measurements from High-Resolution Computed Tomography (HRCT) images are increasingly used to describe COPD since they can quantitatively describe the contribution of the phenotypes. To discover the genetic risk variants, Genome-Association Studies (GWAS) have focused on either the physiological lung function or a simple threshold-based measurement from lung CT, neither of which fully characterizes phenotypic subtypes or the distribution pattern of disease. The proposed studies will take advantage of the rich image and genetic data jointly to build a genetically-informed imaging biomarker to characterize each patient. For each patient, our method summarizes the CT image to a vector representation that accurately describes the severity of the disease. Also, a method to link the representation back to the genetic risk variants will be developed. If successful, these methods can be used to monitor the efficacy of treatment or progression of the disease using imaging data. Successful execution of the second aim will result in better understanding of the etiology of different disease subtypes and discovery of novel genetic pathways that could be used as potential drug targets. Furthermore, the patient representation enables the use of image data to construct a more powerful model to predict the so-called acute exacerbation event. Predicting the exacerbations is clinically important since they cause further damage to the lung.  In Aim 1, we develop and implement a novel image biomarker that is mutually informed by imaging and genetic data from each patient. Our statistical method in Aim 2 elucidates the underlying genetic pathways behind the abnormal anatomical variations explained by the biomarker. We validate our method on data from 10,300 patients in the COPDGene dataset. ! Narrative  Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death worldwide with a devastating socio-economic burden impacting more than three million individuals per year in the US. Measurements from High-Resolution Computed Tomography (HRCT) images are increasingly used to describe COPD. Many factors including several genetic risk variants substantially influence the susceptibility. We propose to take advantage of the rich image and genetic data jointly to understand the underlying biological causes of the disease and discovery of novel genetic pathways that could be used as potential drug targets.",An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD,9692778,R01HL141813,"['Affect ', ' airway obstruction ', ' obstructed airway ', ' obstructed airflow ', ' airflow obstruction ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Back ', ' Dorsum ', ' Cause of Death ', ' Chronic Bronchitis ', ' Computers ', ' Disorder ', ' Disease ', ' Disease Vectors ', ' Family ', ' Feedback ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genome ', ' Genotype ', ' Goals ', ' Joints ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' Chronic Obstructive Airway Disease ', ' Math ', ' Mathematics ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Patients ', ' Phenotype ', ' emphysematous ', ' Emphysema ', ' Pulmonary Emphysema ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' Risk Factors ', ' Smoking ', ' Spirometry ', ' Time ', ' tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Twins ', ' Twin Multiple Birth ', ' Measures ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' Area ', ' Acute ', ' Clinical ', ' Variant ', ' Variation ', ' Biological ', ' Physiological ', ' Physiologic ', ' Link ', ' Predisposition ', ' Susceptibility ', ' lung lobe ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Descriptor ', ' Deformity ', ' Anatomical Abnormality ', ' Anatomic Abnormality ', ' Genetic ', ' clinical Diagnosis ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Pollution ', ' Dimensions ', ' Complex ', ' Event ', ' Pattern ', ' Severity of illness ', ' disease severity ', ' small airways disease ', ' attenuation ', ' novel ', ' economic cost ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' Statistical Methods ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' PFT/FEV1 ', ' Forced Expiratory Volume in 1 Second ', ' Forced Expiratory Volume 1 Test ', ' FEV1%VC ', ' FEV1 ', ' Modeling ', ' drug development ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Pathogenicity ', ' Inflammatory Response ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Address ', ' Data ', ' Economic Burden ', ' High Resolution Computed Tomography ', ' high resolution CT ', ' Resolution ', ' Genetic Risk ', ' Pathologic ', ' Monitor ', ' Process ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' Image ', ' imaging ', ' Pathway interactions ', ' pathway ', ' vector ', ' design ', ' designing ', ' airway remodeling ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Population ', ' alveolar destruction ', ' Heritability ', ' endophenotype ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' Drug Targeting ', ' Radiogenomics ', ' non-invasive imaging ', ' noninvasive imaging ', ' Lung CAT Scan ', ' Lung CT scan ', ' Lung CT ', ' CT Lung Screening ', ' imaging biomarker ', ' imaging-based marker ', ' imaging-based biomarker ', ' imaging-based biological marker ', ' imaging marker ', ' genotyped patients ', ' imaging genetics ', ' high dimensionality ', ' Airway Disease ', ' deep learning ', ' convolutional neural network ', ' convolutional neural nets ', ' ConvNet ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2019,564472,0.07328307427471549
"Lung Navigation System for Localizing and Resecting Nodules Project Abstract  Although Wedge Resection Surgery results in better lung function, tumor recurrence rate is almost double that of lobectomy, with significantly poorer 5-year survival rates. This may be attributed to the difficulty in accurately localizing and resecting the nodules in a deflated lung. Currently, there is no effective method of accurately localizing the nodules and guiding the surgical stapling device to the optimal resection margin. The long-term goal of this research is to investigate algorithms and technologies to manage lung nodules from diagnosis to surgical resection. The objective of this proposal is to design and develop a lung navigation (LungNav) system to localize and excise, with sufficient margin, small and early malignant lung nodules. The experimental methods will be to design and develop the LungNav system integrated with an active nodule tracker called J-bar, machine learning algorithms for determining the optimal resection margin, and tracked surgical stapling device for accurately excising the nodule. Tumor deformation algorithms and augmented reality displays will be developed to visualize the nodule on thoracosopy videos and guide the surgical stapler in real-time to the optimal margin. The hypothesis is that by anchoring the J-bar close to the nodule, the nodule position can be accurately tracked in real-time despite significant tissue deformation when the lung is collapsed and manipulated during surgery. To achieve the goals of this project, we will pursue the following specific aims: 1) Design and develop the nodule tracker (J-bar) and deformation algorithms to estimate the real-time position of the nodule. 2) Investigate a machine-learning approach based on convolutional neural networks (CNN) to determine the optimal resection margin. 3) Design and develop a software navigation module, called LungNav, for visualizing the tumor and navigating the surgical stapler to the optimal resection margin. 4) Validate the design and performance of the LungNav system using ex-vivo lung tissue and live porcine models. The proposed research is significant since it addresses an important problem, which potentially affects several thousand patients each year, of accurately localizing and resecting lung nodules while preserving healthy lung function. The research is innovative since it builds on state-of-the-art machine learning algorithms, navigation systems and augmented reality methods to accurately diagnose and localize the nodule in presence of significant tissue deformation. The expected outcome of the project is the development of CNN-based machine learning algorithms for lung nodule classification and a LungNav system with tumor deformation algorithms and augmented reality methods to localize and guide complete surgical resection of lung nodules. Project Narrative ! The proposed research is significant since it addresses an important problem, which potentially affects several thousand patients each year, of accurately localizing and resecting lung nodules while preserving healthy lung function. The research is innovative since it builds on state-of-the-art machine learning algorithms, navigation systems and augmented reality methods to accurately diagnose and localize the nodule in presence of significant tissue deformation. !",Lung Navigation System for Localizing and Resecting Nodules,9786235,R01EB025964,"['Affect ', ' Algorithms ', ' Systematics ', ' Classification ', ' Clinical Trials ', ' Diagnosis ', ' Electromagnetic ', ' Electromagnetics ', ' Goals ', ' Health Care Systems ', ' Healthcare Systems ', ' Lobectomy ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Methods ', ' Nodule ', ' Patents ', ' Legal patent ', ' Patients ', ' pulmonary nodule ', ' Lung nodule ', ' Recurrent ', ' Recurrence ', ' Research ', ' respiratory function ', ' lung function ', ' Respiratory physiology ', ' Software ', ' Computer software ', ' Surgical Staplers ', ' Survival Rate ', ' suid ', ' porcine ', ' Swine ', ' Suidae ', ' Pigs ', ' Family suidae ', ' Technology ', ' TRSCPY ', ' Pleuroscopy ', ' Pleural Endoscopy ', ' Thoracoscopy ', ' Time ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Measures ', ' Imagery ', ' Visualization ', ' base ', ' sensor ', ' Thoracoscopes ', ' Pleuroscopes ', ' Surface ', ' Malignant - descriptor ', ' Malignant ', ' Phase ', ' Surgical margins ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' lung cancer screening ', ' lung cancer early detection ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' System ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' Surgical Staples ', ' Surgical Stapling ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Surgeon ', ' particle ', ' Performance ', ' novel ', ' Devices ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Positioning Attribute ', ' Position ', ' Structure of parenchyma of lung ', ' Lung Tissue ', ' Lung Parenchyma ', ' Modeling ', ' cancer diagnosis ', ' Address ', ' low-dose spiral CT ', ' low-dose helical computed tomography ', ' low-dose CT ', ' low dose computed tomography ', ' Development ', ' developmental ', ' cost ', ' design ', ' designing ', ' Outcome ', ' Navigation System ', ' innovation ', ' innovative ', ' innovate ', ' Early treatment ', ' early therapy ', ' open source ', ' Network-based ', ' tumor ', ' minimally invasive ', ' arm ', ' screening ', ' accurate diagnosis ', ' Augmented Reality ', ' preservation ', ' convolutional neural network ', ' convolutional neural nets ', ' ConvNet ', ' machine learning algorithm ', ' deep learning algorithm ', ' off-patent ', ' ']",NIBIB,BRIGHAM AND WOMEN'S HOSPITAL,R01,2019,402750,0.10601535364540948
"Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study ABSTRACT Short sleep duration, insomnia disorder, and sleep apnea are all highly prevalent in the US population and are associated with significant morbidity, including poor mental health, impaired neurocognitive function, metabolic dysregulation, and cardiovascular disease. In the context of the high prevalence of pernicious sleep disturbances, there is evidence that sleep disparities exist in the population, such that racial/ethnic minorities  including Mexican-Americans  are at increased risk of sleep disturbances. This is alarming, since this group is also at increased risk for many of the adverse cardiometabolic and functional outcomes linked to sleep disturbances. These associations may be influenced by economic hardship, psychosocial stress, unhealthy behaviors (diet, exercise, alcohol, and smoking), and acculturation  the degree to which an individual adopts (in this case) traditional Mexican versus American culture. The first goal of this project is to examine sleep duration, insomnia symptoms, and sleep apnea severity among Mexican-Americans and examine the role of these social-behavioral factors in this relationship. Second, this study aims to examine the role of sleep and cardiometabolic disease risk in this population and explore the role of acculturation, psychosocial stress, economic hardship, and/or unhealthy behaviors in these associations. To accomplish this, this project will partner with the Mariposa Community Health Center, the federally qualified clinic in the Nogales, AZ area. Nogales is a small city on the US/Mexico border that is an ideal location for studying non-urban Mexican- Americans, as it is made up of 83% Hispanics/Latinos, 33% immigrants, and 77% who primarily speak Spanish at home. This community-engaged project will partner with Mariposa and their Platicamos Salud program that uses experienced Community Health Workers (promotoras de salud) to collect data and perform home visits. The study will recruit N=900 Mexican-Americans and N=200 Non-Hispanic Whites to complete a battery of assessments from a clinic visit (questionnaires, interviews, exam for anthropometry and arterial stiffness, and collection of biomarkers), a 1-night home sleep apnea assessment, a 24-hour ambulatory blood pressure recording, and a 2-week home monitoring period with sleep diary and actigraphy. This will result in a rich dataset that can help to identify and reduce sleep disparities in the population and point to potential intervention approaches to reducing cardiometabolic disease disparities. The analytic plan will take advantage of a machine-learning analytic approach, which will be used to evaluate the complex relationships among all of these variables. This project will address many relevant issues in sleep medicine, health disparities research, and border health. The partnership with Mariposa will enhance recruitment, promote research integrity (or ensure appropriateness of research methods), and facilitate dissemination of the study results into the community through education programs associated with Platicamos Salud and other community outreach efforts. PROJECT NARRATIVE The primary goal of this study is to assess sleep health among Mexican-Americans at the US/Mexico border, characterize relationships with cardiometabolic disease risk, and investigate the role of social-environmental factors including acculturation, stress, socioeconomics, and health behaviors. Short sleep duration, insomnia disorder, and sleep apnea are highly prevalent in the population. These conditions are associated with cardiovascular disease, diabetes, daytime functioning problems, and poor mental health. Disparities in sleep health in racial/ethnic minorities exist, including Mexican-Americans. In particular, social-environmental factors at the US-Mexico border may play an important role in sleep health disparities. This project will not only allow for increased understanding of the complex relationship among sleep, health, and social-environmental pressures, but through a community partnership it can maximize our ability to reduce these disparities. Also, this project has the added benefit of providing information about the role of sleep as a potentially modifiable factor in cardiovascular disease and diabetes disparities as well.",Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study,9672598,R01MD011600,"['Acculturation ', ' Cultural Assimilation ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Anthropometry ', ' Behavior ', ' Blood Pressure ', ' Blood Vessels ', ' vascular ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cities ', ' Clinic Visits ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' Community Developments ', ' community health worker ', ' Community Health Aides ', ' diabetes ', ' Diabetes Mellitus ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' Economics ', ' Educational aspects ', ' Education ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Health behavior ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' indexing ', ' Inflammation ', ' Interview ', ' Lipids ', ' alpha-Lipoproteins ', ' High density lipoprotein ', ' Heavy Lipoproteins ', ' HDL Lipoproteins ', ' HDL ', ' High Density Lipoproteins ', ' beta-Lipoprotein Cholesterol ', ' Low Density Lipoprotein Cholesterol ', ' LDL Cholesterol ', ' LDL Cholesterol Lipoproteins ', ' Medicine ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Mexico ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Phenotype ', ' Play ', ' Poverty ', ' pressure ', ' Questionnaires ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Sleep ', ' sleep-related breathing disorder ', ' Sleep-Disordered Breathing ', ' Sleep Hypopnea ', ' Sleep Apnea ', ' Sleep Apnea Syndromes ', ' sleep loss ', ' sleep insufficiency ', ' sleep deficit ', ' sleep deficiency ', ' sleep debt ', ' insufficient sleep ', ' inadequate sleep ', ' deficient sleep ', ' Sleep Deprivation ', ' sleep disruption ', ' poor sleep ', ' impaired sleep ', ' disturbed sleep ', ' disrupted sleep ', ' aberrant sleep ', ' Sleep disturbances ', ' Smoking ', ' social support network ', ' Social support ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' Work ', ' triacylglycerol LDL ', ' LDL triglyceride lipoprotein ', ' LDL triglyceride ', ' low density lipoprotein triglyceride ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' Satellite Centers ', ' Community Health Centers ', ' Neighborhood Health Center ', ' Research Methods ', ' Research Methodology ', ' Dataset ', ' Data Set ', ' base ', ' sample collection ', ' specimen collection ', ' Area ', ' Link ', ' Ensure ', ' Physical activity ', ' caucasian American ', ' white American ', ' Serum ', ' Blood Serum ', ' Individual ', ' Mexican ', ' Ethnic Origin ', ' Ethnicity ', ' Community Outreach ', ' Immigrant ', ' Metabolic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' diaries ', ' programs ', ' Adopted ', ' Hour ', ' Severities ', ' Complex ', ' Home environment ', ' Home ', ' Clinic ', ' Location ', ' Obstructive Sleep Apnea ', ' Syndrome, Sleep Apnea, Obstructive ', ' American ', ' experience ', ' stressor ', ' arterial stiffness ', ' artery stiffness ', ' artery stiffening ', ' arterial stiffening ', ' Participant ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' social ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Regulation ', ' Modeling ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' actigraph ', ' actigraphy ', ' disparity in health ', ' health disparity ', ' Address ', ' Symptoms ', ' Data ', ' High Prevalence ', ' Intake ', ' Collection ', ' Not Hispanic or Latino ', ' Nonhispanic ', ' Non-Hispanic ', ' Monitor ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' Behavioral ', ' Home visitation ', ' home visit ', ' House Call ', ' Neurocognitive Deficit ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' food security ', ' diet and exercise ', ' functional outcomes ', ' Outcome ', ' Population ', ' Prevalence ', ' Psychosocial Stress ', ' modifiable risk ', ' ethnic minority population ', ' ethnic minority ', ' racial and ethnic ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' community partnership ', ' disparity reduction ', ' reduce disparity ', ' recruit ', ' health assessment ', ' sleep health ', ' sleep hygiene ', ' cardiometabolism ', ' cardiometabolic ', ' sleep behavior ', ' sleep habit ', ' perceived stress ', ' ']",NIMHD,UNIVERSITY OF ARIZONA,R01,2019,717643,0.14299264733359784
"The Detection, Quantification, and Management of Ventilator Dyssynchrony Project Summary/Abstract Despite significant advances in ventilator management, mortality from the acute respiratory distress syn- drome (ARDS) remains unacceptably high. Mechanical ventilation with large tidal volume, high pressure ven- tilation, and repeated alveolar collapse can injure the lung, called ventilator induced lung injury (VILI). Defined as the inappropriate timing and delivery of a breath in response to a patient effort, ventilator dyssynchrony (VD) may potentiate VILI. This proposal outlines a 5-year training programing including mentoring, formal didactics, and practical research experiences which positions Dr. Sottile for a successful clinical research career examining ventilator dyssynchrony (VD), its impact on ventilator induced lung injury (VILI), and its optimal management. An integrated curriculum will optimize an automated VD detection algorithm, delineate which types of VD are deleterious, and determine the ideal ventilator and sedation strategies to minimize VD and improve patient outcomes. This experience will provide Dr. Sottile with the necessary tools to be a leader in signal analysis, ventilator dyssynchrony, advanced mathematical modeling, and critical care research. This program will consist of formal mentoring from four renowned experts in machine learning, mechanical ventilation, critical care research, and modeling of dynamic systems. In addition, coursework in clinical sciences, machine learning, and advanced mathematical modeling will build the theoretical foundation to apply these techniques. This structured curriculum will help Dr. Sottile gain expertise in the computerized detection of VD from real-time ventilator data, the pathophysiology of VD, and the modeling of complex, temporally dynamic, biological systems. The formal curriculum will coincide with three practical experiences. First, Dr. Sottile will optimize his already developed VD identification algorithm to detect additional types of VD that may be injurious to the lung. Second, he will identify which types of VD are associated with deleterious ventilator mechanics. Finally, he will deter- mine the personalized ventilator and sedation strategies to minimize VD, VILI, and the negative consequences of over sedation using linear optimization and lagged linear correlation to account for the dynamic nature of patient physiology. The result of the proposed studies will develop a computerized algorithm to detect seven types of VD, identify which types of VD are most likely to propagate VILI, and determine the optimal ventilator and sedation strategies to improve individual patient outcomes. This will leave Dr. Sottile and the study team positioned to conduct a randomized clinical trial comparing computer-predicted individualized ventilator and se- dation strategies compared to the current standard of care. If successful, this will potentially to revolutionize the use of mechanical ventilation by tailoring evidenced-based therapies to the individual patient. Project Narrative Despite over 50 years of research, the acute respiratory distress syndrome (ARDS) accounts of over 10% of ICU admissions. Despite current treatment strategies focused on reducing ventilator induced lung injury through low tidal volume ventilation or prone position, mortality remains over 30%. This proposal seeks to understand how patient-ventilator interactions may propagate lung injury and will determine optimal treatment strategies to improve patient- ventilator interactions, decrease lung injury, and improve patient outcomes.","The Detection, Quantification, and Management of Ventilator Dyssynchrony",9846014,K23HL145011,"['Accounting ', ' Algorithms ', ' Dysbarism ', ' Barotrauma ', ' Clinical Research ', ' Clinical Study ', ' Computers ', ' Critical Care ', ' Educational Curriculum ', ' Curriculum ', ' lesson plans ', ' Endothelium ', ' Epithelium ', ' Epithelium Part ', ' Esophagus ', ' Foundations ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Manometry ', ' Manometry Biochemistry ', ' Mathematics ', ' Math ', ' Mentors ', ' mortality ', ' Patients ', ' Physiology ', ' pressure ', ' Prone Position ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Adult Respiratory Distress Syndrome ', ' ARDS ', ' Acute Respiratory Distress ', ' Acute Respiratory Distress Syndrome ', ' Adult ARDS ', ' Adult RDS ', ' Da Nang Lung ', ' Shock Lung ', ' Stiff lung ', ' wet lung ', ' Risk ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Technology ', ' Tidal Volume ', ' respiratory airway volume ', ' Time ', ' Training Programs ', ' Measures ', ' surrogate bio-markers ', ' surrogate biomarkers ', ' Surrogate Markers ', ' Outcomes Research ', ' Ventilator ', ' injuries ', ' Injury ', ' career ', ' improved ', ' mechanical respiratory assist ', ' Mechanical ventilation ', ' Clinical ', ' Randomized Clinical Trials ', ' Epithelial ', ' esophageal pressure ', ' esophagus pressure ', ' Neuromuscular Block ', ' Neuromuscular Blockade ', ' Induction of neuromuscular blockade ', ' Individual ', ' Lung damage ', ' lung injury ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' tool ', ' sedation ', ' Sedation procedure ', ' Nature ', ' machine learned ', ' Machine Learning ', ' programs ', ' mechanical ', ' Mechanics ', ' Complex ', ' Techniques ', ' System ', ' interest ', ' experience ', ' Structure ', ' Time Series Analysis ', ' Position ', ' Positioning Attribute ', ' Admission ', ' Admission activity ', ' Modeling ', ' response ', ' Math Models ', ' mathematic model ', ' mathematical modeling ', ' mathematical model ', ' Alveolar ', ' Data ', ' Detection ', ' Research Infrastructure ', ' Clinical Data ', ' Clinical Sciences ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Monitor ', ' computerized ', ' Ventilator-induced lung injury ', ' Outcome ', ' multidisciplinary ', ' trial comparing ', ' evidence base ', ' standard of care ', ' treatment strategy ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biological systems ', ' dynamical system ', ' dynamic system ', ' individual patient ', ' individualized strategies ', ' personalized strategies ', ' improved outcome ', ' Individualized Predictors ', ' individualized predictions ', ' personalized predictors ', ' personalized predictions ', ' optimal therapies ', ' optimal treatments ', ' machine learned algorithm ', ' machine learning algorithm ', ' ventilation ', ' ']",NHLBI,UNIVERSITY OF COLORADO DENVER,K23,2020,170640,0.05824601796995617
"The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites Project Summary/Abstract Background: Blacks have higher rates of cardiovascular disease (CVD), CVD risk markers (elevated blood pressure, cholesterol, and unhealthy glucose levels), and CVD mortality, compared to whites. Despite advances in understanding how CVD disparity is engendered and preventing CVD, blacks compared to whites are still disproportionately burdened by CVD, particularly CVD risk markers. Therefore, more novel targets that drive racial disparity in CVD risk markers must be investigated in order to reduce and eliminate CVD disparity. Evidence indicating that insufficient sleep (sleep duration 6hrs/24 hr. cycle), which disproportionately affects blacks, is linked to concurrent and future CVD risk may offer a potentially novel mechanism explaining CVD risk disparity between blacks and whites. However, it is unclear whether insufficient sleep directly or indirectly drives disparity in CVD risk between blacks and whites? Therefore, the purpose of the proposed K01 study is to investigate whether insufficient sleep independently explains a significant portion of racial disparity in CVD risk markers, while adjusting for the confounding effects of sleep apnea and insomnia (two sleep disorders that cause insufficient sleep). Additionally, since 55% of insufficient sleepers are obese and blacks are twice as likely to be obese compared to whites, the candidate will investigate the independent and combined effects of insufficient sleep and obesity on the disparity in CVD risk markers between blacks and whites. Research: In the proposed K01, the candidate, Dr. Azizi Seixas, will investigate: 1) whether insufficient sleep and/or obesity play an important role in the relationship between race/ethnicity and CVD risk, controlling for sleep apnea and insomnia; and 2) what sleep duration and body mass index profile is associated with lowest probability of CVD risk among blacks and whites, using advanced mathematical analytic methods and complex system simulation modeling. Training: The training plan builds upon the candidate's background and experience in conducting research in sleep disorders and cardiovascular disease (e.g. hypertension and stroke), among minority populations. During the K01, the candidate will receive training in sleep science and physiology, cardiovascular disease and advanced analytical, machine learning, and simulation modeling. He will perform secondary analyses of data from the Sleep Heart Health Study, a NHLBI-funded study. The pedagogical approach includes one-on-one mentorship, course work, mentored laboratory training (practicum), and attendance to targeted conferences and seminars, with the common goal of supporting his transition to being an independent scientist. Project Narrative The overarching objective of this K01 career development award is to foster the transition of Dr. Azizi Seixas into an independent scientist in the area of sleep and cardiovascular disease and health disparities. The proposed study will investigate a novel mechanism underlying associations between insufficient sleep, obesity, and disparity in CVD risk markers between blacks and whites. Findings from the study will be the basis of sleep and obesity interventions to reduce CVD risk, especially among diverse groups burdened by cardiovascular disease.",The effect of insufficient sleep on cardiovascular disease disparity between blacks and whites,9841428,K01HL135452,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Age ', ' ages ', ' Blood Pressure ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Cholesterol ', ' Cohort Studies ', ' Concurrent Studies ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Environment ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Future ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Glucose Intolerance ', ' Goals ', ' Health Services Research ', ' Health Services Evaluation ', ' Medical Care Research ', ' services research ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Life Style ', ' Lifestyle ', ' Mathematics ', ' Math ', ' Mentors ', ' Mentorship ', ' Methodology ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Physiology ', ' Play ', ' Probability ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk Factors ', ' Role ', ' social role ', ' Science ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Work ', ' conference ', ' convention ', ' summit ', ' symposia ', ' symposium ', ' Mediating ', ' Caring ', ' Task Forces ', ' advisory team ', ' Advisory Committees ', ' analytical method ', ' base ', ' Site ', ' Area ', ' Biological ', ' Medical ', ' Link ', ' Training ', ' Failure ', ' Bayesian computation ', ' Bayesian inference ', ' Bayesian network analysis ', ' Bayesian spatial analysis ', ' Bayesian statistical analysis ', ' Bayesian statistical inference ', ' Bayesian statistics ', ' Bayesian Analysis ', ' Fostering ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' machine learned ', ' Machine Learning ', ' Scientist ', ' Complex ', ' System ', ' Syndrome, Sleep Apnea, Obstructive ', ' Obstructive Sleep Apnea ', ' Equation ', ' experience ', ' Structure ', ' Disease Outcome ', ' novel ', ' model-based simulation ', ' models and simulation ', ' Reporting ', ' sleep diseases ', ' sleep dysfunction ', ' sleep dysregulation ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Risk Reduction ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' BMI percentile ', ' BMI z-score ', ' Quetelet index ', ' Body mass index ', ' Address ', ' Data ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Risk Marker ', ' developmental ', ' Development ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' after stroke ', ' poststroke ', ' post stroke ', ' under served population ', ' underserved people ', ' Underserved Population ', ' Minority ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' fasting glucose ', ' social health determinants ', ' Bayesian adaptive designs ', ' Bayesian adaptive models ', ' Bayesian belief network ', ' Bayesian belief updating model ', ' Bayesian framework ', ' Bayesian hierarchical model ', ' Bayesian network model ', ' Bayesian nonparametric models ', ' Bayesian spatial data model ', ' Bayesian spatial image models ', ' Bayesian spatial models ', ' Bayesian statistical models ', ' Bayesian tracking algorithms ', ' Bayesian Modeling ', ' disparities in race ', ' race disparity ', ' racial disparity ', ' cardiovascular health ', ' pedagogical approach ', ' pedagogical development ', ' pedagogical method ', ' pedagogical content ', ' lab experience ', ' lab training ', ' laboratory training ', ' laboratory experience ', ' stroke survivor ', ' reduce disparity ', ' disparity reduction ', ' Heart health ', ' Cardiac health ', ' secondary analysis ', ' sleep physiology ', ' advanced analytics ', ' Comparative Effectiveness Research ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,K01,2020,179820,0.13071578339539583
"Mechanisms of sleep deficiency and effects on brain injury and neurocognitive functions among older blacks Project Summary Translational studies showing a mechanistic interplay between Alzheimers disease (AD) pathogenesis and sleep/circadian disruption has renewed interest in the maxim sleep is of the brain, by the brain, and for the brain. Relative to adults sleeping well, those exhibiting sleep deficiency (SD), defined as poor sleep, sleep apnea, and/or circadian misalignment, have greater AD risk (OR=1.55), cognitive decline (OR=1.68), or preclinical AD (OR=3.78). Since SD is observed early in the course of AD, it constitutes a prime target for prevention. Notwithstanding successes in delineating the mechanisms and functions of sleep, a critical gap remains in elucidating factors undergirding sleep disparities among blacks, marked by a greater AD risk burden. Blacks also shoulder a greater sleep burden as evidenced by a higher prevalence of the main SD indices, which are linked to increased vascular risks, inflammation, brain injury, and cognitive impairment. The multi-disciplinary team will utilize innovative dynamic and geospatial modeling in a multi-level framework to delineate the psychosocial and environmental determinants of SD and its putative effects on the brain health of older blacks. We will leverage the success of the NYU Sleep Disparity Workgroup, comprising investigators with expertise in aging research, translational sleep and circadian sciences, brain health, health disparities, and geospatial and multi-level dynamic modeling. We will leverage the social capital and assets of our Community Steering Committee to enroll 504 blacks (60-75 years) from traditional and non-traditional venues to capture study endpoints. We will investigative the following aims: 1) To ascertain the psychosocial (social/emotional support, mood, discrimination, attitudes) and environmental (household [density, noise, air quality, light, and temperature], socioeconomic position, social capital, neighborhood [built environment]) factors that are associated with SD; 2) To assess effects of SD on markers of brain injury (Hcy, NFL, GFAP, Tau & Amyloid- peptides) and on neurocognitive functions (attention, language, memory, and executive function using the Preclinical Alzheimer Cognitive Composite and Trail Making Test). The contributions of vascular risk (obesity, BP, lipid, and glucose/HbA1C) and inflammation (IL-6, IL-10, and TNF-) will be weighted; 3) To characterize blacks who are at increased risk of SD using Bayesian machine-learning modeling and forecast through Agent-Based modeling which amalgamation of psychosocial and environmental changes will lead to a reduced SD burden and related brain health profile among older blacks over time (5, 10, & 20 yrs.). The investigative team will use novel home-based digital recorders, innovative brain health biomarkers, geospatial analytics and dynamic systems modeling to describe the mechanisms of SD and delineate their potential role in explaining observed disparities in markers of brain health of older blacks. Project Narrative Despite the high risk for sleep-related morbidity, there is a paucity of data on sleep-disrupting psychosocial and environmental stressors associated with sleep deficiency (poor sleep, sleep apnea, and/or circadian misalignment) among older blacks. Our multi-disciplinary team will use novel mHealth devices recording sleep/activity cycles, light, noise, air quality, temperature, and greenspace exposure; novel brain biomarkers; and geospatial analytics to assess effects on sleep deficiency and delineate their role in explaining disparities in the brain and cognitive health of older blacks.",Mechanisms of sleep deficiency and effects on brain injury and neurocognitive functions among older blacks,9976783,R01AG067523,"['Activity Cycles ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Aging ', ' Air ', "" Alzheimer's Disease "", ' AD dementia ', ' Alzheimer ', ' Alzheimer Type Dementia ', ' Alzheimer disease ', ' Alzheimer sclerosis ', ' Alzheimer syndrome ', "" Alzheimer's "", "" Alzheimer's disease dementia "", ' Alzheimers Dementia ', ' Alzheimers disease ', ' Primary Senile Degenerative Dementia ', ' dementia of the Alzheimer type ', ' primary degenerative dementia ', ' senile dementia of the Alzheimer type ', ' Attention ', ' Attitude ', ' Award ', ' Blood Vessels ', ' vascular ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Communities ', ' Discrimination ', ' Cognitive Discrimination ', ' Exhibits ', ' Glial Fibrillary Acidic Protein ', ' Astroprotein ', ' GFA-Protein ', ' GFAP ', ' Glial Fibrillary Acid Protein ', ' Glial Intermediate Filament Protein ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Health ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Household ', ' indexing ', ' Inflammation ', ' Interleukin-6 ', ' B cell differentiation factor ', ' B cell stimulating factor 2 ', ' B-Cell Differentiation Factor ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Stimulatory Factor-2 ', ' BCDF ', ' BSF-2 ', ' BSF2 ', ' HPGF ', ' Hepatocyte-Stimulating Factor ', ' Hybridoma Growth Factor ', ' IFN-beta 2 ', ' IFNB2 ', ' IL-6 ', ' IL6 Protein ', ' MGI-2 ', ' Myeloid Differentiation-Inducing Protein ', ' Plasmacytoma Growth Factor ', ' interferon beta 2 ', ' Language ', ' Leadership ', ' Light ', ' Photoradiation ', ' Lipids ', ' Aphorisms ', ' Maxim ', ' Memory ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Moods ', ' Morbidity - disease rate ', ' Morbidity ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Neighborhoods ', ' Nerve Degeneration ', ' Neuron Degeneration ', ' neural degeneration ', ' neurodegeneration ', ' neurodegenerative ', ' neurological degeneration ', ' neuronal degeneration ', ' Noise ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Psychosocial Factor ', ' psychosocial variables ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Shoulder ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Temperature ', ' Time ', ' Trail Making Test ', ' Amyloid beta-Protein ', ' Alzheimer beta-Protein ', "" Alzheimer's Amyloid beta-Protein "", "" Alzheimer's amyloid "", "" Amyloid Alzheimer's Dementia Amyloid Protein "", ' Amyloid Beta-Peptide ', ' Amyloid Protein A4 ', ' Amyloid  ', ' Amyloid -Peptide ', ' Amyloid -Protein ', ' A ', ' a beta peptide ', ' abeta ', ' amyloid beta ', ' amyloid-b protein ', ' beta amyloid fibril ', ' soluble amyloid precursor protein ', ' Interleukin-10 ', ' CSIF ', ' CSIF-10 ', ' Cytokine Synthesis Inhibitory Factor ', ' IL-10 ', ' IL10 ', ' IL10A ', ' Interleukin 10 Precursor ', ' tau Proteins ', ' MT-bound tau ', ' microtubule bound tau ', ' microtubule-bound tau ', ' tau ', ' tau factor ', '  Proteins ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' base ', ' career ', ' density ', ' Area ', ' Physiologic ', ' Physiological ', ' Link ', ' Acquired brain injury ', ' brain damage ', ' brain-injured ', ' Brain Injuries ', ' Genetic ', ' Exposure to ', ' tool ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' cognitive function ', ' Home ', ' Home environment ', ' Neurocognitive ', ' psychosocial ', ' interest ', ' environmental stressor ', ' experience ', ' success ', ' novel ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Prevention ', ' Devices ', ' Pathogenesis ', ' social ', ' (TNF)- ', ' Cachectin ', ' Macrophage-Derived TNF ', ' Monocyte-Derived TNF ', ' TNF ', ' TNF A ', ' TNF Alpha ', ' TNF- ', ' TNFA ', ' TNF ', ' Tumor Necrosis Factor ', ' Tumor Necrosis Factor-alpha ', ' TNF gene ', ' circadian abnormality ', ' circadian disruption ', ' circadian disturbance ', ' circadian dysfunction ', ' circadian impairment ', ' Circadian Dysregulation ', ' Emotional ', ' sleep diseases ', ' sleep dysfunction ', ' sleep dysregulation ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' neuropathology ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' executive control ', ' executive function ', ' disparity in health ', ' health disparity ', ' Address ', ' social capital ', ' Data ', ' High Prevalence ', ' Strategic Planning ', ' Cognitive ', ' enroll ', ' Enrollment ', ' Translational Science ', ' translation research ', ' Translational Research ', ' preclinical ', ' pre-clinical ', ' environmental change ', ' age dependent ', ' age related ', ' digital ', ' IQ Deficit ', ' intelligence quotient deficit ', ' neurocognitive decline ', ' neurocognitive impairment ', ' Neurocognitive Deficit ', ' Outcome ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' ethnic minority ', ' ethnic minority population ', ' multidisciplinary ', ' translational study ', ' racial and ethnic ', ' Alzheimer risk factor ', ' alzheimer risk ', "" Alzheimer's disease risk "", ' multidisciplinary approach ', ' interdisciplinary approach ', ' high risk ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' m-Health ', ' mobile health ', ' mHealth ', ' vascular contributions ', ' precision interventions ', ' personalized intervention ', ' built environment ', ' dynamical system ', ' dynamic system ', ' greenspace ', ' Green space ', ' brain health ', ' reduce disparity ', ' disparity reduction ', ' circadian desynchronization ', ' circadian misalignment ', ' Circadian desynchrony ', ' circadian ', ' Bayesian machine learning ', ' Bayesian learning ', "" Alzheimer's brain "", "" Alzheimer's disease brain "", ' ']",NIA,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2020,833876,0.018066563675453527
"Using natural language processing and machine learning to identify potentially preventable hospital admissions among outpatients with chronic lung diseases Project Summary Patients living with chronic lung diseases (CLDs) are frequently admitted to the hospital for potentially preventable causes. Such admissions may be discordant with patient preferences and/or represent a low-value allocation of health system resources. To anticipate such admissions, existing clinical prediction models in this eld typically produce an all-cause risk estimate which, even if accurate, overlooks the actionable mechanisms behind admis- sion risk and therefore fails to identify a prescribed response. This limitation may explain the only modest  at best  reductions in hospital admissions and readmissions seen in most intervention bundles that have been tested in this population. An opportunity exists, therefore, to predict hospitalization risk while simultaneously identifying patient phenotypes (i.e. some constellation of social, demographic, clinical, and other characteristics) for which known preventive interventions exist. The proposed study seeks to overcome these limitations and capitalize on this opportunity by (1) conducting semi-structured interviews with hospitalized patients with CLDs, and their caregivers and clinicians, to directly identify modiable risks and their associated phenotypes driving hospital ad- missions; (2) using natural language processing techniques (NLP) to build classication models that will leverage nuanced narrative, social, and clinical information in the unstructured text of clinical encounter notes to identify patients with these phenotypes; and (3) building risk prediction model focused on actionable phenotypes with a wide-array of traditional regression and machine learning approaches while also incorporating large numbers of predictor variables from text data and accounting for time-varying trends. The candidate's preliminary work using basic NLP techniques to signicantly improve the discrimination of clinical prediction models in an inpatient population has motivated this methodologic approach. The rising burden and costs of hospitalizations associated with CLDs, and the increasing attention from federal payers, highlights the critical nature of this work. Completion of this research will build upon the candidate's past training, which includes a Masters of Science in Health Policy Research obtained with NHLBI T32 support, and will provide the experience, education, and mentorship to allow the candidate to become a fully independent investigator. Based on the candidate's tailored training plan, he will acquire advanced skills in mixed-methods research, NLP, and trial design all through coursework, close men- toring and supervision, and direct practice. The skills will position him ideally to submit successful R01s testing the deployment of the proposed clinical prediction models in real-world settings. The candidate's primary mentor, collaborators, and advisors will ensure adherence to the proposed timeline and goals and provide a support- ive environment for him to develop an independent research career testing the real-world deployment of clinical prediction models to reduce low-value and preference-discordant care for patients with CLDs. Project Narrative Every year many people living with chronic lung diseases are admitted to the hospital despite the fact that some of these admissions may have been prevented with early identication and intervention prior to the hospitalization. Previous attempts at preventing such hospitalizations have been limited by their ability to both accurately identify those at risk, and because most risk models do not provide a reason for the likely admission. The proposed work draws directly on the experiences of patients with chronic lung diseases who are admitted to a hospital, and then uses cutting edge statistical and computer science techniques to use information in the electronic health record to accurately predict the risk and the likely reason for future hospital admissions.",Using natural language processing and machine learning to identify potentially preventable hospital admissions among outpatients with chronic lung diseases,9906933,K23HL141639,"['Accounting ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Ambulatory Care ', ' Outpatient Care ', ' outpatient treatment ', ' Attention ', ' Automobile Driving ', ' driving ', ' Classification ', ' Systematics ', ' Communities ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Data Sources ', ' Diagnosis ', ' Discrimination ', ' Cognitive Discrimination ', ' Education ', ' Educational aspects ', ' Future ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Inpatients ', ' Interview ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Mentors ', ' Mentorship ', ' Methods ', ' Methodology ', ' Mission ', ' Natural Language Processing ', ' natural language understanding ', ' Nurses ', ' nurse ', ' Outpatients ', ' Out-patients ', ' Palliative Care ', ' Palliative Therapy ', ' Palliative Treatment ', ' comfort care ', ' Patients ', ' Pennsylvania ', ' Phenotype ', ' Physicians ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Social support ', ' social support network ', ' Supervision ', ' Testing ', ' Time ', ' United States ', ' Universities ', ' Work ', ' Measures ', ' Caregivers ', ' Care Givers ', ' Research Methods ', ' Research Methodology ', ' TimeLine ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' career ', ' improved ', ' Acute ', ' Clinical ', ' Interstitial Lung Diseases ', ' Hospitalization cost ', ' Hospital Costs ', ' Ensure ', ' Training ', ' Early Intervention ', ' instrument ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Patient Preferences ', ' Home ', ' Home environment ', ' Techniques ', ' interest ', ' preference ', ' experience ', ' Performance ', ' computer science ', ' hospital re-admission ', ' re-admission ', ' re-hospitalization ', ' readmission ', ' rehospitalization ', ' hospital readmission ', ' Structure ', ' skills ', ' novel ', ' social ', ' Position ', ' Positioning Attribute ', ' Chronic lung disease ', ' Admission ', ' Admission activity ', ' Early identification ', ' Modeling ', ' career development ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' model development ', ' Bio-Informatics ', ' Bioinformatics ', ' preventing ', ' prevent ', ' Address ', ' Health system ', ' end-of-life ', ' end of life ', ' Symptoms ', ' Adherence ', ' Data ', ' Master of Science ', ' Policy Research ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Risk Estimate ', ' Validation ', ' Monitor ', ' trend ', ' Characteristics ', ' Text ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' cost ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Population ', ' administrative data base ', ' administrative database ', ' innovate ', ' innovative ', ' innovation ', ' modifiable risk ', ' discrete data ', ' Randomization trial ', ' randomized trial ', ' trial design ', ' enthusiastic atmosphere ', ' enthusiastic environment ', ' supportive atmosphere ', ' supportive environment ', ' risk prediction model ', ' statistical learning ', ' structured data ', ' unstructured data ', ' clinical encounter ', ' clinical center ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,K23,2020,194806,0.046404892478558876
"A non-pharmacological multi-modal therapy to improve sleep and cognition and reduce mild cognitive impairment risk Summary Our long-term goal is to improve healthcare with non-pharmacological interventions that use the science of behavior change and new Internet of Things (IoT) devices to augment clinical treatment. When you go to the doctor of the future, instead of prescribing a drug, in many cases the doctor may prescribe a software intervention guiding the patient through a process of facilitated behavior change and environmental optimization. This software approach to healthcare addresses the high-priority of providing services to individuals with limited/no access to care and for addressing the public health issues of insomnia and conversion to Mild Cognitive Impairments (MCI) and Alzheimer's Disease (AD). These diseases are thought to cost the US Healthcare system more than $400 billion/year, with another $400 billion/year cost to U.S. businesses in lost productivity, sick days, and accidents. In our Phase I, we were the first research group to show that non-phase locked auditory stimulation can improve next day performance on attention measures without adversely impacting sleep organization, quality, or total sleep time. Our acoustic intervention increased the percentage and intensity of slow-wave sleep (SWS), the stage of sleep with many regenerative properties and which typically decreases with age. We have additional preliminary evidence that this sound-based intervention, played at the right time and volume during sleep, can enhance next day memory performance. Due to the accumulating support demonstrating the role that sleep quality and SWS play in conversion to MCI and AD from imaging studies, longitudinal studies, and cognitive assessments, our intervention may address both the public health issue of poor sleep quality and AD. In our Phase II, we propose to further address insomnia and AD risk by integrating our deep sleep enhancement intervention and sound masking intervetinos with additional IoT devices, such as the FitBit, Apple Watch, and Oura Ring for more accurately measuring sleep and delivering sleep improvement enhancements, such as smart light bulbs to entrain and strengthen circadian rhythms, and Amazon's Alexa to deliver relaxation interventions and reminders to address compliance. The developed software will include a sleep diary with all relevant sleep statistics viewable by a trained therapist in the gold standard treatment for insomnia, cognitive behavioral therapy for insomnia (CBTi). Displaying this data to the clinician can be used to deliver more personalized interventions and increase compliance with the treatment. We propose to conduct a randomized clinical trial on 65+ aged healthy individuals in an independent living facility that have symptoms for insomnia and compare our enhanced type of CBTi integrated with new IoT technology to typical CBTi and a passive control of sleep hygiene therapy. We hypothesize that our intervention is just as effective as the gold standard treatment for insomnia of CBTi as measured by sleep efficiency on a sleep diary (primary outcome). The system may also have the additional benefit of improving next day cognitive performance (secondary outcome), a meaningful indicator of cognitive decline and AD risk. Exploratory analyses further test the effects of the intervention on a neurodegeneration biomarker panel and additional cognitive performance measures. PROJECT NARRATIVE We propose to develop an improved multi-modal and non-pharmacological intervention to reduce conversion to mild cognitive impairment (MCI) and reduce Alzheimer's Disease (AD) risk in a 65+ population with symptoms of insomnia. We improve sleep, a known risk factor for cognitive decline, AD, and neurodegeneration biomarkers by combining acoustic deep sleep stimulation with Internet of Things device to augment the sleep environment and a system for improving cognitive behavioral therapy for insomnia (CBTi) that leverages big-data. We will run a randomized clinical trial on 100 people over an 8- week period to validate this technology. The primary outcome is sleep efficiency measured on a sleep diary, the typical measure of insomnia in clinical settings. The secondary outcome is cognitive decline measures of memory, executive functioning, and attention. Exploratory measures are additional cognitive tasks and biomarkers that are sensitive to MCI and ADRD. A successful project would yield a new, non- addictive, cheap, and accessible intervention to address insomnia and reduce conversion to MCI / ADRD.",A non-pharmacological multi-modal therapy to improve sleep and cognition and reduce mild cognitive impairment risk,10010093,R44AG056250,"['Accidents ', ' Acoustic Stimulation ', ' Auditory Stimulation ', ' Acoustics ', ' Acoustic ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Aftercare ', ' After Care ', ' After-Treatment ', ' post treatment ', ' Age ', ' ages ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Algorithms ', "" Alzheimer's Disease "", ' AD dementia ', ' Alzheimer ', ' Alzheimer Type Dementia ', ' Alzheimer disease ', ' Alzheimer sclerosis ', ' Alzheimer syndrome ', "" Alzheimer's "", "" Alzheimer's disease dementia "", ' Alzheimers Dementia ', ' Alzheimers disease ', ' Primary Senile Degenerative Dementia ', ' dementia of the Alzheimer type ', ' primary degenerative dementia ', ' senile dementia of the Alzheimer type ', ' Amyloid ', ' Amyloid Substance ', ' Arizona ', ' Arousal ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Attention ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Circadian Rhythms ', ' Nyctohemeral Rhythm ', ' Twenty-Four Hour Rhythm ', ' circadian process ', ' daily biorhythm ', ' Client ', ' Cognition ', ' Cognitive Therapy ', ' Cognition Therapy ', ' Cognitive Psychotherapy ', ' cognitive behavior intervention ', ' cognitive behavior modification ', ' cognitive behavior therapy ', ' cognitive behavioral intervention ', ' cognitive behavioral modification ', ' cognitive behavioral therapy ', ' cognitive behavioral treatment ', ' Combined Modality Therapy ', ' Multimodal Therapy ', ' Multimodal Treatment ', ' combination therapy ', ' combined modality treatment ', ' combined treatment ', ' multi-modal therapy ', ' multi-modal treatment ', ' Communities ', ' Data Display ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Drowsiness ', ' Somnolence ', ' sleepiness ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Feedback ', ' Future ', ' Goals ', ' Gold ', ' Grant ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' Hippocampus (Brain) ', ' Ammon Horn ', ' Cornu Ammonis ', ' Hippocampus ', ' hippocampal ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' hypnotic ', ' Independent Living ', ' Light ', ' Photoradiation ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Maintenance ', ' Masks ', ' Medicine ', ' Memory ', ' middle age ', ' mid life ', ' mid-life ', ' middle aged ', ' midlife ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Nerve Degeneration ', ' Neuron Degeneration ', ' neural degeneration ', ' neurodegeneration ', ' neurodegenerative ', ' neurological degeneration ', ' neuronal degeneration ', ' Noise ', ' Legal patent ', ' Patents ', ' Pathology ', ' Patients ', ' Pharmacology ', ' Play ', ' Positron-Emission Tomography ', ' PET ', ' PET Scan ', ' PET imaging ', ' PETSCAN ', ' PETT ', ' Positron Emission Tomography Medical Imaging ', ' Positron Emission Tomography Scan ', ' Rad.-PET ', ' positron emission tomographic (PET) imaging ', ' positron emission tomographic imaging ', ' positron emitting tomography ', ' Primary Insomnia ', ' Productivity ', ' Public Health ', ' Relaxation ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Running ', ' Sales ', ' Science ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Sleep ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Sleep Stages ', ' Computer software ', ' Software ', ' Sonication ', ' sound ', ' statistics ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Technology ', ' Testing ', ' Thalamic structure ', ' Thalamus ', ' thalamic ', ' Time ', ' Universities ', ' Work ', ' Measures ', ' tau Proteins ', ' MT-bound tau ', ' microtubule bound tau ', ' microtubule-bound tau ', ' tau ', ' tau factor ', '  Proteins ', ' Businesses ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' Custom ', ' Telemedicine ', ' homotypical cortex ', ' isocortex ', ' neopallium ', ' Neocortex ', ' base ', ' improved ', ' Chronic ', ' Solid ', ' Clinical ', ' Phase ', ' Physiologic ', ' Physiological ', ' Medical ', ' Randomized Clinical Trials ', ' Link ', ' Training ', ' Memory Deficit ', ' memory dysfunction ', ' Memory impairment ', ' Delta Wave ', ' Delta Wave sleep ', ' Slow-Wave Sleep ', ' Individual ', ' Sick Day ', ' Illness Days ', ' Letters ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' diaries ', ' cognitive function ', ' Scanning ', ' System ', ' Affective Disorders ', ' Mood Disorders ', ' behavior change ', ' Services ', ' 65+ years old ', ' Aged 65 and Over ', ' age 65 and greater ', ' age 65 and older ', ' aged 65 and greater ', ' aged 65 ', ' human old age (65+) ', ' Performance ', ' sleep control ', ' sleep regulation ', ' neuro-imaging ', ' neuroimaging ', ' novel ', ' Laboratory Study ', ' novel technologies ', ' new technology ', ' Devices ', ' Modeling ', ' Property ', ' Functional impairment ', ' functional disability ', ' develop software ', ' developing computer software ', ' software development ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' Meta-Analysis ', ' executive control ', ' executive function ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' actigraph ', ' actigraphy ', ' Address ', ' Symptoms ', ' Detection ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Older Population ', ' Pharmacological Treatment ', ' Validation ', ' Process ', ' active technique ', ' active treatment ', ' active method ', ' post intervention ', ' randomized placebo controlled trial ', ' cost ', ' co-morbid insomnia ', ' Comorbid Insomnia ', ' NREM ', ' non-REM ', ' non-rapid eye movement ', ' nonREM ', ' nonrapid eye movement ', ' non rapid eye movement ', ' ligand PIB ', ' Pittsburgh Compound-B ', ' Outcome ', ' Population ', ' aged ', ' Consumption ', ' sleep improvement ', ' improvement on sleep ', ' amyloid beta deposition ', ' amyloid  deposition ', ' a deposition ', ' abeta deposition ', ' Alzheimer risk factor ', ' alzheimer risk ', "" Alzheimer's disease risk "", ' beta amyloid associated pathology ', ' -amyloid pathology ', ' beta amyloid pathology ', ' multi-modality ', ' multimodality ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' standard treatment ', ' standard care ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' regenerative ', ' intervention effect ', ' mild cognitive disorder ', ' mild cognitive impairment ', ' BigData ', ' Big Data ', ' cognitive performance ', ' cognitive assessment ', ' cognitive testing ', ' precision interventions ', ' personalized intervention ', ' cognitive task ', ' marker panel ', ' biomarker panel ', ' fitbit ', ' Internet of Things ', ' imaging study ', ' quality of sleep ', ' sleep quality ', ' sleep hygiene ', ' sleep health ', ' applewatch ', ' Apple watch ', ' AD related dementia ', ' ADRD ', ' Alzheimer related dementia ', "" Alzheimer's disease related dementia "", ' side effect ', ' ']",NIA,"PROACTIVE LIFE, INC.",R44,2020,1162520,0.033150786231417866
"Sleep Health Profiles in Middle-aged Workers in Relation to Cardiovascular and Cognitive Health Middle-aged workers are vulnerable to having poor sleep, which is a public concern as it may lead to decreased productivity at work and increased risks of health problems over time. Most studies have associated one aspect of sleep (often focusing on sleep duration) with work or health-related variables, lacking a comprehensive understanding of how the combinations of multiple dimensions of sleep within individuals are associated with work-related stress and health outcomes. For example, a combination of sufficient sleep duration, regular sleep/wake, efficient sleep, and no insomnia symptom may be more predictive of concurrent and later cardiovascular and cognitive health than sleep duration alone. We propose to use multidimensional sleep health profiles that measure which and how many sleep problems co-occur within individuals. Harmonizing two independent project data sets from the Midlife in the United States Study (MIDUS) and Work, Family & Health Study (WFHS), the proposed study aims at examining the relationships between work-to-nonwork conflict (work stress carried over to and interfering with family and personal activities including sleep), sleep health profiles, and cardiovascular and cognitive health. Aim 1 will identify sleep health profiles in middle-aged workers and examine the associations of work-to-nonwork conflict with the sleep health profiles. Using extensive measures of self- reported and actigraphy-measured sleep, we will identify a priori-defined and empirically-derived sleep health profiles in diverse forms and will evaluate reproducibility of sleep health profiles across MIDUS and WFHS samples. Aim 2 will examine the associations of the sleep health profiles with cardiovascular health outcomes. Taking advantage of two cohorts in MIDUS that were sampled before and after the U.S. Great Recession period (2007-2009), we will also examine the health impacts of a macro- level stressor, whether those who were exposed to the economic recession exhibit a stronger link between sleep health profiles and cardiovascular outcomes than a propensity-matched sample who were not exposed to the recession but otherwise equal on all observables. Aim 3 will further examine the associations of the sleep health profiles with cognitive outcomes, leveraging MIDUS longitudinal cognitive data that include objectively measured episodic memory and executive functioning. We will also explore (1) whether sleep health profiles mediate the relationships between work-related stress (work-to-nonwork conflict) and cardiovascular and cognitive health, (2) potential moderation by sex and race, and (3) daily characteristics that predict optimal sleep health nights (using machine-learning). The proposed sleep health profiles can be broadly used to improve prediction accuracy in health screening tools. Focusing on middle-aged workers will contribute to decreasing health disparities in the workforce and promoting work productivity and healthy aging. Findings will inform the development of sleep-focused interventions to improve sleep and health among middle-aged workers who are in greater need. PROJECT NARRATIVE The proposed research is relevant to public health because the identification of sleep health profiles among U.S. middle-aged workers is expected to increase understanding of how the combinations of multiple sleep characteristics relate to work-related stress and cardiovascular and cognitive health. The identified sleep health profile can be broadly used to improve prediction accuracy in health screening tools and can provide a basis for developing population-level sleep health interventions. The proposed research is directly relevant to the part of NIH's mission that pertains to improving the health of the Nation by conducting research on sleep.",Sleep Health Profiles in Middle-aged Workers in Relation to Cardiovascular and Cognitive Health,10248728,R56AG065251,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Aging ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Conflict (Psychology) ', ' Conflict ', ' Cardiovascular Diagnostic Techniques ', ' Cardiovascular Diagnostic Technics ', ' cardiovascular disease diagnosis ', ' cardiovascular disorder diagnosis ', ' Exhibits ', ' Family ', ' Future ', ' Health ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Methods ', ' middle age ', ' mid life ', ' mid-life ', ' middle aged ', ' midlife ', ' Mission ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Physicians ', ' Productivity ', ' Public Health ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Risk ', ' Risk Factors ', ' Sampling Studies ', ' Sleep ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Stress ', ' Testing ', ' Time ', ' United States ', ' Work ', ' Economic Recession ', ' Measures ', ' Occupational Health ', ' Mediating ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Link ', ' screening tools ', ' Screening procedure ', ' Individual ', ' satisfaction ', ' Exposure to ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' machine learned ', ' Machine Learning ', ' cognitive function ', ' Dimensions ', ' Event ', ' Episodic memory ', ' stressor ', ' cohort ', ' Family Health ', ' Family health status ', ' Self-Report ', ' Patient Self-Report ', ' sleep diseases ', ' sleep dysfunction ', ' sleep dysregulation ', ' sleep problem ', ' Sleep Disorders ', ' Sampling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' executive control ', ' executive function ', ' actigraph ', ' actigraphy ', ' disparity in health ', ' health disparity ', ' alertness ', ' Symptoms ', ' Data ', ' Reproducibility ', ' Cognitive ', ' Characteristics ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' Outcome ', ' Population ', ' sleep-focused interventions ', ' healthy aging ', ' high risk ', ' group intervention ', ' cardiovascular health ', ' quality of sleep ', ' sleep quality ', ' sleep hygiene ', ' sleep health ', ' harmonized data ', ' data harmonization ', ' ']",NIA,UNIVERSITY OF SOUTH FLORIDA,R56,2020,412264,0.1332955602999746
"PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning PROJECT SUMMARY Lung cancer is the leading cause of cancer death. In order to increase survival, therapies are urgently needed to intercept the cancer development process and decrease the rate of patients presenting with advanced disease. A potential promising point of interception is to develop therapies to reverse or delay the development of lung premalignant lesions (PMLs). About 20% of lung cancers arise in the epithelial layer of the bronchial airways and these are preceded by the development of PMLs that are important clinical indicators of lung cancer risk in the airways or at remote parenchymal sites. As part of the NCI-Moonshot our group is engaged in creating a multi-omic lung Pre-Cancer Atlas (PCA). The success of this project in creating clinically relevant biomarkers and therapeutics depends on accurate assessments of histology and immune infiltrates in PMLs. Currently, however, pathologic assessment of the morphological stages of increasing abnormality from hyperplasia, metaplasia, dysplasia (mild, moderate, and severe), to invasive carcinoma is challenging and not routine. The objective of the proposed study is to develop and disseminate a computationally efficient deep learning framework to annotate a variety of histologic features in PMLs from the Lung PCA and associate these features with clinical and genomic data. Our central hypothesis is that deep learning can be applied to digitized H&E whole slide images (WSIs) of bronchial PMLs to identify a comprehensive set of histologic features and metrics summarizing their spatial organization that may enhance biomarkers of PML progression to cancer. We will test this hypothesis by pursuing two specific aims. First, we will annotate PMLs and develop a semantic segmentation framework using deep learning to predict histologic features of PMLs. Second, we will disseminate our deep learning framework and show its utility in enhancing PML-associated biomarkers. The proposed study is significant because the framework we develop can be applied to predict other features in the WSIs from PMLs and be modified to encompass other PMLs of the lung (e.g. those associated with lung adenocarcinoma) as well as other premalignant lesions found in other epithelial tissue types such as breast, colon, prostate, etc. Currently, deep learning approaches have not been applied to PMLs, and this proposal is innovative in the unique clinical specimens that it leverages with corresponding genomic and clinical data and in its development of a patch- based convolutional neural network to predict histologic features of PMLs. Our long-term goal is to develop a deep learning framework to predict a variety of features from lung PML WSIs and integrate these with genomic data on these same samples to discover robust biomarkers of PML progression and therapeutics to prevent invasive cancer development. PROJECT NARRATIVE The proposed study aims to develop and disseminate a computationally efficient deep learning framework to annotate histologic features in lung squamous premalignant lesions using digitized H&E whole slide images and associate these features with clinical and genomic data. We also aim to demonstrate the utility of our method in providing image-based features to enhance our genomic biomarkers of premalignant lesion progression. The methods and results based on the whole slide images can be integrated into a larger lung premalignant lesion atlas building initiative to advance lung cancer interception.",PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning,10059031,R21CA253498,"['Atlases ', ' Biopsy ', ' Breast ', ' Bronchoscopy ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Carcinoma ', ' Epithelial cancer ', ' Malignant Epithelial Neoplasms ', ' Malignant Epithelial Tumors ', ' epithelial carcinoma ', ' Colon ', ' Cessation of life ', ' Death ', ' Epithelium ', ' Epithelium Part ', ' Goals ', ' Heterogeneity ', ' Histology ', ' Hyperplasia ', ' Hyperplastic ', ' Immunosuppression ', ' Immunosuppression Effect ', ' Immunosuppressive Effect ', ' immune suppression ', ' Interobserver Variability ', ' Inter-Observer Variability ', ' Inter-Observer Variation ', ' Interobserver Variations ', ' Learning ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Metaplasia ', ' Metaplastic Change ', ' Methods ', ' Minor ', ' Patients ', ' Prostate ', ' Prostate Gland ', ' Prostatic Gland ', ' Semantics ', ' Computer software ', ' Software ', ' Standardization ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Measures ', ' Lung Adenocarcinoma ', ' base ', ' Procedures ', ' Pulmonary imaging ', ' lung scanning ', ' lung imaging ', ' Site ', ' Clinical ', ' Biological ', ' Histologically ', ' Histologic ', ' Medical ', ' Training ', ' Lesion ', ' Epithelial ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' lung cancer early detection ', ' lung cancer screening ', ' Therapeutic ', ' Morphology ', ' dyscrasia ', ' Dysplasia ', ' Pathologist ', ' Research Specimen ', ' Specimen ', ' Pattern ', ' System ', ' cancer risk ', ' Performance ', ' success ', ' Intercept ', ' advanced illness ', ' advanced disease ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Sampling ', ' lung development ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' Institution ', ' preventing ', ' prevent ', ' Correlative Study ', ' Data ', ' precancerous ', ' premalignant ', ' Resolution ', ' Cancer Cause ', ' Cancer Etiology ', ' Clinical Data ', ' Pathologic ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cancer invasiveness ', ' innovate ', ' innovative ', ' innovation ', ' clinical relevance ', ' clinically relevant ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' tumor ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' cloud based ', ' biomarker development ', ' multiomics ', ' multiple omics ', ' genomic marker ', ' genomic biomarker ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' screening program ', ' Immune infiltrates ', ' T cell infiltration ', ' T cell tumor trafficking ', ' immune cell infiltrate ', ' immune infiltration ', ' intratumoral immune cell ', ' tumor immune cell ', ' Tumor-infiltrating immune cells ', ' whole slide imaging ', ' pathology imaging ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' deep learning algorithm ', ' immune microenvironment ', ' immunosuppressive microenvironment ', ' immunosuppressive tumor microenvironment ', ' tumor immune microenvironment ', ' tumor-immune system interactions ', ' ']",NCI,BOSTON UNIVERSITY MEDICAL CAMPUS,R21,2020,424256,0.13851441364246092
"The benefits and harms of lung cancer screening in Florida PROJECT SUMMARY/ABSTRACT Lung cancer is the leading cause of cancer related death in both men and women in the United States. Currently, approximately 70% of lung cancer patients are diagnosed at advanced stages, and the 5-year survival rate of advanced stage lung cancer is very low, at only 16%. Investigators have been searching for effective screening modalities for the early detection of lung cancer so that patients can receive curative treatments at an early stage. When the National Lung Screening Trial (NLST) demonstrated the effectiveness of using low-dose computed tomography (LDCT) scan for lung cancer screening (LCS), researchers and physicians hope to save lives from lung cancer by screening high-risk population who aged 55 to 77 years and have a 30 pack years making history or former smokes who have quitted within the past 15 years. Since the release of the landmark NLST results, many medical associations published guidelines to recommend LDCT-based screening for individuals at high risk for lung cancer and the Centers for Medicare and Medicaid Services (CMS) also decided to cover the LCS for Medicare beneficiaries who are at high risk for lung cancer. While many efforts have been made to accelerate the dissemination the beneficial LCS, the concerns over the high false positive rates (96.4% of the positive results), invasive diagnostic procedures, postprocedural complications and health care costs may hinder the utilization of lung cancer screening. This concern was magnified as researchers and policy makers started questioning whether the complication rate and false positives in real-world settings would be even higher than the rates reported in the NLST, which was conducted in a setting with well-established facilities and proficiency in cancer care. Therefore, we propose to understand the contemporary use of lung cancer screening and associated health care outcomes and costs using data from a real-world setting. Our study has three goals: 1) to develop an innovative computable phenotype algorithm to identify high-risk and low-risk individuals for LCS from both structured and unstructured (i.e., clinical notes) electronic health record (EHR) data and to develop advanced natural language processing (NLP) methods to extract LCS related clinical information from clinical notes such as radiology reports; 2) to determine the appropriate and inappropriate use of LDCT among high-risk and low-risk individuals in Florida and to examine the test results of LDCT, the rates of invasive diagnostic procedures, postprocedural complications, and incidental findings in real-world settings; and 3) to develop and validate a microsimulation model of the clinical courses of LCS incorporating the real-world data in LCS to estimate the long-term benefits and the cost-effectiveness of LCS. Our proposed study has the potential to reduce lung cancer incidence and mortality by informing policymakers and practitioners on the appropriateness of contemporary use of LCS. This knowledge will help both patients and physicians better understand the harm- benefit tradeoff of lung cancer screening and transform such knowledge into practice to prevent avoidable postprocedural complications. PROJECT NARRATIVE Lung cancer screening using Low-dose computed tomography is a promising technique to reduce the burden of lung cancer, the leading cause of cancer-related death in the United States. Concerns over high false positives, invasive diagnostic procedures, postprocedural complications, and downstream health care costs impede developing and promoting lung cancer screening program. Our research is to leverage a large repository of linked electronic health record (EHR) and administrative claims data to understand contemporary use of lung cancer screening and the associated health care outcomes and costs in a real-world setting.",The benefits and harms of lung cancer screening in Florida,9882791,R01CA246418,"['Adoption ', ' Age ', ' ages ', ' Awareness ', ' malignant breast neoplasm ', ' Breast Cancer ', ' malignant breast tumor ', ' Complication ', ' cost effectiveness ', ' Costs and Benefits ', ' Cessation of life ', ' Death ', ' Decision Making ', ' Diagnosis ', ' Eligibility Determination ', ' Eligibility ', ' Protocol Screening ', ' Florida ', ' Future ', ' Goals ', ' Gold ', ' Medicare ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Title 18 ', ' health insurance for disabled ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Health Services Research ', ' Health Services Evaluation ', ' Medical Care Research ', ' services research ', ' Recording of previous events ', ' History ', ' Incidence ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Manuals ', ' Mathematics ', ' Math ', ' men ', "" men's "", ' Methods ', ' mortality ', ' Natural Language Processing ', ' natural language understanding ', ' Patients ', ' Physicians ', ' Professional Organizations ', ' professional association ', ' professional membership ', ' professional society ', ' Publishing ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Smoke ', ' Smoking ', ' Survival Rate ', ' Thoracic Radiography ', ' CXR ', ' chest X ray ', ' chest Xray ', ' chest radiography ', ' lung radiography ', ' radiographic chest image ', ' radiographic lung image ', ' thoracic radiogram ', ' thorax radiography ', ' Time ', ' United States ', ' United States Centers for Medicare and Medicaid Services ', ' Centers for Medicare and Medicaid Services ', ' Health Care Financing Administration ', ' United States Health Care Financing Administration ', ' Use Effectiveness ', ' Woman ', ' Work ', ' County ', ' Information Retrieval ', ' Information extraction ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' health care ', ' Healthcare ', ' Resource Allocation ', ' Dataset ', ' Data Set ', ' economic analysis ', ' economic evaluation ', ' Guidelines ', ' base ', ' Pulmonary imaging ', ' lung scanning ', ' lung imaging ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Medical ', ' Randomized Clinical Trials ', ' Link ', ' Individual ', ' Policy Maker ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Policies ', ' lung cancer early detection ', ' lung cancer screening ', ' Malignant Pancreatic Neoplasm ', ' Pancreas Cancer ', ' Pancreatic Cancer ', ' pancreatic malignancy ', ' Malignant neoplasm of pancreas ', ' machine learned ', ' Machine Learning ', ' Malignant Tumor of the Prostate ', ' Malignant prostatic tumor ', ' Prostate CA ', ' Prostate Cancer ', ' Prostatic Cancer ', ' Malignant neoplasm of prostate ', ' Knowledge ', ' Diagnostic Method ', ' Diagnostic Technique ', ' Diagnostic Procedure ', ' Event ', ' Pattern ', ' Techniques ', ' System ', ' Test Result ', ' American ', ' Performance ', ' Structure ', ' Harm Minimization ', ' Harm Reduction ', ' General Public ', ' General Population ', ' Modality ', ' Colon Cancer ', ' Colonic Carcinoma ', ' cancer in the colon ', ' Colon Carcinoma ', ' Reporting ', ' Incidental Findings ', ' cancer registry ', ' neoplasm registry ', ' Modeling ', ' depository ', ' repository ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' cancer care ', ' Provider ', ' preventing ', ' prevent ', ' Data ', ' Sum ', ' Cancer Control Science ', ' Cancer Control ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' Sputum Cytology ', ' Sputum Cytology Screening ', ' trend ', ' beneficiary ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' cost ', ' Outcome ', ' Population ', ' aged ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' patient centered ', ' patient oriented ', ' economic outcome ', ' high risk ', ' shared decision making ', ' data registry ', ' screening ', ' curative intervention ', ' curative therapeutic ', ' curative therapy ', ' curative treatments ', ' high risk group ', ' high risk population ', ' care costs ', ' screening program ', ' health care outcomes ', ' healthcare outcomes ', ' care outcomes ', ' CT screening ', ' computed tomography screening ', ' deep learning ', ' recommended screening ', ' screening recommendations ', ' screening guidelines ', ' phenotyping algorithm ', ' computable phenotypes ', ' low dose computerized tomography ', ' low-dose CT ', ' low dose computed tomography ', ' ']",NCI,UNIVERSITY OF FLORIDA,R01,2020,337461,0.19336052238585144
"The Health and Behavioral Effects of Sleep Deprivation Among the Urban Poor in India Project Summary/Abstract Evidence demonstrates that sleep deprivation causes impaired cognitive function and is associated with impaired health (e.g. altered immune and cardiovascular function). Yet these conclusions largely derive from correlational relationships or studies of acute sleep deprivation lasting only a few days in sleep labs. Further, research on sleep in disadvantaged populations and sleep disparities is limited, despite severe environmental challenges to sleep among the poor. Moreover, the potentially bi-directional relationship between poor sleep and poor decision-making, a possible mediator of the income-health gradient, remains largely unexplored. In short, while poor sleep could be an important contributor to health disparities and accelerated aging, we know relatively little about the causes and impacts of sleep deprivation in low SES populations and how to address these disparities, a gap that is especially acute in real-world settings with extended time frames. This K01 application will provide key training for career advancement and begin to close this gap in knowledge. To accomplish this goal, a randomized field experiment with 400 participants, each enrolled for over one month, in Chennai, India, will (1) objectively measure sleep and key environmental factors to provide preliminary evidence on the role of environmental causes of sleep deprivation in an urban environment, (2) rigorously evaluate two simple scalable interventions to reduce sleep deprivation among low-income adults in their natural environments, (3) estimate the causal effect of improved sleep on cognitive function, decision- making, health outcomes and behaviors (e.g. blood pressure, alcohol consumption), and earnings, and (4) utilizing questions regarding sleep asked of both RCT participants and a 50,000 person nationally-representative sample, estimate the extent of sleep deprivation and its impacts more broadly in urban India. The training aims underpinning the research aims and the applicant's long-term research goals are to expand knowledge and skills in: (1) cognitive psychology and the measurement of cognitive function, (2) aging, and (3) machine learning and predictive modeling. This training, accomplished through multiple avenues including coursework, directed study, and mentorship, will directly facilitate the proposed research and extend the scope and impact of the applicant's long-term research career studying health disparities and interactions between health and decision-making which may impact both cognitive and physical health as individuals age. Notably, while this application focuses on the impacts of sleep deprivation, the potential for health to shape decision-making is much broader. Constant exposure to other aspects of poor health associated with poverty, such as pain, also have the potential to exert a mental tax, leading to impaired cognition and poor decisions. Such a negative feedback loop between these factors and decision-making has the potential to further exacerbate health disparities. The far-reaching applicability of this idea beyond the direct scope of this proposal opens the door to high public-health significance through a wide variety of channels. Project narrative Although sleep has significant potential to impair cognition and impede health, relatively little is known about the causes and impacts of sleep deprivation in low SES populations and how to address these disparities, a gap that is especially acute in real-world settings with extended time frames. This research will begin to close this gap in knowledge through a 400 person randomized trial in Chennai, India, which will objectively and rigorously measure sleep and key environmental factors impacting sleep, evaluate the impact of two simple and scalable interventions to improve sleep, and estimate the causal effect of improved sleep on cognitive function, decision-making, health outcomes and behaviors (e.g. blood pressure, tobacco consumption), and earnings. Providing rigorous evidence on these relationships and improving our collective understanding of the causes and costs to sleep deprivation, including not just direct health outcomes, but also shifts in preferences and decision-making directly relevant to health, will provide policy-relevant information important to improving health and healthy behaviors as well as promoting heathy and economically-secure aging.",The Health and Behavioral Effects of Sleep Deprivation Among the Urban Poor in India,9863981,K01AG055691,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Aging ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Attention ', ' Behavior ', ' Blood Pressure ', ' Cardiovascular Physiology ', ' cardiovascular function ', ' Career Mobility ', ' career advancement ', ' career transition ', ' Cognition ', ' Cost Measures ', ' Cost metrics ', ' cost measurement ', ' Decision Making ', ' Developing Countries ', ' Developing Nations ', ' Less-Developed Countries ', ' Less-Developed Nations ', ' Third-World Countries ', ' Third-World Nations ', ' Under-Developed Countries ', ' Under-Developed Nations ', ' developing country ', ' developing nation ', ' Disease ', ' Disorder ', ' Economic Models ', ' Environment ', ' Feedback ', ' Food ', ' Food or Food Product ', ' Goals ', ' Health ', ' Health behavior ', ' Health Promotion ', ' Salutogenesis ', ' promoting health ', ' Incidence ', ' Income ', ' Economic Income ', ' Economical Income ', ' India ', ' Insecta ', ' Insects ', ' Insects Invertebrates ', ' Investments ', ' Life Cycle Stages ', ' Life Cycle ', ' life course ', ' Light ', ' Photoradiation ', ' Mentorship ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Morbidity - disease rate ', ' Morbidity ', ' Persons ', ' Noise ', ' Pain ', ' Painful ', ' Personal Satisfaction ', ' well-being ', ' wellbeing ', ' Poverty ', ' Psychomotor Performance ', ' psychomotor function ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Role ', ' social role ', ' Running ', ' Savings ', ' Sleep ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Surveys ', ' Survey Instrument ', ' Taxes ', ' Testing ', ' Time ', ' Tobacco ', ' Translating ', ' Measures ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' career ', ' improved ', ' Acute ', ' Chronic ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Training ', ' mental ', ' Psyche structure ', ' Individual ', ' Logistics ', ' Policies ', ' Measurement ', ' Exposure to ', ' Shapes ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' machine learned ', ' Machine Learning ', ' cognitive psychology ', ' Cognitive Science ', ' Knowledge ', ' programs ', ' cognitive function ', ' Dimensions ', ' physical health ', ' physical conditioning ', ' respiratory ', ' Tobacco Consumption ', ' Tobacco use ', ' preference ', ' skills training ', ' skills ', ' Participant ', ' research study ', ' Self-Report ', ' Patient Self-Report ', ' Impaired health ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Sampling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Inflammatory Response ', ' disparity in health ', ' health disparity ', ' Cellular Immune Function ', ' immune function ', ' low SES ', ' low socio-economic position ', ' low socio-economic status ', ' low socioeconomic position ', ' low socioeconomic status ', ' Low income ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' cognitive change ', ' Address ', ' global health ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Cognitive ', ' enroll ', ' Enrollment ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' discount ', ' Behavioral ', ' cost ', ' health economics ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Outcome ', ' Population ', ' healthy aging ', ' Randomization trial ', ' randomized trial ', ' Secure ', ' adverse consequence ', ' adverse outcome ', ' cognitive ability ', ' behavioral economics ', ' BP reduction ', ' lower BP ', ' lower blood pressure ', ' lowers blood pressure ', ' reduce BP ', ' reduce blood pressure ', ' reduction in BP ', ' reduction in blood pressure ', ' blood pressure reduction ', ' disadvantaged population ', ' experiment ', ' experimental research ', ' experimental study ', ' sleep hygiene ', ' sleep health ', ' diarrheal illness ', ' diarrheal disease ', ' econometrics ', ' ']",NIA,UNIVERSITY OF PENNSYLVANIA,K01,2020,127872,0.12356008834777311
"Machine Learning Development for Subtyping COPD Project Summary Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. To date, researchers have attempted to use standard machine learning methodology to identify more meaningful subtypes of COPD, but these methods often make general assumptions about the data, limiting their ability to penetrate more complex patterns in some data sets. Thus, a meaningful reclassification of COPD subtypes that could lead to more targeted therapies and interventions has been elusive. The applicant introduces a new way of looking at the COPD subtyping problem by recasting it in terms of discovering associations of individuals to disease trajectories  i.e., grouping individuals based on their similarity in response to environmental and/or disease causing variables. The machine learning methods proposed build on the most recent advances in Bayesian nonparametrics, a collection of theoretical ideas and techniques that permit very flexible data representations. In this career development proposal, the applicant hypothesizes that these machine learning methods and extensions thereof  together with data sources not previously leveraged for COPD subtyping  will produce more biologically meaningful sub-groupings of patients, leading to a better understanding of the genetic and biological underpinnings of the disease and ultimately improved patient management. Aim 1 of this application involves evaluating the utility of CT-assessed lung mass  a potentially more discriminative measure of emphysema than conventionally used measures  for defining COPD subtypes using both K-means clustering and our disease trajectory algorithm. The goal of Aim 2 is to evaluate the utility of comorbidity data for defining COPD subtypes using our trajectory clustering algorithm. Novel computed tomography based measures of muscle wasting (cachexia) and pulmonary vascular pruning will be explored to determine their efficacy in subtype determination. Additionally, we will extend and test the trajectory algorithm in order to model discrete outputs (such as physician-diagnosed comorbidities), count data (e.g. exacerbations), and time-to-event data (death). In Aim 3, the applicant will extend our trajectory clustering algorithms to directly incorporate genetic and omics data for subtype discovery. Together, the research proposed in the aims of this award will take full advantage of the comprehensive data set available through the COPDGene study. Execution of the aims in this proposal will be possible through active collaboration with Dr. Ron Kikinis, M.D., a renowned leader in the field of medical image analysis, and Dr. Ed Silverman, an internationally recognized expert in the genetic epidemiology of COPD. Project Narrative Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive loss of lung function with subsequent increasing breathlessness and worsening quality of life. This heterogeneity makes it difficult to predict health decline and develop targeted treatments for better patient care. In carrying out the research outlined in the following proposal, we plan to develop and apply machine learning methods to better identify subpopulations of individuals who have similar forms of COPD, potentially enabling better, targeted therapies.",Machine Learning Development for Subtyping COPD,9948018,K25HL130637,"['Affect ', ' airway obstruction ', ' airflow limitation ', ' airflow obstruction ', ' airway limitation ', ' obstructed airflow ', ' obstructed airway ', ' Algorithms ', ' Award ', ' Blood Vessels ', ' vascular ', ' Cachexia ', ' Cachectic ', ' Cause of Death ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Data Reporting ', ' data representation ', ' Data Sources ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Disease susceptibility ', ' Diathesis ', ' liability to disease ', ' Dyspnea ', ' Breathlessness ', ' Environment ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Health ', ' Heterogeneity ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Medical Imaging ', ' Methods ', ' Methodology ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' mortality ', ' Muscular Atrophy ', ' Muscle Atrophy ', ' muscle breakdown ', ' muscle degradation ', ' muscle deterioration ', ' muscle loss ', ' muscle wasting ', ' Patients ', ' Physicians ', ' Publishing ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Quality of life ', ' QOL ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Smoke ', ' Syndrome ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Measures ', ' Lung Mass ', ' Pulmonary Mass ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Clinical ', ' Biological ', ' peripheral blood ', ' Failure ', ' Individual ', ' Bayesian computation ', ' Bayesian inference ', ' Bayesian network analysis ', ' Bayesian spatial analysis ', ' Bayesian statistical analysis ', ' Bayesian statistical inference ', ' Bayesian statistics ', ' Bayesian Analysis ', ' Disease Progression ', ' Collaborations ', ' Descriptor ', ' Genetic ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' particle ', ' novel ', ' disorder model ', ' Disease model ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Modeling ', ' career development ', ' response ', ' genetic epidemiologic study ', ' genetic epidemiology ', ' disease subgroups ', ' disease subtype ', ' disorder subtype ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Inflammatory Response ', ' genetic association ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' International ', ' Subgroup ', ' Collection ', ' Physiologic Imaging ', ' physiological imaging ', ' Functional Imaging ', ' Scheme ', ' Characteristics ', ' Process ', ' groupings ', ' Grouping ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' flexible ', ' flexibility ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' cigarette smoke ', ' machine learned algorithm ', ' machine learning algorithm ', ' machine learning method ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,K25,2020,189000,0.09184403757293304
"Clinical feasibility of a non-invasive, low-cost wearable for measuring air trapping in COPD ABSTRACT  Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of hospitalization in the US. Exacerbations - a worsening or flare up of symptoms - cause most COPD hospitalizations. Since most exacerbations can be treated with changes of inhalers and/or oral medications, at-home detection of lung function deterioration may facilitate earlier intervention and help delay or prevent hospitalizations. The Standards of Care for monitoring lung function are spirometry, plethysmography, and CT scan. However, these are expensive methods and unsuited for continuous monitoring or at-home use. Various patient self-monitoring approaches have been tried, for example, pulse oximetry, respiratory rate monitoring, and peak flow metering, but their efficacy in reducing hospitalizations has been limited.  A common finding for all forms of COPD is air trapping, defined, as an abnormal increase in the volume of air remaining in the lungs after exhalation is complete. A body of evidence definitively shows that air trapping increases during exacerbations and decreases when exacerbations resolve. Recent reports show that air trapping is an earlier harbinger of deteriorating lung function than spirometric changes, and can be measured by low-frequency ultrasound (1-40 kHz). Acoustic monitoring of air trapping could provide clinicians with a non- invasive tool when medical intervention is needed to avoid unnecessary ER visits and hospitalizations.  Respira Labs has developed a low-cost, non-invasive, acoustic-based wearable device that can continually monitor lung resonance: Sylvee. The device uses known acoustic-based technology with machine- learning algorithms to detect minor changes in lung resonance, which our preliminary results suggest correspond to changes in air trapping. The overall objective of this project is to validate Sylvee's air trapping algorithms in a cohort of 20 healthy controls and 40 COPD patients with and without air trapping, respectively. In Aims 1 and 2, we will miniaturize and add sensors to the Sylvee device and develop a user interface (UI) and a mobile application. In Aims 3 and 4, we will create an Air Trapping Index Report and validate it in a cross-sectional study vis--vis whole body plethysmography as a control. Results of this project provide a go/no-go development decision based on device function. We can apply these results in STTR Phase II, in a larger clinical study to evaluate Sylvee as an at-home monitoring system, with a goal of reducing hospitalizations by at least 30%. Ultimately, Sylvee will allow physicians to remotely monitor their patients' lung function and adjust their medications to reduce healthcare costs and improve patients' quality of life. PROJECT NARRATIVE More than 12 million Americans have been diagnosed with COPD, and another 17 million may have COPD, but are unaware of it. By 2020, the costs associated with COPD are estimated to be $72B billion per year, of which with ~50% are the costs of spent on ER visits and hospitalizations. The goal of this proposal is to establish and validate a seamless and non-obtrusive wearable that measures abnormal air trapping via a novel acoustic technology, which would reduce hospitalizations through at-home monitoring of lung function.","Clinical feasibility of a non-invasive, low-cost wearable for measuring air trapping in COPD",10080272,R41HL152769,"['Acoustics ', ' Acoustic ', ' Activities of Daily Living ', ' Activities of everyday life ', ' daily living functionality ', ' functional ability ', ' functional capacity ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Air ', ' Algorithms ', ' Asthma ', ' Bronchial Asthma ', ' Chronic Bronchitis ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Cross-Sectional Studies ', ' Cross Sectional Analysis ', ' Cross-Sectional Analyses ', ' Cross-Sectional Survey ', ' Disease Frequency Surveys ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diagnosis ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Dyspnea ', ' Breathlessness ', ' Edema ', ' Dropsy ', ' Hydrops ', ' Future ', ' Goals ', ' Health ', ' Heart Rate ', ' Cardiac Chronotropism ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' General Hospitals ', ' Humidity ', ' indexing ', ' Inhalators ', ' Inhaler ', ' Laboratories ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Pulmonary function tests ', ' Lung Function Tests ', ' Respiratory Function Tests ', ' Methods ', ' Military Personnel ', ' Armed Forces Personnel ', ' Military ', ' Miniaturization ', ' Miniaturisations ', ' Minor ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mucous body substance ', ' Mucus ', ' mucous ', ' Noise ', ' Patients ', ' Physicians ', ' Physiology ', ' Plethysmography ', ' Whole Body Plethysmography ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Pulse Oximetry ', ' Quality of life ', ' QOL ', ' Questionnaires ', ' Respiratory Muscles ', ' Ventilatory Muscles ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Risk ', ' Running ', ' San Francisco ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Spirometry ', ' Standardization ', ' Technology ', ' Temperature ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Translating ', ' Ultrasonography ', ' Echography ', ' Echotomography ', ' Medical Ultrasound ', ' Ultrasonic Imaging ', ' Ultrasonogram ', ' Ultrasound Diagnosis ', ' Ultrasound Medical Imaging ', ' Ultrasound Test ', ' diagnostic ultrasound ', ' sonogram ', ' sonography ', ' sound measurement ', ' ultrasound ', ' ultrasound imaging ', ' ultrasound scanning ', ' Veterans ', ' Bronchoconstriction ', ' Bronchial Constriction ', ' Measures ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' Device Designs ', ' Caring ', ' base ', ' sensor ', ' improved ', ' Clinical ', ' Refractory ', ' Phase ', ' Medical ', ' Individual ', ' O3 exposure ', ' ozone exposure ', ' Measurement ', ' Disease Progression ', ' Early Intervention ', ' Personal Medical History ', ' Personal Medical History Epidemiology ', ' Medical History ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Exposure to ', ' tool ', ' Smoker ', ' machine learned ', ' Machine Learning ', ' Frequencies ', ' Oral ', ' Home ', ' Home environment ', ' Clinic ', ' Exhaling ', ' Respiratory Expiration ', ' Exhalation ', ' System ', ' Particulate ', ' meter ', ' respiratory ', ' Oximetry ', ' Oxygen saturation measurement ', ' Medical center ', ' American ', ' experience ', ' success ', ' cohort ', ' novel ', ' Devices ', ' Reporting ', ' intervention therapy ', ' Therapeutic Intervention ', ' Deterioration ', ' develop software ', ' developing computer software ', ' software development ', ' miniaturize ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' air monitoring ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' preventing ', ' prevent ', ' Symptoms ', ' Data ', ' Detection ', ' Regulatory Pathway ', ' Clinical Data ', ' Flare ', ' STTR ', ' Small Business Technology Transfer Research ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' developmental ', ' Development ', ' cost ', ' designing ', ' design ', ' Population ', ' user-friendly ', ' usability ', ' prototype ', ' Secure ', ' screening ', ' Algorithmic Analyses ', ' Analyses of Algorithms ', ' Analysis of Algorithms ', ' Algorithmic Analysis ', ' mobile app ', ' mobile application ', ' cloud based ', ' ED visit ', ' ER visit ', ' Emergency care visit ', ' Emergency hospital visit ', ' Emergency room visit ', ' Emergency department visit ', ' accurate diagnosis ', ' recruit ', ' Android App ', ' Android Application ', ' Cell Phone Application ', ' Cell phone App ', ' Cellular Phone App ', ' Cellular Phone Application ', ' Smart Phone App ', ' Smart Phone Application ', ' Smartphone App ', ' iOS app ', ' iOS application ', ' iPhone App ', ' iPhone Application ', ' smartphone Application ', ' Bluetooth ', ' wearable electronics ', ' wearable technology ', ' wearable device ', ' microphone ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NHLBI,"RESPIRA LABS, LLC",R41,2020,338644,0.14436345769634856
"Groundwork for a Synchrotron MicroCT Imaging Resource for Biology (SMIRB) Project Summary We request a high-flux x-ray source and to acquire new team expertise in segmentation from microCT images, in order to apply a new 3D form of histology developed through our parent R24 to begin to characterize the cellular and tissue geometries of COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) pneumonia, our pandemics most common cause of death. Our novel imaging tool, X-ray histotomography, is based on microCT of fixed and metal-stained tissue. It is unique among 3D imaging methods as the only nondestructive way to achieve pan-cellular imaging (allowing characterization of all cell types and tissues) and is potentially practical. Histotomography uniquely allows direct comparison with todays 2D standard of tissue diagnosis, histology, capable of producing both 3D renderings and undistorted 2D slices at any angle and any slice thickness. Unlike histology, we will also allow us to precisely characterize cellular arrangements into tissues after fixing and staining of samples with metal. The ability to volumetrically characterize cell types and their arrangements in acute respiratory distress syndrome (ARDS) is particularly important because it is what kills most patients in coronavirus-based pandemics, including SARS (severe acute respiratory syndrome coronavirus) in 2003, MERS (Middle East respiratory syndrome coronavirus) in 2012, COVID-19 now. The proposed work will increase our preparedness for future pandemics. ARDS lungs are an ideal human tissue model for mathematically defining human disease because all cell types are affected. The proposed work with COVID-19 lungs will increase the precision with which we understand the different stages of coronavirus lung infection and serve as a model for characterizing the Geometry of Disease across all organ systems. Histotomography in the parent R24 is currently limited to animal models, focusing on the zebrafish. The supplement will allow us to translate our work to human health, which was originally envisioned by the PI, as part of defining the Geometry of Disease. Our experience with this technology tells us that we will be able to characterize the numbers of each of the basic inflammatory cell types, including lymphocytes, neutrophils, and macrophages (which are morphologically distinct) in terms of numbers, volumes, shapes, and density in the inflamed tissue, and to also characterize the changes in the lung epithelia (bronchial ciliated epithelial cells and pneumocytes, cell death, and the filling of airways with fluid and fibrinous exudate, and vascular inflammation. In addition to quantitation of tissue changes, we will also be able to visualize pathological change in the tissues using virtual reality. Histotomography will serve as a way to validate a humanized mouse model of COVID-19 infection by comparing the quantitative changes with those in human autopsy samples. We will be comparing both standard histological sections and histotomographic images from adjacent tissue. Machine learning will ultimately allow us to automate recognition of cell types and pathological change. The proposed augmentation of our instrumentation and expertise will facilitate definitions of the Geometry of Disease across organ systems. Project narrative We request an equipment upgrade and acquisition of expertise to accelerate progress and to pilot the translational use of our ORIP-funded technology to provide the first 3D understanding of the pathogenesis of COVID-19 pneumonia. Histotomography, a new 3D form of histology based on microCT, is the first practical way to turn the current standard of 2D, qualitative, tissue analytics into quantitative, morphometrics that is inclusive of all cell types and tissue architecture. Organismal and tissue phenotyping at both scales makes possible the first 3D, complete phenotyping of cells and tissue architecture, promising to transform human tissue diagnostics, preclinical toxicology, and more comprehensive high-throughput genetic, chemical and disease phenomics.",Groundwork for a Synchrotron MicroCT Imaging Resource for Biology (SMIRB),10169023,R24OD018559,"['Affect ', ' Architecture ', ' Engineering / Architecture ', ' Autopsy ', ' necropsy ', ' postmortem ', ' Biology ', ' Cause of Death ', ' Cell Death ', ' necrocytosis ', ' Cells ', ' Cell Body ', ' Cicatrix ', ' Scars ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Edema ', ' Dropsy ', ' Hydrops ', ' Epithelial Cells ', ' Epithelium ', ' Epithelium Part ', ' Equipment ', ' Exudate ', ' Female ', ' Floods ', ' Flooding ', ' Future ', ' Health ', ' Histology ', ' Human ', ' Modern Man ', ' Infection ', ' instrumentation ', ' Intelligence ', ' Leadership ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Lymphocyte ', ' Lymphocytic ', ' lymph cell ', ' macrophage ', ' male ', ' Mathematics ', ' Math ', ' Metals ', ' Transgenic Mice ', ' Microscopy ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' neutrophil ', ' Blood Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Marrow Neutrophil ', ' Neutrophilic Granulocyte ', ' Neutrophilic Leukocyte ', ' Polymorphonuclear Cell ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Neutrophils ', ' Parents ', ' Patients ', ' Phenotype ', ' Pneumonia ', ' Productivity ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Resources ', ' Research Resources ', ' Adult Respiratory Distress Syndrome ', ' ARDS ', ' Acute Respiratory Distress ', ' Acute Respiratory Distress Syndrome ', ' Adult ARDS ', ' Adult RDS ', ' Da Nang Lung ', ' Shock Lung ', ' Stiff lung ', ' wet lung ', ' Science ', ' Stains ', ' Staining method ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Toxicology ', ' Translating ', ' Work ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Zebrafish ', ' Brachydanio rerio ', ' Danio rerio ', ' Zebra Danio ', ' Zebra Fish ', ' Negative Staining ', ' Synchrotrons ', ' base ', ' density ', ' human morbidity ', ' human mortality ', ' improved ', ' Procedures ', ' Area ', ' Clinical ', ' Histologically ', ' Histologic ', ' Coronaviridae ', ' corona virus ', ' Coronavirus ', ' Chemicals ', ' Evaluation ', ' Training ', ' Epithelial ', ' pneumocyte ', ' Measurement ', ' Cell Components ', ' Cell Structure ', ' Cellular Structures ', ' Funding ', ' MoAb R24 ', ' R-24 Monoclonal Antibody ', ' R24 ', ' Monoclonal Antibody R24 ', ' Tissue Stains ', ' fluid ', ' liquid ', ' Liquid substance ', ' Genetic ', ' Morphology ', ' Normal Tissue ', ' Normal tissue morphology ', ' Shapes ', ' Inflammatory ', ' Diagnostic ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Diagnostic Method ', ' Diagnostic Technique ', ' Diagnostic Procedure ', ' human tissue ', ' Scanning ', ' Source ', ' cell type ', ' Pattern ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Location ', ' Organ System ', ' body system ', ' American ', ' Cell Volumes ', ' experience ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' novel ', ' Pathogenesis ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Modeling ', ' Sampling ', ' virtual reality ', ' Math Models ', ' mathematic model ', ' mathematical modeling ', ' mathematical model ', ' 3-D Imaging ', ' 3D imaging ', ' Three-Dimensional Imaging ', ' vascular inflammation ', ' SARS ', ' SARS coronavirus disease ', ' SARS-CoV disease ', ' Severe Acute Respiratory Syndrome CoV disease ', ' Severe Acute Respiratory Syndrome coronavirus disease ', ' Severe Acute Respiratory Syndrome ', ' SARS Virus ', ' SARS corona virus ', ' SARS-Associated Coronavirus ', ' SARS-CoV ', ' SARS-Related Coronavirus ', ' Severe Acute Respiratory Syndrome Virus ', ' Severe Acute Respiratory Syndrome corona virus ', ' Severe Acute Respiratory Syndrome coronavirus ', ' severe acute respiratory syndrome-CoV ', ' SARS coronavirus ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Thickness ', ' Thick ', ' therapeutic testing ', ' therapeutic evaluation ', ' Preparedness ', ' Readiness ', ' Alveolar ', ' Control Animal ', ' Data ', ' Imaging Instrument ', ' Imaging Tool ', ' Imaging Device ', ' pre-clinical testing ', ' Preclinical Testing ', ' Resolution ', ' Slice ', ' Tissue Model ', ' Pathologic ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' pandemic ', ' pandemic disease ', ' imaging ', ' Image ', ' preclinical ', ' pre-clinical ', ' reconstruction ', ' sub micron ', ' submicron ', ' efficacy evaluation ', ' Outcome ', ' human disease ', ' murine model ', ' mouse model ', ' parent project ', ' phenomics ', ' Geometry ', ' MERS corona virus ', ' MERS coronavirus ', ' MERS virus ', ' MERS-CoV ', ' Middle East Respiratory Syndrome Corona Virus ', ' Middle East Respiratory Syndrome Virus ', ' Middle East Respiratory Syndrome-CoV ', ' Middle Eastern Respiratory Syndrome Corona virus ', ' Middle Eastern Respiratory Syndrome Coronavirus ', ' Middle Eastern Respiratory Syndrome Virus ', ' Middle Eastern Respiratory Syndrome-CoV ', ' Middle East Respiratory Syndrome Coronavirus ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' X-ray microtomography ', ' Xray microtomography ', ' micro CT ', ' micro computed tomography ', ' microtomography ', ' microCT ', ' Tissue imaging ', ' humanized mice ', ' humanized mouse ', ' human imaging ', ' experiment ', ' experimental research ', ' experimental study ', ' pulmonary infections ', ' Lung infections ', ' computational basis ', ' COVID19 ', ' corona virus disease 2019 ', ' coronavirus disease 2019 ', ' COVID-19 ', ' MERS ', ' MERS coronavirus disease ', ' MERS-CoV disease ', ' Middle East Respiratory Syndrome CoV disease ', ' Middle East Respiratory Syndrome coronavirus disease ', ' Middle Eastern Respiratory Syndrome ', ' Middle Eastern Respiratory Syndrome CoV disease ', ' Middle Eastern Respiratory Syndrome coronavirus disease ', ' Middle East Respiratory Syndrome ', ' auto-segmentation ', ' automatic segmentation ', ' autosegmentation ', ' automated segmentation ', ' COVID-19 epidemic ', ' COVID19 epidemic ', ' COVID19 pandemic ', ' corona virus disease 2019 epidemic ', ' corona virus disease 2019 pandemic ', ' coronavirus disease 2019 epidemic ', ' coronavirus disease 2019 pandemic ', ' COVID-19 pandemic ', ' ']",OD,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,R24,2020,655483,0.061386686225544294
"Sleep metrics from machine learning for Alzheimer's disease diagnostics PROJECT SUMMARY This proposal is responsive to NIH solicitation PA-17-089 for projects involving secondary analysis of pre-existing geriatric datasets. While presently there is no cure for Alzheimers disease, existing literature indicates that early diagnosis in the preclinical stage, i.e., before the onset of clinical symptoms, will be key to treatments. There is a pressing need for noninvasive predictors of cognitive decline that can enable early identification of individuals at Alzheimers disease risk. A mounting body of scientific evidence suggests that sleep disturbances (including microarchitectural disruptions to non-rapid-eye-motion sleep and decline in sleep quality) might be the earliest observable symptoms of Alzheimers disease. On-the-go sleep and activity monitoring could address the need for noninvasive indicators of cognitive decline in subjects who are in the (asymptomatic or mildly symptomatic) preclinical stage of Alzheimers disease. Here, we will build on preliminary results that reveal a set of sleep features derived from polysomnography (PSG) that are predictive of cognitive performance. We are proposing to perform secondary analysis of sleep and cognition data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort using state-of-the-art deep learning tools to enable sleep-based prediction of cognitive impairment for early detection of Alzheimers disease. While PSG is the gold standard for sleep measurement, it is not well- suited for routine, day-to-day use. In comparison, wrist-based measurements (e.g. actigraphy, heart rate, ECG, and pulse oximetry) obtained from wearable devices allow on-the-go sleep monitoring. The combination of these on-the-go measures with the latest artificial intelligence tools is a feasible route to early Alzheimers diagnostics. We will use attention-guided long short-term memory autoencoders to identify overt and latent characteristics of the raw time-series datasets, which will allow us to more effectively mine the rich MESA data resource. Our deep learning framework will also take into account sociodemographic variables, indicators of health status, and medications. To ensure scientific rigor, secondary validation of the MESA-trained deep learning models will be performed on PSG and actigraphy data from the Harvard Aging Brain Study, which is a longitudinal study designed to further our understanding of what differentiates normal aging from preclinical Alzheimers disease. To address any concern about the black-box nature of deep learning models, we will compare the learned feature set with sleep microarchitectural features previously computed using classical statistical techniques. Previous data suggests that a subjects apolipoprotein 4 (ApoE4) allele carrier status influences the degree to which their sleep patterns impact their cognitive abilities. We will verify this by incorporating ApoE4 status as an additional input to the deep learning model. Literature shows that over 60% of patients with mild cognitive impairment and Alzheimers disease have at least one clinical sleep disorder. The on-the-go prediction paradigm using noninvasive sleep measurements to be validated in this project will have a significant impact on early Alzheimers diagnostics and facilitate ongoing clinical trials. PROJECT NARRATIVE Sleep disturbances are a common feature of dementia due to Alzheimers disease. Early detection of Alzheimers disease before the onset of symptoms would be critically important for disease management and therapeutics. In this R21 Exploratory Analyses Grant, we propose to develop and validate state-of-the-art deep learning tools to discover novel sleep-based predictors for Alzheimers disease through secondary analysis of sleep, activity, and cognitive data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort of human subjects.",Sleep metrics from machine learning for Alzheimer's disease diagnostics,10042952,R21AG068890,"['Affect ', ' Age ', ' ages ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Alleles ', ' Allelomorphs ', "" Alzheimer's Disease "", ' AD dementia ', ' Alzheimer ', ' Alzheimer Type Dementia ', ' Alzheimer disease ', ' Alzheimer sclerosis ', ' Alzheimer syndrome ', "" Alzheimer's "", "" Alzheimer's disease dementia "", ' Alzheimers Dementia ', ' Alzheimers disease ', ' Primary Senile Degenerative Dementia ', ' dementia of the Alzheimer type ', ' primary degenerative dementia ', ' senile dementia of the Alzheimer type ', ' Apolipoproteins ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Attention ', ' Clinical Trials ', ' Cognition ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Electrocardiogram ', ' ECG ', ' EKG ', ' Electrocardiography ', ' Electroencephalography ', ' EEG ', ' Eye ', ' Eyeball ', ' Goals ', ' Gold ', ' Grant ', ' Health Status Indicators ', ' Health Status Index ', ' Heart Rate ', ' Cardiac Chronotropism ', ' Learning ', ' Literature ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Motion ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Patients ', ' Pulse Oximetry ', ' Research Design ', ' Study Type ', ' study design ', ' Sleep ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Time ', ' Wrist ', ' Measures ', ' Dataset ', ' Data Set ', ' Sleep Monitoring ', ' Somnography ', ' polysomnographic ', ' sleep measurement ', ' sleep polysomnography ', ' Polysomnography ', ' base ', ' human subject ', ' improved ', ' Clinical ', ' Phase ', ' Series ', ' Ensure ', ' Training ', ' Individual ', ' Measurement ', ' Early Intervention ', ' Therapeutic ', ' Genetic ', ' tool ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' Diagnostic ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Consensus ', ' Disorder Management ', ' Disease Management ', ' Route ', ' Techniques ', ' Amentia ', ' Dementia ', ' Cognitive Manifestations ', ' Cognitive Symptoms ', ' Neurobehavioral Signs and Symptoms ', ' neurobehavioral symptom ', ' Neurobehavioral Manifestations ', ' early detection ', ' Early Diagnosis ', ' cohort ', ' novel ', ' Modality ', ' Devices ', ' Early identification ', ' sleep diseases ', ' sleep dysfunction ', ' sleep dysregulation ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' response ', ' drug development ', ' actigraph ', ' actigraphy ', ' Address ', ' Symptoms ', ' Data ', ' Cognitive ', ' Funding Opportunities ', ' Validation ', ' Monitor ', ' Characteristics ', ' preclinical ', ' pre-clinical ', ' National Institute of Aging ', ' National Institute on Aging ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' AD detection ', "" Alzheimer's detection "", ' Alzheimer disease detection ', ' aged brain ', ' aging brain ', ' Alzheimer risk factor ', ' alzheimer risk ', "" Alzheimer's disease risk "", ' normal aging ', ' high risk ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' drug candidate ', ' mild cognitive disorder ', ' mild cognitive impairment ', ' carrier status ', ' cognitive performance ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' cognitive assessment ', ' cognitive testing ', ' cognitive ability ', ' accelerometry ', ' activity monitor ', ' activity tracker ', ' Accelerometer ', ' secondary analysis ', ' data resource ', ' Multi-Ethnic Study of Atherosclerosis ', ' wearable electronics ', ' wearable technology ', ' wearable device ', ' quality of sleep ', ' sleep quality ', ' deep learning ', ' autoencoding neural network ', ' autoencoder ', ' machine learned algorithm ', ' machine learning algorithm ', ' long short term memory ', ' sleep pattern ', ' socio-demographic variables ', ' sociodemographic variables ', ' ']",NIA,UNIVERSITY OF MASSACHUSETTS LOWELL,R21,2020,256922,-0.01726130847533398
"Enhancing the I AM GOLD study with single-cell deep phenotyping and machine learning meta-analysis Project Summary/Abstract Patients with HIV are at increased risk for chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide. In this proposal, our long-term goal is to identify the mechanisms underlying the increased risk of COPD with HIV infection. Our central hypothesis is that enhanced Th17 driven inflammation and chronic Gammaproteobacteria-dominated airway microbiota interact to contribute to obstructive lung disease in HIV+ individuals. This hypothesis is based on the following evidence. First, we have found in HIV- uninfected COPD patients that a genomic signature of Th17 driven airway inflammation marks a COPD subgroup with functional small airway disease, which is thought to precede emphysema. Second, Th17 driven inflammation, a pathway classically thought to defend against bacteria, is enhanced in the airways of HIV+ patients. Third, our group has shown that amongst Ugandan HIV+ patients with pneumonia, a population at higher risk for lung function decline, there are subgroups characterized by distinct lower airway microbial communities with differing immune responses. One subgroup had Pseudomonadaceae-dominated airway microbiota and inflammatory gene expression. Gammaproteobacteria, which includes Pseudomonas, are commonly found in COPD and, as with Th17 inflammation, are associated with emphysema. Thus, the Pseudomonadaceae-dominant pneumonia subgroup may be at higher risk for developing chronic disease in the setting of continued dysbiosis and low level Th17 driven chronic inflammation. Our proposed specific aims will use existing and newly collected samples from our international multi-center study of HIV-associated COPD, I AM OLD (Inflammation, Aging, Microbes and Obstructive Lung Disease), in which HIV+ participants in Uganda and San Francisco are enrolled at the time of acute pneumonia and followed longitudinally. Aim 1 will identify the airway microbial communities and inflammatory gene expression markers at the time of acute infection that are associated with subsequent incident COPD and lung function decline in HIV. Aim 2 will identify the airway microbial communities and inflammatory gene expression markers during chronic stable disease that are enhanced in HIV+COPD compared to participants without COPD (HIV+COPD-). In Aim 3 we will perform integrative analyses of the airway microbiome, microbial and human transcriptome, metabolome and lung radiographic changes in HIV+COPD. We anticipate the following outcomes: 1) identification of the predominant airway microbiome-host response interactions associated with HIV+COPD in two international at- risk populations, 2) identification of metabolome alterations associated with specific microbial communities and inflammatory responses in HIV+COPD, 3) delineation of the range of radiographic abnormalities associated with microbiome-host response interactions in HIV+COPD. We expect these outcomes to have a positive impact, providing a new understanding of the biology underlying the enhanced risk for COPD amongst the HIV- infected population which could direct therapeutic interventions. Project Narrative In this proposal, our long-term goal is to identify the mechanisms underlying the increased risk of COPD with HIV infection. Our central hypothesis is that enhanced Th17 driven inflammation and chronic Gammaproteobacteria-dominated airway microbiota interact to contribute to obstructive lung disease in HIV+ individuals. We will test this hypothesis in an ongoing international multi-center study of HIV-associated COPD in which HIV+ participants in Uganda and San Francisco are enrolled at the time of acute pneumonia, characterized comprehensively for airway infection and the associated inflammatory response, and followed longitudinally.",Enhancing the I AM GOLD study with single-cell deep phenotyping and machine learning meta-analysis,10177730,R01HL143998,"['Aging ', ' Bacteria ', ' Biology ', ' Cause of Death ', ' Cells ', ' Cell Body ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Gene Expression ', ' Goals ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' Human ', ' Modern Man ', ' Infection ', ' Inflammation ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Patients ', ' Phenotype ', ' Pneumonia ', ' Pseudomonadaceae ', ' Pseudomonas ', ' Chrysemonas ', ' Flavimonas ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Risk ', ' San Francisco ', ' Testing ', ' Thoracic Radiography ', ' CXR ', ' chest X ray ', ' chest Xray ', ' chest radiography ', ' lung radiography ', ' radiographic chest image ', ' radiographic lung image ', ' thoracic radiogram ', ' thorax radiography ', ' Time ', ' Uganda ', ' Diagnostic radiologic examination ', ' Conventional X-Ray ', ' Diagnostic Radiology ', ' Diagnostic X-Ray ', ' Diagnostic X-Ray Radiology ', ' Radiography ', ' Roentgenography ', ' X-Ray Imaging ', ' X-Ray Medical Imaging ', ' Xray imaging ', ' Xray medical imaging ', ' conventional Xray ', ' diagnostic Xray ', ' diagnostic Xray radiology ', ' base ', ' Chronic ', ' Individual ', ' Populations at Risk ', ' Multi-center studies ', ' Multicenter Studies ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Inflammatory ', ' machine learned ', ' Machine Learning ', ' small airways disease ', ' microbial ', ' obstructive airway disease ', ' respiratory airway obstruction ', ' Obstructive Lung Diseases ', ' Stable Disease ', ' Participant ', ' Acute Pneumonia ', ' gamma Proteobacteria ', ' -Proteobacteria ', ' Gammaproteobacteria ', ' intervention therapy ', ' Therapeutic Intervention ', ' Sampling ', ' disease subgroups ', ' disease subtype ', ' disorder subtype ', ' Meta-Analysis ', ' Inflammatory Response ', ' International ', ' Subgroup ', ' enroll ', ' Enrollment ', ' pathway ', ' Pathway interactions ', ' decline in function ', ' decline in functional status ', ' functional status decline ', ' functional decline ', ' airway epithelium inflammation ', ' airway inflammation ', ' Outcome ', ' Population ', ' community microbes ', ' microbial community ', ' Microbe ', ' high risk ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' metabonome ', ' metabolome ', ' genomic classifier ', ' genomic signature ', ' acute infection ', ' dysbacteriosis ', ' dysbiotic ', ' microbial imbalance ', ' dysbiosis ', ' airway microbial community ', ' airway microbiota ', ' respiratory microbiota ', ' airway microbiome ', ' respiratory tract microbiome ', ' respiratory microbiome ', ' host microbiome ', ' ']",NHLBI,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2020,89962,-0.020121740748175083
"Eavesdropping on heart-brain conversations during sleep for early detection and prevention of fatal cardiovascular disease ABSTRACT  The intimate link between the heart, brain and sleep is central to our well-being and ability to meet the demands of life. A majority of cardiovascular (CV) deaths occur in the early waking hours from sleep. For example, sudden cardiac arrest (SCA), an extremely prevalent and devastating condition, claims more lives (>350,000/year) in the USA than all disease-related causes of death combined. A defibrillator can prevent SCA, but current clinical strategies are grossly inadequate, both in terms of identifying people at risk and importantly, monitoring and controlling the CV risk. To address this major gap, we are proposing an entirely novel approach for studying heart-brain interactions during sleep. To our knowledge, our compelling new preliminary data and innovative strategy are unprecedented.  In robust preliminary studies of animals and humans, we have identified unique signatures of evolving, potentially fatal, CV disease within electrocardiogram (ECG) and electroencephalogram (EEG) waveforms that otherwise cannot be detected by current clinical methods and conventional statistics. Our powerful new tools reveal these hidden signatures during sleep (i.e., as conscious activity decreases and autonomic control of the heart becomes prominent). This missing link we have identified between the heart, brain, spontaneous intrinsic arousals, and critical CV disease is independent (in multivariate analyses) of sleep disordered breathing (e.g., apnea) and established risk factors. Our novel and highly promising findings may account for the high incidence of CV deaths associated with sleep and have potential for broad application, ranging from animal models to improved reclassification of individuals currently consid- ered low, moderate or high risk in contemporary clinical practice. This is important because asymptomatic individ- uals without advanced CV disease comprise the majority of SCA victims. They also are the ones missed by current risk stratification methods and the most challenging to identify. Further, our fundamental new approach to EEG and ECG analysis will add new, clinically valuable, prognostic insight for patients with advanced CV disease (e.g., heart failure). This robust, inexpensive, personalized strategy for identifying who will and will not need lifesaving therapy will also avoid unnecessary procedures and complications, and thus, will provide substantial socioeconomic benefits.  This paradigm-shifting application for a NIH Directors New Innovator Award incorporates clinical cardiac electro- physiology, critical care and sleep medicine with engineering, mathematics, artificial intelligence, statistical dynamical systems, and molecular, cellular and clinical research to enable early diagnosis and therapy of critical CV disease. Our unique approach for gaining novel mechanistic insight into CV pathology and risk during sleep is likely to spawn new avenues in collaborative multidisciplinary research. Because our new paradigm can be seamlessly incorporated into existing technology readily available in hospitals and clinics, we expect our findings to rapidly transform contem- porary clinical practice in multiple fields. Importantly, the ability to identify and decode hidden EEG and ECG signa- tures of early onset of fatal, subclinical CV illness, including SCA, the leading cause of death in the industrialized world, has extraordinary implications for human health and the potential for broad worldwide application. NARRATIVE  The treatment of heart disease after clinical presentation has limited success. Irreversible organ system damage often initiates by the time the patient presents clinically. We seek to introduce, understand and validate a completely new approach for analyzing heart and brain signals to reveal information about evolving critical disease in an individual that otherwise would remain undetected by current clinical methods until catastrophic clinical presentation. If validated, this new paradigm will have extraordinary implications for human health and the potential to open new avenues in research and therapy.",Eavesdropping on heart-brain conversations during sleep for early detection and prevention of fatal cardiovascular disease,10002962,DP2HL157941,"['Animals ', ' Apnea ', ' Arousal ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Award ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Cause of Death ', ' Clinical Research ', ' Clinical Study ', ' Critical Care ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Electrocardiogram ', ' ECG ', ' EKG ', ' Electrocardiography ', ' Engineering ', ' Health ', ' Heart ', ' Heart Arrest ', ' Asystole ', ' Cardiac Arrest ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Heart failure ', ' cardiac failure ', ' Human ', ' Modern Man ', ' Incidence ', ' Industrialization ', ' Mathematics ', ' Math ', ' Medicine ', ' Methods ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Patients ', ' Personal Satisfaction ', ' well-being ', ' wellbeing ', ' Research ', ' Risk ', ' Risk Factors ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' statistics ', ' Technology ', ' Time ', ' Electric Shock Cardiac Stimulators ', ' Stimulators, Electrical, Cardiac, Shock ', ' Defibrillators ', ' improved ', ' Clinical ', ' Link ', ' prognostic ', ' insight ', ' Consciousness ', ' Conscious ', ' Individual ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' tool ', ' Life ', ' Unnecessary Procedures ', ' Hour ', ' Organ System ', ' body system ', ' Clinics or Hospitals ', ' Clinics and Hospitals ', ' early detection ', ' Early Diagnosis ', ' success ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' novel ', ' Prevention ', ' Cardiovascular Pathology ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Cardiac Electrophysiological Diagnostics ', ' cardiac electrophysiology ', ' Cardiac Electrophysiologic Techniques ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Monitor ', ' Molecular ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' Electroencephalogram ', ' early onset ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' innovate ', ' innovative ', ' innovation ', ' early therapy ', ' Early treatment ', ' high risk ', ' clinical practice ', ' dynamical system ', ' dynamic system ', ' individualized strategies ', ' personalized strategies ', ' Risk stratification ', ' ']",NHLBI,UNIVERSITY OF CINCINNATI,DP2,2020,2407500,0.07824953950660603
"Systems Biology in Vaping Product Exposure ABSTRACT Inhalation of electronically aerosolized vapors, or vaping, has grown substantially in the past decade. A recent outbreak of e-cigarette or vaping product use associated lung injury (EVALI) has raised concern for the public health impact of the behavior. Effects on the lung both acutely and chronically are not well-understood, and mechanisms of lung damage have not been fully elucidated. EVALI cases are in part thought to be due to in- halation of toxic chemicals, such as vitamin E acetate, contained within the diluent of the product; however, factors determining individual susceptibility to EVALI are unclear. Changes in the metabolic milieu of the lung could also alter the structure and function of the lung microbiome, further perpetuating injury. In preliminary studies, we have demonstrated alterations in the lung metabolome in EVALI patients compared to individuals with lung injury from other causes and to a healthy control and an HIV-infected individual with chronic vape use as well as alterations in pulmonary function with chronic vaping. In the current proposal, we will measure multi- ple parallel molecular and clinical datasets to test the hypothesis that interactions of the metabolome, microbi- ome, and the host are critical in development of injury secondary to e-vapor exposure. We will build a compre- hensive, systems-level model of the cellular and microbial milieu in the lung of subjects with chronic e-vapor exposure and from inpatients with acute EVALI to understand the transition from chronic exposure to acute injury. We will apply supervised and unsupervised machine learning algorithms to better understand and clas- sify features distinguishing acute vaping induced lung injury from non-vaping associated lung injury and from chronic lung injury related to e-vapor exposure. In addition, we will develop a novel ex vivo lung perfusion model that can be used for future mechanistic studies arising from our investigations. Leveraging the infra- structure within the Systems Biology of Diffusion Impairment in HIV study (R01HL140963), we have the oppor- tunity to examine a continuum of vaping and lung impairment including chronic vaping in a healthy population, chronic vaping in HIV+ individuals who may have enhanced susceptibility to vaping, and in patients with EVALI through the following aims: Aim 1: To identify causal molecular pathways underlying the host response to chronic e-vapor exposure by integrating clinical features and -omics data from ambulatory individuals. Aim 2: To identify predictive signatures of respiratory impairment from clinical features, transcriptomic, microbiome, and metabolomic data using clinical specimens from hospitalized individuals with EVALI. Aim 3: To develop a clinically relevant ex-vivo model of ENDD exposure to facilitate mechanistic investigation and evaluation of novel therapeutic interventions. This project will leverage existing resources to identify complex associations and causal relationships in vaping-associated lung injury and lay the groundwork for future mechanistic and therapeutic studies. Our study will fill a gap in understanding of the transcriptional, metabolic and microbial landscape of the respiratory tract in individuals with both chronic exposure to e-vapor products and EVALI. PROJECT NARRATIVE Inhalation of electronically aerosolized vapors, or vaping, has grown substantially in the past decade. Effects on the lung both acutely and chronically are not well-understood, and mechanisms that contribute to lung damage have not been fully elucidated. The complexity and the individualized differences in causes of these abnormalities have been challenging to unravel using traditional approaches. In this proposal, we construct a systems modeling approach to identify novel molecular and clinical pathways contributing to acute and chronic vaping-associated lung injury.",Systems Biology in Vaping Product Exposure,10114658,R01HL140963,"['Age ', ' ages ', ' Bacteria ', ' Behavior ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cell Count ', ' Cell Number ', ' Critical Illness ', ' Critically Ill ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diffusion ', ' Disease Outbreaks ', ' Outbreaks ', ' Future ', ' Glutamates ', ' L-Glutamate ', ' glutamatergic ', ' Histidine ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' Human ', ' Modern Man ', ' Inflammation ', ' Inpatients ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Patients ', ' Perfusion ', ' Poison ', ' Toxic Chemical ', ' Toxic Substance ', ' toxic compound ', ' Public Health ', ' Resources ', ' Research Resources ', ' Respiratory System ', ' Pulmonary Body System ', ' Pulmonary Organ System ', ' Respiratory Tracts ', ' Respiratory tract structure ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Sputum ', ' Supervision ', ' Testing ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Vitamin E ', ' Diagnostic radiologic examination ', ' Conventional X-Ray ', ' Diagnostic Radiology ', ' Diagnostic X-Ray ', ' Diagnostic X-Ray Radiology ', ' Radiography ', ' Roentgenography ', ' X-Ray Imaging ', ' X-Ray Medical Imaging ', ' Xray imaging ', ' Xray medical imaging ', ' conventional Xray ', ' diagnostic Xray ', ' diagnostic Xray radiology ', ' Vitamin E Acetate ', ' Tocopherol acetate ', ' alpha-tocopherol acetate ', ' alpha-tocopheryl acetate ', ' d-alpha-Tocopherol acetate ', ' d-alpha-tocopheryl acetate ', ' tocopherolacetate-d-alpha ', ' tocopheryl acetate ', ' cytokine ', ' Measures ', ' Dataset ', ' Data Set ', ' Secondary to ', ' injuries ', ' Injury ', ' Peripheral ', ' Acute ', ' Chronic ', ' Clinical ', ' Evaluation ', ' Susceptibility ', ' Predisposition ', ' Blood Serum ', ' Serum ', ' pulmonary function ', ' Individual ', ' Measurement ', ' Lung damage ', ' lung injury ', ' Clinical Pathways ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Exposure to ', ' Research Specimen ', ' Specimen ', ' Aspirate ', ' Aspirate substance ', ' Investigation ', ' Complex ', ' Oral ', ' System ', ' respiratory ', ' vapor ', ' endotracheal ', ' cohort ', ' microbial ', ' Structure ', ' novel ', ' Devices ', ' Modeling ', ' response ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Systems Biology ', ' Data ', ' Disease Pathway ', ' High Prevalence ', ' Therapy Research ', ' Therapeutic Studies ', ' in vivo ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' microbiome ', ' model of data ', ' model the data ', ' modeling of the data ', ' data modeling ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Population ', ' Consumption ', ' Impairment ', ' transcriptomics ', ' community microbes ', ' microbial community ', ' Cellular model ', ' Cell model ', ' clinical relevance ', ' clinically relevant ', ' aerosolized ', ' demographics ', ' new therapeutic approach ', ' new therapeutic intervention ', ' new therapeutic strategies ', ' new therapy approaches ', ' novel therapeutic approach ', ' novel therapy approach ', ' novel therapeutic intervention ', ' e-cig ', ' e-cigarette ', ' ecig ', ' ecigarette ', ' Electronic cigarette ', ' vaping ', ' model building ', ' metabonome ', ' metabolome ', ' predictive signature ', ' Electronic Nicotine Delivery Product ', ' electronic nicotine delivery device ', ' electronic nicotine distribution system ', ' Electronic Nicotine Delivery Systems ', ' Inhaling ', ' Inhalation ', ' metatranscriptomics ', ' 16S gene sequencing ', ' 16S rRNA amplicon sequencing ', ' 16S rRNA gene amplicon sequencing ', ' 16S rRNA gene sequencing ', ' 16S rRNA genomic profiling ', ' 16S rRNA sequencing ', ' 16S ribosomal RNA gene sequencing ', ' 16S sequencing ', ' 16S ribosomal RNA sequencing ', ' Molecular Disease ', ' pulmonary microbiome ', ' lung microbiome ', ' unsupervised machine learning ', ' unsupervised learning ', ' Infrastructure ', ' machine learned algorithm ', ' machine learning algorithm ', ' vaping product use associated lung injury ', ' vaping-related lung injury ', ' vaping associated lung injury ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2020,572242,0.09198152794278418
"Radiologist-Centered Artificial Intelligence (RCAI) for Lung Cancer Screening and Diagnosis  NARRATIVE Although artificial intelligence (AI) based computer aided diagnosis systems have been shown to be useful in lung cancer screening and diagnosis, current radiology practice still suffers from (1) high rates of missed tumors and (2) imprecise lung nodule characterization (malignant vs. benign). The goal of this proposal is to create novel AI algorithms, called radiologist-centered AI, which tightly integrate in real time the radiologist's reading pattern and AI via an eye-tracking device and to demonstrate their improved efficacy via lung cancer screening experiments using low-dose CT scans. The outcome of this research will be a virtual cognitive assistant (VCA) for radiologists, truly actively collaborating with them instead of passively acting as second opinion tools or replacing them, and ultimately further reducing lung cancer-related deaths.",Radiologist-Centered Artificial Intelligence (RCAI) for Lung Cancer Screening and Diagnosis,10339620,R01CA240639,[''],NCI,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2020,576431,0.15657245721634366
"Leveraging National Sleep Research Resource Data for Personalized Sleep Profiling PROJECT SUMMARY People vary in both the quantity and the quality of their sleep. Traditional sleep stages (for example, slow- wave sleep or REM sleep) can exhibit different neural correlates (as measured by electroencephalography, EEG) in different people and at different times during the night. Standard approaches for characterizing sleep (staging) do not take this variability into account, however. Here we suggest that attempts to use EEG and other data to infer sleep stages should in fact tackle the heterogeneity between and within individuals explicitly, to yield more accurate classification not just of an individuals minute-by-minute sleep, but of the sleepers typical characteristics more generally. Quantitative, data-driven individual sleep profiles will be important prerequisites for emerging large-scale molecular genetics and other omics studies of sleep, and for driving personalized sleep medicine more generally. Specifically, we propose to leverage more than ten thousand whole-night polysomnography (PSG) studies from the demographically diverse National Sleep Research Resource (NSRR), in order to optimally apply machine-learning methods to sleep signals. Most importantly, the NSRR dataset will enable approaches that take the fundamental heterogeneity of sleep into account: this is a rate-limiting step that has not been tackled by previous approaches. We hypothesize that it is not the large training set per se, but rather the increased prospects for better-matched training data, combined with the methods developed here, that will be beneficial. To this end, we will build and disseminate a novel, multi-level automated sleep classifier based on the worlds largest dataset of sleep signals. PROJECT NARRATIVE People vary considerably not just in how much they sleep, but also in the types of sleep they typically have. Standard approaches to describing sleep, primarily developed in the 1960s, only partially capture this variability: we propose to use a range of measures, including brain activity, on over ten thousand sleeping individuals to generate more accurate, data-driven, personalized profiles of how a person's sleep varies over a night. Sleep factors are associated with multiple physical and neuropsychiatric illnesses, and so better measurement of the underlying processes will be critical for future genetic and biomarker studies aimed at understanding the links between sleep, health and disease.",Leveraging National Sleep Research Resource Data for Personalized Sleep Profiling,9852475,R01HL146339,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Automobile Driving ', ' driving ', ' Awareness ', ' Beds ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Classification ', ' Systematics ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Electroencephalography ', ' EEG ', ' Exhibits ', ' Future ', ' Genetic Markers ', ' genetic biomarker ', ' Genome ', ' Goals ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Manuals ', ' Maps ', ' Medicine ', ' Methods ', ' Mythology ', ' Persons ', ' Phenotype ', ' Physiology ', ' Resources ', ' Research Resources ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Sleep ', ' Sleep Stages ', ' REM Sleep ', ' Fast-Wave Sleep ', ' Paradoxical Sleep ', ' Rhombencephalic Sleep ', ' dreaming sleep ', ' rapid eye movement sleep ', ' Supervision ', ' Testing ', ' Time ', ' Work ', ' Measures ', ' Morphologic artifacts ', ' Artifacts ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' Sleep Monitoring ', ' Somnography ', ' polysomnographic ', ' sleep measurement ', ' sleep polysomnography ', ' Polysomnography ', ' Guidelines ', ' base ', ' Label ', ' Link ', ' Training ', ' Delta Wave ', ' Delta Wave sleep ', ' Slow-Wave Sleep ', ' Individual ', ' Measurement ', ' Funding ', ' Genetic ', ' Staging ', ' Morphology ', ' tool ', ' Greek ', ' Neurocognitive ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' heuristics ', ' trait ', ' Stretching ', ' novel ', ' Reporting ', ' Modeling ', ' Sampling ', ' neuropsychiatric ', ' neuropsychiatry ', ' Property ', ' sleep onset ', ' genetic epidemiologic study ', ' genetic epidemiology ', ' Data ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' molecular scale ', ' Sleep Architecture ', ' Stage 1 Sleep ', ' Stage I Sleep ', ' Stage 2 Sleep ', ' Stage II Sleep ', ' NREM ', ' non-REM ', ' non-rapid eye movement ', ' nonREM ', ' nonrapid eye movement ', ' non rapid eye movement ', ' Outcome ', ' Individual Differences ', ' open source ', ' demographics ', ' real world application ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' neural correlate ', ' implicit bias ', ' data resource ', ' sleep hygiene ', ' sleep health ', ' analysis pipeline ', ' machine learning method ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,R01,2020,444813,0.1473452953485527
"Identification of immune cell-cell communication networks and inflammatory pulmonary microenvironments associated with the progression of COPD PROJECT SUMMARY Chronic obstructive pulmonary disease (COPD) is a fatal lung disease that is the fourth leading cause of death in the U.S. Despite an estimated $50 billion in yearly healthcare costs, it has no current cure and only palliat- ive treatments. COPD is clearly characterized by chronic lung inflammation that likely arises from dysregulat- ion of complex networks of immune factors and cells across multiple tissue compartments. Although multiple individual genes and proteins have been associated with COPD risk and progression, global mechanistic understanding of its pathophysiology is lacking, particularly regarding the marked heterogeneity in COPD phenotypes. The overall objective of our study is to gain systems-level insight into complex inflammatory and immune mechanisms underlying COPD, by applying data-driven (also called machine learning) modeling approaches to clinical samples collected from human pulmonary microenvironments and matched immune cell networks from peripheral blood. Our central hypothesis is that immune networks will be more predictive of COPD phenotype, progression, and exacerbation than individual factors. We will test this hypothesis in three Specific Aims, using matched brochoalveolar lavage (BAL) and blood samples collected in SPIROMICS I and II clinical trials. Aim 1 will identify changes in immune cell-cell communication networks, by high-throughput cytokine measurements from stimulated systems of peripheral blood immune cells from smokers with and without COPD and never-smoking controls (collected from the upcoming SPIROMICS II visit; n=150). Aim 2 will determine systems-level changes that occur in the inflamed lung microenvironment, using high-throughput cytokine measurements in BAL samples (both archival from SPIROMICS I, n=200, and collected during upcoming SPIROMICS II bronchoscopies) from smokers with and without COPD and never-smoking controls. We will identify networks associated with longitudinal clinical progression and exacerbation frequency. Aim 3 will integrate measurements across lung and blood tissue compartments to define key combinatorial relationships associated with progression and exacerbation events. Overall, this project will provide systems- level insight into COPD pathogenesis and progression, and create a new paradigm for the study of other pulmonary conditions involving chronic inflammation, including idiopathic pulmonary fibrosis, asthma, and lung transplant. Results will aid in the future development of new non-invasive diagnostic assays and will guide systems-level mechanistic studies that could result in new combinatorial therapies. PROJECT NARRATIVE The goal of this proposal is to gain new systems-level insight into chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide and an enormous cost burden in the U.S. yearly (~50 billion). Despite progress in identifying individual immune factors associated with COPD, there are only palliative treatment options and no cure. New insight generated by this project into how immune cell communication networks and inflammatory pulmonary microenvironments are altered in COPD could be used to identify diagnostic biomarkers and to guide the design of combinatorial therapies.",Identification of immune cell-cell communication networks and inflammatory pulmonary microenvironments associated with the progression of COPD,9888409,R01HL144849,"['Accounting ', ' Archives ', ' Asthma ', ' Bronchial Asthma ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Blood ', ' Blood Reticuloendothelial System ', ' Bronchoscopy ', ' Cause of Death ', ' Cell Communication ', ' Cell Interaction ', ' Cell-to-Cell Interaction ', ' Cells ', ' Cell Body ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Death Records ', ' Disease ', ' Disorder ', ' Epithelium ', ' Epithelium Part ', ' Flow Cytometry ', ' Flow Cytofluorometries ', ' Flow Cytofluorometry ', ' Flow Microfluorimetry ', ' Flow Microfluorometry ', ' flow cytophotometry ', ' Future ', ' Goals ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Immunologic Factors ', ' Immunological Factors ', ' immunologic substance ', ' immunological substance ', ' In Vitro ', ' Inflammation ', ' Irrigation ', ' Lavage ', ' Nonvaginal irrigation ', ' Nonvaginal lavage ', ' irrigation therapy ', ' lavage therapy ', ' other than vaginal Douching ', ' other than vaginal Irrigation ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Lung Transplantation ', ' Lung Grafting ', ' lung transplant ', ' Methods ', ' Mucous Membrane ', ' Mucosa ', ' Mucosal Tissue ', ' Palliative Care ', ' Palliative Therapy ', ' Palliative Treatment ', ' comfort care ', ' Patients ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Spirometry ', ' Testing ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Vision ', ' Sight ', ' visual function ', ' cytokine ', ' Measures ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' health care ', ' Healthcare ', ' Outcome Measure ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' Caring ', ' Blood Sample ', ' Blood specimen ', ' detector ', ' Bronchioalveolar Lavage ', ' Bronchopulmonary Lavage ', ' Lung Lavage ', ' bronchopulmonary lavage therapy ', ' Bronchoalveolar Lavage ', ' Chronic ', ' Clinical ', ' Physiologic ', ' Physiological ', ' prognostic ', ' Epithelial ', ' peripheral blood ', ' insight ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Funding ', ' non-invasive diagnosis ', ' non-invasive diagnostic ', ' noninvasive diagnostic ', ' noninvasive diagnosis ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Inflammatory ', ' Smoker ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Frequencies ', ' Immunes ', ' Immune ', ' Severities ', ' Complex ', ' Event ', ' System ', ' Visit ', ' experience ', ' cohort ', ' Participant ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' Position ', ' Positioning Attribute ', ' Protein Gene Products ', ' Gene Proteins ', ' Proteome ', ' Modeling ', ' Sampling ', ' Data ', ' Clinical Data ', ' enroll ', ' Enrollment ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' disease phenotype ', ' cost ', ' designing ', ' design ', ' adjudicate ', ' Outcome ', ' Lung Inflammation ', ' prospective ', ' combinatorial ', ' clinical relevance ', ' clinically relevant ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' new therapeutic approach ', ' new therapeutic intervention ', ' new therapeutic strategies ', ' new therapy approaches ', ' novel therapeutic approach ', ' novel therapy approach ', ' novel therapeutic intervention ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' prognostic ability ', ' prognostic power ', ' prognostic utility ', ' prognostic value ', ' diagnostic assay ', ' diagnostic marker ', ' diagnostic biomarker ', ' diffuse interstitial pulmonary fibrosis ', ' idiopathic pulmonary fibrosis ', ' never smoking ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2020,319844,0.0747921906345567
"The Role of the Microbiome in the Acute Respiratory Distress Syndrome     DESCRIPTION (provided by applicant): This K23 proposal will complete Robert Dickson, MD's training towards his long-term career goal of improving our understanding and treatment of lung disease by investigation of the microbiome. Dr. Dickson is a Pulmonary and Critical Care physician and scientist at the University of Michigan with established success in the burgeoning field of lung microbiome studies. This proposal builds on Dr. Dickson's previously acquired expertise in pulmonary pathophysiology and microbial ecology with new training in clinical research methods and computational biology. These established and newly-acquired skills will be integrated to improve our understanding of the role of the microbiome in the pathogenesis of the Acute Respiratory Distress Syndrome (ARDS). This research will be conducted under the guidance of primary mentor Gary B. Huffnagle PhD, co- mentor Theodore J. Standiford MD and an advisory board of accomplished investigators with expertise in clinical research methods, computational biology and lung immunology as well as extensive mentoring success. This 5-year plan includes formal coursework, professional development, and progressively independent research, with defined milestones to ensure productivity and a successful transition to independence. The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year. Numerous studies have identified indirect evidence of translocation of bacteria from the gastrointestinal tract to the lung in patients at risk for ARDS, but to date no study has evaluated the role of microbiome in the pathogenesis of ARDS. This proposal will test the hypothesis that translocation of gut bacteria to the lung provokes the inflammation and injury of ARDS via two specific Scientific Aims. Aim 1 will determine if translocation of enteric bacteria to the lung microbiome precedes the clinical development of ARDS, and Aim 2 will determine the temporal relationship between respiratory dysbiosis, host inflammation and the clinical onset of ARDS. Inherent to completing these high-level aims, Dr. Dickson will execute a prospective cohort study of patients at high risk for ARDS, utilize modern culture-independent techniques of bacterial identification to describe the bacterial communities in the lungs and gastrointestinal tracts of high-risk patients, and apply novel techniques of advanced computational modeling to the complex nonlinear system of ARDS pathogenesis. This work will build to at least two R01 proposals: 1) to determine if the lung microbiome contributes to disease progression among patients with established ARDS and 2) to determine if the lung microbiome can be therapeutically manipulated in critically ill patients to prevent or modulate respiratory disease. n addition to building a foundation for a programmatic line of research to understand the role of the microbiome in lung disease, this proposal will provide Dr. Dickson with research skills applicable to additional domains of human microbiome and ARDS research. This K23 award will equip Dr. Dickson to establish himself as an independent investigator and international leader in this promising field. PUBLIC HEALTH RELEVANCE: The Acute Respiratory Distress Syndrome (ARDS) is a major cause of morbidity, mortality and expense, responsible for an estimated 74,500 U.S. deaths per year; the National Institutes of Health have identified the prevention and early treatment of ARDS as a research priority. We lack an understanding of the pathogenesis of ARDS, impeding our ability to predict and prevent its onset. Determination of the role of the microbiome in the pathogenesis of ARDS would both 1) improve our ability to predict the onset of ARDS, enabling targeted preventive interventions and 2) identify novel therapeutic targets at the microbiome/host interface in patients at risk for ARDS.",The Role of the Microbiome in the Acute Respiratory Distress Syndrome,9852338,K23HL130641,"['Bacteria ', ' Catecholamines ', ' Sympathins ', ' Cells ', ' Cell Body ', ' Clinical Research ', ' Clinical Study ', ' Complement ', ' Complement Proteins ', ' Critical Care ', ' Critical Illness ', ' Critically Ill ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Ecology ', ' Environmental Science ', ' Enterobacter ', ' Aerobacter ', ' Enterobacteriaceae ', ' Coliform Bacilli ', ' Enteric Bacteria ', ' Enterobacteria ', ' Epinephrine ', ' Adrenaline ', ' Therapeutic Epinephrine ', ' Foundations ', ' Future ', ' Gastrointestinal tract structure ', ' Alimentary Canal ', ' Digestive Tract ', ' GI Tract ', ' Gastrointestinal Tract ', ' alimentary tract ', ' digestive canal ', ' Goals ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Immigration ', ' indexing ', ' Inflammation ', ' Interleukin-1 beta ', ' Beta Proprotein Interleukin 1 ', ' IL-1 beta ', ' IL-1  ', ' IL-1-b ', ' IL-1 ', ' IL1-Beta ', ' IL1- ', ' IL1B Protein ', ' IL1F2 ', ' IL1 ', ' Interleukin 1beta ', ' Interleukin-1 ', ' Preinterleukin 1 Beta ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Mentors ', ' Michigan ', ' Modernization ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' neutrophil ', ' Blood Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Marrow Neutrophil ', ' Neutrophilic Granulocyte ', ' Neutrophilic Leukocyte ', ' Polymorphonuclear Cell ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Neutrophils ', ' Norepinephrine ', ' Levarterenol ', ' Levonorepinephrine ', ' Noradrenaline ', ' Patients ', ' Physicians ', ' Productivity ', ' outcome forecast ', ' Prognosis ', ' Pseudomonas ', ' Chrysemonas ', ' Flavimonas ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Adult Respiratory Distress Syndrome ', ' ARDS ', ' Acute Respiratory Distress ', ' Acute Respiratory Distress Syndrome ', ' Adult ARDS ', ' Adult RDS ', ' Da Nang Lung ', ' Shock Lung ', ' Stiff lung ', ' wet lung ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Testing ', ' Universities ', ' Work ', ' cytokine ', ' Research Methods ', ' Research Methodology ', ' Immunology ', ' injuries ', ' Injury ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' Logistic Regressions ', ' Nonlinear Models ', ' Non-linear Models ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Development Plans ', ' Disease Progression ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Therapeutic ', ' Inflammatory ', ' machine learned ', ' Machine Learning ', ' Research Priority ', ' computer biology ', ' Computational Biology ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Complex ', ' Techniques ', ' System ', ' respiratory ', ' gastrointestinal ', ' success ', ' gastrointestinal bacteria ', ' microbial ', ' skills ', ' novel ', ' member ', ' Prevention ', ' Pathogenesis ', ' gamma Proteobacteria ', ' -Proteobacteria ', ' Gammaproteobacteria ', ' (TNF)- ', ' Cachectin ', ' Macrophage-Derived TNF ', ' Monocyte-Derived TNF ', ' TNF ', ' TNF A ', ' TNF Alpha ', ' TNF- ', ' TNFA ', ' TNF ', ' Tumor Necrosis Factor ', ' Tumor Necrosis Factor-alpha ', ' TNF gene ', ' Modeling ', ' Sampling ', ' career development ', ' preventing ', ' prevent ', ' Alveolar ', ' Ph.D. ', ' PhD ', ' Doctor of Philosophy ', ' International ', ' K23 Award ', ' K23 Mechanism ', ' K23 Program ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' Mentored Patient-Oriented Research Career Development Award ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' Clinical Data ', ' Computational Technique ', ' developmental ', ' Development ', ' microbiome ', ' human-associated microbiome ', ' Human Microbiome ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' blood infection ', ' bloodstream infection ', ' Sepsis ', ' Trauma ', ' early therapy ', ' Early treatment ', ' patient centered ', ' patient oriented ', ' spatiotemporal ', ' high risk ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' public health relevance ', ' GI microbiota ', ' Gastrointestinal microbiota ', ' enteric microbial community ', ' enteric microbiota ', ' gastrointestinal microbial flora ', ' gut commensal ', ' gut community ', ' gut flora ', ' gut microbe community ', ' gut microbial community ', ' gut microbial composition ', ' gut microbial consortia ', ' gut microbiotic ', ' gut microflora ', ' intestinal flora ', ' intestinal microbes ', ' intestinal microbiota ', ' intestinal microflora ', ' intestinal tract microflora ', ' gut microbiota ', ' clinical risk ', ' Prospective cohort study ', ' clinical development ', ' bacterial microbiome ', ' bacteriome ', ' Microbiomics ', ' microbiome science ', ' microbiome studies ', ' microbiome research ', ' culture-independent analyses ', ' culture-independent approaches ', ' culture-independent molecular techniques ', ' culture-independent techniques ', ' Culture-independent methods ', ' bacteria in the gut ', ' gut bacteria ', ' dysbacteriosis ', ' dysbiotic ', ' microbial imbalance ', ' dysbiosis ', ' pulmonary microbiome ', ' lung microbiome ', ' lung microbial community ', ' pulmonary microbial community ', ' pulmonary microbiota ', ' lung microbiota ', ' bacterial community ', ' airway microbiome ', ' respiratory tract microbiome ', ' respiratory microbiome ', ' host microbiome ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K23,2020,172800,0.11607683332915562
"An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD ! Abstract  Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death worldwide with a devastating socio-economic burden impacting more than three million individuals per year in the US. The primary environmental risk factor in the susceptible population is smoking, which causes an exaggerated inflammatory response. However, many factors including several genetic risk variants substantially influence the susceptibility. Twin-based studies show that families with emphysema have a higher risk for the disease. The two different major phenotypes of COPD are small airway remodeling (airway disease) and alveolar destruction (emphysema). Although these two major phenotypes result in a similar deficiency in global lung function, the relationship between them is complicated and likely involves feedback mechanisms. Developing an objective method to characterize lung phenotypes is critical since treatment candidates vary based on phenotype. Measurements from High-Resolution Computed Tomography (HRCT) images are increasingly used to describe COPD since they can quantitatively describe the contribution of the phenotypes. To discover the genetic risk variants, Genome-Association Studies (GWAS) have focused on either the physiological lung function or a simple threshold-based measurement from lung CT, neither of which fully characterizes phenotypic subtypes or the distribution pattern of disease. The proposed studies will take advantage of the rich image and genetic data jointly to build a genetically-informed imaging biomarker to characterize each patient. For each patient, our method summarizes the CT image to a vector representation that accurately describes the severity of the disease. Also, a method to link the representation back to the genetic risk variants will be developed. If successful, these methods can be used to monitor the efficacy of treatment or progression of the disease using imaging data. Successful execution of the second aim will result in better understanding of the etiology of different disease subtypes and discovery of novel genetic pathways that could be used as potential drug targets. Furthermore, the patient representation enables the use of image data to construct a more powerful model to predict the so-called acute exacerbation event. Predicting the exacerbations is clinically important since they cause further damage to the lung.  In Aim 1, we develop and implement a novel image biomarker that is mutually informed by imaging and genetic data from each patient. Our statistical method in Aim 2 elucidates the underlying genetic pathways behind the abnormal anatomical variations explained by the biomarker. We validate our method on data from 10,300 patients in the COPDGene dataset. ! Narrative  Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death worldwide with a devastating socio-economic burden impacting more than three million individuals per year in the US. Measurements from High-Resolution Computed Tomography (HRCT) images are increasingly used to describe COPD. Many factors including several genetic risk variants substantially influence the susceptibility. We propose to take advantage of the rich image and genetic data jointly to understand the underlying biological causes of the disease and discovery of novel genetic pathways that could be used as potential drug targets.",An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD,9934266,R01HL141813,"['Affect ', ' Air Movements ', ' air flow ', ' airflow ', ' airway obstruction ', ' airflow limitation ', ' airflow obstruction ', ' airway limitation ', ' obstructed airflow ', ' obstructed airway ', "" Alzheimer's Disease "", ' AD dementia ', ' Alzheimer ', ' Alzheimer Type Dementia ', ' Alzheimer disease ', ' Alzheimer sclerosis ', ' Alzheimer syndrome ', "" Alzheimer's "", "" Alzheimer's disease dementia "", ' Alzheimers Dementia ', ' Alzheimers disease ', ' Primary Senile Degenerative Dementia ', ' dementia of the Alzheimer type ', ' primary degenerative dementia ', ' senile dementia of the Alzheimer type ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Back ', ' Dorsum ', ' Cause of Death ', ' Chronic Bronchitis ', ' Disease ', ' Disorder ', ' Disease Vectors ', ' Family ', ' Feedback ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genome ', ' Genotype ', ' Goals ', ' Joints ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Mathematics ', ' Math ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Patients ', ' Phenotype ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Risk Factors ', ' Smoking ', ' Spirometry ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Twin Multiple Birth ', ' Twins ', ' Measures ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' Area ', ' Acute ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Susceptibility ', ' Predisposition ', ' lung lobe ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Descriptor ', ' Anatomic Abnormality ', ' Anatomical Abnormality ', ' Deformity ', ' Genetic ', ' clinical Diagnosis ', ' machine learned ', ' Machine Learning ', ' Pollution ', ' Dimensions ', ' Complex ', ' Event ', ' Pattern ', ' disease severity ', ' Severity of illness ', ' small airways disease ', ' attenuation ', ' novel ', ' economic cost ', ' disease risk ', ' disorder risk ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Reporting ', ' Statistical Methods ', ' FEV1 ', ' FEV1%VC ', ' Forced Expiratory Volume 1 Test ', ' Forced Expiratory Volume in 1 Second ', ' PFT/FEV1 ', ' Pulmonary Function Test/Forced Expiratory Volume 1 ', ' Modeling ', ' drug development ', ' disease subgroups ', ' disease subtype ', ' disorder subtype ', ' Pathogenicity ', ' Inflammatory Response ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Address ', ' Data ', ' Economic Burden ', ' high resolution CT ', ' High Resolution Computed Tomography ', ' Resolution ', ' Genetic Risk ', ' Pathologic ', ' Monitor ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' vector ', ' designing ', ' design ', ' airway remodeling ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' Population ', ' alveolar destruction ', ' Heritability ', ' endophenotype ', ' high risk ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' Risk-associated variant ', ' risk allele ', ' risk gene ', ' risk genotype ', ' risk loci ', ' risk locus ', ' risk variant ', ' Drug Targeting ', ' Radiogenomics ', ' noninvasive imaging ', ' non-invasive imaging ', ' CT Lung Screening ', ' Lung CT ', ' Lung CT scan ', ' computerized tomography lung screening ', ' lung computerized axial tomography scan ', ' lung computerized tomography ', ' lung computerized tomography scan ', ' Lung CAT Scan ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' genotyped patients ', ' imaging genetics ', ' high dimensionality ', ' Airway Disease ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2020,564472,0.07328307427471549
"Microtemporal Processes Underlying Health Behavior Adoption and Maintenance SUMMARY Emerging adulthood (ages 18-24 years) is marked by substantial weight gain, leading to increased lifetime risks of cancer and other chronic diseases. Engaging in sufficient levels of physical activity and sleep, and limiting sedentary time are important contributors to the prevention of weight gain. However, engaging in these healthy behaviors peaks during the childhood and adolescent years, and steeply deteriorates into emerging adulthood. Interventions promoting physical activity, reduced sedentary time, and sufficient sleep typically focus on the adoption of these behaviors. Yet, when these interventions are successful, new patterns of behavior are not maintained and typically regress back to baseline levels. Traditional health behavior theories provide limited guidance regarding factors underlying behavior maintenance. To address this gap, our work suggests that dual-process models of decision-making and behavior can shed light on differences in the mechanisms underlying adoption versus maintenance. Reflective processes (e.g., efficacy, deliberations, self-control) may be activated to a greater extent during behavior adoption. In contrast, reactive processes (e.g., contextual cues, automaticity, habits) may play a greater role in behavior maintenance. However, reactive processes are difficult to measure using retrospective methods because they can unfold on a micro-timescale (i.e., change across minutes or hours). To solve this problem, we propose to use real-time mobile technologies to collect intensive longitudinal data examining differences in the micro-temporal processes underlying the adoption and maintenance of physical activity, low sedentary time, and sufficient sleep duration. We will conduct a prospective within- subject case-crossover observational study across a 12-month period. Ethnically-diverse, emerging adults (ages 18-24, N=300) will be recruited from the Happiness & Health Cohort (R01DA033296). We will conduct intermittent self-report (i.e., ecological momentary assessment) of reflective variables; and continuous, sensor- based passive monitoring of reactive variables (e.g., location, social proximity, voice/text communication) and behaviors (i.e., physical activity, sedentary time, sleep) using smartwatches and smartphones. These data will be used to predict within-subject variation (within-days, between-days) in the likelihood of behavior episodes (e.g., 10 min of physical activity, 120 min sedentary time, 7 hr sleep) and lapses (i.e., failure to achieve recommended levels 7 days). The specific aims are to (1) idiographically use machine learning to identify person-specific combinations of time-varying reflective and reactive factors that predict behavior episodes and lapse; and (2) nomothetically determine whether there are general, group-level patterns of time-varying predictors, and whether those patterns predict successful behavior maintenance outcomes. The data and methods from this project will contribute to the U01/U24 Intensive Longitudinal Behavior Initiatives collective goal to build more predictive health behavior theories that specify targets for personalized interventions. PROJECT NARRATIVE Weight gain increases dramatically emerging adulthood, increasing risk of cancer and chronic disease later in life. This study will use mobile technologies to collect intensive longitudinal data on micro-temporal mechanisms underlying the adoption and maintenance of physical activity, limited sedentary time, and sufficient sleep duration in emerging adults. Results will be used to build more predictive health behavior theories and inform personalized behavior interventions to reduce obesity and improve public health.",Microtemporal Processes Underlying Health Behavior Adoption and Maintenance,9985623,U01HL146327,"['Adoption ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Cues ', ' Decision Making ', ' Exhibits ', ' Goals ', ' Habits ', ' Happiness ', ' positive attitude ', ' Health ', ' Health behavior ', ' Light ', ' Photoradiation ', ' Maintenance ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Methods ', ' Methodology ', ' Persons ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Play ', ' Problem Solving ', ' Public Health ', ' Relapse ', ' Research ', ' Role ', ' social role ', ' Sleep ', ' Specificity ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Vision ', ' Sight ', ' visual function ', ' Voice ', ' Weight Gain ', ' Weight Increase ', ' body weight gain ', ' body weight increase ', ' wt gain ', ' Work ', ' Measures ', ' base ', ' communication behavior ', ' sensor ', ' improved ', ' sedentary ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Variation ', ' Variant ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Physical activity ', ' Failure ', ' pediatric ', ' Childhood ', ' Individual ', ' machine learned ', ' Machine Learning ', ' Life ', ' Adopted ', ' Hour ', ' Pattern ', ' Location ', ' cancer risk ', ' cohort ', ' Structure ', ' Self-Report ', ' Patient Self-Report ', ' Predictive Factor ', ' self control ', ' Self-control as a personality trait ', ' social ', ' Modeling ', ' theories ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' life-time risk ', ' lifetime risk ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Monitor ', ' trend ', ' Characteristics ', ' Process ', ' Text ', ' developmental ', ' Development ', ' Behavioral ', ' weight gain prevention ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' prospective ', ' demographics ', ' successful intervention ', ' early adulthood ', ' emerging adult ', ' emerging adulthood ', ' Sedentary behavior ', ' Sedentary life-style ', ' sedentary lifestyle ', ' precision interventions ', ' personalized intervention ', ' Ecological momentary assessment ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' ethnically diverse ', ' ethnic diversity ', ' recruit ', ' smartwatch ', ' smart watch ', ' sleep habit ', ' sleep behavior ', ' ']",NHLBI,UNIVERSITY OF SOUTHERN CALIFORNIA,U01,2020,663609,0.04711646592084497
"Determinants of insufficient sleep among blacks and effects on disparities in health outcomes Project Summary Insufficient sleep (IS), stemming from sleep apnea, shift work, insomnia, working over 40 hr./week, unfavorable sleep environments and/or volitional reduction of bedtime, is associated with increased risk of cardiovascular disease (CVD) markers (elevated blood pressure, insulin resistance, dyslipidemia and arterial stiffness), inflammatory markers (interleukin-6, tumor necrosis factor-, and C-reactive protein) as well as with brain injury. Compelling evidence shows racial/ethnic disparities in insufficient sleep (IS), with blacks exhibiting a three-fold greater risk of IS relative to whites. Disparities might arise from physiologic and genetic factors, but recent evidence suggests environmental and psychosocial factors are also critical determinants. This study will utilize innovative dynamic modeling in a multi-level framework to delineate the psychosocial and environmental determinants (associative factors) of actigraphic IS and its putative associations with adverse health outcomes among blacks. Individual- and contextual-level data will be captured using novel home-based recordings and GIS data to model the environmental context where sleep occurs. The proposed study will leverage success of the NYU Sleep Disparity Workgroup led by Dr. Jean- Louis (PI), who has been conducting community-engaged sleep research for over 10 years. The workgroup comprises outstanding investigators with expertise in sleep and circadian rhythm, CVD, brain health, health disparities, translational behavioral medicine, and multi-level dynamic modeling. The study will benefit from experience of our standing Community Steering Committee, enabling recruitment of 560 blacks in various venues to participate in weeklong home studies to achieve proposed study aims. The multidisciplinary team will: 1) identify psychosocial (social support, discrimination, and attitudes/beliefs) and environmental (household [density, noise, light, and temperature], socioeconomic position, social capital, and neighborhood [built environment]) factors that are associated with IS; ascertain effects of IS on (a) markers of CVD (obesity, BP, lipid profile, and glucose/ HbA1C) and inflammation (IL-6, IL-10, and TNF-) and on (b) markers of brain injury (tau, amyloid-, neurofilament light, homocysteine, and glial fibrillary acidic protein; and develop profiles of blacks with IS-related adverse health outcomes using individual- and environmental-level data applying innovative multi-level dynamic modeling tools (Bayesia Belief Network and Agent-Based Simulation). This study will provide evidence to delineate factors underlying greater rates of IS among blacks and explain putative associations with markers of CVD, inflammation, and brain injury. These data will provide the foundation for longitudinal studies assessing causal effects of IS on these novel markers and interventions to mitigate adverse effects of IS on health outcomes. Project Narrative This proposal is predicated upon compelling data that blacks exhibit a three-fold greater risk of insufficient sleep (<7 hours) compared with whites, and that insufficient sleep is associated with increased risk of cardiovascular disease and brain injury. It will provide multi-level evidence on the impact of the psychosocial and environmental factors on insufficient sleep among blacks. These data will provide the foundation for interventions to mitigate adverse effects of insufficient sleep on health outcomes among blacks.",Determinants of insufficient sleep among blacks and effects on disparities in health outcomes,9928494,R01HL142066,"['Attitude ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Behavioral Medicine ', ' Behavioral Sciences ', ' Belief ', ' Blood Pressure ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Circadian Rhythms ', ' Nyctohemeral Rhythm ', ' Twenty-Four Hour Rhythm ', ' circadian process ', ' daily biorhythm ', ' Communities ', ' Discrimination ', ' Cognitive Discrimination ', ' Environment ', ' Exhibits ', ' Foundations ', ' Glial Fibrillary Acidic Protein ', ' Astroprotein ', ' GFA-Protein ', ' GFAP ', ' Glial Fibrillary Acid Protein ', ' Glial Intermediate Filament Protein ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Health ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Homocysteine ', ' Household ', ' Inflammation ', ' Insulin Resistance ', ' insulin resistant ', ' Interleukin-6 ', ' B cell differentiation factor ', ' B cell stimulating factor 2 ', ' B-Cell Differentiation Factor ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Stimulatory Factor-2 ', ' BCDF ', ' BSF-2 ', ' BSF2 ', ' HPGF ', ' Hepatocyte-Stimulating Factor ', ' Hybridoma Growth Factor ', ' IFN-beta 2 ', ' IFNB2 ', ' IL-6 ', ' IL6 Protein ', ' MGI-2 ', ' Myeloid Differentiation-Inducing Protein ', ' Plasmacytoma Growth Factor ', ' interferon beta 2 ', ' Laboratories ', ' Light ', ' Photoradiation ', ' Lipids ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Morbidity - disease rate ', ' Morbidity ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Neighborhoods ', ' neurofilament ', ' Noise ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Psychosocial Factor ', ' psychosocial variables ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Role ', ' social role ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Social support ', ' social support network ', ' Temperature ', ' Time ', ' Volition ', ' Amyloid beta-Protein ', ' Alzheimer beta-Protein ', "" Alzheimer's Amyloid beta-Protein "", "" Alzheimer's amyloid "", "" Amyloid Alzheimer's Dementia Amyloid Protein "", ' Amyloid Beta-Peptide ', ' Amyloid Protein A4 ', ' Amyloid  ', ' Amyloid -Peptide ', ' Amyloid -Protein ', ' A ', ' a beta peptide ', ' abeta ', ' amyloid beta ', ' amyloid-b protein ', ' beta amyloid fibril ', ' soluble amyloid precursor protein ', ' Interleukin-10 ', ' CSIF ', ' CSIF-10 ', ' Cytokine Synthesis Inhibitory Factor ', ' IL-10 ', ' IL10 ', ' IL10A ', ' Interleukin 10 Precursor ', ' tau Proteins ', ' MT-bound tau ', ' microtubule bound tau ', ' microtubule-bound tau ', ' tau ', ' tau factor ', '  Proteins ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' base ', ' density ', ' Area ', ' Physiologic ', ' Physiological ', ' Individual ', ' Dyslipidemias ', ' Acquired brain injury ', ' brain damage ', ' brain-injured ', ' Brain Injuries ', ' Genetic ', ' Exposure to ', ' Inflammatory ', ' tool ', ' Level of Evidence ', ' Hour ', ' Home ', ' Home environment ', ' psychosocial ', ' environmental stressor ', ' experience ', ' success ', ' arterial stiffening ', ' artery stiffening ', ' artery stiffness ', ' arterial stiffness ', ' simulation ', ' novel ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Devices ', ' Reporting ', ' social ', ' (TNF)- ', ' Cachectin ', ' Macrophage-Derived TNF ', ' Monocyte-Derived TNF ', ' TNF ', ' TNF A ', ' TNF Alpha ', ' TNF- ', ' TNFA ', ' TNF ', ' Tumor Necrosis Factor ', ' Tumor Necrosis Factor-alpha ', ' TNF gene ', ' Emotional ', ' sleep diseases ', ' sleep dysfunction ', ' sleep dysregulation ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Adverse effects ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' Metabolic syndrome ', ' vulnerable group ', ' Vulnerable Populations ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' disparity in health ', ' health disparity ', ' Low income ', ' Address ', ' social capital ', ' Data ', ' Disease Marker ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Monitor ', ' Modification ', ' day shift ', ' night shift ', ' night work ', ' shiftwork ', ' shift work ', ' under served population ', ' underserved people ', ' Underserved Population ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' ethnic minority ', ' ethnic minority population ', ' multidisciplinary ', ' racial and ethnic ', ' stem ', ' racial and ethnic disparities ', ' high risk ', ' inflammation marker ', ' inflammatory marker ', ' new marker ', ' novel biomarker ', ' novel marker ', ' Healthy People 2020 ', ' built environment ', ' brain health ', ' reduce disparity ', ' disparity reduction ', ' circadian desynchronization ', ' circadian misalignment ', ' Circadian desynchrony ', ' recruit ', ' Bayesian machine learning ', ' Bayesian learning ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2020,822942,0.08449226091599091
"Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study ABSTRACT Short sleep duration, insomnia disorder, and sleep apnea are all highly prevalent in the US population and are associated with significant morbidity, including poor mental health, impaired neurocognitive function, metabolic dysregulation, and cardiovascular disease. In the context of the high prevalence of pernicious sleep disturbances, there is evidence that sleep disparities exist in the population, such that racial/ethnic minorities  including Mexican-Americans  are at increased risk of sleep disturbances. This is alarming, since this group is also at increased risk for many of the adverse cardiometabolic and functional outcomes linked to sleep disturbances. These associations may be influenced by economic hardship, psychosocial stress, unhealthy behaviors (diet, exercise, alcohol, and smoking), and acculturation  the degree to which an individual adopts (in this case) traditional Mexican versus American culture. The first goal of this project is to examine sleep duration, insomnia symptoms, and sleep apnea severity among Mexican-Americans and examine the role of these social-behavioral factors in this relationship. Second, this study aims to examine the role of sleep and cardiometabolic disease risk in this population and explore the role of acculturation, psychosocial stress, economic hardship, and/or unhealthy behaviors in these associations. To accomplish this, this project will partner with the Mariposa Community Health Center, the federally qualified clinic in the Nogales, AZ area. Nogales is a small city on the US/Mexico border that is an ideal location for studying non-urban Mexican- Americans, as it is made up of 83% Hispanics/Latinos, 33% immigrants, and 77% who primarily speak Spanish at home. This community-engaged project will partner with Mariposa and their Platicamos Salud program that uses experienced Community Health Workers (promotoras de salud) to collect data and perform home visits. The study will recruit N=900 Mexican-Americans and N=200 Non-Hispanic Whites to complete a battery of assessments from a clinic visit (questionnaires, interviews, exam for anthropometry and arterial stiffness, and collection of biomarkers), a 1-night home sleep apnea assessment, a 24-hour ambulatory blood pressure recording, and a 2-week home monitoring period with sleep diary and actigraphy. This will result in a rich dataset that can help to identify and reduce sleep disparities in the population and point to potential intervention approaches to reducing cardiometabolic disease disparities. The analytic plan will take advantage of a machine-learning analytic approach, which will be used to evaluate the complex relationships among all of these variables. This project will address many relevant issues in sleep medicine, health disparities research, and border health. The partnership with Mariposa will enhance recruitment, promote research integrity (or ensure appropriateness of research methods), and facilitate dissemination of the study results into the community through education programs associated with Platicamos Salud and other community outreach efforts. PROJECT NARRATIVE The primary goal of this study is to assess sleep health among Mexican-Americans at the US/Mexico border, characterize relationships with cardiometabolic disease risk, and investigate the role of social-environmental factors including acculturation, stress, socioeconomics, and health behaviors. Short sleep duration, insomnia disorder, and sleep apnea are highly prevalent in the population. These conditions are associated with cardiovascular disease, diabetes, daytime functioning problems, and poor mental health. Disparities in sleep health in racial/ethnic minorities exist, including Mexican-Americans. In particular, social-environmental factors at the US-Mexico border may play an important role in sleep health disparities. This project will not only allow for increased understanding of the complex relationship among sleep, health, and social-environmental pressures, but through a community partnership it can maximize our ability to reduce these disparities. Also, this project has the added benefit of providing information about the role of sleep as a potentially modifiable factor in cardiovascular disease and diabetes disparities as well.",Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study,10188262,R01MD011600,"['Acculturation ', ' Cultural Assimilation ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Alcohols ', ' Alcohol Chemical Class ', ' Anthropometry ', ' Behavior ', ' Blood Pressure ', ' Blood Vessels ', ' vascular ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Cities ', ' Clinic Visits ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Community Developments ', ' Community Health Aides ', ' community health worker ', ' Diabetes Mellitus ', ' diabetes ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Economics ', ' Education ', ' Educational aspects ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Goals ', ' Health ', ' Health behavior ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' indexing ', ' Inflammation ', ' Interview ', ' Lipids ', ' High Density Lipoproteins ', ' HDL ', ' HDL Lipoproteins ', ' Heavy Lipoproteins ', ' High density lipoprotein ', ' alpha-Lipoproteins ', ' LDL Cholesterol Lipoproteins ', ' LDL Cholesterol ', ' Low Density Lipoprotein Cholesterol ', ' beta-Lipoprotein Cholesterol ', ' Medicine ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Mexican Americans ', ' Chicanas ', ' Chicanos ', ' Mexico ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Phenotype ', ' Play ', ' Poverty ', ' pressure ', ' Questionnaires ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Smoking ', ' Social support ', ' social support network ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Weight Gain ', ' Weight Increase ', ' body weight gain ', ' body weight increase ', ' wt gain ', ' Work ', ' low density lipoprotein triglyceride ', ' LDL triglyceride ', ' LDL triglyceride lipoprotein ', ' triacylglycerol LDL ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Latino ', ' Community Health Centers ', ' Satellite Centers ', ' Neighborhood Health Center ', ' Research Methods ', ' Research Methodology ', ' Dataset ', ' Data Set ', ' base ', ' specimen collection ', ' sample collection ', ' Area ', ' Link ', ' Ensure ', ' Physical activity ', ' white American ', ' caucasian American ', ' Blood Serum ', ' Serum ', ' Individual ', ' Mexican ', ' Ethnicity ', ' Ethnic Origin ', ' Community Outreach ', ' Immigrant ', ' Metabolic ', ' machine learned ', ' Machine Learning ', ' diaries ', ' programs ', ' Adopted ', ' Hour ', ' Severities ', ' Complex ', ' Home ', ' Home environment ', ' Clinic ', ' Location ', ' Syndrome, Sleep Apnea, Obstructive ', ' Obstructive Sleep Apnea ', ' American ', ' experience ', ' stressor ', ' arterial stiffening ', ' artery stiffening ', ' artery stiffness ', ' arterial stiffness ', ' Participant ', ' disease risk ', ' disorder risk ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' social ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Regulation ', ' Modeling ', ' Functional impairment ', ' functional disability ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' actigraph ', ' actigraphy ', ' disparity in health ', ' health disparity ', ' Address ', ' Symptoms ', ' Data ', ' High Prevalence ', ' Intake ', ' Collection ', ' Non-Hispanic ', ' Nonhispanic ', ' Not Hispanic or Latino ', ' Monitor ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' Behavioral ', ' House Call ', ' home visit ', ' Home visitation ', ' IQ Deficit ', ' intelligence quotient deficit ', ' neurocognitive decline ', ' neurocognitive impairment ', ' Neurocognitive Deficit ', ' food security ', ' diet and exercise ', ' functional outcomes ', ' Outcome ', ' Population ', ' Prevalence ', ' Psychosocial Stress ', ' modifiable risk ', ' ethnic minority ', ' ethnic minority population ', ' racial and ethnic ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' community partnership ', ' reduce disparity ', ' disparity reduction ', ' recruit ', ' health assessment ', ' sleep hygiene ', ' sleep health ', ' cardiometabolic ', ' cardiometabolism ', ' sleep habit ', ' sleep behavior ', ' perceived stress ', ' social factors ', ' ']",NIMHD,UNIVERSITY OF ARIZONA,R01,2020,70693,0.14299264733359784
"Determinants of insufficient sleep among blacks and effects on disparities in health outcomes Project Summary Insufficient sleep (IS), stemming from sleep apnea, shift work, insomnia, working over 40 hr./week, unfavorable sleep environments and/or volitional reduction of bedtime, is associated with increased risk of cardiovascular disease (CVD) markers (elevated blood pressure, insulin resistance, dyslipidemia and arterial stiffness), inflammatory markers (interleukin-6, tumor necrosis factor-, and C-reactive protein) as well as with brain injury. Compelling evidence shows racial/ethnic disparities in insufficient sleep (IS), with blacks exhibiting a three-fold greater risk of IS relative to whites. Disparities might arise from physiologic and genetic factors, but recent evidence suggests environmental and psychosocial factors are also critical determinants. This study will utilize innovative dynamic modeling in a multi-level framework to delineate the psychosocial and environmental determinants (associative factors) of actigraphic IS and its putative associations with adverse health outcomes among blacks. Individual- and contextual-level data will be captured using novel home-based recordings and GIS data to model the environmental context where sleep occurs. The proposed study will leverage success of the NYU Sleep Disparity Workgroup led by Dr. Jean- Louis (PI), who has been conducting community-engaged sleep research for over 10 years. The workgroup comprises outstanding investigators with expertise in sleep and circadian rhythm, CVD, brain health, health disparities, translational behavioral medicine, and multi-level dynamic modeling. The study will benefit from experience of our standing Community Steering Committee, enabling recruitment of 560 blacks in various venues to participate in weeklong home studies to achieve proposed study aims. The multidisciplinary team will: 1) identify psychosocial (social support, discrimination, and attitudes/beliefs) and environmental (household [density, noise, light, and temperature], socioeconomic position, social capital, and neighborhood [built environment]) factors that are associated with IS; ascertain effects of IS on (a) markers of CVD (obesity, BP, lipid profile, and glucose/ HbA1C) and inflammation (IL-6, IL-10, and TNF-) and on (b) markers of brain injury (tau, amyloid-, neurofilament light, homocysteine, and glial fibrillary acidic protein; and develop profiles of blacks with IS-related adverse health outcomes using individual- and environmental-level data applying innovative multi-level dynamic modeling tools (Bayesia Belief Network and Agent-Based Simulation). This study will provide evidence to delineate factors underlying greater rates of IS among blacks and explain putative associations with markers of CVD, inflammation, and brain injury. These data will provide the foundation for longitudinal studies assessing causal effects of IS on these novel markers and interventions to mitigate adverse effects of IS on health outcomes. Project Narrative This proposal is predicated upon compelling data that blacks exhibit a three-fold greater risk of insufficient sleep (<7 hours) compared with whites, and that insufficient sleep is associated with increased risk of cardiovascular disease and brain injury. It will provide multi-level evidence on the impact of the psychosocial and environmental factors on insufficient sleep among blacks. These data will provide the foundation for interventions to mitigate adverse effects of insufficient sleep on health outcomes among blacks.",Determinants of insufficient sleep among blacks and effects on disparities in health outcomes,10181522,R01HL142066,"['Attitude ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Behavioral Medicine ', ' Behavioral Sciences ', ' Belief ', ' Blood Pressure ', ' C-reactive protein ', ' Proteins, specific or class, C-reactive ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Circadian Rhythms ', ' Nyctohemeral Rhythm ', ' Twenty-Four Hour Rhythm ', ' circadian process ', ' daily biorhythm ', ' Communities ', ' Discrimination ', ' Cognitive Discrimination ', ' Environment ', ' Exhibits ', ' Foundations ', ' Glial Fibrillary Acidic Protein ', ' Astroprotein ', ' GFA-Protein ', ' GFAP ', ' Glial Fibrillary Acid Protein ', ' Glial Intermediate Filament Protein ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Health ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Homocysteine ', ' Household ', ' Inflammation ', ' Insulin Resistance ', ' insulin resistant ', ' Interleukin-6 ', ' B cell differentiation factor ', ' B cell stimulating factor 2 ', ' B-Cell Differentiation Factor ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Stimulatory Factor-2 ', ' BCDF ', ' BSF-2 ', ' BSF2 ', ' HPGF ', ' Hepatocyte-Stimulating Factor ', ' Hybridoma Growth Factor ', ' IFN-beta 2 ', ' IFNB2 ', ' IL-6 ', ' IL6 Protein ', ' MGI-2 ', ' Myeloid Differentiation-Inducing Protein ', ' Plasmacytoma Growth Factor ', ' interferon beta 2 ', ' Laboratories ', ' Light ', ' Photoradiation ', ' Lipids ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Morbidity - disease rate ', ' Morbidity ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Neighborhoods ', ' neurofilament ', ' Noise ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Psychosocial Factor ', ' psychosocial variables ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Role ', ' social role ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Social support ', ' social support network ', ' Temperature ', ' Time ', ' Volition ', ' Amyloid beta-Protein ', ' Alzheimer beta-Protein ', "" Alzheimer's Amyloid beta-Protein "", "" Alzheimer's amyloid "", "" Amyloid Alzheimer's Dementia Amyloid Protein "", ' Amyloid Beta-Peptide ', ' Amyloid Protein A4 ', ' Amyloid  ', ' Amyloid -Peptide ', ' Amyloid -Protein ', ' A ', ' a beta peptide ', ' abeta ', ' amyloid beta ', ' amyloid-b protein ', ' beta amyloid fibril ', ' soluble amyloid precursor protein ', ' Interleukin-10 ', ' CSIF ', ' CSIF-10 ', ' Cytokine Synthesis Inhibitory Factor ', ' IL-10 ', ' IL10 ', ' IL10A ', ' Interleukin 10 Precursor ', ' tau Proteins ', ' MT-bound tau ', ' microtubule bound tau ', ' microtubule-bound tau ', ' tau ', ' tau factor ', '  Proteins ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' base ', ' density ', ' Area ', ' Physiologic ', ' Physiological ', ' Individual ', ' Dyslipidemias ', ' Acquired brain injury ', ' brain damage ', ' brain-injured ', ' Brain Injuries ', ' Genetic ', ' Exposure to ', ' Inflammatory ', ' tool ', ' Level of Evidence ', ' Hour ', ' Home ', ' Home environment ', ' psychosocial ', ' environmental stressor ', ' experience ', ' success ', ' arterial stiffening ', ' artery stiffening ', ' artery stiffness ', ' arterial stiffness ', ' simulation ', ' novel ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Devices ', ' Reporting ', ' social ', ' (TNF)- ', ' Cachectin ', ' Macrophage-Derived TNF ', ' Monocyte-Derived TNF ', ' TNF ', ' TNF A ', ' TNF Alpha ', ' TNF- ', ' TNFA ', ' TNF ', ' Tumor Necrosis Factor ', ' Tumor Necrosis Factor-alpha ', ' TNF gene ', ' Emotional ', ' sleep diseases ', ' sleep dysfunction ', ' sleep dysregulation ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Adverse effects ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' Metabolic syndrome ', ' vulnerable group ', ' Vulnerable Populations ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' disparity in health ', ' health disparity ', ' Low income ', ' Address ', ' social capital ', ' Data ', ' Disease Marker ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Monitor ', ' Modification ', ' day shift ', ' night shift ', ' night work ', ' shiftwork ', ' shift work ', ' under served population ', ' underserved people ', ' Underserved Population ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' ethnic minority ', ' ethnic minority population ', ' multidisciplinary ', ' racial and ethnic ', ' stem ', ' racial and ethnic disparities ', ' high risk ', ' inflammation marker ', ' inflammatory marker ', ' new marker ', ' novel biomarker ', ' novel marker ', ' Healthy People 2020 ', ' built environment ', ' brain health ', ' reduce disparity ', ' disparity reduction ', ' circadian desynchronization ', ' circadian misalignment ', ' Circadian desynchrony ', ' recruit ', ' Bayesian machine learning ', ' Bayesian learning ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2020,423748,0.08449226091599091
"A diagnostic model for malignant pulmonary nodules The early detection of lung cancer by low-dose computed tomography (LDCT) followed by effective treatments, including immunotherapy, can reduce the mortality. LDCT is now recommended for lung cancer screening in smokers. However, more than 25% of smokers screened by LDCT have indeterminate pulmonary nodules (PNs), of which only 4% are finally diagnosed to be lung cancers, whereas more than 95% are benign diseases, resulting in over-diagnosis. As a result, large numbers of smokers with indeterminate PNs are referred for invasive biopsies and expensive 2-year multiple follow-up examinations, which carry their own morbidity and mortality. Therefore, there is an unmet clinical need for accurately distinguishing malignant PN (lung cancer) from benign PN in smokers with LDCT-found PNs. However, none of biomarkers and radiological features of PNs provides sufficient diagnostic values required in the clinics for accurately identifying malignant PNs. The objective of this proposed project is to develop a test for specifically differentiating malignant from benign PN. The target population of this test will be smokers with LDCT-found PNs. Its future use in the clinics will spare smokers with benign PNs from invasive biopsies and expensive multiple follow-up examinations, while facilitating effective treatments to be instantly initiated for lung cancer. Therefore, the test could complement LDCT for the early detection lung cancer, and thereby reduce the mortality and cost. Here we propose to develop an easy and cost-effective test for accurately distinguishing malignant from benign lung nodules. Future use of the test will complement CT screening for the early detection of lung cancer, and ultimately reduce lung cancer-associated deaths.",A diagnostic model for malignant pulmonary nodules,9970448,R21CA240556,"['Biometry ', ' Biometrics ', ' Biostatistics ', ' Biopsy ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cells ', ' Cell Body ', ' Complement ', ' Complement Proteins ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Female ', ' Future ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Immunotherapy ', ' Immune mediated therapy ', ' Immunologically Directed Therapy ', ' immune therapeutic approach ', ' immune therapeutic interventions ', ' immune therapeutic regimens ', ' immune therapeutic strategy ', ' immune therapy ', ' immune-based therapies ', ' immune-based treatments ', ' immuno therapy ', ' male ', ' Marriage ', ' men ', "" men's "", ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Pathology ', ' Physics ', ' Prospective Studies ', ' Pulmonology ', ' Pneumology ', ' Pneumonology ', ' Pulmonary Medicine ', ' Lung nodule ', ' pulmonary nodule ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Resources ', ' Research Resources ', ' Sensitivity and Specificity ', ' Target Populations ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Woman ', ' Molecular Genetics ', ' Immune Markers ', ' immune-based biomarkers ', ' immunological biomarkers ', ' immunological markers ', ' Immunologic Markers ', ' base ', ' Procedures ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Benign ', ' Clinical ', ' Malignant ', ' Malignant - descriptor ', ' Medical ', ' Ensure ', ' peripheral blood ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Oncology Cancer ', ' Oncology ', ' lung cancer early detection ', ' lung cancer screening ', ' Smoker ', ' nonsmoker ', ' non-smoker ', ' Diagnostic ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Clinic ', ' success ', ' cohort ', ' novel ', ' Modeling ', ' Micro RNA ', ' miRNA ', ' miRNAs ', ' MicroRNAs ', ' Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cost ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' cost effective ', ' multidisciplinary ', ' effective treatment ', ' effective therapy ', ' molecular biomarker ', ' molecular marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' NGS Method ', ' NGS system ', ' next gen sequencing ', ' nextgen sequencing ', ' next generation sequencing ', ' never smoker ', ' entire genome ', ' full genome ', ' whole genome ', ' radiomics ', ' miRNA biomarkers ', ' miRNA markers ', ' microRNA markers ', ' microRNA biomarkers ', ' radiologic imaging ', ' radiological imaging ', ' high dimensionality ', ' screening program ', ' CT screening ', ' computed tomography screening ', ' low dose computerized tomography ', ' low-dose CT ', ' low dose computed tomography ', ' ']",NCI,UNIVERSITY OF MARYLAND BALTIMORE,R21,2020,168019,0.2068211842569885
"Enhanced Measurement and Modeling of Sleep Electrophysiology to Better Understand Sleep Disparities Project Summary Health disparities associated with race and ethnicity are a major public health issue in the United States. Multiple lines of evidence suggest that differences in people's quality and quantity of sleep may account for part of this problem. Here we wish to study patterns of sleep, using full polysomnography data in a large and diverse cohort, to better understand what causes some individuals and groups to differ in their typical sleep, and to link this variation in sleep to relevant health outcomes. In order to study sleep as a mediator of health disparities associated with race/ethnicity, we propose to first unpack the sleep term into profiles of quantitative traits (Aim 1). Second, we will test for demographic moderators of the associations between race/ethnicity and sleep traits, which can point to likely socioeconomic and social/environmental contextual mediators (Aim 2). Finally, we will demonstrate the relevance of these findings by testing for association with health outcomes  primarily cardiovascular disease risk and measures of allostatic load  and estimating the extent to which sleep accounts for racial/ethnic health disparities (Aim 3). We will apply a targeted array of data-driven analytic methods, from data science, machine learning, computational neuroscience and causal modeling, to characterize individual differences in patterns of sleep. A more nuanced understanding of what constitutes poor sleep is important because different aspects of sleep are likely to have qualitatively different links to demographic and biomedical factors, including age, sex, lifestyle factors, inherited genetic makeup, circadian rhythms, medication effects and current state of physical and mental health. By disentangling this network of inter-related variables, we will be better positioned to understand  and ameliorate  the effects of the numerous factors that can induce racial/ethnic disparities in sleep, and consequently, in health too. Project Narrative Health disparities associated with race and ethnicity are a major public health issue in the United States. Multiple lines of evidence suggest that differences in peoples quality and quantity of sleep may account for part of this problem. We wish to study patterns of sleep in a large and diverse set of people, to better understand what causes some individuals and groups to differ in their typical sleep, and how this might in turn influence important health outcomes.",Enhanced Measurement and Modeling of Sleep Electrophysiology to Better Understand Sleep Disparities,10020195,R21MD012738,"['Age ', ' ages ', ' Ursidae Family ', ' Bears ', ' Ursidae ', ' bear ', ' Circadian Rhythms ', ' Nyctohemeral Rhythm ', ' Twenty-Four Hour Rhythm ', ' circadian process ', ' daily biorhythm ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Electrophysiology (science) ', ' Electrophysiology ', ' Neurophysiology / Electrophysiology ', ' electrophysiological ', ' Ethnic group ', ' ethnicity group ', ' Family ', ' Health ', ' indexing ', ' Life Cycle Stages ', ' Life Cycle ', ' life course ', ' Life Style ', ' Lifestyle ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Methods ', ' Phenotype ', ' Public Health ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Records ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Sleep ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Social Environment ', ' social climate ', ' social context ', ' socioenvironment ', ' socioenvironmental ', ' Testing ', ' United States ', ' Gender ', ' Measures ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Mediating ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' Sleep Monitoring ', ' Somnography ', ' polysomnographic ', ' sleep measurement ', ' sleep polysomnography ', ' Polysomnography ', ' analytical method ', ' base ', ' computational neuroscience ', ' density ', ' improved ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Link ', ' Delta Wave ', ' Delta Wave sleep ', ' Slow-Wave Sleep ', ' Individual ', ' Measurement ', ' Ethnicity ', ' Ethnic Origin ', ' Attenuated ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Frequencies ', ' Hereditary ', ' Inherited ', ' Complex ', ' Techniques ', ' physical health ', ' physical conditioning ', ' psychosocial ', ' Application Context ', ' contextual factors ', ' physical state ', ' cohort ', ' trait ', ' attenuation ', ' novel ', ' Self-Report ', ' Patient Self-Report ', ' race differences ', ' racial difference ', ' ethnicity difference ', ' ethnic difference ', ' Reporting ', ' social ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' Sampling ', ' pharmacobehavioral ', ' behavioral pharmacology ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' disparity in health ', ' health disparity ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Data ', ' Cognitive ', ' life-style factor ', ' lifestyle factors ', ' Process ', ' sex ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' developmental ', ' Development ', ' allostatic load ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' Sleep Architecture ', ' Outcome ', ' social disparities ', ' Individual Differences ', ' Coupling ', ' ethnic minority ', ' ethnic minority population ', ' racial and ethnic ', ' demographics ', ' racial and ethnic disparities ', ' healthy aging ', ' primary outcome ', ' population health ', ' signal processing ', ' genetic make-up ', ' genetic makeup ', ' causal diagram ', ' causal model ', ' Data Science ', ' ethnic health disparity ', ' gender-associated difference ', ' gender difference ', ' racial minority ', ' quality of sleep ', ' sleep quality ', ' sleep habit ', ' sleep behavior ', ' sleep pattern ', ' sleep physiology ', ' sleep spindle ', ' sleep quantity ', ' ']",NIMHD,BRIGHAM AND WOMEN'S HOSPITAL,R21,2020,216813,0.14086460874302653
"Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS Chronic obstructive pulmonary disease (COPD) and emphysema, jointly, are the fourth leading cause of death in the US and globally. Decades of research have not found disease-modifying therapies except for a1 antitrypsin deficiency, a rare disease found by improved phenotyping, characterized by a specific emphysema subtype and caused by gene variants in SERPINA1. This renewal builds on the successful discovery of six new quantitative emphysema subtypes (QES), which were associated independently with greater symptoms, impaired function and increased mortality in addition to several genome-wide significant associations for gene variants. In the renewal, we propose to leverage over 27,000 CTs acquired over 5-7 years of follow-up from 4,500 highly phenotyped and genotyped participants to test if deep and unsupervised learning on new state-of- the-art CTs and CT angiograms will reveal additional deep-learned and molecular QES that suggest mechanistic pathways to treatment. Further, we will collect 60 explanted lungs and use state-of-the art microCT to test if QES have distinct histology and structure. Finally, we will recruit 100 patients undergoing lung cancer CT screening to test if QES will be translatable to clinical low-dose lung cancer screening CT scans acquired on contemporary scanners. Successful completion of these aims will discover new deep QES and molecular QES and validate and translate QES to further subphenotype emphysema and facilitate testing of personalize molecular therapies and, hopefully, replicate the success of therapy for a1-antitrypsin deficiency for more common emphysema subtypes. Project Narrative In the first funding period, we discovered six QES, which are independently associated with morbidity, mortality and distinct gene variants that suggest targetable molecular pathways. This renewal builds upon our successful UML approach with integration of DL, greatly increased CT and genetic data; validates QES with histology; and translates QES to the clinic in order to facilitate testing of molecular therapies of specific QES and to redefine emphysema subtypes in clinical practice.",Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS,10225220,R01HL121270,"['Algorithms ', ' Angiography ', ' Angiogram ', ' angiographic imaging ', ' Blood Vessels ', ' vascular ', ' Cause of Death ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Endothelium ', ' Fibrosis ', ' Genotype ', ' Histology ', ' Learning ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patients ', ' Phenotype ', ' Physiology ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Pulmonary Fibrosis ', ' lung fibrosis ', ' Research ', ' Smoking ', ' Testing ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Translating ', ' improved ', ' Apical ', ' Clinical ', ' Diffuse ', ' Biological ', ' Histologically ', ' Histologic ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Funding ', ' lung cancer early detection ', ' lung cancer screening ', ' Genetic ', ' Smoker ', ' machine learned ', ' Machine Learning ', ' Scanning ', ' Clinic ', ' Pattern ', ' Techniques ', ' success ', ' c new ', ' Orphan Disease ', ' Rare Disorder ', ' orphan disorder ', ' Rare Diseases ', ' Structure ', ' novel ', ' Participant ', ' disease control ', ' disorder control ', ' Computed Tomography Scanners ', ' genome sequencing ', ' Dose ', ' Symptoms ', ' Data ', ' Molecular Target ', ' Reproducibility ', ' Characteristics ', ' Molecular ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Text ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' innovate ', ' innovative ', ' innovation ', ' Impairment ', ' clinical care ', ' population based ', ' genome scale ', ' genomewide ', ' genome-wide ', ' clinical practice ', ' X-ray microtomography ', ' Xray microtomography ', ' micro CT ', ' micro computed tomography ', ' microtomography ', ' microCT ', ' contrast enhanced ', ' entire genome ', ' full genome ', ' whole genome ', ' symptomatology ', ' recruit ', ' CT screening ', ' computed tomography screening ', ' deep learning ', ' unsupervised machine learning ', ' unsupervised learning ', ' Bayesian machine learning ', ' Bayesian learning ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2020,806343,0.05101174030051399
"Single-Cell Transcriptomic Analysis to Identify Drivers of Pulmonary Fibrosis PROJECT SUMMARY This proposal for a K08 Award is motivated by two overarching goals: 1) to support the scientific and professional development of the candidate, Dr. Paul Reyfman, towards achieving his career goal of succeeding as a physician scientist and independent investigator with expertise in systems biology approaches applied to the study of chronic lung disease, and 2) to investigate whether single-cell transcriptomic profiling can provide novel insights into the pathobiology of pulmonary fibrosis. Pulmonary fibrosis is a deadly and progressive condition for which diagnostic approaches remain imprecise and effective therapies are lacking. Together with his mentors, Drs. Scott Budinger and Lus Amaral, the candidate has developed a comprehensive training plan that will ensure Dr. Reyfman acquires new knowledge and proficiencies in developing hypotheses, designing and completing experiments, analyzing data, and communicating findings to the scientific community. As an essential component of this training plan, the candidate will employ systems biology approaches to developing tools for analysis of single-cell transcriptomic datasets generated from patients with pulmonary fibrosis. Single-cell transcriptomic profiling is increasingly used to investigate the pathobiology of disease in humans and as a basis for developing novel biomarkers of disease. Developing and validating tools for analyzing the rapidly growing quantity of single-cell transcriptomic data is as much of a challenge as refining techniques for generating data from healthy and diseased tissues. In particular, it is not known whether analysis of single-cell RNA sequencing (scRNA-Seq) and single-nucleus RNA sequencing (snRNA-Seq) data can be used to quantify accurately the cellular composition of the lung and to identify gene expression differences between health and pulmonary fibrosis. Our preliminary data suggest that scRNA-Seq of lung identifies profibrotic gene expression in patients with pulmonary fibrosis that is heterogeneous between individuals. We also found that scRNA-Seq undersampled certain constituent lung cellular populations. Accordingly, we designed this proposal to test the hypothesis that single-cell transcriptomic analysis of lung samples from patients with pulmonary fibrosis can be used to identify disease endotypes. In Specific Aim 1, the candidate will determine whether snRNA-Seq enables quantification of the cellular composition of the lung during pulmonary fibrosis. In Specific Aim 2, the candidate will develop tools for using scRNA-Seq performed on specimens obtained from patients with SSc-ILD and normal controls to gain novel insights into disease pathobiology. Over the course of this award, the candidate will gain new skills including in generating snRNA-Seq from cryopreserved lung tissue, in lung stereology, in RNA in situ hybridization, in analysis of complementary genomic datasets, and in incorporation of clinical phenotypic information into genomic analyses. Accomplishing the proposed work will provide a rigorous training program for Dr. Reyfman and will provide insights that could lead to improved therapies for patients with pulmonary fibrosis. PROJECT NARRATIVE The studies outlined in this proposal will be essential for future investigations that employ systems biology approaches to investigate the pathobiology of pulmonary fibrosis or to develop novel biomarkers of disease. This proposal will deepen our understanding of the strengths and limitations of single-cell transcriptomic profiling technology for studying human lung samples during health and disease. These findings may form a foundation for the development of biomarkers for diagnosis, prognosis, and prediction of response to therapy in pulmonary fibrosis, and may uncover new targets for therapy.",Single-Cell Transcriptomic Analysis to Identify Drivers of Pulmonary Fibrosis,9892329,K08HL146943,"['Aging ', ' Automobile Driving ', ' driving ', ' Award ', ' Bleomycin ', ' Bleo ', ' Bronchoalveolar Lavage Fluid ', ' Cell Nucleus ', ' Nucleus ', ' Cells ', ' Cell Body ', ' Cicatrix ', ' Scars ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Connective Tissue Diseases ', ' Connective Tissue Disorder ', ' Cryopreservation ', ' Cryofixation ', ' cold preservation ', ' cold storage ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diagnosis ', ' Digestion ', ' Disease ', ' Disorder ', ' Donor person ', ' transplant donor ', ' Environmental Exposure ', ' Epithelial Cells ', ' Fibroblasts ', ' Fibrosis ', ' Foundations ', ' Future ', ' Gases ', ' Gene Expression ', ' Genes ', ' Goals ', ' Gold ', ' Health ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Immunohistochemistry ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry Staining Method ', ' Laboratories ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung Compliance ', ' Lung Transplantation ', ' Lung Grafting ', ' lung transplant ', ' macrophage ', ' Mentors ', ' monocyte ', ' Blood monocyte ', ' Marrow monocyte ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Occupational Exposure ', ' workplace exposure ', ' Patients ', ' Physicians ', ' outcome forecast ', ' Prognosis ', ' Pulmonary Fibrosis ', ' lung fibrosis ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Small Nuclear RNA ', ' Low Molecular Weight Nuclear RNA ', ' Small Molecular Weight RNA ', ' snRNA ', ' uRNA ', ' Systemic Scleroderma ', ' Systemic Sclerosis ', ' progressive systemic sclerosis ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Training Programs ', ' Work ', ' Alveolar Macrophages ', ' Pulmonary Macrophages ', ' therapy selection ', ' Selection for Treatments ', ' Dataset ', ' Data Set ', ' in situ Hybridization Genetics ', ' in situ Hybridization Staining Method ', ' In Situ Hybridization ', ' base ', ' career ', ' improved ', ' Biochemical ', ' Ensure ', ' Training ', ' insight ', ' Individual ', ' Patient Selection ', ' Funding ', ' Biological Function ', ' Biological Process ', ' tool ', ' Diagnostic ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Protocol ', ' Protocols documentation ', ' cell type ', ' Techniques ', ' System ', ' single cell analysis ', ' skills ', ' novel ', ' Reporting ', ' Drug Exposure ', ' Chronic lung disease ', ' Gene Expression Monitoring ', ' Gene Expression Pattern Analysis ', ' Transcript Expression Analyses ', ' Transcript Expression Analysis ', ' gene expression analysis ', ' gene expression assay ', ' transcriptional profiling ', ' Gene Expression Profiling ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Sampling ', ' career development ', ' Genomics ', ' Alveolar ', ' Address ', ' Systems Biology ', ' Data ', ' predict therapeutic response ', ' predict therapy response ', ' predict treatment response ', ' therapy prediction ', ' treatment prediction ', ' treatment response prediction ', ' Prediction of Response to Therapy ', ' Clinical Data ', ' Molecular ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' clinical phenotype ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Population ', ' Impairment ', ' transcriptomics ', ' murine model ', ' mouse model ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' clinical care ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' effective treatment ', ' effective therapy ', ' new marker ', ' novel biomarker ', ' novel marker ', ' clinical practice ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' biomarker development ', ' Personalized medical approach ', ' individualized approach ', ' precision approach ', ' tailored approach ', ' personalized approach ', ' prediction of response ', ' predictive response ', ' predictor of response ', ' response prediction ', ' predicting response ', ' individual patient ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' Risk stratification ', ' experiment ', ' experimental research ', ' experimental study ', ' recruit ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' diffuse interstitial pulmonary fibrosis ', ' idiopathic pulmonary fibrosis ', ' ']",NHLBI,NORTHWESTERN UNIVERSITY AT CHICAGO,K08,2020,163296,0.14180998760782534
"The gut-lung axis influences the development of bronchopulmonary dysplasia This proposal presents a five-year research career development program focused on gut fungal commensal ecology, the mycobiome, in the neonatal period to advance mechanistic understanding of the gut-lung axis in bronchopulmonary dysplasia (BPD). This research development plan is designed to provide the candidate, an Assistant Professor of Pediatrics and neonatologist at the University of Alabama at Birmingham, with the mentorship, training and research experience required to accelerate his development into an independent clinician scientist in neonatal mucosal immunology. To achieve the candidates long-term goal of leading a productive translational research program focused on understanding mucosal immunology in BPD and facilitate his transition to independence, the candidate and his established mentors have devised a comprehensive development plan based on: 1) intensive, personal mentorship from a team with a proven history of productive mentoring; 2) in-depth experiential and focused didactic training to advance his understanding of molecular mycology, gnotobiotics and clinical research methods; and 3) an innovative research plan to produce causal evidence for gut mycobiome involvement in BPD development. The candidates research development plan outlines a focused path to obtain the knowledge, skills and experience required to accelerate his development into an independent clinician scientist who will have a lasting impact on neonatal mucosal immunology.  BPD is the most serious pulmonary complication of preterm birth. Treatments to modify developmental risk factors for BPD are lacking. Neonatal models of the gut-lung axis in other lung diseases, epidemiological studies linking antibiotic exposure with increased risk of BPD development, and the candidates extensive preliminary studies in mice and preterm newborns strongly suggest the gut mycobiome represents a therapeutic target to influence BPD development. This proposal builds on the candidates prior experience and the expertise of his mentors to explore the mechanisms of the neonatal gut-lung axis. We will test two hypotheses. 1) Prenatal antibiotic exposure-induced mycobiome changes drive increased BPD severity by disrupting the gut-lung axis. 2) Colonization with commensal fungi favorably alters the pulmonary mucosal immune response to hyperoxia. Determining if disruption of intestinal commensal microbial communities contributes to the development of lung injury in BPD will inform the development of therapeutics for mitigating BPD. These studies are expected to lay the groundwork translational studies in human preterm newborns. PROJECT NARRATIVE Bronchopulmonary dysplasia, a devastating chronic lung disease with debilitating long-term consequences, affects approximately half of all infants born extremely preterm. The objectives of this proposal are relevant to public health because they aim to establish that bacterial communities in the gut influence development of bronchopulmonary dysplasia by altering the immune responses of the developing lung. Successful completion of this proposal will provide insight into extra-pulmonary contributions to lung development and characterize new targets for therapy, which addresses goals of the NIH to seek mechanistic understanding of the microbiome in the pathobiology of lung diseases and reduce the incidence of chronic lung disease during early life.",The gut-lung axis influences the development of bronchopulmonary dysplasia,9952647,K08HL151907,"['Affect ', ' Alabama ', ' Antibiotics ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Blood Vessels ', ' vascular ', ' Bronchopulmonary Dysplasia ', ' chronic lung disease in infants ', ' chronic lung disease in neonatal infants ', ' chronic lung disease in neonates ', ' chronic lung disease in newborns ', ' chronic lung disease in prematurity ', ' infant chronic lung disease ', ' neonatal chronic lung disease ', ' newborn chronic lung disease ', ' Cell Wall ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Complication ', ' critical developmental period ', ' Disease ', ' Disorder ', ' Ecology ', ' Environmental Science ', ' Education ', ' Educational aspects ', ' Exhibits ', ' Feces ', ' stool ', ' fungus ', ' Gnotobiotic ', ' Gnotobiotics ', ' Goals ', ' Recording of previous events ', ' History ', ' Human ', ' Modern Man ', ' Immune system ', ' allergic/immunologic body system ', ' allergic/immunologic organ system ', ' Incidence ', ' Infant ', ' Newborn Infant ', ' 0-4 weeks old ', ' Newborns ', ' newborn child ', ' newborn children ', ' Inflammation ', ' Intestines ', ' Intestinal ', ' bowel ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Long-Term Effects ', ' Longterm Effects ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Mentors ', ' Mentorship ', ' mortality ', ' Mucous Membrane ', ' Mucosa ', ' Mucosal Tissue ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' The science of Mycology ', ' Mycology ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Pediatrics ', ' Phenotype ', ' Play ', ' Program Development ', ' Public Health ', ' Pulmonary Fibrosis ', ' lung fibrosis ', ' Research ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Specificity ', ' Testing ', ' Time ', ' Universities ', ' Lymphoid Cell ', ' Research Methods ', ' Research Methodology ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' Immunology ', ' base ', ' density ', ' Peripartum ', ' Perinatal ', ' improved ', ' Link ', ' Training ', ' pulmonary function ', ' insight ', ' Development Plans ', ' Hyperoxia ', ' Lung damage ', ' lung injury ', ' Mucosal Immune Responses ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Therapeutic ', ' Exposure to ', ' Morphology ', ' Shapes ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Scientist ', ' Immunes ', ' Immune ', ' Severities ', ' experience ', ' interstitial ', ' professor ', ' Structure ', ' unborn ', ' prenatal ', ' skills ', ' member ', ' Prevention ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' Chronic lung disease ', ' Modeling ', ' career development ', ' lung development ', ' Address ', ' Germ-Free ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Molecular ', ' developmental ', ' Development ', ' preclinical ', ' pre-clinical ', ' microbiome ', ' neonate ', ' designing ', ' design ', ' Neonatal ', ' Population ', ' protective effect ', ' innovate ', ' innovative ', ' innovation ', ' community microbes ', ' microbial community ', ' translational study ', ' murine model ', ' mouse model ', ' therapeutic target ', ' therapeutic agent development ', ' therapeutic development ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' standard of care ', ' GI microbiota ', ' Gastrointestinal microbiota ', ' enteric microbial community ', ' enteric microbiota ', ' gastrointestinal microbial flora ', ' gut commensal ', ' gut community ', ' gut flora ', ' gut microbe community ', ' gut microbial community ', ' gut microbial composition ', ' gut microbial consortia ', ' gut microbiotic ', ' gut microflora ', ' intestinal flora ', ' intestinal microbes ', ' intestinal microbiota ', ' intestinal microflora ', ' intestinal tract microflora ', ' gut microbiota ', ' screening ', ' Pneumonitis ', ' Pulmonary Inflammation ', ' GI microbiome ', ' digestive tract microbiome ', ' enteric microbiome ', ' gastrointestinal microbiome ', ' gut-associated microbiome ', ' intestinal biome ', ' intestinal microbiome ', ' gut microbiome ', ' premature neonates ', ' premature newborn ', ' preterm neonate ', ' preterm newborn ', ' Translational Research Enterprise ', ' translation research enterprise ', ' translational research program ', ' fungal microbiome ', ' mycobiome ', ' gut lung communication ', ' gut-lung axis ', ' bacterial community ', ' neonatal period ', ' pneumonia models ', ' pneumonia model ', ' airway microbiome ', ' respiratory tract microbiome ', ' respiratory microbiome ', ' microbiome community composition ', ' microbiome species composition ', ' microbiome composition ', ' alter microbiome ', ' microbiome adaptation ', ' microbiome perturbation ', ' microbiome alteration ', ' microbiome members ', ' microbiome specimens ', ' microbiome components ', ' ']",NHLBI,UNIVERSITY OF ALABAMA AT BIRMINGHAM,K08,2020,165456,0.13434792005573773
"Molecular characterization of pulmonary edema: a window to an injured lung Acute respiratory distress syndrome (ARDS) is a heterogeneous, life-threatening condition defined by poor oxygenation and bilateral pulmonary edema that carries a mortality rate >40% in most studies. Every ARDS drug trial to date has failed, perhaps because the clinical criteria defining ARDS include a substantial subset of low-risk patients. Clinical scoring systems poorly predict which ARDS patients will develop prolonged respiratory failure and are at increased risk of death.  Molecular profiling of pulmonary edema fluid could serve as a window on the alveolar microenvironment, enabling identification of high-risk patients. Pulmonary edema directly reflects lung pathobiology including loss of barrier integrity, inflammation, and epithelial damage. Unfortunately, free-flowing pulmonary edema has limited clinical utility because it can only be captured in a minority of patients. Molecular characterization of pulmonary edema is now possible in every patient with ARDS because of two critical innovations. First, we discovered that edema fluid condensing in the HME (heat and moisture exchanger) filter of the ventilator circuit, usually discarded as trash, closely reflects free-flowing edema. Second, we developed a non-targeted metabolomic fingerprinting method using mass spectroscopy that characterizes molecular components in trace quantities of fluid. Together, these innovations make it possible to test the central hypothesis that molecular features of edema fluid reflect pathobiology and enable ARDS risk stratification.  To address the prognostic enrichment potential of HME edema fluid, 300 early ARDS patients will be recruited at 3 US centers, with protocolized HME edema fluid collection. Aim 1 is to study whether high HME edema fluid total protein and lung-injury specific proteins predict prolonged respiratory failure 48h in ARDS. Aim 2 is to test whether hypermetabolic edema fluid and inflammatory lipids predict prolonged respiratory failure 48h in ARDS. In Aim 3, LASSO machine learning will be used to integrate all proteomic and metabolomic edema features into a prolonged mechanical ventilation classifier. The robustness of the classifier will be assessed by measuring whether it adds prognostic value to clinical ARDS severity scores, identifying how well key molecular features are reflected in plasma, and testing for replication in an independent cohort.  The goal of these studies is to examine to what extent a novel and readily available lung-specific sample, obtained early in the course of ARDS, reflects biology and can predict ARDS outcomes, thus offering prognostic enrichment for future clinical trials. Successful completion of the Specific Aims offers the potential for a much-needed classification scheme to better refine, understand, and therapeutically-target ARDS. PROJECT NARRATIVE Acute Respiratory Distress Syndrome (ARDS) is a common, life-threatening condition with no approved drug treatments. Pulmonary edema is a cardinal feature of ARDS and is mirrored closely by edema fluid collected passively in the Heat Moisture Exchanger (HME) filter; thus HME filter edema provides a novel and completely non-invasive window to the alveolar microenvironment. This proposal seeks to understand whether molecular characteristics of HME filter edema predict prolonged respiratory failure and could facilitate enrollment of high-risk patients into ARDS clinical trials.",Molecular characterization of pulmonary edema: a window to an injured lung,9945838,R01HL152083,"['Biology ', ' Bronchoscopy ', ' Classification ', ' Systematics ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Pharmacotherapy ', ' Drug Therapy ', ' drug treatment ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Edema ', ' Dropsy ', ' Hydrops ', ' Electrons ', ' Negative Beta Particle ', ' Negatrons ', ' Epithelium ', ' Epithelium Part ', ' Fingerprint ', ' Future ', ' Goals ', ' Heterogeneity ', ' Inflammation ', ' Lipids ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Methods ', ' mortality ', ' Patients ', ' Phenotype ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Proteins ', ' Pulmonary Edema ', ' lung edema ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Adult Respiratory Distress Syndrome ', ' ARDS ', ' Acute Respiratory Distress ', ' Acute Respiratory Distress Syndrome ', ' Adult ARDS ', ' Adult RDS ', ' Da Nang Lung ', ' Shock Lung ', ' Stiff lung ', ' wet lung ', ' Risk ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Testing ', ' Measures ', ' Intensive Care ', ' Ventilator ', ' AGE receptor ', ' RAGE receptor ', ' advanced glycosylation end product receptor ', ' amphoterin receptor ', ' receptor for AGE ', ' receptor for advanced glycation end product ', ' receptor of AGE ', ' receptor for advanced glycation endproducts ', ' mechanical respiratory assist ', ' Mechanical ventilation ', ' Clinical ', ' prognostic ', ' Epithelial ', ' Lung Alveolar Epithelia ', ' alveolar epithelium ', ' peripheral blood ', ' Failure ', ' Individual ', ' Bilateral ', ' Sample Size ', ' Lung damage ', ' lung injury ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' fluid ', ' liquid ', ' Liquid substance ', ' Inflammatory ', ' machine learned ', ' Machine Learning ', ' Life ', ' mechanical ', ' Mechanics ', ' Hour ', ' Severities ', ' Protocol ', ' Protocols documentation ', ' System ', ' ionization ', ' cohort ', ' Informatics ', ' novel ', ' Reporting ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Bio-Informatics ', ' Bioinformatics ', ' pulmonary failure ', ' respiratory insufficiency/failure ', ' Respiratory Failure ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Alveolar ', ' Address ', ' Data ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' Classification Scheme ', ' Collection ', ' enroll ', ' Enrollment ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' protein metabolite ', ' Minority ', ' Outcome ', ' Population ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' multidisciplinary ', ' therapeutic target ', ' high risk ', ' primary outcome ', ' secondary outcome ', ' treatment strategy ', ' effective treatment ', ' effective therapy ', ' prognostic ability ', ' prognostic power ', ' prognostic utility ', ' prognostic value ', ' Risk stratification ', ' recruit ', ' death risk ', ' mortality risk ', ' epithelial injury ', ' ']",NHLBI,STANFORD UNIVERSITY,R01,2020,575013,0.023516692947767648
"Construal level as a novel pathway for affect regulation and cancer control 7. Project Summary/Abstract Lung cancer is the leading major cause of preventable death in the United States, and cigarette smoking is a contributor to lung cancer in 80%90% of cases. Though adult cigarette smoking rates have declined substantially during the past 50 years, they remain as high as 30% in certain groups, such as individuals living in poverty. Quitting is difficult: a given quit attempt results in cessation in fewer than 10% of cases, and most adult cigarette smokers have attempted and failed to quit, and often many times. What is urgently needed are novel interventions for cigarette smoking cessation that operate through different mechanisms from those targeted by existing interventions, which are likely to have been unsuccessful for persistent smokers. A barrier to progress is that the mechanisms of action of most treatments are not known, which makes it difficult to know which treatment will work best for whom. We turn to affective science to identify a candidate technique that could serve as the basis for a novel intervention. Research on affect regulation typically focuses on down- regulation of affective states, such as craving for cigarettes, using effortful strategies such as cognitive reappraisal. However, a new insight in affect regulation is that people can construe, or subjectively understand, events with varying levels of abstraction, and that construing health-related behaviors in high- versus low-level terms promotes health behavior in several domains. For example, smokers who want to quit are more likely to resist a cigarette when they construe the same event (e.g., abstinence) in more abstract, high-level terms (e.g., becoming a better me) versus more concrete, low-level terms (e.g., not smoking this cigarette). There is some evidence that high-level construal might rely on distinct mechanisms from traditional affect regulation and smoking reduction interventions, but its mechanisms of action are unknown. Directly comparing its mechanisms to those of alternative affect regulation strategies and developing tools to induce high-level construal are the next steps on the path toward developing a novel intervention. Also, establishing individual differences in the effects of high-level construal will allow future interventions to be targeted to the individuals for whom they will be maximally effective. We identified two candidate mechanisms through which high-level construal might operate: down-regulation of craving and up-regulation of goal energization (i.e., motivation to quit). Functional magnetic resonance imaging (fMRI) revealed the neural systems engaged by those processes to be distinct. So, we will use multivariate analyses of fMRI data to quantify the similarity of high-level construal to each candidate (Aim 1). This will be done in a longitudinal translational experiment with 4 conditionshigh- level construal, down-regulation of craving, up-regulation of goal energization, and treatment-as-usualin a sample of persistent smokers in poverty, who are the most likely to benefit from a novel, theory-based treatment. The sample size (N = 240) affords an examination of individual differences in the effect of high-level construal on neural activity and craving, and the degree to which they predict smoking reduction (Aim 2). 8. Project Narrative Cigarette smoking is among the leading causes of preventable death in the United States because smoking increases risk for lung cancer and various diseases. Though U.S. smoking rates have declined, a substantial percentage of adults, particularly those living in poverty who have repeatedly tried and failed to quit, still smoke and therefore could benefit from novel interventions for cessation that operate through different mechanisms than those of traditional treatments. This study will use neuroimaging to uncover the mechanisms of action of a promising strategy for affect regulation and smoking cessation and also build profiles of individuals for whom this strategy does and does not work, thereby providing tangible and practical information that public health professionals and clinicians can use to inform personalized treatments for cigarette smoking cessation.",Construal level as a novel pathway for affect regulation and cancer control,9909179,R01CA240452,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Behavior ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Centers for Disease Control and Prevention (U.S.) ', ' CDC ', ' Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' United States Centers for Disease Control and Prevention ', ' Decision Making ', ' Disease ', ' Disorder ', ' Down-Regulation ', ' Downregulation ', ' Fire - disasters ', ' Fires ', ' fire ', ' Future ', ' Goals ', ' Health ', ' Health behavior ', ' Health Promotion ', ' Salutogenesis ', ' promoting health ', ' Light ', ' Photoradiation ', ' Theoretical model ', ' Theoretic Models ', ' Motivation ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Persons ', ' Poverty ', ' Psychology ', ' Public Health ', ' Research ', ' Risk ', ' Science ', ' Smoke ', ' Smoking ', ' Informal Social Control ', ' Self Regulation ', ' Testing ', ' Time ', ' Triage ', ' United States ', ' Up-Regulation ', ' Upregulation ', ' Work ', ' smoking cessation ', ' cease smoking ', ' quit smoking ', ' stop smoking ', ' base ', ' Lateral ', ' Medial ', ' Training ', ' insight ', ' Personality Traits ', ' Stimulus ', ' Individual ', ' cigarette use ', ' cigarette smoking ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Sample Size ', ' tool ', ' Smoker ', ' Cigarette Smoker ', ' machine learned ', ' Machine Learning ', ' Functional MRI ', ' fMRI ', ' Functional Magnetic Resonance Imaging ', ' Knowledge ', ' fighting ', ' Event ', ' Scanning ', ' Pattern ', ' Techniques ', ' System ', ' experience ', ' neural ', ' relating to nervous system ', ' Cigarette ', ' neuro-imaging ', ' neuroimaging ', ' novel ', ' Participant ', ' Reporting ', ' neural function ', ' Neurophysiology - biologic function ', ' Regulation ', ' Sampling ', ' craving ', ' response ', ' theories ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Provider ', ' Data ', ' Cancer Control Science ', ' Cancer Control ', ' Process ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' pathway ', ' Pathway interactions ', ' tobacco control ', ' cost ', ' efficacy trial ', ' Individual Differences ', ' neural mechanism ', ' neuromechanism ', ' Affective ', ' Abstinence ', ' lenses ', ' lens ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' usual care ', ' treatment as usual ', ' arm ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' cognitive process ', ' cognitive regulation ', ' cognitive reappraisal ', ' individualized strategies ', ' personalized strategies ', ' experiment ', ' experimental research ', ' experimental study ', ' preventable mortality ', ' preventable death ', ' ']",NCI,UNIVERSITY OF OREGON,R01,2020,610247,0.041191893105616426
"Feelix @ Home: Testing and optimization of a smart stethoscope for home use to monitor changes in lung status of individuals with chronic conditions Project Summary  The goal of this project is to further develop an existing smart stethoscope in order to be capable of monitoring pediatric patients at home who suffer from asthma as well as adults with COPD. Lung diseases impose a serious burden on healthcare systems, individuals and governments. The World Health Organization (WHO) found that chronic obstructive pulmonary disease (COPD) and lower respiratory infections (LRIs) ranked third and fourth as the leading causes of death in 2016, each claiming 3 million lives annually. LRIs accounted for 14.9% of pediatric deaths, making it the leading cause of infant mortality after pre-term birth. Asthmaa condition for which, like COPD, there is no cureis also the leading chronic disease in children and an estimated 235 million people suffer from the disease worldwide, with over 380,000 deaths from the disease in 2015. Asthma and COPD costed the United States approximately $56 billion and $72 billion last year, respectively. The burden of these diseases and the health disparities across populations is only slated to get worse in the coming decade, as respiratory diseases are expected to increase by 155% due to an aging population and increased pollution, while there is expected to a large shortage of pulmonary specialists, with an expect 7% decline by 2030.  We reasoned that a long-term monitoring solution that can be used in the home by untrained patients, or family members of patients, that could detect and monitor severity of airway inflammation in patients, provide insight into reasons for worsening or improved symptoms, push tailored educational content, and direct patients to medical follow before the situation becomes acute, would empower patients with chronic conditions while also reducing trips to emergency departments and readmission rates to hospitals. We find that several challenges exist when considering long term auscultatory monitoring solutions in non-traditional clinical settings: (1) unpredictable ambient noise, (2) the need for medical expertise to interpret lung sounds, (3) subjectivity in the analysis, and (4) difficulty using and placing the stethoscope. The research team developed a smart stethoscope that was originally intended for use in low-resource countries by community health workers to differentiate between pediatric patients with crackles and wheezes that overcomes many of these challenges. This smart stethoscope address all the challenges above by including (1) adaptive noise suppression that has been objectively and subjectively proven to be superior in all types of noise environments than traditional or other electronic stethoscopes, (2) on-board analysis algorithms that can detect crackles and wheezes in pediatric patients with an accuracy that matches that of a specialist, and (3) a uniform pickup surface that removes the requirement for exact placement of the device to get an accurate recording. In this project, we will validate that the device can be correctly used by parents of children with asthma and accurate recordings can be taken that are similar in quality to those that would be taken by a medical professional. Simultaneously, we will be using patient feedback to iterate on the device and mobile app design to create a version that patients are comfortable using in their home. Once the device and app have been validated in Phase I, we plan to move into directly into Phase II where the device will enter in a second phase of investigation that will include a first-time longitudinal study from parents of pediatric patients taking daily recordings in their home. This data will then be used for the development of algorithms to determine lung sound severities with metrics that can be tracked and predicted over time. In parallel to the this clinical study and algorithm development, recordings will be taken of adult patients with COPD to expand the usability of the device beyond pediatrics. Project Narrative This proposal aims to validate a smart auscultation device for home use and develop algorithms that can track changes in, and severity of, lung sounds in order to monitor patients over long periods of time, improve the clinical relevance of home monitoring for timely interventions, and decrease hospital admissions. Current state of the art technology available to patients suffering from asthma and COPD is unable to intelligently monitor patients at home and no long-term monitoring solutions exist for these conditions, resulting in increases in emergency department visits. The academic partner has developed a smart stethoscope that offers greatly improved audio fidelity in any type of noise environment, automated on-board analysis and detection algorithms of lung sounds, and increased ease of use. The small business partner is in the process of commercializing the device for clinical use by trained, professional personnel. Together, we are aiming to test whether the device can be reliably used by non-trained personnel for home use, develop algorithms that would provide metrics for monitoring trends and severities of lung sounds and predict future severity, expand the current abilities of the stethoscope from pediatrics to all patients, and transfer this technology to the small business partner for further clinical testing and commercial development such that it can improve the long-term outcome for patients with chronic lung conditions.",Feelix @ Home: Testing and optimization of a smart stethoscope for home use to monitor changes in lung status of individuals with chronic conditions,9909859,R42HL147728,"['Acoustics ', ' Acoustic ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Algorithms ', ' Asthma ', ' Bronchial Asthma ', ' Auscultation ', ' Cause of Death ', ' Censuses ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Clinical Research ', ' Clinical Study ', ' Community Health Aides ', ' community health worker ', ' Data Collection ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Dropout ', ' Electronics ', ' electronic device ', ' Environment ', ' Family ', ' Feedback ', ' Focus Groups ', ' Future ', ' Goals ', ' Government ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Housing ', ' Infant Mortality ', ' Infant Mortality Total ', ' Intelligence ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Medical Staff ', ' Noise ', ' Parents ', ' Patient Monitoring ', ' Patient Transfer ', ' Patients ', ' Pediatrics ', ' Physicians ', ' Pulmonology ', ' Pneumology ', ' Pneumonology ', ' Pulmonary Medicine ', ' Questionnaires ', ' Crackles ', ' Rale ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Respiratory Sounds ', ' Breathing Sounds ', ' Lung Sounds ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' sound ', ' Technology ', ' Testing ', ' Time ', ' United States ', ' Universities ', ' Untrained Personnel ', ' Untrained Employee ', ' untrained worker ', ' Wheezing ', ' wheeze ', ' Work ', ' World Health Organization ', ' Caregivers ', ' Care Givers ', ' Businesses ', ' Family member ', ' health care ', ' Healthcare ', ' Specialist ', ' Lower respiratory infection ', ' Lower Respiratory Tract Infection ', ' Dataset ', ' Data Set ', ' Prematurely delivering ', ' Preterm Birth ', ' premature childbirth ', ' premature delivery ', ' preterm delivery ', ' Premature Birth ', ' Disease Costs ', ' Sickness Cost ', ' Cost of Illness ', ' base ', ' Stethoscopes ', ' improved ', ' Site ', ' Surface ', ' Acute ', ' Chronic ', ' Clinical ', ' Phase ', ' Medical ', ' Link ', ' Training ', ' pediatric ', ' Childhood ', ' insight ', ' Individual ', ' participant recruitment ', ' Patient Recruitments ', ' Technology Transfer ', ' Letters ', ' instrument ', ' Pollution ', ' Investigation ', ' Severities ', ' Auditory ', ' Home ', ' Home environment ', ' System ', ' Country ', ' Test Result ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' monitoring device ', ' Participant ', ' Agreement ', ' Categories ', ' Devices ', ' Manpower ', ' personnel ', ' Human Resources ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disparity in health ', ' health disparity ', ' Address ', ' Data ', ' Detection ', ' Clinical Data ', ' Clinical Evaluation ', ' Clinical Testing ', ' clinical test ', ' research clinical testing ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' STTR ', ' Small Business Technology Transfer Research ', ' Monitor ', ' trend ', ' Process ', ' Modification ', ' developmental ', ' Development ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' burden of disease ', ' disease burden ', ' years of life lost to disability ', ' years of life lost to disease ', ' burden of illness ', ' digital ', ' designing ', ' design ', ' airway epithelium inflammation ', ' airway inflammation ', ' clinical site ', ' clinical research site ', ' efficacy trial ', ' Outcome ', ' Population ', ' clinical relevance ', ' clinically relevant ', ' usability ', ' commercialization ', ' aged population ', ' population aging ', ' aging population ', ' improve symptom ', ' symptom improvement ', ' symptomatic improvement ', ' computer assisted detection ', ' computer aided detection ', ' Algorithmic Analyses ', ' Analyses of Algorithms ', ' Analysis of Algorithms ', ' Algorithmic Analysis ', ' mobile app ', ' mobile application ', ' signal processing ', ' ED visit ', ' ER visit ', ' Emergency care visit ', ' Emergency hospital visit ', ' Emergency room visit ', ' Emergency department visit ', ' child patients ', ' pediatric patients ', ' individual patient ', ' recruit ', ' hospital re-admission rates ', ' hospital readmission rate ', ' re-admission rates ', ' re-hospitalization rate ', ' rehospitalization rate ', ' readmission rates ', ' supervised machine learning ', ' supervised learning ', ' algorithm development ', ' smart algorithm ', ' intelligent algorithm ', ' ']",NHLBI,"SONAVI LABS, INC.",R42,2020,222018,0.07690987023312902
"Characterization of Early Response to Chronic Lung Injury using Chest CT Project Summary  In some individuals chronic tobacco smoke exposure results in emphysema and pulmonary fibrosis. Both of these parenchymal changes are irreversible, highlighting the importance of the early identification of their development and progression. Unfortunately, currently available methods for detecting the presence and evolution of these changes have limited sensitivity and specificity for very early disease and for subtle disease progression. Dr. Ashs work has shown that automated objective analysis of computed tomography (CT) scans of the chest can detect clinically relevant radiologic findings called interstitial changes that may represent early pulmonary fibrosis, even in individuals without visually apparent disease. In the first aim of this proposal, Dr. Ash will refine and utilize a more sensitive and specific automated CT analysis tool that he and his lab have developed for the detection of both emphysema and interstitial changes. He will determine if emphysema and interstitial changes detected using this method are clinically significant in those patients deemed normal by previously performed visual analysis and in those deemed normal by other objective approaches. In the second aim, he will determine if areas of locally high density tissue in visually normal appearing lung parenchyma measured using augmented versions of his objective analysis tools are associated with mortality, other clinical outcomes, and peripheral measures of inflammation. Finally, in the third aim he will utilize these techniques to analyze longitudinal CT scans from the COPDGene study that were obtained over 10 years of follow-up, and will identify factors that predict or modify the development and progression of parenchymal changes on CT.  Dr. Ash will perform this work in the Division of Pulmonary and Critical Care Medicine at Brigham and Womens Hospital (BWH), a core teaching hospital of Harvard Medical School, under the mentorship of Dr. George Washko, an expert in the field of medical image analysis and the co-principal investigator of the Applied Chest Imaging Laboratory at BWH. With the guidance of Dr. Washko and his scientific advisory committee, Dr. Ash has developed a comprehensive five year training program to develop the skills needed to become an independent investigator with expertise in quantitative image analysis, including predictive modeling and statistical machine learning.  Dr. Ash is dedicated to a career in academic medicine. His goal is to become a clinician-scientist using the skills gained during this award to improve our ability to detect and monitor smoking related lung disease. The techniques he has proposed may help identify modifiable risk factors and treatments for smoking related lung disease, determine which patients are likely to benefit from treatment, and monitor the response to therapy. Project Narrative Cigarette smoking results in emphysema and pulmonary fibrosis, but only in a minority of smokers. This proposal aims to use advanced objective analysis of chest computed tomography images to detect the earliest manifestations of smoking related lung disease. This will enable us to identify susceptible patients at the earliest possible moment, track their disease progression, and ultimately shift treatment strategies from palliating disease related symptoms to preventing disease development.",Characterization of Early Response to Chronic Lung Injury using Chest CT,9843731,K08HL145118,"['Award ', ' Cicatrix ', ' Scars ', ' Critical Care ', ' Densitometry ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Evolution ', ' Fibrosis ', ' Goals ', ' Hospitals ', ' Teaching Hospitals ', ' Inflammation ', ' Laboratories ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' mange ', ' Medical Imaging ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Methodology ', ' mortality ', ' Patients ', ' Primary Prevention ', ' Publications ', ' Scientific Publication ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Pulmonary Fibrosis ', ' lung fibrosis ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Risk ', ' Risk Factors ', ' medical schools ', ' medical college ', ' school of medicine ', ' Sensitivity and Specificity ', ' Smoking ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Training Programs ', ' Woman ', ' Work ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Measures ', ' Task Forces ', ' advisory team ', ' Advisory Committees ', ' base ', ' career ', ' density ', ' improved ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Peripheral ', ' Area ', ' Chronic ', ' Clinical ', ' Training ', ' Visual ', ' Individual ', ' cigarette use ', ' cigarette smoking ', ' Workshop ', ' Educational workshop ', ' Measurement ', ' Development Plans ', ' Disease Progression ', ' Lung damage ', ' lung injury ', ' Inflammatory ', ' tool ', ' Smoker ', ' Scientist ', ' Tobacco smoke ', ' Scanning ', ' Techniques ', ' disease severity ', ' Severity of illness ', ' respiratory ', ' interstitial ', ' attenuation ', ' skills ', ' novel ', ' disease prevention ', ' disorder prevention ', ' disease risk ', ' disorder risk ', ' novel technologies ', ' new technology ', ' Predictive Factor ', ' Early identification ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' career development ', ' response ', ' Radiologic Finding ', ' preventing ', ' prevent ', ' Symptoms ', ' Detection ', ' Monitor ', ' Principal Investigator ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Minority ', ' Outcome ', ' modifiable risk ', ' clinical relevance ', ' clinically relevant ', ' clinical significance ', ' clinically significant ', ' Network-based ', ' treatment strategy ', ' palliation ', ' quantitative imaging ', ' protein markers ', ' protein biomarkers ', ' exercise capacity ', ' chest CT ', ' chest computed tomography ', ' palliate ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' smoking-induced lung disease ', ' smoking-related lung disease ', ' statistical and machine learning ', ' palliate symptoms ', ' palliation of symptoms ', ' palliating symptoms ', ' ']",NHLBI,BRIGHAM AND WOMEN'S HOSPITAL,K08,2020,170320,0.09884300355990759
"Precision Medicine in Sarcoidosis ABSTRACT Sarcoidosis is a systemic inflammatory disease of unknown etiology characterized by non-caseating granulomas in affected organs, primarily in the lungs. Approximately 30% of patients with sarcoidosis progress to debilitating disease; however, the drivers of susceptibility or resilience to disease remain poorly understood. An inflammatory response to an undefined antigen is postulated as the etiology of granuloma formation, and the pathogenesis has been suggested to involve gene-pathogen interaction, yet analysis of single genes or microbes has not proven applicable to diagnosis of all forms of sarcoidosis. Indeed, rather than a single organism, the disease may represent an interaction between the community of organisms that comprise the lung microbiome (community of organisms that live in and on us) and the host immune response. We propose that understanding the microbiome/host interaction will suggest strategies for precision medicine approaches to sarcoidosis. This proposal addresses this significant gap by investigating interactions between the lung microbiome, host immune and clinical responses in sarcoidosis using multiomics approaches  a critically innovative strategy. Our preliminary data support our novel hypotheses. First, we identified distinct lung microbiomes that differentiated patients with sarcoidosis versus controls. Second, our results identified biomarkers of disease severity that were associated with decreased lung function. Third, a recurrent analytic theme that emerged, regardless of the type of -omic analysis, was that sarcoidosis is characterized by pathways related to apoptosis and autophagy, which is consistent with our observation of decreased abundance of peripheral lymphocytes and functional immune anergy. These data led us to our Overall Hypothesis: Lung microbiome and host immune interactions characterized by apoptosis and autophagy pathways influence sarcoidosis clinical course. This hypothesis will be tested by an observational prospective and validation study of sarcoidosis patients at 5 time points to facilitate time series analyses. Aims 1 and 2 focus on lung microbiome or host immune responses, respectively, in relation to clinical course of sarcoidosis. Using these data in Aim 3, predictive models will be constructed based on integrated data of metagenomic and host-immune interactions. The novelty and significance of our multiomics strategy is to construct models for precision medicine therapies to harness bioinformatic strategies into focused, patient-specific approaches. The long-term significance of this study is to define pathways for sarcoidosis progression or resolution, and to develop database of these findings to further develop more precise, testable, models. PROJECT NARRATIVE Sarcoidosis is a disease of unknown etiology that predominately affects the lung and may affect other organs. We propose to construct a model to predict sarcoidosis progression or resolution by identifying microbial and immune interactions. We postulate that these models will be helpful in designing therapeutic options.",Precision Medicine in Sarcoidosis,9851921,R01HL138628,"['Affect ', ' Antigens ', ' immunogen ', ' Autophagocytosis ', ' autophagy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Communities ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Feces ', ' stool ', ' Genes ', ' Granuloma ', ' Granulomatous Lesion ', ' Immunity ', ' indexing ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lymphocyte ', ' Lymphocytic ', ' lymph cell ', ' Methods ', ' Organism ', ' living system ', ' Patients ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Prospective Studies ', ' Recurrence ', ' Recurrent ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Messenger RNA ', ' mRNA ', ' Sarcoidosis ', ' Besnier-Boeck Disease ', "" Boeck's Sarcoid "", "" Schaumann's Disease "", ' Technology ', ' Testing ', ' Time ', ' cytokine ', ' General Taxonomy ', ' Taxonomy ', ' Apoptosis Pathway ', ' Programmed Cell Death ', ' Apoptosis ', ' base ', ' Organ ', ' Bronchioalveolar Lavage ', ' Bronchopulmonary Lavage ', ' Lung Lavage ', ' bronchopulmonary lavage therapy ', ' Bronchoalveolar Lavage ', ' Peripheral ', ' Clinical ', ' Susceptibility ', ' Predisposition ', ' anergy ', ' Data Bases ', ' data base ', ' Databases ', ' Disease Progression ', ' Biological Function ', ' Biological Process ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Therapeutic ', ' Inflammatory ', ' Immunes ', ' Immune ', ' disease severity ', ' Severity of illness ', ' microbial ', ' novel ', ' validation studies ', ' Time Series Analysis ', ' disorder model ', ' Disease model ', ' Pathogenesis ', ' Modeling ', ' response ', ' Micro RNA ', ' miRNA ', ' miRNAs ', ' MicroRNAs ', ' Bio-Informatics ', ' Bioinformatics ', ' Inflammatory Response ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Address ', ' Data ', ' Resolution ', ' Apoptotic ', ' Differential Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' pathway ', ' Pathway interactions ', ' microbiome ', ' metagenome ', ' deep sequencing ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' resilience ', ' pathogen ', ' innovate ', ' innovative ', ' innovation ', ' transcriptomics ', ' Microbe ', ' metagenome sequencing ', ' metagenomic sequencing ', ' clinical relevance ', ' clinically relevant ', ' Functional Metagenomics ', ' Metagenomics ', ' inflammation marker ', ' inflammatory marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' precision-based medicine ', ' precision medicine ', ' clinical predictors ', ' multiomics ', ' multiple omics ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' pulmonary microbiome ', ' lung microbiome ', ' host microbiome ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NHLBI,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2020,914660,0.14183780501413243
"Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy. Lung cancer patients being treated with radiation can experience serious and sometimes life threatening thoracic side effects from treatment. There is emerging data demonstrating that a novel lung function imaging modality can reduce side-effects and improve quality of life for lung cancer patients undergoing radiation therapy. The novel lung function imaging modality, referred to as 4DCT-ventilation, uses 4DCT data along with image processing techniques to innovatively calculate lung ventilation maps. 4DCT-ventilation can improve outcomes for lung cancer patients by enabling the generation of functional avoidance radiotherapy plans. Functional avoidance uses 4DCT-ventilation to avoid functional portions of the lung, with the hypothesis that reducing dose to functional lung will reduce thoracic side- effects. Our 4DCT-ventilation research has progressed from retrospective studies to an early-phase trial using 4DCT-ventilation for functional avoidance radiotherapy. The early promising toxicity results from 4DCT- ventilation clinical trials is providing a strong rationale for national trials and expanded clinical integration across individual clinics. The problem is that expanded clinical integration of 4DCT-ventilation is currently not possible due to a lack of consistent, efficient, and clinically validated methods. We propose an academic-industry partnership with MIM Software to address these challenges precluding clinical integration of 4DCT-ventilation.  The purpose of our study is to develop methods that enable safe, efficient, and clinically validated methods for clinical integration of 4DCT-ventilation functional avoidance. Our overarching hypothesis is that the 4DCT-ventilation functional avoidance innovations we develop will be demonstrated to reduce lung toxicity in clinics with no prior 4DCT-ventilation experience. The project will be carried out in 3 aims. Aim 1 will develop methods that enable automated 4DCT-ventilation calculations including auto-segmentation, statistically-robust calculation methods, and clinically-efficient quality assurance tools. Aim 2 will develop methods for 4DCT- ventilation functional avoidance radiotherapy including image heterogeneity assessment, development of knowledge-based functional planning methods, and evaluation of metrics most critical in reducing toxicity. In conjunction with our industry partner, the developed methods from Aims 1 and 2 will be integrated in a commercial-grade software tool. Aim 3 will evaluate feasibility by assessing whether 4DCT-ventilation functional avoidance can be demonstrated to reduce toxicity in clinics with no prior 4DCT-ventilation experience.  Our project will generate both the tools and data needed to provide guidance on how to properly incorporate 4DCT-ventilation into clinical care. The methods and data will culminate in a commercial-grade platform suitable for busy clinics. 4DCT-ventilation has great potential to improve outcomes for lung cancer patients and our project will enable the integration of this novel imaging modality into clinical care. Our project proposes to form an academic-industrial partnership to translate a novel lung function imaging modality into radiotherapy clinical care for lung cancer patients. The novel lung function imaging modality is referred to as `4DCT-ventilation,' and uses 4-Dimensional CT data along with image processing techniques to innovatively calculate lung functional maps. 4DCT-ventilation has great potential to reduce toxicity and improve outcomes for lung cancer patients undergoing radiation therapy. Our project will develop methods that will enable widespread clinical integration of this novel imaging modality.",Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer,9884484,R01CA236857,"['Algorithms ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Clinical Trials ', ' Engineering ', ' Environment ', ' Feasibility Studies ', ' Heterogeneity ', ' Industrialization ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Maps ', ' Methods ', ' Study models ', ' Patients ', ' Quality of life ', ' QOL ', ' Radiation therapy ', ' Radiotherapeutics ', ' Radiotherapy ', ' radiation treatment ', ' radio-therapy ', ' treatment with radiation ', ' Research ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Retrospective Studies ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Translating ', ' Generations ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Dataset ', ' Data Set ', ' image processing ', ' quality assurance ', ' improved ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Radiation Pneumonia ', ' Radiation-Induced Pneumonitis ', ' Radiation Pneumonitis ', ' Evaluation ', ' Individual ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' tool ', ' Life ', ' Clinic ', ' Techniques ', ' System ', ' experience ', ' Performance ', ' knowledgebase ', ' knowledge base ', ' Toxicities ', ' Toxic effect ', ' novel ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Radiation ', ' develop software ', ' developing computer software ', ' software development ', ' Institution ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Address ', ' Dose ', ' Data ', ' Resolution ', ' Cancer Patient ', ' Clinical Data ', ' Seminal ', ' Validation ', ' Characteristics ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' clinical significance ', ' clinically significant ', ' 4-dimensional ', ' Four-dimensional ', ' clinical care ', ' standard of care ', ' industrial partnership ', ' industry partnership ', ' industry partner ', ' clinical practice ', ' community center ', ' improved outcome ', ' imaging program ', ' early phase trial ', ' novel imaging technique ', ' Treatment Side Effects ', ' side effect ', ' auto-segmentation ', ' automatic segmentation ', ' autosegmentation ', ' automated segmentation ', ' ventilation ', ' machine learning method ', ' ']",NCI,UNIVERSITY OF COLORADO DENVER,R01,2020,398856,0.19966165723875923
"A scalable non-intrusive image annotation method using eye tracking for training deep learning models in radiology PROJECT SUMMARY/ABSTRACT Machine learning (ML) and articial intelligence have recently emerged as powerful techniques that can augment radiology interpretations and show promise for improving patient outcomes. One of the ways for ML to make a signicant impact on health care is in improving the evaluation of high-volume, low-cost exams for early signs of a wide variety of diseases.The routine chest x-ray is an opportunity for screening for diseases, including cancer, chronic obstructive pulmonary disease (COPD), pneumonia and congestive heart failure. For instance, lung cancer is the most common cause of cancer death in the US, and is typically diagnosed at a higher stage than most other cancers leading to low survival rates. The National Lung Screening Trial reported that low dose computed tomography (LDCT) screening resulted in a 20% reduction in lung cancer mortality; however, few eli- gible people actually undergo LDCT screening. Meanwhile, chest x-rays continue to be the most common form of imaging worldwide. Improved detection from x-rays can direct patients to LDCT. COPD is another important disease that is often under-diagnosed. People with COPD are at increased risk of lung cancer and respiratory infections, or exacerbations, which are associated with higher morbidity and mortality. Furthermore, a chest x-ray may show poorly-dened regions of consolidation that are concerning for pneumonia. Medical attention is re- quired to treat an infection or evaluate for other cause. More generally, methods to detect disease on chest x-rays can be extended to cardiomegaly, pulmonary edema and pleural effusions which are seen in congestive heart failure. Improved detection can direct patients to medical care. Convolutional neural networks (CNN), a highly successful ML model, can be applied to chest x-ray images. However, few annotated medical datasets exist that are sufciently large to train CNNs. Furthermore, it has been shown that bounding boxes used to localize disease can be incorporated into the training of CNNs and signicantly increase their accuracy. Unfortunately, medical datasets with such localized annotations are even rarer and are very limited in the number of cases due to the time-consuming process of creating bounding boxes by radiologists. We propose an innovative integrated approach using eye tracking, speech recording and novel vision and language models to create localized annota- tions in a manner that is non-intrusive to the workow of the radiologist. The novelty of our approach is in the use of eye tracking during routine radiological reading. The challenge is to overcome the relatively ambiguous nature of eye tracking information compared to bounding boxes which provide denitive information about abnormalities. To address this challenge, we will also design new CNN architectures and learning algorithms that can use eye tracking and additional information such as pupil dilation and xation duration. The proposed methodology can easily scale up to create very large datasets without generating additional workload for radiologists. Furthermore, deployed in the reading room, it could provide a continuous stream of annotated images to expand training sets. PROJECT NARRATIVE Machine learning and articial intelligence hold the potential to improve patient outcomes by enhancing the eval- uation of low cost, routine chest x-rays for early imaging abnormalities associated with diseases such as lung cancer, chronic obstructive pulmonary disease and pneumonia and making recommendations for follow-up care. To realize their full potential, machine learning algorithms require training on very large datasets with localized an- notations for abnormalities. We propose a novel data collection methodology using eye tracking that is scalable, non-intrusive to the workow of the radiologist, and can generate very large datasets with localized annotations for the development of novel machine learning algorithms to address signicant medical problems.",A scalable non-intrusive image annotation method using eye tracking for training deep learning models in radiology,9967745,R21EB028367,"['Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Data Collection ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Experimental Designs ', ' Eye ', ' Eyeball ', ' Cardiomegaly ', ' Enlarged Heart ', ' Heart Enlargement ', ' Congestive Heart Failure ', ' Cardiac Failure Congestive ', ' Heart Decompensation ', ' chronic heart failure ', ' Infection ', ' Language ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Manuals ', ' Medical Imaging ', ' Methods ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Mydriasis ', ' Pupil Dilation ', ' Natural Language Processing ', ' natural language understanding ', ' Patients ', ' Pleural effusion disorder ', ' Pleural Effusion ', ' pleural cavity effusion ', ' Pneumonia ', ' Pulmonary Edema ', ' lung edema ', ' Pupil ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Reading ', ' Recommendation ', ' Research ', ' Respiratory Tract Infections ', ' Respiratory Infections ', ' Risk ', ' Speech ', ' Survival Rate ', ' Testing ', ' Thoracic Radiography ', ' CXR ', ' chest X ray ', ' chest Xray ', ' chest radiography ', ' lung radiography ', ' radiographic chest image ', ' radiographic lung image ', ' thoracic radiogram ', ' thorax radiography ', ' Time ', ' Vision ', ' Sight ', ' visual function ', ' Diagnostic radiologic examination ', ' Conventional X-Ray ', ' Diagnostic Radiology ', ' Diagnostic X-Ray ', ' Diagnostic X-Ray Radiology ', ' Radiography ', ' Roentgenography ', ' X-Ray Imaging ', ' X-Ray Medical Imaging ', ' Xray imaging ', ' Xray medical imaging ', ' conventional Xray ', ' diagnostic Xray ', ' diagnostic Xray radiology ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Workload ', ' Work Load ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' Label ', ' improved ', ' Clinical ', ' Malignant ', ' Malignant - descriptor ', ' Phase ', ' Medical ', ' Ensure ', ' Evaluation ', ' Training ', ' Visual ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' radiologist ', ' Localized Disease ', ' lung cancer early detection ', ' lung cancer screening ', ' Diagnostic ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Stream ', ' Techniques ', ' eye tracking ', ' visual tracking ', ' novel ', ' Agreement ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Modeling ', ' Connectionist Models ', ' Neural Network Models ', ' Perceptrons ', ' Neural Network Simulation ', ' data collection methodology ', ' Diameter ', ' Caliber ', ' Address ', ' Data ', ' Detection ', ' Cancer Cause ', ' Cancer Etiology ', ' Collection ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Screening Result ', ' Validation ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Fixation ', ' sample fixation ', ' Text ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cost ', ' designing ', ' design ', ' Outcome ', ' scale up ', ' Consumption ', ' innovate ', ' innovative ', ' innovation ', ' medical attention ', ' screening ', ' model building ', ' CT screening ', ' computed tomography screening ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' machine learned algorithm ', ' machine learning algorithm ', ' neural net architecture ', ' neural network architecture ', ' learning algorithm ', ' large data sets ', ' large datasets ', ' low dose computerized tomography ', ' low-dose CT ', ' low dose computed tomography ', ' ']",NIBIB,UNIVERSITY OF UTAH,R21,2020,243364,0.08245505864155156
"SonoHeal: Smart Resonating Closed-loop Airway Clearance Device Project Summary  Cystic Fibrosis is a genetic disorder that affects 30,000 patients in the USA with an average life span of 37 years and the majority (85%) of the mortality is a result of lung disease. Airway Clearance Therapies (ACT) are extensively used by patients for forceful mechanical clearance of mucus accumulated in airways using high pressure and high frequency vibrations. However, the use of ACTs is intrusive, painful, uncomfortable, and poses tremendous burden on patients who are required to perform ACTs daily for 1-2 hours. Without effective ACT, the mucus-plugged airways trap bacteria causing infections, inflammations, respiratory failures, and other complications. ACT is also used by patients with lung conditions where mucus clearance is necessary (e.g. bronchiectasis, COPD, Asthma).  ACT works on the principle of vibrating the lungs to increase mucus mobility. Ideally, the therapy needs to be individualized and continuously adaptive for effective clearance. However, none of the current ACT devices and techniques, including chest physiotherapy, high-frequency chest compression, oscillation, and acoustic vibration therapies, are adaptive. The challenges with current ACT devices: 1. Brute-force approach: Patients have diverse airway geometry, mucus accretion levels, and obstruction locations. Optimal therapy requires input frequencies to match the resonant frequency of specific airways to target mucus clearance. Current ACT devices work on a set vibration pattern (Vest, oPEP, CPT) or a feeling- based subjective tweaking of input frequencies and airway location (Frequencer, VibraLung), often rendering them ineffective. 2. Subjective Assessment: None of the current devices measure lung function to provide a quantitative assessment of the airway obstruction or therapy progress putting the burden on the patient to determine treatment effectiveness. 3. Poor Quality of Life: As a result, patients perform uncomfortable ACT for long durations to see a positive effect, leading to poor adherence to ACT. Further, home ACTs are considered ineffective for a large segment of the patient population due to the lack of personalized treatment. Cognita Labss proposed solution, SonoHeal, will be the first device to adapt the treatment in real-time based on the patients lung status, such that the right airways are targeted for stimulation/vibration to reduce the reliance on patients guesswork as well as provide effective therapy by localizing airway clearance. SonoHeal will utilize Cognitas patent-pending airway monitoring technology that measures airway obstruction in real- time. Combined with quantified lung response with mucus localization information, SonoHeal will algorithmically tune the right resonant frequency to target patients airways and promote effective mucus removal. In this proposal, Cognitas team will bring years of airway modeling, device technologies and commercialization experience to conduct in-vitro experimentation on multiple lung models to show the feasibility and efficiency of the SonoHeal device in a lab setup. PROJECT NARRATIVE Airway Clearance Therapies (ACT) are critical daily requirement for Cystic Fibrosis patients to remove mucus from the lungs and avoid infections and pulmonary exacerbations. Current ACT devices work on the principals of violently vibrating/shaking the lung which leads to ineffective, uncomfortable and long therapy times. Cognitas SonoHeal will be the first closed- loop innovation that will listen to the lung response while adaptively changing acoustic vibrating pressure waves to target the resonant frequencies of the individual airways and provide most efficient and effective therapy.",SonoHeal: Smart Resonating Closed-loop Airway Clearance Device,10011518,R43HL152912,"['Acoustics ', ' Acoustic ', ' Affect ', ' airway obstruction ', ' airflow limitation ', ' airflow obstruction ', ' airway limitation ', ' obstructed airflow ', ' obstructed airway ', ' Algorithms ', ' Breathing ', ' Respiratory Aspiration ', ' Respiratory Inspiration ', ' inspiration ', ' Asthma ', ' Bronchial Asthma ', ' Bacteria ', ' Bronchiectasis ', ' Cystic Fibrosis ', ' Mucoviscidosis ', ' Disease ', ' Disorder ', ' Elasticity ', ' In Vitro ', ' Infection ', ' Inflammation ', ' Knee ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' mortality ', ' Movement ', ' body movement ', ' Mucins ', ' Mucus Glycoprotein ', ' Mucous body substance ', ' Mucus ', ' mucous ', ' Obstruction ', ' Pain ', ' Painful ', ' Legal patent ', ' Patents ', ' Patients ', ' Physics ', ' pressure ', ' Probability ', ' Quality of life ', ' QOL ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Technology ', ' Testing ', ' Time ', ' Violence ', ' violent ', ' violent behavior ', ' Work ', ' Measures ', ' Treatment Effectiveness ', ' Dataset ', ' Data Set ', ' Electrical Impedance ', ' Impedance ', ' electric impedance ', ' base ', ' Ensure ', ' Training ', ' Individual ', ' Phase 2 Clinical Trials ', ' phase II protocol ', ' Phase II Clinical Trials ', ' machine learned ', ' Machine Learning ', ' mechanical ', ' Mechanics ', ' Hour ', ' Dimensions ', ' Frequencies ', ' Complex ', ' Home ', ' Home environment ', ' Pattern ', ' Techniques ', ' System ', ' Location ', ' vibration ', ' age group ', ' experience ', ' novel ', ' Devices ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Physiatric Procedure ', ' Physical Medicine Procedure ', ' Physical Therapeutics ', ' Physiotherapy ', ' Physical therapy ', ' patient safety ', ' High Frequency Chest Wall Oscillation ', ' High-Frequency Chest Compression ', ' High-Frequency Chest Wall Compression ', ' pulmonary failure ', ' respiratory insufficiency/failure ', ' Respiratory Failure ', ' Adherence ', ' Data ', ' Germ ', ' Localized Therapy ', ' Local Therapy ', ' Monitor ', ' feelings ', ' Feeling ', ' CF patients ', ' individuals with CF ', ' individuals with cystic fibrosis ', ' patients with CF ', ' patients with cystic fibrosis ', ' cystic fibrosis patients ', ' innovate ', ' innovative ', ' innovation ', ' prototype ', ' commercialization ', ' patient population ', ' effective treatment ', ' effective therapy ', ' flexible ', ' flexibility ', ' 3-D print ', ' 3-D printer ', ' 3D printer ', ' 3D printing ', ' three dimensional printing ', ' 3D Print ', ' Geometry ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' experiment ', ' experimental research ', ' experimental study ', ' genetic condition ', ' genetic disorder ', ' Genetic Diseases ', ' optimal therapies ', ' optimal treatments ', ' mucus clearance ', ' learning algorithm ', ' adaptation algorithm ', ' ventilation ', ' ']",NHLBI,"COGNITA LABS, LLC",R43,2020,184234,0.1549180030854635
"Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer Lung cancer is a leading cause of death in the United States. The National Lung Screening Trial (NLST) showed that more lung cancers can be detected at an early stage with low dose CT screening. However, over-diagnosis of indolent lung cancer and benign nodules is one of the major limitations of screening, resulting in unnecessary treatment, biopsy, follow-up, increased radiation exposure, patient anxiety, and cost. Due to a lack of in-depth knowledge of the correlation of structural image features and histologic findings of lung nodules and the absence of validated diagnostic biomarkers for accurate disease categorization, the current diagnosis and management of the screen-detected nodules remains challenging.  The goal of this proposed project is to develop a decision support system (DSS) based on quantitative histopathology correlated CT descriptor (q-PCD) of pulmonary nodules using advanced computer vision and machine learning techniques to characterize the histopathologic features of nodules and analyze their correlations with CT image features for improvement of early detection of lung cancer. We hypothesize that the proposed q-PCD analysis will have strong association with histopathologic characterization, and therefore will be a more effective biomarker for differentiation of invasive, pre-invasive, and benign nodules than conventional image-based features or radiologists' visual judgement. Accurate characterization of the nodule types will assist radiologists in making decision for management of the detected nodules; e.g., enabling early detection and treatment of invasive lung cancer, safe surveillance or replacing lobectomy with limited sublobar resection for pre-invasive lung cancer, and sparing biopsy of benign nodules, thereby reducing morbidity and costs in lung cancer screening programs. Our major specific aims are to 1) collect a large database of LDCT screening cases from NLST project and our institute to develop automated image analysis methods, 2) to develop a new DSS based on quantitative pathologic correlated CT descriptors (q-PCD) of lung nodules, 3) validate the effectiveness of DSS in lung cancer diagnosis. To achieve these aims, we will collect a large data set from the National Lung Screening Trial (NLST) and our institute. The collected database will include the baseline and follow up scans, pathology data, demographic information and other information provided by NLST. We will develop automated segmentation methods to extract the volumes of the solid and sub-solid components of detected lung nodules, develop quantitative methods to characterize the radiologic and pathologic features of lung nodules as well as the surrounding lung parenchyma, develop a novel radiopathomics strategy to correlate pathomics with radiomics, and to identify new imaging biomarkers. We will develop a clinically-translatable DSS with a joint biomarker combining both image and patient information, and evaluate its performance in lung cancer diagnosis, including its effectiveness in baseline screening CT exams and in follow up exams. Narrative: Lung cancer is the second most commonly diagnosed cancer in both men and women in the United States. If successful, we will have developed an automated low dose CT-based quantitative histopathology correlated CT descriptor (q-PCD) which can be included as an independent factor to improve the diagnosis of screening detected nodules. It will not only provide a useful imaging biomarker to assist in lung nodule management for individuals, but also constitute a strong foundation to meet our long-term goal of developing clinically- translatable decision support system (DSS) to facilitate personalized medicine in early detection of lung cancer, optimizing treatment strategies and reducing health care costs",Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer,9934164,U01CA216459,"['Anxiety ', ' Archives ', ' Biopsy ', ' Cause of Death ', ' Computer Vision Systems ', ' computer vision ', ' Database Management Systems ', ' Data Base Management ', ' Data Base Management Systems ', ' database management ', ' database systems ', ' relational database management systems ', ' Decision Making ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Foundations ', ' Goals ', ' Institutes ', ' Joints ', ' Judgment ', ' Lobectomy ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Maps ', ' men ', "" men's "", ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Nodule ', ' Pathology ', ' Patients ', ' Lung nodule ', ' pulmonary nodule ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Reference Standards ', ' Risk Factors ', ' Testing ', ' Thoracic Radiography ', ' CXR ', ' chest X ray ', ' chest Xray ', ' chest radiography ', ' lung radiography ', ' radiographic chest image ', ' radiographic lung image ', ' thoracic radiogram ', ' thorax radiography ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' United States ', ' Woman ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' Decision Aid ', ' base ', ' improved ', ' Benign ', ' Solid ', ' Histologically ', ' Histologic ', ' Evaluation ', ' Indolent ', ' Visual ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' radiologist ', ' lung cancer early detection ', ' lung cancer screening ', ' Descriptor ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scanning ', ' Techniques ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' attenuation ', ' Histopathology ', ' Structure ', ' novel ', ' Reporting ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Decision Support Systems ', ' Property ', ' cancer diagnosis ', ' Effectiveness ', ' Advocate ', ' Data ', ' Reproducibility ', ' Collection ', ' Screening Result ', ' Pathologic ', ' Characteristics ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cost ', ' early therapy ', ' Early treatment ', ' high risk ', ' treatment strategy ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' screening ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' Patient risk ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' diagnostic marker ', ' diagnostic biomarker ', ' unnecessary treatment ', ' radiomics ', ' Radiation exposure ', ' clinically translatable ', ' screening program ', ' therapy optimization ', ' treatment optimization ', ' CT screening ', ' computed tomography screening ', ' pathology imaging ', ' automated image analysis ', ' auto-segmentation ', ' automatic segmentation ', ' autosegmentation ', ' automated segmentation ', ' large data sets ', ' large datasets ', ' low dose computerized tomography ', ' low-dose CT ', ' low dose computed tomography ', ' validate effectiveness ', ' effectiveness validation ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2020,461573,0.21436115699374778
"Dynamic regulatory network models of human response to influenza virus PROJECT SUMMARY The goal of this project is to build mathematical models of human innate immune responses to the global pathogen influenza virus A (IAV). To ensure successful replication, viral pathogens must simultaneously hijack several components of the host cell machinery while either evading or disabling innate cellular defenses. The host genetic background and subsequent viral and host signaling interactions dictate disease severity ranging from asymptomatic to mortality. Recent studies of IAV in genetically diverse murine models confirm the critical role of genotype in host response and outcome. Both molecular targets as well as key proteins involved in IAV pathogenesis could be therapeutically exploited to attenuate or prevent disease. Thus, we construct models of the molecular networks driving early innate IAV response that can be used to model genetic effects. Our experimental system is human lung epithelium, the first-line of defense against and target of IAV.  Aim 1. Genetic predictions from the gene regulatory network (GRN) governing human epithelial IAV response. GRNs describe the control of gene expression by transcription factors (TFs). We showed that integrating ATAC-seq with RNA-seq improves GRN accuracy. To construct a dynamic GRN in our heterogeneous lung tissue model, we propose scRNA-seq and scATAC-seq measurements of IAV infection and IFN stimulation time courses. Our group recently discovered new mechanisms by which the IAV protein Ns1 drives promoter-independent transcriptional read-through and alters 3D-chromatin architecture. Thus, for modeling, we also measure genomic transcription initiation and promoter-capture Hi-C. Following experimental testing and GRN refinement, we will use a deep-learning model trained on DNA sequence and epigenetic data to provide inputs that enable dynamic GRN simulations for thousands of human genotypes. We will identify genetic risk loci and molecular mechanisms driving difference in gene expression responses across individuals.  Aim 2. Model the protein-protein interactions (PPIs) and cellular signaling networks driving the innate immune response to IAV. We developed mutant influenza viruses, each encoding a FLAG-tagged viral protein, while maintaining virulence in vivo. We will use the mutant IAV to map host-virus PPIs in human lung epithelial cells and mouse lung in vivo. Integrating with diverse omics datasets, we will construct a molecular network model connecting virus-host PPIs through cellular signaling pathways to IAV-dependent TFs. We will test pathway reconstruction with epistasis mapping.  Completion of both aims will lead to a GRN spanning virus-host PPIs and cellular signaling to TF control of gene expression in an innate-immune cell type. Our experimental-computational design is widely applicable. This model, and its future adaptation to other cells, will help identify the genetic and molecular mechanisms driving diverse human IAV responses and the network vulnerabilities to be exploited for IAV therapy. PROJECT NARRATIVE Human response to Influenza virus infection varies dramatically between individuals, from mildly symptomatic to death. We will systematically measure and model the innate immune response to IAV at the molecular network level: from host-virus protein-protein interactions through cellular signal transduction to changes in gene expression in human cells. The resulting mathematical model will help identify network vulnerabilities to be exploited for IAV therapy and help predict differences in IAV response in the human population.",Dynamic regulatory network models of human response to influenza virus,9950738,U01AI150748,"['Alleles ', ' Allelomorphs ', ' Architecture ', ' Engineering / Architecture ', ' Automobile Driving ', ' driving ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Affinity Chromatography ', ' affinity purification ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Engineering ', ' Genetic Epistasis ', ' Epistasis ', ' Epistatic Deviation ', ' Interaction Deviation ', ' epistatic relationship ', ' gene x gene interaction ', ' genetic epistases ', ' Epithelial Cells ', ' Epithelium ', ' Epithelium Part ', ' Experimental Designs ', ' Interferon-beta ', ' Endogenous Interferon Beta ', ' Fibroblast Interferon ', ' IFN-Beta ', ' IFN- ', ' IFNb ', ' Interferon- ', ' Natural Interferon Beta ', ' Natural human interferon beta ', ' Flow Cytometry ', ' Flow Cytofluorometries ', ' Flow Cytofluorometry ', ' Flow Microfluorimetry ', ' Flow Microfluorometry ', ' flow cytophotometry ', ' Future ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' Transcriptional Regulatory Elements ', ' regulatory gene ', ' trans acting element ', ' Genome ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Infection ', ' Interferon Type I ', ' Joints ', ' Learning ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Maps ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Genetic Models ', ' mortality ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Genetic Polymorphism ', ' polymorphism ', ' Proteins ', ' Role ', ' social role ', ' Signal Pathway ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Testing ', ' Time ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Viral Proteins ', ' Viral Gene Products ', ' Viral Gene Proteins ', ' virus protein ', ' Virulence ', ' Virus Diseases ', ' Viral Diseases ', ' viral infection ', ' virus infection ', ' virus-induced disease ', ' Virus ', ' transcription factor USF ', ' Upstream Stimulatory Factor ', ' Upstream Transcription Factor ', ' helix-loop-helix activator USF ', ' transcription factor MLTF ', ' cytokine ', ' Measures ', ' Prize ', ' Experimental Models ', ' forest ', ' Mediating ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' improved ', ' Ensure ', ' Training ', ' Epithelial ', ' Individual ', ' Measurement ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Therapeutic ', ' Genetic ', ' Attenuated ', ' Reporter ', ' tool ', ' Knowledge ', ' Immunes ', ' Immune ', ' cell type ', ' Techniques ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Host Defense ', ' Viral ', ' disease severity ', ' Severity of illness ', ' mutant ', ' transcription termination ', ' Viral Genetics ', ' virus genetics ', ' Molecular Modeling Nucleic Acid Biochemistry ', ' Molecular Modeling Protein/Amino Acid Biochemistry ', ' Molecular Models ', ' molecular modeling ', ' simulation ', ' Pathogenesis ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Modeling ', ' response ', ' protein protein interaction ', ' Math Models ', ' mathematic model ', ' mathematical modeling ', ' mathematical model ', ' Functional RNA ', ' Non-Coding ', ' Non-Coding RNA ', ' Non-translated RNA ', ' Noncoding RNA ', ' Nontranslated RNA ', ' noncoding ', ' Untranslated RNA ', ' Genomics ', ' Influenza A ', ' Influenza Viruses Type A ', ' Influenzavirus A ', ' Orthomyxovirus Type A ', ' Type A Influenza ', ' Influenza A virus ', ' Short interfering RNA ', ' siRNA ', ' Small Interfering RNA ', ' Transcription Initiation ', ' Molecular Interaction ', ' Binding ', ' Tracheal Epithelium ', ' preventing ', ' prevent ', ' Influenza Virus ', ' influenzavirus ', ' global health ', ' Data ', ' Molecular Target ', ' Mouse Strains ', ' in vivo ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Genetic Risk ', ' Signaling Molecule ', ' Tissue Model ', ' Transcription Elongation ', ' Validation ', ' Molecular ', ' Pattern recognition receptor ', ' pathway ', ' Pathway interactions ', ' reconstruction ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' pathogen ', ' Population ', ' flu ', ' anti-microbial ', ' antimicrobial ', ' human disease ', ' cellular behavior ', ' cell behavior ', ' murine model ', ' mouse model ', ' network models ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' Risk-associated variant ', ' risk allele ', ' risk gene ', ' risk genotype ', ' risk loci ', ' risk locus ', ' risk variant ', ' Differential Algebraic Equation ', ' Differential Equation ', ' ATACseq ', ' ATAC-seq ', ' experiment ', ' experimental research ', ' experimental study ', ' adaptive immune response ', ' Innate Immune Response ', ' high dimensionality ', ' model of human ', ' human model ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' deep learning ', ' viral pathogen ', ' pathogenic virus ', ' human pathogen ', ' ']",NIAID,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,U01,2020,1202266,0.05238504280570178
"Wearable lung sounds, fluid, and body temperature monitoring for patients with COVID-19 The COVID-19 pandemic has tremendously impacted society, communities, and the healthcare system across the world, and threatens to continue to challenge society for the coming months and years. More than 1 million Americans have been diagnosed with COVID-19, and more than 60,000 Americans have lost their lives as of the writing of this proposal. The ultimate goal of this research is to create a wearable physiological sensing solution for COVID-19 patient management, including diagnosis, triage, and monitoring of patients based on lung sounds, lung fluid, body temperature, and inertial measures captured with the same device. The central innovation lies in the hardware and algorithms that have been proposed for this purpose, building upon the teams prior work in other areas of wearable bio-acoustic sensing and bioimpedance spectroscopy. The following two specific aims are proposed for the research: (1) to design, implement, and validate a wearable sensing system for lung sounds, lung fluid, body temperature, and inertial measurements; and (2) to test and evaluate this system to assess efficacy and potential information derived in patients hospitalized with COVID-19 and persons under investigation for COVID-19 longitudinally. Successful completion of this project would result in a validated prototype for sensing multiple parameters of cardiopulmonary health in patients with COVID-19, with imminent feasibility to transition the technology to commercialization and through regulatory pathways. This would provide a much-needed patient management technology for this novel coronavirus to healthcare practitioners and ultimately a means to monitor patients remotely to ensure that any deterioration in health is detected as early as possible. The novel coronavirus (COVID-19) has affected the US and the rest of the world in an unparalleled manner, taking nearly 60,000 lives in the US alone over the past two months and afflicting more than a million Americans, with costs to society that are difficult to measure or bear. Technologies for improving the management of patients presenting at the emergency room are urgently needed in this era, specifically for determining whether such patients should be cared for in the intensive care unit, via infectious diseases procedures, or otherwise. We propose to design a wearable system for measuring lung sounds, lung fluid, body temperature, and movement in the same device to address these critical needs.","Wearable lung sounds, fluid, and body temperature monitoring for patients with COVID-19",10163297,R01EB023808,"['Acoustics ', ' Acoustic ', ' Affect ', ' Algorithms ', ' Auscultation ', ' Ursidae Family ', ' Bears ', ' Ursidae ', ' bear ', ' Biomedical Engineering ', ' bio-engineered ', ' bio-engineers ', ' bioengineering ', ' Body Temperature ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Communicable Diseases ', ' Infectious Disease Pathway ', ' Infectious Diseases ', ' Infectious Disorder ', ' Diagnosis ', ' Electronics ', ' electronic device ', ' Emergency Medical Technicians ', ' Emergency Medicine Technicians ', ' Emergency Paramedics ', ' emergency medical personnel ', ' Emergency Medicine ', ' Equipment ', ' Future ', ' Goals ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Hospitals ', ' indexing ', ' Intensive Care Units ', ' Joints ', ' Knee ', ' Knee Injuries ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Methods ', ' Movement ', ' body movement ', ' Persons ', ' Patient Monitoring ', ' Patients ', ' Reading ', ' Research ', ' Respiratory Sounds ', ' Breathing Sounds ', ' Lung Sounds ', ' Rest ', ' Resuscitation ', ' Risk ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Skin Temperature ', ' Societies ', ' Spectrum Analysis ', ' Spectroscopy ', ' Spectrum Analyses ', ' Technology ', ' Testing ', ' Time ', ' Translations ', ' Triage ', ' Work ', ' Writing ', ' Measures ', ' Community Health Care ', ' Community Healthcare ', ' health care ', ' Healthcare ', ' Caring ', ' base ', ' sensor ', ' Stethoscopes ', ' improved ', ' Procedures ', ' mechanical respiratory assist ', ' Mechanical ventilation ', ' Site ', ' Area ', ' Acute ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Ensure ', ' Measurement ', ' participant recruitment ', ' Patient Recruitments ', ' fluid ', ' liquid ', ' Liquid substance ', ' machine learned ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Investigation ', ' Event ', ' Home ', ' Home environment ', ' Clinic ', ' Techniques ', ' System ', ' Respiratory distress ', ' respiratory ', ' Cardiopulmonary ', ' Juvenile Chronic Arthritis ', ' Juvenile Chronic Polyarthritis ', ' Juvenile Rheumatoid Arthritis ', ' juvenile arthritis ', ' juvenile idiopathic arthritis ', ' Chronic Childhood Arthritis ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' Medical center ', ' American ', ' synergism ', ' kinematic model ', ' kinematics ', ' novel ', ' novel technologies ', ' new technology ', ' Modality ', ' Devices ', ' Reporting ', ' Early identification ', ' Deterioration ', ' miniaturize ', ' Skin ', ' preventing ', ' prevent ', ' Address ', ' Regulatory Pathway ', ' Collection ', ' Validation ', ' Monitor ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' pandemic ', ' pandemic disease ', ' Output ', ' cost ', ' digital ', ' designing ', ' design ', ' innovate ', ' innovative ', ' innovation ', ' healthy volunteer ', ' prototype ', ' commercialization ', ' multi-modality ', ' multimodality ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' clinical decision-making ', ' screening ', ' Data Analytics ', ' sensing technology ', ' sensor technology ', ' body sensor ', ' body worn sensor ', ' wearable sensor ', ' wearable system ', ' wireless sensor technology ', ' wearable sensor technology ', ' CoV emergence ', ' coronavirus emergence ', ' emergent CoV ', ' emergent coronavirus ', ' emerging CoV ', ' emerging coronavirus ', ' nCoV ', ' new CoV ', ' new coronavirus ', ' novel CoV ', ' novel coronavirus ', ' COVID19 ', ' corona virus disease 2019 ', ' coronavirus disease 2019 ', ' COVID-19 ', ' COVID-19 epidemic ', ' COVID19 epidemic ', ' COVID19 pandemic ', ' corona virus disease 2019 epidemic ', ' corona virus disease 2019 pandemic ', ' coronavirus disease 2019 epidemic ', ' coronavirus disease 2019 pandemic ', ' COVID-19 pandemic ', ' ']",NIBIB,GEORGIA INSTITUTE OF TECHNOLOGY,R01,2020,396542,0.148487852515341
"The role of the lung microbiome in oxygen-induced lung injury PROJECT SUMMARY/ABSTRACT Background and long-term objectives: This proposed research will advance our understanding of how the lung microbiome contributes to the pathogenesis and perpetuation of oxygen-induced lung injury. Inhaled oxygen is among our most commonly administered therapies. Yet hyperoxia - elevated inspired oxygen - causes lethal lung injury in animals, and in humans is associated with increased mortality and development of the acute respiratory distress syndrome. We have recently discovered that hyperoxia acutely alters lung microbiota. This oxygen-induced dysbiosis is strongly and temporally correlated with alveolar inflammation. We have discovered that germ-free mice - experimental mice devoid of microbiota - are protected from oxygen- induced lung injury, an observation that cannot be explained via our conventional model of oxygen-induced lung injury. Conversely, lung injury alters lung microbiota by changing bacterial growth conditions within the lung microenvironment. We have discovered that germ-free mice are protected from non-resolving lung injury (bleomycin), indicating that the microbiome is necessary for perpetuation of lung injury. The discovery of the lung microbiome has thus broadened our model of pathogenesis. The mechanisms by which lung microbiota mediate oxygen-induced lung injury, and are in turn altered by lung injury, are undetermined. The central hypothesis of this proposal is that specific bacteria within the lung ecosystem propel alveolar inflammation in oxygen-induced lung injury, and these bacteria are enriched within the lung microbiome both by hyperoxia itself and by the altered ecology of injured lungs. The rationale is that these discoveries will facilitate the development of therapies for the prevention and treatment of oxygen-related human lung disease. Specific Aim 1: To determine the microbial and molecular pathways by which oxygen therapy alters lung microbiota, mediating host inflammation and injury. We will accomplish this Aim by integrating complementary experimental approaches: in vivo heterogeneity analysis of host-microbiome interactions in mice; in vivo germ-free, gnotobiotic, and antibiotic-treated hyperoxia modeling in mice; data science interrogation of observational human data using a validated machine-learning algorithm. Specific Aim 2: To determine the molecular pathways by which oxygen-induced host inflammation and injury alter lung microbiota, perpetuating respiratory dysbiosis and lung injury. We will accomplish this Aim by integrating complementary experimental approaches: a novel ex vivo culture assay that identifies host- derived mediators of bacterial growth; in vivo augmentation and inhibition of the host response in hyperoxia. This translational research approach will determine 1) the key members of the lung microbiome that mediate oxygen-induced lung injury, 2) the pathways by which these bacteria promote alveolar inflammation, and 3) the ecologic factors within the injured lung environment that promote their growth. PROJECT NARRATIVE Inhaled oxygen is among our most commonly administered therapies, yet hyperoxia - elevated inspired oxygen - causes lethal lung injury in animals, and in humans is associated with increased mortality and severe lung disease. We have recently discovered that the lung microbiome - the communities of microbes living in the respiratory tract - are altered by inhaled oxygen and necessary for the development of oxygen-induced lung injury. This proposed research plan will reveal how the lung microbiome contributes to oxygen-induced lung injury, and provide us with new ways to prevent and treat this common clinical problem.",The role of the lung microbiome in oxygen-induced lung injury,9893017,R01HL144599,"['Animals ', ' Antibiotics ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Bacteria ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Bleomycin ', ' Bleo ', ' Disease ', ' Disorder ', ' Ecology ', ' Environmental Science ', ' Environment ', ' Feedback ', ' Gnotobiotic ', ' Gnotobiotics ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Inflammation ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' mortality ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Oxygen ', ' O element ', ' O2 element ', ' Publishing ', ' Research ', ' Adult Respiratory Distress Syndrome ', ' ARDS ', ' Acute Respiratory Distress ', ' Acute Respiratory Distress Syndrome ', ' Adult ARDS ', ' Adult RDS ', ' Da Nang Lung ', ' Shock Lung ', ' Stiff lung ', ' wet lung ', ' Respiratory System ', ' Pulmonary Body System ', ' Pulmonary Organ System ', ' Respiratory Tracts ', ' Respiratory tract structure ', ' Role ', ' social role ', ' Experimental Models ', ' Mediating ', ' Ecologic Systems ', ' Ecological Systems ', ' Ecosystem ', ' injuries ', ' Injury ', ' Oxygen Inhalation Therapy ', ' Warburg Therapy ', ' oxygen administration ', ' oxygen therapy ', ' Oxygen Therapy Care ', ' Acute ', ' Clinical ', ' Oxidative Stress ', ' Hyperoxia ', ' Lung damage ', ' lung injury ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Nature ', ' Severities ', ' respiratory ', ' human data ', ' microbial ', ' sterile ', ' Sterility ', ' novel ', ' member ', ' Prevention ', ' Pathogenesis ', ' Modeling ', ' preventing ', ' prevent ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Alveolar ', ' in vivo ', ' Germ-Free ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' microbiome ', ' Outcome ', ' Prevention therapy ', ' community microbes ', ' microbial community ', ' therapeutic target ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' Data Science ', ' microbial consortia ', ' microbial flora ', ' microflora ', ' multispecies consortia ', ' microbiota ', ' Inhaling ', ' Inhalation ', ' host microflora ', ' resident microbes ', ' resident microflora ', ' host microbiota ', ' dysbacteriosis ', ' dysbiotic ', ' microbial imbalance ', ' dysbiosis ', ' pulmonary microbiome ', ' lung microbiome ', ' lung microbial community ', ' pulmonary microbial community ', ' pulmonary microbiota ', ' lung microbiota ', ' host microbiome ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2020,415715,0.13374521240940032
"Development of a Rapid Method for Imaging Regional Ventilation in Small Animals w/o Contrast Agents The objective of this R01 application is to develop a rapid method for imaging regional ventilation and lung compliance in small animals without contrast agents. Much of our current understanding of the normal functioning of the lung and mechanisms of lung disease comes from small animal studies. However, lung function imaging in small animal models is technically challenging due to motion and the relatively small size of the lungs. Pulmonary function testing using plethysmography has been employed to assess lung function and injury with limited validity and utility, particularly in small animals. Additionally, only aggregate measures of functional performance are produced and no regional lung changes can be assessed. An improved imaging method that could provide spatially- and temporally-resolved information regarding ventilation would be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases. It would also facilitate drug discovery and efficacy studies aimed to mitigate respiratory pathology. The ideal method would provide quantitative regional functional information, be applicable to longitudinal studies (low radiation dose), and have a simple and affordable implementation that permits widespread use. Currently available imaging methods including micro-CT or MRI fall short in one or more of these requirements.  To address this need, we will establish and evaluate a novel, easy to implement, and highly effective X- ray phase-contrast (XPC) method for ventilation imaging in small animal models. The lung is ideally suited to XPC imaging because it is comprised mainly of air spaces separated by thin tissue structures. The air-tissue interfaces cause the X-ray beam to experience numerous and strong refractions that produce a distinctive texture in the intensity measured over the lungs known as speckle. Detailed information regarding the regional lung air volume (RLAV) distribution is encoded in the speckle. The benefits of exploiting lung speckle for detecting and monitoring lung function are numerous but remain entirely unexplored for benchtop imaging.  Our approach involves a high degree of technical innovation regarding image formation methods and will significantly extend the current boundaries of functional lung imaging in small animals. The proposed method, referred to as parametric XPC (P-XPC) imaging, will produce 2D parametric images that depict the projected RLAV distribution. When differential images are computed for any given two points in the breathing cycle, ventilation or lung compliance imaging will be achieved. Preliminary in vivo and computational studies have been conducted in support of the proposed research. The specific aims of the project are as follows. Aim 1: Develop P-XPC image formation methods for estimating the projected RLAV distribution; Aim 2: Optimize an XPC imaging system for P-XPC imaging. Aim 3: Evaluate the diagnostic capability of P-XPC imaging in two pre-clinical animal models of disease in vivo. The proposed research will result in a novel, easy to implement, and highly effective X-ray phase-contrast (XPC) method for functional lung imaging in small animal models. It will provide spatially- and temporally- resolved information regarding lung ventilation that will be of great value to those studying basic pulmonary physiology and the onset and progression of a large range of respiratory diseases.",Development of a Rapid Method for Imaging Regional Ventilation in Small Animals w/o Contrast Agents,9888370,R01EB023045,"['Air ', ' Animals ', ' Breathing ', ' Respiratory Aspiration ', ' Respiratory Inspiration ', ' inspiration ', ' Communities ', ' Contrast Media ', ' Contrast Agent ', ' Contrast Drugs ', ' Radiopaque Media ', ' Animal Disease Models ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung Compliance ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Pulmonary function tests ', ' Lung Function Tests ', ' Respiratory Function Tests ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Maps ', ' Methods ', ' Motion ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Pathology ', ' Physics ', ' Physiology ', ' Plethysmography ', ' pressure ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Research ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Thinness ', ' Leanness ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Measures ', ' falls ', ' base ', ' detector ', ' improved ', ' Pulmonary imaging ', ' lung scanning ', ' lung imaging ', ' Phase ', ' Evaluation ', ' lung volume ', ' Lung damage ', ' lung injury ', ' Diagnostic ', ' Scientist ', ' Source ', ' Texture ', ' Techniques ', ' System ', ' respiratory ', ' Radiation Dose ', ' Radiation Dose Unit ', ' experience ', ' Performance ', ' drug efficacy ', ' lung pressure ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Structure ', ' novel ', ' Radiation ', ' rapid method ', ' rapid technique ', ' drug discovery ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Address ', ' Resolution ', ' Resource Sharing ', ' in vivo ', ' Physiologic Imaging ', ' physiological imaging ', ' Functional Imaging ', ' Low Dose Radiation ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' preclinical ', ' pre-clinical ', ' cost ', ' computational studies ', ' computer studies ', ' Imaging technology ', ' innovate ', ' innovative ', ' innovation ', ' murine model ', ' mouse model ', ' X-ray microtomography ', ' Xray microtomography ', ' micro CT ', ' micro computed tomography ', ' microtomography ', ' microCT ', ' animal imaging ', ' imaging system ', ' contrast imaging ', ' technical certificate ', ' Technical Degree ', ' efficacy study ', ' parametric imaging ', ' in vivo monitoring ', ' supervised machine learning ', ' supervised learning ', ' ventilation ', ' machine learning method ', ' ']",NIBIB,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,R01,2020,419843,0.181852624679404
"Novel fMRI Strategy to Assess Consciousness in Brain-Injured Patients Multiple studies have shown that some patients who remain behaviorally unresponsive after severe brain damage can modulate their brain activity in response to command. A lack of response to the command- following paradigm in other patients, however, cannot be taken as evidence that consciousness is absent. There is thus an urgent need for neuroimaging tools that are able to diagnose covert consciousness in behaviorally unresponsive subjects without relying on a task. Previous neuroimaging studies of the neural correlates of consciousness (NCCs) have mostly utilized between-state paradigms (e.g., wakefulness vs. sleep) or report-based contrasts, which conflate differences in brain activity supporting consciousness with differences in brain activity supporting behavior or task response. To address these limitations, my sponsor (Dr. Giulio Tononi) has developed a within-state, no-report paradigm that uses serial awakenings to contrast states of consciousness versus unconsciousness during sleep, a physiological unresponsive state. Using high density electroencephalography (EEG), his group has shown that the occurrence of dreaming consciousness during sleep is associated with a reduction of delta activity (sleep slow waves) in a posterior cortical hot zone encompassing occipital, parietal and temporal cortices. To proceed towards clinical applications, it is now essential to confirm and extend these findings using combined EEG-fMRI (functional magnetic resonance imaging). To this effect, in an important new development, Dr. Tononi and collaborators have recently shown that it is possible to faithfully track EEG slow wave activity during sleep by means of a high-frequency (~0.17 Hz) blood-oxygenation level dependent (BOLD) oscillation evident in fMRI. This finding provides an unprecedented opportunity to investigate the NCCs during sleep with high spatial resolution, avoiding potential pitfalls of EEG source modeling, and with unrestricted access to subcortical structures. Taking advantage of these new findings, in this project, I propose to combine the novel fMRI signature of sleep slow waves with a serial awakenings paradigm to locate the NCCs during sleep. Specifically, I will acquire fMRI-EEG data during ~1,080 awakenings from sleep across 40 healthy subjects and investigate the neural correlates of the presence versus absence of dreaming consciousness (Aim 1). I hypothesize that high-frequency BOLD oscillationwhich tracks sleep slow-waveswill show regional decreases in specific posterior cortical areas during dreaming compared to dreamless sleep. In Aim 2, I will use univariate and multivariate modeling approaches based on high-frequency BOLD power and conventional BOLD amplitude to identify the NCCs of specific dream contents (e.g., presence of faces) and complexity. If successful, the proposed experiments will constitute an important step forward in identifying brain regions that sustain consciousness and its contents during behaviorally unresponsive states. These results can open new avenues to improve clinical care in patients with a DOC and inform the assessment of intraoperative awareness in anesthetized subjects. Due to previous methodological oversights that confounded consciousness and behavior, the neural substrates of covert consciousness in unresponsive states are poorly understood. The current project will use serial awakenings with dream reports combined with a novel functional magnetic resonance imaging (fMRI) signature of sleep slow waves to identify the neural correlates of both the presence of consciousness and its contents during sleep, a physiological unresponsive state. The goal is to help clarify a scientific controversy surrounding the neural basis of consciousness at an unprecedented spatial resolution and with an access to subcortical structures, which could ultimately to improve diagnosis through neuroimaging and clinical care for patients with disorders of consciousness.",Novel fMRI Strategy to Assess Consciousness in Brain-Injured Patients,10053237,F32NS114034,"['Affect ', ' Award ', ' Awareness ', ' Behavior ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Consciousness Disorders ', ' Diagnosis ', ' Differential Diagnosis ', ' Dreams ', ' dreaming ', ' Electroencephalography ', ' EEG ', ' Ethics ', ' ethical ', ' Face ', ' faces ', ' facial ', ' Fellowship ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Judgment ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Methods ', ' Methodology ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' neurophysiology ', ' neurophysiological ', ' Occipital lobe ', ' occipital cortex ', ' Parietal Lobe ', ' parietal cortex ', ' Patients ', ' Perception ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Sleep ', ' Computer software ', ' Software ', ' Specificity ', ' Speech ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Temporal Lobe ', ' temporal cortex ', ' Unconscious State ', ' Unconscious ', ' Unconsciousness ', ' consciousness loss ', ' Wakefulness ', ' Measures ', ' base ', ' density ', ' improved ', ' Area ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Training ', ' selective attention ', ' Consciousness ', ' Conscious ', ' Delta Wave ', ' Delta Wave sleep ', ' Slow-Wave Sleep ', ' Funding ', ' Acquired brain injury ', ' brain damage ', ' brain-injured ', ' Brain Injuries ', ' tool ', ' Functional MRI ', ' fMRI ', ' Functional Magnetic Resonance Imaging ', ' Knowledge ', ' Dimensions ', ' Frequencies ', ' Protocol ', ' Protocols documentation ', ' Source ', ' Pattern ', ' System ', ' experience ', ' Accuracy of Diagnosis ', ' diagnostic accuracy ', ' neural control ', ' neural regulation ', ' neuromodulation ', ' neuromodulatory ', ' neuroregulation ', ' neural ', ' relating to nervous system ', ' Structure ', ' skills ', ' expectation ', ' neuro-imaging ', ' neuroimaging ', ' novel ', ' Participant ', ' Reporting ', ' Modeling ', ' response ', ' Vegetative States ', ' Brain region ', ' degenerative condition ', ' degenerative disease ', ' Degenerative Disorder ', ' Address ', ' Board Certification ', ' Data ', ' Resolution ', ' Monitor ', ' Preparation ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' blood oxygenation level dependent ', ' blood oxygen level dependent ', ' NREM ', ' non-REM ', ' non-rapid eye movement ', ' nonREM ', ' nonrapid eye movement ', ' non rapid eye movement ', ' neural mechanism ', ' neuromechanism ', ' Coupled ', ' innovate ', ' innovative ', ' innovation ', ' clinical applicability ', ' clinical application ', ' brain research ', ' cognitive control ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' stimulus processing ', ' fusiform face area ', ' lenses ', ' lens ', ' clinical care ', ' life-sustaining therapy ', ' behavior response ', ' behavioral response ', ' neural correlate ', ' sensory input ', ' Traumatic injury ', ' neuroimaging biomarker ', ' neuroimaging marker ', ' experiment ', ' experimental research ', ' experimental study ', ' fMRI/EEG ', ' functional magnetic resonance imaging/electroencephalography ', ' machine learning method ', ' ']",NINDS,UNIVERSITY OF WISCONSIN-MADISON,F32,2020,67626,0.09807420662365962
"DORMIR: Determinants, Outcomes, Responses and Markers of  Insufficient sleep in Rural-Urban settings Project Summary The widening gap in all-cause and CVD-mortality and morbidity rates in rural and urban America is at an all- time high. Latino/as, the largest minority ethnic group in the U.S., appear to be most affected by rural-urban divide in CVD outcomes, as they are disproportionately burdened by CVD risk (overweight/obesity, hypertension, dyslipidemia, diabetes) and CVD mortality (20%, 2nd leading cause of death among Latino/as) relative to other racial/ethnic groups. Unlike other groups where individuals in rural and urban areas have differing CVD risk, rural and urban Latino/as have similarly high rates of CVD risk. Although, healthy diets/ nutrition, smoking cessation, and regular physical activity are linked to CVD risk, they have not been very effective in reducing the CVD burden among racial/ethnic groups, specifically among Latino/as. Several studies indicate that insufficient sleep (<7hrs./day) explains a significant amount of the CVD burden among Latino/as. Preliminary evidence indicates that insufficient sleep may contribute to the observed CVD burden among Latino/as, as Latino/as have greater odds of experiencing insufficient sleep compared with non-Hispanic whites. Evidence also shows that insufficient sleep, which is associated with potentially life-threatening CVD, is a key modifiable risk factor with great potential to reduce health disparities. However, it is unclear what factors contribute to insufficient sleep (IS) disparities and IS-related CVD burden among rural and urban Latino/as. To address these gaps, we will enroll 525 Latino/as in rural and urban communities to participate in home-based studies using novel mHealth devices. The multidisciplinary team will: 1) identify behavioral, genetic, psychosocial, and environmental factors that are associated with insufficient sleep and IS-related CVD and 2) assess effects of insufficient sleep on CVD risk markers (obesity, blood pressure, lipid profile, and fasting plasma glucose/ HbA1C) and inflammatory risk markers (IL-6, IL-10, and TNF-). This study will provide multi-level evidence supporting epidemiological findings of greater rates of insufficient sleep among Latino/as, which may explain their disproportionate burden of CVD risk. It will also assess whether and why rural and urban differences in IS exist among Latino/as and how that may lead to IS-related CVD outcomes. These data will provide: 1) the foundation for interventions to mitigate adverse effects of insufficient sleep on CVD health outcomes, 2) evidence to delineate factors underlying insufficient sleep and CVD burden among Latino/as in rural and urban settings, and 3) a possible explanation of behavioral, genetic, environmental and psychosocial determinants of insufficient sleep and related CVD risk factors in rural and urban Latino/as. Findings can lead to actionable clinical, lifestyle, and policy interventions to improve Latino health. Project Narrative This proposal is predicated upon compelling data that Latino/as exhibit a greater risk of insufficient sleep (<7 hours) compared with whites, and that insufficient sleep is associated with increased risk of cardiovascular disease and inflammation. It will provide multi-level evidence on behavioral, genetic, psychosocial and environmental determinants of insufficient sleep and sleep-related CVD risk and inflammation markers among rural and urban Latino/as. These data will provide the foundation for interventions to mitigate adverse effects of insufficient sleep on health outcomes.","DORMIR: Determinants, Outcomes, Responses and Markers of  Insufficient sleep in Rural-Urban settings",9976872,R01HL152453,"['Affect ', ' Age ', ' ages ', ' Air ', ' Americas ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Blood Pressure ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cause of Death ', ' Communities ', ' Cessation of life ', ' Death ', ' Diabetes Mellitus ', ' diabetes ', ' Diet ', ' dietary ', ' Discrimination ', ' Cognitive Discrimination ', ' Environment ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Ethnic group ', ' ethnicity group ', ' Exhibits ', ' Foundations ', ' Genetic Markers ', ' genetic biomarker ', ' Behavioral Genetics ', ' Genetic Determinants of Behavior ', ' behavior genetics ', ' Genotype ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Health ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Household ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Inflammation ', ' instrumentation ', ' Insulin Resistance ', ' insulin resistant ', ' Interleukin-6 ', ' B cell differentiation factor ', ' B cell stimulating factor 2 ', ' B-Cell Differentiation Factor ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Stimulatory Factor-2 ', ' BCDF ', ' BSF-2 ', ' BSF2 ', ' HPGF ', ' Hepatocyte-Stimulating Factor ', ' Hybridoma Growth Factor ', ' IFN-beta 2 ', ' IFNB2 ', ' IL-6 ', ' IL6 Protein ', ' MGI-2 ', ' Myeloid Differentiation-Inducing Protein ', ' Plasmacytoma Growth Factor ', ' interferon beta 2 ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Length of Stay ', ' Number of Days in Hospital ', ' hospital days ', ' hospital length of stay ', ' hospital stay ', ' Life Style ', ' Lifestyle ', ' Light ', ' Photoradiation ', ' Lipids ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Neighborhoods ', ' New York ', ' Noise ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Birth Place ', ' Psychosocial Factor ', ' psychosocial variables ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' Science ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Stress ', ' Temperature ', ' Time ', ' smoking cessation ', ' cease smoking ', ' quit smoking ', ' stop smoking ', ' Interleukin-10 ', ' CSIF ', ' CSIF-10 ', ' Cytokine Synthesis Inhibitory Factor ', ' IL-10 ', ' IL10 ', ' IL10A ', ' Interleukin 10 Precursor ', ' Latino ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' base ', ' density ', ' rural region ', ' rural area ', ' urban area ', ' improved ', ' Biological ', ' Link ', ' Physical activity ', ' Individual ', ' Rural ', ' Dyslipidemias ', ' Policies ', ' Funding ', ' Genetic ', ' Inflammatory ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Life ', ' Level of Evidence ', ' Hour ', ' Home ', ' Home environment ', ' System ', ' Healthy diet ', ' balanced diet ', ' good diet ', ' Over weight ', ' Overweight ', ' psychosocial ', ' experience ', ' success ', ' arterial stiffening ', ' artery stiffening ', ' artery stiffness ', ' arterial stiffness ', ' Disease Outcome ', ' novel ', ' population-based study ', ' population-level study ', ' studies of populations ', ' study of the population ', ' Population Study ', ' model-based simulation ', ' models and simulation ', ' Predictive Factor ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Devices ', ' social ', ' (TNF)- ', ' Cachectin ', ' Macrophage-Derived TNF ', ' Monocyte-Derived TNF ', ' TNF ', ' TNF A ', ' TNF Alpha ', ' TNF- ', ' TNFA ', ' TNF ', ' Tumor Necrosis Factor ', ' Tumor Necrosis Factor-alpha ', ' TNF gene ', ' geospatial information system ', ' Geographic Information Systems ', ' Emotional ', ' sleep diseases ', ' sleep dysfunction ', ' sleep dysregulation ', ' sleep problem ', ' Sleep Disorders ', ' Modeling ', ' Sampling ', ' Adverse effects ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' actigraph ', ' actigraphy ', ' disparity in health ', ' health disparity ', ' Address ', ' Data ', ' Diet and Nutrition ', ' Disease Marker ', ' High Prevalence ', ' Collection ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Nonhispanic ', ' Not Hispanic or Latino ', ' Risk Marker ', ' Seminal ', ' Process ', ' sex ', ' Behavioral ', ' fasting plasma glucose ', ' burden of disease ', ' disease burden ', ' years of life lost to disability ', ' years of life lost to disease ', ' burden of illness ', ' designing ', ' design ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' modifiable risk ', ' ethnic minority ', ' ethnic minority population ', ' multidisciplinary ', ' racial and ethnic ', ' population based ', ' inflammation marker ', ' inflammatory marker ', ' m-Health ', ' mobile health ', ' mHealth ', ' health data ', ' clinically actionable ', ' built environment ', ' response markers ', ' response biomarker ', ' circadian desynchronization ', ' circadian misalignment ', ' Circadian desynchrony ', ' urban disparity ', ' urban setting ', ' rural locality ', ' rural place ', ' rural setting ', ' recruit ', ' sleep hygiene ', ' sleep health ', ' circadian ', ' Bayesian machine learning ', ' Bayesian learning ', ' data diversity ', ' diverse data ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2020,847392,0.12134922907085155
"Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood PROJECT SUMMARY Substantial improvements in cancer survival rates could be achieved by developing better tools to detect occult malignancies at an earlier, more curable stage. Unfortunately, efforts to identify serum protein biomarkers that are sufficiently cancer-specific to be used for screening have found little success. Here, we pursue an alternative strategy based on detection of exceptionally tumor-specific mutant DNA fragments in the circulation of patients with early-stage lung cancer. Because these tumor-derived DNA fragments harbor genetic signatures that would be uncommon in healthy individuals, they hold great promise for screening applications where a high frequency of false-positive results would be unacceptable. However, it is a formidable challenge to create an assay that is able to detect trace quantities of mutant DNA released into the bloodstream from a small, early-stage tumor, without knowing the tumors mutation profile beforehand. Additional challenges are posed by economic factors as well as the presence of low-level mutations in the healthy population. To address these challenges, we have assembled a multidisciplinary team with highly complementary expertise from Microsoft Research and from Yale, Rice, and Harvard Universities. In this proposal, we describe innovative solutions in which we apply tools of biochemistry, thermodynamics, machine learning, and biostatistics to develop and validate an ultrasensitive, cost-efficient assay for detecting rare mutant DNA fragments in blood as markers of early-stage lung cancer. PROJECT NARRATIVE Lung cancer has a high fatality rate because most patients are diagnosed at a late stage, when the disease is more difficult to cure. A screening test that finds lung tumor DNA in blood could help to improve survival outcomes.",Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood,9983693,U01CA233364,"['Age ', ' ages ', ' Algorithms ', ' Alleles ', ' Allelomorphs ', ' Back ', ' Dorsum ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Circulation ', ' Bloodstream ', ' Circulation ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Colonoscopy ', ' Diagnosis ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Blood Tests ', ' Hematologic Tests ', ' Hematological Tests ', ' Hematology Testing ', ' Hematopoiesis ', ' Hematopoietic Cellular Control Mechanisms ', ' blood cell formation ', ' Libraries ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung Neoplasms ', ' Lung Tumor ', ' Pulmonary Neoplasms ', ' Mammography ', ' Mammogram ', ' mammographic examinations ', ' mammographic exams ', ' Medicine ', ' Methods ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Patients ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Probability ', ' Research ', ' Rice ', ' Sensitivity and Specificity ', ' Serum Proteins ', ' Skates ', ' Rajidae ', ' Specificity ', ' Survival Rate ', ' Technology ', ' Temperature ', ' Testing ', ' Thermodynamics ', ' Thermodynamic ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Universities ', ' Work ', ' Pap smear ', ' Pap Test ', ' Pap screening ', ' Papanicolaou Smear ', ' Papanicolaou Test ', ' Morphologic artifacts ', ' Artifacts ', ' Tube ', ' base ', ' improved ', ' Cancer Screening for Patients ', ' early cancer detection ', ' Screening for cancer ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Economical Factors ', ' Economic Factors ', ' Training ', ' Lesion ', ' lung base ', ' lung basal segment ', ' Individual ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' lung cancer early detection ', ' lung cancer screening ', ' tool ', ' Smoker ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Frequencies ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' Somatic Mutation ', ' mutant ', ' Performance ', ' success ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' purges ', ' purging ', ' purge ', ' Sampling ', ' depository ', ' repository ', ' T-Stage ', ' Tumor stage ', ' Fatality rate ', ' Address ', ' cost efficient analysis ', ' cost-effective analysis ', ' Cost Effectiveness Analysis ', ' DNA Alteration ', ' DNA mutation ', ' Genetic mutation ', ' Sequence Alteration ', ' genomic alteration ', ' DNA Sequence Alteration ', ' Data ', ' Detection ', ' Predictive Value ', ' precancerous ', ' premalignant ', ' genomic region ', ' Genomic Segment ', ' Nucleic Acid Biochemistry ', ' Tumor-Derived ', ' developmental ', ' Development ', ' neoplastic ', ' cost ', ' designing ', ' design ', ' cost efficient ', ' Population ', ' cancer type ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' multidisciplinary ', ' tumor ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' NGS Method ', ' NGS system ', ' next gen sequencing ', ' nextgen sequencing ', ' next generation sequencing ', ' exome-seq ', ' exome sequencing ', ' screening ', ' tumor cell DNA ', ' tumor-specific DNA ', ' tumor DNA ', ' unclassified variant ', ' variant of uncertain clinical significance ', ' variant of uncertain significance ', ' variant of undetermined significance ', ' variant of unknown significance ', ' cell free circulating DNA ', ' cell free DNA ', ' biochemistry tools ', ' biochemical tools ', ' biomarker development ', ' gene signatures ', ' genetic signature ', ' cancer markers ', ' cancer biomarkers ', ' protein markers ', ' protein biomarkers ', ' survival outcome ', ' cancer survival ', ' high risk group ', ' high risk population ', ' preservation ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NCI,YALE UNIVERSITY,U01,2020,897096,0.020759932163057816
"CRCNS: Unsupervised Learning of Hippocampal Sequence Dynamic in Sleep   In unit recordings from large populations of neurons, fast compressed sequential firing of neurons during rest and early sleep have been found to replay patterns first observed in active awake experience. These remarkable patterns have sparked widespread interest in the scientific community and beyond. Sequence  replay is now considered to play a critical role in the long-term stabilization and storage of mnemonically  important information. However, despite the general acknowledgement of the importance of the sequential structure, very little is known about the null background against which replay is compared. Specifically, are apparently 'non-replaying' spike patterns, as seen in late sleep, just simply noise? Because replay is typically assessed by comparison against a fixed known template, most methods can only determine whether the resemblance to the template is more than what might be expected from  random spike trains. But these methods cannot appraise whether other patterns remain in the nonsignificant events. Recently, the Diba and Kemere labs successfully collaborated to address precisely  this issue. We developed methods based on hidden Markov models (HMMs) to uncover temporal structure in spike trains of neurons in an unsupervised template-free manner. In this proposal, we aim to further improve these methods and to evaluate the hidden structure of spike trains in hippocampal  neuronal populations during sleep. In our second specific aim, we will use HMMs to determine both co-active ensemble (""contextual"") and temporal patterns (""sequential"") structure in hippocampal spike trains in both pre- and post-task sleep. In the third specific aim, we will probe the essence of sleep replay further, by exposing animals to multiple novel and familiar maze environments prior to long durations of sleep. In the fourth specific aim, we will perform closed-loop disruption of neuronal population patterns to  examine the causal interplay and reverberation of these patterns from early to late sleep. In summary, our  proposal is designed to provide strongest characterization to date of the structure of ""noise"" in replay events. RELEVANCE (See instructions):  This study will provide an opening to evaluate the role of sleep in reorganizing information in the brain and  help to identify critical time windows and neuronal activities during sleep which are particularly important  for information storage and stabilization. Our assumptions and deductions about the nature and purpose  of sleep implicitly inform all manner of public policy, from the durations of shifts for hospital and relief  workers, to morning start times of public schools. Understanding the function and mechanisms of sleep H ",CRCNS: Unsupervised Learning of Hippocampal Sequence Dynamic in Sleep  ,9995029,R01NS115233,"['Animals ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cells ', ' Cell Body ', ' Cognition ', ' Communities ', ' Deductibles ', ' Electric Stimulation ', ' Electrical Stimulation ', ' electrostimulation ', ' Environment ', ' Hippocampus (Brain) ', ' Ammon Horn ', ' Cornu Ammonis ', ' Hippocampus ', ' hippocampal ', ' Hospitals ', ' Learning ', ' Memory ', ' Methods ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Neurosciences ', ' Noise ', ' Play ', ' Public Policy ', ' Rest ', ' Role ', ' social role ', ' Schools ', ' Sleep ', ' sound ', ' Time ', ' base ', ' improved ', ' Evaluation ', ' Training ', ' Memory Deficit ', ' memory dysfunction ', ' Memory impairment ', ' awake ', ' Information Storage ', ' Nature ', ' Hour ', ' Event ', ' Pattern ', ' Techniques ', ' interest ', ' Visit ', ' experience ', ' Structure ', ' memory processing ', ' memory process ', ' novel ', ' Reporting ', ' Modeling ', ' theories ', ' Address ', ' Data ', ' pathway ', ' Pathway interactions ', ' Instruction ', ' markov model ', ' designing ', ' design ', ' Population ', ' optogenetics ', ' memory consolidation ', ' unsupervised machine learning ', ' unsupervised learning ', ' ']",NINDS,RICE UNIVERSITY,R01,2020,335611,0.09775043564350816
"STAN-CT: Standardization and Normalization of CT images for Lung Cancer Patients Project Summary/Abstract Lung cancer is the leading cause of cancer death and one of the most common cancers among both men and women in the United States. Recent advances in high-resolution imaging set the stage for radiomics to become an active emerging field in cancer research. However, the promise of radiomics is limited by a lack of image standardization tools, because computed tomography (CT) images are often acquired using scanners from different vendors with customized acquisition parameters, posing a fundamental challenge to radiomic studies across sites. To overcome this challenge, especially for large-scale, multi-site radiomic studies, advanced algorithms are required to integrate, standardize, and normalize CT images from multiple sources. We propose to develop STAN-CT, a deep learning software package that can automatically standardize and normalize a large volume of diagnostic images to facilitate cross-site large-scale image feature extraction for lung cancer characterization and stratification. By precisely mitigating the differences in advanced radiomic features of CT images, STAN-CT will overcome research silos and promote medical image resource sharing, ultimately improving the diagnosis and treatment of lung cancer. Our goal will be achieved through two Aims. In Aim 1, we will develop a working prototype to standardize CT images. First, we will collect raw image data from lung cancer patients and reconstruct CT images using multiple image reconstruction parameters, and we will scan a multipurpose chest phantom along with five different nodule inserts. Then, we will develop and train STAN-CT for CT image standardization. An alternative training architecture will be developed to achieve the improved model training stability. In Aim 2. We will deploy and test STAN-CT for image standardization locally and across three medical centers. First, we will make the STAN-CT software package available to the public by providing a menu-driven web-interface so that that users can conveniently convert medical images that were taken using non-standard protocols to one or multiple standards that they specify. Second, we will deploy STAN-CT at the University of Kentucky for local performance validation. We will test the functionality, reliability, and performance of STAN-CT using both patient chest CT image data collected at large-scale and the phantom image data, both independent to training. Third, we will deploy and test STAN-CT at the University of Kentucky as well as the University of Texas Southwestern Medical Center and Emory University for cross- center performance validation. We will use the same multipurpose chest phantom and both standard and non- standard protocols to validate STAN-CT at the three centers. We will test the generalizability of STAN-CT using clinical CT images of human patients and will determine whether a model trained using the data from one medical center are applicable for images collected at another place. Finally, we will distribute the software package of STAN-CT for public use. STAN-CT will enable a wide range of radiomic researches to identify diagnostic image features that strongly associated with lung cancer prognosis. Project Narrative Computed tomography (CT) is one of the most popular diagnostic image modalities routinely used for assessing anatomical tissue characteristics for disease management. However, CT images are often acquired using scanners from different vendors with different imaging standards, posing a fundamental challenge to radiomic studies across sites. The goal of the Standardization and Normalization of CT images for lung cancer patients (STAN-CT) project is to develop a deep learning software package that can automatically standardize and normalize a large volume of chest CT images to facilitate cross-site large-scale image feature extraction for lung cancer characterization and stratification.",STAN-CT: Standardization and Normalization of CT images for Lung Cancer Patients,9961508,R21CA231911,"['Algorithms ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Architecture ', ' Engineering / Architecture ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Non-Small-Cell Lung Carcinoma ', ' NSCLC ', ' NSCLC - Non-Small Cell Lung Cancer ', ' Non-Small Cell Lung Cancer ', ' Nonsmall Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Communities ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Diagnostic Imaging ', ' Evolution ', ' Faculty ', ' Goals ', ' Human ', ' Modern Man ', ' image reconstruction ', ' image construction ', ' image generation ', ' Kentucky ', ' Medical Imaging ', ' men ', "" men's "", ' Anatomic Models ', ' Anatomical Models ', ' Names ', ' Nodule ', ' Patients ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Quality Control ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Research ', ' Computer software ', ' Software ', ' Standardization ', ' Survival Rate ', ' Testing ', ' Texas ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' United States ', ' Universities ', ' Vendor ', ' Woman ', ' Custom ', ' base ', ' improved ', ' Pulmonary imaging ', ' lung scanning ', ' lung imaging ', ' Site ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Training ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Imaging Phantoms ', ' tool ', ' Life ', ' Disorder Management ', ' Disease Management ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Source ', ' System ', ' Medical center ', ' Performance ', ' trait ', ' member ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Modeling ', ' response ', ' Cancer Treatment ', ' Malignant Neoplasm Therapy ', ' Malignant Neoplasm Treatment ', ' anti-cancer therapy ', ' anticancer therapy ', ' cancer therapy ', ' cancer diagnosis ', ' Computed Tomography Scanners ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Data ', ' Multi-center clinical trial ', ' Multi-site clinical trial ', ' Multicenter clinical trial ', ' Multisite clinical trial ', ' Multi-Institutional Clinical Trial ', ' Resource Sharing ', ' Stratification ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' Cancer Prognosis ', ' Validation ', ' Characteristics ', ' imaging ', ' Image ', ' anti-cancer research ', ' cancer research ', ' anticancer research ', ' Outcome ', ' oncologic imaging ', ' oncology imaging ', ' tumor imaging ', ' cancer imaging ', ' Imaging technology ', ' web interface ', ' spatial temporal variation ', ' prototype ', ' tumor ', ' quantitative imaging ', ' data into knowledge ', ' data to knowledge ', ' radiomics ', ' chest CT ', ' chest computed tomography ', ' high resolution imaging ', ' human imaging ', ' deep learning ', ' computing platform ', ' computational platform ', ' feature extraction ', ' ']",NCI,UNIVERSITY OF KENTUCKY,R21,2020,175505,0.06407178479722458
"Lung Navigation System for Localizing and Resecting Nodules Project Abstract  Although Wedge Resection Surgery results in better lung function, tumor recurrence rate is almost double that of lobectomy, with significantly poorer 5-year survival rates. This may be attributed to the difficulty in accurately localizing and resecting the nodules in a deflated lung. Currently, there is no effective method of accurately localizing the nodules and guiding the surgical stapling device to the optimal resection margin. The long-term goal of this research is to investigate algorithms and technologies to manage lung nodules from diagnosis to surgical resection. The objective of this proposal is to design and develop a lung navigation (LungNav) system to localize and excise, with sufficient margin, small and early malignant lung nodules. The experimental methods will be to design and develop the LungNav system integrated with an active nodule tracker called J-bar, machine learning algorithms for determining the optimal resection margin, and tracked surgical stapling device for accurately excising the nodule. Tumor deformation algorithms and augmented reality displays will be developed to visualize the nodule on thoracosopy videos and guide the surgical stapler in real-time to the optimal margin. The hypothesis is that by anchoring the J-bar close to the nodule, the nodule position can be accurately tracked in real-time despite significant tissue deformation when the lung is collapsed and manipulated during surgery. To achieve the goals of this project, we will pursue the following specific aims: 1) Design and develop the nodule tracker (J-bar) and deformation algorithms to estimate the real-time position of the nodule. 2) Investigate a machine-learning approach based on convolutional neural networks (CNN) to determine the optimal resection margin. 3) Design and develop a software navigation module, called LungNav, for visualizing the tumor and navigating the surgical stapler to the optimal resection margin. 4) Validate the design and performance of the LungNav system using ex-vivo lung tissue and live porcine models. The proposed research is significant since it addresses an important problem, which potentially affects several thousand patients each year, of accurately localizing and resecting lung nodules while preserving healthy lung function. The research is innovative since it builds on state-of-the-art machine learning algorithms, navigation systems and augmented reality methods to accurately diagnose and localize the nodule in presence of significant tissue deformation. The expected outcome of the project is the development of CNN-based machine learning algorithms for lung nodule classification and a LungNav system with tumor deformation algorithms and augmented reality methods to localize and guide complete surgical resection of lung nodules. Project Narrative ! The proposed research is significant since it addresses an important problem, which potentially affects several thousand patients each year, of accurately localizing and resecting lung nodules while preserving healthy lung function. The research is innovative since it builds on state-of-the-art machine learning algorithms, navigation systems and augmented reality methods to accurately diagnose and localize the nodule in presence of significant tissue deformation. !",Lung Navigation System for Localizing and Resecting Nodules,10000098,R01EB025964,"['Affect ', ' Algorithms ', ' Classification ', ' Systematics ', ' Diagnosis ', ' Electromagnetics ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Lobectomy ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Methods ', ' Nodule ', ' Legal patent ', ' Patents ', ' Patients ', ' Lung nodule ', ' pulmonary nodule ', ' Recurrence ', ' Recurrent ', ' Research ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Computer software ', ' Software ', ' Surgical Staplers ', ' Survival Rate ', ' Family suidae ', ' Pigs ', ' Suidae ', ' Swine ', ' porcine ', ' suid ', ' Technology ', ' Thoracoscopy ', ' Pleural Endoscopy ', ' Pleuroscopy ', ' TRSCPY ', ' Time ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Measures ', ' base ', ' sensor ', ' Pleuroscopes ', ' Thoracoscopes ', ' Surface ', ' Malignant ', ' Malignant - descriptor ', ' Surgical margins ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' lung cancer early detection ', ' lung cancer screening ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Surgical Stapling ', ' Surgical Staples ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' Surgeon ', ' particle ', ' Performance ', ' novel ', ' Devices ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Position ', ' Positioning Attribute ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Modeling ', ' cancer diagnosis ', ' Address ', ' developmental ', ' Development ', ' designing ', ' design ', ' Outcome ', ' Navigation System ', ' innovate ', ' innovative ', ' innovation ', ' early therapy ', ' Early treatment ', ' open source ', ' Network-based ', ' tumor ', ' minimally invasive ', ' arm ', ' screening ', ' accurate diagnosis ', ' Augmented Reality ', ' preservation ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' machine learned algorithm ', ' machine learning algorithm ', ' deep learning algorithm ', ' Visualization ', ' Phase 1/2 Clinical Trial ', ' Phase I/II Clinical Trial ', ' low dose computerized tomography ', ' low-dose CT ', ' low dose computed tomography ', ' cost estimation ', ' cost estimate ', ' ']",NIBIB,BRIGHAM AND WOMEN'S HOSPITAL,R01,2020,402750,0.10601535364540948
"Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging The molecular epidemiology of lung cancer in Africa is almost completely unknown, yet molecular profiling and institution of targeted therapy is now standardly used to influence care in patients with actionable mutations. HIV- infection is associated with a markedly increased risk of lung cancer, but its association with lung cancer and how it influences disease outcomes is not well studied. The capacity to correctly diagnose lung cancer on radiological images, tissue specimen acquisition, and subsequent histologic confirmation compounds the problem of under and misdiagnosis of lung cancer in Africa, especially with the prevalence and often presumptive clinical diagnosis of tuberculosis infection. In this consortium proposal, we therefore seek to address the above stated problems by 1) establishing national lung cancer diagnostic referral networks in Uganda and Tanzania, which will allow for improved detection of lung cancer and, hence decrease the lung cancer burden; 2) investigating the role of HIV-1 infection on the incidence and outcomes of lung cancer in the region; 3) determining the molecular profile of lung cancer in East African countries in order to facilitate advocacy for scale- up of targeted therapies (including immune-based therapies); 4) building capacity for lung cancer diagnosis and care in terms of improving imaging, pathology, radiology and tissue acquisition and clinical care of lung cancer 5) creating a lung cancer research collaboration that will build capacity through mentoring of junior researchers for future leadership in the field. At the end of this project, we envision an African-led lung cancer research network, clinical expertise for sample acquisition and care, improved pathology and radiology diagnostics services, a lung cancer screening program, and a large biorepository that should support lung cancer research in the region for many years to come. We propose to study lung cancer in Uganda and Tanzania and the relationship to HIV-1 infection through three project-based and three cores. The results of these studies of the epidemiology, molecular characterization and imaging of lung cancer and the relationship to HIV infection will lead to technological transfer of instrumentation to characterize lung cancer and artificial intelligence algorithms to aid in discerning pulmonary granulomatous disease from lung cancer on radiological imaging. Findings herein may lead to the development of country-specific guidelines in the evaluation and management of lung cancer.","Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging",10084623,U54CA254566,"['Africa ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Diagnosis ', ' Diagnostic Services ', ' diagnosis service ', ' Disease ', ' Disorder ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Future ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HIV-1 ', ' HIV-I ', ' HIV1 ', ' Human Immunodeficiency Virus Type 1 ', ' Human immunodeficiency virus 1 ', ' Immunotherapy ', ' Immune mediated therapy ', ' Immunologically Directed Therapy ', ' immune therapeutic approach ', ' immune therapeutic interventions ', ' immune therapeutic regimens ', ' immune therapeutic strategy ', ' immune therapy ', ' immune-based therapies ', ' immune-based treatments ', ' immuno therapy ', ' Incidence ', ' Infection ', ' instrumentation ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Leadership ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Mentors ', ' Pathology ', ' Patients ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Role ', ' social role ', ' Tanzania ', ' Tissues ', ' Body Tissues ', ' Tuberculosis ', ' M tuberculosis infection ', ' M. tb infection ', ' M. tuberculosis infection ', ' M.tb infection ', ' M.tuberculosis infection ', ' MTB infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mycobacterium tuberculosis infection ', ' TB infection ', ' disseminated TB ', ' disseminated tuberculosis ', ' infection due to Mycobacterium tuberculosis ', ' tuberculosis infection ', ' tuberculous spondyloarthropathy ', ' Uganda ', ' Diagnostic radiologic examination ', ' Conventional X-Ray ', ' Diagnostic Radiology ', ' Diagnostic X-Ray ', ' Diagnostic X-Ray Radiology ', ' Radiography ', ' Roentgenography ', ' X-Ray Imaging ', ' X-Ray Medical Imaging ', ' Xray imaging ', ' Xray medical imaging ', ' conventional Xray ', ' diagnostic Xray ', ' diagnostic Xray radiology ', ' Lung Capacity ', ' Advocacy ', ' Caring ', ' Guidelines ', ' base ', ' improved ', ' Pulmonary imaging ', ' lung scanning ', ' lung imaging ', ' Clinical ', ' Histologically ', ' Histologic ', ' Molecular Epidemiology ', ' Evaluation ', ' Training ', ' Individual ', ' African ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' lung cancer early detection ', ' lung cancer screening ', ' Collaborations ', ' clinical Diagnosis ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Granulomatous ', ' Country ', ' Disease Outcome ', ' Sampling ', ' cancer care ', ' cancer diagnosis ', ' Institution ', ' Address ', ' Detection ', ' Cancer Diagnostics ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' National Cancer Burden ', ' Cancer Burden ', ' Cancer Research Network ', ' Molecular ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' anti-cancer research ', ' cancer research ', ' anticancer research ', ' Outcome ', ' scale up ', ' Population ', ' Prevalence ', ' clinical epidemiology ', ' clinical care ', ' biorepository ', ' biobank ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' actionable variants ', ' actionable mutation ', ' radiologic imaging ', ' radiological imaging ', ' screening program ', ' smart algorithm ', ' intelligent algorithm ', ' ']",NCI,CASE WESTERN RESERVE UNIVERSITY,U54,2020,1024684,0.2214483892945323
"Role of visceral adipose tissue in frailty among patients with Idiopathic Pulmonary Fibrosis PROJECT SUMMARY/ABSTRACT In this application for a 5-year K23 Career Development Award, I propose mentored research and career development leading to a career as an independent clinical and translational investigator in interstitial lung disease (ILD). The goal of this project is to identify the role of body composition in frailty among subjects with idiopathic pulmonary fibrosis (IPF). The prevalence of IPF is rising, currently affecting 1 in 200 older adults. There is no cure for IPF. The only available medications slow disease progression but do not reverse disease. Frailty affects up to 50% of IPF patients, and is characterized by decreased physiologic reserve and increased susceptibility to severe manifestations of acute insults. The most common causes of death in IPF are acute insults. Frailty is thus a potentially modifiable risk factor for morbidity and mortality in IPF. This proposal builds on my preliminary work showing that (1) greater visceral adipose tissue (VAT) is associated with increased frailty, (2) subjects with both sarcopenia and visceral obesity are at greater risk of frailty than those with sarcopenia alone, (3) there may be distinct endotypes of exercise limitation defined by high inflammation alone or low inflammation with high VAT, and (4) down-regulation of the growth hormone (GH) axis may link VAT and frailty. Under the mentorship of Dr. R Graham Barr, I propose to evaluate the roles of body composition by bioelectrical impedance assay (co-mentor Gallagher), inflammation, and neuroendocrine dysregulation associated with frailty risk using a machine-learning approach (co-mentor Valeri). I will also evaluate the role of growth hormone axis dysregulation in sarcopenia with visceral obesity in a rigorous overnight protocol (co-mentor Freda). I propose to perform this in two NHLBI-funded prospective cohorts: Dr. Garcias Families-At-Risk for ILD (R01HL103676) and Dr. Singers Advanced Lung Disease Lung Transplantation Study (R01HL134851). With guidance from my mentors, I have crafted a 5-year career development plan that includes training in body composition analysis (Dr. Gallagher), measurement of complex endocrine systems (Dr. Freda), clinical trials (Dr. Freda), biostatistics (Dr. Valeri), aging in interstitial lung disease (Dr. Garcia), and epidemiology (Dr. Barr). In the last two years of this award, I will apply for R01 funding and transition to independence. The proposed activities will prepare me to conduct patient-oriented research to evaluate the role of body composition in outcomes in ILD. I will also acquire the skills and training required to design and conduct clinical trials targeting novel pathways to prevent and treat frailty in ILD. PROJECT NARRATIVE Idiopathic pulmonary fibrosis (IPF) is an increasingly prevalent chronic lung disease with no available cure; frailty affects 50% of IPF patients, and is associated with increased severity of illness in response to acute insults, which are the most common cause of death in IPF. We identified that visceral adipose tissue is a risk factor for frailty and propose to investigate potential mechanisms linking visceral adipose tissue and frailty, as modifiable risk factors for morbidity and mortality in this growing patient population. Our findings may lead to novel therapies and clinical trials evaluating the role of existing medications in the prevention and treatment of frailty in IPF.",Role of visceral adipose tissue in frailty among patients with Idiopathic Pulmonary Fibrosis,10055250,K23HL150280,"['Adipose tissue ', ' Fatty Tissue ', ' adipose ', ' white adipose tissue ', ' yellow adipose tissue ', ' Adrenal Cortex Hormones ', ' Corticoids ', ' Corticosteroids ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Aging ', ' Arrhythmia ', ' Cardiac Arrhythmia ', ' Heart Arrhythmias ', ' Award ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biology ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Body Composition ', ' Cause of Death ', ' Clinical Investigator ', ' Clinical Trials ', ' Communities ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Down-Regulation ', ' Downregulation ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Endocrine system ', ' Endocrine/Metabolic Organ System ', ' Hormonal System ', ' Metabolic/Endocrine Body System ', ' endocrine gland/system ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Exercise ', ' Family ', ' Future ', ' Goals ', ' Grant ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' hormone analog ', ' Hospitalization ', ' Hospital Admission ', ' Inflammation ', ' Insulin-Like Growth Factor I ', ' IGF-1 ', ' IGF-I ', ' IGF-I-SmC ', ' Insulin-Like Growth Factor 1 ', ' Insulin-Like Somatomedin Peptide I ', ' Somatomedin C ', ' Interleukin-1 beta ', ' Beta Proprotein Interleukin 1 ', ' IL-1 beta ', ' IL-1  ', ' IL-1-b ', ' IL-1 ', ' IL1-Beta ', ' IL1- ', ' IL1B Protein ', ' IL1F2 ', ' IL1 ', ' Interleukin 1beta ', ' Interleukin-1 ', ' Preinterleukin 1 Beta ', ' Interleukin-6 ', ' B cell differentiation factor ', ' B cell stimulating factor 2 ', ' B-Cell Differentiation Factor ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Stimulatory Factor-2 ', ' BCDF ', ' BSF-2 ', ' BSF2 ', ' HPGF ', ' Hepatocyte-Stimulating Factor ', ' Hybridoma Growth Factor ', ' IFN-beta 2 ', ' IFNB2 ', ' IL-6 ', ' IL6 Protein ', ' MGI-2 ', ' Myeloid Differentiation-Inducing Protein ', ' Plasmacytoma Growth Factor ', ' interferon beta 2 ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Lung Transplantation ', ' Lung Grafting ', ' lung transplant ', ' Mentors ', ' Mentorship ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Neurosecretory Systems ', ' Neuroendocrine ', ' Neuroendocrine System ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Phenotype ', ' Pilot Projects ', ' pilot study ', ' Pneumonia ', ' Pulmonary Fibrosis ', ' lung fibrosis ', ' Research ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Societies ', ' Somatotropin ', ' Growth Hormone ', ' Growth Hormone 1 ', ' Pituitary Growth Hormone ', ' somatotropic hormone ', ' Somatotropin-Releasing Hormone ', ' GHRH ', ' GRH ', ' Growth Hormone-Releasing Factor ', ' Growth Hormone-Releasing Hormone ', ' Somatocrinin ', ' Somatoliberin ', ' Steroids ', ' Steroid Compound ', ' Syndrome ', ' Testing ', ' Testosterone ', ' Therapeutic Testosterone ', ' Trans-Testosterone ', ' Transplantation ', ' transplant ', ' Work ', ' Interleukin-1 Receptors ', ' IL-1 Receptors ', ' IL1 Receptors ', ' Tumor Necrosis Factor Receptor ', ' Cachectin Receptors ', ' TNF Receptor Family Protein ', ' TNF Receptor Superfamily ', ' TNF Receptors ', ' TNFR ', ' Tumor Necrosis Factor Receptor Family ', ' Tumor Necrosis Factor Receptor Superfamily ', ' Ischemic Heart ', ' Ischemic Heart Disease ', ' Ischemic myocardium ', ' cardiac ischemia ', ' coronary ischemia ', ' heart ischemia ', ' myocardial ischemia/hypoxia ', ' myocardium ischemia ', ' Myocardial Ischemia ', ' Bioelectrical Impedance ', ' Biolectric Impedance ', ' injuries ', ' Injury ', ' career ', ' Acute ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Series ', ' Interstitial Lung Diseases ', ' Link ', ' Evaluation ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Blood Serum ', ' Serum ', ' muscle bulk ', ' muscle mass ', ' muscle form ', ' Measurement ', ' Development Plans ', ' Disease Progression ', ' Voluntary Muscle ', ' Skeletal Muscle ', ' Selection Criteria ', ' Funding ', ' growth hormone deficiency ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Therapeutic ', ' Abdominal obesity ', ' Android fat distribution ', ' Centripetal obesity ', ' Fat body with thin limbs ', ' Obese face+trunk sparing limbs ', ' Obesity of face and trunk, sparing limbs ', ' Truncal obesity ', ' excess adiposity in midsection ', ' male-type obesity ', ' trunk obesity ', ' visceral obesity ', ' waist-predominant obesity ', ' Central obesity ', ' Deposit ', ' Deposition ', ' machine learned ', ' Machine Learning ', ' Research Priority ', ' Knowledge ', ' Life ', ' frailty ', ' Investigation ', ' Complex ', ' Visceral ', ' Intramuscular ', ' Protocol ', ' Protocols documentation ', ' disease severity ', ' Severity of illness ', ' respiratory ', ' skills training ', ' American ', ' 65+ years old ', ' Aged 65 and Over ', ' age 65 and greater ', ' age 65 and older ', ' aged 65 and greater ', ' aged 65 ', ' human old age (65+) ', ' cohort ', ' novel ', ' Prevention ', ' Chronic lung disease ', ' (TNF)- ', ' Cachectin ', ' Macrophage-Derived TNF ', ' Monocyte-Derived TNF ', ' TNF ', ' TNF A ', ' TNF Alpha ', ' TNF- ', ' TNFA ', ' TNF ', ' Tumor Necrosis Factor ', ' Tumor Necrosis Factor-alpha ', ' TNF gene ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' career development ', ' response ', ' sarcopenic ', ' sarcopenia ', ' patient oriented study ', ' patient oriented research ', ' preventing ', ' prevent ', ' BMI percentile ', ' BMI z-score ', ' Quetelet index ', ' Body mass index ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Data ', ' High Prevalence ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Subgroup ', ' Therapy Clinical Trials ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' health related quality of life ', ' designing ', ' design ', ' Outcome ', ' Prevalence ', ' prospective ', ' modifiable risk ', ' patient centered ', ' patient oriented ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' therapeutic target ', ' translation strategy ', ' translational strategy ', ' translational approach ', ' FDA approved ', ' patient population ', ' lung rehabilitation ', ' pulmonary rehabilitation ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' decreased muscle mass ', ' low muscle mass ', ' reduced muscle mass ', ' sarcopenic obesity ', ' androgenic ', ' circulating markers ', ' circulating biomarkers ', ' Prospective cohort ', ' Prospective cohort study ', ' translational investigator ', ' translational researcher ', ' translational scientist ', ' hormonal secretion ', ' Hormone secretion ', ' diffuse interstitial pulmonary fibrosis ', ' idiopathic pulmonary fibrosis ', ' Infrastructure ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,K23,2020,170856,0.06828074631960993
"2021 International Workshop on Pulmonary Imaging SUMMARY This application requests funding to support the 2021 International Workshop on Pulmonary Imaging, a three- day meeting to be held from February 25-27, 2021, which will be the seventh of its kind hosted by the University of Pennsylvania. The requested funds will primarily be used to cover travel and lodging for junior researchers who will be presenting at the workshop: undergraduate, graduate and junior faculty. Some funds may also be allocated to help pay for live webcasting and publication costs related to workshop materials. As with previous meetings, we intend to stream each session of the meeting in real-time, allowing those who are interested in the proceedings but unable to attend in person to access them online for free. As mortalities associated with pulmonary disease continue to rise worldwide, innovative imaging techniques capable of both diagnosing and helping to treat these pathologies are becoming an increasingly important. As a field, pulmonary imaging currently encompasses a wider range of techniques for the structural, functional and molecular assessment of lung disorders than at any time in its history. What is more, these techniques are being developed and optimized by researchers across an increasingly diverse set of fields such as biology, chemistry, physics, engineering, computer science and medicine. Given the field's rapidly-evolving nature, the existence of a regular forum in which scientists and clinicians can communicate their ideas with each other is of the utmost importance. Given the absence of other scientific meetings with a similarly focused agenda, our previous workshops have succeeded in providing just such a forumallowing a diverse group of pulmonary imaging researchers to come together for the kind of rigorous, collaborative exchange that can continue to advance the field. The specific aims of the proposed workshop are as follows: (1) host a one-day workshop on pulmonary inflammation; (2) inform the pulmonary imaging community of the latest advances in structural, functional and molecular lung imaging; (3) explore the use of pulmonary imaging to evaluate therapeutic response, the inherent obstacles to doing so, and strategies to overcome them; (4) investigate new approaches for integrating deep learning and pulmonary imaging techniques to more accurately diagnose and phenotype disease and predict injury progression; (5) broadcast the entire workshop live online, thereby enabling interested parties not in attendance to access the proceedings in real-time, free of charge. Based on the uniformly positive feedback in response to our one-day boot camp on pulmonary physiology prior to the 2019 workshop, we intend to hold another boot camp before the 2021 meeting, this time focused on pulmonary inflammation. This boot camp will consist of ~5 longer presentations (approximately 1 hour each) on topics related to this central theme, with significant time devoted to question and answer after each, and a final discussion panel aimed at synthesizing the most important issues covered over the course of the day. In addition to this exciting addition to the format, the 2021 workshop will again seek a more equitable balance between functional, structural and molecular imaging approaches to pulmonary disease across the invited talks, while also continuing to expand our recent focus on the topics of imaging assessments of treatment response and the integration of imaging techniques with machine learning. Finally, the 2021 workshop add a session on bridging the gap between current clinical practice and innovative imaging technologies. NARRATIVE This application requests funding to support the 2021 International Workshop on Pulmonary Imaging at the University of Pennsylvania. This recurring workshop provides a necessary and valuable opportunity for researchers working in the fields of functional, structural, and molecular imaging technique development for assessing lung diseases such as lung cancer, COPD, IPF and ARDS to come together in order to discuss and share their work. The full workshop proceedings will be streamed live online, allowing those unable to attend in person the opportunity to both watch and participate in the meeting.",2021 International Workshop on Pulmonary Imaging,10070932,R13HL154586,"['Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Biology ', ' Charge ', ' Chemistry ', ' Communication ', ' Communities ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Engineering ', ' Equilibrium ', ' balance ', ' balance function ', ' Faculty ', ' Feedback ', ' Future ', ' Gases ', ' Heart ', ' Recording of previous events ', ' History ', ' Learning ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Medicine ', ' mortality ', ' Movement ', ' body movement ', ' Persons ', ' Pathology ', ' Pennsylvania ', ' Phenotype ', ' Physics ', ' Physiology ', ' Positron-Emission Tomography ', ' PET ', ' PET Scan ', ' PET imaging ', ' PETSCAN ', ' PETT ', ' Positron Emission Tomography Medical Imaging ', ' Positron Emission Tomography Scan ', ' Rad.-PET ', ' positron emission tomographic (PET) imaging ', ' positron emission tomographic imaging ', ' positron emitting tomography ', ' Protons ', ' H+ element ', ' Hydrogen Ions ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Pulmonology ', ' Pneumology ', ' Pneumonology ', ' Pulmonary Medicine ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Adult Respiratory Distress Syndrome ', ' ARDS ', ' Acute Respiratory Distress ', ' Acute Respiratory Distress Syndrome ', ' Adult ARDS ', ' Adult RDS ', ' Da Nang Lung ', ' Shock Lung ', ' Stiff lung ', ' wet lung ', ' Time ', ' single photon emission computed tomography ', ' SPECT ', ' SPECT imaging ', ' Single-Photon Emission-Computed Radionuclide Tomography ', ' Travel ', ' Universities ', ' Work ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' injuries ', ' Injury ', ' base ', ' density ', ' improved ', ' Pulmonary imaging ', ' lung scanning ', ' lung imaging ', ' Clinical ', ' Workshop ', ' Educational workshop ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Disease Progression ', ' Funding ', ' Collaborations ', ' Nature ', ' machine learned ', ' Machine Learning ', ' programs ', ' Scientist ', ' Hour ', ' Stream ', ' Techniques ', ' Location ', ' interest ', ' meetings ', ' computer science ', ' Structure ', ' novel ', ' graduate student ', ' response ', ' technique development ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Address ', ' International ', ' NIH RFA ', ' Request for Applications ', ' Classification Scheme ', ' Physiologic Imaging ', ' physiological imaging ', ' Functional Imaging ', ' Update ', ' Characteristics ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' disease phenotype ', ' cost ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' Imaging technology ', ' innovate ', ' innovative ', ' innovation ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' clinical practice ', ' undergraduate ', ' undergraduate student ', ' noninvasive imaging ', ' non-invasive imaging ', ' Pneumonitis ', ' Pulmonary Inflammation ', ' accurate diagnosis ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' imaging based approach ', ' imaging approach ', ' deep learning ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,R13,2020,29805,0.09979470856120722
"Macro-vasculature: A Novel Image Biomarker of Lung Cance ABSTRACT  Lung cancer remains the leading cause of cancer related deaths in the United States and worldwide. The high mortality associated with lung cancer is in part due to underutilization of and limited access to lung cancer screening that impedes early diagnosis. The apprehension of some clinicians and policymakers towards lung cancer screening with low-dose computed tomography (LDCT) exams is based on concerns of lead-time bias and high false-positive rate. The development of a robust lung cancer biomarker that reduces screen-detected false positives and improves classification of indeterminate nodules would relieve some of the concerns related to lung cancer screening. Although investigations show that screening with LDCT scans may reduce lung cancer mortality by 20% compared to chest x-ray, it is reported that ~96% of suspicious findings (mostly indeterminate nodules) turn out to be non-cancerous (false positives). Clinical management of screen-detected indeterminate nodules often leads to unnecessary, costly, and potentially harmful follow-up procedures (e.g., follow-up CT scan, positron emission tomography (PET)/CT exam, invasive biopsies). We have developed an exciting and novel image-based macro-vasculature feature to discriminate benign from malignant nodules. We propose to further develop the feature and validate it across a range of CT protocols and scans from other institutions. We will also integrate the macro-vasculature features with clinical information (e.g., age, gender, smoking history, lung function) and evaluate the model's ability to discriminate benign from malignant screen-detected indeterminate nodules. We will investigate if a radiologist's classification of indeterminate nodules improves with the output of the integrative model compared to classification without the integrative model. The success of this project may lead to a novel and robust lung cancer biomarker to accurately assess screen-detected indeterminate nodules that can significantly reduce the number of unnecessary follow-up procedures during lung cancer screening. Project Narrative: We propose to investigate the role of the macro-vasculature surrounding indeterminate lung nodules depicted on CT images to discriminate screen-detected benign and malignant nodules. The goal is to improve lung cancer screening by reducing the number of unnecessary procedure associate the high rate of false positive detections.",Macro-vasculature: A Novel Image Biomarker of Lung Cance,9883874,R01CA237277,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Biopsy ', ' Blood Vessels ', ' vascular ', ' Breast ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cause of Death ', ' Classification ', ' Systematics ', ' Colon ', ' Statistical Data Interpretation ', ' Statistical Data Analyses ', ' Statistical Data Analysis ', ' statistical analysis ', ' Cessation of life ', ' Death ', ' Discrimination ', ' Cognitive Discrimination ', ' Environment ', ' Goals ', ' Grant ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Recording of previous events ', ' History ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nodule ', ' Odds Ratio ', ' Cross-Product Ratio ', ' Relative Odds ', ' Risk Ratio ', ' Patients ', ' Positron-Emission Tomography ', ' PET ', ' PET Scan ', ' PET imaging ', ' PETSCAN ', ' PETT ', ' Positron Emission Tomography Medical Imaging ', ' Positron Emission Tomography Scan ', ' Rad.-PET ', ' positron emission tomographic (PET) imaging ', ' positron emission tomographic imaging ', ' positron emitting tomography ', ' Publishing ', ' Lung nodule ', ' pulmonary nodule ', ' Respiratory physiology ', ' lung function ', ' respiratory function ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Technology ', ' Testing ', ' Thoracic Radiography ', ' CXR ', ' chest X ray ', ' chest Xray ', ' chest radiography ', ' lung radiography ', ' radiographic chest image ', ' radiographic lung image ', ' thoracic radiogram ', ' thorax radiography ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' United States ', ' United States Centers for Medicare and Medicaid Services ', ' Centers for Medicare and Medicaid Services ', ' Health Care Financing Administration ', ' United States Health Care Financing Administration ', ' Work ', ' Gender ', ' Administrator ', ' Risk Assessment ', ' Dataset ', ' Data Set ', ' base ', ' density ', ' improved ', ' Procedures ', ' Benign ', ' Clinical ', ' Malignant ', ' Malignant - descriptor ', ' Variation ', ' Variant ', ' Ensure ', ' Individual ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Policies ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' radiologist ', ' lung cancer early detection ', ' lung cancer screening ', ' Morphology ', ' Smoker ', ' machine learned ', ' Machine Learning ', ' Malignant Tumor of the Prostate ', ' Malignant prostatic tumor ', ' Prostate CA ', ' Prostate Cancer ', ' Prostatic Cancer ', ' Malignant neoplasm of prostate ', ' Unnecessary Procedures ', ' Investigation ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Texture ', ' Pattern ', ' Tobacco smoking ', ' Tobacco smoking behavior ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' success ', ' tumor growth ', ' novel ', ' Participant ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Modeling ', ' Sampling ', ' Property ', ' Cancer Treatment ', ' Malignant Neoplasm Therapy ', ' Malignant Neoplasm Treatment ', ' anti-cancer therapy ', ' anticancer therapy ', ' cancer therapy ', ' cancer diagnosis ', ' Institution ', ' Symptoms ', ' Predictive Value ', ' Cancer Cause ', ' Cancer Etiology ', ' Clinical Management ', ' Smoking History ', ' Spiculation ', ' Spiculate ', ' Tumor Angiogenesis ', ' Characteristics ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' cost ', ' Outcome ', ' multidisciplinary ', ' computer algorithm ', ' Computational algorithm ', ' spatial relationship ', ' demographics ', ' tumor ', ' new marker ', ' novel biomarker ', ' novel marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' longitudinal database ', ' screening ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' cancer markers ', ' cancer biomarkers ', ' Radiation exposure ', ' chest CT ', ' chest computed tomography ', ' CT screening ', ' computed tomography screening ', ' low dose computerized tomography ', ' low-dose CT ', ' low dose computed tomography ', ' ']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2020,415606,0.20878884359043381
"Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS Chronic obstructive pulmonary disease (COPD) and emphysema, jointly, are the fourth leading cause of death in the US and globally. Decades of research have not found disease-modifying therapies except for a1 antitrypsin deficiency, a rare disease found by improved phenotyping, characterized by a specific emphysema subtype and caused by gene variants in SERPINA1. This renewal builds on the successful discovery of six new quantitative emphysema subtypes (QES), which were associated independently with greater symptoms, impaired function and increased mortality in addition to several genome-wide significant associations for gene variants. In the renewal, we propose to leverage over 27,000 CTs acquired over 5-7 years of follow-up from 4,500 highly phenotyped and genotyped participants to test if deep and unsupervised learning on new state-of- the-art CTs and CT angiograms will reveal additional deep-learned and molecular QES that suggest mechanistic pathways to treatment. Further, we will collect 60 explanted lungs and use state-of-the art microCT to test if QES have distinct histology and structure. Finally, we will recruit 100 patients undergoing lung cancer CT screening to test if QES will be translatable to clinical low-dose lung cancer screening CT scans acquired on contemporary scanners. Successful completion of these aims will discover new deep QES and molecular QES and validate and translate QES to further subphenotype emphysema and facilitate testing of personalize molecular therapies and, hopefully, replicate the success of therapy for a1-antitrypsin deficiency for more common emphysema subtypes. Project Narrative In the first funding period, we discovered six QES, which are independently associated with morbidity, mortality and distinct gene variants that suggest targetable molecular pathways. This renewal builds upon our successful UML approach with integration of DL, greatly increased CT and genetic data; validates QES with histology; and translates QES to the clinic in order to facilitate testing of molecular therapies of specific QES and to redefine emphysema subtypes in clinical practice.",Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS,9927683,R01HL121270,"['Algorithms ', ' Angiography ', ' Angiogram ', ' angiographic imaging ', ' Blood Vessels ', ' vascular ', ' Cause of Death ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Endothelium ', ' Fibrosis ', ' Genotype ', ' Histology ', ' Learning ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Patients ', ' Phenotype ', ' Physiology ', ' Pulmonary Emphysema ', ' Emphysema ', ' emphysematous ', ' Pulmonary Fibrosis ', ' lung fibrosis ', ' Research ', ' Smoking ', ' Testing ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Translating ', ' improved ', ' Apical ', ' Clinical ', ' Diffuse ', ' Biological ', ' Histologically ', ' Histologic ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Funding ', ' lung cancer early detection ', ' lung cancer screening ', ' Genetic ', ' Smoker ', ' machine learned ', ' Machine Learning ', ' Scanning ', ' Clinic ', ' Pattern ', ' Techniques ', ' success ', ' c new ', ' Orphan Disease ', ' Rare Disorder ', ' orphan disorder ', ' Rare Diseases ', ' Structure ', ' novel ', ' Participant ', ' disease control ', ' disorder control ', ' Computed Tomography Scanners ', ' genome sequencing ', ' Dose ', ' Symptoms ', ' Data ', ' Molecular Target ', ' Reproducibility ', ' Characteristics ', ' Molecular ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Text ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' innovate ', ' innovative ', ' innovation ', ' Impairment ', ' clinical care ', ' population based ', ' genome scale ', ' genomewide ', ' genome-wide ', ' clinical practice ', ' X-ray microtomography ', ' Xray microtomography ', ' micro CT ', ' micro computed tomography ', ' microtomography ', ' microCT ', ' contrast enhanced ', ' entire genome ', ' full genome ', ' whole genome ', ' symptomatology ', ' recruit ', ' CT screening ', ' computed tomography screening ', ' deep learning ', ' unsupervised machine learning ', ' unsupervised learning ', ' Bayesian machine learning ', ' Bayesian learning ', ' ']",NHLBI,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2020,725923,0.05101174030051399
"Individually-tailored clinical decision support for management of indeterminate pulmonary nodules ABSTRACT (PROJECT DESCRIPTION) The rollout of low-dose computed tomography (LDCT) lung screening programs is accelerating in the United States, aiming for earlier detection of lung cancer to improve long-term survival. However, a consequence of such imaging programs is the increased discovery of indeterminate pulmonary nodules (IPNs). Significant ques- tions remain around the effective management of screen- and incidentally-detected IPNs: while many are benign, a fraction will go on to become cancerous. Diagnostic models for IPNs and associated management guidelines have been described previously, but their real-world validation is limited. Moreover, the majority of models only use a snapshot of the IPN at a single point in time and fail to take into consideration progressive changes. Opportunities now exist to advance such predictive models by encompassing the patient's evolving medical history, combining clinical and imaging biomarkers to improve prediction and individually-tailor the management of IPNs over time. The objective of this imaging informatics proposal is the development of a clinical decision support tool for the management of screen- and incidentally-detected IPNs. We address two key challenges: 1) the development of a continuous-time model for predicting how the IPN will evolve; and 2) the use of this prediction to determine a series of actions over time that will optimize (screening) outcomes for the individual. We first explore the devel- opment of a continuous time belief network (CTBN), a temporal probabilistic model to predict the likelihood of a patient to develop lung cancer. Unlike traditional approaches, CTBNs do not require fixed sampling frequency of the data over time (e.g., all observations made annually) and are thus more amenable to real-world clinical settings and observational datasets. The probabilities computed through the CTBN are subsequently input into a partially-observable Markov decision process (POMDP) to guide IPN management decisions. From the POMDP, policies (sequences of actions over time) can be chosen to achieve a desired goal (e.g., minimizing time to diagnosis), given past and current observations/decisions for an individual. For both the CTBN and POMDP, we explore novel methods in the design and implementation, overcoming computational challenges to realize translation of these models into practice. A web-based interface is implemented, providing a clinical de- cision making tool for physicians to understand the models' recommendations. Evaluation focuses on assessing the performance of the CTBN and POMDP relative to known outcomes and compared to other conventional methods (e.g., logistic regression, decision trees, dynamic belief networks); as well as the overall impact of the system to influence decision-making. This effort advances our past research in probabilistic models and capital- izes on expertise in lung cancer screening, including past leadership of the National Lung Screening Trial (NLST). The result of this effort will be a set of informatics-driven modeling tools and new temporal predictive models informing IPN management. PROGRAM NARRATIVE Low-dose computed tomography (LDCT) lung screening is being implemented nationwide, aiming to reduce mortality due to lung cancer. But questions have been raised regarding false positives, with concerns about the attendant discovery of indeterminate pulmonary nodules (IPNs) and their ensuing long-term surveillance. This project develops new predictive models for the management of IPNs using clinical and imaging information ac- crued over time, providing individually-tailored clinical decision support.",Individually-tailored clinical decision support for management of indeterminate pulmonary nodules,9829087,R01CA226079,"['Belief ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Capital ', ' Decision Making ', ' Decision Trees ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Evolution ', ' Future ', ' Goals ', ' Recording of previous events ', ' History ', ' Leadership ', ' Life Expectancy ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Methods ', ' Methodology ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' mortality ', ' Nodule ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Patients ', ' Physicians ', ' Probability ', ' Lung nodule ', ' pulmonary nodule ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Computer software ', ' Software ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Translating ', ' Translations ', ' United States ', ' Dataset ', ' Data Set ', ' Custom ', ' Guidelines ', ' Practice Guidelines ', ' base ', ' improved ', ' Benign ', ' Clinical ', ' Malignant ', ' Malignant - descriptor ', ' Series ', ' Logistic Regressions ', ' Evaluation ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Policies ', ' Personal Medical History ', ' Personal Medical History Epidemiology ', ' Medical History ', ' lung cancer early detection ', ' lung cancer screening ', ' tool ', ' Smoker ', ' Diagnostic ', ' Frequencies ', ' Dependence ', ' Event ', ' System ', ' Medical center ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' Informatics ', ' novel ', ' disorder model ', ' Disease model ', ' Modeling ', ' Sampling ', ' Address ', ' Data ', ' Clinical Data ', ' Update ', ' Validation ', ' Process ', ' developmental ', ' Development ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' imaging ', ' Image ', ' cost ', ' time use ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' imaging informatics ', ' designing ', ' design ', ' Outcome ', ' Population ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' Cancerous ', ' web based interface ', ' high risk ', ' data base structure ', ' database structure ', ' arm ', ' screening ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' support tools ', ' discrete time ', ' individual patient ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' imaging program ', ' screening program ', ' clinical decision support ', ' CT screening ', ' computed tomography screening ', ' screening policy ', ' recommended screening ', ' screening recommendations ', ' screening guidelines ', ' statistical and machine learning ', ' machine learning method ', ' low dose computerized tomography ', ' low-dose CT ', ' low dose computed tomography ', ' ']",NCI,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2020,456756,0.15351243067658366
"Genetic interaction analysis involving oncogenesis-related genes in lung cancer PROJECT SUMMARY  The development of cancer diseases is driven by the accumulation of many oncogenesis-related genetic alterations and tumorigenesis is triggered by complex networks of involved genes rather than independent actions. The interactions among genetic factors are believed to play important roles in carcinogenesis and contribute to the missing heritability. In this proposal, we designed a filtered gene-gene interaction analysis aiming to identify the epistasis involving important oncogenesis-related genes. Besides the advantage of dimensional reduction and increased power, this filtered interaction analysis will help us identify novel oncogenes or tumor suppressor genes implicated in lung cancer development that will not be revealed in main effect association analysis. It will also identify novel susceptibility variants, including those in intergenic and non-coding regions, affecting lung cancer risk by interacting/modulating with oncogenesis-related genes. Lung cancer is a heterogeneous disease and researchers have identified vast differences in genomic attributes. However, the knowledge about epistatic features in lung cancer subtypes is limited. We will conduct a stratified epistasis analysis by lung cancer histology subtype in the proposed study to reveal subtype-specific genetic interactions and gene networks. The stratified analysis by histology will enhance our understanding about this complicated disease mechanism in lung cancer and has the potential to contribute to precision medicine in lung cancer treatment.  A main challenge in genetic association studies is to understand the functional consequences of identified genetic variants. In this study, we proposed functional annotation analysis including eQTL gene expression analysis, pathway and gene network analysis, and functional annotation of epistasis-involved SNPs. This integrative epistasis and functional annotation analysis will help us pinpoint the causal epistasis and characterize the epistasis-involved genes or regions in lung cancer risk development. It will be a pilot study to explore how the regulatory non-coding variants impact lung cancer risk by interacting with oncogenesis-related genes.  The proposed study will provide insights about the complicated biological interactions that are critical for gene regulation, biochemical networks, and developmental pathways implicated in lung carcinogenesis. In order to finish the proposed study, we collected the genotype data from three independent GWAS studies including 24,037 lung cancer patients and 20,401 healthy controls from the Caucasian population. The genotype and gene expression data in lung tissues from 409 individuals will be applied for eQTL gene expression analysis. NARRATIVE The interactions among genetic factors are believed to play important roles in carcinogenesis and contribute to the missing heritability. In this proposal, we designed an integrative filtered epistasis and functional annotation analysis to identify the genetic interactions involving important oncogenesis-related genes in lung cancer development. Besides the advantage of dimensional reduction and increased power, this filtered interaction analysis will help us identify novel variants, including the regulatory elements in non-coding regions, implicated in lung cancer development that will not be revealed in main effect association analysis.",Genetic interaction analysis involving oncogenesis-related genes in lung cancer,9938517,R21CA235464,"['Adenocarcinoma ', ' Malignant Adenoma ', ' Affect ', ' Canada ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Squamous cell carcinoma ', ' Epidermoid Carcinoma ', ' Planocellular Carcinoma ', ' Squamous Carcinoma ', ' Squamous Cell Epithelioma ', ' Cities ', ' Disease ', ' Disorder ', ' Genetic Epistasis ', ' Epistasis ', ' Epistatic Deviation ', ' Interaction Deviation ', ' epistatic relationship ', ' gene x gene interaction ', ' genetic epistases ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Genotype ', ' Histology ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Odds Ratio ', ' Cross-Product Ratio ', ' Relative Odds ', ' Risk Ratio ', ' Oncogenes ', ' Cancer Genes ', ' Cancer-Promoting Gene ', ' Transforming Genes ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Quantitative Evaluations ', ' Quebec ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Seeds ', ' Plant Embryos ', ' Plant Zygotes ', ' seed ', ' Testing ', ' Translating ', ' Universities ', ' Caucasians ', ' Caucasian ', ' Caucasian Race ', ' Caucasoid ', ' Caucasoid Race ', ' Occidental ', ' white race ', ' Tumor Suppressor Genes ', ' Anti-Oncogenes ', ' Antioncogenes ', ' Cancer Suppressor Genes ', ' Emerogenes ', ' Onco-Suppressor Genes ', ' Oncogenes-Tumor Suppressors ', ' Recessive Oncogenes ', ' Tumor Suppressing Genes ', ' oncosuppressor gene ', ' Dataset ', ' Data Set ', ' Lung Adenocarcinoma ', ' base ', ' Variation ', ' Variant ', ' Biological ', ' Biochemical ', ' insight ', ' Individual ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' participant recruitment ', ' Patient Recruitments ', ' Genetic ', ' tool ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Dimensions ', ' Complex ', ' cancer risk ', ' Cancer Induction ', ' carcinogenesis ', ' gene interaction ', ' novel ', ' Reporting ', ' Single Base Polymorphism ', ' single nucleotide variant ', ' Single Nucleotide Polymorphism ', ' Gene Expression Monitoring ', ' Gene Expression Pattern Analysis ', ' Transcript Expression Analyses ', ' Transcript Expression Analysis ', ' gene expression analysis ', ' gene expression assay ', ' transcriptional profiling ', ' Gene Expression Profiling ', ' Genetic analyses ', ' genetic analysis ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Network Analysis ', ' Pathway Analysis ', ' Functional RNA ', ' Non-Coding ', ' Non-Coding RNA ', ' Non-translated RNA ', ' Noncoding RNA ', ' Nontranslated RNA ', ' noncoding ', ' Untranslated RNA ', ' Genomics ', ' Meta-Analysis ', ' Cancer Treatment ', ' Malignant Neoplasm Therapy ', ' Malignant Neoplasm Treatment ', ' anti-cancer therapy ', ' anticancer therapy ', ' cancer therapy ', ' Oncogenesis ', ' tumorigenesis ', ' genetic association ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Data ', ' Regulatory Element ', ' Cancer Histology ', ' Cancer Patient ', ' Smoking Status ', ' Characteristics ', ' Molecular ', ' sex ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' designing ', ' design ', ' lung carcinogenesis ', ' Population ', ' Heritability ', ' Predisposition gene ', ' predisposing gene ', ' susceptibility allele ', ' susceptibility locus ', ' susceptibility variant ', ' Susceptibility Gene ', ' precision-based medicine ', ' precision medicine ', ' cancer sub-types ', ' cancer subtypes ', ' causal allele ', ' causal gene ', ' causal mutation ', ' causative mutation ', ' causative variant ', ' causal variant ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R21,2020,169149,0.17514202458012365
"Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study ABSTRACT Short sleep duration, insomnia disorder, and sleep apnea are all highly prevalent in the US population and are associated with significant morbidity, including poor mental health, impaired neurocognitive function, metabolic dysregulation, and cardiovascular disease. In the context of the high prevalence of pernicious sleep disturbances, there is evidence that sleep disparities exist in the population, such that racial/ethnic minorities  including Mexican-Americans  are at increased risk of sleep disturbances. This is alarming, since this group is also at increased risk for many of the adverse cardiometabolic and functional outcomes linked to sleep disturbances. These associations may be influenced by economic hardship, psychosocial stress, unhealthy behaviors (diet, exercise, alcohol, and smoking), and acculturation  the degree to which an individual adopts (in this case) traditional Mexican versus American culture. The first goal of this project is to examine sleep duration, insomnia symptoms, and sleep apnea severity among Mexican-Americans and examine the role of these social-behavioral factors in this relationship. Second, this study aims to examine the role of sleep and cardiometabolic disease risk in this population and explore the role of acculturation, psychosocial stress, economic hardship, and/or unhealthy behaviors in these associations. To accomplish this, this project will partner with the Mariposa Community Health Center, the federally qualified clinic in the Nogales, AZ area. Nogales is a small city on the US/Mexico border that is an ideal location for studying non-urban Mexican- Americans, as it is made up of 83% Hispanics/Latinos, 33% immigrants, and 77% who primarily speak Spanish at home. This community-engaged project will partner with Mariposa and their Platicamos Salud program that uses experienced Community Health Workers (promotoras de salud) to collect data and perform home visits. The study will recruit N=900 Mexican-Americans and N=200 Non-Hispanic Whites to complete a battery of assessments from a clinic visit (questionnaires, interviews, exam for anthropometry and arterial stiffness, and collection of biomarkers), a 1-night home sleep apnea assessment, a 24-hour ambulatory blood pressure recording, and a 2-week home monitoring period with sleep diary and actigraphy. This will result in a rich dataset that can help to identify and reduce sleep disparities in the population and point to potential intervention approaches to reducing cardiometabolic disease disparities. The analytic plan will take advantage of a machine-learning analytic approach, which will be used to evaluate the complex relationships among all of these variables. This project will address many relevant issues in sleep medicine, health disparities research, and border health. The partnership with Mariposa will enhance recruitment, promote research integrity (or ensure appropriateness of research methods), and facilitate dissemination of the study results into the community through education programs associated with Platicamos Salud and other community outreach efforts. PROJECT NARRATIVE The primary goal of this study is to assess sleep health among Mexican-Americans at the US/Mexico border, characterize relationships with cardiometabolic disease risk, and investigate the role of social-environmental factors including acculturation, stress, socioeconomics, and health behaviors. Short sleep duration, insomnia disorder, and sleep apnea are highly prevalent in the population. These conditions are associated with cardiovascular disease, diabetes, daytime functioning problems, and poor mental health. Disparities in sleep health in racial/ethnic minorities exist, including Mexican-Americans. In particular, social-environmental factors at the US-Mexico border may play an important role in sleep health disparities. This project will not only allow for increased understanding of the complex relationship among sleep, health, and social-environmental pressures, but through a community partnership it can maximize our ability to reduce these disparities. Also, this project has the added benefit of providing information about the role of sleep as a potentially modifiable factor in cardiovascular disease and diabetes disparities as well.",Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study,9827495,R01MD011600,"['Acculturation ', ' Cultural Assimilation ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Alcohols ', ' Alcohol Chemical Class ', ' Anthropometry ', ' Behavior ', ' Blood Pressure ', ' Blood Vessels ', ' vascular ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Cities ', ' Clinic Visits ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Community Developments ', ' Community Health Aides ', ' community health worker ', ' Diabetes Mellitus ', ' diabetes ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Economics ', ' Education ', ' Educational aspects ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Goals ', ' Health ', ' Health behavior ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' indexing ', ' Inflammation ', ' Interview ', ' Lipids ', ' High Density Lipoproteins ', ' HDL ', ' HDL Lipoproteins ', ' Heavy Lipoproteins ', ' High density lipoprotein ', ' alpha-Lipoproteins ', ' LDL Cholesterol Lipoproteins ', ' LDL Cholesterol ', ' Low Density Lipoprotein Cholesterol ', ' beta-Lipoprotein Cholesterol ', ' Medicine ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Mexican Americans ', ' Chicanas ', ' Chicanos ', ' Mexico ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Phenotype ', ' Play ', ' Poverty ', ' pressure ', ' Questionnaires ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Sleep ', ' Sleep Apnea Syndromes ', ' Sleep Apnea ', ' Sleep Hypopnea ', ' Sleep-Disordered Breathing ', ' sleep-related breathing disorder ', ' Sleep Deprivation ', ' deficient sleep ', ' inadequate sleep ', ' insufficient sleep ', ' sleep debt ', ' sleep deficiency ', ' sleep deficit ', ' sleep insufficiency ', ' sleep loss ', ' Sleep disturbances ', ' aberrant sleep ', ' disrupted sleep ', ' disturbed sleep ', ' impaired sleep ', ' poor sleep ', ' sleep disruption ', ' Smoking ', ' Social support ', ' social support network ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Weight Gain ', ' Weight Increase ', ' body weight gain ', ' body weight increase ', ' wt gain ', ' Work ', ' low density lipoprotein triglyceride ', ' LDL triglyceride ', ' LDL triglyceride lipoprotein ', ' triacylglycerol LDL ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Latino ', ' Community Health Centers ', ' Satellite Centers ', ' Neighborhood Health Center ', ' Research Methods ', ' Research Methodology ', ' Dataset ', ' Data Set ', ' base ', ' specimen collection ', ' sample collection ', ' Area ', ' Link ', ' Ensure ', ' Physical activity ', ' white American ', ' caucasian American ', ' Blood Serum ', ' Serum ', ' Individual ', ' Mexican ', ' Ethnicity ', ' Ethnic Origin ', ' Community Outreach ', ' Immigrant ', ' Metabolic ', ' machine learned ', ' Machine Learning ', ' diaries ', ' programs ', ' Adopted ', ' Hour ', ' Severities ', ' Complex ', ' Home ', ' Home environment ', ' Clinic ', ' Location ', ' Syndrome, Sleep Apnea, Obstructive ', ' Obstructive Sleep Apnea ', ' American ', ' experience ', ' stressor ', ' arterial stiffening ', ' artery stiffening ', ' artery stiffness ', ' arterial stiffness ', ' Participant ', ' disease risk ', ' disorder risk ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' social ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Regulation ', ' Modeling ', ' Functional impairment ', ' functional disability ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' actigraph ', ' actigraphy ', ' disparity in health ', ' health disparity ', ' Address ', ' Symptoms ', ' Data ', ' High Prevalence ', ' Intake ', ' Collection ', ' Non-Hispanic ', ' Nonhispanic ', ' Not Hispanic or Latino ', ' Monitor ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' Behavioral ', ' House Call ', ' home visit ', ' Home visitation ', ' IQ Deficit ', ' intelligence quotient deficit ', ' neurocognitive decline ', ' neurocognitive impairment ', ' Neurocognitive Deficit ', ' food security ', ' diet and exercise ', ' functional outcomes ', ' Outcome ', ' Population ', ' Prevalence ', ' Psychosocial Stress ', ' modifiable risk ', ' ethnic minority ', ' ethnic minority population ', ' racial and ethnic ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' community partnership ', ' reduce disparity ', ' disparity reduction ', ' recruit ', ' health assessment ', ' sleep hygiene ', ' sleep health ', ' cardiometabolic ', ' cardiometabolism ', ' sleep habit ', ' sleep behavior ', ' perceived stress ', ' social factors ', ' ']",NIMHD,UNIVERSITY OF ARIZONA,R01,2020,731043,0.14299264733359784
